Citrus Sinensis ID: 011617

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-
Protein Sequence
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccEEcccEEcccccccEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHccccccccEEEEcEEEEccEEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccEEccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccEEEEEEEccccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEccccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccEcc
Coil and Loop (DISEMBL)
mqesgkagnffknrvqsssfnnrkltrvrklrhvpddelgllmtdracspsaspdsarmspspgtsdhwsssavpkplplpdlaslfrkpessghgfespegrphrgrkstnqtakgsagflshfhkgdsqvlniesvkndlrpsvpvrstptslssshavspqrsnlqnptplhnpksistrrrgfshdlniecanyssradiipksaptsvfsspavspqssktgnvfssfwapkeiqdwstaevpdlgrfvgctspvspfkrnvysadhsplpspprqssqsnlrsprkvyfplrhkslpqnSKELLESnnhlnahplplppgalsppkssvtsavmphimekpsaspkksqwqkgkligrgtfgsvyigtnretgascaikevdiipddpksAECIKQLEQEIKVLGHLKHENIVQyygsevvddHLYIYLEYvhpgsinryVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Flexible Loop (DISEMBL)
mqesgkagnffknrvqsssfnnrkltrvrklrhvpddelgllmTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESsghgfespegrphrgrkSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRStptslssshavspqrsnlqnptplhnpksistrrrgFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSadhsplpspprqssqsnlrsPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMekpsaspkksqwqkGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILnglaylhstntihr
Low Complexity Region (SEG)
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHsplpspprqssqsnlrsprKVYFPLRHKSLPQNSKELLEsnnhlnahplplppgalsppKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Disordered region (IsUnstruct)
**********************************************************************************************************************************************************************************************LNIECANY******************************VFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVS*************************************************************************************************GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS******
Disordered Region (DISOPRED)
********************************************************************************************************************************************************************************************************************************************************************************************************************************************************************QKGKLIGRGTFGSVYIGTNRETGASCAIKEVD***************EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Disordered Region (DISEMBL)
********NFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRA**************************VPKPLPLPDLASLFRK**************************KGSAGFLSHFHKGDSQVLNIESVKNDLRPS***********************QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAP****************GNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYS********************PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL********SAVMPHIM*************KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Disordered Region (DISPRO)
*****************SSFNNRK*****KL********************************************************************************************************************************************************************************************************************************************************************************************************************************KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQESGKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	481	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	no	no	0.272	0.215	0.463	9e-27
Q99759	626	Mitogen-activated protein	yes	no	0.259	0.199	0.414	2e-24
Q61084	626	Mitogen-activated protein	yes	no	0.259	0.199	0.414	4e-24
Q9Y2U5	619	Mitogen-activated protein	no	no	0.278	0.216	0.413	4e-24
O22040	666	Mitogen-activated protein	no	no	0.259	0.187	0.449	9e-24
Q54R82	942	Mitogen-activated protein	no	no	0.261	0.133	0.395	4e-23
Q9FZ36	651	Mitogen-activated protein	no	no	0.328	0.242	0.377	8e-23
Q61083	619	Mitogen-activated protein	no	no	0.278	0.216	0.398	4e-22
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.261	0.191	0.407	1e-21
Q10407	1116	MAP kinase kinase kinase	no	no	0.259	0.112	0.406	1e-21

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  122 bits (305), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 63/136 (46%), Positives = 87/136 (63%), Gaps = 5/136 (3%)

Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           P      + WQKG+L+GRG+FGSVY G + + G   A+KEV ++    ++ ECI+QLE E
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRH 465
           IK+L  L+H+NIV+Y G+     +LYI+LE V  GS+ + Y R   RD   S+V  +TR 
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQ 439

Query: 466 ILNGLAYLHSTNTIHR 481
           IL+GL YLH    IHR
Sbjct: 440 ILDGLKYLHDKGFIHR 455

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  114 bits (284), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/128 (41%), Positives = 85/128 (66%), Gaps = 3/128 (2%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421

Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           E IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480

Query: 474 HSTNTIHR 481
           HS   +HR
Sbjct: 481 HSNMIVHR 488

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  113 bits (282), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 53/128 (41%), Positives = 85/128 (66%), Gaps = 3/128 (2%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421

Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           E IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480

Query: 474 HSTNTIHR 481
           HS   +HR
Sbjct: 481 HSNMIVHR 488

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  112 bits (281), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 57/138 (41%), Positives = 89/138 (64%), Gaps = 4/138 (2%)

Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405

Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
           EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464

Query: 464 RHILNGLAYLHSTNTIHR 481
           R IL G+ YLHS   +HR
Sbjct: 465 RQILEGVHYLHSNMIVHR 482

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  112 bits (279), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 58/129 (44%), Positives = 84/129 (65%), Gaps = 4/129 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGH 412
           W+KG+LIGRG FG+VY+G N ++G   A+K+V I  +     K+   I++LE+E+K+L +
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H NIV+Y G+   DD L I LE+V  GSI+  + E      ES+VR +TR +L GL Y
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEY 187

Query: 473 LHSTNTIHR 481
           LH+   +HR
Sbjct: 188 LHNHAIMHR 196

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  109 bits (273), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 51/129 (39%), Positives = 88/129 (68%), Gaps = 3/129 (2%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGH 412
           +WQKG+++GRG +GSVY+G N++TG   A+K+++I  I  DPK    I    +EI+V+  
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L+H+NIV+Y G+ +    L ++LEY+  GSI+  + +     +E++++ +T+ IL GL++
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 287

Query: 473 LHSTNTIHR 481
           LH+ + IHR
Sbjct: 288 LHANSIIHR 296

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  108 bits (271), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 99/175 (56%), Gaps = 17/175 (9%)

Query: 319 HPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS---------QWQKGKLIGRGTFGS 369
           HP P P    S     +TS +   ++   S SP  +         +W+KG+LIGRG FG+
Sbjct: 26  HPPPFP----SLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGT 81

Query: 370 VYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
           VY+G N ++G   A+K+V I  +     K+   I++LE+E+K+L +L H NIV+Y G+  
Sbjct: 82  VYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVR 141

Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            D+ L I LE+V  GSI+  + E      ES+VR +T  +L GL YLH+   +HR
Sbjct: 142 EDETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHR 195

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2

 Score =  106 bits (265), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 55/138 (39%), Positives = 87/138 (63%), Gaps = 4/138 (2%)

Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   P+ P++++ +  LE 
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPESPETSKEVNALEC 405

Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
           EI++L +L HE IVQYYG   +  +  L I++E    GSI   ++ +   +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMELSPGGSIKDQLKAYGA-LTENVTRKYT 464

Query: 464 RHILNGLAYLHSTNTIHR 481
           R IL G+ YLHS   +HR
Sbjct: 465 RQILEGVHYLHSNMIVHR 482

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  105 bits (261), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/130 (40%), Positives = 76/130 (58%), Gaps = 4/130 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLG 411
           +W +G LIG G+FG VY+G N  +G   A+K+V    +     + A+ +  L  EI +L 
Sbjct: 393 KWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALLQ 452

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            L HE+IVQY GS +  DHL I+LEYV  GS+   +  +     E++V+NF +  L GL 
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYG-SFEETLVKNFIKQTLKGLE 511

Query: 472 YLHSTNTIHR 481
           YLHS   +HR
Sbjct: 512 YLHSRGIVHR 521

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  104 bits (260), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 54/133 (40%), Positives = 76/133 (57%), Gaps = 8/133 (6%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQEIK 408
           +W KG+LIG GT+G V++  N  TG   A+K+V+I P       D    + +  +  EI 
Sbjct: 824 KWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEI-PQTINGRHDQLRKDIVDSINAEIS 882

Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           ++  L H NIVQY G E  +  + I+LEYV  GSI R +R +     E +VR  +R +L 
Sbjct: 883 MIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYG-PFEEQLVRFVSRQVLY 941

Query: 469 GLAYLHSTNTIHR 481
           GL+YLHS   IHR
Sbjct: 942 GLSYLHSKGIIHR 954

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
255538424	692	conserved hypothetical protein [Ricinus	0.916	0.637	0.515	4e-96
225470467	707	PREDICTED: uncharacterized protein LOC10	0.873	0.594	0.464	9e-89
225458499	782	PREDICTED: uncharacterized protein LOC10	0.602	0.370	0.592	3e-86
449470172	709	PREDICTED: uncharacterized protein LOC10	0.900	0.610	0.463	2e-80
255562635	709	conserved hypothetical protein [Ricinus	0.582	0.394	0.552	2e-75
449448516	760	PREDICTED: uncharacterized protein LOC10	0.904	0.572	0.396	1e-72
357465415	700	Mitogen-activated protein kinase kinase	0.823	0.565	0.401	6e-72
356565641	637	PREDICTED: uncharacterized protein LOC10	0.534	0.403	0.549	7e-72
449521088	604	PREDICTED: uncharacterized protein LOC10	0.577	0.460	0.513	6e-70
356553923	702	PREDICTED: MAP kinase kinase kinase mkh1	0.846	0.579	0.421	7e-69

>gi|255538424|ref|XP_002510277.1| conserved hypothetical protein [Ricinus communis] gi|223550978|gb|EEF52464.1| conserved hypothetical protein [Ricinus communis]

 Score =  358 bits (919), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 247/479 (51%), Positives = 299/479 (62%), Gaps = 38/479 (7%)

Query: 21  NNRKLTRVRKLRHVPDDELGLLMT-DRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLP 79
           N ++LTR RK+RH    +LGL  + DR  SP ASPDSAR   SP  S   SS A+P+PLP
Sbjct: 21  NTKRLTRQRKIRHETQQDLGLQFSQDRLNSPPASPDSARKPRSPPCSSSSSSPALPQPLP 80

Query: 80  LPDLASLFRKPESSG----HGF-ESPEGRP--HRGRKSTNQ----TAKGSAGFLSHFHKG 128
           LP+ +   R+ E  G    H    SPE RP     R S +Q    +A GS+ F   F   
Sbjct: 81  LPE-SHFTRRLEPFGFIPGHAVPASPEERPIYLLRRNSADQVDINSATGSSNFQWRFSPQ 139

Query: 129 DSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNP----KSISTRR 184
           D    N+++  + LR ++  RS P    SS  VSP+RSN    +   N     K   T  
Sbjct: 140 DP---NVDTANHGLRLNIAPRSAP----SSPLVSPRRSNAGEFSTTFNAADSTKCSKTCC 192

Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
           +G  +DLNIEC NY       P+SAPTS FSSP VSPQ S T +   SF A         
Sbjct: 193 KGQLNDLNIECVNYKLSWIDSPRSAPTSGFSSPNVSPQRSYTIDFLPSFVA--------- 243

Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
            EVPDLGR  G TS  S  K      D S +  P +QS   N + P K  F L +K    
Sbjct: 244 REVPDLGRHAGHTSRKSLVKTG-NGLDRSAI-YPSQQSPTPNKKPPHKFSFQLHNKMFVG 301

Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
            SKE  E+N+  +AHPLPLPPGA SP +S + S  A++ H +EKP+ S +K+QW KGKLI
Sbjct: 302 KSKEWPETNSQFSAHPLPLPPGAASP-QSFIPSPPAILHHTIEKPNVSLRKTQWLKGKLI 360

Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
           GRGT+GSVY+GTNRETGA CA+KEVDIIP D KS ECIKQLEQEI++L HL+H NIVQYY
Sbjct: 361 GRGTYGSVYVGTNRETGALCAMKEVDIIPGDSKSVECIKQLEQEIRLLQHLEHPNIVQYY 420

Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             E+VDDH YIYLEYV+PGSI++YVREHC  +TESIVRNFTRHIL+GLAYLHS  TIHR
Sbjct: 421 SCEIVDDHFYIYLEYVYPGSISKYVREHCGAMTESIVRNFTRHILSGLAYLHSKKTIHR 479

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera]

 Score =  333 bits (855), Expect = 9e-89,   Method: Compositional matrix adjust.
 Identities = 217/467 (46%), Positives = 270/467 (57%), Gaps = 47/467 (10%)

Query: 25  LTRVRKLRHVPDDELGLLMTDRACS-PSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
           LTR RKLRHV  + +  L+  R+ + P         S S   S    SS VP PLP P+L
Sbjct: 25  LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84

Query: 84  ASLFRKPESSGHGF--ESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKND 141
           A LFR+   S      + P   P  G          S GF     KG+S V        D
Sbjct: 85  ALLFRRNGGSNSNLNCDRPLPSPKEGL---------SRGFEDR-DKGNSFV-------GD 127

Query: 142 LRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPL------HNPKSISTRRRGFSHDLNIEC 195
               V V ST T   S    +  R +++    L          S+   R  F        
Sbjct: 128 GNGEVAVSSTATG--SKVGYNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNF-------- 177

Query: 196 ANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF-SSFWAPKEIQDWSTAEVPDLGRFV 254
                + D+  +SAPTS  SSPAVSPQ +  GN+F S   +P+  Q WS  E+P      
Sbjct: 178 -----KLDVPTRSAPTSSLSSPAVSPQRTSPGNLFLSQNVSPQVFQGWSAPEMPVFDMVT 232

Query: 255 GCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNN 314
           G T  +SP ++ ++S D+SPL SP  +S   N RSP     PL  K   + S    E+N+
Sbjct: 233 GFTPQMSP-EQTMFSTDNSPLHSPTVKSPHVNPRSPSGPASPLHPKISLETSTARRENNS 291

Query: 315 HLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
           H N H LPLPPG ++PP++S   ++ P ++ K  + P  +QWQKGKLIGRGTFGSVY+ T
Sbjct: 292 HANVHRLPLPPGVVAPPQAS---SIHP-VIAKTESFPMTTQWQKGKLIGRGTFGSVYVAT 347

Query: 375 NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434
           NRETGA CA+KEV+++PDDPKSAE IKQLEQEIK+L  LKH NIVQY+GSE V+D LYIY
Sbjct: 348 NRETGALCAMKEVELLPDDPKSAESIKQLEQEIKILSQLKHPNIVQYFGSETVEDRLYIY 407

Query: 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           LEYVHPGSIN+YVREHC  ITES+VRNFTRHIL+GLAYLHST TIHR
Sbjct: 408 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSTKTIHR 454

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458499|ref|XP_002282240.1| PREDICTED: uncharacterized protein LOC100257467 [Vitis vinifera]

 Score =  325 bits (833), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 183/309 (59%), Positives = 214/309 (69%), Gaps = 19/309 (6%)

Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
           RGFS DLN E   Y+ R +I  +SAPTS FSSPA+SPQ    G    S +A   IQD+ +
Sbjct: 228 RGFSQDLNDEACPYNLRVNIPARSAPTSGFSSPALSPQRFSPGERLPSSYA--AIQDFQS 285

Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNL----RSPRKVYFPLRHK 300
              P   R  GC+S +SP K   ++ D+SPL SP  QS   +     +SP  + F L  K
Sbjct: 286 ---PGFDRLPGCSSQMSPLK-TPHTPDYSPLHSPTVQSPCISPCLSPKSPTGIAFSLYPK 341

Query: 301 SLPQNSKELLESNNHLNAHPLPLPPGALSP-----PKSSVT---SAVMPHIMEKPSASPK 352
            LP +     E N H+  HPLPLPP AL P     P  ++T   SA+  H  EKP+    
Sbjct: 342 LLPGSHVTWPEKNGHVTVHPLPLPPIALMPSELPLPPKALTPSESAISHHTAEKPNVPSM 401

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           KSQWQKGKLIGRGTFGSVY+ TNRETGA CA+KEVDIIPDDPKS+ECIKQLEQEIKVL H
Sbjct: 402 KSQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVDIIPDDPKSSECIKQLEQEIKVLHH 461

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           LKH NIVQYYGSE+VDDH YIYLEYVHPGSIN+YV +H   +TE++VRNFTRHIL+GLAY
Sbjct: 462 LKHPNIVQYYGSEIVDDHFYIYLEYVHPGSINKYV-DHFGAMTENVVRNFTRHILSGLAY 520

Query: 473 LHSTNTIHR 481
           LHST TIHR
Sbjct: 521 LHSTKTIHR 529

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449470172|ref|XP_004152792.1| PREDICTED: uncharacterized protein LOC101219854 [Cucumis sativus]

 Score =  305 bits (782), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 222/479 (46%), Positives = 282/479 (58%), Gaps = 46/479 (9%)

Query: 20  FNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSP----GTSDHWSSSAVP 75
           F  R+LTR RKLRH+ D ++G         P + PDS  +S  P    G S+ WSSS  P
Sbjct: 38  FIQRRLTRQRKLRHLTDQDVGFE------HPRSLPDSPDISAKPKSPLGGSERWSSSPSP 91

Query: 76  KPLPLPDLASLFRKPESSGHGFESPEGRPHRG--RKSTNQTAKGSAGFLSHFHKGDSQVL 133
           +PLPLP+L  + R PE   +  +   G P     RK ++      +    H  +  +  L
Sbjct: 92  QPLPLPELFPV-RSPEFGSNYGQGRVGSPVETSVRKCSDHATTNVSRSFGHNQRRVATDL 150

Query: 134 NIESVKNDLRPSVPVRSTPTSLSS-SHAVSPQRSNL---QNPTPLHNPKSISTRRRGFSH 189
            +E V  + R      ++P SLS+ S  ++P +  L    + TP       + + RG   
Sbjct: 151 TLEVVDGNSRTGATAFTSPQSLSANSGKLNPNKEFLFGCSDQTP-------NNKGRGSPT 203

Query: 190 DLNIECANYSSRADIIPK-----SAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
             + E  NY    ++ PK     SAPTS+  SP VSP+ S  GN F    +  E Q+  +
Sbjct: 204 HPSAERGNY----NLTPKKSSSKSAPTSILPSPVVSPRKSYNGNHFVPGLSHHEHQESPS 259

Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
                        SP  P  +   S+   PL SP  +SS SN RS   + FPL  K    
Sbjct: 260 N-----------NSPKVPPLKTALSSQPFPLHSPTARSSISNSRSHNDMTFPLHTKLQKD 308

Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
           NS +  ES+ H+NAHPLPLPP  ++  ++S  S  + + H++EKP  S  K QWQKGKLI
Sbjct: 309 NSIDRSESHAHVNAHPLPLPPPLVASSQASAQSLPSNVHHVIEKPFISSMKGQWQKGKLI 368

Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
           GRGTFGSVY+ TNRETGA CA+KEVD+IPDDPKSAECIKQLEQEI+VL HLKH NIVQYY
Sbjct: 369 GRGTFGSVYLATNRETGALCAMKEVDLIPDDPKSAECIKQLEQEIEVLSHLKHPNIVQYY 428

Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           GSE++ D  YIYLEYV+PGSIN+YVRE C  ITESIVRNFTRHIL+GLAYLHST TIHR
Sbjct: 429 GSEIIGDCFYIYLEYVYPGSINKYVRERCGAITESIVRNFTRHILSGLAYLHSTKTIHR 487

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis]

 Score =  289 bits (740), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 163/295 (55%), Positives = 198/295 (67%), Gaps = 15/295 (5%)

Query: 190 DLNIE-CANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFW--APKEIQDWSTAE 246
           D +++ CA+YS R +   +SAPTS FSSP    Q   T   F  ++    K  Q WS  E
Sbjct: 216 DFSVDHCADYS-RINAPIRSAPTSPFSSP----QKLTTAADFLPYYQMIAKGNQVWSAPE 270

Query: 247 VPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNS 306
           +  L   +    P + F    +S D SPL SPP +S + N +SP      L  +   + S
Sbjct: 271 MATLD--IPGLPPPAFFDYTAFSTDTSPLHSPPSRSPRRNPKSPTGGPASLNARLSIETS 328

Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 366
           +E    N +L  HPLPLPPGA S       S+ +P ++ K  + P KSQWQKGKLIGRGT
Sbjct: 329 REC---NANLEVHPLPLPPGASS--SRPSISSSVPQVISKAESIPLKSQWQKGKLIGRGT 383

Query: 367 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
           FGSVY+ +NRETGA CA+KEVD+ PDDPKSAE IKQLEQEIKVL HLKH NIVQYYGSE+
Sbjct: 384 FGSVYVASNRETGALCAMKEVDMFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI 443

Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           V DH YIYLEYVHPGSIN+YVREHC  ITE++VR+F+RHIL+GLAYLHS  TIHR
Sbjct: 444 VGDHFYIYLEYVHPGSINKYVREHCGAITENVVRSFSRHILSGLAYLHSMKTIHR 498

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus]

 Score =  280 bits (716), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 203/512 (39%), Positives = 274/512 (53%), Gaps = 77/512 (15%)

Query: 5   GKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPG 64
           G A N ++  V    F   + +R RKLR++   E   + +  A     +P+   +S SP 
Sbjct: 36  GSAENNYRGIVWR--FGASRYSRHRKLRNLSGREH--VDSSLAKWSDTAPEPVSLSRSPS 91

Query: 65  TSDHWSSSAVPKPLPLPDLASLFRKPE------SSGHGFESPEGRPHRGRKSTNQTAKGS 118
           TSDH    AVP  LPLP+++ LF+  E      S+G   + P   P           KGS
Sbjct: 92  TSDH---PAVP--LPLPEVSPLFQPRERISTSNSAGGEGDCPLPSP-----------KGS 135

Query: 119 AGFLSHFHKGDSQVLNI------ESVKNDLRPSVPVRSTPTSLSSSHA----VSPQRSNL 168
            G       GD + ++       + +   + P+  ++S   S+   H     +  + S  
Sbjct: 136 RG-----RAGDERDVDRDRNAPPQKIGGGISPNASIKSVSDSVGERHKKEGQIEARLSGR 190

Query: 169 QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGN 228
            N      P++    R GF               D+  +SAPTS ++SP  SPQ + +GN
Sbjct: 191 ANQDARRYPEN---SRNGF-------------WIDVPSRSAPTSPYTSPTPSPQRNISGN 234

Query: 229 VFS-SFWAPKEIQDWSTAEVPD-------LGRFVGCTS--PVSPFKRNV---------YS 269
           + +  + +P   Q WS  E+P+       +G  V      P S   R V          S
Sbjct: 235 ISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLS 294

Query: 270 ADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALS 329
            + SP+ SP  +S   + RSP     PL  K   +      E + H++ HPLPLPPG   
Sbjct: 295 TESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPM 354

Query: 330 PPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI 389
           P  SS ++ +     +  S S  K+QWQKGKLIGRGTFGSVY+ +NR+ GA CA+KEV++
Sbjct: 355 PSASSPSTPISQANTKSESIS-MKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVEL 413

Query: 390 IPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE 449
             DDPKSAE IKQLEQEIK+L  LKH NIVQYYGS+++DD LYIYLEYVHPGSIN+YVRE
Sbjct: 414 FHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVRE 473

Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           HC  +TES+VRNFTRHIL+GLAYLHST TIHR
Sbjct: 474 HCGAMTESVVRNFTRHILSGLAYLHSTKTIHR 505

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357465415|ref|XP_003602992.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355492040|gb|AES73243.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  278 bits (710), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 191/476 (40%), Positives = 254/476 (53%), Gaps = 80/476 (16%)

Query: 20  FNNRKLTRVRKLRHVPDDELG--LLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKP 77
              R+LTR ++L +  D ++G     TD A S S        SP   +SDHWS+SAVP+P
Sbjct: 23  IQQRRLTRQKRLCYPNDQDVGESFHSTDVAVSFSLP-----TSPYRTSSDHWSTSAVPQP 77

Query: 78  LPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIES 137
           LPLP+     R+P+   H    P  R       T ++ + S+    HF    +      +
Sbjct: 78  LPLPESPLTTRRPDH--HAAALPFSRK-SADHDTVRSLRSSSNLGRHFFNTVTG-----N 129

Query: 138 VKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECAN 197
            K+DLR ++P               P R        L +  S     R  SHD + E  +
Sbjct: 130 AKSDLRVNIP---------------PTRG-------LVSSNSSCKDTRKHSHDNDCEGIS 167

Query: 198 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDW------STAEVPDL 250
            +S+     KSAP S+FSSP  SP+   + ++   S   P++  D        TA  PDL
Sbjct: 168 -NSKLQFAAKSAPNSIFSSPVTSPRRLSSVDLLDPSIILPQDFNDMFRVLPAKTAHSPDL 226

Query: 251 G--RFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKE 308
              R  G  SP +  +  +               SQ + +   +V+              
Sbjct: 227 SPRRSFGNHSPANHHRHTIQGG------------SQQHSKFCTRVW-------------- 260

Query: 309 LLESNNHLNAHPLPLPPGALSPPKSS---VTSAVMPHIMEKPSASPKKSQWQKGKLIGRG 365
               NNHL+AHPLPLPP A   P+ S    +S  M H  E   +   K  WQKGKLIGRG
Sbjct: 261 --PENNHLDAHPLPLPPRASPQPQQSPAHQSSVTMNHSTENIHS--MKGHWQKGKLIGRG 316

Query: 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425
           +FGSVY  TN ETGASCA+KEVD++PDDPKS +CIKQL+QEI++LG L H NIV+YYGSE
Sbjct: 317 SFGSVYHATNLETGASCALKEVDLVPDDPKSTDCIKQLDQEIRILGQLHHPNIVEYYGSE 376

Query: 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           VV D L IY+EYVHPGS+ +++++HC  +TES+VRNFTRHIL+GLAYLHST TIHR
Sbjct: 377 VVGDRLCIYMEYVHPGSLQKFMQDHCGVMTESVVRNFTRHILSGLAYLHSTKTIHR 432

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max]

 Score =  277 bits (709), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 156/284 (54%), Positives = 189/284 (66%), Gaps = 27/284 (9%)

Query: 212 SVFSSPAVSPQSSKTGNVFSSFWA-PKEIQDWSTAEVP--DLGRFVGCTSPVSPFKRNVY 268
           S+  SP++SPQ ++ G+    ++A PK  Q WST E+P  D G       P + F  +  
Sbjct: 161 SISGSPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDAGLL-----PPAFFDLSAL 215

Query: 269 SADHSPLP----SPPRQSSQSNLRS---PRKVYFPLRHKSLPQNSKELLESNNH--LNAH 319
           S + S  P    SP R+S Q + R+   P     P+    +P    E    NN   +  H
Sbjct: 216 STETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHE----NNAPPVAVH 271

Query: 320 PLPLPP--GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRE 377
           PLPLPP  G  SPP     +A   H M K  + P KSQW+KGKLIGRGTFGSVY+ TNRE
Sbjct: 272 PLPLPPRAGLTSPP----AAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRE 327

Query: 378 TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437
           TGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D  YIYLEY
Sbjct: 328 TGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEY 387

Query: 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           VHPGSIN+YVR+HC  ITES++RNFTRHIL+GLAYLHS  TIHR
Sbjct: 388 VHPGSINKYVRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHR 431

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus]

 Score =  271 bits (693), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 153/298 (51%), Positives = 193/298 (64%), Gaps = 20/298 (6%)

Query: 203 DIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDWSTAEVPD-------LGRFV 254
           D+  +SAPTS ++SP  SPQ + +GN+ +  + +P   Q WS  E+P+       +G  V
Sbjct: 53  DVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHV 112

Query: 255 GCTS--PVSPFKRNV---------YSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLP 303
                 P S   R V          S + SP+ SP  +S   + RSP     PL  K   
Sbjct: 113 WSAPELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISH 172

Query: 304 QNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIG 363
           +      E + H++ HPLPLPPG   P  SS ++ +     +  S S  K+QWQKGKLIG
Sbjct: 173 ETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESIS-MKNQWQKGKLIG 231

Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423
           RGTFGSVY+ +NR+ GA CA+KEV++  DDPKSAE IKQLEQEIK+L  LKH NIVQYYG
Sbjct: 232 RGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYG 291

Query: 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           S+++DD LYIYLEYVHPGSIN+YVREHC  +TES+VRNFTRHIL+GLAYLHST TIHR
Sbjct: 292 SDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHR 349

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553923|ref|XP_003545300.1| PREDICTED: MAP kinase kinase kinase mkh1-like [Glycine max]

 Score =  267 bits (683), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 200/474 (42%), Positives = 264/474 (55%), Gaps = 67/474 (14%)

Query: 24  KLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
           +LTR RKLRH+   ++G   +D +      P+      S   SDH S SA+P+PLPLP+ 
Sbjct: 29  RLTRQRKLRHLTHQDIGFFHSDESSFLPGLPEFR----SHAGSDHRSFSALPQPLPLPE- 83

Query: 84  ASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLR 143
           A L R+ +S            +R R S++    G A   S  ++        E+V    +
Sbjct: 84  APLTRRAKSIS------SSSVNRRRLSSSLEQHGFAISRSTVYQ--------EAVART-K 128

Query: 144 PSVPVRSTPTSLSSSHAVSPQRSNLQNPTP---LHNPKSISTRRRGFSHDLNIEC---AN 197
           P++ +  +    + ++A      NL+  TP        S    RR  SHD + E      
Sbjct: 129 PTLNLDKSCLDSTLANA----NYNLREHTPAASFLTGNSSWKNRRAVSHDDDSEGNSHLK 184

Query: 198 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCT 257
           Y   A   PKSAPTSV +SP  SP   ++ NV   F+ P    ++S  EV D  + +   
Sbjct: 185 YGVAAK--PKSAPTSVLTSPDTSP--CRSSNV--DFFDPTA--NFSL-EVNDKSKMLSAK 235

Query: 258 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 317
           +  SP + ++    H PL       S +   +P+       HK L +   E    NN L+
Sbjct: 236 TVHSPDQFSI----HCPL-------SLTRYFNPKIEEGSQNHKFLSRVCPE----NNLLD 280

Query: 318 AHPLPLPPGALSPPKSSVT---------SAVMPHIMEK-PSASPKKSQWQKGKLIGRGTF 367
           +HPLPLPP A SP + SV          S++M H  E  PS    K +WQKGKLIGRGTF
Sbjct: 281 SHPLPLPPRASSPEQLSVVLHQSSTMNQSSIMHHATENLPSV---KGRWQKGKLIGRGTF 337

Query: 368 GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427
           GSV+  TN ETGASCA+KEV++I DDP SAECIKQLEQEIK+L  L H NIVQYYGSE V
Sbjct: 338 GSVFHATNIETGASCAMKEVNLIHDDPTSAECIKQLEQEIKILRQLHHPNIVQYYGSETV 397

Query: 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            DHLYIY+EYV+PGSI++++REHC  +TES+V NFTRHIL+GLAYLHS  TIHR
Sbjct: 398 GDHLYIYMEYVYPGSISKFMREHCGAMTESVVCNFTRHILSGLAYLHSNKTIHR 451

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.309	0.208	0.677	3.3e-69
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.307	0.167	0.533	3.4e-44
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.264	0.208	0.562	8.5e-40
ZFIN|ZDB-GENE-120215-96	623	si:dkey-32h20.5 "si:dkey-32h20	0.301	0.232	0.405	1.2e-23
ASPGD|ASPL0000071053	1558	bckA [Emericella nidulans (tax	0.278	0.086	0.425	2.2e-23
UNIPROTKB|F1M9D0	618	Map3k2 "Protein Map3k2" [Rattu	0.278	0.216	0.413	8e-23
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.257	0.203	0.480	1e-22
UNIPROTKB|F1MH06	626	MAP3K3 "Uncharacterized protei	0.278	0.214	0.405	2e-22
UNIPROTKB|Q9Y2U5	619	MAP3K2 "Mitogen-activated prot	0.278	0.216	0.413	2.1e-22
UNIPROTKB|E2RN16	620	MAP3K2 "Uncharacterized protei	0.278	0.216	0.413	2.1e-22

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 3.3e-69, Sum P(2) = 3.3e-69
 Identities = 101/149 (67%), Positives = 122/149 (81%)

Query:   333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
             SS  S   P    K  + P  SQW+KGKLIGRGTFGSVY+ +N ETGA CA+KEV++ PD
Sbjct:   323 SSAASVPSPQAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPD 382

Query:   393 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
             DPKSAECIKQLEQEIK+L +L+H NIVQY+GSE V+D  +IYLEYVHPGSIN+Y+R+HC 
Sbjct:   383 DPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCG 442

Query:   453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +TES+VRNFTRHIL+GLAYLH+  T+HR
Sbjct:   443 TMTESVVRNFTRHILSGLAYLHNKKTVHR 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 410 (149.4 bits), Expect = 3.4e-44, Sum P(2) = 3.4e-44
 Identities = 80/150 (53%), Positives = 108/150 (72%)

Query:   333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
             S+ TS  +P    +  A+    S+W+KG+L+G G+FG VY+G N E+G  CA+KEV +  
Sbjct:   376 SAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCS 435

Query:   392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
             DDPKS E  +QL QEI VL  L+H+NIVQYYGSE VDD LYIYLEYV  GSI + ++E+ 
Sbjct:   436 DDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYG 495

Query:   452 RDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +   E+ +RN+T+ IL+GLAYLH+ NT+HR
Sbjct:   496 Q-FGENAIRNYTQQILSGLAYLHAKNTVHR 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 387 (141.3 bits), Expect = 8.5e-40, Sum P(2) = 8.5e-40
 Identities = 72/128 (56%), Positives = 93/128 (72%)

Query:   354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             S W+KGK +G GTFG VY+G N E G  CAIKEV +I DD  S EC+KQL QEI +L  L
Sbjct:   212 STWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQL 271

Query:   414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
              H NIVQYYGSE+ ++ L +YLEYV  GSI++ ++++    TE +++N+TR IL GLAYL
Sbjct:   272 CHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYL 330

Query:   474 HSTNTIHR 481
             H  NT+HR
Sbjct:   331 HGRNTVHR 338

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

ZFIN|ZDB-GENE-120215-96 si:dkey-32h20.5 "si:dkey-32h20.5" [Danio rerio (taxid:7955)]

 Score = 284 (105.0 bits), Expect = 1.2e-23, Sum P(3) = 1.2e-23
 Identities = 62/153 (40%), Positives = 97/153 (63%)

Query:   333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
             S+ T +VM   +  PS SP+  + W+ GKL+G+G FG V++  + +TG   A+K+V   P
Sbjct:   340 SNPTLSVMD--ISPPSRSPRAPTNWRLGKLLGQGAFGRVFLCYDADTGRELAVKQVQFDP 397

Query:   392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH---LYIYLEYVHPGSINRYVR 448
             D P++++ +  LE EI++L +L HE IVQYYG  + D H   L I++EY+  GSI   ++
Sbjct:   398 DSPETSKEVSALECEIQLLKNLFHERIVQYYGC-LRDTHEKTLSIFMEYMPGGSIKDQLK 456

Query:   449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +   +TE++ R +TR IL G+ YLHS   +HR
Sbjct:   457 SYGA-LTENVTRKYTRQILEGVCYLHSNMIVHR 488

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

ASPGD|ASPL0000071053 bckA [Emericella nidulans (taxid:162425)]

 Score = 277 (102.6 bits), Expect = 2.2e-23, Sum P(3) = 2.2e-23
 Identities = 60/141 (42%), Positives = 86/141 (60%)

Query:   346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECI 400
             KP   P   +  +G+LIG+GT+G VY+G N + G   A+K+V+I P     D  K  E +
Sbjct:  1257 KPQRQPT-FRIIRGQLIGKGTYGRVYLGMNADNGEVLAVKQVEINPRLAGQDTDKIKEMV 1315

Query:   401 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
               L+QEI  + HL+H NIVQY G E  +  + IYLEY+  GSI   +R+H +   ES+V+
Sbjct:  1316 AALDQEIDTMQHLEHPNIVQYLGCERGELSISIYLEYISGGSIGSCLRKHGK-FEESVVK 1374

Query:   461 NFTRHILNGLAYLHSTNTIHR 481
             + TR  L GL+YLH+   +HR
Sbjct:  1375 SLTRQTLEGLSYLHNQGILHR 1395

GO:0005575 "cellular_component" evidence=ND

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0070370 "cellular heat acclimation" evidence=IEA

GO:0030448 "hyphal growth" evidence=IEA

GO:0048021 "regulation of melanin biosynthetic process" evidence=IEA

UNIPROTKB|F1M9D0 Map3k2 "Protein Map3k2" [Rattus norvegicus (taxid:10116)]

 Score = 277 (102.6 bits), Expect = 8.0e-23, Sum P(2) = 8.0e-23
 Identities = 57/138 (41%), Positives = 89/138 (64%)

Query:   347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
             PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct:   345 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPDSPETSKEVNALEC 404

Query:   406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct:   405 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 463

Query:   464 RHILNGLAYLHSTNTIHR 481
             R IL G+ YLHS   +HR
Sbjct:   464 RQILEGVHYLHSNMIVHR 481

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 288 (106.4 bits), Expect = 1.0e-22, Sum P(2) = 1.0e-22
 Identities = 62/129 (48%), Positives = 86/129 (66%)

Query:   354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             + WQKG+L+GRG+FGSVY G + + G   A+KEV ++    ++ ECI+QLE EIK+L  L
Sbjct:   331 TSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389

Query:   414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAY 472
             +H+NIV+Y G+     +LYI+LE V  GS+ + Y R   RD   S+V  +TR IL+GL Y
Sbjct:   390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQILDGLKY 446

Query:   473 LHSTNTIHR 481
             LH    IHR
Sbjct:   447 LHDKGFIHR 455

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 279 (103.3 bits), Expect = 2.0e-22, Sum P(2) = 2.0e-22
 Identities = 56/138 (40%), Positives = 89/138 (64%)

Query:   347 PSASPKKS-QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
             P+ SP     W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE 
Sbjct:   352 PTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411

Query:   406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             EI++L +L+HE IVQYYG   +  +  L I++EY+  GS+   ++ +   +TES+ R +T
Sbjct:   412 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 470

Query:   464 RHILNGLAYLHSTNTIHR 481
             R IL G++YLHS   +HR
Sbjct:   471 RQILEGMSYLHSNMIVHR 488

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q9Y2U5 MAP3K2 "Mitogen-activated protein kinase kinase kinase 2" [Homo sapiens (taxid:9606)]

 Score = 277 (102.6 bits), Expect = 2.1e-22, Sum P(2) = 2.1e-22
 Identities = 57/138 (41%), Positives = 89/138 (64%)

Query:   347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
             PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct:   346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405

Query:   406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct:   406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464

Query:   464 RHILNGLAYLHSTNTIHR 481
             R IL G+ YLHS   +HR
Sbjct:   465 RQILEGVHYLHSNMIVHR 482

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEP

GO:0019901 "protein kinase binding" evidence=IPI

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IDA

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0007257 "activation of JUN kinase activity" evidence=TAS

GO:0004672 "protein kinase activity" evidence=IDA

UNIPROTKB|E2RN16 MAP3K2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 277 (102.6 bits), Expect = 2.1e-22, Sum P(2) = 2.1e-22
 Identities = 57/138 (41%), Positives = 89/138 (64%)

Query:   347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
             PS SP+  + W+ GKL+G+G FG VY+  + +TG   A+K+V   PD P++++ +  LE 
Sbjct:   347 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 406

Query:   406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             EI++L +L HE IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +T
Sbjct:   407 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 465

Query:   464 RHILNGLAYLHSTNTIHR 481
             R IL G+ YLHS   +HR
Sbjct:   466 RQILEGVHYLHSNMIVHR 483

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	481
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	0.001
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.001
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.003
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.004
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.004
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.004

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  174 bits (444), Expect = 2e-51
 Identities = 61/126 (48%), Positives = 85/126 (67%), Gaps = 1/126 (0%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+KG+L+G G+FGSVY G N + G   A+KEV +  D     E +KQLEQEI +L  L+H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIVQY G+E  +D+LYI+LE V  GS+ + ++++     E ++R +TR IL GL YLH 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120

Query: 476 TNTIHR 481
            NT+HR
Sbjct: 121 RNTVHR 126

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  157 bits (400), Expect = 7e-45
 Identities = 56/129 (43%), Positives = 84/129 (65%), Gaps = 6/129 (4%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +W +G+L+GRG+FGSVY+  +++TG   A+K V++  D  +  E    LE+EI++L  L+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57

Query: 415 HENIVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           H NIV+YYGSE     + L I+LEYV  GS+   + +    + E ++R +TR IL GLAY
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116

Query: 473 LHSTNTIHR 481
           LHS   +HR
Sbjct: 117 LHSNGIVHR 125

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  134 bits (340), Expect = 2e-36
 Identities = 41/126 (32%), Positives = 69/126 (54%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  + +G G+FG VY+  +++TG   AIK +             +++ +EIK+L  LKH
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD----RERILREIKILKKLKH 56

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+ Y     +D LY+ +EY   G +   +++  R ++E   R + R IL+ L YLHS
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHS 115

Query: 476 TNTIHR 481
              +HR
Sbjct: 116 KGIVHR 121

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 8e-36
 Identities = 53/126 (42%), Positives = 84/126 (66%), Gaps = 1/126 (0%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W++GKL+G+G FG VY+  + +TG   A+K+V   PD P++ + +  LE EI++L +L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           E IVQYYG    D+ L I++EY+  GS+   ++ +   +TE++ R +TR IL G+ YLHS
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS 122

Query: 476 TNTIHR 481
              +HR
Sbjct: 123 NMIVHR 128

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  129 bits (326), Expect = 2e-34
 Identities = 58/127 (45%), Positives = 83/127 (65%), Gaps = 4/127 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +WQ+G  IG GTFG VY   N +TG   A+KE+ I  +DPK+   IK++  E+KVL  LK
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H N+V+YYG EV  + +YI++EY   G++   + EH R + E ++R +T  +L GLAYLH
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 117 SHGIVHR 123

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  128 bits (324), Expect = 5e-34
 Identities = 58/131 (44%), Positives = 79/131 (60%), Gaps = 6/131 (4%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQEIKVL 410
           W KG+LIG+GT+G VY+  N  TG   A+K+V++        D +  + +K L  EI+ L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L H NIVQY G E  +++L I+LEYV  GSI   +R + R   E +VR FT  +L GL
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGL 121

Query: 471 AYLHSTNTIHR 481
           AYLHS   +HR
Sbjct: 122 AYLHSKGILHR 132

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  123 bits (312), Expect = 2e-32
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 4/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  + +G G+FG+VY   ++ TG   A+K +       KS +      +EI++L  L H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTAR-REIRILRRLSH 57

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +    DHLY+ +EY   G +  Y+      ++E   +     IL GL YLHS
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHS 116

Query: 476 TNTIHR 481
              IHR
Sbjct: 117 NGIIHR 122

Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-32
 Identities = 56/127 (44%), Positives = 74/127 (58%), Gaps = 4/127 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
            +Q G LIGRG FG VY G N ETG   AIK++ +     + A  +K + QEI +L +LK
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEA--LKSIMQEIDLLKNLK 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NIV+Y GS    D LYI LEY   GS+ + +++      ES+V  +   +L GLAYLH
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLH 116

Query: 475 STNTIHR 481
               IHR
Sbjct: 117 EQGVIHR 123

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  120 bits (303), Expect = 1e-31
 Identities = 43/120 (35%), Positives = 69/120 (57%), Gaps = 4/120 (3%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G FG+VY+  +++TG   AIK +        S+  +++L +EI++L  L H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YG    ++HLY+ +EY   GS+   ++E+   ++E  +      IL GL YLHS   IHR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (301), Expect = 8e-31
 Identities = 58/131 (44%), Positives = 79/131 (60%), Gaps = 5/131 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDDPKSAECIKQLEQEIKVL 410
           +W KG LIG G+FGSVY+G N  +G   A+K+V++         +    +  L +EI +L
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L+HENIVQY GS +  DHL I+LEYV  GS+   +  +     E++VRNF R IL GL
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119

Query: 471 AYLHSTNTIHR 481
            YLH+   IHR
Sbjct: 120 NYLHNRGIIHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (281), Expect = 4e-28
 Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  + IG+G FG VY   ++ TG   AIK + +     +S E  +++  EI++L   KH
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+YYGS +  D L+I +E+   GS+   ++   + +TES +    + +L GL YLHS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 476 TNTIHR 481
              IHR
Sbjct: 117 NGIIHR 122

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  105 bits (264), Expect = 8e-26
 Identities = 53/130 (40%), Positives = 85/130 (65%), Gaps = 7/130 (5%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W++GKL+G+G FG VY+  + +TG   A K+V   P+ P++++ +  LE EI++L +L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 416 ENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
           E IVQYYG   + D     L I++EY+  GS+   ++ +   +TES+ R +TR IL G++
Sbjct: 64  ERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMS 120

Query: 472 YLHSTNTIHR 481
           YLHS   +HR
Sbjct: 121 YLHSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (263), Expect = 1e-25
 Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 7/121 (5%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
            +G G++GSVY   ++ETG   AIK V +  D       ++++ +EI +L       IV+
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVK 62

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           YYGS   +  L+I +EY   GS++  ++   + +TE  +       L GL YLHS   IH
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 481 R 481
           R
Sbjct: 123 R 123

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  103 bits (259), Expect = 3e-25
 Identities = 51/130 (39%), Positives = 86/130 (66%), Gaps = 3/130 (2%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           + W+ GKL+G+G FG VY+  + +TG   A+K+V   P+ P++++ +  LE EI++L +L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 414 KHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            HE IVQYYG   + ++  L I++E++  GSI   ++ +   +TE++ R +TR IL G++
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVS 120

Query: 472 YLHSTNTIHR 481
           YLHS   +HR
Sbjct: 121 YLHSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 5e-25
 Identities = 45/120 (37%), Positives = 63/120 (52%), Gaps = 5/120 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   +  TG   AIK + + P D       + ++QEI +L   +H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAY 65

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +GS +  D L+I +EY   GS+    +     ++E  +    R  L GLAYLH T  IHR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 5e-25
 Identities = 52/128 (40%), Positives = 84/128 (65%), Gaps = 3/128 (2%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+ GKL+GRG FG VY+  + +TG   A+K+V   PD  ++++ +  LE EI++L +L+H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           + IVQYYG   +  +  L I++EY+  GSI   ++ +   +TE++ R +TR IL G++YL
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYL 122

Query: 474 HSTNTIHR 481
           HS   +HR
Sbjct: 123 HSNMIVHR 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (254), Expect = 2e-24
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 9/129 (6%)

Query: 358 KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            GK +G G FG VY GT            A+K +     +  S + I++  +E +++  L
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKL 58

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAY 472
            H NIV+  G    ++ L I +EY+  G +  Y+R++  ++++ S + +F   I  G+ Y
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 473 LHSTNTIHR 481
           L S N IHR
Sbjct: 119 LESKNFIHR 127

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (255), Expect = 2e-24
 Identities = 44/126 (34%), Positives = 66/126 (52%), Gaps = 9/126 (7%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
            +K   IG G  G VY  T+R TG   AIK++ +   + +       +  EI ++   KH
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV YY S +V D L++ +EY+  GS+   + ++   + E  +    R +L GL YLHS
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 476 TNTIHR 481
            N IHR
Sbjct: 135 QNVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (254), Expect = 3e-24
 Identities = 38/129 (29%), Positives = 65/129 (50%), Gaps = 8/129 (6%)

Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
             GK +G G FG VY G       +     A+K +     +  S + I++  +E +++  
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H N+V+  G    ++ LYI +EY+  G +  Y+R++   ++ S + +F   I  G+ Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 473 LHSTNTIHR 481
           L S N IHR
Sbjct: 118 LESKNFIHR 126

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 6/128 (4%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             +   + IG+G+FG VY   ++ T    AIK +D+     ++ + I+ ++QEI+ L   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +   I +YYGS +    L+I +EY   GS    ++     + E+ +    R +L GL YL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114

Query: 474 HSTNTIHR 481
           H    IHR
Sbjct: 115 HEEGKIHR 122

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 47/129 (36%), Positives = 83/129 (64%), Gaps = 5/129 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIG-TNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGH 412
           +W KG+++G+G +G+VY G TN   G   A+K+V++   +  +AE   ++L++E+ +L  
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           LKH NIVQY G+ + D+ + I++E+V  GSI+  +      + E +   +T+ IL+G+AY
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY 117

Query: 473 LHSTNTIHR 481
           LH+   +HR
Sbjct: 118 LHNNCVVHR 126

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 4e-23
 Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 6/125 (4%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IG+G+FG VY+   +  G    +KE+D+     K     +    E+K+L  L H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK---EREDALNEVKILKKLNHPNII 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHST 476
           +YY S      L I +EY   G +++ +++  ++     E  + ++   +   L YLHS 
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 477 NTIHR 481
             +HR
Sbjct: 123 KILHR 127

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 15/133 (11%)

Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K +G G FG VY G            A+K +     + +     K   +E +V+  L H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHP 56

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------ITESIVRNFTRHILN 468
           N+V+  G    ++ LY+ LEY+  G +  Y+R+            ++   + +F   I  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 469 GLAYLHSTNTIHR 481
           G+ YL S   +HR
Sbjct: 117 GMEYLASKKFVHR 129

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 8/129 (6%)

Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           + GK +G G FG VY GT       T    A+K +     + +  E      +E  ++  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKK 57

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H NIV+  G     + LYI  EY+  G +  ++R+H   +T   +      I  G+ Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 473 LHSTNTIHR 481
           L S N +HR
Sbjct: 118 LESKNFVHR 126

Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 9/131 (6%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +Q+ +LIGRG +G+VY G +  TG   A+K +++   D   ++    +++E+ +L  L
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD----IQREVALLSQL 56

Query: 414 KH---ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           +     NI +YYGS +    L+I +EY   GS+   ++     I E  +    R +L  L
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVAL 114

Query: 471 AYLHSTNTIHR 481
            Y+H    IHR
Sbjct: 115 KYIHKVGVIHR 125

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 38/128 (29%), Positives = 73/128 (57%), Gaps = 2/128 (1%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHL 413
           +W KG+ +G G F S Y   + +TG   A+K+V  + +     E + + L +EI+++  L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H +I++  G+   D H  +++E++  GS++  + ++     E+++ N+T  +L GL+YL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119

Query: 474 HSTNTIHR 481
           H    IHR
Sbjct: 120 HENQIIHR 127

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 16/136 (11%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
           ++  ++IG GT+G VY   +++TG   AIK +DII D+       +++++E  +L     
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRKYSN 61

Query: 415 HENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRH 465
           H NI  +YG          DD L++ +E    GS+   V   R+  + + E  +    R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 466 ILNGLAYLHSTNTIHR 481
            L GLAYLH    IHR
Sbjct: 122 TLRGLAYLHENKVIHR 137

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S  ++ K++G+G+ G VY   ++ TG   A+K++  +  D    E  KQL +E+K L   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDE---EFRKQLLRELKTLRSC 56

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +   +V+ YG+   +  + I LEY+  GS+   +++    I E ++    R IL GL YL
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115

Query: 474 HST-NTIHR 481
           H+  + IHR
Sbjct: 116 HTKRHIIHR 124

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 9e-20
 Identities = 36/130 (27%), Positives = 71/130 (54%), Gaps = 14/130 (10%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHL 413
           +K + +G GT+G VY   +++TG   A+K++ +  ++   P +   ++    EI +L  L
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALR----EISLLKEL 55

Query: 414 KHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
           KH NIV+    +V+  +  LY+  EY     + +Y+ +    ++ +++++    +L GLA
Sbjct: 56  KHPNIVKLL--DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 472 YLHSTNTIHR 481
           Y HS   +HR
Sbjct: 113 YCHSHRILHR 122

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 7/123 (5%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+GT+G VY   +  T    AIKE+       + +  ++ L +EI +  +LKH NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYLHSTNT 478
           Y GS+  +    I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 479 IHR 481
           +HR
Sbjct: 130 VHR 132

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   ++ETG   A K + I     +S E ++    EI +L   KH
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKH 61

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV  Y +   ++ L+I +E+   G+++  + E  R +TE  +R   R +L  L +LHS
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 476 TNTIHR 481
              IHR
Sbjct: 122 HKVIHR 127

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 6/121 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
           IG G  G V+   +RETG + A+K+V +     +    I  Q  +EIK L   +H  +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
                       + +EY+ P  ++  +R+  R + E+ V+++ R +L G+AY+H+   +H
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 481 R 481
           R
Sbjct: 123 R 123

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 48/131 (36%), Positives = 68/131 (51%), Gaps = 8/131 (6%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           PKK ++ + + IG+G  G+VY   +  TG   AIK++++    PK    I     EI V+
Sbjct: 17  PKK-KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII----NEILVM 70

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
              KH NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L  L
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQAL 128

Query: 471 AYLHSTNTIHR 481
            +LHS   IHR
Sbjct: 129 EFLHSNQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 42/126 (33%), Positives = 61/126 (48%), Gaps = 9/126 (7%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           + G  IG+G FG V +G  R  G   A+K    + DD  +A+       E  V+  L+H 
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQ---AFLAEASVMTTLRHP 60

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHS 475
           N+VQ  G  +  + LYI  EY+  GS+  Y+R   R  IT +    F   +  G+ YL  
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120

Query: 476 TNTIHR 481
            N +HR
Sbjct: 121 KNFVHR 126

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 4/121 (3%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G G +G V    N+ TG   AIK+     DD    +      +E+KVL  L+HENIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL---REVKVLRQLRHENIVN 64

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
              +      LY+  EYV   ++   +      +    VR++   +L  +AY HS N IH
Sbjct: 65  LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 481 R 481
           R
Sbjct: 124 R 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 5/121 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G  G V    +R TG   A+K    I  +   A   KQ+ +E+ +L       IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVK---TIRLEINEAI-QKQILRELDILHKCNSPYIVGF 64

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIH 480
           YG+   +  + I +EY+  GS+++ ++E    I E I+      +L GL YLH     IH
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 481 R 481
           R
Sbjct: 125 R 125

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 7e-16
 Identities = 46/131 (35%), Positives = 70/131 (53%), Gaps = 21/131 (16%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQEIKVLGHLK 414
           K +G GTFGSVY+  N+ETG   AIK++       K       EC+    +E+K L  L 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMN--LREVKSLRKLN 55

Query: 415 -HENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 470
            H NIV+    EV   +D LY   EY+  G++ + +++   +  +ES++R+    IL GL
Sbjct: 56  EHPNIVKLK--EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 471 AYLHSTNTIHR 481
           A++H     HR
Sbjct: 113 AHIHKHGFFHR 123

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 78.6 bits (192), Expect = 9e-16
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  + +G G+FG VY+  +R+     A+K   +       ++ +++  +EI++L  L H
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKV--LAKKLESKSKEVERFLREIQILASLNH 56

Query: 416 E-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 472
             NIV+ Y     +  LY+ +EYV  GS+   +++      ++ES        IL+ L Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 473 LHSTNTIHR 481
           LHS   IHR
Sbjct: 117 LHSKGIIHR 125

Length = 384

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 41/124 (33%), Positives = 64/124 (51%), Gaps = 10/124 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   N++TG   A+K+  I  ++ K    I  +  EIK+L  L+H NIV+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63

Query: 422 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
              E+V       +Y+  EY+    +   +       TES ++ + + +L GL YLHS  
Sbjct: 64  K--EIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 478 TIHR 481
            +HR
Sbjct: 121 ILHR 124

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 6/122 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G    VY           AIK +D+     K    + +L +E++ +    H N+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTI 479
           Y S VV D L++ + Y+  GS+   ++       + E+I+    + +L GL YLHS   I
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 480 HR 481
           HR
Sbjct: 125 HR 126

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 43/127 (33%), Positives = 68/127 (53%), Gaps = 10/127 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IG G +G V    ++ TG   AIK++  + DD   A   K++ +EIK+L HL+HENI+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA---KRILREIKLLRHLRHENII 62

Query: 420 Q-----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
                    S    + +YI  E +    +++ ++   + +T+  ++ F   IL GL YLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120

Query: 475 STNTIHR 481
           S N IHR
Sbjct: 121 SANVIHR 127

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 49/131 (37%), Positives = 71/131 (54%), Gaps = 12/131 (9%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLK 54

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
            LKH+NIV+ Y     D  L +  EY     + +Y  + C  DI   IV++F   +L GL
Sbjct: 55  ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF-DSCNGDIDPEIVKSFMFQLLKGL 112

Query: 471 AYLHSTNTIHR 481
           A+ HS N +HR
Sbjct: 113 AFCHSHNVLHR 123

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAE-CIKQLEQEIKVLGHLKHEN 417
           K IG+G F  VY       G   A+K+V I    D K+ + C+K    EI +L  L H N
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLLKQLDHPN 63

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINR---YVREHCRDITESIVRNFTRHILNGLAYLH 474
           +++Y  S + ++ L I LE    G ++R   + ++  R I E  +  +   + + L ++H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 124 SKRIMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 38/122 (31%), Positives = 61/122 (50%), Gaps = 6/122 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQ 420
           IG+G+FG V+    +      A+K++D+   + +   E I     E +VL  L    I++
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTI 479
           YY S +    L I +EY   G +++ ++    R + E  V  F   IL GLA+LHS   +
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 480 HR 481
           HR
Sbjct: 124 HR 125

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 38/124 (30%), Positives = 63/124 (50%), Gaps = 6/124 (4%)

Query: 361 LIGRGTFG--SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           LIG+       V++  ++ T    A+K++++   D  S E +K L+QEI     L+H NI
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
           + Y  S +VD  LY+    +  GS    ++ H  + + E  +    + +LN L Y+HS  
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 478 TIHR 481
            IHR
Sbjct: 122 FIHR 125

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 38/128 (29%), Positives = 68/128 (53%), Gaps = 8/128 (6%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK   IG GT+G VY   ++ TG   AIK++ +  +        K   +EIK+L  L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57

Query: 416 ENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            NI++    +V      LY+  E++    + + +++  R + ES+++++   +L GLA+ 
Sbjct: 58  PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 474 HSTNTIHR 481
           HS   +HR
Sbjct: 115 HSHGILHR 122

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 39/133 (29%), Positives = 57/133 (42%), Gaps = 15/133 (11%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           + IG+G+FG+V     +  G     KE+D      K  E  +QL  E+ +L  LKH NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EK-QQLVSEVNILRELKHPNIV 62

Query: 420 QYYGSEVVDDH--LYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +YY   +   +  LYI +EY   G     I +  +E    I E  +      +L  L   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYEC 121

Query: 474 H-----STNTIHR 481
           H         +HR
Sbjct: 122 HNRSDPGNTVLHR 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 43/126 (34%), Positives = 65/126 (51%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNH 68

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L YLHS
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 476 TNTIHR 481
              IHR
Sbjct: 129 MKIIHR 134

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 47/135 (34%), Positives = 70/135 (51%), Gaps = 20/135 (14%)

Query: 357 QKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----QEIK 408
           +K +++G G FG V    Y   N  TG   A+K +          EC +Q      +EI 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEIN 58

Query: 409 VLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +L  L HENIV+Y G  SE     L + +EYV  GS+  Y+ +H  ++ + ++  F + I
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQI 116

Query: 467 LNGLAYLHSTNTIHR 481
             G+AYLHS + IHR
Sbjct: 117 CEGMAYLHSQHYIHR 131

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 6/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   N  TG   AIK + + P      E    ++QEI ++   KH NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +GS +  D L+I +E+   GS+   +      ++ES +   +R  L GL YLHS   +HR
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 48/143 (33%), Positives = 73/143 (51%), Gaps = 11/143 (7%)

Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
           IMEK     S    K ++ + + IG+G  G+V+   +  TG   AIK++++    PK   
Sbjct: 4   IMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKEL 62

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
            I     EI V+  LK+ NIV +  S +V D L++ +EY+  GS+   V E C D  E+ 
Sbjct: 63  II----NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQ 116

Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
           +    R  L  L +LH+   IHR
Sbjct: 117 IAAVCRECLQALEFLHANQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 36/128 (28%), Positives = 68/128 (53%), Gaps = 4/128 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++K +++GRG FG V++   +       IK+   IP +  + +     + E +VL  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLS 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
           H NI++YY + + D  L I +EY   G++  Y+++ C   + E  + +F   IL  L ++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 474 HSTNTIHR 481
           H+   +HR
Sbjct: 118 HTKLILHR 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 43/120 (35%), Positives = 63/120 (52%), Gaps = 6/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G GT+G VY   N  TG   A+K + + P D  S      ++QEI ++   KH NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVAY 71

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +GS +  + L+I +EY   GS+   +      ++E  +    R  L GLAYLHS   +HR
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 273 SPLPSPPRQSSQSNLRS-PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 331
            P   P   +++   +S PR+   P     LPQ    L        A PLPLPP + S  
Sbjct: 6   PPPGVPLPSTARHTTKSRPRRR--PDLTLPLPQRDPSL--------AVPLPLPPPSSSSS 55

Query: 332 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
            SS +SA        PSA+   S+ ++   IG G  G+VY   +R TG   A+K +    
Sbjct: 56  SSSSSSA----SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111

Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
           +D       +Q+ +EI++L  + H N+V+ +     +  + + LE++  GS+     E  
Sbjct: 112 ED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGT 162

Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               E  + +  R IL+G+AYLH  + +HR
Sbjct: 163 HIADEQFLADVARQILSGIAYLHRRHIVHR 192

Length = 353

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 43/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 125

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 13/133 (9%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC------IKQLEQEIK 408
           +++KGK +G GT+  VY   ++ETG   AIK+  I   + K A+       ++    EIK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALR----EIK 54

Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +L  LKH NI+          ++ +  E++    + + +++    +T + ++++    L 
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 469 GLAYLHSTNTIHR 481
           GL YLHS   +HR
Sbjct: 114 GLEYLHSNWILHR 126

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 36/129 (27%), Positives = 69/129 (53%), Gaps = 7/129 (5%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
            +++ + +G GT+ +VY G NR TG   A+KE+ +  ++   +  I+    EI ++  LK
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELK 56

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAY 472
           HENIV+ +     ++ L +  EY+    + +Y+        +  + V++FT  +L G+A+
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 473 LHSTNTIHR 481
            H    +HR
Sbjct: 116 CHENRVLHR 124

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 42/120 (35%), Positives = 63/120 (52%), Gaps = 6/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS +    L+I +EY+  GS    +R    D  E  +    + IL GL YLHS   IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 125

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 45/134 (33%), Positives = 67/134 (50%), Gaps = 7/134 (5%)

Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK    I     EI
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII----NEI 68

Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 126

Query: 468 NGLAYLHSTNTIHR 481
             L +LHS   IHR
Sbjct: 127 QALEFLHSNQVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 5e-13
 Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 7/134 (5%)

Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           S    K ++ + + IG+G  G+VY   +  TG   AIK++++    PK    I     EI
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII----NEI 67

Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  +    R  L
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 125

Query: 468 NGLAYLHSTNTIHR 481
             L +LHS   IHR
Sbjct: 126 QALDFLHSNQVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 43/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG VY G +  T    AIK +D+     ++ + I+ ++QEI VL       I +Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS +    L+I +EY+  GS    ++     + E+ +    R IL GL YLHS   IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 125

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 17/125 (13%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIKVLGHLKHE 416
           IG G+ G V I T++ TG   A+K++D+           KQ     L  E+ ++   +H 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLR----------KQQRRELLFNEVVIMRDYQHP 76

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NIV+ Y S +V D L++ +E++  G++   V  H R + E  +      +L  L++LH+ 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQ 134

Query: 477 NTIHR 481
             IHR
Sbjct: 135 GVIHR 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 5e-13
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 14/130 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENI 418
           +L+G GT+G VY G + +TG   AIK +D+  D+       ++++QEI +L  +  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNI 65

Query: 419 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
             YYG+ +      +DD L++ +E+   GS+   ++      + E  +    R IL GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 472 YLHSTNTIHR 481
           +LH    IHR
Sbjct: 126 HLHQHKVIHR 135

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 41/126 (32%), Positives = 63/126 (50%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ETG   A K +D      KS E ++    EI +L    H
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDH 61

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +   +++L+I +E+   G+++  + E  R +TE  +R   +  L  L YLH 
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 476 TNTIHR 481
              IHR
Sbjct: 122 NKIIHR 127

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 16/135 (11%)

Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FG V++G   + E      +  V  +  +  S +  K  E+E ++L + +HENIV
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------------ITESIVRNFTRHI 466
           ++YG     D   +  EY+  G +N+++R H  D             +T S +      I
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 467 LNGLAYLHSTNTIHR 481
            +G+ YL S + +HR
Sbjct: 132 ASGMVYLASQHFVHR 146

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 14/130 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENI 418
           +++G GT+G VY G + +TG   AIK +D+  D+       ++++ EI +L  +  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE------EEIKLEINMLKKYSHHRNI 75

Query: 419 VQYYGSEVV------DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
             YYG+ +       DD L++ +E+   GS+   V+      + E  +    R IL GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 472 YLHSTNTIHR 481
           +LH+   IHR
Sbjct: 136 HLHAHKVIHR 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 41/120 (34%), Positives = 64/120 (53%), Gaps = 3/120 (2%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY  TN  T    A+K++       ++ E  + + +E+K L  LKH N ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 10/128 (7%)

Query: 360 KLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K +G G FG V +         TG   A+K ++   ++   ++     E+EI++L  L H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLDH 65

Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           ENIV+Y G   +     L + +EY+  GS+  Y++ H   I    +  F+  I  G+ YL
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 474 HSTNTIHR 481
            S   IHR
Sbjct: 126 GSQRYIHR 133

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 5/121 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQ 420
           I +G +G V++   + TG   AIK   +I       +  + Q+  E  +L   +   +V+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            Y S     +LY+ +EY+  G +   + E+   + E + R +   I+  L YLHS   IH
Sbjct: 58  LYYSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 481 R 481
           R
Sbjct: 117 R 117

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G  GSV     + TG   A+K +   P+     +  KQ+ +E+++    K   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKY 64

Query: 422 YGSEVVDDH---LYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS 475
           YG+  +D+    + I +EY   GS++     V++    I E ++      +L GL+YLHS
Sbjct: 65  YGA-FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 476 TNTIHR 481
              IHR
Sbjct: 124 RKIIHR 129

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 4/123 (3%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IG G+FG +Y+   +     C IKE+D+     K  E  K   +E+ +L  +KH NIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            ++ S   +  L+I +EY   G +  R  R+     +E  + ++   I  GL ++H    
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 479 IHR 481
           +HR
Sbjct: 123 LHR 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 37/120 (30%), Positives = 61/120 (50%), Gaps = 3/120 (2%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY   +  T    AIK++       +S E  + + +E++ L  L+H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +       L GLAYLHS   IHR
Sbjct: 81  KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 44/127 (34%), Positives = 65/127 (51%), Gaps = 9/127 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K IGRG F  VY  T    G   A+K+V I  + D    A+CIK    EI +L  L H N
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 63

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLH 474
           +++YY S + D+ L I LE    G ++R ++   +  R I E  V  +   + + L ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 124 SRRVMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 33/128 (25%), Positives = 61/128 (47%), Gaps = 3/128 (2%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
              ++ K +G GTFG V++  +R +    A+K + I   +    +  + +  E +VL  +
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI--PEVIRLKQEQHVHNEKRVLKEV 58

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H  I++ + +E     LY+ +EYV  G +  Y+R      + S    +   I+  L YL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYL 117

Query: 474 HSTNTIHR 481
           HS   ++R
Sbjct: 118 HSKEIVYR 125

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 5/127 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLH 474
            NIV+       ++ LY+  E++H   + +++       I   +++++   +L GLA+ H
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 118 SHRVLHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 39/132 (29%), Positives = 71/132 (53%), Gaps = 15/132 (11%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
           +QK + IG GT+G VY   ++ TG   A+K++ +  +D   P +A  I+    EI +L  
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IR----EISLLKE 54

Query: 413 LKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNG 469
           L H NIV+    +VV  ++ LY+  E++    + +Y+       +   +++++   +L G
Sbjct: 55  LNHPNIVRLL--DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111

Query: 470 LAYLHSTNTIHR 481
           +AY HS   +HR
Sbjct: 112 IAYCHSHRVLHR 123

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 32/138 (23%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IGRG +G V    N ET    AIK++    D+   A   K+  +EIK+L HL HEN++
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVI 67

Query: 420 Q----------------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
                            Y   E++D  L+  +      S      +HC        + F 
Sbjct: 68  AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS-----DDHC--------QYFL 114

Query: 464 RHILNGLAYLHSTNTIHR 481
             +L GL Y+HS N +HR
Sbjct: 115 YQLLRGLKYIHSANVLHR 132

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 63.3 bits (155), Expect = 4e-11
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 9/125 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
           K +G G+FG V +  ++ +G   A+K    I    K  + +KQ+E    E ++L  ++H 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALK----ILSKAKIVK-LKQVEHVLNEKRILQSIRHP 61

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +V  YGS   D +LY+ +EYV  G +  ++R+      E + R +   ++  L YLHS 
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 477 NTIHR 481
           + ++R
Sbjct: 121 DIVYR 125

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 9/135 (6%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQE 406
            K+++ +K K++G G FG+VY G     G       AIK +     +  S +  K++  E
Sbjct: 4   LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDE 59

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             V+  + H ++V+  G  +      I  + +  G +  YVR H  +I    + N+   I
Sbjct: 60  AYVMASVDHPHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118

Query: 467 LNGLAYLHSTNTIHR 481
             G++YL     +HR
Sbjct: 119 AKGMSYLEEKRLVHR 133

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 22/142 (15%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S++   + +G G+ G V+   + +     A+K+  I+  DP+S   +K   +EIK++  L
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQS---VKHALREIKIIRRL 59

Query: 414 KHENIVQYY------GSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITESIV 459
            H+NIV+ Y      GS++ +D         +YI  EY+        V E    ++E   
Sbjct: 60  DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL--ANVLEQGP-LSEEHA 116

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           R F   +L GL Y+HS N +HR
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHR 138

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 32/146 (21%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +++T    A+K+  ++ ++ K    I  L +EIK+L  L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITAL-REIKILQLL 68

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY------VREHCR------------DIT 455
           KHEN+V          +L I +        NRY      V E C               T
Sbjct: 69  KHENVV----------NL-IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117

Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
            S ++   + +LNGL Y+H    +HR
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHR 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 33/123 (26%), Positives = 63/123 (51%), Gaps = 4/123 (3%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +++G+G FG   +    E  +    KEV++     K     +    EI +L  L+H NI+
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            YY   + D+ L I +EY + G++ ++ VR+  +   E +V  +   I++ ++Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 479 IHR 481
           +HR
Sbjct: 123 LHR 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 12/133 (9%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           ++  K +G+G +G V    N ET    + AIK++  +    K     + L +E+K+L H 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRAL-RELKLLRHF 58

Query: 414 K-HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           + H+NI   Y  ++V     + LY+Y E +    +++ +R     +T++  ++F   IL 
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP-LTDAHFQSFIYQILC 116

Query: 469 GLAYLHSTNTIHR 481
           GL Y+HS N +HR
Sbjct: 117 GLKYIHSANVLHR 129

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 11/125 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           IG G +G V    +  +G   AIK++    D P  A   K+  +E+K+L H KH+NI+  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNIIAI 69

Query: 420 -QYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHST 476
                    D   +Y+ ++ +    ++  +  H    +TE  +R F   +L GL Y+HS 
Sbjct: 70  RDILRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 477 NTIHR 481
           N IHR
Sbjct: 127 NVIHR 131

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 43/137 (31%), Positives = 64/137 (46%), Gaps = 25/137 (18%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           GKL G GTFG VY     +TG   A+K+  I+  + K    I  L +EIK+L  LKH N+
Sbjct: 14  GKL-GEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITAL-REIKILKKLKHPNV 69

Query: 419 VQY------YGSEVVDDHLYIYLEYVHP-------GSI-NRYVREHCRDITESIVRNFTR 464
           V           +       +Y+  V P       G + N  V+     +TES ++ +  
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVK-----LTESQIKCYML 122

Query: 465 HILNGLAYLHSTNTIHR 481
            +L G+ YLH  + +HR
Sbjct: 123 QLLEGINYLHENHILHR 139

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 3/120 (2%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY   +  T    AIK++       +S E  + + +E+K L  +KH N ++Y
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++ K K IG G+FG   +  ++E G    IKE++I    PK  E   +  +E+ VL ++K
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMK 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAY 472
           H NIVQY  S   + +LYI ++Y   G + + +    R +   E  + ++   I   L +
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKH 116

Query: 473 LHSTNTIHR 481
           +H    +HR
Sbjct: 117 VHDRKILHR 125

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 11/143 (7%)

Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQ-- 402
           S S  +   QKG  +G GT+G V    +  TG   AIK+V II    D  K  + +    
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 403 ----LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
                 +E+K++  +KHENI+      V  D + + ++ +    + + V    R +TES 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQ 120

Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
           V+     ILNGL  LH    +HR
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHR 143

Length = 335

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 3/120 (2%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 22/133 (16%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV--------- 409
           GK+IG G+F +V +   +ET    AIK +D            +QL +E KV         
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILD-----------KRQLIKEKKVKYVKIEKEV 54

Query: 410 LGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           L  L  H  I++ Y +   +++LY  LEY   G + +Y+R++   + E   R +   IL 
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILL 113

Query: 469 GLAYLHSTNTIHR 481
            L YLHS   IHR
Sbjct: 114 ALEYLHSKGIIHR 126

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 8/126 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           K +G+G++GSVY           A+KEVD+      +  + +     EI++L  + H NI
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASVNHPNI 61

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHS 475
           + Y  + +  + L I +EY   G +++ + +     + I E  +      +L GL  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 476 TNTIHR 481
              +HR
Sbjct: 122 QKILHR 127

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 9/124 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           + IG+G FG VY G  +      A+K     + PD        K L QE ++L    H N
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK-----RKFL-QEAEILKQYDHPN 53

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+  G  V    +YI +E V  GS+  ++R+    +T   +   +     G+ YL S N
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 478 TIHR 481
            IHR
Sbjct: 114 CIHR 117

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 10/123 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENIVQ 420
           IG G++G V+   NRETG   AIK+     DDP     IK++  +EI++L  LKH N+V 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVN 64

Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
               EV      L++  EY     +N   + + R + E +++      L  + + H  N 
Sbjct: 65  LI--EVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 479 IHR 481
           IHR
Sbjct: 122 IHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 21/136 (15%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           Q++K + IG GT+G VY   +R T  + A+K++ +  +D   P +A       +EI +L 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA------IREISLLK 56

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYV------HPGSINRYVREHCRDITESIVRNFTRH 465
            ++H NIV+       +  LY+  EY+      H  S   + +         +++ +   
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQ 110

Query: 466 ILNGLAYLHSTNTIHR 481
           IL G+AY HS   +HR
Sbjct: 111 ILRGIAYCHSHRVLHR 126

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 18/132 (13%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   +++TG   A+K+V +  D+ K    I  + +EIK+L  L H NIV  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71

Query: 422 YGSEVVDDH------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
              E+V D              Y+  EY+    +   +       +E  +++F + +L G
Sbjct: 72  K--EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFMKQLLEG 128

Query: 470 LAYLHSTNTIHR 481
           L Y H  N +HR
Sbjct: 129 LNYCHKKNFLHR 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 8/123 (6%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           L+G G++G V    ++ETG   AIK      +        K   +EI++L  L+HEN+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
               EV      LY+  E+V    ++  + ++   + ES VR +   IL G+ + HS N 
Sbjct: 65  LI--EVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121

Query: 479 IHR 481
           IHR
Sbjct: 122 IHR 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T + TG   A+K++D+     +  +  + L  E+ ++    HEN+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+YLH+   IHR
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 142

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 34/139 (24%), Positives = 60/139 (43%), Gaps = 21/139 (15%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
           +++   IG G +G+VY   +  TG   A+K+V +   +   P S        +EI +L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54

Query: 413 LK---HENIVQYYG-SEVVDDH----LYIYLEYVHPGSINRYVREHC--RDITESIVRNF 462
           L+   H NIV+               L +  E+V    +  Y+   C    +    +++ 
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDL 112

Query: 463 TRHILNGLAYLHSTNTIHR 481
            R +L G+ +LHS   +HR
Sbjct: 113 MRQLLRGVDFLHSHRIVHR 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
           W+  + IG+GT+G V+   N++ G+  A+K +D I D        +++E E  +L  L  
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKALSD 73

Query: 415 HENIVQYYG-----SEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHI 466
           H N+V++YG          D L++ LE  + GS+   V+   +    + E I+       
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 467 LNGLAYLHSTNTIHR 481
           L GL +LH   TIHR
Sbjct: 134 LMGLQHLHVNKTIHR 148

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 15/135 (11%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
           W+  + IG+GT+G VY  TN++ G+  A+K +D I D        +++E E  +L  L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSLPN 77

Query: 415 HENIVQYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHI 466
           H N+V++YG     D      L++ LE  + GS+   V+        + E+++       
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 467 LNGLAYLHSTNTIHR 481
           L GL +LH+   IHR
Sbjct: 138 LLGLQHLHNNRIIHR 152

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 9/133 (6%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLG 411
           + +Q  K IGRG F  VY  T        A+K+V I    D     +C+K    EI +L 
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLLK 57

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN---RYVREHCRDITESIVRNFTRHILN 468
            L H N+++Y  S + D+ L I LE    G ++   +Y ++  R I E  V  +   + +
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 469 GLAYLHSTNTIHR 481
            + ++HS   +HR
Sbjct: 118 AVEHMHSRRVMHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 38/128 (29%), Positives = 66/128 (51%), Gaps = 11/128 (8%)

Query: 360 KLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           + +G+G FGSV    Y      TG   A+K++        +AE ++  E+EI++L  L+H
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64

Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +NIV+Y G        +L + +EY+  GS+  Y+++H   +    +  +   I  G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 474 HSTNTIHR 481
            S   +HR
Sbjct: 125 GSKRYVHR 132

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 35/125 (28%), Positives = 65/125 (52%), Gaps = 12/125 (9%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENI 418
           IG GT+G VY G N++TG   A+K++ +  ++   P +A       +EI +L  L+H NI
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA------IREISLLKELQHPNI 61

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 476
           V      + +  LY+  E++    + +Y+    +   +   +V+++   IL G+ + HS 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 477 NTIHR 481
             +HR
Sbjct: 121 RVLHR 125

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 28/133 (21%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           I  GT+G VY   +++TG   A+K++ +  +  K    I  L +EI +L  L+H NIV  
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTV 69

Query: 422 YGSEVV----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFT--------RHILN 468
              EVV     D +Y+ +EYV          EH  + + E++ + F           +L+
Sbjct: 70  --KEVVVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 469 GLAYLHSTNTIHR 481
           G+A+LH    +HR
Sbjct: 118 GVAHLHDNWILHR 130

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 11/122 (9%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G FG V +G  R  G   A+K    I +D  +   +     E  V+  L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLA----EASVMTQLRHSNLVQL 64

Query: 422 YGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTI 479
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL + N +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124

Query: 480 HR 481
           HR
Sbjct: 125 HR 126

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 34/123 (27%), Positives = 56/123 (45%), Gaps = 3/123 (2%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G+FG V  G    +G       V  +  D K ++ +    +E  ++  L HEN++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNT 478
           + YG  V+   L +  E    GS+   +R+        S + ++   I NG+ YL S   
Sbjct: 60  RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 479 IHR 481
           IHR
Sbjct: 119 IHR 121

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 16/135 (11%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
           ++Q    +G G +G V    + +TG   AIK++      P +SA   K+  +E+++L H+
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71

Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHI 466
            HEN++     +  +  ++D   +YL  V       +N  V+  C+ +++  ++     I
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK--CQKLSDDHIQFLVYQI 127

Query: 467 LNGLAYLHSTNTIHR 481
           L GL Y+HS   IHR
Sbjct: 128 LRGLKYIHSAGIIHR 142

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 7/127 (5%)

Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLK 414
           K K+IG G FG V+ G  +  G     KEV +     K     KQ +    E  ++G   
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NI++  G         I  EY+  G++++Y+R+H  + +   +    R I  G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 475 STNTIHR 481
             N +HR
Sbjct: 125 DMNYVHR 131

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 10/132 (7%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           ++++K   IG GT+G VY   +  +G   A+K+V +  D+ +    I  L +EI +L +L
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNL 63

Query: 414 KHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +H NIV+    EVV     D +++ +EY     +   +       +ES V+     +L G
Sbjct: 64  RHPNIVEL--KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 470 LAYLHSTNTIHR 481
           L YLH    IHR
Sbjct: 121 LQYLHENFIIHR 132

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 35/120 (29%), Positives = 64/120 (53%), Gaps = 7/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T + +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 32/120 (26%), Positives = 61/120 (50%), Gaps = 7/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I   + +G   A+K +D+     +  +  + L  E+ ++   +H+N+V+ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V + L++ +E++  G++   V +    + E  +      +L  L YLHS   IHR
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 22/137 (16%)

Query: 362 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +G G FG V++         +     A+K +    D+ +     K   +E ++L +L+HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQHE 67

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 464
           +IV++YG  V  D L +  EY+  G +N+++R H  D            +T+S + +  +
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 465 HILNGLAYLHSTNTIHR 481
            I  G+ YL S + +HR
Sbjct: 128 QIAAGMVYLASQHFVHR 144

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 47/130 (36%), Positives = 66/130 (50%), Gaps = 15/130 (11%)

Query: 362 IGRGTFGSVY--IGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENI 418
           IGRGT+G VY     N + G   AIK+      D +    I Q   +EI +L  LKHEN+
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 419 VQYYGSEVVDDH----LYIYLEYV-HP-GSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
           V     EV  +H    +Y+  +Y  H    I ++ R+  R  I  S+V++    ILNG+ 
Sbjct: 65  VSL--VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 472 YLHSTNTIHR 481
           YLHS   +HR
Sbjct: 123 YLHSNWVLHR 132

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 34/122 (27%), Positives = 59/122 (48%), Gaps = 7/122 (5%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V++G  R      AIK ++      + A   +   +E KV+  L H  +V
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAIN------EGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       LYI  E++  G +  Y+R+    +++ ++ +  + +  G+ YL   + I
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 480 HR 481
           HR
Sbjct: 123 HR 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 31/123 (25%), Positives = 62/123 (50%), Gaps = 5/123 (4%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +++G G+FG   +  +  +    A+KE+ +    PKS+  ++   +E  +L  +KH NIV
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            +  S   D HLYI +EY   G + + ++ +  +   E  +  +   +  G+ ++H    
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 479 IHR 481
           +HR
Sbjct: 122 LHR 124

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 11/124 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHEN 417
           +G G FG V +   +    + A+K V       K         + +  E ++L    H  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+ Y +     ++Y+ +EY   G +   +R+      E   R +   ++    YLH+  
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRG 113

Query: 478 TIHR 481
            I+R
Sbjct: 114 IIYR 117

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 12/127 (9%)

Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGHLKHE 416
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 66

Query: 417 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           NIV+Y G  +E   + + + +E++  GS+  Y+  +   I       +   I  G+ YL 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 127 SRQYVHR 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 12/133 (9%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++Q    IG G +G V   T++ TG   AIK+  I P +     C + L +EIK+L   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-HQTFCQRTL-REIKILRRF 60

Query: 414 KHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           KHENI+                +YI  E +    + + ++   + ++   ++ F   IL 
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKT--QHLSNDHIQYFLYQILR 117

Query: 469 GLAYLHSTNTIHR 481
           GL Y+HS N +HR
Sbjct: 118 GLKYIHSANVLHR 130

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 9/123 (7%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKE---VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           IG+G FG V I   R+T    A+K       +         ++ +  E ++L  L H  +
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFL 62

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V  + S   ++++Y+ ++ +  G + RY        +E  V+ +   I+  L YLHS   
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 479 IHR 481
           IHR
Sbjct: 122 IHR 124

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 36/127 (28%), Positives = 55/127 (43%), Gaps = 15/127 (11%)

Query: 359 GKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
            K +G G FG V++G    +   A   I+E  +  DD           +E KV+  L H 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59

Query: 417 NIVQYYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           N+VQ YG  V      ++I  EY+  G +  Y+RE    +    + +    +   + YL 
Sbjct: 60  NLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 475 STNTIHR 481
           S   IHR
Sbjct: 118 SNGFIHR 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 41/124 (33%), Positives = 56/124 (45%), Gaps = 11/124 (8%)

Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K +G G FG V  G  R     A   IKE  +  D+           +E KV+  L HE 
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEK 60

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +VQ YG       +YI  EY+  G +  Y+REH +    S +    + +  G+AYL S  
Sbjct: 61  LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 478 TIHR 481
            IHR
Sbjct: 121 FIHR 124

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 38/123 (30%), Positives = 60/123 (48%), Gaps = 7/123 (5%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           +L+G+G FG V+ GT ++     A+K   + +P + K    IK L  E ++L    H NI
Sbjct: 1   ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELK----IKFL-SEARILKQYDHPNI 54

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V+  G       +YI +E V  G    ++R+   ++    +  F      G+AYL S N 
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 479 IHR 481
           IHR
Sbjct: 115 IHR 117

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 7/123 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G +GSVY   +R TG + A+KE+ +  D+ K  + I +L+    +L       IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST-NT 478
           YG+  ++  +Y+ +EY+  GS+++          I E ++R  T  ++ GL +L    N 
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 479 IHR 481
           IHR
Sbjct: 125 IHR 127

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 36/130 (27%), Positives = 62/130 (47%), Gaps = 5/130 (3%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G++ +VY G ++ TG   A+KE+ +  ++      I+    E  +L 
Sbjct: 3   KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLK 58

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH NIV  +        L +  EY+    + +Y+ +    ++   VR F   +L GLA
Sbjct: 59  DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 472 YLHSTNTIHR 481
           Y H    +HR
Sbjct: 118 YCHQRRVLHR 127

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 32/127 (25%), Positives = 54/127 (42%), Gaps = 17/127 (13%)

Query: 362 IGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEI----KVLGHLK 414
           +G G FGSV  G            A+K +          E I   ++E      V+  L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H  IV+  G     + L + +E    G + +Y+++  R+I  S ++     +  G+AYL 
Sbjct: 55  HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE 112

Query: 475 STNTIHR 481
           S + +HR
Sbjct: 113 SKHFVHR 119

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 31/124 (25%), Positives = 58/124 (46%), Gaps = 11/124 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLGHLKHEN 417
           +G+G+FG V +   ++TG   A+K +       K     ++  +    E  +L  + H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+ + +   ++ LY+ LEY   G +  ++ +     +E   R +   I+  L YLHS  
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG 113

Query: 478 TIHR 481
            I+R
Sbjct: 114 IIYR 117

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 36/145 (24%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 13  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--------------CRDITE 456
             L+H++IV++YG       L +  EY+  G +NR++R H                 +T 
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
             +      I +G+ YL S + +HR
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHR 146

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           + +G G++ +VY G +R  G   A+K + +  ++      I+    E  +L  LKH NIV
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
             +      + L    EY+H   + +Y+ +H   +    VR F   +L GLAY+H  + +
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125

Query: 480 HR 481
           HR
Sbjct: 126 HR 127

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 12/127 (9%)

Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K KL G G +G VY G  ++   + A+K +  D +         +++  +E  V+  +KH
Sbjct: 11  KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKH 61

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLH 474
            N+VQ  G    +   YI  E++  G++  Y+RE  R    ++V  +    I + + YL 
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 475 STNTIHR 481
             N IHR
Sbjct: 122 KKNFIHR 128

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHE-- 416
           K I +G FGSVY+   R TG   AIK   ++   D  +   +  ++ E  ++  ++ E  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIK---VLKKSDMIAKNQVTNVKAERAIM-MIQGESP 57

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            + + Y S    D+LY+ +EY++ G     ++     + E   + +   ++ G+  LH  
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 477 NTIHR 481
             IHR
Sbjct: 117 GIIHR 121

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 38/124 (30%), Positives = 63/124 (50%), Gaps = 5/124 (4%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +++G+G++G V +  +R  G    IK++++      S    K  EQE ++L  LKH NIV
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 420 QYYGS-EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
            Y  S E  D  LYI + +   G +   ++E   + + E+ V  +   I   L YLH  +
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 478 TIHR 481
            +HR
Sbjct: 123 ILHR 126

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 19/137 (13%)

Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FG V++    N        +  V  + D   +A   K  ++E ++L +L+HE+IV
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 464
           ++YG     D L +  EY+  G +N+++R H  D               +  S + +   
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 465 HILNGLAYLHSTNTIHR 481
            I +G+ YL S + +HR
Sbjct: 131 QIASGMVYLASQHFVHR 147

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 34/131 (25%), Positives = 62/131 (47%), Gaps = 10/131 (7%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLG 411
           +   +  + +G G FG V++GT   T    A+K +       K      +   QE +++ 
Sbjct: 5   RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL-------KPGTMSPEAFLQEAQIMK 56

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGL 470
            L+H+ +VQ Y     ++ +YI  EY+  GS+  +++    + +    + +    I  G+
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 471 AYLHSTNTIHR 481
           AYL S N IHR
Sbjct: 117 AYLESRNYIHR 127

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 10/145 (6%)

Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           P+  P   +W         GK +G G FG V   T      S A+ +V +    P +   
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80

Query: 400 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITE 456
            ++ L  E+K++ HL  HENIV   G+  +   + +  EY   G +  ++R      +T 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
             + +F+  +  G+A+L S N IHR
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHR 165

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++S   + KL G+G FG V++GT   T    AIK +      P++        QE +V+
Sbjct: 4   PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVM 55

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNG 469
             L+HE +VQ Y + V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G
Sbjct: 56  KKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114

Query: 470 LAYLHSTNTIHR 481
           +AY+   N +HR
Sbjct: 115 MAYVERMNYVHR 126

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 33/150 (22%), Positives = 65/150 (43%), Gaps = 23/150 (15%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
            + +   GK +G G FG V         N    ++ A+K +     +   ++ + ++E  
Sbjct: 10  PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM- 68

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------CRDIT 455
           +K++G  KH+NI+   G    +  LY+ +EY   G++  ++R              R   
Sbjct: 69  MKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 456 ESI----VRNFTRHILNGLAYLHSTNTIHR 481
           E++    + +F   +  G+ +L S   IHR
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHR 156

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 14/144 (9%)

Query: 344 MEKPSASP-KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-- 400
             KP  S  K S ++ G+ +G G+FG V I  ++ TG   AIK +       K  E +  
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKM 59

Query: 401 KQLE---QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
           KQ++   QE  +L  L H  IV    S   ++ +Y  LE+V  G +  ++R+  R     
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPND 118

Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
           + + +   ++    YLHS + I+R
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYR 142

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K++G+G+FG V +    GTN         K+V +  DD    EC   +E+ +  L   +H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VEC-TMVERRVLALA-WEH 55

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +   + +    +HL+  +EY++ G +  +++       E+  R +   I+ GL +LH 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK 114

Query: 476 TNTIHR 481
              I+R
Sbjct: 115 KGIIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 32/128 (25%), Positives = 62/128 (48%), Gaps = 13/128 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           KL+G+G  G V++   + TG   A+K +D   +I  +      +K++  E ++L  L H 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEILATLDHP 61

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 473
            +   Y S   + +L + ++Y   G + R ++     C  ++E + R +   +L  L YL
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYL 119

Query: 474 HSTNTIHR 481
           H    ++R
Sbjct: 120 HLLGIVYR 127

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 36/134 (26%), Positives = 67/134 (50%), Gaps = 10/134 (7%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLG 411
             +++  K +G G +G+V    +R TGA  AIK++      P  +E   K+  +E+++L 
Sbjct: 14  PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69

Query: 412 HLKHENIVQ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           H+KHEN++     +     +D     YL     G+    + +H + ++E  ++     +L
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQML 128

Query: 468 NGLAYLHSTNTIHR 481
            GL Y+H+   IHR
Sbjct: 129 KGLKYIHAAGIIHR 142

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 33/145 (22%), Positives = 59/145 (40%), Gaps = 22/145 (15%)

Query: 359 GKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPK-----------SAECIKQLEQE 406
            + +G G FG V++         S      +   D P            S    +   +E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----------CRDITE 456
           +K+L  L   NI +  G   VD  L + +EY+  G +N+++++H           + ++ 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
           S +      I +G+ YL S N +HR
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHR 154

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 21/137 (15%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-------LEQE 406
             ++  K+IGRG FG V++  +++TG   A+K +       + ++ IK+        E++
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERD 53

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDITESIVRNFTR 464
           I          IV+ Y S   ++HLY+ +EY+ PG   +N  +R+      E   R +  
Sbjct: 54  ILA--DADSPWIVKLYYSFQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIA 108

Query: 465 HILNGLAYLHSTNTIHR 481
            ++  L  +H    IHR
Sbjct: 109 ELVLALDSVHKLGFIHR 125

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 11/126 (8%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+K    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE------VAHTLTESRVLQNTRH 54

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS 113

Query: 476 TNTIHR 481
            + ++R
Sbjct: 114 CDVVYR 119

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 5/130 (3%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K + +G G++ +VY G ++  G   A+K + +  ++      I+    E  +L 
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLK 58

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH NIV  +      + L +  EYVH   + +Y+ +H   +    V+ F   +L GL+
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 472 YLHSTNTIHR 481
           Y+H    +HR
Sbjct: 118 YIHQRYILHR 127

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 33/136 (24%), Positives = 64/136 (47%), Gaps = 14/136 (10%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLEQEIK 408
           ++K + IG GT+G VY   ++ TG   A+K+  +  D+   P +A      ++ L + I 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRH 465
           ++  L  E++ +  G       LY+  EY+       ++   R   R +    +++F   
Sbjct: 63  IVRLLDVEHVEEKNGKPS----LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 466 ILNGLAYLHSTNTIHR 481
           +L G+A+ H    +HR
Sbjct: 119 LLKGVAHCHKHGVMHR 134

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 37/133 (27%), Positives = 71/133 (53%), Gaps = 12/133 (9%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
           ++Q    +G G +GSV    + +TG   A+K++      P +S    K+  +E+++L H+
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHM 73

Query: 414 KHENIVQ----YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           KHEN++     +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 131

Query: 469 GLAYLHSTNTIHR 481
           GL Y+HS + IHR
Sbjct: 132 GLKYIHSADIIHR 144

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 22/136 (16%)

Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +G+G+FG VY G  +     E     AIK V+   ++    E I+ L  E  V+      
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL-NEASVMKEFNCH 69

Query: 417 NIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRH 465
           ++V+  G  VV       + +E +  G +  Y+R    +          T          
Sbjct: 70  HVVRLLG--VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 466 ILNGLAYLHSTNTIHR 481
           I +G+AYL +   +HR
Sbjct: 128 IADGMAYLAAKKFVHR 143

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 11/132 (8%)

Query: 361 LIGRGTFGSVYIGTNRETGAS-CAIKEVDII-PDDPKSA----ECIKQLEQEIKVLG-HL 413
            +G G FG VY    +  G +  A+KE+++  P   K      + I  +  E+ ++   L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
           +H NIV+YY + + +D LYI ++ +    +  +   ++E  +  TE  + N    ++  L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 471 AYLHSTNTI-HR 481
            YLH    I HR
Sbjct: 127 RYLHKEKRIVHR 138

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 33/132 (25%), Positives = 67/132 (50%), Gaps = 11/132 (8%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVL 410
           + ++   + +G G FG V+ G  +      AIK   I+    KS + +KQ   ++E++ L
Sbjct: 5   REEFTLERKLGSGYFGEVWEGLWKNR-VRVAIK---IL----KSDDLLKQQDFQKEVQAL 56

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNG 469
             L+H++++  +    V + +YI  E +  GS+  ++R    + +  + + +    +  G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 470 LAYLHSTNTIHR 481
           +AYL   N+IHR
Sbjct: 117 MAYLEEQNSIHR 128

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G+G+FG V +   + T    A+K +    I+ DD    EC    E+ +  L   KH 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECT-MTEKRVLALAG-KHP 56

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            + Q +      D L+  +EYV+ G +  +++       E   R +   I+ GL +LH  
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 477 NTIHR 481
             I+R
Sbjct: 116 GIIYR 120

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 11/129 (8%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            +   G++IG G FG+V  G    TG   A+K +       K     +   +E  V+  L
Sbjct: 6   QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKL 56

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAY 472
            H+N+V+  G  ++ + LYI +E +  G++  ++R   R +   I +  F+  +  G+ Y
Sbjct: 57  HHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 473 LHSTNTIHR 481
           L S   +HR
Sbjct: 116 LESKKLVHR 124

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 22/143 (15%)

Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           SP KS ++ G +IG G+FG VY     +T    AIK+V     DP+         +E+ +
Sbjct: 63  SPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYK------NRELLI 112

Query: 410 LGHLKHENIV---QYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCRD---ITESI 458
           + +L H NI+    YY +E    +     L + +E++ P ++++Y++ + R+   +   +
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFL 171

Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
           V+ ++  +   LAY+HS    HR
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHR 194

Length = 440

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 29/132 (21%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 420
           +G G FG V    ++ TG + AIK+   I     +    K+  +E+K+L HL+HENI+  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKK---IMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 421 -----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
                      Y+ +E++   L+  L                R + +  ++ F   IL G
Sbjct: 75  SDIFISPLEDIYFVTELLGTDLHRLLT--------------SRPLEKQFIQYFLYQILRG 120

Query: 470 LAYLHSTNTIHR 481
           L Y+HS   +HR
Sbjct: 121 LKYVHSAGVVHR 132

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 36/130 (27%), Positives = 63/130 (48%), Gaps = 5/130 (3%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   + K + +G GT+ +V+ G ++ T    A+KE+ +  ++      I+    E+ +L 
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLK 59

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH NIV  +     D  L +  EY+    + +Y+ +    ++   V+ F   IL GLA
Sbjct: 60  DLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 472 YLHSTNTIHR 481
           Y H    +HR
Sbjct: 119 YCHRRKVLHR 128

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 6/121 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H NIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPNIVR 57

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
             G       +YI +E V  G    ++R     +    +     +   G+ YL S + IH
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 481 R 481
           R
Sbjct: 118 R 118

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 25/159 (15%)

Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 6   EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65

Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 66  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122

Query: 451 CRDITE--------SIVRNFTRHILNGLAYLHSTNTIHR 481
             DI            + + T  +  G+ YL S   IHR
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 7/120 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G FG V++G   E     AIK +       + A   +   +E +V+  L H  +VQ 
Sbjct: 12  IGSGQFGLVWLGYWLEK-RKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YG       + +  E++  G ++ Y+R      ++  +      +  G+AYL S+N IHR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 32/121 (26%), Positives = 63/121 (52%), Gaps = 7/121 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G GT+ +V+ G ++ T    A+KE+ +  ++      I+    E+ +L +LKH NIV  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIH 480
           +     +  L +  EY+    + +Y+ ++C ++ +   V+ F   +L GL+Y H    +H
Sbjct: 69  HDIIHTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 481 R 481
           R
Sbjct: 127 R 127

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 6/121 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G  GSV    +  TG   A K V I     KS    KQ+ +E++++   +   IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKS-SVRKQILRELQIMHECRSPYIVSF 68

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-H 480
           YG+ + ++++ + +E++  GS++R  ++    I   I+      ++ GL YL++ + I H
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 481 R 481
           R
Sbjct: 128 R 128

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 26/154 (16%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYI------------GTNRETGASCAIKEVDIIPDDPKSAE 398
           P++    K KL G G FG V++            G     G    +    +  D  K+A 
Sbjct: 3   PRQQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--RE------H 450
                 +EIK++  LK+ NI++  G  V DD L +  EY+  G +N+++  RE      H
Sbjct: 62  --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 451 CRDITESIVRNF---TRHILNGLAYLHSTNTIHR 481
             +I    + N       I +G+ YL S N +HR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 14/128 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
           K+IG+G+FG V +  ++  G   A+K +       K A   K+ ++ I      +L ++K
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVK 54

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
           H  +V  + S    D LY  L+YV+ G +  ++ RE  R   E   R +   I + L YL
Sbjct: 55  HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYL 112

Query: 474 HSTNTIHR 481
           HS N I+R
Sbjct: 113 HSLNIIYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 6/124 (4%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +++G+G+FG V +   +E+G   A+K  + D+I  D    EC    E+ I  L    H  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 57

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           + Q Y      D L+  +E+V+ G +  ++++  R   E+  R +   I + L +LH   
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG 116

Query: 478 TIHR 481
            I+R
Sbjct: 117 IIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 8/126 (6%)

Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           G+ IG G FG VY G          + A+K        P   E   +  QE  ++    H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVRE---KFLQEAYIMRQFDH 66

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            +IV+  G  + ++ ++I +E    G +  Y++ +   +  + +  ++  +   LAYL S
Sbjct: 67  PHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 476 TNTIHR 481
              +HR
Sbjct: 126 KRFVHR 131

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
             Q  +++G G  G+VY   +  T    A+K   +IP D  + E  KQ+  E+++L    
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVK---VIPLD-ITVELQKQIMSELEILYKCD 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
              I+ +YG+  V++ + I  E++  GS++ Y     R I E ++      ++ GL YL 
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW 112

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 113 SLKILHR 119

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 10/124 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQ 420
           IG GTF  V    +R+TG   AIK    +    KS E +  L +EI+ L  L  H NI++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKC---MKKHFKSLEQVNNL-REIQALRRLSPHPNILR 62

Query: 421 YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
               EV+ D     L  V      ++   ++   R + E  V+++   +L  L ++H   
Sbjct: 63  LI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 478 TIHR 481
             HR
Sbjct: 121 IFHR 124

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 21/132 (15%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENI 418
           K +G G +GSV    ++ TG   AIK++      P  +E   K+  +E+ +L H++HEN+
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 419 V---QYYGSEVVDDHLY-IYLEYVHPGSINRYVREHCRDI-----TESIVRNFTRHILNG 469
           +     + S V  D     YL  V P     Y++   + I     +E  V+     +L G
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYL--VMP-----YMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 470 LAYLHSTNTIHR 481
           L Y+HS   IHR
Sbjct: 130 LKYIHSAGIIHR 141

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 5/120 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G GT+ +VY G ++ T    A+KE+ +  ++      I+    E+ +L  LKH NIV  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +     +  L +  EY+    + +Y+ +    I    V+ F   +L GL Y H    +HR
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 5/124 (4%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G+G+FG+VY+  +++  A   +K +  IP  +    E + Q  QE ++L  L H  IV+
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKLDHPAIVK 66

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTN 477
           ++ S +  D   I  EY     ++  + E       ++E+ V  +   +L G+ Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 478 TIHR 481
            +HR
Sbjct: 127 ILHR 130

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 37/128 (28%), Positives = 57/128 (44%), Gaps = 13/128 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASC---AIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHL 413
           K+IG G FG V  G  +  G      AIK +       K+    KQ      E  ++G  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-------KAGSSDKQRLDFLTEASIMGQF 62

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H NI++  G       + I  EY+  GS+++++RE+    T   +    R I +G+ YL
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 474 HSTNTIHR 481
              N +HR
Sbjct: 123 SEMNYVHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 31/157 (19%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLE-- 404
           P+K    K KL G G FG V++    G  +      +   +D+  + P     +K L   
Sbjct: 3   PRKRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFS---LDVSGNQPVLV-AVKMLRED 57

Query: 405 ----------QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---- 450
                     +EIK++  LK  NI++     +  D L +  EY+  G +N+++  H    
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 451 ------CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                    I+ S +      I +G+ YL S N +HR
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 16/134 (11%)

Query: 360 KLIGRGTFGSVYIGTNRE-----TGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             +G G FG VY GT  +     +G    A+K +     D +  E +K    E  ++ + 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK----EAHLMSNF 56

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR------HIL 467
            H NIV+  G  ++++  YI +E +  G +  Y+R+   +     +            + 
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 468 NGLAYLHSTNTIHR 481
            G  YL   + IHR
Sbjct: 117 KGCVYLEQMHFIHR 130

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 34/150 (22%), Positives = 59/150 (39%), Gaps = 26/150 (17%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
             GK +G G FG V   T            V +  + ++  S+E ++ L  E  +L  + 
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVN 61

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------------------C 451
           H ++++ YG+   D  L + +EY   GS+  ++RE                         
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           R +T   + +F   I  G+ YL     +HR
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHR 151

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 33/123 (26%), Positives = 62/123 (50%), Gaps = 9/123 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V++GT        A+K +      P+S        +E +++  L+H+ +V
Sbjct: 12  KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPES------FLEEAQIMKKLRHDKLV 64

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 478
           Q Y + V ++ +YI  EY+  GS+  ++++   R +    + +    +  G+AY+   N 
Sbjct: 65  QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 479 IHR 481
           IHR
Sbjct: 124 IHR 126

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 54

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 112

Query: 475 STNTIHR 481
           S + ++R
Sbjct: 113 SRDVVYR 119

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 32/160 (20%)

Query: 351 PKKSQWQK-------GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS--- 396
           P+  +W+        GK +G G FG V     IG ++E         V ++  D      
Sbjct: 8   PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67

Query: 397 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------E 449
           ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E
Sbjct: 68  SDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124

Query: 450 HCRDITESIVRNFT--------RHILNGLAYLHSTNTIHR 481
           +C + T+      +          +  G+ YL S   IHR
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 33/124 (26%), Positives = 59/124 (47%), Gaps = 10/124 (8%)

Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           + +G G FG V+ G  N  T    A+K +     DPK          E +++  L+H  +
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPK------DFLAEAQIMKKLRHPKL 63

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +Q Y    +++ +YI  E +  GS+  Y++    R +    + +    + +G+AYL + N
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123

Query: 478 TIHR 481
            IHR
Sbjct: 124 YIHR 127

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
           K+IG+G+FG V +  ++      A+K +       K A   K+ E+ I      +L ++K
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQ------KKAILKKKEEKHIMSERNVLLKNVK 54

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
           H  +V  + S    D LY  L+Y++ G +  ++ RE C    E   R +   I + L YL
Sbjct: 55  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 112

Query: 474 HSTNTIHR 481
           HS N ++R
Sbjct: 113 HSLNIVYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 33/130 (25%), Positives = 57/130 (43%), Gaps = 1/130 (0%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ +K KL+G G FG+V+ G     G S  I        D    +  +++   +  +G
Sbjct: 5   KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            L H  IV+  G       L +  +    GS+  +VR+H   +    + N+   I  G+ 
Sbjct: 65  SLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 124 YLEEHRMVHR 133

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 33/138 (23%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV 419
            IGRG FG+V    ++ +G   A+K +    D+ K     K+L  ++ V+        IV
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQ---KRLLMDLDVVMRSSDCPYIV 66

Query: 420 QYYGS-----------EVVD---DHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
           ++YG+           E++D   D  Y            +YV E  +  I E I+     
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFY------------KYVYEVLKSVIPEEILGKIAV 114

Query: 465 HILNGLAYLHST-NTIHR 481
             +  L YL      IHR
Sbjct: 115 ATVKALNYLKEELKIIHR 132

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 37/138 (26%), Positives = 58/138 (42%), Gaps = 36/138 (26%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G FG V+  T+   G   A+K++  +  +  S    K++ +E+K+L   KH+N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE--------SIVRN----------FT 463
                        L+ + P  I+ +  E    +TE         IV            F 
Sbjct: 65  -------------LDILQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109

Query: 464 RHILNGLAYLHSTNTIHR 481
             IL GL YLHS   +HR
Sbjct: 110 YQILRGLKYLHSAGILHR 127

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 16/129 (12%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----EIKV-LGHL 413
           K+IG+G+FG V +   +  G+  A+K +       +    +K+ EQ     E  V L +L
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVL-------QKKTILKKKEQNHIMAERNVLLKNL 53

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 472
           KH  +V  + S    + LY  L+YV+ G +  ++ RE C    E   R +   + + + Y
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGY 111

Query: 473 LHSTNTIHR 481
           LHS N I+R
Sbjct: 112 LHSLNIIYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 349 ASPK----KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           A PK    +++   GK +G G FG V     IG +++         V ++ DD      +
Sbjct: 3   ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62

Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R         
Sbjct: 63  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119

Query: 449 --EHCRDITESI----VRNFTRHILNGLAYLHSTNTIHR 481
             + C+   E +    + +    +  G+ YL S   IHR
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 32/129 (24%), Positives = 60/129 (46%), Gaps = 14/129 (10%)

Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHL 413
           ++IG+G FG VY GT   +      CA+K ++ I D       ++++EQ +K   ++   
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------LEEVEQFLKEGIIMKDF 53

Query: 414 KHENIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
            H N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ Y
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 473 LHSTNTIHR 481
           L S   +HR
Sbjct: 114 LASKKFVHR 122

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 12/123 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K IG G FG V++  ++ T      K +    + +  KS     QL  E+ V+  LKH+N
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRELKHKN 73

Query: 418 IVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAY 472
           IV+Y    +   +  LYI +E+   G ++R +++  +    I E  + + TR +L+ LAY
Sbjct: 74  IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133

Query: 473 LHS 475
            H+
Sbjct: 134 CHN 136

Length = 1021

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 1/130 (0%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 5   KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 65  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 124 YLEERRLVHR 133

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 11/126 (8%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + +G   A+    KEV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE------VAHTLTESRVLKNTRH 54

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +     S    D L   +EYV+ G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS 113

Query: 476 TNTIHR 481
              ++R
Sbjct: 114 GKIVYR 119

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 16/129 (12%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K++G+G+FG V +   +  G   A+    K+V +I DD    EC      E +VL  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTM---VEKRVLA-LAW 53

Query: 416 EN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAY 472
           EN  +   Y +    +HL+  +E+++ G +  ++++  R D+  +    +   I+ GL +
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQF 111

Query: 473 LHSTNTIHR 481
           LHS   I+R
Sbjct: 112 LHSKGIIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 9/121 (7%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +++  L+H+ +V  
Sbjct: 14  LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66

Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y + V ++ +YI  E++  GS+  +++E   + +    + +    I +G+AY+   N IH
Sbjct: 67  Y-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125

Query: 481 R 481
           R
Sbjct: 126 R 126

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 32/127 (25%), Positives = 65/127 (51%), Gaps = 12/127 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K++G+G+FG V++   + T    AI    K+V ++ DD    EC   +E+ +  L   +H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VEC-TMVEKRVLSLA-WEH 55

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLH 474
             +   Y +    ++L+  +EY++ G +  +++  H  D+  +    +   I+ GL +LH
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLH 113

Query: 475 STNTIHR 481
           S   ++R
Sbjct: 114 SKGIVYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 33/133 (24%), Positives = 67/133 (50%), Gaps = 12/133 (9%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
           ++Q    +G G +GSV    +       A+K++      P +S    ++  +E+++L H+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS----RPFQSLIHARRTYRELRLLKHM 71

Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILN 468
           KHEN++     +  +  +++   +YL     G+ +N  V+  C+ +++  V+     +L 
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLR 129

Query: 469 GLAYLHSTNTIHR 481
           GL Y+HS   IHR
Sbjct: 130 GLKYIHSAGIIHR 142

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 37/145 (25%), Positives = 63/145 (43%), Gaps = 25/145 (17%)

Query: 359 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLG 411
           GK +G G FG V      G ++          V ++ D   D   A+ I ++E  +K++G
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIG 75

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFT- 463
             KH+NI+   G    +  LY+ +EY   G++  ++R       ++  DIT+      + 
Sbjct: 76  --KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 464 -------RHILNGLAYLHSTNTIHR 481
                    +  G+ YL S   IHR
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHR 158

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 14/127 (11%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
           K+IGRG FG V +  ++ +    A+K +          E IK+ +     +E  ++ H  
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAHAN 101

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
            E IVQ + +   D +LY+ +EY+  G +   +  +  DI E   R +T  ++  L  +H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH 159

Query: 475 STNTIHR 481
           S   IHR
Sbjct: 160 SMGFIHR 166

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 14/129 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           ++IG+G++G V    +  TG   AIK+++ + +    A  I    +EIK+L  L+H +IV
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL---REIKLLRLLRHPDIV 62

Query: 420 QYYG-------SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           +           E  D  +Y+  E +   S    V +   D+T    + F   +L  L Y
Sbjct: 63  EIKHIMLPPSRREFKD--IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 473 LHSTNTIHR 481
           +H+ N  HR
Sbjct: 119 IHTANVFHR 127

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 31/124 (25%), Positives = 63/124 (50%), Gaps = 10/124 (8%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 12  KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 64

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 477
           + Y     ++ +YI  EY+  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 123

Query: 478 TIHR 481
            IHR
Sbjct: 124 YIHR 127

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 4/121 (3%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G G +G V    ++ET    AIK+     D  ++ E  +   +E+K+L  LK ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
              +      LY+  EYV    +   + E    +    VR++   ++  + + H  + +H
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 481 R 481
           R
Sbjct: 124 R 124

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 10/128 (7%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +K   +G G  G V    +R +G   A K +  +I P          Q+ +E+KVL    
Sbjct: 4   EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECN 57

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
              IV +YG+   D  + I +E++  GS+++ +++  R I E+I+   +  +L GL YL 
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLR 116

Query: 475 STNTI-HR 481
             + I HR
Sbjct: 117 EKHKIMHR 124

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G+G+FG V +   + T    AIK +    I+ DD    +C    E+ I  L   KH 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDC-TMTEKRILALAA-KHP 56

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +   +      D L+  +EYV+ G +  +  +  R   E   R +   +   L +LH  
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 477 NTIHR 481
             I+R
Sbjct: 116 GVIYR 120

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 6/123 (4%)

Query: 362 IGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IGRG     SVY+  +  TG    ++  D+   +  + E +K L+ E+ +    +H NI+
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEVVLSHFFRHPNIM 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 478
             +        L++   ++  GS N  ++ +  + ++E+++ N     L GL YLH    
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 479 IHR 481
           IHR
Sbjct: 123 IHR 125

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 9/124 (7%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV---DIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
           +GRG FG V +   ++TG   AIK +   DII  D+ +S  C K++    +     +H  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHPF 63

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +V  +     +DH+   +EY   G +  ++  H    +E     +   ++ GL YLH   
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 478 TIHR 481
            ++R
Sbjct: 122 IVYR 125

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 35/125 (28%), Positives = 62/125 (49%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKV-LGHLKHE 416
           K+IG+G+FG V +   +  G   A+K  +  I+ +  +     K +  E  V L ++KH 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ----KHIMAERNVLLKNVKHP 56

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +V  + S    + LY  L++V+ G +  +++   R   E   R +   I + L YLHS 
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI 115

Query: 477 NTIHR 481
           N ++R
Sbjct: 116 NIVYR 120

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 30/125 (24%), Positives = 58/125 (46%), Gaps = 13/125 (10%)

Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K +G G FG V++G        A  ++K+  + P+             E  ++  L+H  
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------AFLAEANLMKQLQHPR 62

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHST 476
           +V+ Y + V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   
Sbjct: 63  LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 477 NTIHR 481
           N IHR
Sbjct: 122 NYIHR 126

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 31/124 (25%), Positives = 58/124 (46%), Gaps = 11/124 (8%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLKHEN 417
           +G+G +G V++   ++TG   A+K +       KS       ++ +  E  +L   K E 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +V+   +   D++LY+ +EYV PG   R +  +   ++E   R +   +   +  LH   
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 478 TIHR 481
            IHR
Sbjct: 122 YIHR 125

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 34/125 (27%), Positives = 54/125 (43%), Gaps = 7/125 (5%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGK----REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI+   G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 477 NTIHR 481
             +HR
Sbjct: 126 GYVHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 32/134 (23%), Positives = 52/134 (38%), Gaps = 11/134 (8%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
              + +G G FG VY G  R         +V +  +P+     +    L  E  ++    
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFN 67

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------ITESIVRNFTRHIL 467
           H+NIV+  G        +I LE +  G +  ++RE  R        +T   +    R + 
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVA 126

Query: 468 NGLAYLHSTNTIHR 481
            G  YL   + IHR
Sbjct: 127 KGCKYLEENHFIHR 140

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 20/109 (18%)

Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
           PD  K+A       +E+K+L  LK  NI++  G  V +D L +  EY+  G +N+++  H
Sbjct: 56  PDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH 113

Query: 451 CRD------------------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
             D                  I+ S + +    I +G+ YL S N +HR
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 14/128 (10%)

Query: 360 KLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHL 413
           + +G G+FG V + T + E     AIK  +        ++ IKQ +      E K+L ++
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKILNYI 88

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H   V  YGS   + +LY+ LE+V  G    ++R + R     +   +   I+    YL
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYL 147

Query: 474 HSTNTIHR 481
            S N ++R
Sbjct: 148 QSLNIVYR 155

Length = 340

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 1/130 (0%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++++K K++G G FG+VY G     G    I        +  S +  K++  E  V+ 
Sbjct: 5   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 65  SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 124 YLEERRLVHR 133

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.3 bits (97), Expect = 8e-04
 Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 20/130 (15%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHE 416
           L+GRG FG V +   + TG   A+K +       KS     E +   E+E  +L      
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMK------KSVLLAQETVSFFEEERDILSISNSP 61

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS-----INRYVREHCRDITESIVRNFTRHILNGLA 471
            I Q   +    D+LY+ +EY  PG      +NRY  +      E + + +   ++  + 
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEY-QPGGDLLSLLNRYEDQ----FDEDMAQFYLAELVLAIH 116

Query: 472 YLHSTNTIHR 481
            +H    +HR
Sbjct: 117 SVHQMGYVHR 126

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 14/135 (10%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QE 406
           K   ++  K+IGRG FG V +  ++ T    A+K +          E IK+ +     +E
Sbjct: 41  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 93

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  +
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 151

Query: 467 LNGLAYLHSTNTIHR 481
           +  L  +HS   IHR
Sbjct: 152 VLALDAIHSMGFIHR 166

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 24/143 (16%)

Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG+G FG V+              +  V ++ ++  SA+     ++E  ++    H NIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIV 71

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR--------------- 464
           +  G   V   + +  EY+  G +N ++R        S+  + +                
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 465 ------HILNGLAYLHSTNTIHR 481
                  +  G+AYL     +HR
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHR 154

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 7/125 (5%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI+   G       + I  E++  G+++ ++R++    T   +    R I  G+ YL   
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 477 NTIHR 481
           N +HR
Sbjct: 126 NYVHR 130

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 27/121 (22%), Positives = 53/121 (43%), Gaps = 2/121 (1%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G+GTF  ++ G  RE G    + + +++    D       +   +   ++  L H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
             YG  V  D   +  EYV  GS++ Y++++   I  S      + +   L +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122

Query: 480 H 480
           H
Sbjct: 123 H 123

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 31/127 (24%), Positives = 59/127 (46%), Gaps = 14/127 (11%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
           K+IGRG FG V +  ++ +    A+K +          E IK+ +     +E  ++    
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
              +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   + +T  ++  L  +H
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH 159

Query: 475 STNTIHR 481
           S   IHR
Sbjct: 160 SMGLIHR 166

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 9/118 (7%)

Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
           +I   P   P  S+W+        G+++G G FG V  GT      S  + +V +    P
Sbjct: 18  YIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKP 77

Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
            +    KQ L  E+K++ HL  H NIV   G+      +YI  EY   G +  Y+ ++
Sbjct: 78  TARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV +  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRVLQNSRH 54

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS 113

Query: 476 T-NTIHR 481
             N ++R
Sbjct: 114 EKNVVYR 120

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 2/81 (2%)

Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
           Q+ +E++VL       IV +YG+   D  + I +E++  GS+++ ++E  + I E I+  
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGK 107

Query: 462 FTRHILNGLAYLHSTNTI-HR 481
            +  +L GLAYL   + I HR
Sbjct: 108 VSIAVLRGLAYLREKHQIMHR 128

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 32/124 (25%), Positives = 62/124 (50%), Gaps = 11/124 (8%)

Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           K +G G FG V++ T N+ T    A+K +      P S   ++    E  V+  L+H+ +
Sbjct: 12  KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSMS-VEAFLAEANVMKTLQHDKL 63

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
           V+ + + V  + +YI  E++  GS+  +++ +         + +F+  I  G+A++   N
Sbjct: 64  VKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 478 TIHR 481
            IHR
Sbjct: 123 YIHR 126

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 25/133 (18%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQ---EIKVLGHLKH 415
           KLI  G +G+VY+  ++ET    A+K+++      K    ++ Q++Q   E  +L   ++
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-------VRNFTRHILN 468
             +V  + S     HL + +EYV  G         C  + ++I        R +    + 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGD--------CATLLKNIGALPVDMARMYFAETVL 112

Query: 469 GLAYLHSTNTIHR 481
            L YLH+   +HR
Sbjct: 113 ALEYLHNYGIVHR 125

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 35/128 (27%), Positives = 54/128 (42%), Gaps = 16/128 (12%)

Query: 362 IGRGTFGSVYIGTNRETGASCA---IKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKHE 416
           IG G FG V +G     G S A   +KE+        SA   +QL   QE++    L H 
Sbjct: 3   IGNGWFGKVLLG-EAHRGMSKARVVVKELR------ASATPDEQLLFLQEVQPYRELNHP 55

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRH-ILNGLAY 472
           N++Q  G  +      + LE+   G +  Y+R        + +  V       + +GL +
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 473 LHSTNTIH 480
           LH  + IH
Sbjct: 116 LHQADFIH 123

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
            ++G+G+FG V +   + T    AIK +    II DD    EC   +E+ +  L   K  
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECT-MVEKRVLALPG-KPP 61

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            + Q +      D LY  +EYV+ G +  ++++  +   E     +   I  GL +LHS 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 477 NTIHR 481
             I+R
Sbjct: 121 GIIYR 125

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 29/122 (23%), Positives = 59/122 (48%), Gaps = 7/122 (5%)

Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FG+V  G    +++  + A+K   I+ +D        +L +E  V+  L +  IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           +  G     +   + +E    G +N++++++ + +TE  +      +  G+ YL  TN +
Sbjct: 60  RMIGI-CEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 480 HR 481
           HR
Sbjct: 118 HR 119

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 20/138 (14%)

Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           +IG G FG V     ++ G   + AIK +     +    +   +LE   K LGH  H NI
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK-LGH--HPNI 65

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------------EH--CRDITESIVRNFT 463
           +   G+     +LYI +EY   G++  ++R             EH     +T   +  F 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 464 RHILNGLAYLHSTNTIHR 481
             +  G+ YL     IHR
Sbjct: 126 SDVATGMQYLSEKQFIHR 143

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	481
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.92
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.9
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.9
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.87
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.85
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.85
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.85
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.85
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.85
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.84
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.84
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.84
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.84
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.84
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.84
KOG0198	313	consensus MEKK and related serine/threonine protei	99.84
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.83
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.83
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.83
KOG0605	550	consensus NDR and related serine/threonine kinases	99.83
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.83
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.83
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.83
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.83
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.83
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.82
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.82
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.82
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.82
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.81
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.81
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.81
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.81
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.81
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.81
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.81
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.81
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.81
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.81
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.8
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.8
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.8
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.8
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.8
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.8
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.8
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.8
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.8
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.8
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.79
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.79
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.79
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.79
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.79
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.79
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.79
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.79
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.79
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.79
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.79
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.79
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.79
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.79
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.79
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.78
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.78
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.78
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.78
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.78
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.78
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.78
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.78
KOG0589	426	consensus Serine/threonine protein kinase [General	99.78
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.78
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.78
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.78
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.78
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.78
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.78
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.78
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.78
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.78
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.78
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.78
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.78
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.78
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.78
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.78
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.78
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.78
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.78
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.78
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.78
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.78
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.78
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.78
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.77
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.77
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.77
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.77
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.77
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.77
KOG0610	459	consensus Putative serine/threonine protein kinase	99.77
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.77
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.77
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.77
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.77
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.77
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.77
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.77
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.77
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.77
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.77
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.77
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.77
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.77
KOG0586	596	consensus Serine/threonine protein kinase [General	99.77
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.77
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.77
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.77
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.77
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.77
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.77
PHA03212	391	serine/threonine kinase US3; Provisional	99.77
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.76
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.76
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.76
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.76
KOG0578	550	consensus p21-activated serine/threonine protein k	99.76
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.76
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.76
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.76
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.76
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.76
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.76
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.76
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.76
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.76
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.76
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.76
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.76
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.76
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.76
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.76
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.76
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.76
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.75
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.75
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.75
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.75
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.75
PHA03211	461	serine/threonine kinase US3; Provisional	99.75
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.75
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.75
PTZ00267	478	NIMA-related protein kinase; Provisional	99.75
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.75
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.75
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.75
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.75
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.75
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.75
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.75
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.75
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.75
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.75
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.75
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.75
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.74
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.74
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.74
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.74
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.74
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.74
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.74
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.74
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.74
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.74
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.74
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.74
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.74
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.74
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.74
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.74
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.74
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.74
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.74
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.74
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.74
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.74
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.74
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.74
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.73
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.73
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.73
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.73
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.73
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.73
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.73
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.73
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.73
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.73
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.73
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.73
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.73
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.73
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.73
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.73
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.73
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.73
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.73
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.73
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.73
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.73
PHA03209	357	serine/threonine kinase US3; Provisional	99.73
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.73
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.73
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.73
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.73
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.73
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.73
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.73
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.73
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.73
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.73
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.73
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.73
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.73
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.73
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.73
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.72
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.72
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.72
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.72
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.72
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.72
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.72
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.72
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.72
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.72
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.72
PTZ00283	496	serine/threonine protein kinase; Provisional	99.72
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.72
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.72
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.72
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.72
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.72
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.72
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.72
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.72
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.72
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.72
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.72
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.72
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.72
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.72
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.72
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.72
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.72
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.72
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.72
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.72
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.72
PLN00009	294	cyclin-dependent kinase A; Provisional	99.72
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.71
PTZ00036	440	glycogen synthase kinase; Provisional	99.71
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.71
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.71
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.71
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.71
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.71
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.71
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.71
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.71
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.71
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.71
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.71
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.71
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.71
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.71
PTZ00284	467	protein kinase; Provisional	99.71
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.71
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.71
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.71
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.71
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.71
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.71
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.7
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.7
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.7
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.7
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.7
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.7
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.7
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.7
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.7
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.7
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.7
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.7
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.69
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.69
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.69
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.69
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.69
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.69
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.69
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.69
PHA03207	392	serine/threonine kinase US3; Provisional	99.69
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.69
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.69
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.69
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.69
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.69
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.69
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.69
PHA02988	283	hypothetical protein; Provisional	99.69
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.69
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.68
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.68
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.68
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.68
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.68
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.68
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.68
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.68
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.68
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.68
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.68
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.67
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.67
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.67
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.67
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.67
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.67
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.67
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.67
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.67
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.67
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.67
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.67
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.66
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.66
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.66
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.66
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.66
KOG1152	772	consensus Signal transduction serine/threonine kin	99.66
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.66
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.65
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.65
KOG0584	632	consensus Serine/threonine protein kinase [General	99.65
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.65
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.65
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.65
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.64
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.64
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.64
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.64
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.63
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.63
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.62
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.62
PRK09188	365	serine/threonine protein kinase; Provisional	99.62
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.62
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.61
PHA03210	501	serine/threonine kinase US3; Provisional	99.61
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.61
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.61
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.6
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.6
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.6
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.59
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.59
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.58
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.57
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.57
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.57
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.56
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.54
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.54
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.53
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.53
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.52
PRK10345	210	hypothetical protein; Provisional	99.52
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.52
PHA02882	294	putative serine/threonine kinase; Provisional	99.52
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.5
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.48
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.48
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.48
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.47
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.43
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.41
KOG3653	534	consensus Transforming growth factor beta/activin	99.41
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.41
PRK14879	211	serine/threonine protein kinase; Provisional	99.4
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.38
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.36
smart00090	237	RIO RIO-like kinase.	99.35
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.35
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.34
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.33
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.33
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.31
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.31
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.3
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.29
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.29
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.28
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.27
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.27
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.23
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.21
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.16
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.13
PRK12274	218	serine/threonine protein kinase; Provisional	99.06
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.04
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.02
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.02
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.0
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.97
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.88
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	98.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.29
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.22
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.2
KOG1243	690	consensus Protein kinase [General function predict	98.18
PLN00181	793	protein SPA1-RELATED; Provisional	98.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.13
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.13
KOG3087	229	consensus Serine/threonine protein kinase [General	97.96
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	97.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	97.68
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.59
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.51
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.35
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.0
PF01636	239	APH: Phosphotransferase enzyme family This family	96.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.66
PLN02876	822	acyl-CoA dehydrogenase	96.57
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.56
PRK09902	216	hypothetical protein; Provisional	96.32
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	96.13
PRK10593	297	hypothetical protein; Provisional	96.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	95.86
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	95.6
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	94.32
KOG0576	829	consensus Mitogen-activated protein kinase kinase	94.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	94.29
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	93.73
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	92.94
PRK09550	401	mtnK methylthioribose kinase; Reviewed	92.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	92.23
KOG2270	520	consensus Serine/threonine protein kinase involved	91.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	91.52
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	91.5
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	89.91
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	87.99
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	87.85
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	87.7
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	87.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	82.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	81.52
PLN02756	418	S-methyl-5-thioribose kinase	81.25
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	80.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	80.59
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	80.57

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.92  E-value=6.9e-25  Score=225.87  Aligned_cols=127  Identities=31%  Similarity=0.582  Sum_probs=117.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|.+.+.||+|+||.||+|+++.++..||||.|...   .......+.+..||++|+.++|+|||.|++++.++++
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~---~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKK---KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhh---ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            3567899999999999999999999999999999998642   2255667788899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.||||.+||+.+ +.+.|..++.++.||+.||+|||+++||||
T Consensus        84 i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHR  133 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHR  133 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999999999885 789999999999999999999999999998

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=3e-23  Score=214.09  Aligned_cols=129  Identities=29%  Similarity=0.441  Sum_probs=116.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHH--HHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e--~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++..........+  ....+.+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            56789999999999999999999999999999999986554443321  2234679999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|||||||+||+|++++-.+ +.+.|..-+.|++||+.||+|||++||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HR  300 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHR  300 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccc
Confidence            999999999999999999774 889999999999999999999999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=4.8e-23  Score=220.35  Aligned_cols=125  Identities=34%  Similarity=0.572  Sum_probs=114.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|.+++.||+|+|+.||.+++..+|+.||+|+|.....  ......+++.+||+|.+.|+|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            789999999999999999999999999999999963221  223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|+|+.++|..+++. .+.++|.++++|++||+.||.|||+++||||
T Consensus        96 vLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHR  142 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHR  142 (592)
T ss_pred             EEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceec
Confidence            9999999999999985 5899999999999999999999999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.1e-22  Score=213.97  Aligned_cols=128  Identities=27%  Similarity=0.476  Sum_probs=114.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-  428 (481)
                      ......|+++++||+|+||.||+|++..+|+.||+|+|+...   ...+......+||.||++|+|||||+|.++.... 
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN---EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc---CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            345578999999999999999999999999999999997533   3345566778899999999999999999998877 


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+|||+|||+ .||.-++......|++.+|+.||+||+.||+|||.+||+||
T Consensus       190 ~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR  242 (560)
T KOG0600|consen  190 SGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR  242 (560)
T ss_pred             CceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeec
Confidence             67999999997 99999998766789999999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=6.4e-21  Score=198.44  Aligned_cols=130  Identities=28%  Similarity=0.514  Sum_probs=115.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d  429 (481)
                      ...+.|.+++.||+|+||+|++|.+..++..||||++.............+.+.+||.+|+.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567999999999999999999999999999999977643211111234556778999999999 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||.||+|+++|.. .+.+.|..++.|++||+.||+|||.+||+||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HR  144 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHR  144 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeC
Confidence            99999999999999999988 6999999999999999999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.85  E-value=3.5e-21  Score=196.45  Aligned_cols=128  Identities=27%  Similarity=0.420  Sum_probs=116.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|+++++||+|+||+||+++.+++++.||+|++++......  ...+.+..|..||..++||.||+++..|.+.+.
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            345689999999999999999999999999999999975443222  345778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+||+.||+|+.+|+.. +.|.|..++.|+.+|+.||.|||++|||||
T Consensus       100 LylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyR  149 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYR  149 (357)
T ss_pred             EEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeec
Confidence            99999999999999999874 889999999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.85  E-value=1.8e-21  Score=192.17  Aligned_cols=124  Identities=27%  Similarity=0.447  Sum_probs=112.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|.+.++||+|+||.||+|.+..+|+.||||+|++...   .........+||++|+.++|+|||.|+++|...+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~---kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA---KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc---ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            478999999999999999999999999999999986421   11223456779999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||+ .||+..|++....+...+++.|+.|+++||+|||.+.|+||
T Consensus        79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHR  125 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHR  125 (318)
T ss_pred             EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            999996 99999999887889999999999999999999999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1.1e-21  Score=202.32  Aligned_cols=128  Identities=27%  Similarity=0.535  Sum_probs=118.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..+.+|++.+.||+|+||+|-+|.+...|..||||.|+.  +.-++++.+-.+.+||+||..|+|||||++|++|+..+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK--dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK--DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh--hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            455689999999999999999999999999999999874  344667777789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.|||||..+|+|++||.+ ++.++|.+++.|++||+.|+.|||.++++||
T Consensus       128 IvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHR  177 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHR  177 (668)
T ss_pred             EEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceec
Confidence            9999999999999999987 4899999999999999999999999999998

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.5e-20  Score=190.78  Aligned_cols=125  Identities=24%  Similarity=0.395  Sum_probs=112.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||+|++..+++.||||+++...  .........+.+|+.+|..++|+||++++++|.+++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE--MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            37999999999999999999999999999999997421  1123345667889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||.+|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~  125 (364)
T cd05599          79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHR  125 (364)
T ss_pred             EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=193.12  Aligned_cols=126  Identities=28%  Similarity=0.482  Sum_probs=115.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ....+.+.++.||+|..|.||++.++.+++.+|+|+|..    ..+....+++.+|+++++.++|||||.+||+|..++ 
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            345578889999999999999999999999999999953    244566789999999999999999999999999999 


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      .++|+||||++|+|.++++.. +.++|..+..|+.++++||.|||+ ++||||
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR  203 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHR  203 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeec
Confidence            599999999999999999875 889999999999999999999996 899998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.2e-20  Score=191.26  Aligned_cols=125  Identities=22%  Similarity=0.344  Sum_probs=112.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.++||+|+||.||++.+..+++.||||++....  .......+.+.+|+++|++++|+||++++++|.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            37999999999999999999999999999999986321  1123345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|.+++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus        79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHr  125 (377)
T cd05629          79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHR  125 (377)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999764 779999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.84  E-value=2.4e-20  Score=190.59  Aligned_cols=125  Identities=24%  Similarity=0.332  Sum_probs=111.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....  .........+.+|+.+|+.++|+||+++++.|..++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            37999999999999999999999999999999985321  1112234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||++|+|.+++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus        79 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHr  125 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHR  125 (376)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            99999999999999764 678999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.84  E-value=3.6e-20  Score=190.39  Aligned_cols=124  Identities=23%  Similarity=0.344  Sum_probs=111.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++++.||+|+||+||+|.+..+++.||||++....  .......+.+.+|+.+|+.++|+||+++++++.+.+.+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            6899999999999999999999999999999986421  12234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+||+|.+++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHr  125 (381)
T cd05626          80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHR  125 (381)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999764 679999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.84  E-value=3.5e-20  Score=189.10  Aligned_cols=125  Identities=22%  Similarity=0.334  Sum_probs=112.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||+|.+..+++.||||+++...  .........+.+|+.+|.+++|+||+++++.+.+.+.+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            36899999999999999999999999999999986321  1223345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHr  125 (363)
T cd05628          79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHR  125 (363)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            99999999999999764 789999999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.84  E-value=4.1e-20  Score=189.58  Aligned_cols=124  Identities=23%  Similarity=0.336  Sum_probs=111.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|+++++||+|+||.||+|.+..+++.||||++....  .........+.+|+.+|++++|+|||++++.|.+++.+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            6899999999999999999999999999999986321  12234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||++|+|.+++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHr  125 (382)
T cd05625          80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHR  125 (382)
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999764 679999999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-20  Score=191.21  Aligned_cols=124  Identities=46%  Similarity=0.829  Sum_probs=111.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--E
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--H  430 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--~  430 (481)
                      ..+|.+++.||+|+||.||++.+..+|..+|||.+...    ... ..+.+.+|+.+|.+|+|+|||+++|......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            45799999999999999999999999999999998753    111 1677899999999999999999999865554  6


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|+|||+.+|+|.++++..++.++|..++.|++||++||+|||++|||||
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~  141 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHC  141 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            999999999999999998875589999999999999999999999999997

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.83  E-value=1.4e-19  Score=183.70  Aligned_cols=122  Identities=28%  Similarity=0.429  Sum_probs=107.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|+++++||+|+||.||+|.+..+++.||||++...    ......+.+.+|+++|+.++|+||+++++++..++.
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            3456789999999999999999999999999999998532    233445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|||||++|+|...     ..+.+..+..|+.||+.||+|||++|||||
T Consensus       147 ~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  192 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHR  192 (353)
T ss_pred             EEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            9999999999998643     345688889999999999999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.83  E-value=4.9e-21  Score=191.93  Aligned_cols=124  Identities=25%  Similarity=0.399  Sum_probs=110.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|+++.++|+|+||.||+|+++++|+.||||++.-.   ..+....+-..+||++|++|+|+|+|.|+++|.....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            4788999999999999999999999999999988532   3344555667899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||+ .++.+-|+.+...+.+..++.|+.|++.|+.|||.++||||
T Consensus        79 VFE~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHR  125 (396)
T KOG0593|consen   79 VFEYCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHR  125 (396)
T ss_pred             Eeeecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecc
Confidence            999998 55555666667889999999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.8e-22  Score=206.46  Aligned_cols=126  Identities=32%  Similarity=0.450  Sum_probs=112.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d  429 (481)
                      ....+|.+.++||.|+||.||+|+.+.+|+.||||.++...   ...+..-. .+|++-|++|. |+|||+|.+++.+.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf---~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF---YSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh---ccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            45678999999999999999999999999999999997422   22222222 46999999999 999999999999988


Q ss_pred             -EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+|+|||||+ .+|+++++.....|+|..|+.||.||++||+|+|.+|+.||
T Consensus        83 ~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR  134 (538)
T KOG0661|consen   83 RILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR  134 (538)
T ss_pred             ceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence             8999999996 99999999988889999999999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.83  E-value=2.2e-20  Score=197.78  Aligned_cols=129  Identities=22%  Similarity=0.365  Sum_probs=117.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++++.||+|+||.||+|+.+.||+.||||++++.  +......++.+..|-.+|...+.++||+||..|.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS--~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS--EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH--HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            44567999999999999999999999999999999999742  3344555677888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++||||||++|||+..+|.. .+.|+|.+++.|+.+++.||+.||+.|||||
T Consensus       215 ~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHR  265 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHR  265 (550)
T ss_pred             eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            99999999999999999977 4889999999999999999999999999998

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.83  E-value=6.9e-20  Score=184.54  Aligned_cols=128  Identities=27%  Similarity=0.408  Sum_probs=113.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+..+++.||||+++...  .......+.+.+|+.+|+.++|+||+++++++..++.
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            34578999999999999999999999999999999986321  1122334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+.+|+|.+++... +.+.+..++.|+.||+.||+|||++||+||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  142 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYR  142 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999999999764 779999999999999999999999999997

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=7.5e-20  Score=183.75  Aligned_cols=125  Identities=22%  Similarity=0.365  Sum_probs=111.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++....  ......+.+.+|+.+|..++|+||+++++++...+.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            479999999999999999999999999999999874211  122345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||++||+|.+++... +.+.+..++.|+.||+.||.|||++||+||
T Consensus        79 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  125 (333)
T cd05600          79 AMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHR  125 (333)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.7e-20  Score=196.41  Aligned_cols=134  Identities=29%  Similarity=0.526  Sum_probs=116.8

Q ss_pred             CCCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCc---E-EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeee
Q 011617          346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---S-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY  421 (481)
Q Consensus       346 ~~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~-VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL  421 (481)
                      +..++....+..+.++||+|+||.||+|..+..+.   . ||||..+.  ......+.++.+.+|.++|++++|+|||++
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            34555666677788999999999999999865432   3 89998863  122456778899999999999999999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+...+..+|||||+|.||+|.+||++....++..+...++.+.+.||+|||.+++|||
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHR  286 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHR  286 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcch
Confidence            999999999999999999999999999876679999999999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=3.8e-20  Score=182.56  Aligned_cols=125  Identities=26%  Similarity=0.410  Sum_probs=111.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+.+|+.+|+.++|+||+++++++.+++.+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            37899999999999999999999999999999986321  1122344568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+|+|.+++... +.+.+..+..|+.||+.||+|||++||+||
T Consensus        79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  125 (291)
T cd05612          79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYR  125 (291)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999999764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=7.1e-20  Score=184.56  Aligned_cols=126  Identities=20%  Similarity=0.295  Sum_probs=112.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++.+..+++.||||++....  .......+.+.+|+.++..++|+||+++++++..++.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            47999999999999999999999999999999986311  1122334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.||+|.+++......+++..++.|+.||+.||+|||+++|+||
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  126 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR  126 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEC
Confidence            999999999999997756779999999999999999999999999997

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.82  E-value=1.5e-19  Score=181.15  Aligned_cols=126  Identities=21%  Similarity=0.325  Sum_probs=113.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++.+..+++.||||+++...  ....+..+.+.+|+.+++.++|+||+++++++...+.+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            36999999999999999999999999999999997421  1123345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~  126 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR  126 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            999999999999998765789999999999999999999999999997

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.82  E-value=1.8e-19  Score=181.72  Aligned_cols=126  Identities=19%  Similarity=0.265  Sum_probs=111.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++++..+++.||||++....  .........+.+|+.++..+.|+||+++++++..++.+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999986321  1122334557889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.||+|.+++......+.+..++.|+.||+.||+|||++||+||
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHr  126 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR  126 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999999999999998755789999999999999999999999999997

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.82  E-value=1.8e-19  Score=183.43  Aligned_cols=125  Identities=21%  Similarity=0.351  Sum_probs=112.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++.+..+++.||||+++...  ....+....+.+|+.+|..++|+||+++++.+.+++.+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            36899999999999999999999999999999986321  1223345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHr  125 (360)
T cd05627          79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHR  125 (360)
T ss_pred             EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            99999999999999764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.82  E-value=1.9e-19  Score=174.45  Aligned_cols=126  Identities=21%  Similarity=0.392  Sum_probs=110.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ...+|++.+.||+|+||.||+|.+.   ..+..||+|.++..    ........+.+|+.+|.+++|+||+++++++...
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            3457999999999999999999875   34567999988632    2233446788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+||||||+.+|+|.+++......+++..++.|+.||+.||+|||++||+||
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~  131 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK  131 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            99999999999999999998765679999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.81  E-value=3.2e-20  Score=196.84  Aligned_cols=127  Identities=29%  Similarity=0.490  Sum_probs=112.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ...+|..++.||+|+|++||+|.++.+++.||||++.+...-.  +..++-+..|-.+|.+| .||.||+||..|.++..
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik--e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK--EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh--hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3468999999999999999999999999999999986433211  12234566788899999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+||||+++|+|.++|++. +.|+|.+++.|+.||+.||+|||.+|||||
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHR  198 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHR  198 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceec
Confidence            99999999999999999885 899999999999999999999999999998

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=1.5e-19  Score=181.73  Aligned_cols=125  Identities=26%  Similarity=0.415  Sum_probs=111.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...  .........+.+|+.+|..+.|+||+++++++.+++.+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD--MIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH--HhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            37999999999999999999999999999999987321  1112344668889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++... +.+++..++.|+.||+.||.|||++||+||
T Consensus        79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~  125 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHR  125 (350)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999775 789999999999999999999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.81  E-value=9.1e-20  Score=189.39  Aligned_cols=127  Identities=31%  Similarity=0.515  Sum_probs=109.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcE-EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~-VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ........+.+.||+|+||+||+|.++  |.. ||||++.....+   ....+.|.+|+.+|.+++|||||+++|++...
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~---~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD---DESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            344455666777999999999999997  455 999998643222   22277899999999999999999999999988


Q ss_pred             C-EEEEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccC
Q 011617          429 D-HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN-TIHR  481 (481)
Q Consensus       429 d-~lyLVmEy~~GGSL~~lL~~-~~~~Lse~~I~~I~~QIl~GL~YLHskg-IIHR  481 (481)
                      . .++|||||+++|+|.+++.. ....++...+..|+.||+.||.|||+++ ||||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr  167 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR  167 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec
Confidence            7 79999999999999999987 3688999999999999999999999999 9998

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.81  E-value=2.2e-19  Score=180.21  Aligned_cols=119  Identities=27%  Similarity=0.384  Sum_probs=105.8

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      ++||+|+||.||+|.+..+|+.||||+++...  .........+.+|+.+|+.++|+||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV--IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            47999999999999999999999999987321  1123345567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHr  119 (323)
T cd05571          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYR  119 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            99999999764 779999999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.81  E-value=6.4e-19  Score=173.27  Aligned_cols=124  Identities=25%  Similarity=0.422  Sum_probs=109.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.++||.|+||.||+|.+..++..||+|+++......    ....+.+|+.+|+.++|+||+++++++..++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            467999999999999999999999999999999986432211    1235667999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++......+++..++.++.||+.||+|||++||+||
T Consensus        80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  127 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR  127 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999997 69999997765668999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.81  E-value=3.2e-19  Score=186.49  Aligned_cols=128  Identities=28%  Similarity=0.458  Sum_probs=115.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~  428 (481)
                      ......|++++.||+|.||.||+|..+.+|+.+|+|.+......  .......+.+|+.+|+++. |+|||++++.|++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            44567899999999999999999999999999999999754322  2224568889999999998 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||+|.||.|++.|...  .++|.++..++.||+.+++|||..|||||
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHr  159 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHR  159 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceec
Confidence            9999999999999999999775  49999999999999999999999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.81  E-value=7e-19  Score=173.96  Aligned_cols=124  Identities=27%  Similarity=0.466  Sum_probs=109.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||||+++......    ....+.+|+.+|+.++|+||+++++++.+++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            468999999999999999999999999999999986432211    1234667999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++....+.+.+..++.++.||+.||+|||++|||||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  127 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR  127 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999995 78988887766779999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=6.5e-19  Score=183.63  Aligned_cols=131  Identities=25%  Similarity=0.436  Sum_probs=119.3

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ..+....++|++.+.||.|.-+.||+|..+.+++.||||++.+...    ...+..+.+|+..|+.++||||++++.+|.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4556778899999999999999999999999999999999986432    233678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..+|+||.||.+|++.++++... ..|.|..|..|++++++||.|||.+|.|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHR  150 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHR  150 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceec
Confidence            9999999999999999999998753 459999999999999999999999999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.81  E-value=6e-19  Score=173.24  Aligned_cols=125  Identities=18%  Similarity=0.237  Sum_probs=108.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++.+.||+|+||.||+|.+..+|+.||||.+.....  ........+.+|+.+|.+++|+||+.+++++.+++.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh--hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            37889999999999999999999999999999863221  1122334577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||.+|+|..++... ...+++..+..++.||+.||+|||+++||||
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~  126 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR  126 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            9999999999888653 2468999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=7.8e-19  Score=168.01  Aligned_cols=127  Identities=42%  Similarity=0.802  Sum_probs=113.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|+++++||+|+||.||+|.+..+++.||+|++.............+.+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            36899999999999999999999999999999987543333334456778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++... +.+++..++.|+.||+.||.|||++||+||
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  128 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHR  128 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999764 678999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.80  E-value=5.3e-19  Score=180.01  Aligned_cols=128  Identities=24%  Similarity=0.376  Sum_probs=111.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCC-cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....+|++.+.||+|+||.||+|.+..++ ..||+|++.....  ......+.+.+|+.+|+.++|+||+++++++...+
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            45578999999999999999999976655 6799999863211  12234556788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+.+|+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  155 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYR  155 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            999999999999999999764 679999999999999999999999999998

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.80  E-value=3.7e-19  Score=178.82  Aligned_cols=119  Identities=27%  Similarity=0.379  Sum_probs=105.6

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      +.||+|+||.||++.+..+|+.||+|+++....  ........+.+|+++|+.++|+||++++++|...+.+||||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            479999999999999999999999999874211  123345667789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|..++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  119 (323)
T cd05595          79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR  119 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999988764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.80  E-value=5.8e-19  Score=177.78  Aligned_cols=126  Identities=18%  Similarity=0.275  Sum_probs=111.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.++||+|+||.||+++++.+++.||+|++....  .........+.+|+.++..++|+||+++++++...+.+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            37999999999999999999999999999999985311  1112233457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+|+|.+++......+.+..++.|+.||+.||+|||++||+||
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHr  126 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR  126 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999999999999998766789999999999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=8e-19  Score=172.36  Aligned_cols=125  Identities=20%  Similarity=0.253  Sum_probs=108.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++.++||+|+||.||++.+..+++.||||++.....  ........+.+|+.+|+.++|+||+++++++..++.+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            48899999999999999999999999999999863211  1222335567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++|+|.+++... ...+++..+..|+.||+.||.|||+++||||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  126 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR  126 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            9999999999988653 2468999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.80  E-value=5.5e-19  Score=181.65  Aligned_cols=127  Identities=27%  Similarity=0.349  Sum_probs=111.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.++||+|+||.||++.+..+++.||||++....  .........+.+|+.+|+.++|+||+++++++.+++.
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34578999999999999999999999999999999986321  1112233457789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++..  ..+++..+..|+.||+.||+|||++|||||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHR  166 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            9999999999999999865  468999999999999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.80  E-value=6.8e-19  Score=181.36  Aligned_cols=127  Identities=23%  Similarity=0.342  Sum_probs=111.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.++||+|+||.||++.+..+++.||+|++.....  ......+.+.+|+.+++.++|+||+++++++..++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            345789999999999999999999999999999999863211  112234557789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.+|+|.+++..  ..+++..++.|+.||+.||+|||++||+||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHr  166 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHR  166 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999999999999999965  468999999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.80  E-value=6.9e-19  Score=177.44  Aligned_cols=119  Identities=27%  Similarity=0.382  Sum_probs=105.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      +.||+|+||.||++.+..+++.||||+++...  .........+.+|+.+|+.++|+||+++++++..++.+||||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV--IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            47999999999999999999999999987421  1223345677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|..++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus        79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  119 (328)
T cd05593          79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYR  119 (328)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            99999998764 679999999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.80  E-value=9.4e-19  Score=167.91  Aligned_cols=126  Identities=30%  Similarity=0.674  Sum_probs=112.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC-CcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~-~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      +|+.++.||+|+||.||++.+..+++.||+|++....... ......+.+.+|+++|+.++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4888999999999999999999999999999987433221 223356788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++... +.+++..+..|+.||+.||.|||++||+||
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~  127 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHR  127 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999764 678999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.80  E-value=7e-19  Score=171.44  Aligned_cols=124  Identities=24%  Similarity=0.406  Sum_probs=107.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.++.+++.||||+++....   .....+.+.+|+.+++.++|+||+++++++..++.+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            379999999999999999999999999999999874322   22334567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.++.+..+. .....+.+..++.|+.||+.||.|||+++|+||
T Consensus        78 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  124 (287)
T cd07848          78 VFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR  124 (287)
T ss_pred             EEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999877665544 434679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=6.3e-19  Score=175.79  Aligned_cols=117  Identities=26%  Similarity=0.327  Sum_probs=104.3

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|+||.||+|.+..+++.||||+++...  .........+..|+.+|.+++|+||+++++++...+.+||||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            799999999999999999999999986321  112334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++... +.+.+..++.|+.||+.||.|||++||+||
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~Hr  117 (312)
T cd05585          79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYR  117 (312)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            999999764 779999999999999999999999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.79  E-value=5.8e-19  Score=177.13  Aligned_cols=128  Identities=24%  Similarity=0.410  Sum_probs=106.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      ....++|+++++||+|+||.||+|.+.     .++..||||+++..    ......+.+.+|+.+|..+ +|+|||++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence            345678999999999999999999752     34567999988621    2233456788899999999 8999999999


Q ss_pred             EEEeC-CEEEEEEeccCCCCHHHHHHHhC---------------------------------------------------
Q 011617          424 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  451 (481)
Q Consensus       424 ~f~~~-d~lyLVmEy~~GGSL~~lL~~~~---------------------------------------------------  451 (481)
                      ++... +.+|+|||||++|+|.+++....                                                   
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (338)
T cd05102          79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN  158 (338)
T ss_pred             EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence            88764 46899999999999999997531                                                   


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          452 ----------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       452 ----------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                ..+.+..+..|+.||+.||+|||++|||||
T Consensus       159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  198 (338)
T cd05102         159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHR  198 (338)
T ss_pred             cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Confidence                      237788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.79  E-value=1.7e-18  Score=171.01  Aligned_cols=126  Identities=26%  Similarity=0.413  Sum_probs=106.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECC----------------CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH  415 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~----------------tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H  415 (481)
                      ..++|++.++||+|+||.||+|.+..                ++..||||+++..    ........+.+|+.+|..++|
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h   78 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKD   78 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCC
Confidence            35689999999999999999998643                3446999988632    223445678899999999999


Q ss_pred             CCeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC------------------RDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       416 PNIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~------------------~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      +||+++++++.+.+.+||||||+.+|+|.+++....                  ..+++..+..|+.||+.||.|||++|
T Consensus        79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999999986521                  23677889999999999999999999


Q ss_pred             CccC
Q 011617          478 TIHR  481 (481)
Q Consensus       478 IIHR  481 (481)
                      |+||
T Consensus       159 ivH~  162 (304)
T cd05096         159 FVHR  162 (304)
T ss_pred             cccc
Confidence            9997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.79  E-value=9.2e-20  Score=184.70  Aligned_cols=126  Identities=25%  Similarity=0.395  Sum_probs=110.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--C
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--D  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d  429 (481)
                      ....|+++..|++|+||.||.|+++.+++.||+|+++..+..   ..+.-...+||.+|.+++|+|||.+-++....  +
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek---~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK---EGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc---CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            346799999999999999999999999999999999854421   12223456799999999999999999988754  5


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+ .||..++......|...+++.++.|++.||+|||.+.|+||
T Consensus       151 ~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHR  201 (419)
T KOG0663|consen  151 KIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHR  201 (419)
T ss_pred             eeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEec
Confidence            7999999997 99999998876789999999999999999999999999998

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.79  E-value=1.3e-18  Score=167.43  Aligned_cols=124  Identities=33%  Similarity=0.564  Sum_probs=111.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...     ......+.+|+.++++++|+||+++++++..++.+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            4568999999999999999999999999999999986321     12234677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+.+++|.+++... +.+++..+..++.||+.||+|||+++|+||
T Consensus        82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHR  130 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999764 678999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.79  E-value=1.6e-18  Score=164.70  Aligned_cols=126  Identities=48%  Similarity=0.850  Sum_probs=113.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+++.|+||++..........+..+.+.+|+.+++.++|+||+++++++..++.+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47889999999999999999998899999999875444344456677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++... ..+++..+..++.||+.||+|||++||+||
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  126 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR  126 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999764 568999999999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.79  E-value=1.3e-18  Score=174.53  Aligned_cols=124  Identities=23%  Similarity=0.294  Sum_probs=108.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeCCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~d~lyL  433 (481)
                      +|++.+.||+|+||.||+|.+..+++.||||+++....  ......+.+..|++++..+.| ++|+++++++...+.+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            58999999999999999999999999999999874211  122344567789999999976 568899999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++... +.+.+..++.|+.||+.||+|||++||+||
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  125 (324)
T cd05587          79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYR  125 (324)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.79  E-value=9.5e-19  Score=176.25  Aligned_cols=119  Identities=23%  Similarity=0.352  Sum_probs=105.3

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.+..+++.||||+++...  ....+....+..|+.++..+ +|+||++++++|...+.+|||||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            47999999999999999999999999997421  12233456678899999988 6999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|+|.+++... +.+++..++.|+.||+.||.|||++||+||
T Consensus        79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  120 (329)
T cd05588          79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYR  120 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999999998764 789999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.79  E-value=2.5e-18  Score=173.07  Aligned_cols=125  Identities=26%  Similarity=0.424  Sum_probs=112.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.+.||+|+||.||++.+..++..||+|++...    ........+.+|+++|++++|+||+++++++..++.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            457899999999999999999999999999999998642    2234556788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ||||||+++|+|.+++... ..+.+..+..|+.||+.||.|||++ +||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~  128 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHR  128 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcC
Confidence            9999999999999999764 6799999999999999999999986 69997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.79  E-value=1.6e-18  Score=172.70  Aligned_cols=122  Identities=25%  Similarity=0.492  Sum_probs=105.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-----C
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D  429 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-----d  429 (481)
                      +|++.++||+|+||.||+|.+..++..||||+++...   ........+.+|+.+|+.++|+||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            5899999999999999999999999999999986321   1222335678899999999999999999988643     2


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||. ++|.+++... ..+++..++.|+.||+.||.|||++|||||
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  127 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHR  127 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            5899999995 7999998764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.79  E-value=3.2e-18  Score=164.94  Aligned_cols=127  Identities=40%  Similarity=0.743  Sum_probs=111.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  431 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~l  431 (481)
                      .+|+++++||+|+||.||+|.+..++..||||++.............+.+.+|+.+++.+.|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999999864332233345567889999999999999999999998763  568


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++|||+.+++|.+++... ..+.+..+..++.||+.||+|||+++|+||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  130 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHR  130 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            9999999999999999764 668999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.79  E-value=1.4e-19  Score=191.29  Aligned_cols=127  Identities=27%  Similarity=0.476  Sum_probs=110.5

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .+......+++++.||+|.||.||+|.++.. ..||+|.++...   .   ..+.+.+|+.+|++|+|+|||+|++++..
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~---m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS---M---SPEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccc---c---ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            3445566778899999999999999999742 469999987421   1   12466689999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~-~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||..|+|.+||+. .+..+....+..|+.||++||+||+++++|||
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR  327 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR  327 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence            9999999999999999999987 55779999999999999999999999999998

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.79  E-value=1.2e-18  Score=174.66  Aligned_cols=122  Identities=22%  Similarity=0.387  Sum_probs=104.7

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHH---hhCCCCCeeeeeeEEEeCCEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL---GHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL---~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      |++.+.||+|+||.||+|.+..+++.||||+++....  ......+.+.+|++++   ..++|+||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            7889999999999999999999999999999974211  1122345566676655   5667999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+.+|+|..++..  +.+++..+..|+.||+.||.|||++||+||
T Consensus        79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHr  125 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYR  125 (324)
T ss_pred             EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            99999999999988854  579999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.79  E-value=1.6e-19  Score=192.10  Aligned_cols=123  Identities=33%  Similarity=0.533  Sum_probs=113.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|.+.+.||+|.||.||+|+.+.+.+.||||.+.+.   +.....++.+.+|++|++.|+|||||.++++|+....+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            4788999999999999999999999999999998643   3455667889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||. |+|+.+|.. .+.++|+.++.|+.|++.||.|||+++|+||
T Consensus        79 Vte~a~-g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhr  124 (808)
T KOG0597|consen   79 VTEYAV-GDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHR  124 (808)
T ss_pred             Eehhhh-hhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            999997 599999987 4889999999999999999999999999998

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.79  E-value=1.5e-18  Score=178.60  Aligned_cols=127  Identities=24%  Similarity=0.344  Sum_probs=111.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+.+|+.+++.++|+||+++++++..++.
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34579999999999999999999999999999999986321  1112234557789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.||+|.+++..  ..+++..++.++.||+.||.|||++|||||
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  166 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHR  166 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9999999999999999965  458999999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.79  E-value=3.8e-18  Score=163.94  Aligned_cols=126  Identities=29%  Similarity=0.461  Sum_probs=111.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||||.++...  .........+.+|+.+|+.++|+||+++++++...+.+|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            57999999999999999999999999999999886422  2334455678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+++++|.+++..   ....+++..+..++.||+.||.|||+++|+||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  130 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR  130 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence            9999999999998853   23458899999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.78  E-value=3.9e-18  Score=169.05  Aligned_cols=124  Identities=27%  Similarity=0.446  Sum_probs=109.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.++||+|+||.||+|.+..+++.||||+++......    ....+.+|+.+++.++|+||+++++++..++.+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            467999999999999999999999999999999987533221    1234567999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++......+.+..++.++.||+.||+|||++||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~  128 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR  128 (309)
T ss_pred             EEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999997 68999887765668999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.78  E-value=1.8e-18  Score=173.39  Aligned_cols=121  Identities=23%  Similarity=0.443  Sum_probs=107.0

Q ss_pred             EeEEeccC--CcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          358 KGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       358 i~k~IG~G--tFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      ++++||+|  +|++||++.++.+|+.||||+++...   ...+..+.+.+|+.+++.++|+||++++++|..++.+|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh---ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            46789999  68899999999999999999986422   22344567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+++|+|.+++..+ ...+++..++.|+.||+.||+|||+++||||
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~  125 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR  125 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            999999999999764 3458999999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.78  E-value=3.1e-18  Score=173.09  Aligned_cols=125  Identities=25%  Similarity=0.426  Sum_probs=112.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++.++||+|+||.||++.+..++..+|+|.++..    ........+.+|+++|+.++|+||++++++|..++.+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            457899999999999999999999999999999988642    1234456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ||||||+.+|+|.+++... +.+.+..+..++.||+.||.|||++ +|+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~  128 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHR  128 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence            9999999999999999764 6789999999999999999999985 79997

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.78  E-value=2e-18  Score=169.13  Aligned_cols=126  Identities=27%  Similarity=0.464  Sum_probs=110.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+++.||||+++..............+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48899999999999999999999999999999975332212233445677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+ +++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~  126 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHR  126 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999 899999997653479999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.78  E-value=1.7e-18  Score=173.65  Aligned_cols=119  Identities=28%  Similarity=0.381  Sum_probs=104.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      +.||+|+||.||++.+..+|+.||+|+++....  ........+.+|++++..++|+||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            479999999999999999999999999974221  123345567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      +|+|..++... +.+++..++.|+.||+.||+|||+ +|||||
T Consensus        79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr  120 (325)
T cd05594          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYR  120 (325)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence            99999988763 679999999999999999999997 799997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.78  E-value=5.9e-18  Score=161.86  Aligned_cols=123  Identities=24%  Similarity=0.464  Sum_probs=110.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.++||+|+||.||++.+..+++.||+|.++...    .....+.+.+|+.+++.++|+||+++++.+.+++.+|++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            5899999999999999999999999999999986422    233456778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++... ...+++..+..|+.||+.||.|||++||+|+
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~  124 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR  124 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            9999999999998653 3458999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.78  E-value=2.6e-18  Score=172.26  Aligned_cols=125  Identities=22%  Similarity=0.362  Sum_probs=107.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~  430 (481)
                      +|++++.||+|+||.||++++.   .+++.||||+++.... .......+.+..|+.+|..+. |+||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            4899999999999999999864   5788999999863211 112233456788999999995 8999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.+|+|.+++... ..+++..++.|+.||+.||+|||++||+||
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr  129 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYR  129 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            99999999999999999764 679999999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.78  E-value=3.2e-18  Score=167.92  Aligned_cols=125  Identities=26%  Similarity=0.460  Sum_probs=111.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++.+..+++.||||++....  .......+.+.+|+++|+.++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            37999999999999999999999999999999986321  1122345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++... +.+++..+..|+.||+.||+|||++||+||
T Consensus        79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~  125 (290)
T cd05580          79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYR  125 (290)
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            99999999999999774 779999999999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.78  E-value=3.8e-19  Score=186.90  Aligned_cols=126  Identities=25%  Similarity=0.420  Sum_probs=113.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE-E
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-L  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~-l  431 (481)
                      .++|.++++||+|+||.+++++++..+..|++|+|.......   ...+..++|+.+++++.|||||.|++.|+.++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            468999999999999999999999999999999998644322   223467789999999999999999999999988 9


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+||+||+|.+.|.... ..|.|+.+..|+.||+.||.|||+++|+||
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHR  130 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHR  130 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            99999999999999997754 679999999999999999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.78  E-value=6.4e-19  Score=176.31  Aligned_cols=127  Identities=28%  Similarity=0.471  Sum_probs=114.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|+..+.||.|+||.|.+++.+.+|..||+|++++...  -....++...+|..+|+.+.||.+++|++.|.+.+++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            45689999999999999999999999999999999864221  1223345677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++||.|+.+++. .+.|+|..++.|+.||+.||+|||.++||+|
T Consensus       120 ymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYR  168 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYR  168 (355)
T ss_pred             EEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeec
Confidence            999999999999999987 5899999999999999999999999999998

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.78  E-value=4.3e-18  Score=169.27  Aligned_cols=123  Identities=27%  Similarity=0.408  Sum_probs=110.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||++.+..++..+|+|.++..    .......++.+|+++|++++|+||++++++|..++.+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            3699999999999999999999999999999988632    123445678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ||||+++++|.++++.. +.+++..+..|+.||+.||.|||+ ++|+||
T Consensus        77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~  124 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHR  124 (308)
T ss_pred             EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEEC
Confidence            99999999999999764 779999999999999999999998 589997

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.78  E-value=1.7e-18  Score=168.17  Aligned_cols=124  Identities=34%  Similarity=0.589  Sum_probs=112.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||.|+||.||++.+..+++.||+|.++.     ......+.+..|+++++.++|+||+++++.+..++.+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            3569999999999999999999988999999999863     23445567888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~  127 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR  127 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999998766779999999999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.78  E-value=2.3e-18  Score=184.61  Aligned_cols=127  Identities=24%  Similarity=0.406  Sum_probs=113.6

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .++....+..++..||+|.||+||+|+|..   .||||+++..   ....+.++.|++|+.+|++-+|.||+-+.|+++.
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            445556677899999999999999999975   4999999853   2345578899999999999999999999999987


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ... .||+.+|+|-+|+.+|+.....|....++.|++||++||.|||.++||||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHr  512 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHR  512 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            777 99999999999999998877889999999999999999999999999997

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.78  E-value=4.8e-19  Score=180.01  Aligned_cols=125  Identities=27%  Similarity=0.540  Sum_probs=110.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC-eeeeeeEEEeCC--
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDD--  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN-IVqL~g~f~~~d--  429 (481)
                      ...|+..++||+|+||+||+|..+.+|+.||+|+++...+++   .......+||.+|+.|+|.| ||.|++++.+.+  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            456888899999999999999999999999999998754432   23345677999999999999 999999999887  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~~~---~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+++||||++ -+|.+|+....   ..++...++.|++||+.||+|||+++||||
T Consensus        87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHR  144 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHR  144 (323)
T ss_pred             cccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence                8999999996 99999998764   358889999999999999999999999998

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.78  E-value=3.2e-18  Score=171.51  Aligned_cols=124  Identities=24%  Similarity=0.306  Sum_probs=107.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyL  433 (481)
                      +|.+.+.||+|+||.||+|.+..+++.||||+++...  .......+.+..|+.++..+ .|++|+++++++...+.+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            5889999999999999999999999999999987421  11222344566788888777 58999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++... +.+++..+..|+.||+.||+|||++||+||
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  125 (323)
T cd05616          79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYR  125 (323)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence            99999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.78  E-value=2.9e-18  Score=165.69  Aligned_cols=125  Identities=27%  Similarity=0.445  Sum_probs=109.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ..+|++++.||+|+||.||+|.+..++.   .+|+|.++..    ......+.+.+|+.+|+.++|+||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3579999999999999999999865543   6899987532    12334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++......+++..+..|+.||+.||.|||+++|+||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~  130 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR  130 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeh
Confidence            9999999999999999998766678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.78  E-value=2.3e-18  Score=171.99  Aligned_cols=119  Identities=23%  Similarity=0.330  Sum_probs=103.0

Q ss_pred             eEEeccCCcEEEEEEEE---CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          359 GKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~d---k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      ++.||+|+||.||++++   ..+|+.||+|+++....   .......+.+|+++|++++|+||+++++++...+.+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL   77 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence            36799999999999986   35789999999874211   1122345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+|+|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  122 (318)
T cd05582          78 DFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYR  122 (318)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.78  E-value=2.3e-18  Score=165.14  Aligned_cols=121  Identities=28%  Similarity=0.479  Sum_probs=106.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||++.++. +..+|+|.++..   ..   ...++.+|+.+|+.++|+||+++++++...+.+||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~---~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG---AM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC---Cc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            568999999999999999998764 567999987521   11   12467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++....+.+++..+..++.||+.||+|||++||+||
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR  124 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999997655678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.78  E-value=3e-18  Score=162.98  Aligned_cols=122  Identities=35%  Similarity=0.565  Sum_probs=108.0

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |++++.||+|+||.||++.+..+++.||+|++....   ..........+|+.+++.++|+||+++++++...+.+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            889999999999999999999999999999997421   12222233455999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+++|.+++.. ...+.+..+..++.||+.||+|||+++|+||
T Consensus        78 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~  122 (260)
T PF00069_consen   78 EYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHR  122 (260)
T ss_dssp             EEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence            99998899999984 3789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=5.6e-19  Score=190.77  Aligned_cols=128  Identities=31%  Similarity=0.532  Sum_probs=115.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...+-|++++.||.|+-|.|-+|++..||+..|||+|....  .........+++||.||+.+.||||+++|++++.+.+
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            44578999999999999999999999999999999996432  1222334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|+||++||.|++|+..+ +.+.|.++..|+.||+.||.|||..+|+||
T Consensus        87 lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHR  136 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHR  136 (786)
T ss_pred             EEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceec
Confidence            99999999999999999875 889999999999999999999999999998

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.78  E-value=2.7e-18  Score=163.93  Aligned_cols=118  Identities=27%  Similarity=0.467  Sum_probs=105.8

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      +.||+|+||.||+|.+..+++.||+|.+..    ....+....+.+|+++|+.++|+||+++++++...+.+||||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCc----cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            468999999999999999999999998752    1234455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|.+++......+.+..+..++.||+.||.|||+++|+||
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  118 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR  118 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            999999997655678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.78  E-value=7.8e-18  Score=160.70  Aligned_cols=124  Identities=35%  Similarity=0.592  Sum_probs=112.6

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++....     ....+.+.+|+.+++.++|+||+++++++...+.+|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            458999999999999999999999889999999987421     224567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||+.+++|.+++......+++..+..++.||+.||+|||+++|+||
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~  125 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR  125 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceec
Confidence            9999999999999998765789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.78  E-value=3.2e-18  Score=172.71  Aligned_cols=119  Identities=25%  Similarity=0.373  Sum_probs=104.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      +.||+|+||.||+|.+..+++.||+|+++....  ......+.+.+|+.++.++ +|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            479999999999999999999999999974321  2234456678899888776 7999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++... +.+.+..++.|+.||+.||.|||++||+||
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~  120 (329)
T cd05618          79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYR  120 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            999999988764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.78  E-value=5.6e-18  Score=166.39  Aligned_cols=125  Identities=22%  Similarity=0.288  Sum_probs=108.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.....  ........+.+|+.+|+.++|+||+.+++.+..++.+|++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            47888999999999999999999999999999864221  1222345577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++.... ..+++..+..++.||+.||.|||+++||||
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~  126 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR  126 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            99999999998886532 469999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.78  E-value=3.3e-18  Score=165.09  Aligned_cols=126  Identities=44%  Similarity=0.757  Sum_probs=110.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC-----CCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d-----~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      +|.+.+.||.|+||.||+|.+..+|+.||||+++.....     .......+.+..|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            689999999999999999999989999999988642111     112234567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++||||+.+++|.++++.. +.+.+..++.|+.||+.||.|||+++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHR  132 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            999999999999999999775 679999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.78  E-value=2.8e-18  Score=172.41  Aligned_cols=124  Identities=23%  Similarity=0.294  Sum_probs=107.1

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyL  433 (481)
                      .|+..+.||+|+||.||+|.++.+|+.||||+++...  .......+.+..|+.++..+. |++|+++++++...+.+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            4788999999999999999999999999999987321  112233456677888888886 5788899999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHr  125 (323)
T cd05615          79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYR  125 (323)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.78  E-value=3.7e-18  Score=164.81  Aligned_cols=125  Identities=25%  Similarity=0.405  Sum_probs=111.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ..+|++.+.||+|+||.||+|.+..+++   .||||.++..    ......+.+..|+.+++.++|+||+++++++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            3568999999999999999999887665   5999987532    23445677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++||||+.+++|.+++....+.+++..++.|+.|++.||.|||++||+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~  130 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR  130 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            9999999999999999998766779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.78  E-value=5.1e-18  Score=163.09  Aligned_cols=126  Identities=46%  Similarity=0.804  Sum_probs=111.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC----cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~----s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      +|.+++.||.|+||.||+|.+..+++.+|+|++........    ..+..+.+.+|+.++++++|+||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            48889999999999999999988899999998864322211    22345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++||||+.+++|.+++... +.+++..+..++.||+.||+|||++||+||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~  130 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHR  130 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            99999999999999999764 778999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.78  E-value=2.2e-18  Score=165.06  Aligned_cols=124  Identities=24%  Similarity=0.414  Sum_probs=111.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+.+|++++++++|+||+++++++...+.+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            5899999999999999999999999999999986422  22334567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.|++|.+++... ..+.+..+..|+.||+.||.|||+++|+|+
T Consensus        79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~  124 (258)
T cd05578          79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHR  124 (258)
T ss_pred             EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999999999999764 689999999999999999999999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.78  E-value=3e-18  Score=167.86  Aligned_cols=118  Identities=22%  Similarity=0.285  Sum_probs=102.2

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|+||.||++.+..+++.||+|++....  .......+.+..|+++|+.++|+||+++++++..++.+||||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHH--HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            799999999999999999999999986321  112223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|..++..   ....+++..++.|+.||+.||+|||+++|+||
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  121 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR  121 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99988753   23568999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.78  E-value=7.5e-18  Score=160.27  Aligned_cols=124  Identities=29%  Similarity=0.478  Sum_probs=111.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|.+.+.||+|+||.||+|.+..+++.|++|++....   ......+.+.+|+++++.++|+||+++++++..++..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            4889999999999999999999999999999986432   2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++... ...+.+..+..++.||+.||.|||++||+||
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~  125 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR  125 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999774 4678999999999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.78  E-value=1.7e-18  Score=178.32  Aligned_cols=128  Identities=27%  Similarity=0.409  Sum_probs=108.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEE-----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~d-----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      .....+|+++++||+|+||.||+|.+     ..++..||||+++...    .....+.+.+|+.+|..+ +|+|||++++
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            44566899999999999999999974     3456689999986321    123346788899999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhC----------------------------------------------------
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHC----------------------------------------------------  451 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~----------------------------------------------------  451 (481)
                      ++...+..|+|||||++|+|.++++...                                                    
T Consensus       107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  186 (375)
T cd05104         107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR  186 (375)
T ss_pred             eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence            9999999999999999999999996531                                                    


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          452 ----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       452 ----------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                            ..+++..+..|+.||+.||+|||++|||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  238 (375)
T cd05104         187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHR  238 (375)
T ss_pred             cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence                                  136788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.77  E-value=7e-18  Score=161.44  Aligned_cols=126  Identities=28%  Similarity=0.465  Sum_probs=111.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++...  .......+.+.+|+++++.++|+||+++++++...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE--MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            57999999999999999999999899999999986422  1223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++...   ...+.+..+..++.||+.||.|||++||+||
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  130 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR  130 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            99999999999998642   3458999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.77  E-value=9.1e-18  Score=160.35  Aligned_cols=124  Identities=25%  Similarity=0.447  Sum_probs=111.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|+..+.||.|+||.||++++..+++.+++|++....   ......+++.+|+.+|++++|+||+++++++...+.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            5899999999999999999999999999999986432   2233456778999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||.+++|.+++... ...+++..+..++.|++.||.|||++||+||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR  125 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            9999999999999764 3568999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.77  E-value=2.7e-18  Score=171.92  Aligned_cols=119  Identities=24%  Similarity=0.352  Sum_probs=103.2

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|++..+++.||||+++...  ....+....+..|++++..+ +|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            46999999999999999999999999986321  11223345567788888866 7999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|+|..++... +.+.+..++.|+.||+.||+|||++||+||
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  120 (321)
T cd05591          79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYR  120 (321)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999999999764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.77  E-value=5.9e-18  Score=188.02  Aligned_cols=126  Identities=25%  Similarity=0.400  Sum_probs=113.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.++||+|+||.||+|.+..+++.||||+++...  .........+..|+.++..++|+||+++++++...+.+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            468999999999999999999999999999999986422  233455677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+.|++|.+++... +.+.+..++.|+.||+.||+|||.++||||
T Consensus        81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHr  128 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHR  128 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            999999999999999764 678999999999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.6e-19  Score=176.24  Aligned_cols=129  Identities=26%  Similarity=0.480  Sum_probs=114.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      -..++|.+++.||+|.||.||+|+.+.++-.||+|++.+..  -...+...++.+||+|-..|+||||+++|++|.++..
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            34568999999999999999999999999999999986322  1223344678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||++||...|.|++.|+.. ..+++|.....|+.|++.||.|||.++||||
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhR  148 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHR  148 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccC
Confidence            99999999999999999853 4679999999999999999999999999998

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.77  E-value=8.2e-18  Score=162.46  Aligned_cols=126  Identities=41%  Similarity=0.792  Sum_probs=111.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CCEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY  432 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d~ly  432 (481)
                      .|+.++.||+|+||.||+|.+..++..||+|++..........+..+.+.+|+.+++.++|+||+++++++..  .+.++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6899999999999999999999999999999987544333444556788999999999999999999999876  36789


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+++|.+++... +.+++..++.++.||+.||+|||+++|+||
T Consensus        83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~  130 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHR  130 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            999999999999999764 568999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.77  E-value=5e-19  Score=183.14  Aligned_cols=130  Identities=25%  Similarity=0.352  Sum_probs=115.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ......|+++++||.|.-|.||+++.+.++..+|||++....  ......+.+++.|-+||+.++||.++.||..|+.+.
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~--l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES--LASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH--HhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            345578999999999999999999999999999999996422  122445567788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++||+||||.||+|+.+++.+ ++.|++..++.|+.+++.||+|||..|||.|
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYR  203 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYR  203 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeec
Confidence            999999999999999999874 4779999999999999999999999999987

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.77  E-value=6.4e-18  Score=162.92  Aligned_cols=125  Identities=28%  Similarity=0.426  Sum_probs=109.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ..+|++.+.||+|+||.||+|.+..+   ...||||.++..    ........+.+|+.+|+.++|+||+++++++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            35799999999999999999998654   356899987532    23344567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..||+|||+.+++|.+++....+.+++..+..++.||+.||.|||+++|+||
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  130 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR  130 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999998766789999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.77  E-value=8.2e-18  Score=165.48  Aligned_cols=125  Identities=20%  Similarity=0.260  Sum_probs=109.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++.+.||+|+||.||++.+..+++.||||.+....  .........+.+|+.+|+.++|+||+.+++.+...+.+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            3788899999999999999999999999999986422  12233345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++.... ..+.+..+..|+.||+.||.|||+++|+||
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~  126 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR  126 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            99999999999986532 458999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.77  E-value=3.1e-18  Score=171.64  Aligned_cols=119  Identities=24%  Similarity=0.399  Sum_probs=101.1

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.+..+++.||||+++....  ......+.+..|..++.. ++|+||+++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999874211  112233445556666665 47999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+|..+++.. +.+++..+..|+.||+.||+|||+++|+||
T Consensus        79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~  120 (316)
T cd05592          79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYR  120 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.77  E-value=2.8e-18  Score=165.18  Aligned_cols=123  Identities=36%  Similarity=0.592  Sum_probs=110.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|+++...     ......+.+|+.+++.++|+||+++++.+...+.+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            457999999999999999999999999999999986421     223356778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||
T Consensus        83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  130 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHR  130 (267)
T ss_pred             EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999999764 679999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.77  E-value=3.2e-18  Score=171.10  Aligned_cols=119  Identities=28%  Similarity=0.407  Sum_probs=100.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH-HHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~-iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|++..+++.||||++.....  ......+.+..|+. +++.++|+||+++++++...+.+|||||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999863211  11222334445554 678899999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|+|..++.. ...+.+..++.|+.||+.||.|||++||+||
T Consensus        79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~  120 (321)
T cd05603          79 NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYR  120 (321)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999998876 4779999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.77  E-value=7.3e-18  Score=164.05  Aligned_cols=124  Identities=30%  Similarity=0.545  Sum_probs=107.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEE----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~d----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-  427 (481)
                      ..+|++.+.||+|+||.||+|..    ..++..||||+++.     ......+.+.+|+++|+.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-----STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   77 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence            45899999999999999999974    45688999999863     233445678899999999999999999998754 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...+||||||+++++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~  132 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHR  132 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence             346899999999999999997655678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.77  E-value=4.3e-18  Score=165.22  Aligned_cols=121  Identities=31%  Similarity=0.539  Sum_probs=104.6

Q ss_pred             EEeEEeccCCcEEEEEEEEC----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          357 QKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ++.+.||.|.||.||+|.+.    ..+..|+||.++.    ....+..+.+.+|+++|++++|+||++++|++...+.++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            57899999999999999988    3456799999852    234455778899999999999999999999999888899


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||.+|+|.++|... ...+++..+..|+.||+.||.|||+++|||+
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~  127 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHG  127 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999885 5679999999999999999999999999996

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.77  E-value=3.6e-18  Score=171.29  Aligned_cols=119  Identities=28%  Similarity=0.413  Sum_probs=101.2

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH-HHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~-iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||+||+|.+..+|+.||||++.....  ......+.+..|.. +++.++|+||+++++++..++.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            469999999999999999999999999863211  11222344555554 577899999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++.. .+.+++..++.|+.||+.||+|||++||+||
T Consensus        79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~  120 (325)
T cd05604          79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYR  120 (325)
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999876 4779999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.77  E-value=3.8e-18  Score=170.97  Aligned_cols=119  Identities=30%  Similarity=0.441  Sum_probs=101.0

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH-HHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~-iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.+..+|+.||||++.....  ......+.+..|+. +++.++|+||+++++++...+.+||||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            479999999999999999999999999863211  11122334445544 567899999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++... +.+.+..++.|+.||+.||+|||++||+||
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~  120 (323)
T cd05575          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYR  120 (323)
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            999999999764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.77  E-value=9.8e-18  Score=163.70  Aligned_cols=124  Identities=27%  Similarity=0.453  Sum_probs=109.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|++.+.||+|+||.||+|.++.+++.||||++........    ...+.+|+.+++.++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            4689999999999999999999998999999999864322111    124567999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++......+.+..++.++.||+.||.|||+++|+||
T Consensus        80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~  127 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR  127 (291)
T ss_pred             EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999997 69999997765678999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.77  E-value=6.2e-18  Score=165.76  Aligned_cols=126  Identities=34%  Similarity=0.556  Sum_probs=114.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...+.|+++++||.|+||.||+|++..+++.+++|.+..     ...+..+.+.+|+.+++.++|+||+++++++..++.
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence            345789999999999999999999999999999999863     234556778889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+||||+.+++|..++......+++..+..++.||+.||.|||+++|+||
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  134 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR  134 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence            999999999999999887655779999999999999999999999999997

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.77  E-value=4.9e-18  Score=170.99  Aligned_cols=119  Identities=23%  Similarity=0.348  Sum_probs=105.1

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.+..+++.||||+++...  ....+..+.+.+|+.++.++ +|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999997421  12234456688899999888 5999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|+|..++... +.+++..++.|+.||+.||+|||++||+||
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHr  120 (327)
T cd05617          79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYR  120 (327)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999999998764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.1e-17  Score=161.33  Aligned_cols=127  Identities=41%  Similarity=0.762  Sum_probs=110.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  431 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~l  431 (481)
                      .+|.+++.||+|+||.||+|.+..+++.||||.+..........+....+.+|+.+++.++|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            379999999999999999999999999999998854322223345567889999999999999999999998764  468


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|||+.+++|.+++... +.+.+..++.|+.||+.||.|||+++|+||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~  130 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHR  130 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            9999999999999999764 568999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.77  E-value=3.6e-18  Score=183.29  Aligned_cols=128  Identities=29%  Similarity=0.469  Sum_probs=116.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ......|.+.++||+|.|++|.++.+..++..||||++....   .+......+.+|+++|+.|.|||||+++.+.+.+.
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~---ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ---LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc---cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            456678999999999999999999999999999999886433   34444556889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+.+|.+++||..+ +.+.+..++.++.|++.+++|||.++||||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHr  179 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHR  179 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceecc
Confidence            999999999999999999886 778889999999999999999999999998

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.77  E-value=1.1e-17  Score=159.06  Aligned_cols=124  Identities=27%  Similarity=0.505  Sum_probs=110.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||++.+..+++.+|||.+....   ...+..+.+.+|+.+|+.++|+||+++++.+..++.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            5899999999999999999999999999999986432   2233457788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~  125 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR  125 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999997643 458999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.77  E-value=3.1e-18  Score=171.89  Aligned_cols=119  Identities=24%  Similarity=0.406  Sum_probs=103.1

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|+++.+++.||||+++....  ......+.+..|+.++..+ +|+||+++++++...+.+|||||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999863211  1122345667788888876 6999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|.+++... ..+++..+..|+.||+.||+|||++||+||
T Consensus        79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~  120 (320)
T cd05590          79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYR  120 (320)
T ss_pred             CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            999999999764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.77  E-value=9.1e-18  Score=161.47  Aligned_cols=125  Identities=34%  Similarity=0.717  Sum_probs=109.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC-CCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d-~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      +|++++.||.|+||.||+|.+ .+++.+|+|.++..... ....+..+.+.+|+.+|+.++|+||+++++++...+.+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 46889999998743221 1223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.+++|.+++... ..+.+..+..++.||+.||+|||+++|+|+
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  126 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHR  126 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999999999764 678999999999999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.77  E-value=4.2e-18  Score=170.91  Aligned_cols=121  Identities=23%  Similarity=0.298  Sum_probs=103.6

Q ss_pred             eEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      +++||+|+||.||++++.   .+++.||||+++.... .........+.+|+.+|+.++|+||++++++|..++.+||||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            368999999999999864   5688999999874211 011223356778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+++|.+++... +.+.+..++.++.||+.||+|||++||+||
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  124 (323)
T cd05584          80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYR  124 (323)
T ss_pred             eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999764 778999999999999999999999999997

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.77  E-value=1e-17  Score=162.28  Aligned_cols=123  Identities=28%  Similarity=0.489  Sum_probs=110.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+|..||+|++.....   .....+.+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            58999999999999999999999999999999874321   123346788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+ +++|.+++......+.+..++.++.||+.||+|||+++|+||
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  123 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR  123 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999 999999997766779999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.77  E-value=9.3e-19  Score=183.56  Aligned_cols=129  Identities=29%  Similarity=0.430  Sum_probs=107.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC---------CcHHHHHHHHHHHHHHhhCCCCCeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------KSAECIKQLEQEIKVLGHLKHENIVQY  421 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~---------~s~e~~k~l~~EI~iL~~L~HPNIVqL  421 (481)
                      ....+|++++.||+|.||+|-+|.+..+++.||||++...+...         .....++++.+||.||++|.|+|||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999999999999999996432111         011124578899999999999999999


Q ss_pred             eeEEEeC--CEEEEEEeccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVD--DHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~--d~lyLVmEy~~GGSL~~lL~~~~~~-Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++..+.  +.+|||+|||..|.+...--  .+. +++.+++.|++.++.||+|||.+|||||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR  234 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHR  234 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            9998764  67999999999888754322  233 8999999999999999999999999998

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.77  E-value=7e-18  Score=175.56  Aligned_cols=118  Identities=20%  Similarity=0.302  Sum_probs=106.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|++.+.||+|+||.||+|.+..+++.||||....           ..+.+|+.+|+.|+|+|||+++++|..++.
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            445689999999999999999999999999999996531           245689999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++|||++. ++|..++... ..+++..++.|+.||+.||.|||++|||||
T Consensus       158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHr  206 (391)
T PHA03212        158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHR  206 (391)
T ss_pred             eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            999999995 8999998764 678999999999999999999999999998

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.76  E-value=1.2e-17  Score=164.68  Aligned_cols=125  Identities=27%  Similarity=0.448  Sum_probs=110.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++.++||+|+||.||+|.+..+++.||||.++......    ....+.+|+.+++.++|+||+++++++..++.+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            3568999999999999999999999999999999987433221    123466799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+. ++|.+++......+.+..++.++.||+.||+|||+++|+||
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~  128 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR  128 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            99999996 79999987766778999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.76  E-value=4.5e-18  Score=170.33  Aligned_cols=119  Identities=25%  Similarity=0.374  Sum_probs=103.7

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.+..+++.||||+++....  ........+..|+.++..+ +|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999874211  1123345667788888887 6999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++... +.+++..+..|+.||+.||.|||+++|+||
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~  120 (318)
T cd05570          79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYR  120 (318)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence            999999998764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.76  E-value=1.3e-17  Score=161.82  Aligned_cols=123  Identities=28%  Similarity=0.537  Sum_probs=107.6

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+++.||||+++....+   ....+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            589999999999999999999999999999998643221   12235677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++....  ..+.+..++.|+.||+.||+|||++||+||
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  125 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR  125 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            99997 78988886532  568999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.76  E-value=6.4e-19  Score=166.63  Aligned_cols=124  Identities=34%  Similarity=0.544  Sum_probs=113.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|.+.++||+|+||+||+|+++++++.||+|.+++..++....   ....+||.+|+.|+|.|||++++....+..+-+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            46888999999999999999999999999999998765554433   456679999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||+ -+|.+|....++.+..+.++.+|.|+++||.|||+++++||
T Consensus        79 vfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhr  125 (292)
T KOG0662|consen   79 VFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHR  125 (292)
T ss_pred             eHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhc
Confidence            999995 89999998888999999999999999999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=7.1e-19  Score=187.30  Aligned_cols=125  Identities=34%  Similarity=0.559  Sum_probs=113.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .+....|...++||+|+-|.||.|....+++.||||.+.+....     ..+-+.+||.+|+.++|+|||.+++.|..++
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            45567899999999999999999999999999999999764332     2246789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|||||+||+|.+.+..  ..++|.+|..|+++++.||+|||.+|||||
T Consensus       344 eLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHr  393 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHR  393 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence            99999999999999999965  559999999999999999999999999998

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.76  E-value=6.8e-18  Score=168.15  Aligned_cols=125  Identities=27%  Similarity=0.475  Sum_probs=108.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcE----EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~----VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||||+++.    .......+.+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            456899999999999999999998766664    88898752    1233445678889999999999999999999876


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      . ..++++||+.+|+|.+++......+.+..+..++.||+.||+|||++|||||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~  133 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR  133 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            4 5789999999999999998766678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.76  E-value=1.3e-17  Score=164.96  Aligned_cols=124  Identities=24%  Similarity=0.394  Sum_probs=110.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|.||.||++.+..+++.||||.+....  .........+.+|+.+++.++|+||+++++.+..++.+|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            6899999999999999999999999999999886321  11233456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||++|++|.++++.. +.+.+..+..++.||+.||.|||+++|+||
T Consensus        80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  125 (305)
T cd05609          80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHR  125 (305)
T ss_pred             EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.1e-18  Score=185.75  Aligned_cols=128  Identities=23%  Similarity=0.398  Sum_probs=112.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~  428 (481)
                      .....+|.+.++||+|.||+|+++..+.+++.||||++++.  +-...+.++.+..|.+|+.... ||.+++|+.+|.+.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~--~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKG--DILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecc--ceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            34567999999999999999999999999999999999853  3344455678888999888875 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|+||||+.|||+..++  +.+.|+|..++.|+..|+.||.|||++|||+|
T Consensus       442 ~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYR  492 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYR  492 (694)
T ss_pred             CeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceee
Confidence            9999999999999944443  24789999999999999999999999999998

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.76  E-value=5.3e-18  Score=169.94  Aligned_cols=119  Identities=21%  Similarity=0.359  Sum_probs=102.0

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ++||+|+||.||+|.++.+|+.||||+++.....  .....+.+..|+.++.. ++|+||+++++++..++.+||||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4799999999999999999999999999742110  11223456667777775 48999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++... +.+++..+..|+.||+.||+|||++||+||
T Consensus        79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr  120 (316)
T cd05620          79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYR  120 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999999999764 779999999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.76  E-value=1.5e-17  Score=158.89  Aligned_cols=123  Identities=43%  Similarity=0.817  Sum_probs=111.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++....   .....+.+.+|+.+++.++|+||+++++++...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc---chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            58999999999999999999998999999999874322   245677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+++++|.+++... ..+.+..+..|+.||+.||.|||+++|+||
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~  123 (264)
T cd06626          78 MEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHR  123 (264)
T ss_pred             EecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999764 568999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.76  E-value=6.1e-18  Score=169.66  Aligned_cols=119  Identities=28%  Similarity=0.394  Sum_probs=99.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHH-HHHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI-~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      +.||+|+||.||+|.+..+++.||+|++.....  ........+..|. .+++.++|+||+++++++...+.+||||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            479999999999999999999999999863211  1111223344444 4578899999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|.+++... +.+.+..++.|+.||+.||.|||++||+||
T Consensus        79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHr  120 (325)
T cd05602          79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYR  120 (325)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999999999764 678999999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=9.3e-20  Score=181.43  Aligned_cols=127  Identities=31%  Similarity=0.473  Sum_probs=111.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeee-EEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-SEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g-~f~~~d~  430 (481)
                      ...+|++.++||+|.||.||++....+|+.+|.|.++.   +..+....+.+..||.+|++|+|||||++|+ .|..++.
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            34579999999999999999999999999999999873   3344555677888999999999999999998 5666666


Q ss_pred             -EEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CccC
Q 011617          431 -LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS--TN--TIHR  481 (481)
Q Consensus       431 -lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHs--kg--IIHR  481 (481)
                       ++||||||.+|||..+|+.   ..+.++|..++.|+.|++.||.+||.  ..  |+||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHR  152 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHR  152 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeec
Confidence             9999999999999999864   34679999999999999999999999  44  8897

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.76  E-value=4.7e-18  Score=166.23  Aligned_cols=116  Identities=18%  Similarity=0.301  Sum_probs=99.2

Q ss_pred             EeccCCcEEEEEEEECCCC------------------------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC
Q 011617          361 LIGRGTFGSVYIGTNRETG------------------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE  416 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~tg------------------------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP  416 (481)
                      +||+|+||.||+|....++                        ..|++|++..     ........+.+|+.+++.++|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            6999999999999853221                        3477887742     2233445678899999999999


Q ss_pred             CeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       417 NIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+++++++...+..||||||+++|+|..++....+.+.+..+..|+.||+.||+|||+++|+||
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~  141 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHG  141 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCC
Confidence            99999999999999999999999999999997756779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.76  E-value=8.2e-18  Score=175.99  Aligned_cols=98  Identities=27%  Similarity=0.405  Sum_probs=81.5

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCC-----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQY  421 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~t-----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL  421 (481)
                      ......++|+++++||+|+||.||+|.+...     +..||||+++..    ......+.+.+|+++|.++. |+|||++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            3355677899999999999999999987432     346999988632    22334467889999999996 9999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHH
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVRE  449 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~  449 (481)
                      ++++...+.+|||||||++|+|.++|..
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~  134 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHK  134 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHH
Confidence            9999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.76  E-value=6.9e-18  Score=169.34  Aligned_cols=119  Identities=22%  Similarity=0.375  Sum_probs=101.7

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      +.||+|+||.||+|.+..+++.||||+++.....  .......+..|+.++.. ++|+||+++++++...+.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4799999999999999999999999999742110  11223445667777775 58999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|.+++... ..+++..+..|+.||+.||+|||++|||||
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHr  120 (316)
T cd05619          79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYR  120 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            999999999763 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.76  E-value=2e-17  Score=157.99  Aligned_cols=124  Identities=29%  Similarity=0.464  Sum_probs=110.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||++.+..+|+.||+|++.....   .....+.+.+|+.+++.++|+||+++++++...+..|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            58999999999999999999999999999999864221   223446788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++.... ..+++..+..|+.||+.||.|||+++|+|+
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR  125 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            99999999999997642 358899999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.76  E-value=7.9e-18  Score=162.28  Aligned_cols=122  Identities=32%  Similarity=0.473  Sum_probs=106.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.+.||+|+||.||++.+.. +..+|||.++..   ..   ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~---~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG---SM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC---cc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            3579999999999999999998764 445999987521   11   1246788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+|+|.+++......+.+..+..|+.||+.||.|||++||+||
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR  124 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999999999999998755578999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.76  E-value=5.3e-18  Score=174.84  Aligned_cols=129  Identities=27%  Similarity=0.432  Sum_probs=109.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCC-----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY  422 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~  422 (481)
                      +.....+|++++.||+|+||.||+|.+...|     ..||||+++..    ...+....+.+|+.+|+.+ +|+|||+++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS----AHTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC----CCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            3455678999999999999999999865433     57999998632    1233456788899999999 899999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------------------------------------------
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  451 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------------------------------------------  451 (481)
                      +++...+.+|||||||.+|+|.++++...                                                   
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            99999999999999999999999986421                                                   


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          452 ------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       452 ------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                        ..+++..+..|+.||+.||.|||++||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHr  236 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHR  236 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence                              236788899999999999999999999998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.76  E-value=1.3e-17  Score=161.58  Aligned_cols=124  Identities=30%  Similarity=0.452  Sum_probs=108.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ....+.+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3799999999999999999999999999999988643211   1223457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||++++.|..++.. ...+++..++.++.||+.||+|||+++|+||
T Consensus        78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~  124 (286)
T cd07847          78 VFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHR  124 (286)
T ss_pred             EEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999998888877654 4679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.76  E-value=7.4e-18  Score=161.96  Aligned_cols=126  Identities=32%  Similarity=0.513  Sum_probs=110.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||++.+..+++.+|||.+....  .........+.+|+.+++.++|+||+++++++..++.+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            47889999999999999999999999999999886422  2233445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.+++|.+++...   ...+++..++.|+.||+.||.|||++||+||
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  130 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR  130 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999999998642   3458999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.76  E-value=5.6e-18  Score=164.53  Aligned_cols=123  Identities=36%  Similarity=0.572  Sum_probs=108.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.++....   .......+.+|+.+++.++|+||+++++++.+.+.+|++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            58999999999999999999999999999999864322   112234567799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++....+.+++..++.++.||+.||.|||+++|+||
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~  123 (284)
T cd07839          78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR  123 (284)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            99996 68988887656779999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.76  E-value=2.6e-17  Score=158.90  Aligned_cols=122  Identities=34%  Similarity=0.593  Sum_probs=107.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .+.....||+|+||.||+|.+..++..||+|.+..     ......+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecC-----CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            33345689999999999999999999999998753     2334456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~L--se~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++......+  .+..+..++.||+.||+|||+++|+||
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~  132 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR  132 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            99999999999998654555  889999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.75  E-value=1.1e-17  Score=161.32  Aligned_cols=124  Identities=24%  Similarity=0.465  Sum_probs=110.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|.+.+.||+|+||.||+|.+..++..||+|+++.      .......+.+|+++|+.++|+||+++++++..++.+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC------CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            44579999999999999999999999999999998752      122345688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|||+.+++|.+++.... ..+.+..++.++.||+.||+|||+++|+||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  128 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR  128 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            99999999999999997643 458999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.75  E-value=3.1e-17  Score=156.65  Aligned_cols=124  Identities=29%  Similarity=0.552  Sum_probs=110.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++++.||.|+||.||+|.+..++..+|+|++....    .....+.+.+|+++|+.++|+||+++++.+..++..||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            47999999999999999999998899999999885321    12255778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~--~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+++++|.++++..  ...+.+..+..++.||+.||+|||++||+||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~  126 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR  126 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999764  2468999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.5e-18  Score=183.28  Aligned_cols=127  Identities=26%  Similarity=0.456  Sum_probs=116.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..+-|.+.+.||+|.|+.|-+|++.-+|++||||+|.+.+.+..   ....+.+|+++|+.++|||||+||++...+..+
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            34679999999999999999999999999999999986654433   345788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+|+-++|+|++||-++...+.|...++|+.||+.||.|||+-++|||
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHR  142 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHR  142 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcc
Confidence            99999999999999999888899999999999999999999999999998

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.75  E-value=2.3e-17  Score=159.90  Aligned_cols=122  Identities=30%  Similarity=0.581  Sum_probs=107.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.++||.|+||.||+|++..+|+.||||+++.....    .....+.+|+.++++++|+||+++++++...+.+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            589999999999999999999999999999998743221    1234566799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++....  ..+.+..+..++.||+.||.|||++||+||
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~  124 (284)
T cd07836          77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR  124 (284)
T ss_pred             EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            99997 68999887643  468999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.75  E-value=2e-17  Score=159.36  Aligned_cols=125  Identities=28%  Similarity=0.483  Sum_probs=109.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ..+|+..+.||+|+||.||+|.+..++.   .+|||.++..    ......+.+.+|+++++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            3578899999999999999999876654   6899987532    12334567888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|+||||+.+++|.+++....+.+++..+..|+.|++.||+|||++||+||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  131 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR  131 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            9999999999999999998766789999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.75  E-value=6.8e-17  Score=172.60  Aligned_cols=117  Identities=18%  Similarity=0.297  Sum_probs=105.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....           ..+.+|+++|++|+|+|||++++++..++..|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            4579999999999999999999999999999996431           23457999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+. ++|..++......+++..++.|+.||+.||.|||++|||||
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr  284 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR  284 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence            9999995 89999987655679999999999999999999999999998

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.75  E-value=1.8e-17  Score=161.18  Aligned_cols=125  Identities=27%  Similarity=0.471  Sum_probs=109.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCc----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|++.+.||+|+||.||+|.++.+|+    .+|+|.++..    ........+.+|+.+|+.++|+||+++++++..
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45689999999999999999999877665    4888877532    224455678889999999999999999999887


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...++||||+.+|+|.+++..+...+++..+..++.||+.||+|||+++|+||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR  133 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence             78999999999999999998766779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.75  E-value=2.6e-17  Score=163.12  Aligned_cols=126  Identities=25%  Similarity=0.419  Sum_probs=112.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+....  .......+.+.+|+++|..++|+||+++++.+...+.+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            37999999999999999999999999999999986422  2223355678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  127 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR  127 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999753 3568999999999999999999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.75  E-value=2.9e-17  Score=175.06  Aligned_cols=125  Identities=21%  Similarity=0.306  Sum_probs=109.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCC-CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~t-g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....|.+.++||+|+||.||+|....+ ++.||+|.+..     ........+.+|+.+|+.++|+|||+++++|..++.
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            345699999999999999999998877 77889987642     223344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||++||+|.++|+..   ...+.+..+..|+.||+.||.|||+++||||
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHr  193 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR  193 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEEC
Confidence            99999999999999988642   3468999999999999999999999999998

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.75  E-value=9.8e-18  Score=171.42  Aligned_cols=122  Identities=25%  Similarity=0.450  Sum_probs=107.1

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-----
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----  429 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-----  429 (481)
                      +|++++.||+|+||.||++.+..+++.||||++....   ......+.+.+|+.+|+.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            4788999999999999999999999999999885321   22334567889999999999999999999998776     


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~  127 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHR  127 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            7999999996 789888865 3679999999999999999999999999997

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.75  E-value=3.7e-17  Score=161.64  Aligned_cols=125  Identities=31%  Similarity=0.511  Sum_probs=111.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|++.+.||+|+||.||+|.+..++..||+|.+....     ....+.+.+|+.+++.+.|+||+++++.+...+
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            344579999999999999999999999999999999986422     122356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|+||||+.+++|.+++..  ..+.+..+..++.||+.||.|||.+||+||
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~  140 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999865  468999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.75  E-value=1.5e-17  Score=162.38  Aligned_cols=125  Identities=29%  Similarity=0.488  Sum_probs=108.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEE----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~d----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ..-|++.+.||+|+||.||+|++    ..++..||+|.++..    ........+.+|+.+|+.++|+||+++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34578999999999999999985    456788999998632    2234456788999999999999999999998775


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        +.+|+||||++|++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~  133 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR  133 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence              56999999999999999997655578999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=6.2e-18  Score=175.58  Aligned_cols=122  Identities=27%  Similarity=0.470  Sum_probs=105.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-EEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-~ly  432 (481)
                      +.|....+||+|+||.||+|...+ |..||||++....  ..  . .++|.+|+.+|.+++|+|||+|+|||.+.+ ..+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~--~~--~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNS--GQ--G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCC--Cc--c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            578888999999999999999765 4889999775321  11  1 345999999999999999999999999988 599


Q ss_pred             EEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Q 011617          433 IYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN---TIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~-~Lse~~I~~I~~QIl~GL~YLHskg---IIHR  481 (481)
                      ||+|||.+|+|.++|..... .++|....+|+.++++||+|||+..   ||||
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr  201 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHR  201 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence            99999999999999987545 8899999999999999999999863   9998

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.75  E-value=1.6e-17  Score=162.54  Aligned_cols=118  Identities=23%  Similarity=0.285  Sum_probs=100.8

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|+||.||++.++.+|+.||+|++.....  ......+.+..|+.+|++++|+||+++++++..++.+||||||+.|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHh--hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            7999999999999999999999999863211  11112234566999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|..++.... ..+.+..+..++.||+.||+|||++||+||
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  119 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR  119 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEc
Confidence            9998886532 358899999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.75  E-value=3.4e-17  Score=162.01  Aligned_cols=125  Identities=32%  Similarity=0.511  Sum_probs=111.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.+.||+|+||.||++.+..+++.||||.+....     ....+.+.+|+.+++.++|+||+++++++...+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345579999999999999999999999999999999986321     122356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+++++|.+++..  ..+.+..+..++.|++.||.|||+++|+||
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~  139 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHR  139 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999865  568999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.75  E-value=2.4e-17  Score=161.12  Aligned_cols=130  Identities=23%  Similarity=0.436  Sum_probs=110.7

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCC-----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY  421 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL  421 (481)
                      .......+|++.+.||+|+||.||++.+....     ..+|+|.++..    ...+....+.+|+.++..+ +|+||+++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            34556678999999999999999999976433     67999988632    2233446688899999999 79999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~~---------------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++..++.+|++|||+.+|+|.++++..               ...+++..+..|+.||+.||+|||+++|+||
T Consensus        82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~  156 (293)
T cd05053          82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR  156 (293)
T ss_pred             EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999999999999642               2468899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.75  E-value=1.9e-17  Score=161.20  Aligned_cols=122  Identities=34%  Similarity=0.559  Sum_probs=109.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++.+.||+|+||.||+|.+..++..+++|.+..     ......+.+.+|+.+++.++|+||+++++++..++..|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            47888999999999999999999999999998852     2334556788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|..++......+++..+..++.||+.||.|||++||+||
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~  127 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR  127 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999886655679999999999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.75  E-value=1.9e-17  Score=158.84  Aligned_cols=124  Identities=23%  Similarity=0.475  Sum_probs=108.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.++||+|+||.||+|.+. .+..||+|.+...      ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678999999999999999999965 4567999987531      1224678889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|++|||+.+++|.++++.. ...+++..+..++.||+.||+|||+++|+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~  127 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR  127 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999999764 3568899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.75  E-value=3.3e-17  Score=159.89  Aligned_cols=118  Identities=28%  Similarity=0.478  Sum_probs=105.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.++||+|+||.||+|.+..+++.||||.+...    ...+..+.+.+|+++|++++|+||+++++++...+..++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            688899999999999999999999999999998632    2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|..+     ..+++..+..++.||+.||+|||+++|+||
T Consensus        78 ~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  119 (279)
T cd06619          78 TEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHR  119 (279)
T ss_pred             EecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            999999999654     347899999999999999999999999997

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.75  E-value=1e-17  Score=160.99  Aligned_cols=121  Identities=30%  Similarity=0.433  Sum_probs=105.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||++.+. ++..+|+|++...   ...   ...+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~---~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG---AMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC---CCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            46889999999999999999886 4667999987521   111   2356779999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++++|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  124 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR  124 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999998755678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.75  E-value=6e-18  Score=162.07  Aligned_cols=124  Identities=23%  Similarity=0.458  Sum_probs=109.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|+++++||.|+||.||+|.+.. +..+|+|++..     ........+..|+.+|+.++|+||+++++++...+.+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKS-----DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccc-----cchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            34579999999999999999999987 88899999863     2222345688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+++++|.++++.. ...+.+..+..|+.||+.||.|||++||+||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~  128 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR  128 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            9999999999999999763 3568999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.74  E-value=1.2e-17  Score=162.16  Aligned_cols=124  Identities=31%  Similarity=0.470  Sum_probs=108.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.++||+|+||.||+|.+..+++.||||++.....   .....+.+.+|+++|+.++|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC---cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            368999999999999999999998999999998753221   12334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.++.|..++.. ...+.+..++.++.||+.||+|||+++|+||
T Consensus        78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~  124 (286)
T cd07846          78 VFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHR  124 (286)
T ss_pred             EEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999998888887754 3568999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.74  E-value=2.2e-17  Score=159.44  Aligned_cols=125  Identities=32%  Similarity=0.506  Sum_probs=108.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECC----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-  427 (481)
                      ..+|++.+.||+|+||.||++.+..    +++.||||+++....    ....+.+.+|+++++.+.|+||+++++++.. 
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----EQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc----hHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            4578889999999999999998643    478899999863221    1345678999999999999999999999877 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ....+++|||+++++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~  133 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR  133 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence             567999999999999999998765579999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.74  E-value=2.6e-17  Score=160.34  Aligned_cols=125  Identities=22%  Similarity=0.375  Sum_probs=107.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEEC----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ...|++.+.||+|+||.||+|.+.    ..+..||+|.++..    ...+....+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            467899999999999999999863    35578999988631    2234456788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC----------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~----------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +..|++|||+.+++|.+++....                ..+++..+..++.||+.||.|||+++|+||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~  148 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK  148 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehh
Confidence            99999999999999999985321                247889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.74  E-value=2.6e-17  Score=156.59  Aligned_cols=122  Identities=34%  Similarity=0.580  Sum_probs=111.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||+|+||.||+|.+..++..|++|.+...       ...+.+.+|+++++.++|+||+++++++..+..+|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            35799999999999999999999988999999998631       11568889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+++|.+++......+++..+..++.||+.||.|||+++|+||
T Consensus        75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~  123 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR  123 (256)
T ss_pred             EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999998766778999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.74  E-value=3.1e-17  Score=162.53  Aligned_cols=129  Identities=24%  Similarity=0.434  Sum_probs=108.7

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECC-------CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ  420 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~-------tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVq  420 (481)
                      +....++|.+++.||+|+||.||++.+..       ++..+|+|.++..    ........+.+|+.+++.+ +|+||++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34556789999999999999999998643       2346999988631    1233456788899999999 7999999


Q ss_pred             eeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       421 L~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++...+.+|+||||+.+|+|.+++....               ..+++..+..|+.||+.||+|||++||+||
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~  164 (307)
T cd05098          89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR  164 (307)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999999999999997632               247889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.74  E-value=3.3e-17  Score=162.33  Aligned_cols=129  Identities=29%  Similarity=0.510  Sum_probs=112.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ......|++.+.||+|.||.||+|.+..+++.||||++...  .....+..+.+.+|+.+++.++|+||+++++++..++
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecc--ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            34456799999999999999999999989999999988632  2233445567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..||||||+. |+|.+++......+.+..+..++.||+.||.|||+++|+||
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~  139 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR  139 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999999996 78888876655679999999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.74  E-value=2.3e-17  Score=161.34  Aligned_cols=125  Identities=28%  Similarity=0.450  Sum_probs=106.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcE----EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~----VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|++.+.||+|+||.||+|.+..++..    +++|.+.    ..........+..|+.++..+.|+||+++++++. 
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            456899999999999999999999877764    5566553    1223344567888999999999999999999875 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ....+++|||+.+|+|.+++....+.+++..+..|+.||+.||.|||+++|+||
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~  133 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR  133 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            456889999999999999998766789999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=1.4e-17  Score=167.04  Aligned_cols=117  Identities=22%  Similarity=0.286  Sum_probs=99.4

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      ||+|+||.||+|++..+++.||||++.....  ........+..|..++..+   .|+||+++++++...+.+||||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999999999999999999863211  1122233445566776655   6999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|..++.. .+.+++..++.|+.||+.||+|||++||+||
T Consensus        79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHr  120 (330)
T cd05586          79 SGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYR  120 (330)
T ss_pred             CCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999999976 4779999999999999999999999999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.74  E-value=2e-17  Score=160.28  Aligned_cols=124  Identities=31%  Similarity=0.474  Sum_probs=108.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++....   .....+.+.+|+++|+.+.|+||+++++++..++.+|+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            379999999999999999999999999999998864221   22344678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.++.+..++.. ...+++..+..++.||+.||.|||+++|+||
T Consensus        78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  124 (288)
T cd07833          78 VFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHR  124 (288)
T ss_pred             EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999987777666544 4669999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.74  E-value=1.3e-17  Score=162.45  Aligned_cols=124  Identities=28%  Similarity=0.544  Sum_probs=109.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++.+.||+|+||.||++.+..++..||+|.++..    ........+.+|+.++++++|+||+++++++...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3688999999999999999999999999999988632    223344678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~--~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ||||+++++|..++...  ...+++..+..++.||+.||.|||+ ++|+||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~  127 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR  127 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeC
Confidence            99999999999998763  2378999999999999999999997 599997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.74  E-value=5.4e-17  Score=154.81  Aligned_cols=124  Identities=30%  Similarity=0.474  Sum_probs=107.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-CCEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHLYI  433 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-~d~lyL  433 (481)
                      .|++.+.||+|+||.||++.+..+++.||+|++....   ......+.+.+|+.+++.++|+||+++++.+.. ++.+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            4899999999999999999999999999999986422   223345668889999999999999999998764 446899


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~  126 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR  126 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999764 3458999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.74  E-value=7.9e-17  Score=151.55  Aligned_cols=123  Identities=46%  Similarity=0.903  Sum_probs=111.1

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLY  432 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~ly  432 (481)
                      +|++.+.||+|+||.||+|.+..+++.|++|++.....   .....+.+.+|+.+++.++|+||+++++.+...  +.++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            58899999999999999999998999999999864322   144567888999999999999999999999988  8999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++++|+
T Consensus        78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~  125 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHR  125 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999999875 589999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.74  E-value=3.2e-17  Score=156.99  Aligned_cols=124  Identities=26%  Similarity=0.475  Sum_probs=108.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.++||+|+||.||+|.+.. +..+|||.+....   .   ..+.+.+|+.+++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT---M---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc---c---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            456789999999999999999999764 5779999886321   1   23567889999999999999999999999899


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+||||+++++|.+++.... ..+++..+..|+.||+.||.|||++||+||
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~  127 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR  127 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            999999999999999997643 468999999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.74  E-value=3.3e-17  Score=160.10  Aligned_cols=126  Identities=25%  Similarity=0.439  Sum_probs=109.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCC----------------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETG----------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH  415 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg----------------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H  415 (481)
                      ...+|++++.||+|+||.||+|.+...+                ..||+|.+...    ......+.+.+|+++|+.++|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~   78 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSD   78 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCC
Confidence            3468999999999999999999876543                45799987632    223456778899999999999


Q ss_pred             CCeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       416 PNIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~----------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+++++++..++.++++|||+.+++|.+++....          ..+++..+..++.||+.||+|||+++|+||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~  154 (296)
T cd05051          79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR  154 (296)
T ss_pred             CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            999999999999999999999999999999997642          168999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.74  E-value=1.8e-17  Score=160.27  Aligned_cols=125  Identities=22%  Similarity=0.424  Sum_probs=107.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCC-----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~t-----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|++.+.||+|+||.||+|+++.+     .+.|++|.+..    .........+.+|+++|++++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC----ccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            46899999999999999999997543     45688887742    1223356678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCR--------DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~--------~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..|+||||+++|+|.+++.....        .+++..+..++.||+.||+|||+++|+||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~  141 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR  141 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence            9999999999999999999976421        58999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.74  E-value=3.2e-17  Score=159.51  Aligned_cols=125  Identities=25%  Similarity=0.385  Sum_probs=109.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|.+...    ........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4679999999999999999999976     6778999987532    223334567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..||||||+.+++|.+++....      ..+.+..+..|+.||+.||+|||+++|+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  140 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR  140 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            999999999999999999997643      258899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.74  E-value=3.7e-17  Score=162.15  Aligned_cols=126  Identities=25%  Similarity=0.450  Sum_probs=107.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcE--EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~--VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      ...+|++.+.||+|+||.||+|.++.++..  +|+|.++.    .........+.+|+.++.++ +|+||+++++++..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            346899999999999999999999877765  46666542    12334456788899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|+||||+.+++|.+++....               ..+++..++.|+.||+.||+|||++||+||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~  148 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR  148 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            99999999999999999997532               257899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.74  E-value=4.2e-17  Score=157.54  Aligned_cols=127  Identities=22%  Similarity=0.349  Sum_probs=108.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC-----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t-----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....+|++.+.||+|+||.||+|.+...     +..||||.+...    ........+.+|+.+|+.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            4567899999999999999999998643     378999987521    2233345678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+..|+||||+.+|+|.+++....         ..+.+..+..|+.||+.||.|||+++|+||
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  143 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR  143 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            99999999999999999999996531         236788999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.74  E-value=2.1e-17  Score=161.47  Aligned_cols=124  Identities=24%  Similarity=0.400  Sum_probs=111.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.+.||+|+||.||++.+..+++.||+|++...    ......+.+.+|+++++.++|+||+++++++...+.+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            46789999999999999999999999999999988632    12334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      |||||+++++|.+++... +.+.+..+..++.||+.||.|||+ ++|+||
T Consensus        80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~  128 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHR  128 (284)
T ss_pred             EEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            999999999999998764 679999999999999999999997 689997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.74  E-value=5.8e-17  Score=157.72  Aligned_cols=123  Identities=24%  Similarity=0.447  Sum_probs=99.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEe----
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV----  427 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~----  427 (481)
                      +|++.+.||+|+||.||+|.++.+++.||||+++........   ...+.+|+.+++.+   +|+||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            589999999999999999999999999999998753221111   12344566666554   79999999998864    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...++++|||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||
T Consensus        78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  132 (288)
T cd07863          78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR  132 (288)
T ss_pred             CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence             345899999997 68999887632 458999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.74  E-value=4.2e-17  Score=158.72  Aligned_cols=122  Identities=34%  Similarity=0.592  Sum_probs=109.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|+..++||.|+||.||+|.+..++..||||+++..    ........+.+|+.+++.+.|+||+++++++.+.+.+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            4688889999999999999999999999999998632    223445778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++..  +.+.+..+..++.||+.||+|||+++|+|+
T Consensus        80 v~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~  125 (277)
T cd06640          80 IMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHR  125 (277)
T ss_pred             EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCc
Confidence            9999999999999864  568999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.74  E-value=6.2e-17  Score=157.98  Aligned_cols=124  Identities=25%  Similarity=0.461  Sum_probs=99.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECC-CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEe--
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV--  427 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~-tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~--  427 (481)
                      .+|++.+.||+|+||.||+|.+.. .+..||||+++........   ...+.+|+.+++.+   .|+||+++++++..  
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            379999999999999999999854 4678999998753322211   22344566666655   69999999998863  


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ---~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ...+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~  134 (290)
T cd07862          78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR  134 (290)
T ss_pred             CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence               456999999996 7999998763 2458999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.74  E-value=4.5e-17  Score=155.90  Aligned_cols=122  Identities=31%  Similarity=0.522  Sum_probs=108.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++.+.||.|+||.||+|.+.  |+.||||.++..      ....+++.+|+.+++.++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccc------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            4568999999999999999999875  788999998632      11456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+.+++|.++++... ..+.+..+..++.||+.||.|||+++|+||
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  126 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR  126 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence            99999999999999997643 368999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.74  E-value=8.2e-17  Score=157.48  Aligned_cols=124  Identities=27%  Similarity=0.462  Sum_probs=107.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|++.+.||+|+||.||+|.+..+++.||||++.......    ....+.+|+.+|+.++|+||+++++++..++..|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            368999999999999999999999999999999986432211    1234567999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++......+.+..++.++.||+.||.|||.+||+||
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  127 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR  127 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999995 78888776655668899999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.73  E-value=6.6e-18  Score=162.73  Aligned_cols=117  Identities=24%  Similarity=0.423  Sum_probs=100.9

Q ss_pred             EEeccCCcEEEEEEEECCCCc-------EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETGA-------SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~-------~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      +.||+|+||.||+|.+...+.       .+|+|.+..     ......+.+.+|+.+|+.+.|+||+++++++..++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            368999999999999865443       377776642     22344567888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+.+|+|.++++.....+.+..++.++.||+.||+|||++||+||
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~  124 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG  124 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999999999999998765678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.73  E-value=3.6e-17  Score=155.65  Aligned_cols=124  Identities=26%  Similarity=0.508  Sum_probs=109.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|.+.+.||+|+||.||++.+..+|..||+|.+.....   .....+.+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM---PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc---cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            58899999999999999999999999999999864321   112345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++.... ..+++..+..|+.||+.||.|||+++|+||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~  125 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR  125 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999997643 357999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.73  E-value=5e-17  Score=165.24  Aligned_cols=123  Identities=21%  Similarity=0.342  Sum_probs=104.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ..++|++.+.||+|+||.||++.+..+|+.||||++....   ........+.+|+.+++.++|+||+++++++...+  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            4578999999999999999999999999999999986321   22334456778999999999999999999986543  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+|+||||+. ++|.+++.   ..+++..+..++.||+.||.|||++||+||
T Consensus        96 ~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHr  147 (359)
T cd07876          96 EEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHR  147 (359)
T ss_pred             cccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                5899999996 56777664   348899999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.73  E-value=5.4e-17  Score=159.12  Aligned_cols=127  Identities=22%  Similarity=0.361  Sum_probs=105.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....+|++.++||+|+||.||+|.++.     .+..||+|.++..    ........+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            445789999999999999999997642     2457999987521    1222334577899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+..|+||||+.+|+|.++++...         ..+....+..|+.||+.||.|||+++|+||
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  143 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR  143 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            99999999999999999999997532         224677889999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.73  E-value=5.2e-17  Score=158.10  Aligned_cols=122  Identities=35%  Similarity=0.611  Sum_probs=108.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .-|++.+.||.|+||.||+|.+..+++.||||++...    ......+.+.+|+.++..++|+||+++++++..++..|+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            3578899999999999999999889999999987532    223345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+|+
T Consensus        80 v~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (277)
T cd06641          80 IMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR  125 (277)
T ss_pred             EEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecC
Confidence            9999999999999864  568999999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.73  E-value=3.4e-17  Score=157.46  Aligned_cols=124  Identities=24%  Similarity=0.432  Sum_probs=107.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+.. ++.||||.++...      ...+.+.+|+.+++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            345679999999999999999999754 5679999986321      123567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++|||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  127 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR  127 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999997643 468999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.73  E-value=3.2e-17  Score=157.99  Aligned_cols=123  Identities=33%  Similarity=0.614  Sum_probs=106.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC---
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD---  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~---  428 (481)
                      .+.|++.+.||+|+||.||+|.+..+++.||||++....      .....+.+|+.++..+ +|+||+++++++...   
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            457889999999999999999999999999999986421      1124677899999998 699999999998753   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +.+||+|||+.+++|.+++... ...+.+..+..++.||+.||+|||+++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~  135 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR  135 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence               4689999999999999999764 3468999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.73  E-value=2.6e-18  Score=186.84  Aligned_cols=126  Identities=27%  Similarity=0.471  Sum_probs=110.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ...-|...+.||+|+||.||.+.++.+|+.||||.++...    .....+.+.+||++|++|+|+|||+++++-++..  
T Consensus        11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            3467889999999999999999999999999999987432    2333467788999999999999999999876544  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~--~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          ...||||||.||||..++..  +...++|.+++.++..+..||.|||++|||||
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHR  144 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHR  144 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceec
Confidence                47899999999999999975  45679999999999999999999999999998

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.73  E-value=2.5e-17  Score=158.41  Aligned_cols=125  Identities=33%  Similarity=0.540  Sum_probs=111.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~ly  432 (481)
                      .+|++.+.||+|+||.||++.+..+++.||||++.....  ......+.+.+|+.++.++. |+||+++++++..++.+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            379999999999999999999999999999999864221  22233467788999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+.+++|.+++... +.+++..+..|+.||+.||.|||++|++|+
T Consensus        79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~  126 (280)
T cd05581          79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHR  126 (280)
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999999999999999874 679999999999999999999999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.73  E-value=5.3e-17  Score=157.72  Aligned_cols=127  Identities=21%  Similarity=0.371  Sum_probs=106.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ...++|++.+.||+|+||.||+|.+..     ++..||||+++..    ........+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            345689999999999999999998642     3567999987521    2223345688899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+..++||||+.+++|.+++....         ..+.+..+..++.||+.||.|||+++|+||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~  143 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR  143 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999999997532         125678899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.73  E-value=9.6e-17  Score=151.51  Aligned_cols=124  Identities=29%  Similarity=0.533  Sum_probs=111.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||.|+||.||++.+..++..|++|++....   ...+..+.+.+|+++++.++|+||+++++.+...+.++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            5899999999999999999999899999999986432   2234556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++...   ...+++..+..|+.||+.||.|||++||+|+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~  127 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR  127 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            9999999999999764   3779999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=6.5e-17  Score=154.78  Aligned_cols=124  Identities=31%  Similarity=0.585  Sum_probs=108.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD-  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d-  429 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.+++|++....      .....+.+|+.+++.+ .|+||+++++++.... 
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            3478999999999999999999999889999999986321      2335788999999998 6999999999997644 


Q ss_pred             -----EEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -----~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           .+||||||+++++|.+++...   ...+.+..++.++.||+.||.|||+++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~  137 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR  137 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence                 599999999999999998653   3678999999999999999999999999997

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.73  E-value=5.7e-17  Score=157.63  Aligned_cols=125  Identities=32%  Similarity=0.565  Sum_probs=106.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEE---
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV---  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~---  426 (481)
                      ....+|++.+.||+|+||.||++.+..+++.+|+|+++..      ......+.+|+.+++.+ +|+||+++++++.   
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4567899999999999999999999999999999987531      11224577899999999 6999999999874   


Q ss_pred             --eCCEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 --VDDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 --~~d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+.+||||||+++++|.+++..   ....+.+..+..++.||+.||.|||+++|+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  148 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR  148 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence              34579999999999999998863   23568899999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.73  E-value=3.2e-17  Score=159.13  Aligned_cols=125  Identities=25%  Similarity=0.401  Sum_probs=108.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCC-----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg-----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|++.+.||+|+||.||+|.+...+     ..||+|.++..    ........+.+|+.+|..++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            357899999999999999999976554     67999987532    233445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..|++|||+++++|.+++....               ..+.+..+..++.||+.||.|||+++|+||
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~  148 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHR  148 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            999999999999999999997531               457889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.73  E-value=2e-17  Score=167.59  Aligned_cols=128  Identities=25%  Similarity=0.406  Sum_probs=105.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      ....++|++++.||+|+||.||+|.+.     .+++.||||.++..    ........+.+|+.+|..+ +|+||+++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG   78 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence            345678999999999999999999853     45778999998632    1233456788899999999 6899999999


Q ss_pred             EEEeC-CEEEEEEeccCCCCHHHHHHHhC---------------------------------------------------
Q 011617          424 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  451 (481)
Q Consensus       424 ~f~~~-d~lyLVmEy~~GGSL~~lL~~~~---------------------------------------------------  451 (481)
                      ++... ..++++||||.+|+|.+++....                                                   
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (343)
T cd05103          79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL  158 (343)
T ss_pred             eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence            87654 56899999999999999986521                                                   


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          452 ---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       452 ---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                     ..+++..+..|+.||+.||+|||+++|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~  203 (343)
T cd05103         159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHR  203 (343)
T ss_pred             ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                           236778889999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.73  E-value=8.7e-17  Score=153.31  Aligned_cols=122  Identities=32%  Similarity=0.545  Sum_probs=111.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||+|.+..+++.|+||++....    .....+.+.+|+.++..++|+||+++++++...+.+|+|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            6889999999999999999999999999999986421    114456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+ ++++||
T Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~  124 (264)
T cd06623          78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHR  124 (264)
T ss_pred             EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccC
Confidence            9999999999999764 779999999999999999999999 999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=1.2e-16  Score=151.17  Aligned_cols=123  Identities=46%  Similarity=0.747  Sum_probs=111.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|.||.||++.+..+++.|++|.+....   ........+.+|++++.+++|+||+++++++..++.+|++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            5889999999999999999999899999999986432   2234567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus        78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~  123 (254)
T cd06627          78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHR  123 (254)
T ss_pred             EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            9999999999999764 779999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.73  E-value=4.4e-17  Score=160.93  Aligned_cols=130  Identities=25%  Similarity=0.452  Sum_probs=109.2

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEEC-------CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV  419 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk-------~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIV  419 (481)
                      .......+|.+++.||+|+||.||+|.+.       ..+..||||.++..    ......+.+.+|+.+++.+ +|+||+
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~   84 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNII   84 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCch
Confidence            34566789999999999999999999753       23456899987521    2234456788999999999 799999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       420 qL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++++...+.+|++|||+.+|+|.+++....               ..+++..+..++.||+.||.|||++||+||
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~  161 (304)
T cd05101          85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR  161 (304)
T ss_pred             heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999999999999999999997631               247788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.73  E-value=2.7e-17  Score=172.22  Aligned_cols=98  Identities=26%  Similarity=0.422  Sum_probs=81.7

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQY  421 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL  421 (481)
                      .+....++|.++++||+|+||.||+|.+.     ..++.||||+++..    ......+.+.+|+++|..+. |+|||++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST----ARSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC----CChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            34556678999999999999999999964     34567999998632    12233456888999999997 9999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHH
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVRE  449 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~  449 (481)
                      ++++...+.+|||||||.+|+|.++|+.
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~  134 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHR  134 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHh
Confidence            9999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.73  E-value=1.2e-16  Score=156.68  Aligned_cols=124  Identities=29%  Similarity=0.458  Sum_probs=107.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL  431 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~l  431 (481)
                      +.|...+.||.|.||.||+|.+..+++.||+|.+....    .......+.+|+++|+.++|+||++++++|...  +.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            36899999999999999999999999999999986421    224456788899999999999999999998654  479


Q ss_pred             EEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++++|.+++..   ....+++..+..|+.||+.||.|||+++|+||
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~  129 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR  129 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999999999998753   23568999999999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.73  E-value=4.6e-17  Score=161.72  Aligned_cols=129  Identities=27%  Similarity=0.426  Sum_probs=109.5

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY  422 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~  422 (481)
                      +.....+|.+.+.||+|+||.||++.+.     .++..||+|.++..    ......+.+.+|+.+++++ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            3455568999999999999999999852     34557999987632    1233456788999999999 799999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++...+.+|++|||+.+|+|.++++... ..+++..+..|+.||+.||+|||+++|+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~  165 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHR  165 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence            99999999999999999999999997643 338999999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.73  E-value=3.2e-17  Score=161.23  Aligned_cols=126  Identities=25%  Similarity=0.424  Sum_probs=106.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCC--------------CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRET--------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN  417 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~t--------------g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN  417 (481)
                      ...+|++.+.||+|+||.||+|.+..+              ...||||.++..    ........+.+|+++|+.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~   78 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPN   78 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCC
Confidence            346899999999999999999987543              235899988632    22344567889999999999999


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~-----------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+++++++...+.+|+||||+.+++|.+++....           ..+.+..+..++.||+.||.|||+++|+||
T Consensus        79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~  153 (295)
T cd05097          79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR  153 (295)
T ss_pred             cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            9999999999999999999999999999996531           136788999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.73  E-value=3e-17  Score=167.62  Aligned_cols=117  Identities=20%  Similarity=0.288  Sum_probs=105.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+...           .....|+.+|+.++|+||+++++++...+..|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            4579999999999999999999999999999997531           12245899999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+. ++|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999995 79999987766789999999999999999999999999998

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.73  E-value=4e-17  Score=154.46  Aligned_cols=118  Identities=30%  Similarity=0.517  Sum_probs=105.1

Q ss_pred             EEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      +.||+|+||.||+|.+...   +..||+|+++....    ....+.+.+|++++..++|+||+++++++...+.++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc----hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4799999999999999866   88899999864221    1145778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~--------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+.+++|.+++...        ...+++..+..++.||+.||+|||+++|+||
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  129 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR  129 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence            99999999999875        3779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=5.1e-18  Score=183.77  Aligned_cols=118  Identities=35%  Similarity=0.630  Sum_probs=108.6

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      .-+||+|+||.||.|+++.+...+|||.|..     ++.+..+-+.+||.+.++|+|.|||+|+|++..++++-|+||-+
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence            3479999999999999999999999999852     33445677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~L--se~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+|..+|+...+.+  .|..+-.|.+||++||+|||++.||||
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHR  699 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHR  699 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeec
Confidence            9999999999888888  899999999999999999999999998

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.4e-18  Score=185.63  Aligned_cols=130  Identities=29%  Similarity=0.516  Sum_probs=118.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ..+....|.-++.||.|+||.||.|.+..+.+.||||++.  .......+...+|..|++.|++|.|||+|.|-|||..+
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMs--ySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeecc--ccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            3455567888999999999999999999999999999986  34455667778899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...|||||||- |+..++|.-+.+.+.|..|..|+.+.+.||.|||+++.|||
T Consensus        99 ~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHR  150 (948)
T KOG0577|consen   99 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHR  150 (948)
T ss_pred             chHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence            99999999995 89999998888899999999999999999999999999998

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.73  E-value=5.8e-17  Score=161.31  Aligned_cols=131  Identities=23%  Similarity=0.416  Sum_probs=109.7

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECC-------CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCe
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI  418 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~-------tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNI  418 (481)
                      ..+.....+|++++.||+|+||.||++++..       ....+|+|.++..    ........+.+|+.+++.+ +|+||
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   80 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNI   80 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCe
Confidence            3445566799999999999999999998642       2456899987531    2234456788899999999 59999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++++...+.+|++|||+.+|+|.+++....               ..+.+..+..|+.||+.||.|||++||+||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~  158 (314)
T cd05099          81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR  158 (314)
T ss_pred             eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999999999999999999999999999997632               347889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.73  E-value=5.8e-17  Score=158.91  Aligned_cols=125  Identities=30%  Similarity=0.564  Sum_probs=108.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      +..+|.+.+.||+|+||.||++...     .++..+|+|.+..     ......+.+.+|+.+|++++|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV   77 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4568999999999999999999853     3456689998752     23345567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+|+||||+.+++|.+++....            ..+++..+..|+.||+.||+|||++||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~  144 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHR  144 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999997542            248999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.73  E-value=2.8e-17  Score=159.06  Aligned_cols=125  Identities=29%  Similarity=0.541  Sum_probs=108.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||||.++..    ...+..+.+.+|+++|+.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            4578999999999999999998743     3578999988632    223345688899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~-------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+|+||||+.+++|.+++....             ..+.+..+..++.||+.||.|||++||+||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~  146 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHR  146 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecc
Confidence            999999999999999999997642             347889999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.73  E-value=1.1e-16  Score=152.13  Aligned_cols=124  Identities=28%  Similarity=0.482  Sum_probs=108.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CCEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY  432 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d~ly  432 (481)
                      +|++.+.||.|+||.||++.+..++..||+|++...   .......+++.+|+.+++.++|+||+++++++..  ...+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            588999999999999999999999999999988632   2234445678899999999999999999998764  45689


Q ss_pred             EEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCccC
Q 011617          433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH-----STNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLH-----skgIIHR  481 (481)
                      ++|||+.+++|.+++...   ...+++..++.++.||+.||+|||     +++|+||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~  134 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHR  134 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceec
Confidence            999999999999999753   467899999999999999999999     8999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.73  E-value=5e-17  Score=159.95  Aligned_cols=125  Identities=25%  Similarity=0.413  Sum_probs=106.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECC----------------CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE  416 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~----------------tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP  416 (481)
                      .++|++.++||+|+||.||++.+..                ++..+|+|+++..    ........+.+|+.+|+.++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence            4579999999999999999986542                3446899987632    2234456788999999999999


Q ss_pred             CeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       417 NIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~----------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+++++++..++.+|++|||+.+++|.+++....          ..+++..+..|+.||+.||+|||++||+||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~  154 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR  154 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999999999999999999997632          236778999999999999999999999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=5.7e-17  Score=156.97  Aligned_cols=122  Identities=32%  Similarity=0.565  Sum_probs=109.6

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....    .......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            36889999999999999999999999999999986321    22334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++..  ..+++..++.++.||+.||.|||+++|+||
T Consensus        77 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~  122 (274)
T cd06609          77 IMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHR  122 (274)
T ss_pred             EEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999975  378999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.73  E-value=1e-16  Score=158.74  Aligned_cols=125  Identities=30%  Similarity=0.521  Sum_probs=111.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ......|++.+.||.|.||.||+|.+..+++.||||++....     ....+.+.+|+.+++.++|+||+++++++...+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            344568999999999999999999999999999999986321     122356788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+.+++|..++..  ..+++..+..++.||+.||.|||++||+||
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~  139 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHR  139 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999865  468999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.73  E-value=7.1e-17  Score=157.00  Aligned_cols=125  Identities=26%  Similarity=0.406  Sum_probs=108.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCc----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|++.++||+|+||.||+|.+..++.    .||+|.++..    ......+.+.+|+.++..+.|+||+.+++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45689999999999999999999877776    3799987532    234445678889999999999999999998865


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...+++|||+++|+|.++++.+.+.+++..+..++.||+.||+|||+++|+||
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~  133 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR  133 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence             45789999999999999998765779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.73  E-value=5.4e-17  Score=163.13  Aligned_cols=131  Identities=25%  Similarity=0.460  Sum_probs=109.6

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCC-------CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCe
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI  418 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~t-------g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNI  418 (481)
                      +.+.....+|++++.||+|+||.||+|.+...       +..||+|.++..    ......+.+.+|+.+++++ +|+||
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence            34556677899999999999999999986432       236899987521    2234456788999999999 79999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++++..++.+|++|||+.+|+|.+++....               ..+.+..+..|+.||+.||+|||++||+||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~  158 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR  158 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999999999999999999999999999997531               247788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1e-18  Score=181.76  Aligned_cols=126  Identities=36%  Similarity=0.586  Sum_probs=114.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|...++||+|.||.||+|.+..+++.||||++.+.    ..+..++.+++||.+|.+++++||.+||+.|..+..
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            3455788889999999999999999999999999999763    334567889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+||||.||++.++++. +..+.|..+..|+++++.||.|||.++.|||
T Consensus        86 LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHr  135 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHR  135 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecc
Confidence            9999999999999999976 4556999999999999999999999999998

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.73  E-value=5.9e-17  Score=156.53  Aligned_cols=125  Identities=23%  Similarity=0.411  Sum_probs=106.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ...+|++.++||+|+||.||+|.+...   ...||||.+...    ......+.+.+|+.+++.+.|+||+++++++.+ 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            356799999999999999999997654   345889987532    123455678899999999999999999998764 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +..|+||||+.+|+|.+++......+.+..+..++.||+.||+|||+++++||
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~  131 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR  131 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            56789999999999999998755578999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.73  E-value=3.8e-17  Score=160.04  Aligned_cols=125  Identities=27%  Similarity=0.429  Sum_probs=108.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH  430 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~  430 (481)
                      ..+|++.+.||.|.||.||+|.+..+++.+|||.++.....   ......+.+|+.++..++|+||+++++++...  +.
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            35799999999999999999999999999999999743221   22234567799999999999999999999887  88


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+. ++|.+++......+++..++.|+.||+.||+|||+++|+||
T Consensus        81 ~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~  130 (293)
T cd07843          81 IYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR  130 (293)
T ss_pred             EEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999999997 69999987755679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.72  E-value=6.5e-17  Score=154.46  Aligned_cols=122  Identities=28%  Similarity=0.457  Sum_probs=107.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++.+.||+|+||.||++.+.. +..+|+|.++...   ..   ...+.+|+++++++.|+||+++++++......|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~---~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA---MS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC---CC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            3578999999999999999998864 6789999875321   11   245778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+++|.+++....+.+.+..+..++.||+.||+|||+++|+||
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~  124 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR  124 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999998765678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.72  E-value=5.5e-17  Score=158.48  Aligned_cols=126  Identities=23%  Similarity=0.420  Sum_probs=108.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ...+|++.+.||+|+||.||++.+.     .++..||||++...    ......+.+.+|+.+++++.|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            3567999999999999999999874     35678999988531    23344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~---------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++.+|++|||+.+|+|.+++....                     ..+.+..+..++.||+.||+|||+++|+||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~  154 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR  154 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999999999999999999997532                     236788899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.72  E-value=7.8e-17  Score=157.86  Aligned_cols=127  Identities=28%  Similarity=0.441  Sum_probs=107.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ...++|++.++||+|+||.||+|.+..+++.||||++.....   .......+.+|+.+++.++|+||+++++++...+ 
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            455689999999999999999999999999999999864221   1112234567999999999999999999887643 


Q ss_pred             -------EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -------~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                             ..|+||||+. ++|.+++......+++..++.++.||+.||+|||++||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~  143 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHR  143 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence                   4699999996 68988887655579999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.72  E-value=4.2e-17  Score=159.77  Aligned_cols=126  Identities=27%  Similarity=0.468  Sum_probs=107.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ...+|++.+.||+|+||.||+|.++.+|+.||||+++....   .......+.+|+.+++.++|+||+++++++...+  
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            45689999999999999999999999999999999874321   1122345678999999999999999999987655  


Q ss_pred             --------EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 --------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 --------~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                              .+||||||+. ++|..++......+++..++.|+.||+.||.|||++||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~  140 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMD-HDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHR  140 (302)
T ss_pred             hhccccCCcEEEEEcccC-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                    7999999997 58888887655679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.72  E-value=7.2e-17  Score=159.36  Aligned_cols=124  Identities=33%  Similarity=0.529  Sum_probs=110.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||++.+..++..||+|.+...     .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            3457899999999999999999999888999999998532     11223567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|+||||+++++|.+++..  ..+++..+..++.||+.||.|||++||+||
T Consensus        91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~  139 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  139 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            9999999999999999965  458899999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.72  E-value=3.6e-17  Score=155.85  Aligned_cols=115  Identities=21%  Similarity=0.383  Sum_probs=99.0

Q ss_pred             EEeccCCcEEEEEEEECCCC----------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          360 KLIGRGTFGSVYIGTNRETG----------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg----------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      +.||+|+||.||+|.+..++          ..+++|.++...     . ....+.+|+.+|+.++|+||+++++++.. +
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----R-DSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----h-hHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46899999999999998766          347777664211     1 14678889999999999999999999888 7


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|+||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  125 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHG  125 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecc
Confidence            7899999999999999998764579999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.72  E-value=8.9e-17  Score=160.44  Aligned_cols=128  Identities=31%  Similarity=0.523  Sum_probs=111.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|...+.||+|+||.||++.+..++..+|||++...  .....+..+.+.+|+.+|+.++|+||+++++++..++.
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecC--CCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            3345588999999999999999999999999999988632  22334556678889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .||||||+. |+|.+++......+++..+..++.||+.||.|||+++|+||
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  149 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999996 68888886656779999999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.72  E-value=5.3e-17  Score=156.03  Aligned_cols=123  Identities=24%  Similarity=0.435  Sum_probs=105.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|+++++||+|+||.||+|.+. +++.||+|.+....   .   ....+.+|+.+|+.++|+||+++++++ ..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   74 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---M---SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEP   74 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---C---cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCC
Confidence            45578999999999999999999865 46789999886321   1   234678899999999999999999886 4567


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++|||+.+++|.+++... ...+++..+..++.||+.||+|||++||+||
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~  126 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR  126 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            99999999999999998753 3568999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.72  E-value=7.1e-17  Score=172.67  Aligned_cols=127  Identities=30%  Similarity=0.429  Sum_probs=108.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      +...+...++++||+|.||.|.+|+.. .+.+||+|.++..    ......+.|..||++|.+|+|||||.|+|+|..++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            445677889999999999999999954 3689999998732    22334578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~-Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++|||||++|+|.+||..+.-. +.......|+.||+.||+||.+.++|||
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHr  661 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHR  661 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhc
Confidence            999999999999999999876322 3445556699999999999999999998

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.72  E-value=7.4e-17  Score=154.89  Aligned_cols=123  Identities=22%  Similarity=0.391  Sum_probs=103.5

Q ss_pred             eEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE--
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--  430 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~--  430 (481)
                      |++++.||+|+||.||+|.+..+   +..||||+++..   .........+.+|+.+|+.++|+||+++++++...+.  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            57889999999999999997653   477999998632   2234445678899999999999999999998866543  


Q ss_pred             ----EEEEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 ----LYIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 ----lyLVmEy~~GGSL~~lL~~~~-----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+++|||+.+|+|..++....     ..+++..+..++.||+.||.|||+++|+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~  137 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR  137 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence                799999999999999985421     358999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.72  E-value=1.1e-16  Score=158.45  Aligned_cols=126  Identities=29%  Similarity=0.450  Sum_probs=107.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--C
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--D  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d  429 (481)
                      ...+|++.++||+|+||.||+|.+..+|+.||||+++......   .....+.+|+.+|++++|+||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            4568999999999999999999999999999999987432211   1122455699999999999999999998765  5


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+. ++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHR  132 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            6999999996 68999987655779999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1.2e-16  Score=171.80  Aligned_cols=128  Identities=20%  Similarity=0.299  Sum_probs=110.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ....+|++.++||+|+||.||+|.+..+|+.||||++....   ........+.+|+.+|..+.|+||+++++.+...+ 
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            44579999999999999999999999999999999986432   23445567888999999999999999998776432 


Q ss_pred             -------EEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -------HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -------~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                             .+++||||+.+|+|.++|+..   ...+.+..+..|+.||+.||.|||+++||||
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr  167 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR  167 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence                   378999999999999999753   3468999999999999999999999999998

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.72  E-value=6e-17  Score=153.59  Aligned_cols=122  Identities=31%  Similarity=0.532  Sum_probs=107.5

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCC----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      +++.+.||.|+||.||++.+...+    ..||+|+++..    ...+..+.+.+|+.+|..++|+||+++++++...+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356789999999999999998766    88999998632    2222557888999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~-Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++|||+.+++|.+++...... +++..+..++.||+.||.|||+++|+||
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~  127 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHR  127 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence            9999999999999999765444 9999999999999999999999999997

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.72  E-value=5e-17  Score=157.76  Aligned_cols=117  Identities=20%  Similarity=0.338  Sum_probs=99.4

Q ss_pred             EEeccCCcEEEEEEEECCC------------CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRET------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~t------------g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      +.||+|+||.||+|+....            ...+++|++..     ........+.+|+.++..++|+||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4689999999999985322            23477887642     223345567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +...+|||||+++|+|..++......+++..+..|+.||+.||+|||+++||||
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  129 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHG  129 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence            999999999999999999987655679999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.72  E-value=5.9e-17  Score=156.45  Aligned_cols=118  Identities=24%  Similarity=0.436  Sum_probs=97.8

Q ss_pred             EEeccCCcEEEEEEEECC--CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~--tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      +.||+|+||.||+|....  ....+|+|.+..    .........+.+|+.+++.++|+||+++++.+...+.+||||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA----SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCc----cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            368999999999997533  334677787642    12344456778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCR----DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~----~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|+|.+++.....    .+.+..+..|+.||+.||+|||+++|+||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  124 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHS  124 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecc
Confidence            999999999976432    24678889999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.72  E-value=7.8e-17  Score=155.98  Aligned_cols=121  Identities=32%  Similarity=0.631  Sum_probs=107.6

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHL  431 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~l  431 (481)
                      .|++.+.||+|+||.||+|.+..+++.||||.++...    .......+.+|+.+++.+.   |+||+++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            5788899999999999999999999999999886321    2234457788999999986   99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+.+++|.++++.  +.+++..+..++.||+.||.|||++||+||
T Consensus        78 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~  125 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHR  125 (277)
T ss_pred             EEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            999999999999999865  478999999999999999999999999997

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.72  E-value=5e-17  Score=157.20  Aligned_cols=122  Identities=27%  Similarity=0.485  Sum_probs=103.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++.++||+|+||.||+|.+..+ ..||+|+++...   .   ..+.+.+|+.+++.++|+||+++++.+. ++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---M---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI   75 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---c---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence            456799999999999999999998765 459999886311   1   1246788999999999999999999864 5668


Q ss_pred             EEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+.+|+|.+++... ...+++..+..++.||+.||+|||+++|+||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~  126 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  126 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999764 2457899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.72  E-value=7.1e-17  Score=157.64  Aligned_cols=124  Identities=27%  Similarity=0.504  Sum_probs=105.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCE--
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH--  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~--  430 (481)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++....   .......+.+|+.+++.+. |+||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            369999999999999999999999999999998864321   1122346778999999995 6999999999987766  


Q ss_pred             ---EEEEEeccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 ---LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 ---lyLVmEy~~GGSL~~lL~~~~----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +|+||||++ ++|.+++....    ..+++..++.++.||+.||.|||+++|+||
T Consensus        78 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~  134 (295)
T cd07837          78 KPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR  134 (295)
T ss_pred             CceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence               899999997 58999886532    358999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.72  E-value=1.4e-16  Score=154.30  Aligned_cols=123  Identities=25%  Similarity=0.438  Sum_probs=102.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH-HHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~-iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ++|++.+.||+|+||.||++.+..+|+.||||+++....   ... ..++..|+. +++.++|+||+++++++..++.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            378999999999999999999999999999999864221   112 234444555 466778999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ++|||++ |+|.+++...   ...+++..+..++.||+.||+|||++ +|+||
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~  128 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHR  128 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC
Confidence            9999996 7888887652   34689999999999999999999998 99997

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.72  E-value=6.7e-17  Score=162.11  Aligned_cols=119  Identities=27%  Similarity=0.464  Sum_probs=104.5

Q ss_pred             EEeccC--CcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          360 KLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       360 k~IG~G--tFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      ..||+|  +||.||++++..+|+.||||++....   ...+..+.+.+|+.+++.++|+||++++++|..++.+|+||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456666  99999999999999999999986422   2334567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+++|.+++.... ..+++..+..++.||+.||+|||++||+||
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHr  125 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR  125 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999997642 458999999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.72  E-value=1.8e-17  Score=160.97  Aligned_cols=122  Identities=36%  Similarity=0.617  Sum_probs=108.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|+..+.||+|+||.||+|.+..++..||+|.++..    ......+.+.+|+.+++.++|+||+++++++..++.+|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            3577788999999999999999988999999988632    223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++..  ..+.+..++.++.||+.||.|||+++|+|+
T Consensus        80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~  125 (277)
T cd06642          80 IMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHR  125 (277)
T ss_pred             EEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            9999999999999864  568999999999999999999999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.72  E-value=3.2e-17  Score=157.20  Aligned_cols=127  Identities=25%  Similarity=0.436  Sum_probs=108.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|.+.+.||+|+||.||++.+...+..+++|+++.............++..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58999999999999999999988777777777764333222223334567799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|..++..   ....+++..++.++.||+.||.|||++||+|+
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~  130 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHR  130 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            999999999998864   23568999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.72  E-value=9.3e-17  Score=156.30  Aligned_cols=118  Identities=22%  Similarity=0.277  Sum_probs=102.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|+||.||+|.+..+|+.||+|++.....  ........+.+|+++|+.++|+||+++++++...+.+||||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            6899999999999999999999999863211  11223445678999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++.... ..+.+..+..|+.||+.||.|||++||+||
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~  119 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR  119 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999997643 368999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.72  E-value=3.9e-17  Score=176.36  Aligned_cols=122  Identities=28%  Similarity=0.510  Sum_probs=110.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CC-----CeeeeeeEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE-----NIVQYYGSEV  426 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HP-----NIVqL~g~f~  426 (481)
                      ..+|.+.+.||+|+||+|.+|.+..+++.||||+|+      .......+...||++|..|+ |.     |||+++++|.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK------NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeec------cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            358899999999999999999999999999999997      34566778888999999997 43     8999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+++|||+|++. -+|++||+.+. ..|+...++.|+.||+.||.+||+.+|||+
T Consensus       259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHc  313 (586)
T KOG0667|consen  259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHC  313 (586)
T ss_pred             cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999994 99999998753 558999999999999999999999999996

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.72  E-value=4.7e-17  Score=155.88  Aligned_cols=123  Identities=28%  Similarity=0.446  Sum_probs=111.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....    ..+..+++.+|+.+++.+.|+||+++++++..++.+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            6788899999999999999999999999999986422    224456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      |||+.+++|.+++......+++..+..++.||+.||+|||+ .+|+||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~  125 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR  125 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecC
Confidence            99999999999998755789999999999999999999999 999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.72  E-value=5.3e-17  Score=154.24  Aligned_cols=117  Identities=26%  Similarity=0.473  Sum_probs=104.6

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||.|+||.||++.+..+|+.+++|++....  .......+.+.+|+.+++.++|+||+++++.+..++.+|++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999999999999999986321  222345677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++... +.+++..+..|+.||+.||.|||+++|+||
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~  117 (265)
T cd05579          79 DLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHR  117 (265)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecC
Confidence            999999774 579999999999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.72  E-value=1.3e-16  Score=181.53  Aligned_cols=126  Identities=21%  Similarity=0.354  Sum_probs=109.6

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.++||+|+||.||+|.+..+|+.||||+++...  .......+.+.+|+++++.++|+||+++++++.+.+..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            58999999999999999999999999999999986321  2233445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~----------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||++||+|.+++...          ...+....+..|+.||+.||+|||++|||||
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHR  137 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHR  137 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999998642          1234567788999999999999999999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.72  E-value=1e-16  Score=153.84  Aligned_cols=117  Identities=22%  Similarity=0.322  Sum_probs=104.5

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||.|+||.||+|.+..+++.||+|++....  .......+.+.+|+.+++.++|+||+++++.+..++.+|++|||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhc--chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            699999999999999899999999986422  222344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++... ..+++..+..++.||+.||+|||+++++|+
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~  117 (262)
T cd05572          79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYR  117 (262)
T ss_pred             cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            999999764 668999999999999999999999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.72  E-value=2.1e-16  Score=148.02  Aligned_cols=122  Identities=36%  Similarity=0.632  Sum_probs=110.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|.+.+.||+|.||.||++.+..+++.+++|++....     ....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4888999999999999999999889999999986321     13557888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++......+++..+..++.||+.||+|||.+|++||
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~  122 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR  122 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence            99999999999997754679999999999999999999999999997

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.72  E-value=1.3e-16  Score=153.56  Aligned_cols=123  Identities=22%  Similarity=0.434  Sum_probs=106.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.++||+|+||.||++.+. .+..+|+|.++.      .......+.+|+.+++.++|+||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP------GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCC------ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            45678999999999999999999865 456699998752      12334678889999999999999999999877 77


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|++|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~  126 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR  126 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            89999999999999999763 3457888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.72  E-value=9.1e-17  Score=158.43  Aligned_cols=124  Identities=27%  Similarity=0.464  Sum_probs=106.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..    ......+.+.+|+.++.++ +|+||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            478999999999999999999877765  4688877521    2233456788899999999 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++|||+++++|.+++....               ..+.+..++.|+.||+.||+|||++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~  143 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHR  143 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999999999999997532               247899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.72  E-value=1e-16  Score=152.57  Aligned_cols=117  Identities=29%  Similarity=0.491  Sum_probs=102.5

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      ++||+|+||.||+|... ++..+|+|.++..    ........+.+|+.+++.++|+||+++++++...+..|+||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            46899999999999864 5788999987532    223344568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|.+++......+.+..+..++.||+.||.|||++||+||
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~  117 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR  117 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999997655678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.72  E-value=1.3e-16  Score=155.23  Aligned_cols=124  Identities=33%  Similarity=0.612  Sum_probs=107.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEe---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~---  427 (481)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++...      ......+..|+.++..+ +|+||+++++++..   
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            446899999999999999999999999999999988531      22335677899999988 69999999999853   


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ---~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         .+.+||+|||+.+|+|.+++... ...+.+..+..++.||+.||.|||++||+||
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~  145 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHR  145 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence               46799999999999999999764 2458899999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.72  E-value=1.1e-16  Score=156.82  Aligned_cols=124  Identities=27%  Similarity=0.484  Sum_probs=106.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.+.||+|.||.||+|.+..+|+.||||++.....   .....+.+.+|+++++.++|+||+++++++...+..|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            479999999999999999999999999999998864321   12233567789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+. ++|.+++.... ..+.+..+..++.||+.||+|||+++|+||
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~  126 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR  126 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            999995 68888876532 336889999999999999999999999997

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.71  E-value=6.6e-17  Score=157.05  Aligned_cols=123  Identities=28%  Similarity=0.556  Sum_probs=107.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|++.+.||.|+||.||+|++..+++.||||+++....   .......+.+|+++++.++|+||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            48899999999999999999999999999998864221   122234677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++... ...+.+..+..++.||+.||+|||+++|+||
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~  124 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR  124 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99995 7899988653 3568999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.71  E-value=1.3e-16  Score=168.53  Aligned_cols=120  Identities=24%  Similarity=0.442  Sum_probs=101.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ...+|+++++||+|+||.||+|.+..+++.||||++...      .   ....+|+.+|+.++|+|||+++++|...   
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------P---QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------c---chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            346899999999999999999999999999999988521      1   1234699999999999999999887542   


Q ss_pred             -----CEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -----DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -----d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           ..+++|||||. ++|.+++..   ....+++..++.|+.||+.||+|||++|||||
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr  194 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR  194 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence                 25789999996 678777653   24679999999999999999999999999998

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.71  E-value=1.2e-18  Score=174.79  Aligned_cols=121  Identities=32%  Similarity=0.562  Sum_probs=111.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .-|.++.+||+|+||.||+|.++++|..+|||.+-+.       ..++.+..||.||++++.++||+|||.|.....+||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            4588899999999999999999999999999998542       235678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||..|++.++++...+.+.|.+|..+++..++||+|||...-|||
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHR  153 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHR  153 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHh
Confidence            999999999999999888999999999999999999999999988887

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.7e-17  Score=169.36  Aligned_cols=124  Identities=30%  Similarity=0.486  Sum_probs=109.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-----  427 (481)
                      ...|...+.||+|+||.|+.+.++.+|+.||||++..   .....-..++..+|+++|++++|+|||.+++++..     
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            4567778999999999999999999999999998851   23445567788899999999999999999999876     


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      -+.+|||+|+| +.||.+.|+.. ..+++..+..+++||+.||+|+|+.||+||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHR  149 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHR  149 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccccccc
Confidence            24699999999 59999999873 559999999999999999999999999998

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.71  E-value=6.5e-17  Score=155.42  Aligned_cols=123  Identities=26%  Similarity=0.486  Sum_probs=104.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.++||+|+||.||+|.+. .+..+|+|.++...   ..   .+.+.+|+.+|++++|+||+++++++. .+.
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT---MS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC---CC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            34568999999999999999999865 45679999886321   11   246788999999999999999999874 567


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  126 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR  126 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            89999999999999999764 2458999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.71  E-value=3.9e-17  Score=164.47  Aligned_cols=123  Identities=24%  Similarity=0.427  Sum_probs=105.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+.+|+.+|+.++|+||+++++++...    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            468999999999999999999999999999999986321   1223345677899999999999999999987643    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+|++||++ +++|.++++.  ..+++..++.|+.||+.||.|||++||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  142 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHR  142 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence              3579999998 7899988853  579999999999999999999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.71  E-value=1.1e-16  Score=156.90  Aligned_cols=123  Identities=28%  Similarity=0.470  Sum_probs=104.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+...    ........+.+|+.+|+.+.|+||+++++.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            57889999999999999998753     2346888877531    22344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREH-----------------------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~-----------------------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|++|||+.+++|.+++...                       ...+.+..+..|+.||+.||+|||+++||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~  151 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR  151 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence            999999999999999998642                       1247789999999999999999999999997

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.71  E-value=1e-16  Score=162.46  Aligned_cols=123  Identities=20%  Similarity=0.324  Sum_probs=104.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ..++|++.+.||+|+||.||++.+..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            4578999999999999999999999999999999886321   2334456777899999999999999999998654   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ..+|+||||++ ++|.+++..   .+++..+..++.||+.||.|||++|||||
T Consensus        92 ~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHr  143 (355)
T cd07874          92 EEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHR  143 (355)
T ss_pred             cccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence               35799999996 677777743   48899999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.71  E-value=1.2e-16  Score=156.14  Aligned_cols=125  Identities=22%  Similarity=0.346  Sum_probs=107.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      .|++.+.||.|+||.||++.+.   .+|+.||+|+++.... .......+.+.+|+.+|..+ +|+||+.+++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            4889999999999999999874   4789999999863211 11122345677899999999 58999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++... ..+.+..+..++.||+.||.|||++||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~  129 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYR  129 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999999764 678999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.71  E-value=1.8e-17  Score=183.20  Aligned_cols=126  Identities=24%  Similarity=0.450  Sum_probs=109.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ...+.+..+.||+|+||+||+|+..     .....||||.++.    ..+.+..++|++|+++|..|+|+|||+|+|+|.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3456778899999999999999853     2345699999872    344556789999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~-------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++.+|+|+|||..|||.+||+.+.             ..++..+...|+.||+.||+||-++.+|||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHR  627 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHR  627 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccccc
Confidence            9999999999999999999997532             127889999999999999999999999998

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.71  E-value=1.3e-16  Score=156.55  Aligned_cols=124  Identities=27%  Similarity=0.510  Sum_probs=106.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|.+.+.||+|+||.||+|++..     ++..+++|.++.     ......+.+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            4579999999999999999998642     445688888752     233445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..++||||+.+++|.+++..+.               +.+++..++.|+.||+.||+|||+++|+||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~  147 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR  147 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999997532               347899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.71  E-value=1.1e-16  Score=154.99  Aligned_cols=118  Identities=26%  Similarity=0.378  Sum_probs=98.8

Q ss_pred             EEeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      +.||+|+||.||+|.+.  .++..+|+|.++...    .......+.+|+.+++.++|+||+++++++...+.+|+||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            46899999999999864  345678999876321    223345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|+|.+++....    ....+..+..++.||+.||.|||+++|+||
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~  124 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHS  124 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            99999999997532    245677888999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.71  E-value=1.9e-16  Score=181.18  Aligned_cols=129  Identities=29%  Similarity=0.500  Sum_probs=111.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-  428 (481)
                      .....+|+++++||+|+||.||+|.+..++..||+|++....   ........+..|+.+|+.|.|+|||+++++|... 
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            345679999999999999999999999999999999986432   2334456788899999999999999999998654 


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-------NTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHsk-------gIIHR  481 (481)
                       +.+|||||||.+|+|.++|...   .+.+++..++.|+.||+.||.|||..       +||||
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR  149 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR  149 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence             5699999999999999999753   35699999999999999999999984       59997

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.71  E-value=3.3e-16  Score=153.22  Aligned_cols=124  Identities=31%  Similarity=0.559  Sum_probs=107.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~--  428 (481)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|++...      ......+.+|+.++..+ +|+||+++++++...  
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            457899999999999999999999999999999988531      11234667899999998 799999999998754  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +.+|+||||+.+++|.++++.   ....+.+..++.++.||+.||+|||+++|+||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  152 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR  152 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence               368999999999999998863   23568999999999999999999999999997

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.71  E-value=2.1e-16  Score=154.26  Aligned_cols=125  Identities=34%  Similarity=0.594  Sum_probs=112.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|+..+.||+|.||.||+|.+..++..|++|+++....      ..+.+.+|+.+++.++|+||+++++++...+.
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            455679999999999999999999998899999999864211      34677889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++|||+++++|.+++......+++..+..|+.||+.||.|||.+||+|+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~  140 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR  140 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            999999999999999998764489999999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.71  E-value=1.5e-16  Score=153.79  Aligned_cols=116  Identities=24%  Similarity=0.413  Sum_probs=99.5

Q ss_pred             EeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          361 LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      .||+|+||.||+|.+.  ..+..||+|++...    ......+.+.+|+.+|++++|+||+++++++. .+..++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            4899999999999875  44557999988532    22344567889999999999999999999875 55789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  119 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR  119 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeec
Confidence            9999999997655779999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00284 protein kinase; Provisional

Probab=99.71  E-value=1.6e-15  Score=160.66  Aligned_cols=122  Identities=17%  Similarity=0.302  Sum_probs=101.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC------CCeeeeeeEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH------ENIVQYYGSE  425 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H------PNIVqL~g~f  425 (481)
                      ..++|++.++||+|+||.||+|.+..+++.||||+++..      ......+..|+.+++.++|      .+|++++++|
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            357899999999999999999999999999999998632      1223345557777666654      4688999888


Q ss_pred             EeC-CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          426 VVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       426 ~~~-d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ..+ +.+|||||++ |++|.+++..+ +.+.+..++.|+.||+.||+|||. .|||||
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHr  256 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHT  256 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence            764 5799999998 78999998764 779999999999999999999998 599998

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.71  E-value=1.5e-16  Score=156.47  Aligned_cols=124  Identities=30%  Similarity=0.499  Sum_probs=105.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECC--CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~--tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~  430 (481)
                      +|++.++||+|+||.||+|.+..  +++.||||.+.....  ......+.+.+|+.++..++|+||+++++++...  +.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            58899999999999999999988  889999999874221  1122235667899999999999999999999988  88


Q ss_pred             EEEEEeccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||++ ++|.+++....    ..+.+..++.|+.||+.||.|||+++|+||
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~  132 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR  132 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeC
Confidence            999999996 67877775432    368999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.71  E-value=7.3e-17  Score=183.45  Aligned_cols=127  Identities=24%  Similarity=0.451  Sum_probs=112.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCc-----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ......++++.||+|+||.||.|.......     .||||.++..    .+.+...+|.+|..+|++++|||||+++|++
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            345677899999999999999999764332     3899988642    3456678899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+....+|++|||+||||..||++.      ...++..++..|+.||++|+.||+++++|||
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR  826 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR  826 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence            9999999999999999999999986      5678999999999999999999999999998

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.71  E-value=1.7e-16  Score=153.16  Aligned_cols=122  Identities=30%  Similarity=0.528  Sum_probs=107.4

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--CEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYI  433 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d~lyL  433 (481)
                      |++.++||.|+||.||+|.+..+++.+|+|++....   ......+.+.+|+.+++.++|+||+++++++...  +.+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678999999999999999999999999999997432   1223345677899999999999999999999988  89999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+. ++|.+++......+.+..++.++.||+.||+|||++|++|+
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~  124 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHR  124 (287)
T ss_pred             Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999997 69999887654679999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.71  E-value=1.5e-16  Score=155.41  Aligned_cols=125  Identities=26%  Similarity=0.496  Sum_probs=107.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ...+|++.++||+|+||.||++...     .++..+|+|.++.     ........+.+|+++++.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCT   77 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence            3467899999999999999999743     3466789998752     23445567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~--------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+..|++|||+.+++|.+++....              ..+.+..+..++.||+.||+|||++||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~  146 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHR  146 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            9999999999999999999997642              247899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.71  E-value=1.4e-16  Score=151.73  Aligned_cols=117  Identities=30%  Similarity=0.500  Sum_probs=104.1

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      ++||+|+||.||++.+.. ++.||+|+++...    ..+..+.+.+|+++++++.|+||+++++++...+..|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL----PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            469999999999999877 8999999886321    12345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|.+++......+.+..+..++.|++.||.|||+++|+||
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~  117 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR  117 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehh
Confidence            999999997755678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.71  E-value=2e-16  Score=154.09  Aligned_cols=120  Identities=33%  Similarity=0.512  Sum_probs=102.1

Q ss_pred             eEEeEEeccCCcEEEEEEEE----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--C
Q 011617          356 WQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--D  429 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~d----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--d  429 (481)
                      |++.+.||+|+||.||++..    ..++..||+|.++..    ........+.+|+.+|+.++|+||+++++++...  .
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            49999999999999988753    356788999988632    1223345678899999999999999999987653  4


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|++|||+.+++|.+++..  ..+++..++.|+.||+.||.|||+++|+||
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~  131 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHR  131 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            68999999999999999975  459999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.70  E-value=1.9e-16  Score=153.01  Aligned_cols=121  Identities=25%  Similarity=0.340  Sum_probs=103.2

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC--CEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--DHLY  432 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~--d~ly  432 (481)
                      |++.++||+|.||.||+|.+..++..||+|+++.....   ... ....+|+.++.++. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            67899999999999999999999999999988642211   111 23346888888885 99999999999987  8899


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+. ++|.+++......+++..++.++.||+.||+|||+++|+||
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~  124 (282)
T cd07831          77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR  124 (282)
T ss_pred             EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999996 68888887655679999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.70  E-value=1.5e-16  Score=153.28  Aligned_cols=122  Identities=25%  Similarity=0.477  Sum_probs=102.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|.+...||+|+||.||+|.+..+ ..+|+|.+....   .   ..+.+.+|+.+++.++|+||+++++++. .+..
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---M---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---c---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            445799999999999999999998664 458999875311   1   2246778999999999999999998875 5678


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++|||+.+++|.++++... ..+.+..+..++.||+.||.|||++||+||
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  126 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR  126 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            99999999999999997643 347899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.70  E-value=1.8e-16  Score=152.74  Aligned_cols=123  Identities=22%  Similarity=0.403  Sum_probs=101.9

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-----
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----  428 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-----  428 (481)
                      |.++++||+|+||.||+|.+..++.  .+|||.++..   .......+.+.+|+.+|+.++|+||+++++++...     
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccC---cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            3568899999999999999887765  5899988642   22344567788899999999999999999986532     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~-----~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...+++|||+.+|+|.+++...     ...+++..+..++.||+.||+|||+++|+||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  136 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR  136 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence             2478999999999999987432     2347899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.70  E-value=1.9e-16  Score=161.35  Aligned_cols=123  Identities=21%  Similarity=0.320  Sum_probs=104.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            4578999999999999999999999999999999986322   2233445677899999999999999999987643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ..+|+||||+. ++|.+++..   .+++..+..++.||+.||+|||++|||||
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  150 (364)
T cd07875          99 EEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHR  150 (364)
T ss_pred             cccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence               35899999996 678887753   48899999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.7e-18  Score=184.35  Aligned_cols=125  Identities=30%  Similarity=0.518  Sum_probs=116.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..+.|.++..||.|+||+||+|.++.++...|.|+|.     .+..+.++++.-||.||..|+||+||+|++.|..++.+
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL  104 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL  104 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce
Confidence            3467899999999999999999999998888899885     35677888999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||++|||.||-...++-..+..+++.+|..+++|++.||.|||+++||||
T Consensus       105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHR  154 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHR  154 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhh
Confidence            99999999999999887777899999999999999999999999999998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.70  E-value=6.6e-17  Score=171.22  Aligned_cols=121  Identities=28%  Similarity=0.474  Sum_probs=107.9

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      -.+.||+|.||.||-|+++.+|+.||||+|.+..-..+.+   .++++|+.||+++.||.||.|.-.|++.+.+++|||-
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence            3678999999999999999999999999997544333222   6788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.|.-|+.+|....++++|...+.++.||+.||.|||.+||||+
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHC  688 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHC  688 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeec
Confidence            98666777777777999999999999999999999999999995

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.70  E-value=9.4e-17  Score=158.75  Aligned_cols=121  Identities=29%  Similarity=0.524  Sum_probs=107.6

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|.....||+|+||.||++.+..++..||||++..     ......+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            456667889999999999999998999999998853     223445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++..  +.+.+..+..++.||+.||+|||+++|+||
T Consensus        97 v~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~  142 (292)
T cd06658          97 VMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHR  142 (292)
T ss_pred             EEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            9999999999998854  568999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.70  E-value=3e-16  Score=152.44  Aligned_cols=127  Identities=20%  Similarity=0.354  Sum_probs=108.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ....+|++.+.||+|+||.||+|.+..    ++..|++|.++.    .......+.+.+|+.+|+.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            345789999999999999999999876    357789998752    233445677889999999999999999999876


Q ss_pred             e-CCEEEEEEeccCCCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 V-DDHLYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~-~d~lyLVmEy~~GGSL~~lL~~~~-------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      . .+..++++||+.+++|.+++....       ..+++..+..++.||+.||+|||+++|+||
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~  141 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK  141 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            5 567999999999999999997632       358899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.70  E-value=2.3e-16  Score=149.70  Aligned_cols=124  Identities=27%  Similarity=0.442  Sum_probs=109.4

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|++.++||+|+||.||++++..+++.+|||++....   ........+.+|+.+++.++|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            5889999999999999999999999999999986422   1233445677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++...   ...+.+..+..++.||+.||+|||++||+||
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~  127 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR  127 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            9999999999998652   3568999999999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.70  E-value=1.6e-16  Score=157.37  Aligned_cols=125  Identities=24%  Similarity=0.469  Sum_probs=106.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcE----EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~----VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|+..+.||+|+||.||+|.+..++..    +|+|.+..    .........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE----TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            456889999999999999999999877764    67777642    1223344568889999999999999999998865


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      . ..+++|||+.+|+|.+++..+...+.+..+..|+.||+.||+|||+++|+||
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  133 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR  133 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            4 5679999999999999998765678999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.70  E-value=2e-16  Score=152.05  Aligned_cols=116  Identities=23%  Similarity=0.442  Sum_probs=100.1

Q ss_pred             EeccCCcEEEEEEEE--CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          361 LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       361 ~IG~GtFG~VYla~d--k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      +||+|+||.||+|.+  ..++..+|+|+++..   .......+.+.+|+.+|+.+.|+||+++++++. .+..+|||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC---CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            689999999999975  456788999988632   233445677889999999999999999999875 55679999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|.+++... ..+++..+..|+.||+.||+|||++||+||
T Consensus        78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~  119 (257)
T cd05116          78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHR  119 (257)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            999999999764 679999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.70  E-value=1.1e-16  Score=162.31  Aligned_cols=128  Identities=27%  Similarity=0.436  Sum_probs=105.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|+++..    ......+.+..|+.++.++ +|+||+++++
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~~   78 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLLG   78 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhheee
Confidence            345568999999999999999999754     34578999988631    1233456678899999999 7999999999


Q ss_pred             EEEe-CCEEEEEEeccCCCCHHHHHHHhC---------------------------------------------------
Q 011617          424 SEVV-DDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------  451 (481)
Q Consensus       424 ~f~~-~d~lyLVmEy~~GGSL~~lL~~~~---------------------------------------------------  451 (481)
                      ++.. ++.++++|||+.+++|.++|....                                                   
T Consensus        79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (337)
T cd05054          79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE  158 (337)
T ss_pred             eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence            8765 457999999999999999986421                                                   


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          452 ---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       452 ---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                               ..+++..+..|+.||+.||+|||++||+||
T Consensus       159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHr  197 (337)
T cd05054         159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHR  197 (337)
T ss_pred             chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                     257899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.69  E-value=3.2e-16  Score=158.84  Aligned_cols=125  Identities=26%  Similarity=0.486  Sum_probs=107.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ...++|++.+.||+|+||.||++.+..++..||||++...   .......+.+.+|+.+|+.++|+||+++++++..+. 
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            3567899999999999999999999999999999988532   122334456788999999999999999999987654 


Q ss_pred             -----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           .+|+||||+ +++|.+++..  ..+++..++.|+.||+.||+|||++||+||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~  142 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHR  142 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                 469999999 7899988864  568999999999999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.69  E-value=5.2e-16  Score=154.91  Aligned_cols=125  Identities=33%  Similarity=0.538  Sum_probs=109.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|...++||+|+||.||+|++..+++.|+||++....  .......+.+.+|+.+++.++|+||+++++++...+..||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            44777888999999999999999999999999986422  2334455678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+. |+|.+++......+.+..+..++.||+.||.|||++||+||
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~  145 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  145 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999995 78888887655779999999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.69  E-value=1.9e-16  Score=151.38  Aligned_cols=117  Identities=27%  Similarity=0.441  Sum_probs=101.4

Q ss_pred             EEeccCCcEEEEEEEECC-CCc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~-tg~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      ++||+|+||.||+|.+.. .+.  .||||.+.....    ....+.+.+|+.++++++|+||+++++.+.. +.+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999999865 333  589998863211    1566788999999999999999999999988 89999999


Q ss_pred             ccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+++++|.+++.... ..+.+..+..++.||+.||.|||+++|+||
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  121 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR  121 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            999999999998754 468999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.69  E-value=1.8e-17  Score=167.48  Aligned_cols=117  Identities=22%  Similarity=0.389  Sum_probs=107.9

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEEEec
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      .+.||+|+|+.|-.|....+|..||||+|.+.     ......++.+|++++.+++ |+||++|+++|+++..+|||||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            56899999999999999999999999998643     3345568889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |.||.|..+|+++ ..|+|.++..++++|+.||+|||.+||.||
T Consensus       158 m~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHR  200 (463)
T KOG0607|consen  158 MRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHR  200 (463)
T ss_pred             ccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence            9999999999885 889999999999999999999999999998

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.69  E-value=2.5e-16  Score=157.96  Aligned_cols=127  Identities=30%  Similarity=0.415  Sum_probs=106.5

Q ss_pred             CCCeE-EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcH---------HHHHHHHHHHHHHhhCCCCCeeeee
Q 011617          353 KSQWQ-KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------ECIKQLEQEIKVLGHLKHENIVQYY  422 (481)
Q Consensus       353 ~~~Y~-i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~---------e~~k~l~~EI~iL~~L~HPNIVqL~  422 (481)
                      ..+|. +.+.||.|+||.||+|.+..+++.||||+++.........         .....+.+|+.+|+.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34564 5688999999999999999999999999986432211000         0112467899999999999999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++..++.+|+||||+. |+|.+++.. ...+++..+..++.||+.||+|||++||+||
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~  143 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHR  143 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999996 799999865 4679999999999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.69  E-value=1.2e-18  Score=170.93  Aligned_cols=128  Identities=23%  Similarity=0.356  Sum_probs=113.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.+.||+|.|+.||.+.+..+|+.+|+|+|...+...   ...+++.+|++|-+.|+|||||+|++.+..+.
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            345678999999999999999999999999999999987533222   24567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..|||+|+|+|++|..-|-.. .-++|..+..+++||+.+|.|||.+|||||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHR  134 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHR  134 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceec
Confidence            999999999999998766553 568999999999999999999999999998

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.69  E-value=3.5e-16  Score=150.07  Aligned_cols=119  Identities=25%  Similarity=0.425  Sum_probs=98.9

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHH-HhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~i-L~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      +.||.|+||.||+|.+..+++.||||++.....  ........+..|..+ +..++|+||+++++++...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            579999999999999999999999999863211  112222334445444 44568999999999999999999999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++|.++++.. +.+++..+..|+.||+.||.|||+++|+||
T Consensus        80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~  121 (260)
T cd05611          80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHR  121 (260)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.69  E-value=2.8e-16  Score=152.40  Aligned_cols=118  Identities=27%  Similarity=0.495  Sum_probs=100.7

Q ss_pred             EEeccCCcEEEEEEEECCCCcE--EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~--VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      +.||+|+||.||+|.+..++..  +|+|.++.    .......+.+.+|+.++.++ +|+||+++++++...+.+|++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc----cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999999887764  67887752    12334456788899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+.+|+|.+++....               ..+.+..++.++.||+.||+|||++||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~  136 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR  136 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            999999999997532               247899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.69  E-value=3e-16  Score=162.41  Aligned_cols=118  Identities=22%  Similarity=0.314  Sum_probs=103.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ...+|.+++.||+|+||.||+|...  ..+..||+|.+...          +...+|+++|++++|+|||++++++...+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            3468999999999999999999764  34677999987521          23457999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++|||||
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999995 899999854 4789999999999999999999999999998

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.69  E-value=1.3e-16  Score=158.09  Aligned_cols=122  Identities=27%  Similarity=0.514  Sum_probs=107.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|.....||+|+||.||++.+..+++.||||++....     ....+.+.+|+.++..++|+||+++++++..++.+|
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence            345566778999999999999999899999999986421     122356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+++++|..++..  ..+++..+..++.||+.||.|||++||+||
T Consensus        95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  141 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR  141 (297)
T ss_pred             EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999998854  568999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.69  E-value=3.5e-16  Score=150.03  Aligned_cols=121  Identities=30%  Similarity=0.506  Sum_probs=103.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE-eCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~-~~d~  430 (481)
                      ...+|++.+.||+|+||.||++...  |..+|+|.++..       ...+.+.+|+.+++.++|+||+++++++. .++.
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            4568999999999999999999865  778999987521       12356788999999999999999999765 4567


Q ss_pred             EEEEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~-~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++|||+++++|.++++.... .+.+..+..++.||+.||+|||++||+||
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  126 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR  126 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            9999999999999999976433 48899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.69  E-value=5.9e-16  Score=151.83  Aligned_cols=118  Identities=25%  Similarity=0.291  Sum_probs=97.0

Q ss_pred             EeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH---HHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~---iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      .||+|+||.||++.+..+++.||||++..........  ...+.+|..   ++....|+||+.+++++..++.+|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            4899999999999999999999999986432221111  122233433   34445799999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+++|.+++..+ +.+.+..+..|+.||+.||.|||+++|+||
T Consensus        79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~  121 (279)
T cd05633          79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYR  121 (279)
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCC
Confidence            9999999999764 679999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.69  E-value=4.9e-16  Score=152.08  Aligned_cols=120  Identities=24%  Similarity=0.298  Sum_probs=97.1

Q ss_pred             EeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHH-HHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e-~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      .||+|+||.||++.+..+++.||||.+..........+ .......++.+++...|+||+.+++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999864322111111 11111223345555689999999999999999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++|.+++... +.+++..++.|+.||+.||+|||+++|+||
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  121 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYR  121 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence            99999998763 679999999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.69  E-value=2.5e-16  Score=152.92  Aligned_cols=122  Identities=27%  Similarity=0.543  Sum_probs=106.2

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |++.++||.|.+|.||+|.+..+|..||||++.....   .......+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            6788999999999999999999999999999864321   1122345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~  123 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR  123 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            9995 79999987643 368999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.69  E-value=1.7e-16  Score=175.79  Aligned_cols=127  Identities=24%  Similarity=0.423  Sum_probs=109.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeE-EEe
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGS-EVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~-f~~  427 (481)
                      .....++++.+.|.+|+|+.||+|.+...|..||+|++-.     .++..++.+++||.+|++|. |+|||.|++. ...
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            3445678899999999999999999998889999998853     35778889999999999997 9999999993 221


Q ss_pred             ------CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 ------DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 ------~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                            .-+++|.||||.||.|.+++... ...|+|.+|++|+.|+++||.+||...  ||||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHR  170 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHR  170 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchh
Confidence                  13589999999999999999642 255999999999999999999999997  9998

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.69  E-value=1.4e-16  Score=154.92  Aligned_cols=125  Identities=20%  Similarity=0.308  Sum_probs=106.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCC-----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~t-----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ..+|.+.+.||+|+||.||+|.+..+     ++.||||+++..    ........+.+|+.++..++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            34688899999999999999987543     567999998632    223345678889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~---------------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+++++||+.+++|.+++...               ...+.+..+..++.||+.||.|||++||+||
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~  148 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHK  148 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            99999999999999999998532               1347888999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=99.69  E-value=4.8e-16  Score=153.48  Aligned_cols=117  Identities=22%  Similarity=0.278  Sum_probs=101.8

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----CCEEEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYL  435 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----~d~lyLVm  435 (481)
                      ..||+|++|.||+|.+  +|+.||||.++..  ........+.+.+|+.+|.+++|+||+++++++.+    ...++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccc--ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            6799999999999998  5889999998642  23344456778899999999999999999999877    35789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      |||.+|+|.+++... ..+++.....|+.||+.||.|||.. +++||
T Consensus       102 Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hr  147 (283)
T PHA02988        102 EYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK  147 (283)
T ss_pred             EeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            999999999999774 6789999999999999999999984 99997

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.69  E-value=6.7e-18  Score=192.38  Aligned_cols=124  Identities=42%  Similarity=0.777  Sum_probs=114.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      -+|+.+..||.|.||+||.|.+.++|+..|+|.++....+   ....+.+.+|+++|..|+|||||+|||+....+.+||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            4789999999999999999999999999999999865543   4456778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .||||++|+|.++++. ++...|...+.|..|++.||.|||++|||||
T Consensus      1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHR 1358 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHR 1358 (1509)
T ss_pred             HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceec
Confidence            9999999999999965 5788999999999999999999999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.68  E-value=8.9e-17  Score=176.18  Aligned_cols=128  Identities=27%  Similarity=0.438  Sum_probs=115.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      +.+....++.++||.|.||.||.|..+..|+   .||||.+|.    +..+....+|..|..||.+++|||||.|.|+..
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            3445677899999999999999999887664   499999984    334555678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ....++||+|||++|+|..||+++.++|+..++..+++.|+.||+||-++|+|||
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHR  755 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHR  755 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhh
Confidence            9999999999999999999999999999999999999999999999999999998

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.68  E-value=4e-16  Score=149.54  Aligned_cols=118  Identities=26%  Similarity=0.520  Sum_probs=98.8

Q ss_pred             EEeccCCcEEEEEEEECC---CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE-eCCEEEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDHLYIYL  435 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~---tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~-~~d~lyLVm  435 (481)
                      +.||+|+||.||+|.+..   .+..||||.+...    ......+.+.+|+.+++.++|+||+++++++. .++..|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            468999999999998753   3456999987421    23344567888999999999999999999765 455689999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+|+|.+++......+.+..+..++.||+.||.|||+++|+||
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  122 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR  122 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            9999999999997755667888899999999999999999999997

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.68  E-value=7e-16  Score=151.54  Aligned_cols=121  Identities=29%  Similarity=0.509  Sum_probs=108.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|...+.||+|+||.||++.+..+++.++||+++..     .....+.+.+|+.+++.+.|+||+++++++...+..|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            4566778999999999999999989999999988632     22334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.+++|.+++..  ..+++..+..|+.||+.||+|||++||+||
T Consensus        94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~  139 (285)
T cd06648          94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHR  139 (285)
T ss_pred             EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999876  568999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.68  E-value=4.5e-16  Score=149.36  Aligned_cols=116  Identities=28%  Similarity=0.464  Sum_probs=99.6

Q ss_pred             EEeccCCcEEEEEEEECCCC---cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg---~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      ++||+|+||.||+|.+...+   ..+|+|.+....    .....+.+.+|+.+|+.+.|+||+++++++. .+..++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEeccccc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            47999999999999876554   679999886321    1134567888999999999999999999865 556899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+.+|+|.+++... ..+++..+..++.||+.||+|||.++|+||
T Consensus        76 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  119 (257)
T cd05060          76 LAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHR  119 (257)
T ss_pred             eCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            99999999999874 579999999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.68  E-value=2.3e-16  Score=156.42  Aligned_cols=115  Identities=25%  Similarity=0.496  Sum_probs=95.7

Q ss_pred             eEEeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CCEEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIY  434 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d~lyLV  434 (481)
                      +++||+|+||.||+|.++  .+++.||+|.++...   .    ...+.+|+.+|+.++|+||+++++++..  +..+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---I----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---C----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            578999999999999975  466889999885321   1    1346679999999999999999999864  4569999


Q ss_pred             EeccCCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~--------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++....        ..+++..++.|+.||+.||.|||++|||||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHr  132 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR  132 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence            99995 78988876421        258899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.68  E-value=3.9e-16  Score=157.93  Aligned_cols=121  Identities=27%  Similarity=0.511  Sum_probs=105.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|++....     ....+.+.+|+.+|+.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            578999999999999999999999999999999986422     13446778899999999999999999776543    


Q ss_pred             ----------CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ----------d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                +.+|+||||+. ++|.+++..  +.+.+..++.|+.||+.||.|||++||+||
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~  138 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHR  138 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                      46899999996 699888854  568999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.68  E-value=5.2e-16  Score=152.10  Aligned_cols=125  Identities=26%  Similarity=0.460  Sum_probs=105.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      .++|++.++||+|+||.||+|.++.+++.||||++........   ....+.+|+++|+.++|+||+++++++...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            5789999999999999999999999999999999864322111   123456799999999999999999987543    


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ----d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          ..+|+||||+. ++|..++......+++..++.++.||+.||+|||++||+||
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~  139 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHR  139 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence                35799999996 67888776655689999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.68  E-value=8.2e-17  Score=164.57  Aligned_cols=119  Identities=32%  Similarity=0.477  Sum_probs=101.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      .-.|.-.++||.|.||.||.|...++++.||||++..  +..       --.+|+.+|+.++|||||+|..+|...    
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~--d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ--DKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecC--CCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            3468889999999999999999999999999998842  111       123589999999999999999888642    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .++.+|||||+ -+|..+++..   +..++...++.|+.||++||+|||..||+||
T Consensus        94 ~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR  149 (364)
T KOG0658|consen   94 EVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR  149 (364)
T ss_pred             hhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC
Confidence             25778999996 8999999753   5779999999999999999999999999998

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.68  E-value=2.6e-16  Score=158.28  Aligned_cols=124  Identities=28%  Similarity=0.499  Sum_probs=106.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----C
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----D  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----~  428 (481)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+.+|+.+|+.++|+||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            3689999999999999999999999999999999864221   12234567789999999999999999998763    3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  131 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHR  131 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            56999999995 7999998653 669999999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.68  E-value=5.7e-16  Score=155.86  Aligned_cols=122  Identities=29%  Similarity=0.519  Sum_probs=104.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      .++|++.++||+|+||.||+|.+..+|+.||||+++...    .......+.+|+.+|+.++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            468999999999999999999999999999999986321    123345677899999999999999999887654    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+|++|||+. ++|..++..  ..+.+..++.++.||+.||.|||++|||||
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~  130 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHR  130 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence             35899999996 688888754  579999999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.68  E-value=8.2e-16  Score=155.14  Aligned_cols=124  Identities=27%  Similarity=0.464  Sum_probs=106.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-CCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-~d~  430 (481)
                      ..++|++.+.||.|+||.||+|.+..+++.||||++....   ......+.+.+|+.+++.++|+||++++++|.. .+.
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            4568999999999999999999999999999999875321   112234567789999999999999999999876 567


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|++|||+ +++|.++++.  ..+.+..+..++.||+.||+|||+++|+||
T Consensus        85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~  132 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHR  132 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999 5799988864  468899999999999999999999999997

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.67  E-value=2.2e-16  Score=152.37  Aligned_cols=122  Identities=28%  Similarity=0.534  Sum_probs=107.8

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |++.++||+|.||.||+|++..+++.||+|++....   ......+.+..|+.+++.++|+||+++++++...+.+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            677899999999999999999999999999987432   12223456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+. ++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  122 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHR  122 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9997 69999998754679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.67  E-value=4.2e-16  Score=154.35  Aligned_cols=120  Identities=28%  Similarity=0.475  Sum_probs=105.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|....+||+|+||.||++.+..+++.||||++...     .......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            344557899999999999999999999999987531     223456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+.+++|.+++..  ..+.+..++.++.||+.||+|||++||+||
T Consensus        96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~  140 (292)
T cd06657          96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHR  140 (292)
T ss_pred             EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999998753  568999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.67  E-value=5.3e-16  Score=150.55  Aligned_cols=117  Identities=24%  Similarity=0.347  Sum_probs=96.1

Q ss_pred             EeccCCcEEEEEEEECCC--CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEecc
Q 011617          361 LIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV  438 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~t--g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~  438 (481)
                      .||+|+||.||+|.....  ...+++|.++..    ......+.+.+|+.+++.++|+||+++++.+.....+||||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            689999999999975433  234556665421    12334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          439 HPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       439 ~GGSL~~lL~~~~---~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+|.+++....   ..+.+..+..++.||+.||+|||+++|+||
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~  123 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHS  123 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            9999999997632   346677888999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.67  E-value=5.5e-16  Score=151.42  Aligned_cols=125  Identities=23%  Similarity=0.337  Sum_probs=106.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      +|++.+.||+|+||.||++.+.   .+++.||||.++.... .......+.+.+|+.++..+ +|+||+++++++..++.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4889999999999999999864   4578899999863211 11223345678899999999 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+.+|+|.+++... ..+.+..++.++.|++.||.|||+++|+||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~  129 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYR  129 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999998764 678999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.67  E-value=2.8e-16  Score=151.20  Aligned_cols=118  Identities=25%  Similarity=0.450  Sum_probs=100.0

Q ss_pred             EEeccCCcEEEEEEEECCCC------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETG------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      +.||+|+||.||+|++....      +.+|||.+...    ........+.+|+.+|+.++|+||+++++++...+..|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            36899999999999976543      67999987521    112334578889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|.+++...      ...+.+..+..++.||+.||.|||+++|+||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  130 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHR  130 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999999999753      1347889999999999999999999999996

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.67  E-value=3.8e-16  Score=150.74  Aligned_cols=122  Identities=31%  Similarity=0.555  Sum_probs=107.6

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |++.+.||+|+||.||+|.+..+++.+++|+++....   .......+.+|+.+|+.++|+||+++++++..++.+|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE---SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            6778999999999999999998999999999864221   2233467788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+. ++|.+++......+++..+..++.||+.||.|||+++|+|+
T Consensus        78 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~  122 (283)
T cd05118          78 EFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR  122 (283)
T ss_pred             eccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9996 59999887755789999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.67  E-value=6.7e-16  Score=148.82  Aligned_cols=127  Identities=24%  Similarity=0.475  Sum_probs=106.8

Q ss_pred             CeEEeEEeccCCcEEEEEEEECC-CCcEEEEEEeecCCCC-----CCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEe
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV  427 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~-tg~~VAIK~Ik~~~~d-----~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~  427 (481)
                      .|++.+.||+|+||.||+|.+.. .++.+|+|.+......     ........++.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999999987 6788999988643211     1234455677789988875 789999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ++..||+|||+++++|.+++..   ....+++..++.++.||+.||.|||+ ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~  138 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR  138 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeec
Confidence            9999999999999999998853   34568999999999999999999996 689996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.67  E-value=5.3e-16  Score=156.39  Aligned_cols=124  Identities=31%  Similarity=0.501  Sum_probs=106.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.++....   .......+.+|+.+|+.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            3579999999999999999999999999999999864221   222345667899999999999999999987654    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+||||||+. ++|.+++... +.+.+..+..|+.||+.||.|||+++|+||
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~  132 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHR  132 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence             34899999995 7999998764 779999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.67  E-value=4.9e-16  Score=148.81  Aligned_cols=119  Identities=27%  Similarity=0.503  Sum_probs=102.6

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||+|+||.||++..  +++.||+|.++..       .....+.+|+.+++.++|+||+++++++.. +..|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcE
Confidence            46799999999999999999874  5788999988531       123567889999999999999999999865 4579


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||+.+++|.+++.... ..+.+..+..++.||+.||.|||++|++||
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~  124 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR  124 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999999999999997643 358899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.67  E-value=1e-15  Score=155.35  Aligned_cols=123  Identities=22%  Similarity=0.344  Sum_probs=105.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   ........+.+|+.+++.++|+||++++++|...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            4578999999999999999999999999999999885321   2233445677899999999999999999998654   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ...||||||+. ++|.+++...   +++..+..++.||+.||+|||.+||+||
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~  142 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHR  142 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence               35799999995 6888888542   8999999999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.67  E-value=6e-16  Score=146.70  Aligned_cols=117  Identities=26%  Similarity=0.409  Sum_probs=104.2

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|+||.||++.+..+++.||+|+++...  .........+..|+.+++.++|+||+++++.+..++.+|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhh--hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            699999999999999889999999986432  222335567888999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++... ..+++..+..++.||+.||.|||+++++|+
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~  117 (250)
T cd05123          79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYR  117 (250)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999999764 578999999999999999999999999996

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.67  E-value=4.8e-16  Score=150.61  Aligned_cols=121  Identities=34%  Similarity=0.506  Sum_probs=104.4

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLV  434 (481)
                      |++.+.||+|+||.||+|.+..+++.|+||++......    .......+|+..+..+. |+||+++++++..++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67899999999999999999988999999988632211    11123456889999999 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+ +|+|.+++.... ..+++..+..++.||+.+|.|||++||+|+
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  123 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR  123 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999 789999987643 478999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.66  E-value=1.3e-15  Score=151.55  Aligned_cols=127  Identities=31%  Similarity=0.525  Sum_probs=110.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ....|+..+.||+|+||.||+|.+..+++.||||.+....  .......+++.+|+++++.++|+||+++++++...+..
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            3446888899999999999999999999999999886321  22334456788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+. |+|.+++......+.+..+..++.||+.||.|||+++|+||
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~  139 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  139 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999996 78888876655678999999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.66  E-value=7.8e-16  Score=152.21  Aligned_cols=121  Identities=30%  Similarity=0.401  Sum_probs=100.7

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |.+++.+|.|  |.||+++...+++.||||+++..   ....+..+.+.+|+.+|+.++|+||+++++++..++.+|++|
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   78 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVS   78 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEE
Confidence            3444444444  45666666668999999998742   123445678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+|+|.+++... ...+.+..++.++.||+.||+|||+++|+||
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~  125 (314)
T cd08216          79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR  125 (314)
T ss_pred             eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999764 3568999999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.66  E-value=1.5e-15  Score=153.97  Aligned_cols=124  Identities=27%  Similarity=0.463  Sum_probs=105.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++...   ......+.+.+|+.++..++|+||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            4578999999999999999999999999999999886321   1222345677899999999999999999988643   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +.+|+++|++ +++|.++++.  ..+++..++.|+.||+.||+|||++||+||
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  144 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR  144 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence               3478999987 7899888854  469999999999999999999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.66  E-value=1.3e-15  Score=148.57  Aligned_cols=117  Identities=20%  Similarity=0.295  Sum_probs=96.6

Q ss_pred             CCeEEeEEe--ccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          354 SQWQKGKLI--GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i~k~I--G~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      +.|++.+.+  |+|+||.||++..+.++..+|+|++.....        ..+  |+.+...+ +|+||++++++|...+.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--------NAI--EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--------chh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            345555555  999999999999999999999999863211        011  22222222 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+||||+++++|.+++... ..+.+..++.|+.||+.||.|||++||+||
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  133 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHN  133 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            99999999999999999774 589999999999999999999999999997

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.66  E-value=2.5e-15  Score=145.35  Aligned_cols=122  Identities=25%  Similarity=0.429  Sum_probs=102.2

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEeCCE--
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDH--  430 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~~d~--  430 (481)
                      |++.+.||+|+||.||+|++..+++.||||+++....   .......+.+|+.+++++   .|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            6889999999999999999998899999999974322   112224455677777665   59999999999998876  


Q ss_pred             ---EEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 ---LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 ---lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+|+
T Consensus        78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~  131 (287)
T cd07838          78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHR  131 (287)
T ss_pred             CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence               999999996 68999887643 368999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.66  E-value=8.9e-17  Score=171.76  Aligned_cols=127  Identities=20%  Similarity=0.303  Sum_probs=107.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcH---HHHHHHHHHHHHHhhCC---CCCeeeeeeEEEe
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---ECIKQLEQEIKVLGHLK---HENIVQYYGSEVV  427 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~---e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~  427 (481)
                      ..|...+.||+|+||+|++|.++.....|+||.|.+...-...+   ..+-.+-.||.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            56899999999999999999999998899999986432111111   11122446999999998   9999999999999


Q ss_pred             CCEEEEEEecc-CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYV-HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~-~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++||+||-. +|.||++||..+ ..+.|.+++.|++||+-|+++||++|||||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhr  694 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHR  694 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceec
Confidence            99999999965 456999999764 889999999999999999999999999998

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.66  E-value=9.1e-16  Score=170.00  Aligned_cols=126  Identities=32%  Similarity=0.554  Sum_probs=109.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEe-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV-  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~-  427 (481)
                      .+..+.|++.+.||.|+||+||+++++.+++..|+|++....+      .-+.++.|.+||+.+ .|+|++.+||+|.. 
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d------~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED------EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc------ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3456789999999999999999999999999999998864321      124566788888876 59999999999864 


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ----DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ----~d~lyLVmEy~~GGSL~~lL~~-~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          +|++|||||||.||+..++++. .+..+.|..|.+|++.++.||.+||.+.+|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHR  147 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHR  147 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeee
Confidence                5789999999999999999976 35679999999999999999999999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.65  E-value=1.6e-16  Score=170.54  Aligned_cols=129  Identities=24%  Similarity=0.446  Sum_probs=114.1

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ..++.+..+..+..+||.|.||.||.|.|+.-.-.||||.++      .+.-.++.|..|..+|+.++|+|+|+|+|+|.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            455666777888899999999999999999888889999986      23345677888999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~-~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+-.+|||+|||..|+|.+||++.++ .++...+.+++.||..||+||..+++|||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHR  389 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHR  389 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence            99999999999999999999998543 46777888899999999999999999998

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.65  E-value=1.3e-15  Score=150.50  Aligned_cols=115  Identities=26%  Similarity=0.500  Sum_probs=95.0

Q ss_pred             eEEeccCCcEEEEEEEECC--CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CCEEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIY  434 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~--tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d~lyLV  434 (481)
                      +++||+|+||.||+|.+..  ++..||+|.++...   .    ...+.+|+.+|+.++|+||+++++++..  +..+|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---I----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---C----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            5789999999999999754  56789999885311   1    1346679999999999999999999854  5679999


Q ss_pred             EeccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~--------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+. ++|.+++...        ...+.+..++.|+.||+.||.|||+++||||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~  132 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHR  132 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence            99996 6888887532        1247899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.65  E-value=2.2e-16  Score=170.09  Aligned_cols=126  Identities=34%  Similarity=0.626  Sum_probs=110.8

Q ss_pred             CCe-EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE--
Q 011617          354 SQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--  430 (481)
Q Consensus       354 ~~Y-~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~--  430 (481)
                      ++| +...+||+|+|-+||+|.|..+|..||--.+++. +-.+..+.++++..|+.+|+.|+|+|||++|+++.+.++  
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~-d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR-DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHH-HhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            344 5677899999999999999999999987666532 334567778899999999999999999999999988765  


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk--gIIHR  481 (481)
                      +.+|+|++..|+|..|++++ +.+....++.|++||++||.|||.+  -||||
T Consensus       118 in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHR  169 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHR  169 (632)
T ss_pred             eeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCcccc
Confidence            89999999999999999886 8899999999999999999999998  59998

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.65  E-value=1.7e-15  Score=146.02  Aligned_cols=123  Identities=22%  Similarity=0.381  Sum_probs=101.4

Q ss_pred             eEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC---
Q 011617          356 WQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  429 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d---  429 (481)
                      |.+.+.||+|+||.||+|.+.   .++..||||+++..   .......+++.+|+.+|+.++|+||+++++++...+   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            677899999999999999865   35788999988632   223344567888999999999999999999886532   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ---HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ---~lyLVmEy~~GGSL~~lL~~~-----~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ..++++||+.+|+|..++...     ...+++..+..++.||+.||+|||+++|+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR  137 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence               257899999999999887532     1247899999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.65  E-value=8.2e-16  Score=153.33  Aligned_cols=122  Identities=32%  Similarity=0.534  Sum_probs=107.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-----
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----  429 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-----  429 (481)
                      +|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            5899999999999999999999899999999886321   12344567888999999999999999999988775     


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|++|||+. ++|.+++... ..+++..++.|+.||+.||+|||++||+||
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~  127 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHR  127 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            7999999997 6899998663 589999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=2.9e-17  Score=185.35  Aligned_cols=127  Identities=24%  Similarity=0.320  Sum_probs=112.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|.++++||+|+||.|.+++.+.+++.||||++..+.  .........|..|-.+|...+.++||+++..|.+++++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e--MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE--MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH--HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            4568999999999999999999999999999999986421  11111234577888999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|||||+||||..++.+. ..++|.++++|+..|+.||.-||+.|+|||
T Consensus       151 YlVMdY~pGGDlltLlSk~-~~~pE~~ArFY~aEiVlAldslH~mgyVHR  199 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKF-DRLPEDWARFYTAEIVLALDSLHSMGYVHR  199 (1317)
T ss_pred             EEEEecccCchHHHHHhhc-CCChHHHHHHHHHHHHHHHHHHHhccceec
Confidence            9999999999999999886 489999999999999999999999999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.64  E-value=2.6e-16  Score=167.90  Aligned_cols=111  Identities=30%  Similarity=0.516  Sum_probs=99.8

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      ..-++-||.|+-|.||+|+..  ++.||||+++-            .-+.+|+.|++|+|+|||.|.|+|...-.+||||
T Consensus       126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             hhhhhhhccCcccceeeeecc--CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            344667999999999999976  67899998851            2235899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||..|-|+.+|+. +..++...+..|..+|+.||.|||.++||||
T Consensus       192 EfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHR  236 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHR  236 (904)
T ss_pred             eccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhh
Confidence            99999999999987 4889999999999999999999999999998

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.64  E-value=3.6e-15  Score=146.79  Aligned_cols=127  Identities=25%  Similarity=0.385  Sum_probs=106.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~  428 (481)
                      ....++|++.+.||+|+||.||+|.+..+++.||||.++...    .......+..|+.++.++. |+||+++++++.++
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----ChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            455678999999999999999999999889999999986422    1223345566777666664 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ..+|++|||+. +.|..++......+++..+..++.||+.||.|||+ ++|+||
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~  139 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR  139 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence            99999999995 68888877655679999999999999999999997 599997

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.64  E-value=1e-15  Score=153.93  Aligned_cols=124  Identities=25%  Similarity=0.419  Sum_probs=105.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~--  428 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.+|||++....   ........+.+|+.++.++ +|+||+++++++...  
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            3568999999999999999999999889999999885321   1222334567899999999 999999999998654  


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+|+||||+. ++|..+++.  +.+.+..++.++.||+.||+|||++||+||
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~  131 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHR  131 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            36899999996 699999865  378899999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=4.1e-16  Score=167.95  Aligned_cols=125  Identities=25%  Similarity=0.355  Sum_probs=110.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .-|.+++.||-|+||+|+++...++...||+|.+++.  |-.....+..++.|-.||..-+.++||+||..|.+++++|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa--DVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA--DVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHH--HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            4688999999999999999998899999999998632  22223334456778999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||++|||+..+|-.. +.|.|..++.|+.++..||+++|.+|+|||
T Consensus       707 VMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHR  753 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHR  753 (1034)
T ss_pred             EEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceec
Confidence            99999999999998764 889999999999999999999999999998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=2.2e-15  Score=158.75  Aligned_cols=122  Identities=22%  Similarity=0.421  Sum_probs=106.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-----C---CCeeeeee
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----H---ENIVQYYG  423 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-----H---PNIVqL~g  423 (481)
                      ...+|.+.++||.|.|++||+|.+....+.||+|+++      ......+....||++|+++.     |   ..||+|++
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            3489999999999999999999999999999999997      33455667788999999984     2   36999999


Q ss_pred             EEEeC----CEEEEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 011617          424 SEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHST-NTIH  480 (481)
Q Consensus       424 ~f~~~----d~lyLVmEy~~GGSL~~lL~~-~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIH  480 (481)
                      .|...    .++|+|+|++ |.+|..+|+. .++.+....++.|++||+.||.|||.+ ||||
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH  211 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIH  211 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            99753    4799999999 7899999876 457799999999999999999999976 9999

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.63  E-value=5.1e-15  Score=148.74  Aligned_cols=122  Identities=31%  Similarity=0.552  Sum_probs=102.7

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCC--CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC---
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD---  428 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~t--g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~---  428 (481)
                      +|++.+.||+|+||.||++.+..+  +..||||++....   ......+.+.+|+.+++++ +|+||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            488999999999999999999887  8899999886322   1222345677899999999 599999999875432   


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+|++|||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~  129 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHR  129 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             45899999995 799999865 4679999999999999999999999999997

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2.4e-16  Score=159.62  Aligned_cols=127  Identities=26%  Similarity=0.343  Sum_probs=113.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      -..+|..+++||+|+||+|.+|+.+.+++.||||++++...  ..++.+.....|-++|+.++||.+..|-..|..++.+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi--iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI--IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe--eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            45688999999999999999999999999999999975332  2334445566788999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||..||.|+.+|.. +..|+|...+.|..+|+.||.|||+++||.|
T Consensus       244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYR  292 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYR  292 (516)
T ss_pred             EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeee
Confidence            999999999999999966 5889999999999999999999999999987

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.62  E-value=2.5e-15  Score=152.03  Aligned_cols=124  Identities=26%  Similarity=0.449  Sum_probs=107.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~-  430 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+.+|+.+++.+.|+||+++++++...+. 
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            4568999999999999999999999999999999875321   223344567789999999999999999998876654 


Q ss_pred             -----EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 -----lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           +|+||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~  142 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHR  142 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence                 99999999 6899999865  569999999999999999999999999997

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=3.9e-15  Score=155.03  Aligned_cols=119  Identities=13%  Similarity=0.111  Sum_probs=91.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC-CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeee-eeeEEEeC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ-YYGSEVVD  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~-tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVq-L~g~f~~~  428 (481)
                      ....+|++.+.||+|+||+||+|.++. ++..+|||++.............+.+.+|+++|++++|+||+. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            345689999999999999999999876 6777899986421110112334567899999999999999984 5442    


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +..|||||||+|++|.. +..    ..   ...|+.||+.||.|||++|||||
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHr  135 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHN  135 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeC
Confidence            46899999999999963 211    11   14678999999999999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.62  E-value=1.6e-15  Score=173.37  Aligned_cols=114  Identities=25%  Similarity=0.420  Sum_probs=99.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|...+.||+|+||.||+|++..++..||||+++...  .       ....|+++|++++|||||+++|++..++..|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN--S-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc--c-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            4566778999999999999999899999999885321  1       112368889999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH---STNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH---skgIIHR  481 (481)
                      ||||++|+|.++++.    +++..+..|+.||+.||+|||   +.+||||
T Consensus       762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            999999999999953    789999999999999999999   6699997

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.61  E-value=4.9e-15  Score=144.50  Aligned_cols=123  Identities=25%  Similarity=0.405  Sum_probs=103.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~ly  432 (481)
                      .+|+..+.||+|+||.||++.+..+++.||||++.....    ......+.+|+.++.++. |+||+++++++..++..|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            356778899999999999999999999999999864221    244567888999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHH---H-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          433 IYLEYVHPGSINRYVR---E-HCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~---~-~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ++|||+. +++.++..   . ....+++..+..++.||+.||+|||+. +|+||
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~  132 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHR  132 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeecc
Confidence            9999996 56655432   2 236799999999999999999999975 99997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.61  E-value=2.5e-15  Score=161.55  Aligned_cols=129  Identities=21%  Similarity=0.309  Sum_probs=97.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCc-EEEEEEeecC------------CCCCCcHHHHHHHHHHHHHHhhCCCCCe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA-SCAIKEVDII------------PDDPKSAECIKQLEQEIKVLGHLKHENI  418 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-~VAIK~Ik~~------------~~d~~s~e~~k~l~~EI~iL~~L~HPNI  418 (481)
                      ...+|+++++||+|+||+||+|.++.... .+++|.+...            ............+.+|+.+|+.++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999998654322 2232311100            0001122345568899999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++++++...+..|+|||++. ++|.+++....    .......++.|+.||+.||+|||++|||||
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHr  291 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR  291 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            999999999999999999995 78888775421    223467788999999999999999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.61  E-value=1.5e-14  Score=133.73  Aligned_cols=122  Identities=34%  Similarity=0.631  Sum_probs=107.8

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      |.+.+.||.|.||.||++.+..+++.+|||.+......    ...+.+.+|+..++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            67789999999999999999988999999998632111    24578889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.+++|.+++......+++..+..++.+++.+|.|||+++++|+
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  122 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHR  122 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999889999997753338999999999999999999999999996

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.61  E-value=2.5e-16  Score=153.60  Aligned_cols=118  Identities=25%  Similarity=0.452  Sum_probs=105.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD-  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d-  429 (481)
                      ..++|++.+++|+|.|+.||.|.+..+.+.|+||+++.        ...+++.+||+||..|. |+|||+|+++..+.. 
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            56789999999999999999999999999999999973        33478999999999997 999999999987754 


Q ss_pred             -EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ...||+||+.+.+...+.    ..++..+|+.|+.||++||.|||++||+||
T Consensus       108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHR  156 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHR  156 (338)
T ss_pred             cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccc
Confidence             378999999988887765    448889999999999999999999999998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.60  E-value=4.6e-16  Score=171.27  Aligned_cols=126  Identities=29%  Similarity=0.453  Sum_probs=109.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcE----EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~----VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ......++.++||+|+||.||+|.|...|+.    ||||++..    ....+....+.+|..+|..|+|+||++|++++.
T Consensus       693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            3455677899999999999999999766654    77777652    233444567888999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ... +.||++||++|.|.+|++.+...+...+...|..||++||.|||++.+|||
T Consensus       769 ~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHr  822 (1177)
T KOG1025|consen  769 LST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHR  822 (1177)
T ss_pred             cch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhh
Confidence            766 899999999999999999998999999999999999999999999999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.60  E-value=1.3e-15  Score=165.65  Aligned_cols=126  Identities=22%  Similarity=0.332  Sum_probs=109.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC-Cc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-GA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t-g~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....+..+.++||+|.||.|+.|.|... |+  .||||.++.....    ....+|.+|+.+|.+|+|+|+|+|||+..+
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            3456778899999999999999999754 33  3899998743322    256789999999999999999999999877


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~-~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+.+|||++++|+|.+.|++ ....|-...+..|+.||+.||.||..+++|||
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHR  236 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHR  236 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence             789999999999999999987 55678999999999999999999999999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.60  E-value=8.6e-15  Score=140.09  Aligned_cols=106  Identities=17%  Similarity=0.235  Sum_probs=92.4

Q ss_pred             CCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCCCHH
Q 011617          365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN  444 (481)
Q Consensus       365 GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GGSL~  444 (481)
                      |.||.||++.+..+++.||+|.++...          ....|...+....|+||+++++++...+..||+|||+.+|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986321          1223444555667999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       445 ~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++... ..+++..+..|+.||+.||+|||+++|+||
T Consensus        74 ~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  109 (237)
T cd05576          74 SHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCR  109 (237)
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            999764 569999999999999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.59  E-value=2.9e-15  Score=161.35  Aligned_cols=121  Identities=25%  Similarity=0.476  Sum_probs=103.9

Q ss_pred             eEEeEEeccCCcEEEEEEEECC--CCc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRE--TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~--tg~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      .++.++||+|-||.||+|.+..  .|+  .||||..+..    ...+..+.|..|..+|++++|||||+|+|++. +..+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~  465 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPM  465 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----CChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccce
Confidence            4567789999999999998743  233  3888987631    12233578889999999999999999999966 5689


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||++..|.|..||+.+...++...+..|+.||+.+|.|||++++|||
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHR  515 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHR  515 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhh
Confidence            99999999999999999988899999999999999999999999999998

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.59  E-value=1.4e-14  Score=146.70  Aligned_cols=122  Identities=26%  Similarity=0.489  Sum_probs=103.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||+++...   ........+.+|+.+++.+.|+||+++++++...    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            468999999999999999999999999999999886321   1222345677899999999999999999998754    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+|+||||+. .+|..++   ...+.+..+..++.||+.||+|||+++|+||
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~  141 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR  141 (342)
T ss_pred             CCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence              34799999996 5777665   2468999999999999999999999999997

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.59  E-value=1.9e-16  Score=171.31  Aligned_cols=125  Identities=34%  Similarity=0.590  Sum_probs=113.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|.+...||.|+||.||+++++.+++..|+|+|++...+     ...-+++||-+++.++|+|||-|+|.|...+.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            4567899999999999999999999999999999999875533     23456789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+||||.||+|.+..+. .+.++|.+|.+++++.++||+|||.+|-+||
T Consensus        87 lwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hR  136 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHR  136 (829)
T ss_pred             cEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccc
Confidence            9999999999999988755 4889999999999999999999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.58  E-value=4.3e-14  Score=126.89  Aligned_cols=116  Identities=36%  Similarity=0.666  Sum_probs=102.8

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCC
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG  441 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GG  441 (481)
                      ||+|.+|.||++.+..+++.+++|++.....    ....+.+.+|+.+++.+.|++|+++++++...+..+++|||+.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc----hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            6899999999999988899999999863221    113467889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       442 SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|.+++......+++..+..++.+++.+|+|||++|++|+
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~  116 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR  116 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999997643578999999999999999999999999996

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=7.5e-15  Score=156.64  Aligned_cols=127  Identities=23%  Similarity=0.348  Sum_probs=109.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~  428 (481)
                      ......|+++++||+|+.++||++... +...||+|++..   ...+...+.-+.+||.+|.+|+ |.+||+||++...+
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            455678999999999999999999854 346688887653   3455677888999999999996 89999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++||||||-+ .||.++|++....+....++.|..||+.+++++|++||||-
T Consensus       433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHS  484 (677)
T KOG0596|consen  433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHS  484 (677)
T ss_pred             ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeec
Confidence            99999999774 99999998876666666999999999999999999999993

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.1e-15  Score=158.67  Aligned_cols=129  Identities=24%  Similarity=0.308  Sum_probs=109.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~  428 (481)
                      .....+|..+.+||+|+||+|.+|..+.+.+.||||+++...  -...+.++.-..|-++|.... -|.+++|+.+|.+-
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV--iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce--eeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            345578999999999999999999999999999999997421  111122233445777887765 67999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|+||||+.||+|...|++. +.|.|..+..|+.+|+.||-|||++|||.|
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYR  474 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYR  474 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeee
Confidence            9999999999999999999875 889999999999999999999999999987

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.57  E-value=2.5e-15  Score=149.60  Aligned_cols=128  Identities=23%  Similarity=0.452  Sum_probs=113.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC---CcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~---~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      -.+|.-.+.||+|..+.|..|.++.+|+.+|+|++.......   ...+..+...+|+.||+++ .||+||++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356778899999999999999999999999999997654322   2334455667899999998 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+++|+|+|..|.|++||... ..++|...+.||+||+.|+.|||.++||||
T Consensus        96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHR  147 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHR  147 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence            9999999999999999999774 789999999999999999999999999998

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.56  E-value=1.7e-15  Score=152.95  Aligned_cols=126  Identities=27%  Similarity=0.469  Sum_probs=105.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCC----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....|+..+.||+|+||.||+|.-..++    +.+|||+++-.++.   ........+||.+++.|+|+|||.|..+|..
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~---tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG---TGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC---CCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            3457999999999999999999655443    36899998754332   1223456679999999999999999999887


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~----~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       +..+|+++||.+ .||.++|+.+    ...++...++.|+.||+.||.|||++-|+||
T Consensus        99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHR  156 (438)
T KOG0666|consen   99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHR  156 (438)
T ss_pred             cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeec
Confidence             778999999997 8999999754    2568999999999999999999999999998

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=2.6e-15  Score=156.74  Aligned_cols=126  Identities=26%  Similarity=0.427  Sum_probs=108.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC--CCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-CCE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDH  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~--d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-~d~  430 (481)
                      ++|-++.+||+|+|+.||+|.+......||+|+-.+.++  +.+.....+...+|.+|.+.|+|+.||++|++|.. .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            567788999999999999999998889999997654331  22333445667889999999999999999999975 567


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcc
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIH  480 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk--gIIH  480 (481)
                      +|-|+|||+|.||..||+.+ +-++|.+++.|+.||+.||.||.+.  .|||
T Consensus       543 FCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIH  593 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIH  593 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeee
Confidence            99999999999999999885 8899999999999999999999987  5887

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.54  E-value=1.4e-14  Score=142.58  Aligned_cols=129  Identities=22%  Similarity=0.310  Sum_probs=112.4

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....+.++|.+.++||+|+|+.||+++...++..||+|++..     ...+.++...+||+..++++||||++++++...
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            345677899999999999999999999999999999999864     234566788899999999999999999987654


Q ss_pred             C-----CEEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 D-----DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 ~-----d~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                      +     ...||++.|...|+|.+.|...   +..++|.++..|+.+|++||++||+..  +.||
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~  153 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHR  153 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCccccc
Confidence            3     3499999999999999998652   346899999999999999999999998  8887

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.53  E-value=4.9e-14  Score=133.59  Aligned_cols=119  Identities=18%  Similarity=0.126  Sum_probs=88.7

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcH---------------------HHHHHHHHHHHHHhhCCCCC
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------------ECIKQLEQEIKVLGHLKHEN  417 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~---------------------e~~k~l~~EI~iL~~L~HPN  417 (481)
                      ...||+|+||.||+|.+. +|+.||||+++.........                     ........|+++|..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 89999999997532111110                     01123456999999998877


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YL-HskgIIHR  481 (481)
                      |...+.+.. .+ .+|||||+.|+++...+.. .+.+++..+..++.||+.+|.|| |+.|||||
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr  142 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHA  142 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            754433322 22 3899999998877655433 36799999999999999999999 79999998

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.53  E-value=1.1e-14  Score=146.47  Aligned_cols=120  Identities=22%  Similarity=0.280  Sum_probs=102.2

Q ss_pred             CCCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEe--
Q 011617          352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV--  427 (481)
Q Consensus       352 ~~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~--  427 (481)
                      ...+|++. ++||-|--|+|..|.++.+|+.+|+|++..      .    .+.++|+++.... .|+|||+++++|..  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------S----PKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------C----HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            34456553 579999999999999999999999998852      1    3456788877666 59999999999864  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 --DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 --~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ...+.||||.|+||+|+..|++++ ..|+|.++..|++||+.||.|||..+|.||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHR  185 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHR  185 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhc
Confidence              356999999999999999998863 459999999999999999999999999998

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=8.5e-15  Score=148.94  Aligned_cols=132  Identities=22%  Similarity=0.306  Sum_probs=116.0

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEE
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSE  425 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f  425 (481)
                      ..+.....+|.++++||+|+|++|.++..+.+.+.||||++++...  .+.+.+.+++.|..++.+. +||.+|-|+.+|
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            3445567899999999999999999999999999999999985432  2234566788888888876 599999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++..+++|.||+.||+|..+++.. ..++|+.++.|..+|+.||.|||++|||.|
T Consensus       321 qtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyr  375 (593)
T KOG0695|consen  321 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYR  375 (593)
T ss_pred             cccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeee
Confidence            9999999999999999999998775 789999999999999999999999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.52  E-value=9.9e-14  Score=134.26  Aligned_cols=113  Identities=21%  Similarity=0.339  Sum_probs=88.7

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-----CCCCeeeeeeEEEeCC--
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-----KHENIVQYYGSEVVDD--  429 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-----~HPNIVqL~g~f~~~d--  429 (481)
                      .-.+.||+|+||.||.  +..++.. +||++....     ....+.+.+|+.+++.+     .|+||+++||++.++.  
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            3457899999999995  5666655 688876421     11335788999999999     5799999999999873  


Q ss_pred             -EEE-EEEec--cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCccC
Q 011617          430 -HLY-IYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGL-AYLHSTNTIHR  481 (481)
Q Consensus       430 -~ly-LVmEy--~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL-~YLHskgIIHR  481 (481)
                       .++ +||||  +.+|+|.++++.  +.+.+.  ..++.|++.++ +|||+++||||
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~Ivhr  129 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTM  129 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeec
Confidence             434 78999  557999999965  346666  36788888888 99999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.52  E-value=9e-15  Score=166.45  Aligned_cols=126  Identities=32%  Similarity=0.524  Sum_probs=103.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----  427 (481)
                      ...+|+..+.||+|+||.||+++++-+|..||||+|.+..    ......++.+|+++|.+|+|||||+||..+..    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            4567889999999999999999999999999999986432    44556778899999999999999999854310    


Q ss_pred             ---------------------------------------------------C----------------------------
Q 011617          428 ---------------------------------------------------D----------------------------  428 (481)
Q Consensus       428 ---------------------------------------------------~----------------------------  428 (481)
                                                                         .                            
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                               0                            


Q ss_pred             ------------------------------------CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 011617          429 ------------------------------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY  472 (481)
Q Consensus       429 ------------------------------------d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~Y  472 (481)
                                                          -.+||-||||+...|.++++.+...-.....+.+++||+.||+|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence                                                13799999999888888887642222578889999999999999


Q ss_pred             HHHCCCccC
Q 011617          473 LHSTNTIHR  481 (481)
Q Consensus       473 LHskgIIHR  481 (481)
                      +|++|||||
T Consensus       713 IH~~giIHR  721 (1351)
T KOG1035|consen  713 IHDQGIIHR  721 (1351)
T ss_pred             HHhCceeec
Confidence            999999998

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.52  E-value=3.1e-13  Score=133.83  Aligned_cols=129  Identities=20%  Similarity=0.320  Sum_probs=94.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHH------HHHHHHHHHHHhhCCCCCeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAEC------IKQLEQEIKVLGHLKHENIVQY  421 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~------~k~l~~EI~iL~~L~HPNIVqL  421 (481)
                      ...++|++.++||+|+||.||+|.+..+   +..+|+|+.............      ......++..+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4557899999999999999999998877   666777765432211111110      0112234455667789999999


Q ss_pred             eeEEEeCC----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++....    ..+++||++. .++.+++... ..+++..++.|+.||+.||+|||+++||||
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99876543    4688889884 6777777553 457899999999999999999999999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.50  E-value=1.9e-13  Score=128.57  Aligned_cols=119  Identities=13%  Similarity=0.101  Sum_probs=89.3

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc---------------------HHHHHHHHHHHHHHhhCCCCC
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------------------AECIKQLEQEIKVLGHLKHEN  417 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s---------------------~e~~k~l~~EI~iL~~L~HPN  417 (481)
                      .+.||+|+||+||+|.+. +|+.||||+++........                     ......+..|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 8999999999754211100                     011234567999999999998


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      |.....+....  .||||||++|+++...+.. ...+++..+..|+.|++.+|.|||. +||+||
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr  142 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG  142 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            75544443332  4899999988755443222 2568889999999999999999999 999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.48  E-value=3.9e-13  Score=124.69  Aligned_cols=111  Identities=35%  Similarity=0.598  Sum_probs=97.8

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCCCHHH
Q 011617          366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR  445 (481)
Q Consensus       366 tFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GGSL~~  445 (481)
                      +||.||+|.+..+++.+|+|++.....  .  ...+.+.+|+++++.++|+||+++++++......+++|||+.+++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~--~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKI--K--KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccc--c--cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            589999999998899999999863221  1  115688899999999999999999999999999999999999889999


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       446 lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++... ..+++..+..++.+|+.+|.|||+.+|+|+
T Consensus        77 ~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  111 (244)
T smart00220       77 LLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHR  111 (244)
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecC
Confidence            99764 448999999999999999999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.48  E-value=2.3e-14  Score=150.24  Aligned_cols=129  Identities=22%  Similarity=0.286  Sum_probs=111.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .....|..-++||+|+||.||-|.-+.+|++||+|++.......  ..-.....+|-.||.++..+.||.+-..|++.+.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            34567888999999999999999999999999999885322211  1122345678899999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|||..|.||||..+|...+ ..|+|..++.|+.+|+.||++||..+||.|
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR  311 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR  311 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence            999999999999999997753 469999999999999999999999999987

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=5.4e-16  Score=152.96  Aligned_cols=127  Identities=26%  Similarity=0.450  Sum_probs=107.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--  428 (481)
                      ...++|.+..+||+|+||.||+|+.+.+|+.||+|++-..  +. ...+-....+||++|..|+|+||+.++++|...  
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme--ne-KeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME--NE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh--cc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            4567899999999999999999999999999999876421  11 112233456699999999999999999887542  


Q ss_pred             ------CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ------d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                            ..+|+||++|+ .||..+|......|+..+|+.+|.+++.||.|+|.+.|+||
T Consensus        91 p~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHR  148 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHR  148 (376)
T ss_pred             CcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence                  34999999997 89999997766789999999999999999999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.47  E-value=4.1e-13  Score=145.37  Aligned_cols=130  Identities=16%  Similarity=0.295  Sum_probs=94.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC----------------CCCcEEEEEEeecCCCCCCcHHH----------HHHHH
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR----------------ETGASCAIKEVDIIPDDPKSAEC----------IKQLE  404 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk----------------~tg~~VAIK~Ik~~~~d~~s~e~----------~k~l~  404 (481)
                      ...++|++.++||+|+||.||+|.+.                ..+..||||+++..... ...+.          .+...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhH
Confidence            35678999999999999999999752                23467999998642111 01111          11233


Q ss_pred             HHHHHHhhCCCCCe-----eeeeeEEEe--------CCEEEEEEeccCCCCHHHHHHHhCC-------------------
Q 011617          405 QEIKVLGHLKHENI-----VQYYGSEVV--------DDHLYIYLEYVHPGSINRYVREHCR-------------------  452 (481)
Q Consensus       405 ~EI~iL~~L~HPNI-----VqL~g~f~~--------~d~lyLVmEy~~GGSL~~lL~~~~~-------------------  452 (481)
                      .|+.++.+++|.++     ++++++|..        ++..||||||+.+++|.++++...+                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            47777777776654     677777653        3568999999999999999864211                   


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          453 ----DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       453 ----~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+.+..++.|+.||+.||.|||.++|+||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHr  333 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHR  333 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence                23567788999999999999999999998

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.43  E-value=6.4e-13  Score=146.70  Aligned_cols=130  Identities=28%  Similarity=0.439  Sum_probs=108.9

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEEC--C-C----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR--E-T----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV  419 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk--~-t----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIV  419 (481)
                      .++....+.++.+.||+|.||+||+|...  . .    ...||||.++...   . ....+.+..|+++|+.+. |+||+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~-~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---S-SSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---C-cHHHHHHHHHHHHHHHhcCCcchh
Confidence            34455556677889999999999999743  1 1    3458999886322   2 245678899999999986 99999


Q ss_pred             eeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       420 qL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++|++...+.+++|+||+..|+|.+|++...               ..++..++..++.||+.||+||+++++|||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence            99999999999999999999999999998764               248999999999999999999999999998

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.41  E-value=2.6e-13  Score=139.88  Aligned_cols=123  Identities=24%  Similarity=0.310  Sum_probs=106.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC--C----CeeeeeeE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--E----NIVQYYGS  424 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H--P----NIVqL~g~  424 (481)
                      ....+|++.+++|+|+||+|..|.+..++..||||+++..      ....+...-||++|+++.+  |    -+|++.++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3467899999999999999999999999999999998732      2233455669999999942  2    48899999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH  480 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIH  480 (481)
                      |.-.+.+|||+|.+ |-+++++|+.+ ...|....|+.|..||+.+|+|||+++|+|
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~H  215 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTH  215 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceee
Confidence            99999999999988 67999999873 467999999999999999999999999999

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.41  E-value=4.1e-13  Score=141.40  Aligned_cols=117  Identities=27%  Similarity=0.433  Sum_probs=99.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh--CCCCCeeeeeeEEEeCC-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~--L~HPNIVqL~g~f~~~d-  429 (481)
                      ....++..+||+|.||.||+|+..  ++.||||++.        .+..+.+.+|-+|.+.  ++|+||++|++...... 
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp--------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP--------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecC--------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            456778899999999999999976  4899999885        3344567777777665  57999999999876655 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccC
Q 011617          430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---------NTIHR  481 (481)
Q Consensus       430 ---~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk---------gIIHR  481 (481)
                         .+|||+||.+.|+|.+||+.  ..+++.....|+.-|++||+|||+.         .|+||
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHR  340 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHR  340 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccc
Confidence               79999999999999999986  5789999999999999999999964         48887

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=8e-13  Score=138.48  Aligned_cols=119  Identities=29%  Similarity=0.475  Sum_probs=97.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHh--hCCCCCeeeeeeEEEeC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG--HLKHENIVQYYGSEVVD  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~--~L~HPNIVqL~g~f~~~  428 (481)
                      ...++.++.+.||+|.||.||.|.|+  |+.||||++....      +  +.+.+|.+|.+  .|+|+||..|++.-..+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E--~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------E--RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------h--hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            34578899999999999999999997  8999999985321      1  23445555555  57999999999886654


Q ss_pred             C----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccC
Q 011617          429 D----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHR  481 (481)
Q Consensus       429 d----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk--------gIIHR  481 (481)
                      +    ++|||++|.+.|+|++||..  ..++.....+++.-++.||+|||..        .|.||
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR  340 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR  340 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence            3    59999999999999999975  6789999999999999999999954        37776

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.40  E-value=2.4e-12  Score=121.13  Aligned_cols=115  Identities=19%  Similarity=0.211  Sum_probs=91.7

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC---cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEe
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~---s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      +.||+|++|.||+|.+  .|..+++|+.........   .......+.+|+.++..+.|++|+....++...+..+|+||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            6799999999999987  567789997642211111   11123457789999999999998887777777888999999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |++|++|.+++... .   . ....++.+|+.+|.+||+++|+||
T Consensus        80 ~~~G~~L~~~~~~~-~---~-~~~~i~~~i~~~l~~lH~~~i~H~  119 (211)
T PRK14879         80 YIEGEPLKDLINSN-G---M-EELELSREIGRLVGKLHSAGIIHG  119 (211)
T ss_pred             EeCCcCHHHHHHhc-c---H-HHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999998653 2   2 788899999999999999999997

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.38  E-value=5e-12  Score=128.39  Aligned_cols=121  Identities=25%  Similarity=0.355  Sum_probs=101.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCC-cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC----CCeeeeeeEE-EeC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----ENIVQYYGSE-VVD  428 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg-~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H----PNIVqL~g~f-~~~  428 (481)
                      +|++.++||+|+||.||++.+...+ +.+|+|..........     ..+..|+.+|..+..    .++..+++.. ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999988765 5688887764221111     145568888888863    6899999998 578


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.||||+++ |.+|.++.+... +.|+...+..|+.|++.+|++||+.|+|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHR  146 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHR  146 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccC
Confidence            8899999988 799999987655 789999999999999999999999999998

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.36  E-value=3.4e-12  Score=125.74  Aligned_cols=124  Identities=25%  Similarity=0.319  Sum_probs=107.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~  428 (481)
                      .....+|.++++||.|+||.+|+|....+|+.||||+-..   ....    .++.-|.++...|++ ..|..+..++...
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~---~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS---KAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc---cCCC----cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            3556899999999999999999999999999999997642   2222    245668888888875 6788888888888


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++-.+|||++ |-+|++++.-+...|+...+..++.|++.-|+|+|.+++|||
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHR  135 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHR  135 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccc
Confidence            9999999999 799999998877889999999999999999999999999998

>smart00090 RIO RIO-like kinase

Probab=99.35  E-value=2.7e-12  Score=125.98  Aligned_cols=123  Identities=15%  Similarity=0.073  Sum_probs=92.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEE-ECCCCcEEEEEEeecCCCCCCc-------------------HHHHHHHHHHHHHHhhC
Q 011617          354 SQWQKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKS-------------------AECIKQLEQEIKVLGHL  413 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~-dk~tg~~VAIK~Ik~~~~d~~s-------------------~e~~k~l~~EI~iL~~L  413 (481)
                      .-|++.+.||+|+||.||+|. +..+|+.||||+++........                   ......+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            368899999999999999999 6678999999999743211000                   01123467899999999


Q ss_pred             CCCC--eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccC
Q 011617          414 KHEN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-TIHR  481 (481)
Q Consensus       414 ~HPN--IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg-IIHR  481 (481)
                      .+.+  +.++++.    ...||||||+.|++|..++.. ...+.+..+..|+.||+.+|.|||.+| |+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~  173 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHG  173 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence            7532  3444432    235899999998888766533 245667778899999999999999999 9997

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.35  E-value=6.7e-13  Score=137.98  Aligned_cols=119  Identities=26%  Similarity=0.410  Sum_probs=105.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECC---CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~---tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~  427 (481)
                      ....|.+.++||+|+|+.||++.+..   ..+.||+|.+....       ....+.+|+++|..+. +.||+++.+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            34578999999999999999999877   67889999986432       2246888999999985 8999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++..+||||++..+..+++..    ++..+++.|++.++.||+|+|.+|||||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHR  156 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHR  156 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCcccc
Confidence            9999999999999999998854    6789999999999999999999999998

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.34  E-value=6.3e-12  Score=137.81  Aligned_cols=122  Identities=20%  Similarity=0.305  Sum_probs=85.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC----CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeE--
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS--  424 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t----g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~--  424 (481)
                      ...++|++.++||+|+||.||+|.+..+    +..||||++....    ..   +.+.+|  .+....+.+++.++..  
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~---e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AV---EIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hh---HHHHHH--HHHhhchhhHHHHHHhhh
Confidence            4567899999999999999999999988    8999999875211    11   111111  1112222222222221  


Q ss_pred             ----EEeCCEEEEEEeccCCCCHHHHHHHhCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 ----EVVDDHLYIYLEYVHPGSINRYVREHCRD-------------------ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 ----f~~~d~lyLVmEy~~GGSL~~lL~~~~~~-------------------Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          ...++.+||||||+.+++|.+++......                   ..+..+..|+.||+.||+|||+++||||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                23456799999999999999998753211                   1234577899999999999999999998

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.33  E-value=4.7e-11  Score=111.35  Aligned_cols=121  Identities=31%  Similarity=0.529  Sum_probs=104.0

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC-CeeeeeeEEEeCCEEEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-NIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP-NIVqL~g~f~~~d~lyLV  434 (481)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....  ........+.+|+.++..+.|+ +|+.+++.+......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLE--SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhc--cchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            788999999999999999987   7789998864322  1113467788899999999988 799999999888889999


Q ss_pred             EeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||+.++++.+++....  ..+.+..+..++.||+.+|.|+|.++++||
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hr  125 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR  125 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999998776643  279999999999999999999999999998

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.33  E-value=7.6e-12  Score=116.84  Aligned_cols=111  Identities=21%  Similarity=0.271  Sum_probs=85.2

Q ss_pred             EeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC---cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~---s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      .||+|+||.||+|.+  .+..+++|+.........   ......++.+|++++..+.|.+|.....++...+..+|||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999985  467889998542211111   122346678899999999988766555556667778999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++|++|.+++... ..       .++.||+.+|.+||+.||+||
T Consensus        79 ~~g~~l~~~~~~~-~~-------~~~~~i~~~l~~lH~~gi~H~  114 (199)
T TIGR03724        79 IEGKPLKDVIEEG-ND-------ELLREIGRLVGKLHKAGIVHG  114 (199)
T ss_pred             ECCccHHHHHhhc-HH-------HHHHHHHHHHHHHHHCCeecC
Confidence            9999999988542 11       789999999999999999997

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.1e-12  Score=130.80  Aligned_cols=124  Identities=20%  Similarity=0.389  Sum_probs=106.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeee-EEEe
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYG-SEVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g-~f~~  427 (481)
                      ....+.|.+.+.||+|.||++.+|+++.+...+++|.+.      .....+++|.+|...--.|. |.|||.-|+ .|..
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp------~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP------RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC------cchhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            345678999999999999999999999999999999885      22334577888887766665 899997775 5778


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+.++|||++.|||..-+..  ..+.|...+.++.|++.||.|||+++||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHR  145 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHR  145 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhc
Confidence            8899999999999999987754  558999999999999999999999999998

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.31  E-value=7.1e-12  Score=127.91  Aligned_cols=123  Identities=22%  Similarity=0.300  Sum_probs=107.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d  429 (481)
                      ...-.|.++++||+|.||.+++|++.-+++.||||.--..   .    ..-++..|.+..+.|. .++|.+.|.+....-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---S----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecccc---C----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            3456899999999999999999999999999999965321   1    1246777888888875 689999998877788


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +-.||||++ |-+|++++..++..|+...+..++.|++.-|+|+|++++|.|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYR  148 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYR  148 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeec
Confidence            889999999 799999999888899999999999999999999999999887

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.30  E-value=1.8e-11  Score=132.96  Aligned_cols=117  Identities=16%  Similarity=0.171  Sum_probs=90.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecC--CCCC-CcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII--PDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~--~~d~-~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..|...++||+|+||.||+|.+...  .+++|+....  .... ......+.+.+|+++|..++|++|+..+.++...+.
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3456789999999999999987543  3444432211  1111 111234568889999999999999988877777788


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||++|++|.+++.         ....++.||+.+|.|||+++||||
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHr  452 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHG  452 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccC
Confidence            899999999999999885         346789999999999999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=2.2e-13  Score=135.94  Aligned_cols=120  Identities=28%  Similarity=0.511  Sum_probs=102.9

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-----EE
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HL  431 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-----~l  431 (481)
                      +-.+-||-|+||.||-+.+..+|+.||+|++-   ....+-...+.+.+|+++|.-++|.||...+++..-..     .+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p---nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP---NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcc---hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            34578999999999999999999999999874   22234445678899999999999999999999876543     48


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+++|+|. .||.++|-. ...++.+.++-+++||++||+|||..+|+||
T Consensus       133 YV~TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHR  180 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHR  180 (449)
T ss_pred             HHHHHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhc
Confidence            99999995 899998865 4779999999999999999999999999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.29  E-value=2.7e-11  Score=119.30  Aligned_cols=117  Identities=13%  Similarity=0.130  Sum_probs=92.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHH------HHHHHHHHhhCCCCCeeeeeeEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~------l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ..++|+..++||.|+||.||+...  ++..||||++....  .........      +++|+..+.+|.|++|..+.+++
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~--~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV--KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhc--CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            357899999999999999999765  36679999986322  222333333      67899999999999999999887


Q ss_pred             EeC--------CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVD--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~--------d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.        +..+|+|||++|.+|.++..     +++    ....+|+.+|..||++||+||
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~  159 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSG  159 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccC
Confidence            644        35899999999999987742     333    245699999999999999997

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.28  E-value=1.9e-11  Score=122.16  Aligned_cols=125  Identities=24%  Similarity=0.348  Sum_probs=108.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~  430 (481)
                      +.++.+.+..||.|+-|+||++..+.+|..+|||.+..    ..+.+..+++...+.++.+.. .|+||+.+|+|..+..
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            34556778899999999999999999999999999974    245666788888888776665 8999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ++|.||.| ..-++++++.-.+.++|..+-.+..-|++||.||.++ +||||
T Consensus       166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHR  216 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHR  216 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeec
Confidence            99999999 4677788877778899999999999999999999875 89998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.27  E-value=8.2e-12  Score=120.79  Aligned_cols=128  Identities=20%  Similarity=0.401  Sum_probs=108.9

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEe
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV  427 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~  427 (481)
                      .+...+....+..||+|+||.|-+.++..+|...|+|.++....    .+..+++.+|+.+... ..+|.+|.+||.+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            45566777888999999999999999999999999999975432    3445667778876554 569999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      +..+||.||.|+ .+|.+|.++   +++.++|..+-+|+.-++.||+|||++ .||||
T Consensus       117 egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHR  173 (282)
T KOG0984|consen  117 EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHR  173 (282)
T ss_pred             cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhc
Confidence            999999999996 888887653   467899999999999999999999997 89998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.4e-11  Score=133.58  Aligned_cols=132  Identities=22%  Similarity=0.380  Sum_probs=106.3

Q ss_pred             CCCcccCCCCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCC
Q 011617          339 VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHEN  417 (481)
Q Consensus       339 ~~p~~~~~~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPN  417 (481)
                      ..+..++..........|.+...||.|+|+.|-.|.+..+++..++|++.....         +..+|+.++.. -+|+|
T Consensus       307 va~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~n  377 (612)
T KOG0603|consen  307 VAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPN  377 (612)
T ss_pred             cChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCc
Confidence            344444443444567789999999999999999999999999999999864321         23346655544 46999


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+++++.+.+..++|+|||++.|+-|.+-+... ..+. .++..|+.||+.+|.|||++|||||
T Consensus       378 iv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhR  439 (612)
T KOG0603|consen  378 IVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHR  439 (612)
T ss_pred             ceeecceecCCceeeeeehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeec
Confidence            999999999999999999999999888877653 3333 7888899999999999999999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.1e-12  Score=139.32  Aligned_cols=128  Identities=20%  Similarity=0.263  Sum_probs=111.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+++++..||-|+||.|-++........+|+|++++.....  ....+.+..|-+||.+++.+.||+||-.|.++.+
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            34567788899999999999999877655568999987544322  2234567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|++||-|-||.|...|++. +.|.+...+.|+.-+++|++|||.+|||.|
T Consensus       495 vYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYR  544 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYR  544 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceec
Confidence            99999999999999999885 889999999999999999999999999987

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.21  E-value=3.3e-12  Score=127.18  Aligned_cols=126  Identities=25%  Similarity=0.356  Sum_probs=103.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHH-hhCCCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL-~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....+.+-+..||.|+||.|++..++.+|+.+|||.|+...+    ....+++..|.... +.-+.+|||++||....++
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            344556667889999999999999999999999999985433    33445677777654 4456899999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          430 HLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~----~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      ..||.||+|+ .+|.++.+.    ....++|..+-.|+.-++.||.||.+. +||||
T Consensus       137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHR  192 (361)
T KOG1006|consen  137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHR  192 (361)
T ss_pred             ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhc
Confidence            9999999996 777766532    246799999999999999999999865 89998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.16  E-value=1e-10  Score=110.21  Aligned_cols=115  Identities=17%  Similarity=0.148  Sum_probs=84.9

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc-----------------HHHHHHHHHHHHHHhhCCCCC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------AECIKQLEQEIKVLGHLKHEN  417 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s-----------------~e~~k~l~~EI~iL~~L~HPN  417 (481)
                      .|.+.+.||+|+||.||++.+. +|+.||||++.........                 .........|+.++..+.+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4788899999999999999875 7999999987642210000                 011123567899999988774


Q ss_pred             --eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          418 --IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       418 --IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ++.+++    .+..+++|||++|++|.++...       .....++.+|+.+|.++|++||+||
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~  149 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHG  149 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcC
Confidence              444443    3456899999999998765421       3456788999999999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.13  E-value=5.6e-11  Score=131.98  Aligned_cols=114  Identities=29%  Similarity=0.453  Sum_probs=93.5

Q ss_pred             EEeEEeccCCcEE-EEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEE
Q 011617          357 QKGKLIGRGTFGS-VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       357 ~i~k~IG~GtFG~-VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .-.+.+|.|+-|+ ||+|...  |+.||||.+-        .++.....+||.+|+.-+ |+|||++|+...+...+||.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            3345688888875 7999875  6789999874        345566788999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHh--CCCCCH-HHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREH--CRDITE-SIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~--~~~Lse-~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|+|. .+|.++++..  ...... ...+.++.|++.||++||.-+||||
T Consensus       582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHR  630 (903)
T KOG1027|consen  582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHR  630 (903)
T ss_pred             ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccc
Confidence            99995 9999999763  111222 5667889999999999999999998

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.06  E-value=1.3e-09  Score=106.42  Aligned_cols=110  Identities=13%  Similarity=0.076  Sum_probs=81.0

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEEE
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      .+...|++|+||.||++..  .+..++.+.+..... ....-+...+.+|+++|++|. +++|++++++    +..|++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~-~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPW-WLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchh-hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            3567899999999997764  567777776642110 001111225788999999996 5889999886    4579999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+.|.+|.+.+..       . ...++.|++.+|+|||++|||||
T Consensus        78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHr  115 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHN  115 (218)
T ss_pred             eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccC
Confidence            99999898755421       1 13578899999999999999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.04  E-value=1.4e-10  Score=117.90  Aligned_cols=122  Identities=20%  Similarity=0.325  Sum_probs=103.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ...+|.-++.+|.|.- .|..+.+.-.++.||||++....   ......++..+|..++..+.|+|||+++.+|.-.   
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---ccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            4468888999999988 78888888889999999885432   2233456777899999999999999999999754   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ..+|+|||||. ++|.+.+...   ++-..+.+|+.|++.|++|||+.||+||
T Consensus        91 ~~~~e~y~v~e~m~-~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihR  142 (369)
T KOG0665|consen   91 EEFQEVYLVMELMD-ANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHR  142 (369)
T ss_pred             HHHHhHHHHHHhhh-hHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeec
Confidence               35899999996 9999998743   7788999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.02  E-value=1.1e-09  Score=101.02  Aligned_cols=115  Identities=18%  Similarity=0.227  Sum_probs=76.0

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHH-H------------------HHHHHHHHHHHhhCCCCC--
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-C------------------IKQLEQEIKVLGHLKHEN--  417 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e-~------------------~k~l~~EI~iL~~L~HPN--  417 (481)
                      ++.||+|+||.||+|.+. +++.||||+++.......... .                  ......|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999976 789999999864221111110 0                  011235666666665432  


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~-lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      +.+++++    ...+|||||+.++.+.. .+... . . ...+..++.+++.++.+||. ++|+||
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~  139 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-L-LEDPEELYDQILELMRKLYREAGLVHG  139 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-h-h-cccHHHHHHHHHHHHHHHhhccCcCcC
Confidence            4455543    34689999999854332 22221 1 1 16778899999999999999 999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=5.1e-10  Score=128.08  Aligned_cols=127  Identities=22%  Similarity=0.298  Sum_probs=97.8

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .......+|.+.+.||+|+||+||+|...+ |+.||+|+-+.  ..........+++.-++ +.  --+-|+.+..++..
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P--~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKP--PNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVF  765 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecC--CCceeeeehHHHHHhhc-hh--hhcchHHHHHHHcc
Confidence            334455789999999999999999999877 99999998752  12222222223322222 11  12456677777777


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.-+||+||.+.|+|.+++. ..+.++|..+..|+.||+..|+.||.++|||+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHg  818 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHG  818 (974)
T ss_pred             CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecc
Confidence            888999999999999999997 45889999999999999999999999999995

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.00  E-value=7.4e-10  Score=118.32  Aligned_cols=122  Identities=18%  Similarity=0.315  Sum_probs=105.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC------CCCeeeeeeEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK------HENIVQYYGSEV  426 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~------HPNIVqL~g~f~  426 (481)
                      ..+|.+....|+|-|+.|..|.+...|..||||+|+.      ++..-+.=..|++||++|.      .-+++.|+-.|.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3577888889999999999999999999999999972      2333445567999999995      238999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~--~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+++|||+|-+. .+|.++|++.+.  .|....++.|+.|++.||+.|...||+|.
T Consensus       505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHa  560 (752)
T KOG0670|consen  505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHA  560 (752)
T ss_pred             hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeec
Confidence            9999999999984 999999988653  46788999999999999999999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.97  E-value=1.9e-09  Score=92.95  Aligned_cols=107  Identities=19%  Similarity=0.238  Sum_probs=86.8

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC--CCeeeeeeEEEeCCEEEEEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H--PNIVqL~g~f~~~d~lyLVm  435 (481)
                      +.+.||.|.++.||++....  ..+++|.+....    .   ...+..|+.++..+.+  .+++++++++...+..|++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~----~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSRE----K---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCC----c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            45789999999999999754  678999875321    1   3467789999999976  58999999888888999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---NTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk---gIIHR  481 (481)
                      ||+.|+.+..+        .......++.+++.+|++||..   +|+|+
T Consensus        73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~  113 (155)
T cd05120          73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHG  113 (155)
T ss_pred             EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEec
Confidence            99988777654        4566677899999999999985   69986

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.88  E-value=1.7e-08  Score=99.21  Aligned_cols=115  Identities=15%  Similarity=0.180  Sum_probs=79.9

Q ss_pred             eEEec-cCCcEEEEEEEECCCCcEEEEEEeecCC-------C-CCCcHHHHHHHHHHHHHHhhCCCCCe--eeeeeEEEe
Q 011617          359 GKLIG-RGTFGSVYIGTNRETGASCAIKEVDIIP-------D-DPKSAECIKQLEQEIKVLGHLKHENI--VQYYGSEVV  427 (481)
Q Consensus       359 ~k~IG-~GtFG~VYla~dk~tg~~VAIK~Ik~~~-------~-d~~s~e~~k~l~~EI~iL~~L~HPNI--VqL~g~f~~  427 (481)
                      +..|| .|+.|.||.+...  +..++||.++...       . ..........+.+|+.++..|.|.+|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34565 6677777777653  6778999875211       0 01112234567889999999998775  677766443


Q ss_pred             CC----EEEEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DD----HLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d----~lyLVmEy~~G-GSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..    ..+|||||++| .+|.+++..  ..+.+..    +.||+.+|.+||++||+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~Hr  166 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHA  166 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCC
Confidence            22    23599999997 699998864  3455543    5789999999999999997

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=98.61  E-value=4.3e-08  Score=102.28  Aligned_cols=127  Identities=20%  Similarity=0.317  Sum_probs=97.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCc-----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....++++..++-+|+||.||.|.|++...     .|-+|.++.    ..+.-.+..+..|--+|..+.|+|+.++.++.
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            445678888999999999999998874322     233444431    12233345567788888888999999999987


Q ss_pred             EeC-CEEEEEEeccCCCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVD-DHLYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~-d~lyLVmEy~~GGSL~~lL~~~~-------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+ +.-++++.++.-|+|..||+...       ..++..++..++.||+.||+|||.++|||.
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHk  420 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHK  420 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            654 55778888998899999998421       347788899999999999999999999993

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.46  E-value=7e-08  Score=106.96  Aligned_cols=123  Identities=24%  Similarity=0.344  Sum_probs=96.7

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCC-CCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~-~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      ....++|.|+||.|+.+......+.++.|..+... ...........+..|+.+-..|.|+||+..+..+......+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56788999999999988877767767776554210 11222333344777888888899999998888777766666669


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||++ ||+.++... +.+...++..++.||+.||+|||.+||.||
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahr  444 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHR  444 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceec
Confidence            99998 999999763 679999999999999999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.38  E-value=2.4e-07  Score=101.47  Aligned_cols=120  Identities=13%  Similarity=0.110  Sum_probs=72.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC----------------------C-------CcHHHHHHHH
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----------------------P-------KSAECIKQLE  404 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d----------------------~-------~s~e~~k~l~  404 (481)
                      ..|.. +.||.|++|+||+|..+.+|+.||||+++.....                      .       ...+..+.+.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 7899999999999999888999999999632100                      0       0012233344


Q ss_pred             HHHHHHhhC----------CCCCeeeeeeEEEe-CCEEEEEEeccCCCCHHHHH--HHhCC---CCCHHHHHHHHHHHHH
Q 011617          405 QEIKVLGHL----------KHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYV--REHCR---DITESIVRNFTRHILN  468 (481)
Q Consensus       405 ~EI~iL~~L----------~HPNIVqL~g~f~~-~d~lyLVmEy~~GGSL~~lL--~~~~~---~Lse~~I~~I~~QIl~  468 (481)
                      +|+.++...          .+.+.+.+-.++.+ ....+||||||+|+.|.++.  ...+.   .+.+..+..++.||+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence            444443333          12222332222221 23467999999999998753  22211   255556666666665 


Q ss_pred             HHHHHHHCCCccC
Q 011617          469 GLAYLHSTNTIHR  481 (481)
Q Consensus       469 GL~YLHskgIIHR  481 (481)
                            ..|++|+
T Consensus       278 ------~~GffHa  284 (537)
T PRK04750        278 ------RDGFFHA  284 (537)
T ss_pred             ------hCCeeeC
Confidence                  4788886

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.32  E-value=1.6e-06  Score=92.80  Aligned_cols=119  Identities=13%  Similarity=0.071  Sum_probs=71.6

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc-----------------------------HHHHH------HH
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------------------AECIK------QL  403 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s-----------------------------~e~~k------~l  403 (481)
                      .+.||.|++|+||+|+.+ +|+.||||+.+........                             .+...      ++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999965 6899999998632100000                             00011      13


Q ss_pred             HHHHHHHhhC----CCCCeeeeeeEE-EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 011617          404 EQEIKVLGHL----KHENIVQYYGSE-VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN-GLAYLHSTN  477 (481)
Q Consensus       404 ~~EI~iL~~L----~HPNIVqL~g~f-~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~-GL~YLHskg  477 (481)
                      .+|.+.+..+    ++.+-+.+-..+ ......+|||||++|++|.++.......+.   ...++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            3444444444    232223322222 223447899999999999988754212222   3345555555 477889999


Q ss_pred             CccC
Q 011617          478 TIHR  481 (481)
Q Consensus       478 IIHR  481 (481)
                      ++|+
T Consensus       278 ~~H~  281 (437)
T TIGR01982       278 FFHA  281 (437)
T ss_pred             ceeC
Confidence            9997

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.29  E-value=6.2e-06  Score=79.60  Aligned_cols=116  Identities=14%  Similarity=0.173  Sum_probs=80.6

Q ss_pred             EEeccCCcEEEEEEEECC------CCcEEEEEEeecCCC-----------CC--------Cc-H-HHHHHHHHHHHHHhh
Q 011617          360 KLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPD-----------DP--------KS-A-ECIKQLEQEIKVLGH  412 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~------tg~~VAIK~Ik~~~~-----------d~--------~s-~-e~~k~l~~EI~iL~~  412 (481)
                      ..||.|.-+.||.|....      .+..+|||+.+....           +.        .+ . ....+.+.|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543      357899999864211           10        00 1 112234589999999


Q ss_pred             CCC--CCeeeeeeEEEeCCEEEEEEeccCCCCHHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccC
Q 011617          413 LKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHR  481 (481)
Q Consensus       413 L~H--PNIVqL~g~f~~~d~lyLVmEy~~GGSL~~-lL~~~~~~Lse~~I~~I~~QIl~GL~YL-HskgIIHR  481 (481)
                      +..  -++.+.+++    ..-+|||||+.+..+.. .+++  ..+.+..+..+..+++.+|.+| |..||||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            863  466777764    45689999997554422 2332  3456667788899999999999 89999996

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.23  E-value=8.9e-07  Score=92.93  Aligned_cols=128  Identities=23%  Similarity=0.345  Sum_probs=90.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCc-----------------------------------EEEEEEeecCCCCCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----------------------------------SCAIKEVDIIPDDPK  395 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-----------------------------------~VAIK~Ik~~~~d~~  395 (481)
                      ...++|+++..||+|.-..||.+....+|.                                   ..|||.+-....+..
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            345789999999999999999886443221                                   245565533333333


Q ss_pred             cHHHHHHHHHHHH------H--------Hhh--------CCCCCeeeeeeEEEeC-------------------------
Q 011617          396 SAECIKQLEQEIK------V--------LGH--------LKHENIVQYYGSEVVD-------------------------  428 (481)
Q Consensus       396 s~e~~k~l~~EI~------i--------L~~--------L~HPNIVqL~g~f~~~-------------------------  428 (481)
                      +...++...+|+.      +        .+.        -+|||||.++++|.+.                         
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            4444444444431      1        111        2599999999988652                         


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+|+||.... .+|.+|+-.  ...+....+.|+.|+++|+.|||.+||.||
T Consensus       314 ~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhR  365 (598)
T KOG4158|consen  314 EPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHR  365 (598)
T ss_pred             CCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhh
Confidence              24899999885 899999965  456677788899999999999999999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.22  E-value=2.4e-06  Score=79.88  Aligned_cols=111  Identities=15%  Similarity=0.160  Sum_probs=83.4

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC--CCeeeeeeEEEeC---CEEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVD---DHLYIY  434 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H--PNIVqL~g~f~~~---d~lyLV  434 (481)
                      +.|+.|.++.||++.... |+.+++|.......  .  .....+..|+++++.+.+  .++.+++.+....   +..|+|
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~--~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGAL--L--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCccc--C--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            678999999999998643 67899998753211  0  123467789999999875  3457777765543   367899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |||++|.++.+.+..  ..+++.....++.+|+.+|.+||+..
T Consensus        79 ~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~  119 (223)
T cd05154          79 MERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVD  119 (223)
T ss_pred             EEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            999998888775532  45788889999999999999999753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.20  E-value=2.5e-07  Score=93.04  Aligned_cols=120  Identities=22%  Similarity=0.302  Sum_probs=98.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++..+..+|.+...|..|+|+|.  |..++.|++++..   ......++|..|.-.|+-+.||||..+++.|...-++
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             chhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            3455667778899999999999997  4456667776432   2233446788898899999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      .++..||+.|+|+.+|++.. .-.+..++..++..|++|++|||.-
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl  308 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL  308 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc
Confidence            99999999999999998642 3367788999999999999999975

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.18  E-value=4.2e-06  Score=92.40  Aligned_cols=99  Identities=23%  Similarity=0.330  Sum_probs=81.3

Q ss_pred             EEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC
Q 011617          372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC  451 (481)
Q Consensus       372 la~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~  451 (481)
                      .|..+.++..|.|.+++...     .+....+.+.++.|+.|+||||++|++.++.+..+|||+|.|  --|..++++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~-----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSN-----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCC-----chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-
Confidence            46667888889998886422     133456677888999999999999999999999999999988  5777788663 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-HCCCccC
Q 011617          452 RDITESIVRNFTRHILNGLAYLH-STNTIHR  481 (481)
Q Consensus       452 ~~Lse~~I~~I~~QIl~GL~YLH-skgIIHR  481 (481)
                         +...+...+.||+.||.||| +.+++|.
T Consensus       102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHg  129 (690)
T KOG1243|consen  102 ---GKEEVCLGLFQILAALSFLNDDCNLVHG  129 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHHhccCCeeec
Confidence               47888889999999999997 5689984

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.18  E-value=6.2e-07  Score=101.88  Aligned_cols=68  Identities=21%  Similarity=0.256  Sum_probs=56.8

Q ss_pred             CCC-CCeeeeeeEE-------EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          413 LKH-ENIVQYYGSE-------VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       413 L~H-PNIVqL~g~f-------~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.| .||..++++|       ...+.++++|||+ +++|.++|......+++..++.|++||+.||.|||++|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            345 5777888877       2335688889988 589999997655669999999999999999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.13  E-value=4.4e-06  Score=75.43  Aligned_cols=104  Identities=13%  Similarity=0.039  Sum_probs=72.5

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCe-eeeeeEEEeCCEEEEEEec
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNI-VqL~g~f~~~d~lyLVmEy  437 (481)
                      .+.|+.|.++.||++...  ++.|++|.......      ....+..|+.+++.+.+.++ .+++.+.  .+.-++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            467889999999999864  77899998642110      11245678888888865444 4555543  3345799999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----ccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-----IHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgI-----IHR  481 (481)
                      ++|.++...         ......++.+++.+|+.||..++     +|+
T Consensus        73 i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg  112 (170)
T cd05151          73 IEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHN  112 (170)
T ss_pred             cCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence            998887543         01123467899999999999985     886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.13  E-value=3.8e-07  Score=99.66  Aligned_cols=117  Identities=19%  Similarity=0.288  Sum_probs=96.8

Q ss_pred             EeccCCcEEEEEEEE---CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEEEe
Q 011617          361 LIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       361 ~IG~GtFG~VYla~d---k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLVmE  436 (481)
                      .+|+|+||.|+++.-   ...|..||+|+++..........   ....|-.++..++ |+.+|+++..|..+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            378999999998752   34577899999875433222222   3445777888887 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       437 y~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |..||+|...+.+ ...+.+...+.+...++.+++++|+.+||||
T Consensus        78 ~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyr  121 (612)
T KOG0603|consen   78 FLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYR  121 (612)
T ss_pred             hcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence            9999999998866 4789999999999999999999999999987

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.96  E-value=4.9e-05  Score=73.36  Aligned_cols=122  Identities=20%  Similarity=0.197  Sum_probs=88.2

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCC--CCCC-cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~--~d~~-s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      ....|-+|+-+.|+++.+.  |+.+.||.=-...  .... ..-..++..+|+++|.++.--.|.--.-+|.+.+.-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5677889999999999875  7888888532100  0011 112234577899999998766665555567777778899


Q ss_pred             EeccCC-CCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHP-GSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~G-GSL~~lL~~~~~~-Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||++| .++.+++...... ........++++|-..|.-||.++|||+
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHG  137 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHG  137 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecc
Confidence            999986 3888998775433 3344447899999999999999999995

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=97.94  E-value=4.5e-05  Score=77.77  Aligned_cols=125  Identities=21%  Similarity=0.301  Sum_probs=79.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC----------CCeeeeee
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----------ENIVQYYG  423 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H----------PNIVqL~g  423 (481)
                      ..+.++..||.|+|+.||.+++.++|+.+|+|+.....+  ......+++++|.-....+.+          -.++..++
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            357889999999999999999999999999999865442  222345667766644444322          12333333


Q ss_pred             EEEe---------CC--------EEEEEEeccCCCCHHHHHHH---hCCC---CCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011617          424 SEVV---------DD--------HLYIYLEYVHPGSINRYVRE---HCRD---ITESIVRNFTRHILNGLAYLHSTNTIH  480 (481)
Q Consensus       424 ~f~~---------~d--------~lyLVmEy~~GGSL~~lL~~---~~~~---Lse~~I~~I~~QIl~GL~YLHskgIIH  480 (481)
                      ....         ..        +.+++|+-+. +||.+++..   ....   +....-..+..|+++.+++||..||||
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH  168 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH  168 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence            3221         11        2466777774 889888653   2111   112233445689999999999999999


Q ss_pred             C
Q 011617          481 R  481 (481)
Q Consensus       481 R  481 (481)
                      +
T Consensus       169 g  169 (288)
T PF14531_consen  169 G  169 (288)
T ss_dssp             S
T ss_pred             c
Confidence            5

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=97.68  E-value=1.1e-05  Score=93.17  Aligned_cols=121  Identities=21%  Similarity=0.215  Sum_probs=95.1

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      +|...+.||++.|=+|.+|++.+ |. |+||++-. .++...-...++...|++ ...+++||++.+.-+...+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk-~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVK-QDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEec-cCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68889999999999999999764 44 88898743 333334334444455666 6667899999998877777778999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      =+|+. .+|++.|... .-+...+-+.|+-||+.||.-||..||+|+
T Consensus       100 Rqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHG  144 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHG  144 (1431)
T ss_pred             HHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            99994 8999988653 446677888899999999999999999996

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.61  E-value=0.0002  Score=77.75  Aligned_cols=107  Identities=15%  Similarity=0.208  Sum_probs=80.9

Q ss_pred             EEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----CCEEEEEEeccCC-CC
Q 011617          368 GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHP-GS  442 (481)
Q Consensus       368 G~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----~d~lyLVmEy~~G-GS  442 (481)
                      .+.|++....+|..|++|.+....+...     .+...-+++++++.|.|||++.++|..    +..+++|++|.++ ++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            4679999999999999999843221111     112234678899999999999999873    4569999999986 47


Q ss_pred             HHHHHHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011617          443 INRYVRE--------------HCRDITESIVRNFTRHILNGLAYLHSTNTI  479 (481)
Q Consensus       443 L~~lL~~--------------~~~~Lse~~I~~I~~QIl~GL~YLHskgII  479 (481)
                      |.++.-.              .+...+|..++.|+.||..||.++|..|+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLA  415 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLA  415 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCce
Confidence            8776421              123467999999999999999999998863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.59  E-value=5.1e-06  Score=92.35  Aligned_cols=126  Identities=25%  Similarity=0.442  Sum_probs=103.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCC-CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  430 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~t-g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~  430 (481)
                      ...|.+.+.||+|+|+.|-+.....+ ...+|+|.+...   .+.....+.+..|+.+-+.+. |.|++.+++.....+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~---~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIP---PKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCC---CCccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            44677788899999999998886443 345777766532   244555667777888888887 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccC
Q 011617          431 LYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH-STNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL-~~~~~~Lse~~I~~I~~QIl~GL~YLH-skgIIHR  481 (481)
                      .++++||..|+++.+.+ ......+.......++.|+..||.|+| ..++.||
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~  148 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHR  148 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccC
Confidence            99999999999999988 544336888899999999999999999 9999997

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.51  E-value=0.00051  Score=66.34  Aligned_cols=111  Identities=18%  Similarity=0.252  Sum_probs=78.2

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCC---CCCcHH-HHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAE-CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~---d~~s~e-~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVm  435 (481)
                      ..|++|+-+.||.+.+.  |..+.+|. ++.+.   ...+.. ...+..+|.++|.++.--.|..-+=++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            45789999999999774  33455553 22111   111111 2234677999999987666655555667778889999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       436 Ey~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||++|-.|.+++...        ...+++.+-.-+.-||.+||||+
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHG  116 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHG  116 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecC
Confidence            999988888888653        25677788888999999999995

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.40  E-value=0.0032  Score=63.56  Aligned_cols=79  Identities=14%  Similarity=0.224  Sum_probs=58.7

Q ss_pred             HHHHHHHHhhCCCCCe--eeeeeEEEe-----CCEEEEEEeccCCC-CHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH
Q 011617          403 LEQEIKVLGHLKHENI--VQYYGSEVV-----DDHLYIYLEYVHPG-SINRYVREH-CRDITESIVRNFTRHILNGLAYL  473 (481)
Q Consensus       403 l~~EI~iL~~L~HPNI--VqL~g~f~~-----~d~lyLVmEy~~GG-SL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YL  473 (481)
                      +.+|...+..|..-+|  ...+.+++.     ...-+||||++++. +|.+++... .....+.....++.+|+..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            6678888887753333  344444433     23578999999876 899998642 24456778889999999999999


Q ss_pred             HHCCCccC
Q 011617          474 HSTNTIHR  481 (481)
Q Consensus       474 HskgIIHR  481 (481)
                      |++||+|+
T Consensus       155 H~~Gi~Hg  162 (268)
T PRK15123        155 HAAGINHR  162 (268)
T ss_pred             HHCcCccC
Confidence            99999996

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.35  E-value=8.1e-05  Score=81.15  Aligned_cols=127  Identities=25%  Similarity=0.308  Sum_probs=101.2

Q ss_pred             CCCCCCeEEeEEecc--CCcEEEEEEEE--CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeE
Q 011617          350 SPKKSQWQKGKLIGR--GTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGS  424 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~--GtFG~VYla~d--k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~  424 (481)
                      ......+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.........   +.-.+|+...++++ |+|.++.+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~---~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS---KRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc---ccccchhhcccccCccccccccCcc
Confidence            344566778899999  99999999988  8889999999754322111111   12234666666665 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHHCCCcc
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----GLAYLHSTNTIH  480 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~----GL~YLHskgIIH  480 (481)
                      ++..+.+||-+|+| +.+|..+...-+.-+.+..++.++.+...    ||.++|..+|+|
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~  245 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVH  245 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccc
Confidence            99999999999999 58998888776566889999999999999    999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.33  E-value=0.00029  Score=76.53  Aligned_cols=71  Identities=28%  Similarity=0.502  Sum_probs=64.6

Q ss_pred             HhhCCCCCeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-cc
Q 011617          410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-IH  480 (481)
Q Consensus       410 L~~L~HPNIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgI-IH  480 (481)
                      |+.+.|.|+.+++|.+.++..+++|.+||..|+|.+.+......+++-....++++|+.||.|||.-.| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            457889999999999999999999999999999999998866788999999999999999999998765 44

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.31  E-value=0.00017  Score=78.63  Aligned_cols=128  Identities=26%  Similarity=0.167  Sum_probs=98.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEe
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~  427 (481)
                      .....+|..+..||.|.|+.|+.+..+ .++..|++|.+....  ....+.+.. ..|+.+...+ .|.+++.++..+..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcc-hhhhhHhhHhhcccccCCCCCCccc
Confidence            344568899999999999999988755 677889999875321  111222222 2355555555 48999999999998


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++.||-.|||+++++...+.. ...+.+...+.++.|++.++.|+|++.++|+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~  390 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHL  390 (524)
T ss_pred             cccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence            9999999999999988776633 2558899999999999999999999999985

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.05  E-value=0.00038  Score=72.17  Aligned_cols=110  Identities=23%  Similarity=0.418  Sum_probs=74.5

Q ss_pred             EEEEEEECCCCcEEEEEEeec--CCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-----EEEEEEeccCCC
Q 011617          369 SVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPG  441 (481)
Q Consensus       369 ~VYla~dk~tg~~VAIK~Ik~--~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-----~lyLVmEy~~GG  441 (481)
                      .||++.+...|..|.--.+..  .++.....+..+.+   ..-|-++.|-|||+++.++.+..     ...+++|||.-|
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~v---FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg  157 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAV---FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG  157 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHH---HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence            467777666665554333321  11111222222222   22344557999999998887543     488899999999


Q ss_pred             CHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccC
Q 011617          442 SINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST--NTIHR  481 (481)
Q Consensus       442 SL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHsk--gIIHR  481 (481)
                      +|..+|+.   +...+....+++|+.||+.||.|||..  -|||.
T Consensus       158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            99999975   235688999999999999999999986  47763

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.00  E-value=0.0015  Score=62.60  Aligned_cols=105  Identities=18%  Similarity=0.222  Sum_probs=65.2

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCCC------------C---------CcHHHHHHHHHHHHHHhhCCCC--CeeeeeeEE
Q 011617          369 SVYIGTNRETGASCAIKEVDIIPDD------------P---------KSAECIKQLEQEIKVLGHLKHE--NIVQYYGSE  425 (481)
Q Consensus       369 ~VYla~dk~tg~~VAIK~Ik~~~~d------------~---------~s~e~~k~l~~EI~iL~~L~HP--NIVqL~g~f  425 (481)
                      .||.|... .|..+|||+.+.....            .         .......+.++|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48988864 4778999998643110            0         1122234678899999999865  566776542


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCccC
Q 011617          426 VVDDHLYIYLEYVH--PGSINRYVREHCRDITESIVRNFTRHILNGLAY-LHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~--GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~Y-LHskgIIHR  481 (481)
                          .-+|||||++  |..+..+...   .+.......++.+++..+.. +|..||||+
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHG  131 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHG  131 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEES
T ss_pred             ----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceec
Confidence                3469999998  5556544432   22255667788888886665 579999996

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.82  E-value=0.014  Score=54.47  Aligned_cols=102  Identities=18%  Similarity=0.287  Sum_probs=76.7

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC--CeeeeeeEEEe---CCEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEVV---DDHLYI  433 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP--NIVqL~g~f~~---~d~lyL  433 (481)
                      ++.|+.|..+.||+.....  ..+++|....       ......+..|..+++.|...  .+.+++.....   ....++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            5789999999999999765  4789998641       14456777898888888533  35677664433   345899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      +|++++|..+..       .........++.+++..|.-||..
T Consensus        73 ~~~~i~g~~~~~-------~~~~~~~~~~~~~~~~~l~~lh~~  108 (239)
T PF01636_consen   73 LMEYIPGRPLDD-------ELSPEQRPELLRQLGRALAQLHQV  108 (239)
T ss_dssp             EEEEESSEEHHH-------TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred             EEEEeccccccc-------cccccccccccccchhhhhhcccc
Confidence            999999888876       466788888999999999999976

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.66  E-value=0.0041  Score=63.36  Aligned_cols=115  Identities=18%  Similarity=0.196  Sum_probs=80.0

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC---------------CCCc--HHHHHHHHHHHHHHhhCCCC--
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------DPKS--AECIKQLEQEIKVLGHLKHE--  416 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~---------------d~~s--~e~~k~l~~EI~iL~~L~HP--  416 (481)
                      +.++..||-|.-+.||.|.+. .|..+|||.=+....               ...+  .......++|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457899999999999999965 588899996542210               0111  11233467899999999754  


Q ss_pred             CeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       417 NIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .|.+.+++    +.-.+||||++|-.|...-      +....+..++..|+.-+.-+-..||||+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHG  226 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHG  226 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCcccc
Confidence            67777654    6778999999976665432      2345555666667777766668899995

>PLN02876 acyl-CoA dehydrogenase

Probab=96.57  E-value=0.01  Score=68.55  Aligned_cols=111  Identities=17%  Similarity=0.190  Sum_probs=76.4

Q ss_pred             eEEeccCCcEEEEEEEECCCC--cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCe--eeeeeEEEeC---CE
Q 011617          359 GKLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI--VQYYGSEVVD---DH  430 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg--~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNI--VqL~g~f~~~---d~  430 (481)
                      .+.|+.|.++.+|+......+  ..+++|+.....    .......+.+|+++|+.|. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~----~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK----LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc----cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            577899999999998765432  356666542111    0111246778999999996 6655  7777776654   46


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      .|+||||++|..+.+-   ....++..+...+..+++..|..||..
T Consensus       119 ~flVME~v~G~~~~~~---~~~~~~~~~r~~l~~~l~~~La~LH~v  161 (822)
T PLN02876        119 AFYIMEYLEGRIFVDP---KLPGVAPERRRAIYRATAKVLAALHSA  161 (822)
T ss_pred             ceEEEEecCCcccCCc---cCCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence            7899999986543321   112456777888999999999999974

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.56  E-value=0.0054  Score=59.10  Aligned_cols=82  Identities=27%  Similarity=0.388  Sum_probs=59.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCee-eeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIV-qL~g~f~~~d~ly  432 (481)
                      ......+.|++|++|.||+|.|.  |..+|+|+-+.  + .    ....++.|.++|..+.-.++. ++|.+    +..+
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~--d-s----~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~   88 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR--D-S----PRRNLEKEAKILEILAGEGVTPEVYFY----GEDF   88 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc--CceEEEEEecC--C-c----chhhHHHHHHHHHHhhhcCCCceEEEe----chhh
Confidence            34456788999999999999987  55889987542  1 1    235677899999998866654 55544    2334


Q ss_pred             EEEeccCCCCHHHHHH
Q 011617          433 IYLEYVHPGSINRYVR  448 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~  448 (481)
                      +.|||++|-.|.++..
T Consensus        89 i~me~i~G~~L~~~~~  104 (201)
T COG2112          89 IRMEYIDGRPLGKLEI  104 (201)
T ss_pred             hhhhhhcCcchhhhhh
Confidence            5699999889887764

>PRK09902 hypothetical protein; Provisional

Probab=96.32  E-value=0.036  Score=54.58  Aligned_cols=118  Identities=14%  Similarity=0.166  Sum_probs=76.1

Q ss_pred             eccCCcEEEEEEEECCCCcEEEEEEeec-CCCCCCcHHHHHHHHHHHHHHhhCCCCC--eeeeeeEEEe----CCEEEEE
Q 011617          362 IGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVV----DDHLYIY  434 (481)
Q Consensus       362 IG~GtFG~VYla~dk~tg~~VAIK~Ik~-~~~d~~s~e~~k~l~~EI~iL~~L~HPN--IVqL~g~f~~----~d~lyLV  434 (481)
                      -|+|+.+.|+.....  |+.+=+|.-.. .........-...+.+|+..|..|..-+  +.+.......    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            366888888876643  33566776531 0000000011246778998888885332  4444422222    2358999


Q ss_pred             EeccCC-CCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHP-GSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~G-GSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|-+.| -+|.+++.+.. ...++..-..++.+|+..|.-||+.|+.|+
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hg  152 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHG  152 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            998864 49999886531 345777778999999999999999999996

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.13  E-value=0.037  Score=53.12  Aligned_cols=79  Identities=15%  Similarity=0.190  Sum_probs=59.6

Q ss_pred             HHHHHHHHHhhCCCC--CeeeeeeEEEeC----CEEEEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 011617          402 QLEQEIKVLGHLKHE--NIVQYYGSEVVD----DHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLH  474 (481)
Q Consensus       402 ~l~~EI~iL~~L~HP--NIVqL~g~f~~~----d~lyLVmEy~~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH  474 (481)
                      ...+|...+..|..-  .+.+.+.+.+..    ...+||||++++. +|.+++... ..........++.+|+..+.-||
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHH
Confidence            456677777776533  344555555442    2468999999875 899999763 33777788899999999999999


Q ss_pred             HCCCccC
Q 011617          475 STNTIHR  481 (481)
Q Consensus       475 skgIIHR  481 (481)
                      ++||+|+
T Consensus       136 ~~gi~H~  142 (206)
T PF06293_consen  136 DAGIYHG  142 (206)
T ss_pred             HCcCCCC
Confidence            9999996

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK10593 hypothetical protein; Provisional

Probab=96.12  E-value=0.031  Score=56.83  Aligned_cols=107  Identities=15%  Similarity=0.120  Sum_probs=74.3

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC---CCeeeeeeEEEe---C
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEVV---D  428 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H---PNIVqL~g~f~~---~  428 (481)
                      .....+.||.|..+.||...... + .+.+|..+..    .   ....+..|...|+.|..   -.|.++++++..   .
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~----~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~   85 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSF----S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP   85 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC-C-CEEEEEeccc----c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence            34456789999999999886432 3 4666764310    0   11367778888888853   357788877654   3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      +.-+||||+++|+.+.+.      .........+..+++.+|+-||..
T Consensus        86 g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         86 GPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            668999999998877651      123445667778889999999974

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=95.86  E-value=0.007  Score=70.49  Aligned_cols=89  Identities=25%  Similarity=0.453  Sum_probs=60.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|..+|+|-.|+||.||+..++.+.+.+|+|+-+       +...++   +   +|.....+.+|          
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-------q~lilR---n---ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-------QNLILR---N---ILTFAGNPFVV----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcccc-------cchhhh---c---cccccCCccee----------
Confidence            345678999999999999999999999999999995322       111111   1   23333344333          


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                 ||...+++.- +.+....        +.+++|||..||+||
T Consensus       136 -----------gDc~tllk~~-g~lPvdm--------vla~Eylh~ygivhr  167 (1205)
T KOG0606|consen  136 -----------GDCATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHR  167 (1205)
T ss_pred             -----------chhhhhcccC-CCCcchh--------hHHhHhhccCCeecC
Confidence                       6666666542 4443332        789999999999998

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=95.60  E-value=0.079  Score=51.85  Aligned_cols=101  Identities=14%  Similarity=0.109  Sum_probs=70.4

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC--eeeeeeEEEeCCEEEEEEec
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN--IVqL~g~f~~~d~lyLVmEy  437 (481)
                      ..||.|..+.||+..    +..+++|....    ...   ...+.+|.+++..+..-+  +.+.+++....+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~----~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNP----GFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCC----CCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            578999999999742    44577787642    111   234677999998886433  46778877778888999999


Q ss_pred             cCCCC-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          438 VHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       438 ~~GGS-L~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      ++|.. +...+.     ........++.+++..|.-||..
T Consensus        76 i~G~~~~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~  110 (226)
T TIGR02172        76 IVGKRSFSRIIS-----DNPSRLEEIAKIFAEMAKKLHST  110 (226)
T ss_pred             cCCccchhhhhc-----CCHHHHHHHHHHHHHHHHHHhCC
Confidence            99763 433332     23445556788888888889974

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.25  E-value=0.52  Score=46.22  Aligned_cols=112  Identities=18%  Similarity=0.253  Sum_probs=72.7

Q ss_pred             CCCeEEeEEeccCCc-EEEEEEEECCCCcEEEEEEeecCC---CC-------CCcH------HHHHHHHHHHHHHhhC--
Q 011617          353 KSQWQKGKLIGRGTF-GSVYIGTNRETGASCAIKEVDIIP---DD-------PKSA------ECIKQLEQEIKVLGHL--  413 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtF-G~VYla~dk~tg~~VAIK~Ik~~~---~d-------~~s~------e~~k~l~~EI~iL~~L--  413 (481)
                      ...++.++.||.|.- |.||+++..  |+.||+|+.+...   .+       ....      ....-|..|-+....|  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            378999999999999 999999865  7799999943211   00       0000      1223456676655544  


Q ss_pred             -CCCCe--eeeeeEEEeCC------------------EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 011617          414 -KHENI--VQYYGSEVVDD------------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY  472 (481)
Q Consensus       414 -~HPNI--VqL~g~f~~~d------------------~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~Y  472 (481)
                       .+.++  |+++|++.-..                  ...||.||+....          .+....    +.+|++-|..
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~  179 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKI  179 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHH
Confidence             56666  99999974321                  1467888776333          122333    4567778889


Q ss_pred             HHHCCCcc
Q 011617          473 LHSTNTIH  480 (481)
Q Consensus       473 LHskgIIH  480 (481)
                      +|..||+=
T Consensus       180 ~~k~gI~~  187 (207)
T PF13095_consen  180 LHKLGIVP  187 (207)
T ss_pred             HHHCCeee
Confidence            99999863

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.58  E-value=0.19  Score=48.67  Aligned_cols=98  Identities=16%  Similarity=0.136  Sum_probs=65.6

Q ss_pred             eccCCc-EEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          362 IGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       362 IG~GtF-G~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      |-.|.. ..||+....  +..+.+|+....   .     ...+..|+++++.+. +--+.+++++....+.-+||||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~---~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSG---P-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCC---c-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            444555 788988643  356777865421   0     234567888888774 3446688887777677899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      |..|.....       ......++.++...|.-||..
T Consensus        76 G~~l~~~~~-------~~~~~~~~~~l~~~l~~lH~i  105 (244)
T cd05150          76 GVPAAALWE-------ELEPERLVDALAEALRRLHAL  105 (244)
T ss_pred             CccHhHhhc-------ccCHHHHHHHHHHHHHHHhcC
Confidence            878764431       112235778888888888875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=94.32  E-value=0.24  Score=50.16  Aligned_cols=116  Identities=11%  Similarity=0.116  Sum_probs=72.4

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc-------------------HHHHHHHHHHHHHHhhCC--CCC
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-------------------AECIKQLEQEIKVLGHLK--HEN  417 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s-------------------~e~~k~l~~EI~iL~~L~--HPN  417 (481)
                      ...|..|.-+.||+|.. .++..+|+|+++......+.                   .....+...|+.-|+.+.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44778899999999985 45788999999743221111                   111223456777777764  344


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      +.+-+++.    .-.|||||+... .-.=.|++  -.+...++..+..+++++|.-|-. .++||.
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg  191 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHG  191 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccc
Confidence            55555543    246999999422 11111222  233444677888889999988866 899995

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=94.30  E-value=0.0049  Score=68.76  Aligned_cols=119  Identities=18%  Similarity=0.087  Sum_probs=84.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC-eeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN-IVqL~g~f~~~d~  430 (481)
                      ..+.|.....+++|+++++|+.+...+...+ .+.+...          ..+.-++++|.+++||| ++.+++-+..++.
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            3345556677889999999998876655544 6665421          23445888999999999 8888888888999


Q ss_pred             EEEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|.|+++.++ +-..........+.+..+..+.+.-+++|+|||+---+||
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~  360 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHR  360 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCc
Confidence            99999999877 2221111112346667777888888999999998644443

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.29  E-value=0.12  Score=57.34  Aligned_cols=29  Identities=17%  Similarity=0.222  Sum_probs=25.5

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEee
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD  388 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik  388 (481)
                      .+.||.-..|+||+|..+. |+.||||+-+
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~  194 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQH  194 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecC
Confidence            4678999999999999876 9999999875

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.98  E-value=0.16  Score=56.04  Aligned_cols=28  Identities=18%  Similarity=0.215  Sum_probs=25.2

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEee
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVD  388 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik  388 (481)
                      +-|+.++-|+||.|+.+. |+.||||+.+
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqr  158 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQR  158 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecC
Confidence            678999999999999765 9999999985

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=93.73  E-value=0.63  Score=46.32  Aligned_cols=116  Identities=15%  Similarity=0.190  Sum_probs=66.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHH------HHHHHHHHhhCCC---CCeeeeee
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKH---ENIVQYYG  423 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~------l~~EI~iL~~L~H---PNIVqL~g  423 (481)
                      ..+|...+++-......|.+-..  .|+.+.+|..+...  ...+.....      ..+++..+..+..   -.++.++-
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            35777778877777666666553  46788889765311  111111111      1233333333332   22333222


Q ss_pred             EEE-----eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEV-----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~-----~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+     .....+|+|||++|..|.++..     +.+    .+...|+.+|.-||+.|++|+
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HG  159 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHG  159 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccC
Confidence            222     1234678999999988876642     222    244567788999999999995

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=92.94  E-value=0.92  Score=44.00  Aligned_cols=113  Identities=19%  Similarity=0.277  Sum_probs=73.2

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC-----------CcHHHHHHHHHHHHHHhhCC------CCCeeee
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQEIKVLGHLK------HENIVQY  421 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~-----------~s~e~~k~l~~EI~iL~~L~------HPNIVqL  421 (481)
                      ...||+|+.-.||..-+   ....+||++.......           ......++..+|+.....+.      +..|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            46789999999996432   3447889886432000           00112355666776666665      7789999


Q ss_pred             eeEEEeCCEEEEEEeccCC------CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011617          422 YGSEVVDDHLYIYLEYVHP------GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH  480 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~G------GSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIH  480 (481)
                      ||+.+++.-+-+|+|.+..      -+|.++++.  +.+++ .+...+.   .=.+||-+++|+.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~---~f~~~l~~~~Iv~  141 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALD---EFKRYLLDHHIVI  141 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHH---HHHHHHHHcCCee
Confidence            9999999999999998742      368888854  44666 4444433   3445666666654

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=92.68  E-value=1.3  Score=47.55  Aligned_cols=88  Identities=15%  Similarity=0.143  Sum_probs=56.8

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCC-CCCCc-HHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKS-AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~-~d~~s-~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+.||.|.++.||.+.+...++.+.||.-.... ..... .-...+...|.+.|..+.   -..+.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            467899999999999986433579999753110 00111 122345666777777763   3467788766  4456789


Q ss_pred             EEeccCCCC-HHHHHH
Q 011617          434 YLEYVHPGS-INRYVR  448 (481)
Q Consensus       434 VmEy~~GGS-L~~lL~  448 (481)
                      ||||+++.. +.+.+.
T Consensus       109 VME~L~~~~~lr~~Ll  124 (401)
T PRK09550        109 VMEDLSDHKILRKGLI  124 (401)
T ss_pred             EEecCCCccHHHHHHh
Confidence            999998654 444443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=92.23  E-value=0.014  Score=68.09  Aligned_cols=126  Identities=15%  Similarity=0.172  Sum_probs=93.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .+.+.+.+-+-+|.|+.++.+.-..+|-..++|+..+..  .......+.+..+-.++-...+|-++.....+......+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap--~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAP--KIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccch--hhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            456777888899999999999888888777777664321  111111223333434444455677777766677778899


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+|+|+.+++|...|+.- +...++-.+.++..+..+++|||...++||
T Consensus       881 L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~  928 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHR  928 (1205)
T ss_pred             hhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcc
Confidence            999999999999999774 678888889999999999999999988886

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=91.77  E-value=0.68  Score=49.68  Aligned_cols=119  Identities=18%  Similarity=0.146  Sum_probs=73.0

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCC----CC----------------CC-cHHHHHHHHHHHHHHhhCCCC
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DD----------------PK-SAECIKQLEQEIKVLGHLKHE  416 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~----~d----------------~~-s~e~~k~l~~EI~iL~~L~HP  416 (481)
                      +--+|..|.-+.||.+.. .+|..+|||+++...    +.                .. .+-..-+.+.|++-|..|..-
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            445677888999999884 568889999986321    10                00 111223556788888888755


Q ss_pred             CeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcc
Q 011617          417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIH  480 (481)
Q Consensus       417 NIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH-skgIIH  480 (481)
                      .|..---++. . .-.|||+|+. .+=.-.-+...-.++...+..+-.|++.-|.-|- ..++||
T Consensus       227 GIP~PePIlL-k-~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVH  288 (520)
T KOG2270|consen  227 GIPCPEPILL-K-NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVH  288 (520)
T ss_pred             CCCCCCceee-e-cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceec
Confidence            5432222211 2 2368999994 3322211112355777788888888888888774 457777

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=91.52  E-value=0.041  Score=59.99  Aligned_cols=74  Identities=23%  Similarity=0.476  Sum_probs=60.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ......+..+..+|.|+||.|+-+.+..++..+|||.|.+.    ..........+|..-+.++.|++|+.++..|..
T Consensus        45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk----n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLK----NREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhccccccccccccCccccCCccccccchhhHHHHhccc----chhhhhhhhhccccchhhhcccchhhheeceec
Confidence            34557788999999999999999999888889999998642    233344567778889999999999999887764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=91.50  E-value=1  Score=43.09  Aligned_cols=100  Identities=18%  Similarity=0.171  Sum_probs=60.5

Q ss_pred             eEEeccCCcEEEEEEEECC-CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeCCEEEEEEe
Q 011617          359 GKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~-tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~d~lyLVmE  436 (481)
                      .+.|..|-...||++.... .++.|.+|+.....      ...-...+|+.++..+.. .-+.++++.+.  +  .++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~------~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT------ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc------cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence            4567778888999987543 35678888764211      111123468888888753 33455554432  2  47999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       437 y~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |++|..+....      +.   -..++.++++.|+-||...
T Consensus        73 ~i~G~~l~~~~------~~---~~~~~~~la~~l~~lH~~~  104 (235)
T cd05157          73 FIPGRTLEPED------LR---NPKIYRLIARELAKLHSIK  104 (235)
T ss_pred             eeCCCcCCHHH------cc---ChHHHHHHHHHHHHHhccc
Confidence            99976654221      10   1235667888888888653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=89.91  E-value=0.088  Score=57.52  Aligned_cols=119  Identities=19%  Similarity=0.213  Sum_probs=70.1

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeee-------E
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-------S  424 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g-------~  424 (481)
                      .+.+.+-+++..++.++...-...   .+.++-|..++     ..........+++-.+....|-+...+.+       .
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~-----d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~  319 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV-----DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES  319 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhc-----cchhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence            344555566666666654442222   22333333221     12122233444555555544444333333       1


Q ss_pred             EE-----eCCEEEEEEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EV-----VDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~-----~~d~lyLVmEy~~GGSL~~lL~~~--~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.     ...++||.|++|...+|.+||...  ....+......++.||+.|++|   ++.|||
T Consensus       320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihr  380 (516)
T KOG1033|consen  320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHR  380 (516)
T ss_pred             ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhh
Confidence            11     123699999999999999999642  2346778889999999999999   888886

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=87.99  E-value=1.7  Score=44.47  Aligned_cols=95  Identities=20%  Similarity=0.158  Sum_probs=55.9

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEEE
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~ly  432 (481)
                      .+..+.|+.|....+|...  .+++.+.+|+-...        ....+..|..-|+.|.   --.|.+.+++...++.-|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            4567788999999999877  56778899976521        1134566777777663   456788898888777789


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS  475 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs  475 (481)
                      |||||++.+..        .   .    .-...+..+|+-||.
T Consensus        89 Llle~l~~~~~--------~---~----~~~~~lg~~LA~LH~  116 (288)
T PF03881_consen   89 LLLEFLEMGSP--------S---P----PDWEELGRQLAALHQ  116 (288)
T ss_dssp             EEEE-------------------C----CHHHHHHHHHHHHHH
T ss_pred             EEEEeecCCCC--------C---c----hhHHHHHHHHHHHhh
Confidence            99999974411        0   0    112446677888998

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=87.85  E-value=1.9  Score=51.70  Aligned_cols=82  Identities=24%  Similarity=0.358  Sum_probs=64.4

Q ss_pred             HHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE----EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 011617          398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL  473 (481)
Q Consensus       398 e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~----lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YL  473 (481)
                      ..+...+.|+..+.++.|.|++.++.+-.....    +.+.-|+|...++...++.. +.+....++.+..++++||+|+
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHH
Confidence            334455668888999999999999988654432    33445788888998888764 7788999999999999999999


Q ss_pred             HHCCCcc
Q 011617          474 HSTNTIH  480 (481)
Q Consensus       474 HskgIIH  480 (481)
                      |.....|
T Consensus       303 h~~~l~~  309 (1351)
T KOG1035|consen  303 HSLSLEH  309 (1351)
T ss_pred             HHhccce
Confidence            9986554

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=87.70  E-value=1.3  Score=42.87  Aligned_cols=97  Identities=11%  Similarity=0.121  Sum_probs=59.1

Q ss_pred             EEeccCCcE-EEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC---CeeeeeeEEEeC---CEEE
Q 011617          360 KLIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE---NIVQYYGSEVVD---DHLY  432 (481)
Q Consensus       360 k~IG~GtFG-~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP---NIVqL~g~f~~~---d~ly  432 (481)
                      +.|+.|+.. .||+..     ..+.+|....       ......+.+|.++|..|...   -+.++++.....   ...|
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~   70 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW   70 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence            456766665 588652     2466675431       11234678899999887532   344555443322   2358


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      ++||+++|.++....      +.  ....+..++++.|.-||..
T Consensus        71 ~l~~~i~G~~l~~~~------~~--~~~~l~~~la~~l~~LH~i  106 (235)
T cd05155          71 SVYRWLEGETATAAA------LS--DPSEFAEDLADFLAALRQI  106 (235)
T ss_pred             EEEEeecCCCCCccc------cC--CHHHHHHHHHHHHHHHhCC
Confidence            899999988875431      11  1225778888888889965

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=87.66  E-value=0.28  Score=43.49  Aligned_cols=45  Identities=16%  Similarity=0.284  Sum_probs=33.7

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH  412 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~  412 (481)
                      .+-||.|+.|+||+|..+. |+.||||+.+        ....+.+...+.+|+.
T Consensus        16 ~~PlasASiaQVh~a~l~~-g~~VaVKV~r--------P~i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKD-GEEVAVKVQR--------PGIEEQIEADLRILRR   60 (119)
T ss_pred             cchhhheehhhheeeeecc-cchhhhhhcc--------hHHHHHHHHHHHHHHH
Confidence            3568999999999999765 8999999876        2334555666666654

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=82.79  E-value=3  Score=41.75  Aligned_cols=99  Identities=18%  Similarity=0.186  Sum_probs=60.9

Q ss_pred             EEeccCCcEEEEEEEECC------CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC-eeeeeeEEEeCCEEE
Q 011617          360 KLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLY  432 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~------tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN-IVqL~g~f~~~d~ly  432 (481)
                      +.|..|--..||+.....      .++.+++|+.....      .......+|++++..+...+ ..++++++. +   .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFP-N---G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeC-C---C
Confidence            455567777899887543      25778888864211      11234566888888775333 345565543 2   3


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      +||||++|..+....      +.   -..++.+++..|..||...
T Consensus        74 ~v~e~i~G~~l~~~~------~~---~~~~~~~ia~~L~~lH~~~  109 (302)
T cd05156          74 RIEEFIPSRTLTTEE------LR---DPDISAEIARRMAKLHSIV  109 (302)
T ss_pred             chhheeCCCcCCHhH------cC---CcHHHHHHHHHHHHhhCCC
Confidence            589999876664321      00   1236778899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=81.52  E-value=0.52  Score=49.81  Aligned_cols=115  Identities=13%  Similarity=0.139  Sum_probs=71.5

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC---------------CCCcHHHHH--HHHHHHHHHhhCCC-C
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------DPKSAECIK--QLEQEIKVLGHLKH-E  416 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~---------------d~~s~e~~k--~l~~EI~iL~~L~H-P  416 (481)
                      -+.++..||-|.-+.||++-+. .|..+++|.=++...               ....+..+.  ....|...|+.|.. .
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4567899999999999999865 477788885432110               001111111  13458888887753 2


Q ss_pred             -CeeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          417 -NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       417 -NIVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       -|.+.++    .+.-++|||++.|-.|.+.-+-       ..+..+...++.-|.-|-.+|+||+
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHg  226 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHG  226 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceec
Confidence             2444443    4667899999988777654321       2233444455555667788999995

>PLN02756 S-methyl-5-thioribose kinase

Probab=81.25  E-value=15  Score=39.73  Aligned_cols=108  Identities=16%  Similarity=0.122  Sum_probs=63.0

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC--CCCcHHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~--d~~s~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+.||.|....||+..+.  +..++||.-.....  .........+...|...|+.+.   -..|.++|.++.  +.-+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3678899999999998863  45688886541111  0000011233334566666553   357888887655  5567


Q ss_pred             EEEeccCC--CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 011617          433 IYLEYVHP--GSINRYVREHCRDITESIVRNFTRHILNGLA  471 (481)
Q Consensus       433 LVmEy~~G--GSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~  471 (481)
                      |+|||+++  ..+.+-+-.  +.........+...++..|-
T Consensus       112 lvME~L~~~~~ilr~~Ll~--G~~~p~~a~~ig~~la~tLf  150 (418)
T PLN02756        112 IGMRYLEPPHIILRKGLIA--GIEYPLLAEHMSDYMAKTLF  150 (418)
T ss_pred             EEEeecCCcceehhhhhcc--CCCCHHHHHHHHHHHHHHHh
Confidence            88999976  245554432  22335555556555655544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=80.77  E-value=7.7  Score=41.32  Aligned_cols=87  Identities=10%  Similarity=0.049  Sum_probs=52.3

Q ss_pred             EeccCCcEEEEEEEECCCCcEEEEEEeecCCC--CCCcHHHHHHHHHHHHHHhhCC--CC-CeeeeeeEEEeCCEEEEEE
Q 011617          361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYIYL  435 (481)
Q Consensus       361 ~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~--d~~s~e~~k~l~~EI~iL~~L~--HP-NIVqL~g~f~~~d~lyLVm  435 (481)
                      .||.|...-||++.+...++.++||.-.....  .....-...+...|...|+...  -| .+.++|.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            57999999999999754336799997532110  1111122334455777776653  23 5666654  3555667999


Q ss_pred             eccCCC-CHHHHHHH
Q 011617          436 EYVHPG-SINRYVRE  449 (481)
Q Consensus       436 Ey~~GG-SL~~lL~~  449 (481)
                      |++... .|.+.|-+
T Consensus        80 EdL~~~~ilR~~Li~   94 (370)
T TIGR01767        80 EDLSHHKIARKGLIE   94 (370)
T ss_pred             hhCccchHHHHHHHc
Confidence            999654 45455533

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=80.59  E-value=3  Score=41.39  Aligned_cols=98  Identities=18%  Similarity=0.175  Sum_probs=61.3

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC--Ceeeeee------EEEeC
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYG------SEVVD  428 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP--NIVqL~g------~f~~~  428 (481)
                      ...+.|..|.-..+|+....  +..+++|+...     ..   ...+..|+.++..|.+-  .+.+++.      +....
T Consensus        17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEK-----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             hheecccCccccceEEEEeC--CCcEEEEEcCC-----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            34567777887899988643  34688887642     11   13455677777777432  2445443      22345


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      +..+++|||++|..+..        .+.    ..+.++.+.|+-||..
T Consensus        87 ~~~~~l~~~i~G~~~~~--------~~~----~~~~~lg~~La~lH~~  122 (296)
T cd05153          87 GKPAALVEFLAGEHLTR--------PTA----AHCRQIGEALARLHLA  122 (296)
T ss_pred             CceEEEEEeCCCCCCCC--------CCH----HHHHHHHHHHHHHHHH
Confidence            66899999999776532        122    2456777888888854

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=80.57  E-value=3.1  Score=39.71  Aligned_cols=68  Identities=21%  Similarity=0.192  Sum_probs=51.5

Q ss_pred             HHHHHHHhhCCC-CCeeeeeeEEEeCCEEEEEEeccCCCCHHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          404 EQEIKVLGHLKH-ENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       404 ~~EI~iL~~L~H-PNIVqL~g~f~~~d~lyLVmEy~~GGSL~~l---L~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      .+|.-+|+.+.+ +++.+++|+|-.    +++.||+..+++...   +.. .....+....+|+.+++..+.+|+..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            348888888876 699999999742    578899987766421   111 13467999999999999999999874

Proteins in this uncharacterised family are described as transmembrane proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	481
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		9e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-04
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-04
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-04

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 72/130 (55%), Gaps = 2/130 (1%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++ G L+G+G+F  VY   +  TG   AIK +D        A  +++++ E+K+  
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID--KKAMYKAGMVQRVQNEVKIHC 66
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH +I++ Y      +++Y+ LE  H G +NRY++   +  +E+  R+F   I+ G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 472 YLHSTNTIHR 481
           YLHS   +HR
Sbjct: 127 YLHSHGILHR 136

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 66/120 (55%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G++GSVY   ++ETG   AIK+V +  D       ++++ +EI ++      ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKY 89
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS   +  L+I +EY   GS++  +R   + +TE  +    +  L GL YLH    IHR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +LHS
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 476 TNTIHR 481
              IHR
Sbjct: 136 KRIIHR 141

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ETGA  A K ++      KS E ++    EI++L    H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +LHS
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 476 TNTIHR 481
              IHR
Sbjct: 128 KRIIHR 133

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 14/130 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENI 418
           +L+G GT+G VY G + +TG   AIK +D+  D+       ++++QEI +L  +  H NI
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNI 83
Query: 419 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
             YYG+ +      +DD L++ +E+   GS+   ++      + E  +    R IL GL+
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 472 YLHSTNTIHR 481
           +LH    IHR
Sbjct: 144 HLHQHKVIHR 153

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 342 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
            +    R  L  L +LHS   IHR
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHR 140

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 342 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
            +    R  L  L +LHS   IHR
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHR 140

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 342 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 62
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 63  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 116
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
            +    R  L  L +LHS   IHR
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHR 140

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 342 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 5   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 63
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 64  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 117
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
            +    R  L  L +LHS   IHR
Sbjct: 118 QIAAVCRECLQALEFLHSNQVIHR 141

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 342 HIMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
            I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++    PK  
Sbjct: 5   EILEKLRIIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKE 63
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
             I     EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E 
Sbjct: 64  LIIN----EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EG 117
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
            +    R  L  L +LHS   IHR
Sbjct: 118 QIAAVCRECLQALEFLHSNQVIHR 141

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 476 TNTIHR 481
              IHR
Sbjct: 154 NKIIHR 159

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 476 TNTIHR 481
              IHR
Sbjct: 154 NKIIHR 159

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 476 TNTIHR 481
              IHR
Sbjct: 154 NKIIHR 159

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 68/123 (55%), Gaps = 7/123 (5%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+GT+G VY G +       AIKE   IP+  + +   + L +EI +  HLKH+NIVQ
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE---IPE--RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNT 478
           Y GS   +  + I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 479 IHR 481
           +HR
Sbjct: 144 VHR 146

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 68/123 (55%), Gaps = 7/123 (5%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+GT+G VY G +       AIKE   IP+  + +   + L +EI +  HLKH+NIVQ
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKE---IPE--RDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNT 478
           Y GS   +  + I++E V  GS++  +R     +   E  +  +T+ IL GL YLH    
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 479 IHR 481
           +HR
Sbjct: 130 VHR 132

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 472 YLHSTNTIHR 481
           + HS N +HR
Sbjct: 116 FCHSRNVLHR 125

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA       +EI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 472 YLHSTNTIHR 481
           + HS N +HR
Sbjct: 116 FCHSRNVLHR 125

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 73/138 (52%), Gaps = 7/138 (5%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           M+   A P++  + K + IG+G+FG V+ G +  T    AIK +D+     ++ + I+ +
Sbjct: 13  MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDI 67
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
           +QEI VL       + +YYGS + D  L+I +EY+  GS    +     D  E+ +    
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATIL 125
Query: 464 RHILNGLAYLHSTNTIHR 481
           R IL GL YLHS   IHR
Sbjct: 126 REILKGLDYLHSEKKIHR 143

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 10/133 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           SQ+++ + +G GT+ +VY G N+ TG   A+KEV +  ++   +  I+    EI ++  L
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKEL 60
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILN 468
           KHENIV+ Y     ++ L +  E++    + +Y+         R +  ++V+ F   +L 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 469 GLAYLHSTNTIHR 481
           GLA+ H    +HR
Sbjct: 120 GLAFCHENKILHR 132

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 64/127 (50%), Gaps = 9/127 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K IGRG F  VY       G   A+K+V I  + D    A+CIK    EI +L  L H N
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 93
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRHILNGLAYLH 474
           +++YY S + D+ L I LE    G ++R +   ++  R I E  V  +   + + L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 475 STNTIHR 481
           S   +HR
Sbjct: 154 SRRVMHR 160

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIX 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 128

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 148

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS + D  L+I +EY+  GS    +     D  E+ +    R IL GL YLHS   IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 128

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 73/142 (51%), Gaps = 11/142 (7%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           MPH + +PS          G+++G+G FG     T+RETG    +KE  +I  D ++   
Sbjct: 2   MPHRIFRPS------DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQ-- 51
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
            +   +E+KV+  L+H N++++ G    D  L    EY+  G++   ++        S  
Sbjct: 52  -RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR 110
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
            +F + I +G+AYLHS N IHR
Sbjct: 111 VSFAKDIASGMAYLHSMNIIHR 132

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 116
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 117 GVVYLHGIGITHR 129

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 5/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           +P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI +
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 56
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
              L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 470 LAYLHSTNTIHR 481
           + YLH     HR
Sbjct: 116 VVYLHGIGITHR 127

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 63/120 (52%), Gaps = 6/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG V+ G +  T    AIK +D+     ++ + I+ ++QEI VL       + +Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YGS +    L+I +EY+  GS    +R    D  E  +    + IL GL YLHS   IHR
Sbjct: 87  YGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 144

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 213
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 84
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 143
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 144 ANALSYCHSKRVIHR 158

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G  G V +  NR T  + A+K VD+     ++ +C + +++EI 
Sbjct: 1   AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIC 56
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA 115
Query: 469 GLAYLHSTNTIHR 481
           G+ YLH     HR
Sbjct: 116 GVVYLHGIGITHR 128

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 84
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 143
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 144 ANALSYCHSKRVIHR 158

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 64/120 (53%), Gaps = 6/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G+FG VY G +  T    AIK +D+     ++ + I+ ++QEI VL       I +Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +GS +    L+I +EY+  GS    ++     + E+ +    R IL GL YLHS   IHR
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 140

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 75
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 134
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 135 ANALSYCHSKRVIHR 149

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 119 ANALSYCHSKRVIHR 133

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 123 ANALSYCHSKRVIHR 137

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 119 ANALSYCHSKRVIHR 133

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 119 ANALSYCHSKRVIHR 133

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 60
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 119
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 120 ANALSYCHSKRVIHR 134

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 60
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 119
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 120 ANALSYCHSKRVIHR 134

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 123 ANALSYCHSKRVIHR 137

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 61
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 121 ANALSYCHSKRVIHR 135

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 63
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 122
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 123 ANALSYCHSKRVIHR 137

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 136
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 194

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 61
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 121 ANALSYCHSKRVIHR 135

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 151

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 58
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 117
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 118 ANALSYCHSKRVIHR 132

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW       G+ +G+G FG+VY+   R++    A+K   +     + A    QL +E+
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQLRREV 63
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  R   E     +   + 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELA 122
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 123 NALSYCHSKRVIHR 136

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 149

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW       G+ +G+G FG+VY+   R++    A+K   +     + A    QL +E+
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQLRREV 63
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  R   E     +   + 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELA 122
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 123 NALSYCHSKRVIHR 136

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 61
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 121 ANALSYCHSKRVIHR 135

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 61
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 120
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 121 ANALSYCHSKRVIHR 135

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 3/120 (2%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 140

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T R +G   A+K++D+     +  +  + L  E+ ++   +HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 86
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+ LH+   IHR
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQGVIHR 144

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V I T + TG   A+K++D+     +  +  + L  E+ ++    H+N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V D L++ +E++  G++   V  H R + E  +      +L  L+YLH+   IHR
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 165

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 3/120 (2%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY   +       AIK++       +S E  + + +E++ L  L+H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 63
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G + + +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITEL 122
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 123 ANALSYCHSKRVIHR 137

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 8/138 (5%)
Query: 349 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           A   K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL
Sbjct: 2   AMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQL 59
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
            +E+++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYI 118
Query: 464 RHILNGLAYLHSTNTIHR 481
             + N L+Y HS   IHR
Sbjct: 119 TELANALSYCHSKRVIHR 136

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 119 NALSYCHSKRVIHR 132

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRRE 63
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G + + +++  +   E     +   +
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITEL 122
Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 123 ANALSYCHSKRVIHR 137

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 119 NALSYCHSKRVIHR 132

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 58
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 59  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 117
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 118 NALSYCHSKRVIHR 131

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 119 NALSYCHSKRVIHR 132

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 119 NALSYCHSKRVIHR 132

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 353 KSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K QW     + G+ +G+G FG+VY+   + +    A+K   +     + A    QL +E+
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKV--LFKAQLEKAGVEHQLRREV 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           ++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELA 118
Query: 468 NGLAYLHSTNTIHR 481
           N L+Y HS   IHR
Sbjct: 119 NALSYCHSKKVIHR 132

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G FG V++   R +G    IK ++      +S   ++Q+E EI+VL  L H NI++ 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 422 YGSEVVDDH--LYIYLEYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 476
           +  EV +D+  +YI +E    G +  R V    R   ++E  V    + ++N LAY HS 
Sbjct: 86  F--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 477 NTIHR 481
           + +H+
Sbjct: 144 HVVHK 148

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 355 QW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEI 61
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 120
Query: 470 LAYLHSTNTIHR 481
           L+Y HS   IHR
Sbjct: 121 LSYCHSKRVIHR 132

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 355 QW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEI 61
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 120
Query: 470 LAYLHSTNTIHR 481
           L+Y HS   IHR
Sbjct: 121 LSYCHSKRVIHR 132

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 4/136 (2%)
Query: 347 PSASPKKSQ-WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           P  SP+  + +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +
Sbjct: 2   PLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIR 58
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           EI +L  L H NIV+       ++ LY+  E++H              I   +++++   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 466 ILNGLAYLHSTNTIHR 481
           +L GLA+ HS   +HR
Sbjct: 119 LLQGLAFCHSHRVLHR 134

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 355 QW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEI 64
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 123
Query: 470 LAYLHSTNTIHR 481
           L+Y HS   IHR
Sbjct: 124 LSYCHSKRVIHR 135

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 4/136 (2%)
Query: 347 PSASPKKSQ-WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           P  SP+  + +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +
Sbjct: 2   PLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIR 58
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           EI +L  L H NIV+       ++ LY+  E++H              I   +++++   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 466 ILNGLAYLHSTNTIHR 481
           +L GLA+ HS   +HR
Sbjct: 119 LLQGLAFCHSHRVLHR 134

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 355 QW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           QW     + G+ +G+G FG+VY+   +++    A+K   +     + A    QL +E+++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEI 64
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 123
Query: 470 LAYLHSTNTIHR 481
           L+Y HS   IHR
Sbjct: 124 LSYCHSKRVIHR 135

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   AIK +D    +P S   +++L +E+++
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRI 67
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R+  R I++ 
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 126
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 127 VQYCHQKRIVHR 138

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   AIK +D    +P S   +++L +E+++
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRI 64
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R+  R I++ 
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 123
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 124 VQYCHQKRIVHR 135

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H    +         I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 333 SSVTSAV--MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII 390
           +S+TSA    PHI            ++  K IG+G F  V +  +  TG   A+K +D  
Sbjct: 2   NSITSATDEQPHI----------GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKT 51
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
             +P S   +++L +E++++  L H NIV+ +     +  LY+ +EY   G +  Y+  H
Sbjct: 52  QLNPTS---LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 108
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            R + E   R   R I++ + Y H    +HR
Sbjct: 109 GR-MKEKEARAKFRQIVSAVQYCHQKYIVHR 138

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 476 TNTIHR 481
              +HR
Sbjct: 124 HRVLHR 129

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 476 TNTIHR 481
              +HR
Sbjct: 126 HRVLHR 131

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 476 TNTIHR 481
              +HR
Sbjct: 124 HRVLHR 129

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 476 TNTIHR 481
              +HR
Sbjct: 126 HRVLHR 131

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 476 TNTIHR 481
              +HR
Sbjct: 124 HRVLHR 129

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E+VH              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 476 TNTIHR 481
              +HR
Sbjct: 123 HRVLHR 128

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 476 TNTIHR 481
              +HR
Sbjct: 123 HRVLHR 128

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 476 TNTIHR 481
              +HR
Sbjct: 123 HRVLHR 128

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 476 TNTIHR 481
              +HR
Sbjct: 123 HRVLHR 128

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 355 QW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           QW     + G+ +G+G FG+VY+   ++     A+K   +     + A    QL +E+++
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKV--LFKAQLEKAGVEHQLRREVEI 58
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   + N 
Sbjct: 59  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANA 117
Query: 470 LAYLHSTNTIHR 481
           L+Y HS   IHR
Sbjct: 118 LSYCHSKRVIHR 129

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 23/151 (15%)
Query: 344 MEKPSASPK---KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKS 396
           M  P++ P    K   +K + +G G FG V    Y  TN  TG   A+K +         
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------K 52
Query: 397 AECIKQ----LEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREH 450
           A+C  Q     +QEI +L  L HE+I++Y G   +  +  L + +EYV  GS+  Y+  H
Sbjct: 53  ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH 112
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              + + ++  F + I  G+AYLHS + IHR
Sbjct: 113 SIGLAQLLL--FAQQICEGMAYLHSQHYIHR 141

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y++ H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 476 TNTIHR 481
              IHR
Sbjct: 136 KRYIHR 141

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 347 PSASPKKSQWQKGKL-----IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA 397
           P  S   +Q+++  L     +G+G FGSV    Y      TG   A+K++        + 
Sbjct: 16  PRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTE 70
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
           E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I 
Sbjct: 71  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
              +  +T  I  G+ YL +   IHR
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHR 156

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI----------TESIVRNFTRH 465
            +IV+   +   D  LY+  E++    +       C +I          +E++  ++ R 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL-------CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 466 ILNGLAYLHSTNTIHR 481
           IL  L Y H  N IHR
Sbjct: 139 ILEALRYCHDNNIIHR 154

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 347 PSASPKKSQWQKGKL-----IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA 397
           P  S   +Q+++  L     +G+G FGSV    Y      TG   A+K++        + 
Sbjct: 16  PRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTE 70
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
           E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I 
Sbjct: 71  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 130
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
              +  +T  I  G+ YL +   IHR
Sbjct: 131 HIKLLQYTSQICKGMEYLGTKRYIHR 156

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 476 TNTIHR 481
              IHR
Sbjct: 164 KRYIHR 169

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 476 TNTIHR 481
              IHR
Sbjct: 138 KRYIHR 143

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 3/136 (2%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           K     K   +  G  +G GTFG V IG ++ TG   A+K ++      +S + + ++++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           EI+ L   +H +I++ Y         ++ +EYV  G +  Y+ +H R + E   R   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQ 119
Query: 466 ILNGLAYLHSTNTIHR 481
           IL+ + Y H    +HR
Sbjct: 120 ILSAVDYCHRHMVVHR 135

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 23/151 (15%)
Query: 344 MEKPSASPK---KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKS 396
           M  P++ P    K   +K + +G G FG V    Y  TN  TG   A+K +         
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------K 52
Query: 397 AECIKQ----LEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREH 450
           A+C  Q     +QEI +L  L HE+I++Y G   +  +  L + +EYV  GS+  Y+  H
Sbjct: 53  ADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH 112
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              + + ++  F + I  G+AYLH+ + IHR
Sbjct: 113 SIGLAQLLL--FAQQICEGMAYLHAQHYIHR 141

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 476 TNTIHR 481
              IHR
Sbjct: 140 KRYIHR 145

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 476 TNTIHR 481
              IHR
Sbjct: 137 KRYIHR 142

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 476 TNTIHR 481
              IHR
Sbjct: 136 KRYIHR 141

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 476 TNTIHR 481
              IHR
Sbjct: 139 KRYIHR 144

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 67/136 (49%), Gaps = 3/136 (2%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           K     K   +  G  +G GTFG V IG ++ TG   A+K ++      +S + + ++++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           EI+ L   +H +I++ Y         ++ +EYV  G +  Y+ +H R + E   R   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQ 119
Query: 466 ILNGLAYLHSTNTIHR 481
           IL+ + Y H    +HR
Sbjct: 120 ILSAVDYCHRHMVVHR 135

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 476 TNTIHR 481
              IHR
Sbjct: 133 KRYIHR 138

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 476 TNTIHR 481
              IHR
Sbjct: 132 KRYIHR 137

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 476 TNTIHR 481
              IHR
Sbjct: 131 KRYIHR 136

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 476 TNTIHR 481
              IHR
Sbjct: 133 KRYIHR 138

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 476 TNTIHR 481
              IHR
Sbjct: 133 KRYIHR 138

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GL++ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 3/129 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAY 472
            +IV+   +   D  LY+  E++    +   + +        +E++  ++ R IL  L Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 473 LHSTNTIHR 481
            H  N IHR
Sbjct: 148 CHDNNIIHR 156

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 418 IVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 476 TNTIHR 481
              IHR
Sbjct: 134 KRYIHR 139

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 353 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQL----E 404
           K   +K + +G G FG V    Y  TN  TG   A+K +           C  QL    +
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQ 59
Query: 405 QEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +EI++L  L HE+IV+Y G   +  +  + + +EYV  GS+  Y+  HC  + + ++  F
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 117
Query: 463 TRHILNGLAYLHSTNTIHR 481
            + I  G+AYLH+ + IHR
Sbjct: 118 AQQICEGMAYLHAQHYIHR 136

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 20/139 (14%)
Query: 353 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQL----E 404
           K   +K + +G G FG V    Y  TN  TG   A+K +           C  QL    +
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQ 58
Query: 405 QEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +EI++L  L HE+IV+Y G   +  +  + + +EYV  GS+  Y+  HC  + + ++  F
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 116
Query: 463 TRHILNGLAYLHSTNTIHR 481
            + I  G+AYLH+ + IHR
Sbjct: 117 AQQICEGMAYLHAQHYIHR 135

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G +G VY+G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 93
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 480
            G   ++   YI  EY+  G++  Y+RE  R ++T  ++      I + + YL   N IH
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 481 R 481
           R
Sbjct: 154 R 154

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 340 MPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
           M  +ME  S +P           ++ G+ +G+G FG+VY+   +++    A+K +     
Sbjct: 2   MQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI 61
Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
           + +  E   QL +EI++  HL H NI++ Y        +Y+ LEY   G + + +++ C 
Sbjct: 62  EKEGVE--HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC- 118
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
              E         + + L Y H    IHR
Sbjct: 119 TFDEQRTATIMEELADALMYCHGKKVIHR 147

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++  ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI----------TESIVRNFTRH 465
            +IV+   +   D  LY+  E++    +       C +I          +E++  ++ R 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL-------CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 466 ILNGLAYLHSTNTIHR 481
           IL  L Y H  N IHR
Sbjct: 139 ILEALRYCHDNNIIHR 154

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+ ++ +   D ++        +EI +L  L H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 476 TNTIHR 481
              +HR
Sbjct: 122 HRVLHR 127

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+ ++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +G+G FGSV    Y      TG   A+K++        + E ++  E+EI++L  L+H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 418 IVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           IV+Y G        +L + +E++  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 476 TNTIHR 481
              IHR
Sbjct: 136 KRYIHR 141

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 3/137 (2%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
           +K     K   +  G  +G GTFG V +G +  TG   A+K ++      +S + + ++ 
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIR 64
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
           +EI+ L   +H +I++ Y        +++ +EYV  G +  Y+ ++ R + E   R   +
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQ 123
Query: 465 HILNGLAYLHSTNTIHR 481
            IL+G+ Y H    +HR
Sbjct: 124 QILSGVDYCHRHMVVHR 140

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 3/139 (2%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           + E P        +  G+ +G+G FG+VY+   ++     A+K +     + +  E   Q
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQ 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           L +EI++  HL+H NI++ Y        +Y+ LE+   G + + +++H R   E     F
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATF 120
Query: 463 TRHILNGLAYLHSTNTIHR 481
              + + L Y H    IHR
Sbjct: 121 MEELADALHYCHERKVIHR 139

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/120 (25%), Positives = 61/120 (50%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+ G V +   + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y S +V + L++ +E++  G++   V +    + E  +      +L  LAYLH+   IHR
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHR 165

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 11/139 (7%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           S  +  ++  ++IG G    V            AIK +++     K    + +L +EI+ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQA 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------EHCRDIT-ESIVRNF 462
           +    H NIV YY S VV D L++ ++ +  GS+   ++      EH   +  ES +   
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 463 TRHILNGLAYLHSTNTIHR 481
            R +L GL YLH    IHR
Sbjct: 127 LREVLEGLEYLHKNGQIHR 145

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 3/120 (2%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G   +VY+  +       AIK + I P + +  E +K+ E+E+     L H+NIV  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE--ETLKRFEREVHNSSQLSHQNIVSM 76
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +  DD  Y+ +EY+   +++ Y+  H     ++ + NFT  IL+G+ + H    +HR
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI-NFTNQILDGIKHAHDMRIVHR 135

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 11/139 (7%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           S  +  ++  ++IG G    V            AIK +++     K    + +L +EI+ 
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQA 61
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------EHCRDIT-ESIVRNF 462
           +    H NIV YY S VV D L++ ++ +  GS+   ++      EH   +  ES +   
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 463 TRHILNGLAYLHSTNTIHR 481
            R +L GL YLH    IHR
Sbjct: 122 LREVLEGLEYLHKNGQIHR 140

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++     +         I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++     +         I   +++++   +L GLA+ HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 476 TNTIHR 481
              +HR
Sbjct: 124 HRVLHR 129

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E+V               I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++               I   +++++   +L GLA+ HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 476 TNTIHR 481
              +HR
Sbjct: 125 HRVLHR 130

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 69/126 (54%), Gaps = 10/126 (7%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           LIGRG++G VY+  ++ T  + AIK+V+ + +D    +C K++ +EI +L  LK + I++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDC-KRILREITILNRLKSDYIIR 89
Query: 421 YYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            Y   + D     D LYI LE +    + +  +     +TE  ++    ++L G  ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEEHIKTILYNLLLGENFIHE 147
Query: 476 TNTIHR 481
           +  IHR
Sbjct: 148 SGIIHR 153

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 22/137 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASC-----AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +G G FG V++    E    C      +  V  + D   +A   K   +E ++L +L+HE
Sbjct: 21  LGEGAFGKVFLA---ECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHE 75
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 464
           +IV++YG  V  D L +  EY+  G +N+++R H  D            +T+S + +  +
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 465 HILNGLAYLHSTNTIHR 481
            I  G+ YL S + +HR
Sbjct: 136 QIAAGMVYLASQHFVHR 152

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K++ +   D ++        +EI +L  L H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++               I   +++++   +L GLA+ HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 476 TNTIHR 481
              +HR
Sbjct: 123 HRVLHR 128

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 19/149 (12%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 400
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 88
Query: 401 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 452
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 89  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +E       R +L+G+ Y+H    +HR
Sbjct: 147 -FSEVDAARIIRQVLSGITYMHKNKIVHR 174

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 19/149 (12%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 400
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 87
Query: 401 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 452
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 88  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +E       R +L+G+ Y+H    +HR
Sbjct: 146 -FSEVDAARIIRQVLSGITYMHKNKIVHR 173

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A++   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A++   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +  L H NIV+ +     +  LY+ +EY   G +  Y+  H R + E   R   R I++ 
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 89
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 149 LHGKGIIHR 157

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 66
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 125
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 126 LHGKGIIHR 134

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 19/149 (12%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 400
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +        S   +
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQV 64
Query: 401 KQ------LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR 452
           KQ      L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R
Sbjct: 65  KQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +E       R +L+G+ Y+H    +HR
Sbjct: 123 -FSEVDAARIIRQVLSGITYMHKNKIVHR 150

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 91
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 150
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 151 LHGKGIIHR 159

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 146 LHGKGIIHR 154

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 65
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 124
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 125 LHGKGIIHR 133

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 89
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 149 LHGKGIIHR 157

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 146 LHGKGIIHR 154

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 146 LHGKGIIHR 154

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 3/120 (2%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG+VY+   ++     A+K +     + +  E   QL +EI++  HL+H NI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILRM 79
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y        +Y+ LE+   G + + +++H R   E     F   + + L Y H    IHR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHR 138

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 63
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 122
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 123 LHGKGIIHR 131

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 88
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 148 LHGKGIIHR 156

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 64
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 123
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 124 LHGKGIIHR 132

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 4/128 (3%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            +++   L+G G++G V    N++TG   AIK+  +  DD K  + I    +EIK+L  L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAM--REIKLLKQL 81
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +HEN+V            Y+  E+V    ++  +      +   +V+ +   I+NG+ + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDD-LELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 474 HSTNTIHR 481
           HS N IHR
Sbjct: 141 HSHNIIHR 148

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           Q + G+LIG+G FG VY G  R  G   AI+ +DI  D+      +K  ++E+      +
Sbjct: 34  QLEIGELIGKGRFGQVYHG--RWHG-EVAIRLIDIERDNEDQ---LKAFKREVMAYRQTR 87
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           HEN+V + G+ +   HL I        ++   VR+    +  +  R   + I+ G+ YLH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 475 STNTIHR 481
           +   +H+
Sbjct: 148 AKGILHK 154

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 336 TSAVMPHIMEKPSASPK---KSQW----QKGKL---IGRGTFGSVYIGTNRETGASCAIK 385
           T  + P +ME   A+     +S W    ++ KL   IG+G FG V +G  R  G   A+K
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVK 222
Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSIN 444
               I +D  +    +    E  V+  L+H N+VQ  G  V +   LYI  EY+  GS+ 
Sbjct: 223 ---CIKNDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 445 RYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTIHR 481
            Y+R   R +     +  F+  +   + YL   N +HR
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--L 403
           K  A   K  ++  + +G G F  V +   + TG   A+K +      PK A   K+  +
Sbjct: 14  KKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCI------PKKALKGKESSI 67
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNF 462
           E EI VL  +KHENIV         +HLY+ ++ V  G + +R V +     TE      
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTL 125
Query: 463 TRHILNGLAYLHSTNTIHR 481
            R +L+ + YLH    +HR
Sbjct: 126 IRQVLDAVYYLHRMGIVHR 144

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 6/129 (4%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGH 412
            +++K   IG G++G V+   NR+TG   AIK+     DDP     IK++  +EI++L  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRMLKQ 58
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           LKH N+V           L++  EY     ++   R + R + E +V++ T   L  + +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNF 117
Query: 473 LHSTNTIHR 481
            H  N IHR
Sbjct: 118 CHKHNCIHR 126

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 93
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y     D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 94  LDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 152
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 153 LHGKGIIHR 161

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 12/133 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 414 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 469 GLAYLHSTNTIHR 481
            +  LH +N IHR
Sbjct: 124 AVKVLHGSNVIHR 136

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 16/143 (11%)
Query: 347 PSASP--KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
           PS++P  K S +   K+IG+G+FG V +  ++      A+K +       K A   K+ E
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEE 82
Query: 405 QEIK-----VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESI 458
           + I      +L ++KH  +V  + S    D LY  L+Y++ G +  ++ RE C    E  
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPR 140
Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
            R +   I + L YLHS N ++R
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYR 163

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 129
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 130 LHGKGIIHR 138

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 12/133 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 414 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 469 GLAYLHSTNTIHR 481
            +  LH +N IHR
Sbjct: 124 AVKVLHGSNVIHR 136

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 85
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 144
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 145 LHGKGIIHR 153

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 68/133 (51%), Gaps = 12/133 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +Q   L+G G +G V   T++ TG   AIK+++  P D K    ++ L +EIK+L H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFD-KPLFALRTL-REIKILKHF 66
Query: 414 KHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           KHENI+  +  +  D     + +YI  E +    ++R +      +++  ++ F    L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLR 123
Query: 469 GLAYLHSTNTIHR 481
            +  LH +N IHR
Sbjct: 124 AVKVLHGSNVIHR 136

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI +EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +V +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 85
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 144
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 145 LHGKGIIHR 153

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 18/139 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 414 KHENIVQ-----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           KHEN+V            Y   +     ++ + E+   G ++  + +     T S ++  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 130
Query: 463 TRHILNGLAYLHSTNTIHR 481
            + +LNGL Y+H    +HR
Sbjct: 131 MQMLLNGLYYIHRNKILHR 149

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI +EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G FG V +G  R  G   A+K    I +D  +    +    E  V+  L+H N+VQ 
Sbjct: 20  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATA----QAFLAEASVMTQLRHSNLVQL 70
Query: 422 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 479
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 71  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 480 HR 481
           HR
Sbjct: 131 HR 132

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G FG V +G  R  G   A+K    I +D  +    +    E  V+  L+H N+VQ 
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATA----QAFLAEASVMTQLRHSNLVQL 79
Query: 422 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 479
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 480 HR 481
           HR
Sbjct: 140 HR 141

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI 400
           P +  + S +    +++  +++G+G+FG V +  ++ TG  CA+K +       K+ +  
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK-- 76
Query: 401 KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESI 458
           + L +E+++L  L H NI++ Y  E  +D  Y YL  E    G +   +    R  +E  
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVD 133
Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
                R +L+G+ Y+H    +HR
Sbjct: 134 AARIIRQVLSGITYMHKNKIVHR 156

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG+G FG V +G  R  G   A+K    I +D  +    +    E  V+  L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATA----QAFLAEASVMTQLRHSNLVQL 64
Query: 422 YGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITES-IVRNFTRHILNGLAYLHSTNTI 479
            G  V +   LYI  EY+  GS+  Y+R   R +     +  F+  +   + YL   N +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 480 HR 481
           HR
Sbjct: 125 HR 126

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 327
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y + V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 328 Y-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 481 R 481
           R
Sbjct: 387 R 387

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 22/142 (15%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S++   K +G G  G V+   + +     AIK+  I+  DP+S   +K   +EIK++  L
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQS---VKHALREIKIIRRL 65
Query: 414 KHENIVQYY------GSEVVDD--------HLYIYLEYVHPGSINRYVREHCRDITESIV 459
            H+NIV+ +      GS++ DD         +YI  EY+     N  V E    + E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--VLEQG-PLLEEHA 122
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           R F   +L GL Y+HS N +HR
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHR 144

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHENIVQ 420
           IGRG++G V I   + T    A K++      PK   E + + +QEI+++  L H NI++
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            Y +   +  +Y+ +E    G +   V  H R   ES      + +L+ +AY H  N  H
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 481 R 481
           R
Sbjct: 130 R 130

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY++ GS+  +++ E  + +    + + +  I +G+AY+   N +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 481 R 481
           R
Sbjct: 135 R 135

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHENIVQ 420
           IGRG++G V I   + T    A K++      PK   E + + +QEI+++  L H NI++
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            Y +   +  +Y+ +E    G +   V  H R   ES      + +L+ +AY H  N  H
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 481 R 481
           R
Sbjct: 147 R 147

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 24/142 (16%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 414 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 127
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           +   + +LNGL Y+H    +HR
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHR 149

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 67/137 (48%), Gaps = 16/137 (11%)
Query: 353 KSQWQKGKLIGRGTFGSV----YIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQE 406
           K   +K + +G G FG V    Y  TN  TG   A+K +  D  P            +QE
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG------WKQE 83
Query: 407 IKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
           I +L  L HE+I++Y G   +     L + +EYV  GS+  Y+  H   + + ++  F +
Sbjct: 84  IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQ 141
Query: 465 HILNGLAYLHSTNTIHR 481
            I  G+AYLH+ + IHR
Sbjct: 142 QICEGMAYLHAQHYIHR 158

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY++ GS+  +++ E  + +    + + +  I +G+AY+   N +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 481 R 481
           R
Sbjct: 135 R 135

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 9/129 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGH 412
           ++ GK++G G+F +  +     T    AIK ++   II ++      +  + +E  V+  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSR 86
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H   V+ Y +   D+ LY  L Y   G + +Y+R+      E+  R +T  I++ L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 473 LHSTNTIHR 481
           LH    IHR
Sbjct: 146 LHGKGIIHR 154

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 6/124 (4%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           G+ IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+  G       +YI +E V  G    ++R     +    +         G+ YL S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 478 TIHR 481
            IHR
Sbjct: 234 CIHR 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 24/142 (16%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 73
Query: 414 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 126
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           +   + +LNGL Y+H    +HR
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHR 148

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 53/124 (42%), Gaps = 6/124 (4%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           G+ IGRG FG V+ G  R      A+K   + +P D K+     +  QE ++L    H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+  G       +YI +E V  G    ++R     +    +         G+ YL S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 478 TIHR 481
            IHR
Sbjct: 234 CIHR 237

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 58/125 (46%), Gaps = 6/125 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           K+IG G FG VY G  +    S   KEV +     K+    KQ      E  ++G   H 
Sbjct: 50  KVIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  G++++++RE   + +   +    R I  G+ YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 477 NTIHR 481
           N +HR
Sbjct: 167 NYVHR 171

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 24/142 (16%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +R+TG   A+K+V  + ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 414 KHENIVQYY--------------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
           KHEN+V                 GS  +   ++ + E+   G ++  + +     T S +
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYL---VFDFCEHDLAGLLSNVLVK----FTLSEI 127
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           +   + +LNGL Y+H    +HR
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHR 149

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI +EY+  G +  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           IG G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 477 NTIHR 481
           + IHR
Sbjct: 150 DIIHR 154

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 68  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 481 R 481
           R
Sbjct: 127 R 127

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 69
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 70  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 481 R 481
           R
Sbjct: 129 R 129

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 68/128 (53%), Gaps = 16/128 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHENI 418
           +G G +GSV    + +TG   A+K++       K  + I   K+  +E+++L H+KHEN+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL------SKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 419 V----QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +     +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 153
Query: 474 HSTNTIHR 481
           HS + IHR
Sbjct: 154 HSADIIHR 161

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 19/139 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++Q  ++ G+GTFG+V +G  + TG S AIK+V     DP+      Q+ Q++ V   L 
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAV---LH 77
Query: 415 HENIVQ---YYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITE---SIVRNFTR 464
           H NIVQ   Y+ +    +  D +L + +EYV P +++R  R + R        +++ F  
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 465 HILNGLAYLH--STNTIHR 481
            ++  +  LH  S N  HR
Sbjct: 137 QLIRSIGCLHLPSVNVCHR 155

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G FG VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 480
            G    +   YI  E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 481 R 481
           R
Sbjct: 133 R 133

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 71
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 72  YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 130
Query: 481 R 481
           R
Sbjct: 131 R 131

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 4/122 (3%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IG+G F  V +  +  TG   A+K   II     ++  +++L +E++++  L H NIV
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 69
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           + +     +  LY+ +EY   G +  Y+  H   + E   R   R I++ + Y H    +
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW-MKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 480 HR 481
           HR
Sbjct: 129 HR 130

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 14/131 (10%)
Query: 352 KKSQWQKGKL-IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           ++  W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   
Sbjct: 90  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMAC 139
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNG 469
             L    IV  YG+      + I++E +  GS+ + V+E  C  + E     +    L G
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 197
Query: 470 LAYLHSTNTIH 480
           L YLHS   +H
Sbjct: 198 LEYLHSRRILH 208

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 120 YMATQISSAMEYLEKKNFIHR 140

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 480
            G    +   YI +E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 481 R 481
           R
Sbjct: 133 R 133

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 477 NTIHR 481
           + IHR
Sbjct: 151 DIIHR 155

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 477 NTIHR 481
           + IHR
Sbjct: 147 DIIHR 151

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 477 NTIHR 481
           + IHR
Sbjct: 156 DIIHR 160

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 DIIHR 156

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 14/131 (10%)
Query: 352 KKSQWQKGKL-IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           ++  W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   
Sbjct: 71  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMAC 120
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNG 469
             L    IV  YG+      + I++E +  GS+ + V+E  C  + E     +    L G
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 178
Query: 470 LAYLHSTNTIH 480
           L YLHS   +H
Sbjct: 179 LEYLHSRRILH 189

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 DIIHR 156

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 477 NTIHR 481
           + IHR
Sbjct: 157 DIIHR 161

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 477 NTIHR 481
           + IHR
Sbjct: 157 DIIHR 161

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 DIIHR 156

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 477 NTIHR 481
           + IHR
Sbjct: 150 DIIHR 154

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 477 NTIHR 481
           + IHR
Sbjct: 147 DIIHR 151

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 477 NTIHR 481
           + IHR
Sbjct: 164 DIIHR 168

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 477 NTIHR 481
           + IHR
Sbjct: 165 DIIHR 169

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 481 R 481
           R
Sbjct: 304 R 304

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 DIIHR 156

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 4/132 (3%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
            P    ++  K IG+G F  V +  +  TG   A+K   II     ++  +++L +E+++
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRI 66
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
              L H NIV+ +     +  LY+  EY   G +  Y+  H R   E   R   R I++ 
Sbjct: 67  XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRX-KEKEARAKFRQIVSA 125
Query: 470 LAYLHSTNTIHR 481
           + Y H    +HR
Sbjct: 126 VQYCHQKFIVHR 137

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 477 NTIHR 481
           + IHR
Sbjct: 156 DIIHR 160

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
           +G G +G+V    +  TGA  AIK++      P  +E   K+  +E+++L H++HEN++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 421 ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
               +   E +DD    YL     G+    + +H + + E  ++     +L GL Y+H+ 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAA 147
Query: 477 NTIHR 481
             IHR
Sbjct: 148 GIIHR 152

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 477 NTIHR 481
           + IHR
Sbjct: 147 DIIHR 151

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 14/140 (10%)
Query: 350 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 56
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 461
             +E  V+  +KH N+VQ  G    +   YI +E++  G++  Y+RE  R ++   ++  
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I + + YL   N IHR
Sbjct: 117 MATQISSAMEYLEKKNFIHR 136

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 481 R 481
           R
Sbjct: 304 R 304

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 477 NTIHR 481
           + IHR
Sbjct: 150 DIIHR 154

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 477 NTIHR 481
           + IHR
Sbjct: 168 DIIHR 172

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 477 NTIHR 481
           + IHR
Sbjct: 150 DIIHR 154

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 477 NTIHR 481
           + IHR
Sbjct: 151 DIIHR 155

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 143
Query: 477 NTIHR 481
           + IHR
Sbjct: 144 DIIHR 148

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEA------FLQEAQVMKKLRHEKLVQL 245
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 246 YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 481 R 481
           R
Sbjct: 305 R 305

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 477 NTIHR 481
           + IHR
Sbjct: 147 DIIHR 151

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 477 NTIHR 481
           + IHR
Sbjct: 168 DIIHR 172

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 477 NTIHR 481
           + IHR
Sbjct: 143 DIIHR 147

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 24  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 143
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E  R +    + +F+  +  G+A+L S N IHR
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHR 176

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 477 NTIHR 481
           + IHR
Sbjct: 151 DIIHR 155

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 477 NTIHR 481
           + IHR
Sbjct: 141 DIIHR 145

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 477 NTIHR 481
           + IHR
Sbjct: 142 DIIHR 146

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 477 NTIHR 481
           + IHR
Sbjct: 142 DIIHR 146

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++  + IG G +G V     R TG   AIK+   IP+        K+  +E+K+L H K
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKK---IPNAFDVVTNAKRTLRELKILKHFK 112
Query: 415 HENIVQY---------YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           H+NI+           YG       +Y+ L+ +   S    +    + +T   VR F   
Sbjct: 113 HDNIIAIKDILRPTVPYGEF---KSVYVVLDLME--SDLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 466 ILNGLAYLHSTNTIHR 481
           +L GL Y+HS   IHR
Sbjct: 168 LLRGLKYMHSAQVIHR 183

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL 413
           W+  + +G G FG V    +++TG   AIK+   ++ P + +   C+     EI+++  L
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN-RERWCL-----EIQIMKKL 70
Query: 414 KHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFT 463
            H N+V     EV D        D   + +EY   G + +Y+   E+C  + E  +R   
Sbjct: 71  NHPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 464 RHILNGLAYLHSTNTIHR 481
             I + L YLH    IHR
Sbjct: 129 SDISSALRYLHENRIIHR 146

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAYLHSTNTIH 480
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 481 R 481
           R
Sbjct: 124 R 124

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL 413
           W+  + +G G FG V    +++TG   AIK+   ++ P + +   C+     EI+++  L
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN-RERWCL-----EIQIMKKL 69
Query: 414 KHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFT 463
            H N+V     EV D        D   + +EY   G + +Y+   E+C  + E  +R   
Sbjct: 70  NHPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 464 RHILNGLAYLHSTNTIHR 481
             I + L YLH    IHR
Sbjct: 128 SDISSALRYLHENRIIHR 145

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 19/135 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIK 408
           +++  +++G+G+FG V +  ++ TG  CA+K +        S   +KQ      L +E++
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQVKQKTDKESLLREVQ 78
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +L  L H NI + Y  E  +D  Y YL  E    G +   +    R  +E       R +
Sbjct: 79  LLKQLDHPNIXKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQV 135
Query: 467 LNGLAYLHSTNTIHR 481
           L+G+ Y H    +HR
Sbjct: 136 LSGITYXHKNKIVHR 150

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAYLHSTNTIH 480
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 481 R 481
           R
Sbjct: 124 R 124

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 477 NTIHR 481
           + IHR
Sbjct: 165 DIIHR 169

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG GT+G VY   N   G + A+K++ +  +D        +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIH 480
           Y  +V+     + L + H     + + + C    ES+  ++F   +LNG+AY H    +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 481 R 481
           R
Sbjct: 124 R 124

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  ++HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKIRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 477 NTIHR 481
           + IHR
Sbjct: 141 DIIHR 145

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 261
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 322 YMATQISSAMEYLEKKNFIHR 342

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKSAECI 400
           E P     + +   GK +G G FG V     +G +++         V ++ DD  + E +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEEDL 84
Query: 401 KQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCR 452
             L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+  
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 453 DI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
           DI        T   + + T  +  G+ YL S   IHR
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 477 NTIHR 481
           + IHR
Sbjct: 165 DIIHR 169

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E  R +    + +F+  +  G+A+L S N IHR
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHR 184

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 477 NTIHR 481
           + IHR
Sbjct: 164 DIIHR 168

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 154
Query: 477 NTIHR 481
           + IHR
Sbjct: 155 DIIHR 159

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 119
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 120 YMATQISSAMEYLEKKNFIHR 140

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           ++IG G FG VY       G   A+K     PD+  S + I+ + QE K+   LKH NI+
Sbjct: 13  EIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNII 69
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-- 477
              G  + + +L + +E+   G +NR +    + I   I+ N+   I  G+ YLH     
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 478 -TIHR 481
             IHR
Sbjct: 128 PIIHR 132

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG   +  + E G    IKE++I     K  E   +  +E+ VL ++KH NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
             S   +  LYI ++Y   G + + +  +      E  + ++   I   L ++H    +H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 481 R 481
           R
Sbjct: 149 R 149

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 132 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 477 NTIHR 481
           + IHR
Sbjct: 141 DIIHR 145

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 477 NTIHR 481
           + IHR
Sbjct: 151 DIIHR 155

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++  + IG G +G V     R TG   AIK+   IP+        K+  +E+K+L H K
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKK---IPNAFDVVTNAKRTLRELKILKHFK 111
Query: 415 HENIVQY---------YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           H+NI+           YG       +Y+ L+ +   S    +    + +T   VR F   
Sbjct: 112 HDNIIAIKDILRPTVPYGE---FKSVYVVLDLME--SDLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 466 ILNGLAYLHSTNTIHR 481
           +L GL Y+HS   IHR
Sbjct: 167 LLRGLKYMHSAQVIHR 182

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 5/120 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G GT+ +VY G ++ T    A+KE+ +  ++      I+    E+ +L  LKH NIV  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +     +  L +  EY+    + +Y+ +    I    V+ F   +L GLAY H    +HR
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 245 YAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 481 R 481
           R
Sbjct: 304 R 304

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ +YI  EY+  G +  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 481 R 481
           R
Sbjct: 138 R 138

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 120 YMATQISSAMEYLEKKNFIHR 140

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 72
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 480
            G    +   YI  E++  G++  Y+RE  R +++  ++      I + + YL   N IH
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 481 R 481
           R
Sbjct: 133 R 133

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 120 YMATQISSAMEYLEKKNFIHR 140

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 247 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 300
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 360
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 361 YMATQISSAMEYLEKKNFIHR 381

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           +SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 59
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 120 YMATQISSAMEYLEKKNFIHR 140

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 92
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI----LNGLAYLH 474
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 93  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 475 STNTIHR 481
             + IHR
Sbjct: 151 ENHHIHR 157

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 11/131 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 410
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 471 AYLHSTNTIHR 481
            YLH+   IHR
Sbjct: 156 QYLHNNRVIHR 166

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 11/131 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 410
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 471 AYLHSTNTIHR 481
            YLH+   IHR
Sbjct: 156 QYLHNNRVIHR 166

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 92
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI----LNGLAYLH 474
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 93  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 475 STNTIHR 481
             + IHR
Sbjct: 151 ENHHIHR 157

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 11/131 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI----KQLEQEIKVL 410
           ++ +G+ +G+G F   Y  T+ +T    A K V      PKS        +++  EI + 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLLKPHQKEKMSTEIAIH 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L + ++V ++G    DD +Y+ LE     S+   + +  + +TE   R F R  + G+
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV 155
Query: 471 AYLHSTNTIHR 481
            YLH+   IHR
Sbjct: 156 QYLHNNRVIHR 166

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 14/140 (10%)
Query: 350 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 59
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 461
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 119
Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I + + YL   N IHR
Sbjct: 120 MATQISSAMEYLEKKNFIHR 139

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 14/140 (10%)
Query: 350 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 56
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 461
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I + + YL   N IHR
Sbjct: 117 MATQISSAMEYLEKKNFIHR 136

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ +K K++G G FG+V+ G     G S  I     + +D    +  + +   +  +G
Sbjct: 29  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 88
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            L H +IV+  G       L +  +Y+  GS+  +VR+H   +   ++ N+   I  G+ 
Sbjct: 89  SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 147
Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 148 YLEEHGMVHR 157

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 18  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 77
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 78  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 134
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 135 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 173

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 15  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 75  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 131
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 132 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 170

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 70/131 (53%), Gaps = 10/131 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++   LIGRG++G VY+  ++    + AIK+V+ + +D    +C K++ +EI +L  LK 
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED--LIDC-KRILREITILNRLKS 86
Query: 416 ENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           + I++ +   + +     D LYI LE +    + +  +     +TE  V+    ++L G 
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEQHVKTILYNLLLGE 144
Query: 471 AYLHSTNTIHR 481
            ++H +  IHR
Sbjct: 145 KFIHESGIIHR 155

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 13  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 73  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 129
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 130 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 168

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 101
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 161 YMYQLFRSLAYIHSFGICHR 180

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 101
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 161 YMYQLFRSLAYIHSFGICHR 180

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/123 (23%), Positives = 58/123 (47%), Gaps = 5/123 (4%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K +++G G FG V+      TG   A K +       +  +  ++++ EI V+  L H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHAN 147
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           ++Q Y +    + + + +EYV  G +   + +   ++TE     F + I  G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 478 TIH 480
            +H
Sbjct: 208 ILH 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G  +G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV+   +HEN+
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENL 86
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI----LNGLAYLH 474
           V+  G     D L +   Y+  GS+    R  C D T  +  +    I     NG+ +LH
Sbjct: 87  VELLGFSSDGDDLCLVYVYMPNGSL--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 475 STNTIHR 481
             + IHR
Sbjct: 145 ENHHIHR 151

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 103
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 104 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 162
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 163 YMYQLFRSLAYIHSFGICHR 182

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 14/140 (10%)
Query: 350 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 57
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 461
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 117
Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I + + YL   N IHR
Sbjct: 118 MATQISSAMEYLEKKNFIHR 137

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 105
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 106 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 164
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 165 YMYQLFRSLAYIHSFGICHR 184

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 95
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 96  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 154
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 155 YMYQLFRSLAYIHSFGICHR 174

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 146
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 147 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 205
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 206 YMYQLFRSLAYIHSFGICHR 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+HS 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 477 NTIHR 481
           + IHR
Sbjct: 141 DIIHR 145

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 14  GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 67
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 68  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 127
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 128 YMATQISSAMEYLEKKNFIHR 148

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ +K K++G G FG+V+ G     G S  I     + +D    +  + +   +  +G
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            L H +IV+  G       L +  +Y+  GS+  +VR+H   +   ++ N+   I  G+ 
Sbjct: 71  SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 130 YLEEHGMVHR 139

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 9/126 (7%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           Q  K +G G FG V++GT        AIK +      P+S        +E +++  LKH+
Sbjct: 12  QLIKRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTMSPES------FLEEAQIMKKLKHD 64
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHS 475
            +VQ Y   V ++ +YI  EY++ GS+  ++++   R +    + +    +  G+AY+  
Sbjct: 65  KLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 476 TNTIHR 481
            N IHR
Sbjct: 124 MNYIHR 129

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 349 ASPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           +P ++  P       ++ +G+ +G+G F   Y  T+ +T    A K V      PKS   
Sbjct: 15  IPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------PKSMLL 65
Query: 400 I----KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
                +++  EI +   L + ++V ++G    DD +Y+ LE     S+   + +  + +T
Sbjct: 66  KPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVT 124
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
           E   R F R  + G+ YLH+   IHR
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHR 150

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 22/157 (14%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR----- 452
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R     
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 453 --------DITESIVRNFTRHILNGLAYLHSTNTIHR 481
                    ++   + +F+  +  G+A+L S N IHR
Sbjct: 152 PAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHR 188

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 14/140 (10%)
Query: 350 SPKKSQWQKGKL-------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
           SP   +W+  +        +G G +G VY G  ++   + A+K    + +D    E   +
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---E 57
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRN 461
             +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R ++   ++  
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 117
Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I + + YL   N IHR
Sbjct: 118 MATQISSAMEYLEKKNFIHR 137

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KVLGHLKHEN 417
           IG G FGSV+    R  G   AIK        P +    +Q   +E+    VLG  +H +
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAVLG--QHSH 72
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHILNGLAYLH 474
           +V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +  GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 475 STNTIH 480
           S + +H
Sbjct: 133 SMSLVH 138

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KVLGHLKHEN 417
           IG G FGSV+    R  G   AIK        P +    +Q   +E+    VLG  +H +
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAVLG--QHSH 68
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHILNGLAYLH 474
           +V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +  GL Y+H
Sbjct: 69  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
Query: 475 STNTIH 480
           S + +H
Sbjct: 129 SMSLVH 134

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KVLGHLKHEN 417
           IG G FGSV+    R  G   AIK        P +    +Q   +E+    VLG  +H +
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAVLG--QHSH 70
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHILNGLAYLH 474
           +V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +  GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 475 STNTIH 480
           S + +H
Sbjct: 131 SMSLVH 136

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G +G VY G  ++   + A+K    + +D    E   +  +E  V+  +KH N+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 76
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIH 480
            G    +   YI  E++  G++  Y+RE  R ++   ++      I + + YL   N IH
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 481 R 481
           R
Sbjct: 137 R 137

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEI---KVLGHLKHEN 417
           IG G FGSV+    R  G   AIK        P +    +Q   +E+    VLG  +H +
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR----SKKPLAGSVDEQNALREVYAHAVLG--QHSH 70
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT---ESIVRNFTRHILNGLAYLH 474
           +V+Y+ +   DDH+ I  EY + GS+   + E+ R ++   E+ +++    +  GL Y+H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 475 STNTIH 480
           S + +H
Sbjct: 131 SMSLVH 136

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y+R       E 
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEX 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 72
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 73  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 131
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 132 YMYQLFRSLAYIHSFGICHR 151

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V          +  K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 79
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 139 YMYQLFRSLAYIHSFGICHR 158

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 79
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 139 YMYQLFRSLAYIHSFGICHR 158

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 86
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 87  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 145
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 146 YMYQLFRSLAYIHSFGICHR 165

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 80
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 81  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 139
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 140 YMYQLFRSLAYIHSFGICHR 159

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 75
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 76  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 134
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 135 YMYQLFRSLAYIHSFGICHR 154

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--- 454
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 455 --------TESI--VRNFTRHILNGLAYLHSTNTIHR 481
                   T S   + +F+  +  G+A+L S N IHR
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 6/124 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           +++G+G+FG V +   +ETG   A+K +  D+I  D    EC    E+ I  L    H  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 85
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           + Q +      D L+  +E+V+ G +  ++++  R   E+  R +   I++ L +LH   
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG 144
Query: 478 TIHR 481
            I+R
Sbjct: 145 IIYR 148

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 68
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 69  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 127
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 128 YMYQLFRSLAYIHSFGICHR 147

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 71
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 72  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 130
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 131 YMYQLFRSLAYIHSFGICHR 150

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 67/125 (53%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + ++G   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 115
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+  C+ +T+  V+     IL GL Y+HS 
Sbjct: 116 LDVFTPATSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 477 NTIHR 481
           + IHR
Sbjct: 174 DIIHR 178

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G FG V++GT   T    AIK +      P++        QE +V+  L+HE +VQ 
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 68
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y   V ++ + I  EY+  GS+  +++ E  + +    + +    I +G+AY+   N +H
Sbjct: 69  YAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 127
Query: 481 R 481
           R
Sbjct: 128 R 128

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +++G G F  V++   R TG   A+K +   P    S+     LE EI VL  +KHENIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHENIV 69
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNT 478
                     H Y+ ++ V  G +   + E  R + TE       + +L+ + YLH    
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 479 IHR 481
           +HR
Sbjct: 128 VHR 130

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+V  + D        +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--LQDK-------RFKNRELQIM 67
Query: 411 GHLKHENIVQ----YYGSEVVDDHLY--IYLEYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y  + L+YV P ++ R  R + R    +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 127 YMYQLFRSLAYIHSFGICHR 146

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ + Y   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 19/137 (13%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FG V++    N        +  V  + D   +A   K  ++E ++L +L+HE+IV
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 80
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 464
           ++YG     D L +  EY+  G +N+++R H  D               +  S + +   
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 465 HILNGLAYLHSTNTIHR 481
            I +G+ YL S + +HR
Sbjct: 141 QIASGMVYLASQHFVHR 157

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 345 EKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAE 398
           E+PS   K     ++  K++G+G+FG V++   ++T    AI    K+V ++ DD    E
Sbjct: 7   ERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VE 63
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
           C   +E+ +  L   +H  +   + +    ++L+  +EY++ G +  ++ + C     S 
Sbjct: 64  C-TMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSR 120
Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
              +   I+ GL +LHS   ++R
Sbjct: 121 ATFYAAEIILGLQFLHSKGIVYR 143

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 12/127 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHLKHENIVQ 420
           IGRG+F +VY G + ET    A  E+     D K  +  +Q  ++E + L  L+H NIV+
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL----QDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 421 YYGS--EVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           +Y S    V     I L  E    G++  Y++   +     ++R++ R IL GL +LH+ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRF-KVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 477 N--TIHR 481
               IHR
Sbjct: 149 TPPIIHR 155

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 73/140 (52%), Gaps = 14/140 (10%)
Query: 348 SASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIK 401
           SA+P  +   ++++   +G GT+G VY   +  T  + AIK + +  ++   P +A    
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI--- 81
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
              +E+ +L  L+H NI++       +  L++  EY     + +Y+ ++  D++  ++++
Sbjct: 82  ---REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKS 136
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           F   ++NG+ + HS   +HR
Sbjct: 137 FLYQLINGVNFCHSRRCLHR 156

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 338 AVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-------I 390
           A+ P +  +         + K + +G G +G V +   +   +  AIK +          
Sbjct: 20  AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 391 PDDPKSAECI-KQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVHPGS----- 442
            DD K+ E   +++  EI +L  L H NI++ +  +V +D  Y YL  E+   G      
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 443 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           INR+  + C         N  + IL+G+ YLH  N +HR
Sbjct: 138 INRHKFDECD------AANIMKQILSGICYLHKHNIVHR 170

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
           E P     + +   GK +G G FG V     +G +++         V ++ DD      +
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
           + + ++E  +K++G  KH+NI+   G+   D  LY+ + Y   G++  Y+R       E+
Sbjct: 86  DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEY 142
Query: 451 CRDI--------TESIVRNFTRHILNGLAYLHSTNTIHR 481
             DI        T   + + T  +  G+ YL S   IHR
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+VY G      A   +K VD  P      E  +    E+ VL   +H NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTP------EQFQAFRNEVAVLRKTRHVNILLF 97
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G  +  D+L I  ++    S+ +++           + +  R    G+ YLH+ N IHR
Sbjct: 98  MGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/120 (26%), Positives = 60/120 (50%), Gaps = 13/120 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 115
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 173

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--SQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   IKE  +  DD           +E +V+  L H  +V
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEAEVMMKLSHPKLV 85
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 480 HR 481
           HR
Sbjct: 146 HR 147

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    + +TG   A+K+   +    +S    K+  +E+++L H+KHEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 420 --QYYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  +++   +YL  ++    +N  V+   + +T+  V+     IL GL Y+HS 
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX--QKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 477 NTIHR 481
           + IHR
Sbjct: 145 DIIHR 149

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/120 (26%), Positives = 60/120 (50%), Gaps = 13/120 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 131
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 189

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 31/166 (18%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R         
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 449 -------------EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                        E  R +    + +F+  +  G+A+L S N IHR
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHR 182

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 12/127 (9%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA-ECIKQLEQEIKVLGHLKHE 416
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 83
Query: 417 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           NIV+Y G  +E   + + + +E++  GS+  Y+ ++   I       +   I  G+ YL 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 475 STNTIHR 481
           S   +HR
Sbjct: 144 SRQYVHR 150

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 117
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 176
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 177 YLHSLDLIYR 186

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 89
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 148
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 149 YLHSLDLIYR 158

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/126 (24%), Positives = 64/126 (50%), Gaps = 10/126 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           K++G+G+FG V++   ++T    AI    K+V ++ DD    EC   +E+ +  L   +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VEC-TMVEKRVLSLA-WEH 77
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +   + +    ++L+  +EY++ G +  ++ + C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 476 TNTIHR 481
              ++R
Sbjct: 137 KGIVYR 142

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 156
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 157 YLHSLDLIYR 166

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 155
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 156 YLHSLDLIYR 165

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 156
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 157 YLHSLDLIYR 166

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/120 (26%), Positives = 60/120 (50%), Gaps = 13/120 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +GRG+FG V+   +++TG  CA+K+V +          + ++E+ +   G L    IV  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAG-LSSPRIVPL 129
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           YG+      + I++E +  GS+ + +++  C  + E     +    L GL YLH+   +H
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILH 187

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 12/127 (9%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSA-ECIKQLEQEIKVLGHLKHE 416
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L HE
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 71
Query: 417 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           NIV+Y G  +E   + + + +E++  GS+  Y+ ++   I       +   I  G+ YL 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 475 STNTIHR 481
           S   +HR
Sbjct: 132 SRQYVHR 138

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 24/159 (15%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAE 398
           P+  P   +W       Q GK +G G FG V   T    G   A+ +V + +      A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 399 CIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
             + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R       E+
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 451 CRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +        ++   + +F+  +  G+A+L S N IHR
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 36  KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 95
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 96  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMM 154
Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 155 YLEERRLVHR 164

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K IG G FG   +  ++ T    A+K ++      + A   + +++EI     L+H NIV
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINHRSLRHPNIV 79
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           ++    +   HL I +EY   G +   +    R  +E   R F + +L+G++Y HS    
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 480 HR 481
           HR
Sbjct: 139 HR 140

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K IG G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 8/86 (9%)
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDIT 455
           I+Q+ QEI +L  L H N+V+    EV+DD    HLY+  E V+ G +        + ++
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLS 135
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
           E   R + + ++ G+ YLH    IHR
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHR 161

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 11/124 (8%)
Query: 360 KLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K +G G FG V +G    +   A   IKE  +  D         +  QE + +  L H  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---------EFFQEAQTMMKLSHPK 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +V++YG    +  +YI  EY+  G +  Y+R H + +  S +      +  G+A+L S  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 478 TIHR 481
            IHR
Sbjct: 125 FIHR 128

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 88
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 89  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 147
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 148 EYLHSLDLIYR 158

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++Q+ K +G G +G V +  ++ TGA  AIK +        +      L  E+ VL  L 
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLKQLD 79
Query: 415 HENIVQYYGSEVVDD--HLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 470
           H NI++ Y  E  +D  + Y+ +E    G +     +R+   ++  +++    + +L+G 
Sbjct: 80  HPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLSGT 134
Query: 471 AYLHSTNTIHR 481
            YLH  N +HR
Sbjct: 135 TYLHKHNIVHR 145

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 26/139 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +LIG G FG V+   +R  G +  IK V    ++ K+       E+E+K L  L H NIV
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--NNEKA-------EREVKALAKLDHVNIV 67
Query: 420 QYYGSEVVDDH----------------LYIYLEYVHPGSINRYV-REHCRDITESIVRNF 462
            Y G     D+                L+I +E+   G++ +++ +     + + +    
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 463 TRHILNGLAYLHSTNTIHR 481
              I  G+ Y+HS   I+R
Sbjct: 128 FEQITKGVDYIHSKKLINR 146

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 5/119 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G FG V+  T R TG + A K V + P +       + + +EI+ +  L+H  +V  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDK----ETVRKEIQTMSVLRHPTLVNL 113
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           + +   D+ + +  E++  G +   V +    ++E     + R +  GL ++H  N +H
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++ ++ K++G G FG+VY G     G +  I     I ++    +   +   E  ++ 
Sbjct: 13  KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 72
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + H ++V+  G   +   + +  + +  G +  YV EH  +I   ++ N+   I  G+ 
Sbjct: 73  SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMM 131
Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 132 YLEERRLVHR 141

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 5/119 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G FG V+  T R TG + A K V + P +       + + +EI+ +  L+H  +V  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDK----ETVRKEIQTMSVLRHPTLVNL 219
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           + +   D+ + +  E++  G +   V +    ++E     + R +  GL ++H  N +H
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 9/127 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G   G G FG VY G    T  + A+K++  + D   + E  +Q +QEIKV    +HEN+
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVD-ITTEELKQQFDQEIKVXAKCQHENL 83
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN----FTRHILNGLAYLH 474
           V+  G     D L +   Y   GS+    R  C D T  +  +      +   NG+ +LH
Sbjct: 84  VELLGFSSDGDDLCLVYVYXPNGSL--LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 475 STNTIHR 481
             + IHR
Sbjct: 142 ENHHIHR 148

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 E---QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 156
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 157 YLHSLDLIYR 166

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 52  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 106
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 165
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYR 186

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++Q+ K +G G +G V +  ++ TGA  AIK +        +      L  E+ VL  L 
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLKQLD 62
Query: 415 HENIVQYYGSEVVDD--HLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 470
           H NI++ Y  E  +D  + Y+ +E    G +     +R+   ++  +++    + +L+G 
Sbjct: 63  HPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLSGT 117
Query: 471 AYLHSTNTIHR 481
            YLH  N +HR
Sbjct: 118 TYLHKHNIVHR 128

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHR 171

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NIV +
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYV-REHCRD-ITESIVRNFTRHILNGLAYLHSTN-- 477
            G+     +L I  EY+  GS+ R + +   R+ + E    +    +  G+ YLH+ N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 478 TIHR 481
            +HR
Sbjct: 160 IVHR 163

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +     D +    +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K +     D +    +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 32  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 86
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 145
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYR 166

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 480 HR 481
           HR
Sbjct: 143 HR 144

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NIV +
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYV-REHCRD-ITESIVRNFTRHILNGLAYLHSTN-- 477
            G+     +L I  EY+  GS+ R + +   R+ + E    +    +  G+ YLH+ N  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 478 TIHR 481
            +HR
Sbjct: 160 IVHR 163

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K IG G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY+  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K IG G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY+  G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +     +    E  ++G   H 
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHP 94
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 477 NTIHR 481
             +HR
Sbjct: 155 GYVHR 159

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 81
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +   I+   
Sbjct: 82  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 140
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 141 EYLHSLDLIYR 151

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 18  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 72
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR 131
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYR 152

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 480 HR 481
           HR
Sbjct: 143 HR 144

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 106
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 477 NTIHR 481
             +HR
Sbjct: 167 GYVHR 171

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 52  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 106
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 165
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYR 186

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 39/152 (25%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +LIG G FG V+   +R  G +  I+ V    +         + E+E+K L  L H NIV
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE---------KAEREVKALAKLDHVNIV 68
Query: 420 QY--------YGSEVVDDH---------------------LYIYLEYVHPGSINRYV-RE 449
            Y        Y  E  DD                      L+I +E+   G++ +++ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               + + +       I  G+ Y+HS   IHR
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHR 160

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 420 --QYYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  ++D   +YL     G+ +N  V+  C+ +++  V+     +L GL Y+HS 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 477 NTIHR 481
             IHR
Sbjct: 143 GIIHR 147

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 106
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 477 NTIHR 481
             +HR
Sbjct: 167 GYVHR 171

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 156
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 157 YLHSLDLIYR 166

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +     +    E  ++G   H 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHP 77
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 477 NTIHR 481
             +HR
Sbjct: 138 GYVHR 142

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 17  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 72
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 73  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 132 KGMNYLEDRRLVHR 145

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 104
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  EY+  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 477 NTIHR 481
             +HR
Sbjct: 165 GYVHR 169

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 85
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 144
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYR 165

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 420
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 421 ---YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  ++D   +YL     G+ +N  V+  C+ +++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 477 NTIHR 481
             IHR
Sbjct: 151 GIIHR 155

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 65
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL   + I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 480 HR 481
           HR
Sbjct: 126 HR 127

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 14  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 66
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 480 HR 481
           HR
Sbjct: 127 HR 128

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 345 EKPSA-SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           E PS  + +  Q+ + K +G G+FG V +  ++E+G   A+K    I D  K  + +KQ+
Sbjct: 26  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVK-LKQI 80
Query: 404 EQ---EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
           E    E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R   E   R
Sbjct: 81  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR 139
Query: 461 NFTRHILNGLAYLHSTNTIHR 481
            +   I+    YLHS + I+R
Sbjct: 140 FYAAQIVLTFEYLHSLDLIYR 160

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+C +        ++   + +    +  G+ YL S   IHR
Sbjct: 134 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 67
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 480 HR 481
           HR
Sbjct: 128 HR 129

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/124 (25%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 19  KRLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 71
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 477
           + Y     ++ +YI  EY+  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 130
Query: 478 TIHR 481
            IHR
Sbjct: 131 YIHR 134

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 62  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+C +        ++   + +    +  G+ YL S   IHR
Sbjct: 119 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 67
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 125
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 126 SRDVVYR 132

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 130 KGMNYLEDRRLVHR 143

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 8/128 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +Q+ K +G G +G V +  ++ T    AIK   II     S     +L +E+ VL  L H
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 473
            NI++ Y       + Y+ +E    G +   +  R    ++  +++    + +L+G+ YL
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLSGVTYL 152
Query: 474 HSTNTIHR 481
           H  N +HR
Sbjct: 153 HKHNIVHR 160

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 17  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 72
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 73  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 132 KGMNYLEDRRLVHR 145

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 21  KELGTGQFGVVKYGKWRGQ-YDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 73
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 480 HR 481
           HR
Sbjct: 134 HR 135

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 69
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 70  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 129 KGMNYLEDRRLVHR 142

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 130 KGMNYLEDRRLVHR 143

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 10  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 480 HR 481
           HR
Sbjct: 123 HR 124

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 130 KGMNYLEDRRLVHR 143

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 69
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 70  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 129 KGMNYLEDRRLVHR 142

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 131 KGMNYLEDRRLVHR 144

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V  G  R      AIK   +I +   S +   +  +E KV+ +L HE +V
Sbjct: 15  KELGTGQFGVVKYGKWR-GQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 67
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG       ++I  EY+  G +  Y+RE         +    + +   + YL S   +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 480 HR 481
           HR
Sbjct: 128 HR 129

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 422 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 150
Query: 480 HR 481
           HR
Sbjct: 151 HR 152

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 474
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 120
Query: 475 STNTIHR 481
               +HR
Sbjct: 121 RHKIVHR 127

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 72
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 474
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 129
Query: 475 STNTIHR 481
               +HR
Sbjct: 130 RHKIVHR 136

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 73
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 474
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 130
Query: 475 STNTIHR 481
               +HR
Sbjct: 131 RHKIVHR 137

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 414 KHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVR-EHCRDITESIV 459
            H+ +V+YY + +   +             L+I +EY   G++   +  E+     +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           R F R IL  L+Y+HS   IHR
Sbjct: 120 RLF-RQILEALSYIHSQGIIHR 140

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 4/120 (3%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G G+FG V + T+ +T    A+K +       K ++   ++E+EI  L  L+H +I++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           Y        + + +EY   G +  Y+ E  R +TE   R F + I+  + Y H    +HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHKIVHR 132

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +Q  K +G G+FG V +  +  TG   A+K ++        ++   ++E+EI  L  L+H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLRH 67
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLH 474
            +I++ Y      D + + +EY      +  V+   RD ++E   R F + I++ + Y H
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH 124
Query: 475 STNTIHR 481
               +HR
Sbjct: 125 RHKIVHR 131

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 65
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 480 HR 481
           HR
Sbjct: 126 HR 127

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 69
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 127
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 128 SRDVVYR 134

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 68
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 128
Query: 480 HR 481
           HR
Sbjct: 129 HR 130

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/127 (23%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L+
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSLR 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 132
Query: 475 STNTIHR 481
           +    HR
Sbjct: 133 AMQVCHR 139

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/127 (23%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++  K IG G FG   +  ++++    A+K ++      +  +    +++EI     L+
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIAANVKREIINHRSLR 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y H
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 132
Query: 475 STNTIHR 481
           +    HR
Sbjct: 133 AMQVCHR 139

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 66/130 (50%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 96
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 155
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 156 YLHSLDLIYR 165

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 32/167 (19%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSA 397
           I+E P     +     GK +G G FG V   T      R    + A+K   ++ ++   +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPS 68
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-------- 449
           E ++ L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE        
Sbjct: 69  E-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 450 ---------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                            R +T   + +F   I  G+ YL   + +HR
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHR 174

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 480 HR 481
           HR
Sbjct: 124 HR 125

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/128 (23%), Positives = 62/128 (48%), Gaps = 7/128 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYC 131
Query: 474 HSTNTIHR 481
           H+    HR
Sbjct: 132 HAMQVCHR 139

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 32/167 (19%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSA 397
           I+E P     +     GK +G G FG V   T      R    + A+K   ++ ++   +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPS 68
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-------- 449
           E ++ L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE        
Sbjct: 69  E-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 450 ---------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                            R +T   + +F   I  G+ YL     +HR
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           KL+G+GTFG V +   + TG   A+    KEV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
             +     +    D L   +EY + G +  ++ RE  R  TE   R +   I++ L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 345 EKPSASPKKSQWQK---GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAEC 399
           E P  +  K  +QK     +IGRG    V    +R TG   A+K +++  +   P+  E 
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 400 IKQ-LEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
           +++   +E  +L  +  H +I+    S      +++  + +  G +  Y+ E    ++E 
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEK 200
Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
             R+  R +L  +++LH+ N +HR
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHR 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/130 (21%), Positives = 60/130 (46%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           +  +++K   +G G F +VY   ++ T    AIK++ +           +   +EIK+L 
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            L H NI+    +     ++ +  +++    +   ++++   +T S ++ +    L GL 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 472 YLHSTNTIHR 481
           YLH    +HR
Sbjct: 127 YLHQHWILHR 136

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 340 MPHIMEKP---SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS 396
           MP  +E P    A   +  +    ++G G F  V +  ++ T    AIK +     + K 
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE 60
Query: 397 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDIT 455
                 +E EI VL  +KH NIV          HLY+ ++ V  G + +R V +     T
Sbjct: 61  G----SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--T 114
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
           E         +L+ + YLH    +HR
Sbjct: 115 ERDASRLIFQVLDAVKYLHDLGIVHR 140

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 7/123 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
           +G G +GSV    ++ +G   AIK++      P  +E   K+  +E+ +L H++HEN++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 421 YYGSEVVDDHLYIYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
                     L  + ++  V P       +    + +E  ++     +L GL Y+HS   
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 479 IHR 481
           +HR
Sbjct: 166 VHR 168

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 94
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL   
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 477 NTIHR 481
           N +HR
Sbjct: 155 NYVHR 159

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 32/167 (19%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSA 397
           I+E P     +     GK +G G FG V   T      R    + A+K   ++ ++   +
Sbjct: 12  ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPS 68
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-------- 449
           E ++ L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE        
Sbjct: 69  E-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 450 ---------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                            R +T   + +F   I  G+ YL     +HR
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 61/130 (46%), Gaps = 1/130 (0%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++++K K++G G FG+VY G     G    I    +   +  S +  K++  E  V+ 
Sbjct: 47  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMA 106
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 107 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 166 YLEDRRLVHR 175

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           K +G G FG V++G    +    A+K +      P +   ++   +E  ++  L+H+ +V
Sbjct: 18  KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 70
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 477
           + Y     ++ +YI  E++  GS+  +++  E  + +   ++ +F+  I  G+AY+   N
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 129
Query: 478 TIHR 481
            IHR
Sbjct: 130 YIHR 133

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/127 (23%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++  K IG G FG   +  ++++    A+K ++      +  +  + +++EI     L+
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE------RGEKIDENVKREIINHRSLR 72
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y H
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 131
Query: 475 STNTIHR 481
           +    HR
Sbjct: 132 AMQVCHR 138

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           ++IG G FG V  G  +  G     +E+ +     KS    KQ      E  ++G   H 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 68
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL   
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 477 NTIHR 481
           N +HR
Sbjct: 129 NYVHR 133

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 422 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 480 HR 481
           HR
Sbjct: 128 HR 129

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/128 (23%), Positives = 61/128 (47%), Gaps = 7/128 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            +++  K IG G FG   +  +++     A+K ++      +  +  + +++EI     L
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE------RGEKIDENVKREIINHRSL 72
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +H NIV++    +   HL I +EY   G +   +    R  +E   R F + +++G++Y 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYA 131
Query: 474 HSTNTIHR 481
           H+    HR
Sbjct: 132 HAMQVAHR 139

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 339 VMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVD 388
           V PH  E P+ +  +       +     K++G G FG V  G  +   +   S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  + +     E  ++G   H NI++  G       + I  E +  GS++ ++R
Sbjct: 83  VGYTEKQRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHR 171

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY   G +  ++R   R   E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQE 406
           K   ++  K+IGRG FG V +  ++ T    A+K +          E IK+       +E
Sbjct: 67  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 119
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  +
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 177
Query: 467 LNGLAYLHSTNTIHR 481
           +  L  +HS   IHR
Sbjct: 178 VLALDAIHSMGFIHR 192

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 19  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 74
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 75  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 133
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 134 KGMNYLEDRRLVHR 147

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 422 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 126
Query: 480 HR 481
           HR
Sbjct: 127 HR 128

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
           +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 422 YGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           + S   +   Y+  + V  G +  +   RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 480 HR 481
           HR
Sbjct: 128 HR 129

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQE 406
           K   ++  K+IGRG FG V +  ++ T    A+K +          E IK+       +E
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 124
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  +
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 182
Query: 467 LNGLAYLHSTNTIHR 481
           +  L  +HS   IHR
Sbjct: 183 VLALDAIHSMGFIHR 197

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 130 KGMNYLEDRRLVHR 143

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 70
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 71  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 130 KGMNYLEDRRLVHR 143

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 82
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 479 IHR 481
           IHR
Sbjct: 142 IHR 144

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 131 KGMNYLEDRRLVHR 144

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 135 KGMNYLEDRRLVHR 148

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 61/136 (44%), Gaps = 18/136 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           + +GRG FG V+   N+    + AIK + +    P      +++ +E+K L  L+H  IV
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHPGIV 66
Query: 420 QYYGSEVVDD------------HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRH 465
           +Y+ + +  +            +LYI ++     ++  ++   C   +   S+  +    
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 466 ILNGLAYLHSTNTIHR 481
           I   + +LHS   +HR
Sbjct: 127 IAEAVEFLHSKGLMHR 142

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 23  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 78
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 79  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 137
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 138 KGMNYLEDRRLVHR 151

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 346 KPSASPKK--SQWQK------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
           KP+AS  +  S WQ         LIG G++G V    ++      AIK++  + +D    
Sbjct: 37  KPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LI 94
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCR 452
           +C K++ +EI +L  L H+++V+     +  D      LY+ LE +      +  R    
Sbjct: 95  DC-KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVY 152
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
            +TE  ++    ++L G+ Y+HS   +HR
Sbjct: 153 -LTELHIKTLLYNLLVGVKYVHSAGILHR 180

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 135 KGMNYLEDRRLVHR 148

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 38  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 93
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 94  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 152
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 153 KGMNYLEDRRLVHR 166

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 131 KGMNYLEDRRLVHR 144

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 16  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 71
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 72  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 131 KGMNYLEDRRLVHR 144

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 11/122 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           IG G FG V++G   N++  A   I+E  +  +D           +E +V+  L H  +V
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHPKLV 66
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           Q YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     I
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 480 HR 481
           HR
Sbjct: 127 HR 128

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 90
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 476 TNTIHR 481
              +HR
Sbjct: 151 KKFVHR 156

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 109
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 476 TNTIHR 481
              +HR
Sbjct: 170 KKFVHR 175

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 82
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 479 IHR 481
           IHR
Sbjct: 142 IHR 144

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQE 406
           K   ++  K+IGRG FG V +  ++ T    A+K +          E IK+       +E
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 124
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   R +T  +
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 182
Query: 467 LNGLAYLHSTNTIHR 481
           +  L  +HS   IHR
Sbjct: 183 VLALDAIHSMGFIHR 197

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 477 NTIHR 481
           + +HR
Sbjct: 151 SAVHR 155

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ- 405
           P+ +  + +++K   IG+G FG V+ G   +  +  AIK + I+ D     E I++ ++ 
Sbjct: 14  PTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEF 70
Query: 406 --EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             E+ ++ +L H NIV+ YG  ++ +   + +E+V  G +   + +    I  S+     
Sbjct: 71  QREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 464 RHILNGLAYLHSTN--TIHR 481
             I  G+ Y+ + N   +HR
Sbjct: 129 LDIALGIEYMQNQNPPIVHR 148

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
           K IG+G FG V+ G   +  +  AIK + I+ D     E I++ ++   E+ ++ +L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ Y+ + 
Sbjct: 84  NIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 477 N--TIHR 481
           N   +HR
Sbjct: 142 NPPIVHR 148

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 83
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 476 TNTIHR 481
              +HR
Sbjct: 144 KKFVHR 149

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 17  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 70
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 71  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 479 IHR 481
           IHR
Sbjct: 130 IHR 132

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 110
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 476 TNTIHR 481
              +HR
Sbjct: 171 KKFVHR 176

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 10  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 65
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 66  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 124
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 125 EGMNYLEDRRLVHR 138

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
           K IG+G FG V+ G   +  +  AIK + I+ D     E I++ ++   E+ ++ +L H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ Y+ + 
Sbjct: 84  NIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 477 N--TIHR 481
           N   +HR
Sbjct: 142 NPPIVHR 148

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 476 TNTIHR 481
              +HR
Sbjct: 152 KKFVHR 157

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 62
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 63  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 122 KGMNYLEDRRLVHR 135

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 55/124 (44%), Gaps = 11/124 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 418
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 478 TIHR 481
            +HR
Sbjct: 137 IVHR 140

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 37/150 (24%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 414 KHENIVQYYGSEVVDDH-------------LYIYLEY---------VHPGSINRYVREHC 451
            H+ +V+YY + +   +             L+I +EY         +H  ++N+   E+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           R           R IL  L+Y+HS   IHR
Sbjct: 120 R---------LFRQILEALSYIHSQGIIHR 140

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +K++E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKEIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +K++E    E ++L
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKEIEHTLNEKRIL 95
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 155 EYLHSLDLIYR 165

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 55/124 (44%), Gaps = 11/124 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 418
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 478 TIHR 481
            +HR
Sbjct: 137 IVHR 140

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 18/148 (12%)
Query: 344 MEKPSASPK----KSQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPK 395
           ME   A PK     ++++  KL+G+GTFG V +   + TG   A+    KEV +  D+  
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-- 191
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDI 454
               +     E +VL + +H  +     S    D L   +EY + G +  ++ RE  R  
Sbjct: 192 ----VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVF 245
Query: 455 TESIVRNFTRHILNGLAYLHS-TNTIHR 481
           +E   R +   I++ L YLHS  N ++R
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYR 273

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 36/145 (24%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 49  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 456
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
             +      +  G+ YL   + +HR
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHR 182

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 8   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 67
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 125
Query: 463 TRHILNGLAYLHSTNTIHR 481
              +L  + YLH    IHR
Sbjct: 126 FYQMLLAVQYLHENGIIHR 144

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 89
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 476 TNTIHR 481
              +HR
Sbjct: 150 KKFVHR 155

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           ++++ G+ IG G+FG +Y+GTN +T    AIK  ++    P       QL  E K+   L
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRIL 59
Query: 414 KHENI---VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           +       V+++G E   D+  + ++ + P S+        R ++   V      ++N +
Sbjct: 60  QGGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 471 AYLHSTNTIHR 481
            ++HS + +HR
Sbjct: 117 EFVHSKSFLHR 127

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 88
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 476 TNTIHR 481
              +HR
Sbjct: 149 KKFVHR 154

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 18/148 (12%)
Query: 344 MEKPSASPK----KSQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPK 395
           ME   A PK     ++++  KL+G+GTFG V +   + TG   A+    KEV +  D+  
Sbjct: 137 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-- 194
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDI 454
               +     E +VL + +H  +     S    D L   +EY + G +  ++ RE  R  
Sbjct: 195 ----VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVF 248
Query: 455 TESIVRNFTRHILNGLAYLHS-TNTIHR 481
           +E   R +   I++ L YLHS  N ++R
Sbjct: 249 SEDRARFYGAEIVSALDYLHSEKNVVYR 276

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 463 TRHILNGLAYLHSTNTIHR 481
              +L  + YLH    IHR
Sbjct: 120 FYQMLLAVQYLHENGIIHR 138

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 463 TRHILNGLAYLHSTNTIHR 481
              +L  + YLH    IHR
Sbjct: 120 FYQMLLAVQYLHENGIIHR 138

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 86
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 476 TNTIHR 481
              +HR
Sbjct: 147 KKFVHR 152

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 90
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 476 TNTIHR 481
              +HR
Sbjct: 151 KKFVHR 156

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IG G FG V  G  +  G    + AIK + +   + +     +    E  ++G   H 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR----RDFLCEASIMGQFDHP 104
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           N+V   G       + I +E++  G+++ ++R+H    T   +    R I  G+ YL   
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 477 NTIHR 481
             +HR
Sbjct: 165 GYVHR 169

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 476 TNTIHR 481
              +HR
Sbjct: 152 KKFVHR 157

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 119
Query: 463 TRHILNGLAYLHSTNTIHR 481
              +L  + YLH    IHR
Sbjct: 120 FYQMLLAVQYLHENGIIHR 138

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 7/139 (5%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 1   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 60
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +E EI++L  L H  I++       +D+ YI LE +  G +   V  + R + E+  + +
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLY 118
Query: 463 TRHILNGLAYLHSTNTIHR 481
              +L  + YLH    IHR
Sbjct: 119 FYQMLLAVQYLHENGIIHR 137

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLG 411
           Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRILQ 97
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            +    + +   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+    
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFE 156
Query: 472 YLHSTNTIHR 481
           YLHS + I+R
Sbjct: 157 YLHSLDLIYR 166

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 55/124 (44%), Gaps = 11/124 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVLGHLKHENI 418
           ++G G F  V +  ++ T    AIK +       K A   K+  +E EI VL  +KH NI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           V          HLY+ ++ V  G + +R V +     TE         +L+ + YLH   
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLG 136
Query: 478 TIHR 481
            +HR
Sbjct: 137 IVHR 140

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 36/145 (24%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 20  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 456
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
             +      +  G+ YL   + +HR
Sbjct: 129 GQLLAVASQVAAGMVYLAGLHFVHR 153

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 7/123 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
           +G G +GSV    ++ +G   AIK++      P  +E   K+  +E+ +L H++HEN++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 421 YYGSEVVDDHLYIYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
                     L  + ++  V P       +      +E  ++     +L GL Y+HS   
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 479 IHR 481
           +HR
Sbjct: 148 VHR 150

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ + +G G+FG V +  ++ETG   A+K    I D  K  + +KQ+E    E ++ 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIQ 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    +V+   S   + +LY+ LEY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    + +   S   + +LY+ +EY   G +  ++R   R  +E   R +   I+   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 40  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 93
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 94  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 477 NTIHR 481
           + IHR
Sbjct: 151 SIIHR 155

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++  G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + + ++ +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 135 KGMNYLEDRRLVHR 148

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 33  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 86
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 87  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 477 NTIHR 481
           + IHR
Sbjct: 144 SIIHR 148

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/125 (24%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +  + +     E  ++G   H 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----EASIMGQFDHP 106
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  E +  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 477 NTIHR 481
             +HR
Sbjct: 167 GYVHR 171

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/125 (24%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K++G G FG V  G  +   +   S AIK + +   + +     +    E  ++G   H 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHP 77
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  E +  GS++ ++R+H    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 477 NTIHR 481
             +HR
Sbjct: 138 GYVHR 142

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 36/145 (24%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
           +G G FG V++       A C     +++P+  K    +K L           ++E ++L
Sbjct: 26  LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------------ITE 456
             L+H++IV+++G       L +  EY+  G +NR++R H  D              +  
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
             +      +  G+ YL   + +HR
Sbjct: 135 GQLLAVASQVAAGMVYLAGLHFVHR 159

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 150
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 476 TNTIHR 481
              +HR
Sbjct: 211 KKFVHR 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 94
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 95  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 SIIHR 156

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 94
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 95  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 477 NTIHR 481
           + IHR
Sbjct: 152 SIIHR 156

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+G+FG V    +R T    A+K ++      K    I    +E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 421 YYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 479 IHR 481
           +HR
Sbjct: 143 VHR 145

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 71
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 477 NTIHR 481
           + IHR
Sbjct: 129 SIIHR 133

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 15  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 68
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 69  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 477 NTIHR 481
           + IHR
Sbjct: 126 SIIHR 130

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 14/151 (9%)
Query: 341 PHIMEKPSASPK-------KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
           PH  E+P  + +        S+    K+IG G  G V  G  R  G     ++V +    
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKA 84
Query: 394 PKSAECIKQ---LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
            K+    +Q      E  ++G   H NI++  G         I  EY+  GS++ ++R H
Sbjct: 85  LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               T   +    R +  G+ YL     +HR
Sbjct: 145 DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 14/151 (9%)
Query: 341 PHIMEKPSASPK-------KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
           PH  E+P  + +        S+    K+IG G  G V  G  R  G     ++V +    
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKA 84
Query: 394 PKSAECIKQ---LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
            K+    +Q      E  ++G   H NI++  G         I  EY+  GS++ ++R H
Sbjct: 85  LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               T   +    R +  G+ YL     +HR
Sbjct: 145 DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 66
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 477 NTIHR 481
           + IHR
Sbjct: 124 SIIHR 128

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 71
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 477 NTIHR 481
           + IHR
Sbjct: 129 SIIHR 133

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 26/166 (15%)
Query: 342 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 450
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 451 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHR 481
              C   + +I+             +F+  +  G+A+L S N IHR
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 66
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYSTA-PQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 477 NTIHR 481
           + IHR
Sbjct: 124 SIIHR 128

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 477 NTIHR 481
           + +HR
Sbjct: 130 SYVHR 134

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVL 410
            Q+++ K +G G+FG V +  + ETG   A+K    I D  K  + +KQ+E    E ++L
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVK-LKQIEHTLNEKRIL 96
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             +    + +   S   + +LY+ +EY   G +  ++R   R   E   R +   I+   
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHARFYAAQIVLTF 155
Query: 471 AYLHSTNTIHR 481
            YLHS + I+R
Sbjct: 156 EYLHSLDLIYR 166

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 481 R 481
           R
Sbjct: 145 R 145

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHLKHE 416
           K+IG G FG V  G  +  G     +E+ +     K+    KQ      E  ++G   H 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI+   G       + I  EY+  GS++ ++R++    T   +    R I +G+ YL   
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 477 NTIHR 481
           + +HR
Sbjct: 136 SYVHR 140

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 61/125 (48%), Gaps = 10/125 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           +G G +GSV    +       A+K+   +    +S    ++  +E+++L HLKHEN++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKK---LSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 420 --QYYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
              +  +  ++D   +YL     G+ +N  V+     +++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA--LSDEHVQFLVYQLLRGLKYIHSA 150
Query: 477 NTIHR 481
             IHR
Sbjct: 151 GIIHR 155

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 6/131 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   +++   +G G  G V    +R +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 14  KDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL---EIKPA-IRNQIIRELQVLH 69
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ ++E  R I E I+   +  +L GLA
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLA 128
Query: 472 YLHSTNTI-HR 481
           YL   + I HR
Sbjct: 129 YLREKHQIMHR 139

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G   +     A+K +++    P+  +  K    E+ VL   +H NI
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK---NEVGVLRKTRHVNI 66
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR--NFTRHILNGLAYLHST 476
           + + G       L I  ++    S+  Y   H  +    +++  +  R    G+ YLH+ 
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 477 NTIHR 481
           + IHR
Sbjct: 124 SIIHR 128

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 66  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 121
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 180
Query: 472 YLHSTNTI-HR 481
           YL   + I HR
Sbjct: 181 YLREKHKIMHR 191

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 96
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 476 TNTIHR 481
              +HR
Sbjct: 157 KKFVHR 162

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 411
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 412 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 137
Query: 471 AYLHSTNTIHR 481
             LH  N +HR
Sbjct: 138 CALHKLNIVHR 148

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 476 TNTIHR 481
              +HR
Sbjct: 152 KKFVHR 157

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----- 450
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 451 ----------CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                        ++   + +    +  G+ YL S   IHR
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 92
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 476 TNTIHR 481
              +HR
Sbjct: 153 KKFVHR 158

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 481 R 481
           R
Sbjct: 145 R 145

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 69
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 128
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 129 LHSLQIAH 136

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 411
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 412 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 137
Query: 471 AYLHSTNTIHR 481
             LH  N +HR
Sbjct: 138 CALHKLNIVHR 148

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 92
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 476 TNTIHR 481
              +HR
Sbjct: 153 KKFVHR 158

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 69
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 128
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 129 LHSLQIAH 136

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 26/166 (15%)
Query: 342 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 27  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 450
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 451 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHR 481
              C   + +I+             +F+  +  G+A+L S N IHR
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 192

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 91
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 476 TNTIHR 481
              +HR
Sbjct: 152 KKFVHR 157

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY GT   N      CA+K ++ I D  +    + Q   E  ++    H 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHP 89
Query: 417 NIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           N++   G  +  +    + L Y+  G +  ++R    + T   +  F   +  G+ +L S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 476 TNTIHR 481
              +HR
Sbjct: 150 KKFVHR 155

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 26/166 (15%)
Query: 342 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 22  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 81
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 450
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 82  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 141
Query: 451 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHR 481
              C   + +I+             +F+  +  G+A+L S N IHR
Sbjct: 142 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 187

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 26/161 (16%)
Query: 347 PSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           P+  P   +W+        GK +G G FG V   T      S A   V +    P +   
Sbjct: 25  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 400 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----CR 452
            ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R       C 
Sbjct: 85  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 453 DITESIVR------------NFTRHILNGLAYLHSTNTIHR 481
             + +I+             +F+  +  G+A+L S N IHR
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 185

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 26/166 (15%)
Query: 342 HIMEKPSASPKKSQWQK-------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
           ++   P+  P   +W+        GK +G G FG V   T      S A   V +    P
Sbjct: 27  YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-- 450
            +    ++ L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R    
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 451 ---CRDITESIVR------------NFTRHILNGLAYLHSTNTIHR 481
              C   + +I+             +F+  +  G+A+L S N IHR
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 192

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 37/150 (24%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVXLLASL 59
Query: 414 KHENIVQYYGSEVVDDH-------------LYIYLEY---------VHPGSINRYVREHC 451
            H+ +V+YY + +   +             L+I  EY         +H  ++N+   E+ 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           R           R IL  L+Y+HS   IHR
Sbjct: 120 R---------LFRQILEALSYIHSQGIIHR 140

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLG 411
           ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 412 HLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
            +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  +
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 124
Query: 471 AYLHSTNTIHR 481
             LH  N +HR
Sbjct: 125 CALHKLNIVHR 135

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 481 R 481
           R
Sbjct: 135 R 135

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 481 R 481
           R
Sbjct: 139 R 139

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 16/142 (11%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDPKSAECIKQL 403
           S S     W    ++G+G   +V+ G +++TG   AIK  + I    P D +        
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------- 55
Query: 404 EQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVRE--HCRDITESIV 459
            +E +VL  L H+NIV+ +    E    H  + +E+   GS+   + E  +   + ES  
Sbjct: 56  -REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
               R ++ G+ +L     +HR
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHR 136

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/125 (21%), Positives = 63/125 (50%), Gaps = 13/125 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLKHE 416
           IG+G+FG V I    +T    A+K ++         +C+++ E     +E++++  L+H 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +V  + S   ++ +++ ++ +  G +  +++++     E  V+ F   ++  L YL + 
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQNQ 134
Query: 477 NTIHR 481
             IHR
Sbjct: 135 RIIHR 139

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 20/152 (13%)
Query: 340 MPHIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIP 391
           +P +  KP    +K  W+         K +G G FG V++ T N+ T    A+K +    
Sbjct: 161 VPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMK--- 215
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--E 449
             P S   ++    E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++  E
Sbjct: 216 --PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 271
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +     ++ +F+  I  G+A++   N IHR
Sbjct: 272 GSKQPLPKLI-DFSAQIAEGMAFIEQRNYIHR 302

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 481 R 481
           R
Sbjct: 135 R 135

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQE 406
           +S +   + I  G++G+V  G + E G   AIK V     D ++   +      K++ +E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 407 IKVLGHLKHENI-----VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
           I++L H  H NI     +  +  E     LY+  E +    + + + +    I+   ++ 
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           F  HIL GL  LH    +HR
Sbjct: 139 FMYHILLGLHVLHEAGVVHR 158

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/135 (23%), Positives = 60/135 (44%), Gaps = 14/135 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQE 406
           K   +   K+IGRG FG V +  ++ +    A+K +          E IK+       +E
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLL-------SKFEMIKRSDSAFFWEE 125
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             ++       +VQ + +   D +LY+ +EY+  G +   +  +  D+ E   + +T  +
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEV 183
Query: 467 LNGLAYLHSTNTIHR 481
           +  L  +HS   IHR
Sbjct: 184 VLALDAIHSMGLIHR 198

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKV 409
           ++++  KL+G+GTFG V +   + TG   A+    KEV +  D+      +     E +V
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 63
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 468
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 121
Query: 469 GLAYLHS-TNTIHR 481
            L YLHS  N ++R
Sbjct: 122 ALDYLHSEKNVVYR 135

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKV 409
           ++++  KL+G+GTFG V +   + TG   A+    KEV +  D+      +     E +V
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 62
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 468
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 120
Query: 469 GLAYLHST-NTIHR 481
            L YLHS  N ++R
Sbjct: 121 ALDYLHSEKNVVYR 134

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 481 R 481
           R
Sbjct: 139 R 139

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQE 406
           +S +   + I  G++G+V  G + E G   AIK V     D ++   +      K++ +E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 407 IKVLGHLKHENI-----VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
           I++L H  H NI     +  +  E     LY+  E +    + + + +    I+   ++ 
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 462 FTRHILNGLAYLHSTNTIHR 481
           F  HIL GL  LH    +HR
Sbjct: 139 FMYHILLGLHVLHEAGVVHR 158

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 8   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 65
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 66  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 163

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++  G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 20  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 75
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 76  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 135 KGMNYLEDRRLVHR 148

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 12  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 69
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 70  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 126
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 127 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 167

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 11  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 68
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 69  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 125
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 126 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 166

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 20/152 (13%)
Query: 340 MPHIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIP 391
           +P +  KP    +K  W+         K +G G FG V++ T N+ T    A+K +    
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMK--- 221
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--E 449
             P S   ++    E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++  E
Sbjct: 222 --PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 277
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +     ++ +F+  I  G+A++   N IHR
Sbjct: 278 GSKQPLPKLI-DFSAQIAEGMAFIEQRNYIHR 308

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAI----KEVDIIPDDPKSAECIKQLEQEIKV 409
           ++++  KL+G+GTFG V +   + TG   A+    KEV +  D+      +     E +V
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 61
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILN 468
           L + +H  +     S    D L   +EY + G +  ++ RE  R  +E   R +   I++
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVS 119
Query: 469 GLAYLHST-NTIHR 481
            L YLHS  N ++R
Sbjct: 120 ALDYLHSEKNVVYR 133

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 16/142 (11%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDDPKSAECIKQL 403
           S S     W    ++G+G   +V+ G +++TG   AIK  + I    P D +        
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------- 55
Query: 404 EQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVRE--HCRDITESIV 459
            +E +VL  L H+NIV+ +    E    H  + +E+   GS+   + E  +   + ES  
Sbjct: 56  -REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
               R ++ G+ +L     +HR
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHR 136

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGL 133
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 76
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 77  LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 174

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGH 412
           +  G+ +G G F  V     + TG   A K +       KS+      + +E+E+ +L  
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKE 70
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           ++H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYY 129
Query: 473 LHSTNTIH 480
           LHS    H
Sbjct: 130 LHSLQIAH 137

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G+GTF  ++ G  RE G    + E +++    D       +   +   ++  L H+++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
             YG  V  D   +  E+V  GS++ Y++++   I         + +   + +L     I
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135
Query: 480 H 480
           H
Sbjct: 136 H 136

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 472 YLHSTNTI-HR 481
           YL   + I HR
Sbjct: 119 YLREKHKIMHR 129

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++  G FG+VY G     G       AIKE+     +  S +  K++  E 
Sbjct: 13  KETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGT---------NRETGASCAIKEVDIIPDDPK 395
           E P     + +   GK +G G FG V +           NR T  +  + + D    D  
Sbjct: 60  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 117
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR------- 448
            ++ I ++E  +K++G  KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 118 LSDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 449 EHCRD--------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E+  +        ++   + +    +  G+ YL S   IHR
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 2/121 (1%)
Query: 362 IGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           +G G+FG V  G  +  +G + ++    + PD     E +    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            YG  V+   + +  E    GS+   +R+H        +  +   +  G+ YL S   IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 481 R 481
           R
Sbjct: 135 R 135

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 418
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 89
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 473
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 474 HSTNTIHR 481
           HS   IHR
Sbjct: 150 HSLKIIHR 157

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+G+FG V    +R T    A+K ++      K    I    +E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 421 YYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 479 IHR 481
           +HR
Sbjct: 143 VHR 145

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 26/132 (19%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 90
Query: 420 ----------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
                     Q     +V D +            + Y    C+ ++   +  F   IL G
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM----------ETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 470 LAYLHSTNTIHR 481
           L Y+HS N +HR
Sbjct: 141 LKYIHSANVLHR 152

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 7/125 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETG--ASC-AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IG G FG V  G  +  G   SC AIK +     + +  E +     E  ++G  +H 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS----EASIMGQFEHP 77
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           NI++  G       + I  E++  G+++ ++R +    T   +    R I +G+ YL   
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 477 NTIHR 481
           + +HR
Sbjct: 138 SYVHR 142

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
           IG G +G V    +       AIK++   P + ++  C + L +EIK+L   +HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTY-CQRTL-REIKILLRFRHENIIGI 106
Query: 420 -QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
                +  ++    +YL   H    + Y     + ++   +  F   IL GL Y+HS N 
Sbjct: 107 NDIIRAPTIEQMKDVYL-VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 479 IHR 481
           +HR
Sbjct: 166 LHR 168

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++G+G+FG V    +R T    A+K ++      K    I    +E+++L  L H NI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 421 YYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
            +  E+++D    YI  E    G +   + +  R  +E       + + +G+ Y+H  N 
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNI 142
Query: 479 IHR 481
           +HR
Sbjct: 143 VHR 145

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 418
           K++G G+ G+V    + + G   A+K + I         C   L  EIK+L     H N+
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIAL-MEIKLLTESDDHPNV 89
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT-----RHILNGLAYL 473
           ++YY SE  D  LYI LE  +    +    ++  D    + + +      R I +G+A+L
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 149
Query: 474 HSTNTIHR 481
           HS   IHR
Sbjct: 150 HSLKIIHR 157

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 13/125 (10%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           K +G G FG V++ T N+ T    A+K +      P S   ++    E  V+  L+H+ +
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSM-SVEAFLAEANVMKTLQHDKL 72
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHST 476
           V+ +   V  + +YI  E++  GS+  +++  E  +     ++ +F+  I  G+A++   
Sbjct: 73  VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFIEQR 130
Query: 477 NTIHR 481
           N IHR
Sbjct: 131 NYIHR 135

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G  G V+  +++ +G   A K + +   + K A    Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPA-IRNQIIRELQVLH 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 472 YLHSTNTI-HR 481
           YL   + I HR
Sbjct: 119 YLREKHKIMHR 129

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	481
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-56
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-27
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-22
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-21
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-19
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-18
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-17
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-15
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-14
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-14
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-11
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-10
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-08
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-08
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-06
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  187 bits (478), Expect = 3e-56
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 7/139 (5%)

Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
           +      +  +     ++G+GT+G VY G +       AIKE+       + +   + L 
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLH 67

Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNF 462
           +EI +  HLKH+NIVQY GS   +  + I++E V  GS++  +R     +   E  +  +
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 463 TRHILNGLAYLHSTNTIHR 481
           T+ IL GL YLH    +HR
Sbjct: 128 TKQILEGLKYLHDNQIVHR 146

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  172 bits (439), Expect = 4e-50
 Identities = 36/179 (20%), Positives = 68/179 (37%), Gaps = 14/179 (7%)

Query: 303 PQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLI 362
             +   L ++ +  +A    L P         +T  + P          +         +
Sbjct: 10  AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREEVHWMTHQPRV 66

Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
           GRG+FG V+   +++TG  CA+K+V +               +E+     L    IV  Y
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPLY 116

Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           G+      + I++E +  GS+ + ++     + E     +    L GL YLH+   +H 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  165 bits (421), Expect = 6e-48
 Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 13/159 (8%)

Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
              +      +    +     S      +    IGRG+F +VY G + ET    A  E+ 
Sbjct: 4   RNQQQDDIEELETKAVGM---SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHPGSIN 444
              D   +    ++ ++E ++L  L+H NIV++Y S          + +  E +  G++ 
Sbjct: 61  ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117

Query: 445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNT--IHR 481
            Y++     +   ++R++ R IL GL +LH+     IHR
Sbjct: 118 TYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  152 bits (385), Expect = 1e-42
 Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 7/138 (5%)

Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
             S   +++ + + IG G FGSV+    R  G   AIK               +   +E+
Sbjct: 5   MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREV 61

Query: 408 KVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 463
                L +H ++V+Y+ +   DDH+ I  EY + GS+   + E+ R      E+ +++  
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 464 RHILNGLAYLHSTNTIHR 481
             +  GL Y+HS + +H 
Sbjct: 122 LQVGRGLRYIHSMSLVHM 139

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  144 bits (365), Expect = 1e-39
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 5/156 (3%)

Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
                 V        +         + ++  K IGRG F  VY       G   A+K+V 
Sbjct: 7   GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           I   D   A+      +EI +L  L H N+++YY S + D+ L I LE    G ++R ++
Sbjct: 67  I--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 449 EHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +    I E  V  +   + + L ++HS   +HR
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 6e-36
 Identities = 35/172 (20%), Positives = 65/172 (37%), Gaps = 3/172 (1%)

Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
           L + N        L P  +S    +  +   P        S  +  +Q+   +G G++G 
Sbjct: 13  LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72

Query: 370 VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429
           V+   ++E G   A+K        PK  +  ++L +        +H   V+   +     
Sbjct: 73  VFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            LY+  E     S+ ++       + E+ V  + R  L  LA+LHS   +H 
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 7e-35
 Identities = 32/185 (17%), Positives = 67/185 (36%), Gaps = 8/185 (4%)

Query: 299 HKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK 358
           H     +S  +   +              +  P                  S K   +  
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--E 416
            K IG G    V+   N E     AIK V++   D ++   +     EI  L  L+   +
Sbjct: 61  LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSD 116

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            I++ Y  E+ D ++Y+ +E  +   +N ++++    I     +++ +++L  +  +H  
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQH 174

Query: 477 NTIHR 481
             +H 
Sbjct: 175 GIVHS 179

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  131 bits (331), Expect = 2e-34
 Identities = 28/132 (21%), Positives = 60/132 (45%), Gaps = 8/132 (6%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   +   K IG G    V+   N E     AIK V++   D ++   +     EI  L 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLN 62

Query: 412 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
            L+   + I++ Y  E+ D ++Y+ +E  +   +N ++++  + I     +++ +++L  
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEA 120

Query: 470 LAYLHSTNTIHR 481
           +  +H    +H 
Sbjct: 121 VHTIHQHGIVHS 132

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (328), Expect = 2e-34
 Identities = 29/140 (20%), Positives = 62/140 (44%), Gaps = 8/140 (5%)

Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           +   S S K   +   K IG G    V+   N E     AIK V++   +    + +   
Sbjct: 18  LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSY 73

Query: 404 EQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
             EI  L  L+   + I++ Y  E+ D ++Y+ +E  +   +N ++++  + I     ++
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS 131

Query: 462 FTRHILNGLAYLHSTNTIHR 481
           + +++L  +  +H    +H 
Sbjct: 132 YWKNMLEAVHTIHQHGIVHS 151

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  130 bits (329), Expect = 3e-34
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 12/181 (6%)

Query: 310 LESNNHLNAHPLPLP-------PGALSPPKSSVTSAVM--PHIMEKPSASPKKSQWQKGK 360
           +   +H + H   +P        GA+ P  +   +  +  P + E       +  +   +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
            IG G+FG+VY   +       AIK++          E  + + +E++ L  L+H N +Q
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
           Y G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAYLHS N IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177

Query: 481 R 481
           R
Sbjct: 178 R 178

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (320), Expect = 2e-33
 Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 5/129 (3%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
              W+    +G G FG VY   N+ETGA  A K ++   ++      ++    EI++L  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILAT 72

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
             H  IV+  G+   D  L+I +E+   G+++  + E  R +TE  ++   R +L  L +
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 473 LHSTNTIHR 481
           LHS   IHR
Sbjct: 133 LHSKRIIHR 141

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (316), Expect = 5e-33
 Identities = 42/139 (30%), Positives = 73/139 (52%), Gaps = 10/139 (7%)

Query: 348 SASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLE 404
           +    +    ++ G L+G+G+F  VY   +  TG   AIK   +I       A  +++++
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59

Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITESIVRNF 462
            E+K+   LKH +I++ Y     +D  Y+Y  LE  H G +NRY++   +  +E+  R+F
Sbjct: 60  NEVKIHCQLKHPSILELY--NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117

Query: 463 TRHILNGLAYLHSTNTIHR 481
              I+ G+ YLHS   +HR
Sbjct: 118 MHQIITGMLYLHSHGILHR 136

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (307), Expect = 2e-31
 Identities = 37/149 (24%), Positives = 61/149 (40%), Gaps = 11/149 (7%)

Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           M         S  +  ++  ++IG G    V            AIK +++          
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---- 56

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
           + +L +EI+ +    H NIV YY S VV D L++ ++ +  GS+   ++           
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 454 -ITESIVRNFTRHILNGLAYLHSTNTIHR 481
            + ES +    R +L GL YLH    IHR
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHR 145

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (303), Expect = 7e-31
 Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 7/126 (5%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +   + +G G++GSVY   ++ETG   AIK+V +  D       ++++ +EI ++     
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            ++V+YYGS   +  L+I +EY   GS++  +R   + +TE  +    +  L GL YLH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 476 TNTIHR 481
              IHR
Sbjct: 144 MRKIHR 149

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (302), Expect = 9e-31
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 7/138 (5%)

Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           M+   A P++  + K + IG+G+FG V+ G +  T    AIK +D+   + +    I+ +
Sbjct: 13  MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDI 67

Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
           +QEI VL       + +YYGS + D  L+I +EY+  GS    +      + E+ +    
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATIL 125

Query: 464 RHILNGLAYLHSTNTIHR 481
           R IL GL YLHS   IHR
Sbjct: 126 REILKGLDYLHSEKKIHR 143

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (303), Expect = 1e-30
 Identities = 34/128 (26%), Positives = 63/128 (49%), Gaps = 4/128 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++ + + IG G+FG   +  + E G    IKE++I      S++  ++  +E+ VL ++K
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANMK 81

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
           H NIVQY  S   +  LYI ++Y   G + + +         E  + ++   I   L ++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 474 HSTNTIHR 481
           H    +HR
Sbjct: 142 HDRKILHR 149

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (297), Expect = 4e-30
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 7/129 (5%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           K ++ + + IG+G  G+VY   +  TG   AI+++++     K       +  EI V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRE 73

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
            K+ NIV Y  S +V D L++ +EY+  GS+   V E C  + E  +    R  L  L +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131

Query: 473 LHSTNTIHR 481
           LHS   IHR
Sbjct: 132 LHSNQVIHR 140

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (297), Expect = 8e-30
 Identities = 37/170 (21%), Positives = 72/170 (42%), Gaps = 14/170 (8%)

Query: 320 PLPLPPGA-----LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
           P P  PG      ++ P +   +     I E       + ++ +G+ +G+G F   +  +
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 375 NRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
           + +T    A K   I+P          +++  EI +   L H+++V ++     +D+ ++
Sbjct: 62  DADTKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFV 116

Query: 434 Y--LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +  LE     S+    +     +TE   R + R I+ G  YLH    IHR
Sbjct: 117 FVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHR 165

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (294), Expect = 8e-30
 Identities = 32/144 (22%), Positives = 65/144 (45%), Gaps = 12/144 (8%)

Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAEC 399
           P ++  P     + ++ +G+ +G+G F   +  ++ +T    A K   I+P         
Sbjct: 5   PEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQ 58

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITES 457
            +++  EI +   L H+++V ++     +D+ +++  LE     S+    +     +TE 
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEP 115

Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
             R + R I+ G  YLH    IHR
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHR 139

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  116 bits (293), Expect = 1e-29
 Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 19/142 (13%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
            S +++  ++G+G FG V    N       AIK++        + E +  +  E+ +L  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58

Query: 413 LKHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVREHCRDITESIV 459
           L H+ +V+YY + +   +             L+I +EY   G++   +     +      
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
               R IL  L+Y+HS   IHR
Sbjct: 119 WRLFRQILEALSYIHSQGIIHR 140

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 3e-29
 Identities = 30/135 (22%), Positives = 61/135 (45%), Gaps = 12/135 (8%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
              W    ++G+G   +V+ G +++TG   AIK   +  ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63

Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
           L H+NIV+ +   + ++    H  + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 467 LNGLAYLHSTNTIHR 481
           + G+ +L     +HR
Sbjct: 122 VGGMNHLRENGIVHR 136

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (294), Expect = 4e-29
 Identities = 31/137 (22%), Positives = 62/137 (45%), Gaps = 6/137 (4%)

Query: 348 SASPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
           S  P+   ++   +IG+G     +V +   + TG    ++ +++   +  S E +  L+ 
Sbjct: 19  SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQG 75

Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
           E+ V     H NIV Y  + + D+ L++   ++  GS    +  H  D + E  +    +
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 465 HILNGLAYLHSTNTIHR 481
            +L  L Y+H    +HR
Sbjct: 136 GVLKALDYIHHMGYVHR 152

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (290), Expect = 4e-29
 Identities = 36/170 (21%), Positives = 73/170 (42%), Gaps = 8/170 (4%)

Query: 313 NNHLNAHPLPLPPGALSPPKSSVTSA-VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
           ++H ++  + L    L      VT       +         +        IG G+ G V 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62

Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431
           +   + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ Y S +V + L
Sbjct: 63  LAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117

Query: 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           ++ +E++  G++   V +    + E  +      +L  LAYLH+   IHR
Sbjct: 118 WVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHR 165

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  113 bits (284), Expect = 2e-28
 Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 22/152 (14%)

Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
           MP   E          ++    IG G++G       +  G     KE+D       +   
Sbjct: 1   MPSRAED---------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAE 48

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---I 454
            + L  E+ +L  LKH NIV+YY    +  +  LYI +EY   G +   + +  ++   +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108

Query: 455 TESIVRNFTRHILNGLAYLHSTNT-----IHR 481
            E  V      +   L   H  +      +HR
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (288), Expect = 2e-28
 Identities = 30/135 (22%), Positives = 61/135 (45%), Gaps = 12/135 (8%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
              W    ++G+G   +V+ G +++TG   AIK   +  ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63

Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
           L H+NIV+ +   + ++    H  + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 467 LNGLAYLHSTNTIHR 481
           + G+ +L     +HR
Sbjct: 122 VGGMNHLRENGIVHR 136

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 3e-28
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 14/137 (10%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
              ++  +L+G GT+G VY G + +TG   AIK +D+  D+       ++++QEI +L  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKK 76

Query: 413 L-KHENIVQYYGS------EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTR 464
              H NI  YYG+        +DD L++ +E+   GS+   ++      + E  +    R
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 465 HILNGLAYLHSTNTIHR 481
            IL GL++LH    IHR
Sbjct: 137 EILRGLSHLHQHKVIHR 153

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  113 bits (284), Expect = 1e-27
 Identities = 28/130 (21%), Positives = 54/130 (41%), Gaps = 11/130 (8%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           K  +    ++G G  G++            A+K +          EC    ++E+++L  
Sbjct: 23  KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--------ECFSFADREVQLLRE 73

Query: 413 L-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
             +H N+++Y+ +E      YI +E     ++  YV +              +   +GLA
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 472 YLHSTNTIHR 481
           +LHS N +HR
Sbjct: 133 HLHSLNIVHR 142

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  110 bits (276), Expect = 3e-27
 Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 18/139 (12%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +  + +GRG FG V+   N+    + AIK + +    P      +++ +E+K L  L+H 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 417 NIVQYYGS------------EVVDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNF 462
            IV+Y+ +                 +LYI ++     ++  ++   C   +   S+  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 463 TRHILNGLAYLHSTNTIHR 481
              I   + +LHS   +HR
Sbjct: 124 FLQIAEAVEFLHSKGLMHR 142

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (272), Expect = 8e-27
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)

Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
           KK QW     + G+ +G+G FG+VY+   +++    A+K +       + A    QL +E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRRE 59

Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +++  HL+H NI++ YG       +Y+ LEY   G++ R +++  +   E     +   +
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118

Query: 467 LNGLAYLHSTNTIHR 481
            N L+Y HS   IHR
Sbjct: 119 ANALSYCHSKRVIHR 133

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  107 bits (270), Expect = 1e-26
 Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 26/142 (18%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++ +LIG G FG V+   +R  G +  IK V        + E   + E+E+K L  L H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNE---KAEREVKALAKLDHV 64

Query: 417 NIVQYYGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIV 459
           NIV Y G                       L+I +E+   G++ +++ +   + + + + 
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
                 I  G+ Y+HS   I+R
Sbjct: 125 LELFEQITKGVDYIHSKKLINR 146

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (278), Expect = 3e-26
 Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 18/148 (12%)

Query: 346 KPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           +  + P ++   W+  + +G G FG V    +++TG   AIK+         S +  ++ 
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC----RQELSPKNRERW 59

Query: 404 EQEIKVLGHLKHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYV--REHCRD 453
             EI+++  L H N+V     EV D        D   + +EY   G + +Y+   E+C  
Sbjct: 60  CLEIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           + E  +R     I + L YLH    IHR
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHR 145

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 1e-25
 Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 8/138 (5%)

Query: 349 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           A   K ++       G+ +G+G FG+VY+   ++     A+K +       +      QL
Sbjct: 4   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQL 61

Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
            +EI++  HL+H NI++ Y        +Y+ LE+   G + + +++H R   E     F 
Sbjct: 62  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFM 120

Query: 464 RHILNGLAYLHSTNTIHR 481
             + + L Y H    IHR
Sbjct: 121 EELADALHYCHERKVIHR 138

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (260), Expect = 3e-25
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 9/135 (6%)

Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K   I+ D  ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57

Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +   L HEN+V++Y        +  Y++LEY   G +   +      + E   + F   +
Sbjct: 58  INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114

Query: 467 LNGLAYLHSTNTIHR 481
           + G+ YLH     HR
Sbjct: 115 MAGVVYLHGIGITHR 129

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (261), Expect = 6e-25
 Identities = 32/131 (24%), Positives = 63/131 (48%), Gaps = 6/131 (4%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G  G V+  +++ +G   A K + +            Q+ +E++VL 
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLH 86

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 145

Query: 472 YLHST-NTIHR 481
           YL      +HR
Sbjct: 146 YLREKHKIMHR 156

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  102 bits (257), Expect = 2e-24
 Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 9/128 (7%)

Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-E 416
             K +GRG F  V    ++ TG   A K    +    +  +C  ++  EI VL   K   
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
            ++  +  EV ++   I L  EY   G I +  + E    ++E+ V    + IL G+ YL
Sbjct: 90  RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 474 HSTNTIHR 481
           H  N +H 
Sbjct: 148 HQNNIVHL 155

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (254), Expect = 2e-24
 Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 29/152 (19%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---------------------IIPDD 393
           Q+     IG+G++G V +  N       A+K +                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE 449
            +    I+Q+ QEI +L  L H N+V+    EV+D    DHLY+  E V+ G +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVP-T 130

Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               ++E   R + + ++ G+ YLH    IHR
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQKIIHR 161

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 3e-24
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 9/135 (6%)

Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           A P    W   + +G G +G V +  NR T  + A+K   I+ D  ++ +C + +++EI 
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57

Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
           +   L HEN+V++Y        +  Y++LEY   G +   +      + E   + F   +
Sbjct: 58  INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114

Query: 467 LNGLAYLHSTNTIHR 481
           + G+ YLH     HR
Sbjct: 115 MAGVVYLHGIGITHR 129

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (253), Expect = 3e-24
 Identities = 28/133 (21%), Positives = 55/133 (41%), Gaps = 10/133 (7%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
              +    +GRG +G V    +  +G   A+K +    +  +     K+L  ++ +    
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRT 62

Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNG 469
                 V +YG+   +  ++I +E +   S     + V +  + I E I+      I+  
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 470 LAYLHST-NTIHR 481
           L +LHS  + IHR
Sbjct: 122 LEHLHSKLSVIHR 134

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (252), Expect = 4e-24
 Identities = 40/128 (31%), Positives = 66/128 (51%), Gaps = 11/128 (8%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + +G G FG V++   R +G    IK    I  D +S   ++Q+E EI+VL  L H NI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIK---TINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYL 473
           ++ +  EV +D+  +Y+  E    G +  R V    R   ++E  V    + ++N LAY 
Sbjct: 83  IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 474 HSTNTIHR 481
           HS + +H+
Sbjct: 141 HSQHVVHK 148

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (254), Expect = 5e-24
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 8/137 (5%)

Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
               P    ++  K IG+G F  V +  +  TG   AIK   II     +   +++L +E
Sbjct: 8   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFRE 64

Query: 407 IKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
           ++++  L H NIV+ +  EV++    LY+ +EY   G +  Y+  H R + E   R+  R
Sbjct: 65  VRIMKILNHPNIVKLF--EVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFR 121

Query: 465 HILNGLAYLHSTNTIHR 481
            I++ + Y H    +HR
Sbjct: 122 QIVSAVQYCHQKRIVHR 138

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (257), Expect = 6e-24
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 17/136 (12%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           K+     K++G G+ G+V        G   A+K + I        +       EIK+L  
Sbjct: 14  KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTE 64

Query: 413 LK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV------REHCRDITESIVRNFTRH 465
              H N+++YY SE  D  LYI LE     ++   V       E+ +   E    +  R 
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 466 ILNGLAYLHSTNTIHR 481
           I +G+A+LHS   IHR
Sbjct: 124 IASGVAHLHSLKIIHR 139

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + +G+G F  V    ++ TG   A K   II     SA   ++LE+E ++   L+H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHST 476
           V+ + S   +   Y+  + V  G +    V RE     +E+   +  + IL  +AY HS 
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSN 124

Query: 477 NTIHR 481
             +HR
Sbjct: 125 GIVHR 129

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 1e-23
 Identities = 38/181 (20%), Positives = 70/181 (38%), Gaps = 17/181 (9%)

Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
           + S++H + H   L P        +   A    +       P +SQ+Q G L+G G FGS
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHA--TKLAPGKEKEPLESQYQVGPLLGSGGFGS 58

Query: 370 VYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYG 423
           VY G         AIK    +      D        ++  E+ +L  +      +++   
Sbjct: 59  VYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL- 114

Query: 424 SEVVD--DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
            +  +  D   + LE   P   +  ++ E    + E + R+F   +L  + + H+   +H
Sbjct: 115 -DWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 172

Query: 481 R 481
           R
Sbjct: 173 R 173

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (250), Expect = 2e-23
 Identities = 25/124 (20%), Positives = 48/124 (38%), Gaps = 8/124 (6%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + +GRG FG V+      +  +   K    +            +++EI +L   +H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAK---FV---KVKGTDQVLVKKEISILNIARHRNI 63

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +  + S    + L +  E++    I  R        + E  + ++   +   L +LHS N
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHN 122

Query: 478 TIHR 481
             H 
Sbjct: 123 IGHF 126

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 31/132 (23%), Positives = 66/132 (50%), Gaps = 6/132 (4%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLG 411
           ++ +  K IG+G FG V+ G   +  +  AIK + +   + ++   E  ++ ++E+ ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
           +L H NIV+ YG  ++ +   + +E+V  G +   + +    I  S+       I  G+ 
Sbjct: 79  NLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 472 YLHSTNT--IHR 481
           Y+ + N   +HR
Sbjct: 137 YMQNQNPPIVHR 148

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 28/126 (22%), Positives = 59/126 (46%), Gaps = 10/126 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
             ++G+G+FG V    +R T    A+K   +I       +    + +E+++L  L H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           ++ +  E+++D    Y+  E    G + +  ++      +E       + + +G+ Y+H 
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139

Query: 476 TNTIHR 481
            N +HR
Sbjct: 140 HNIVHR 145

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 9/139 (6%)

Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLE 404
           K     K   +  G  +G GTFG V IG ++ TG   A+K   I+     +S + + +++
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIK 59

Query: 405 QEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           +EI+ L   +H +I++ Y  +V+      ++ +EYV  G +  Y+ +H R + E   R  
Sbjct: 60  REIQNLKLFRHPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRL 116

Query: 463 TRHILNGLAYLHSTNTIHR 481
            + IL+ + Y H    +HR
Sbjct: 117 FQQILSAVDYCHRHMVVHR 135

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 10/125 (8%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              IGRG++G V I   + T    A K    IP      E + + +QEI+++  L H NI
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPK--YFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           ++ Y  E  +D+  IYL  E    G +   V        ES      + +L+ +AY H  
Sbjct: 69  IRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKL 125

Query: 477 NTIHR 481
           N  HR
Sbjct: 126 NVAHR 130

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 39/214 (18%), Positives = 78/214 (36%), Gaps = 14/214 (6%)

Query: 269 SADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL 328
             D        +    S  +  R  +   +      +  E +   +   +      P   
Sbjct: 11  GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70

Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
           +P    +       +  K  A        K +++G G FG V+      TG   A K + 
Sbjct: 71  APFDHRI-------VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV 447
                 +  +  ++++ EI V+  L H N++Q Y +    + + + +EYV  G + +R +
Sbjct: 124 T-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            E    +TE     F + I  G+ ++H    +H 
Sbjct: 179 DESYN-LTELDTILFMKQICEGIRHMHQMYILHL 211

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (252), Expect = 4e-23
 Identities = 29/125 (23%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
             ++G+G+FG V    +R T    A+K   +I       +    + +E+++L  L H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
           ++ +  E+++D    Y+  E    G +   + +  R  +E       + + +G+ Y+H  
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140

Query: 477 NTIHR 481
           N +HR
Sbjct: 141 NIVHR 145

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 23/135 (17%), Positives = 48/135 (35%), Gaps = 14/135 (10%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
            +   + +G G F  V +      G   A+K +          +  ++ ++E  +     
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFN 84

Query: 415 HENIVQYYGSEVVDD----HLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHI 466
           H NI++     + +       ++ L +   G+    I R   +    +TE  +      I
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGI 143

Query: 467 LNGLAYLHSTNTIHR 481
             GL  +H+    HR
Sbjct: 144 CRGLEAIHAKGYAHR 158

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 32/131 (24%), Positives = 58/131 (44%), Gaps = 16/131 (12%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
           G+ +G G F  V     + TG   A K    I        +     +++E+E+ +L  ++
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
           H NI+  +  ++ ++   + L  E V  G + +    +E    +TE     F + IL+G+
Sbjct: 67  HPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121

Query: 471 AYLHSTNTIHR 481
            YLHS    H 
Sbjct: 122 HYLHSKRIAHF 132

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.2 bits (245), Expect = 6e-23
 Identities = 30/122 (24%), Positives = 54/122 (44%), Gaps = 7/122 (5%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
           +G GT G V+    R+TG   A+K++    +  +     K++  ++ V+        IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQ 88

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTI 479
            +G+ + +  ++I +E +   +     R     I E I+   T  I+  L YL      I
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 480 HR 481
           HR
Sbjct: 148 HR 149

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (251), Expect = 6e-23
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 9/126 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
            +++G+G+FG V +  ++ TG  CA+K   +I     K     + L +E+++L  L H N
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 418 IVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           I++ Y  E  +D  Y YL  E    G +   +    R  +E       R +L+G+ Y+H 
Sbjct: 88  IMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHK 144

Query: 476 TNTIHR 481
              +HR
Sbjct: 145 NKIVHR 150

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 14/146 (9%)

Query: 341 PHIMEKPSASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
             +   P   P      ++   K IG G FG   +  ++ T    A+K    I       
Sbjct: 4   APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID 60

Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDIT 455
           E    +++EI     L+H NIV++   EV+    HL I +EY   G +   +    R  +
Sbjct: 61  E---NVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNAGR-FS 114

Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
           E   R F + +L+G++Y HS    HR
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHR 140

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 3/126 (2%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            ++IG+G F  V    NRETG   A+K VD+           + L++E  +   LKH +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDI-TESIVRNFTRHILNGLAYLHS 475
           V+   +   D  LY+  E++    +    V R     + +E++  ++ R IL  L Y H 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 476 TNTIHR 481
            N IHR
Sbjct: 149 NNIIHR 154

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 7e-23
 Identities = 37/162 (22%), Positives = 60/162 (37%), Gaps = 8/162 (4%)

Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
                              P +            +Q+ K +G G +G V +  ++ T   
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 382 CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVH 439
            AIK   II     S     +L +E+ VL  L H NI++ Y  +  +D    YL  E   
Sbjct: 65  RAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY--DFFEDKRNYYLVMECYK 119

Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G +   +    +   E       + +L+G+ YLH  N +HR
Sbjct: 120 GGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHR 160

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.6 bits (244), Expect = 7e-23
 Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           +  +   +++G G F  V++   R TG   A+K    I   P   +    LE EI VL  
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK---CIKKSPAFRD--SSLENEIAVLKK 62

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
           +KHENIV          H Y+ ++ V  G + +R + R      TE       + +L+ +
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAV 119

Query: 471 AYLHSTNTIHR 481
            YLH    +HR
Sbjct: 120 KYLHENGIVHR 130

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 9/125 (7%)

Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
           IGRG +GSV    ++ +G   A+K +    D+ +     KQL  ++ V+        IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQ 85

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 476
           +YG+   +   +I +E +       Y          I E I+   T   +  L +L    
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 477 NTIHR 481
             IHR
Sbjct: 146 KIIHR 150

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 7/127 (5%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKH 415
            K +G G  G V +   R+T    AI+ +          + A+    +E EI++L  L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 416 ENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
             I++       D    YI LE +  G +   V  + R + E+  + +   +L  + YLH
Sbjct: 200 PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 256

Query: 475 STNTIHR 481
               IHR
Sbjct: 257 ENGIIHR 263

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 37/140 (26%), Positives = 60/140 (42%), Gaps = 9/140 (6%)

Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ 402
           S  PK  + ++   K +G G  G V +   R+T    AIK +          + A+    
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61

Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
           +E EI++L  L H  I++       D    YI LE +  G +   V  + R + E+  + 
Sbjct: 62  VETEIEILKKLNHPCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKL 118

Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +L  + YLH    IHR
Sbjct: 119 YFYQMLLAVQYLHENGIIHR 138

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 38/123 (30%), Positives = 63/123 (51%), Gaps = 5/123 (4%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+++G+G FG     T+RETG    +KE+          E  +   +E+KV+  L+H N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           +++ G    D  L    EY+  G++   ++        S   +F + I +G+AYLHS N 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 479 IHR 481
           IHR
Sbjct: 130 IHR 132

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 16/131 (12%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
           G+ +G G F  V     + TG   A K    I        +     + +E+E+ +L  ++
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
           H N++  +  EV ++   + L  E V  G + +    +E    +TE     F + ILNG+
Sbjct: 73  HPNVITLH--EVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127

Query: 471 AYLHSTNTIHR 481
            YLHS    H 
Sbjct: 128 YYLHSLQIAHF 138

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 8/158 (5%)

Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK 385
           G      +              +++     +   + +G+G F  V    ++ TG   A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-N 444
              II     SA   ++LE+E ++   L+H NIV+ + S   +   Y+  + V  G +  
Sbjct: 61  ---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117

Query: 445 RYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             V RE     +E+   +  + IL  +AY HS   +HR
Sbjct: 118 DIVAREF---YSEADASHCIQQILESIAYCHSNGIVHR 152

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.7 bits (243), Expect = 2e-22
 Identities = 31/194 (15%), Positives = 62/194 (31%), Gaps = 32/194 (16%)

Query: 320 PLPLPPGALSPPKSSVTSAVMPHIMEK--------PSASPKKSQWQK------------- 358
           P     G +  P   V +     ++ K         S+ P   +WQ              
Sbjct: 3   PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQL 62

Query: 359 -------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
                    L+G G F  VY  T  +   +   ++  +    P +        Q ++ L 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHIL 467
                  +++Y + +  +   +  E    G+    IN Y     + + + +V +F   +L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 468 NGLAYLHSTNTIHR 481
             +  +H    IH 
Sbjct: 183 YMIEQVHDCEIIHG 196

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 29/129 (22%), Positives = 55/129 (42%), Gaps = 12/129 (9%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
           G+ +G G F  V     + TG   A K    I        +     +++E+E+ +L  + 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
           H N++  +        + + LE V  G + +    +E    ++E    +F + IL+G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130

Query: 473 LHSTNTIHR 481
           LH+    H 
Sbjct: 131 LHTKKIAHF 139

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 23/144 (15%)

Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAEC 399
           +MEK         ++K   IG G++G V+   NR+TG   AIK+     DD    K A  
Sbjct: 1   MMEK---------YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-- 49

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITES 457
           ++    EI++L  LKH N+V     EV      L++  EY    ++   +  + R + E 
Sbjct: 50  LR----EIRMLKQLKHPNLVNLL--EVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEH 102

Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
           +V++ T   L  + + H  N IHR
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHR 126

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 23/181 (12%)

Query: 314 NHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPK-----------KSQWQKGKLI 362
           +H + H   +  G  +    S++S          S  P               ++    +
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
           GRG    VY    + T    A+K +       K+ +  K +  EI VL  L H NI++  
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLK------KTVD-KKIVRTEIGVLLRLSHPNIIKLK 114

Query: 423 GSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
                   + + LE V  G + +R V + +    +E    +  + IL  +AYLH    +H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVH 171

Query: 481 R 481
           R
Sbjct: 172 R 172

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 26/181 (14%), Positives = 70/181 (38%), Gaps = 29/181 (16%)

Query: 324 PPGALSPPKSSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASC 382
           P G++    S+ ++ +  ++ +      K  + ++  + + +G F  + +    +     
Sbjct: 2   PLGSMKDILSNYSNLI--YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57

Query: 383 AIKEVD------------IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429
           A+K+ +               D           + E++++  +K+E  +      ++ + 
Sbjct: 58  ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE--GIITNY 115

Query: 430 -HLYIYLEYVHPGSINRYVREHCR-------DITESIVRNFTRHILNGLAYLHSTNTI-H 480
             +YI  EY+   SI ++              I   +++   + +LN  +Y+H+   I H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175

Query: 481 R 481
           R
Sbjct: 176 R 176

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 23/158 (14%)

Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
           S      T  +    MEK         ++   L+G G++G V    N++TG   AIK+  
Sbjct: 9   SSGVDLGTENLYFQSMEK---------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59

Query: 389 IIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSI 443
              DD    K A  ++    EIK+L  L+HEN+V     EV       Y+  E+V   +I
Sbjct: 60  ESDDDKMVKKIA--MR----EIKLLKQLRHENLVNLL--EVCKKKKRWYLVFEFVD-HTI 110

Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +      +   +V+ +   I+NG+ + HS N IHR
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR 148

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 17/153 (11%)

Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDII 390
            I+ +   + +            + + +G G FG V +         TG   A+K +   
Sbjct: 2   DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-- 59

Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVR 448
                    I  L++EI++L +L HENIV+Y G  +E   + + + +E++  GS+  Y+ 
Sbjct: 60  --PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117

Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           ++   I       +   I  G+ YL S   +HR
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 150

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 16/144 (11%)

Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
           M   + +    ++Q  + +G+G F  V        G   A     II     SA   ++L
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKL 57

Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI------TES 457
           E+E ++   LKH NIV+ + S   + H Y+  + V  G       E   DI      +E+
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSEA 110

Query: 458 IVRNFTRHILNGLAYLHSTNTIHR 481
              +  + IL  + + H    +HR
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHR 134

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 8/126 (6%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            ++IG G FG VY       G   A+K     PD+  S + I+ + QE K+   LKH NI
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNI 68

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           +   G  + + +L + +E+   G +NR +    + I   I+ N+   I  G+ YLH    
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 479 ---IHR 481
              IHR
Sbjct: 127 VPIIHR 132

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 26/151 (17%), Positives = 63/151 (41%), Gaps = 13/151 (8%)

Query: 341 PHIMEKPSASPKKSQ----WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD 393
           P  +E    +  + +    +     +G G FG V+   ++E      +K +    ++ D 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66

Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE---YVHPGSINRYVREH 450
                 + ++  EI +L  ++H NI++    ++ ++  +  L    +     +  ++  H
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRH 124

Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            R + E +     R +++ + YL   + IHR
Sbjct: 125 PR-LDEPLASYIFRQLVSAVGYLRLKDIIHR 154

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 26/126 (20%), Positives = 55/126 (43%), Gaps = 11/126 (8%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + +G G FG V+    + TG     K ++              ++ EI ++  L H  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKL 110

Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           +  +  +  +D   + L  E++  G + +R   E  + ++E+ V N+ R    GL ++H 
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 167

Query: 476 TNTIHR 481
            + +H 
Sbjct: 168 HSIVHL 173

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHL 413
            +   + +G G+FG V + T+ +T    A+K    I     K ++   ++E+EI  L  L
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66

Query: 414 KHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
           +H +I++ Y  +V+     + + +EY   G +  Y+ E  R +TE   R F + I+  + 
Sbjct: 67  RHPHIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVEKKR-MTEDEGRRFFQQIICAIE 122

Query: 472 YLHSTNTIHR 481
           Y H    +HR
Sbjct: 123 YCHRHKIVHR 132

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 31/129 (24%), Positives = 56/129 (43%), Gaps = 12/129 (9%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
           G+ +G G F  V     + TG   A K    I        +   C +++E+E+ +L  + 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
           H NI+  +        + + LE V  G + +    +E    ++E    +F + IL+G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130

Query: 473 LHSTNTIHR 481
           LH+    H 
Sbjct: 131 LHTKKIAHF 139

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 36/177 (20%), Positives = 68/177 (38%), Gaps = 27/177 (15%)

Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
                +          A+ P +  +         + K + +G G +G V +   +   + 
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 382 CAIK--------EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
            AIK        +     D+    +  +++  EI +L  L H NI++ +  +V +D  Y 
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYF 121

Query: 434 YL--EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           YL  E+   G       + +++         E    N  + IL+G+ YLH  N +HR
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF--------DECDAANIMKQILSGICYLHKHNIVHR 170

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.4 bits (240), Expect = 2e-21
 Identities = 37/218 (16%), Positives = 75/218 (34%), Gaps = 24/218 (11%)

Query: 265 RNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLP 324
            N +       P+ P        +  R      + K +          +N++        
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI 384
           P  +      V                    +   + +G G FG V+  T R TG + A 
Sbjct: 145 PQPVEIKHDHV-----------------LDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI- 443
           K V             + + +EI+ +  L+H  +V  + +   D+ + +  E++  G + 
Sbjct: 188 KFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            +   EH + ++E     + R +  GL ++H  N +H 
Sbjct: 243 EKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 279

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 10/145 (6%)

Query: 341 PHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAE 398
           P   ++      K   +  G  +G GTFG V +G +  TG   A+K   I+     +S +
Sbjct: 2   PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITE 456
            + ++ +EI+ L   +H +I++ Y  +V+     +++ +EYV  G +  Y+ ++ R + E
Sbjct: 59  VVGKIRREIQNLKLFRHPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKNGR-LDE 115

Query: 457 SIVRNFTRHILNGLAYLHSTNTIHR 481
              R   + IL+G+ Y H    +HR
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHR 140

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 38/234 (16%), Positives = 79/234 (33%), Gaps = 30/234 (12%)

Query: 261 SPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHP 320
           S    N ++ +        R     N R  R+ +         Q++  L E+    +A P
Sbjct: 8   SSGVDNKFNKERRRARREIRHLPNLN-REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66

Query: 321 LPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA 380
                                 + +  +A     ++    +IGRG    V    +R TG 
Sbjct: 67  KGTENLYFQSMGPE------DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 381 SCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL- 435
             A+K ++         +  E  +   +E  +L  +  H +I+     +  +   +++L 
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLV 178

Query: 436 -EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            + +  G                    +E   R+  R +L  +++LH+ N +HR
Sbjct: 179 FDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEAVSFLHANNIVHR 224

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 29/162 (17%), Positives = 60/162 (37%), Gaps = 39/162 (24%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              IG+G++G V +    +T A  AIK ++       + + +++++ E++++  L H NI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI----------------------------------- 443
            + Y     + ++ + +E  H G +                                   
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 444 ----NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               + +         E ++ N  R I + L YLH+    HR
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 33/135 (24%), Positives = 63/135 (46%), Gaps = 15/135 (11%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
           ++  G L+G G++G V    + ET    A+K   I+      +       +++EI++L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSIN--RYVREHCRDITESIVRNFTRHI 466
           L+H+N++Q    +V+ +     +Y+ +EY   G       V E  R         +   +
Sbjct: 63  LRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-R-FPVCQAHGYFCQL 118

Query: 467 LNGLAYLHSTNTIHR 481
           ++GL YLHS   +H+
Sbjct: 119 IDGLEYLHSQGIVHK 133

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 6/123 (4%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+LIG+G FG VY G         AI+   +I  +  + + +K  ++E+      +HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V + G+ +   HL I        ++   VR+    +  +  R   + I+ G+ YLH+   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 479 IHR 481
           +H+
Sbjct: 152 LHK 154

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 20/164 (12%)

Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
            PP    T    P   ++      +++++ G L+G+G FG+V+ G         AIK   
Sbjct: 9   GPPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK--- 62

Query: 389 IIP----DDPKSAECIKQLEQEIKVL----GHLKHENIVQYYGSEVVD--DHLYIYLEYV 438
           +IP                  E+ +L        H  +++    +  +  +   + LE  
Sbjct: 63  VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL--DWFETQEGFMLVLERP 120

Query: 439 HPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            P   +  Y+ E    + E   R F   ++  + + HS   +HR
Sbjct: 121 LPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHR 163

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 19/169 (11%)

Query: 318 AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTN 375
           AH      G L            P  M   +A    S  ++++   +G GT+G VY   +
Sbjct: 2   AHHHHHHMGTLEAQTQG------PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID 55

Query: 376 RETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432
             T  + AIK + +  ++   P +A  I+    E+ +L  L+H NI++       +  L+
Sbjct: 56  TVTNETVAIKRIRLEHEEEGVPGTA--IR----EVSLLKELQHRNIIELKSVIHHNHRLH 109

Query: 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +  EY     + +Y+ +   D++  ++++F   ++NG+ + HS   +HR
Sbjct: 110 LIFEYAE-NDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR 156

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 4/123 (3%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IGRG FG V+ G  R      A+K      +     +   +  QE ++L    H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRET-LPPDLKAKFLQEARILKQYSHPNI 174

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V+  G       +YI +E V  G    ++R     +    +         G+ YL S   
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 479 IHR 481
           IHR
Sbjct: 235 IHR 237

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 11/136 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           ++   +  + +G+G FGSV +         TG   A+K++        + E ++  E+EI
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREI 62

Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           ++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   I    +  +T  
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 466 ILNGLAYLHSTNTIHR 481
           I  G+ YL +   IHR
Sbjct: 123 ICKGMEYLGTKRYIHR 138

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 28/132 (21%), Positives = 58/132 (43%), Gaps = 14/132 (10%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----QLEQEIKVLGHLK 414
            +++GRG    V    ++ T    A+K +D+      SAE ++       +E+ +L  + 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 415 -HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNG 469
            H NI+Q    +  + + + +L  + +  G + +    +     ++E   R   R +L  
Sbjct: 82  GHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEV 136

Query: 470 LAYLHSTNTIHR 481
           +  LH  N +HR
Sbjct: 137 ICALHKLNIVHR 148

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 29/123 (23%), Positives = 54/123 (43%), Gaps = 7/123 (5%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+ IG G+FG+VY G         A+K   ++     + + ++  + E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           + + G       L I  ++    S+  ++           + +  R    G+ YLH+ + 
Sbjct: 83  LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 479 IHR 481
           IHR
Sbjct: 142 IHR 144

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.3 bits (220), Expect = 9e-20
 Identities = 44/130 (33%), Positives = 69/130 (53%), Gaps = 10/130 (7%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           +++K + IG GT+G+V+   NRET    A+K V +  DD   P SA  ++    EI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR----EICLLK 56

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 472 YLHSTNTIHR 481
           + HS N +HR
Sbjct: 116 FCHSRNVLHR 125

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 23/152 (15%)

Query: 341 PHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
           PH+  K     KK+          +++G G  G V    N+ T    A+K   ++ D   
Sbjct: 2   PHV--KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--- 53

Query: 396 SAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHPGSI-NRYVRE 449
                 +  +E+++     +  +IV+              L I +E +  G + +R    
Sbjct: 54  ----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109

Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             +  TE       + I   + YLHS N  HR
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 18/148 (12%)

Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK 395
            SA   +          +  + +G+G FGSV +         TG   A+K++        
Sbjct: 27  GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HS 81

Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
           + E ++  E+EI++L  L+H+NIV+Y G        +L + +EY+  GS+  Y+++H   
Sbjct: 82  TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           I    +  +T  I  G+ YL +   IHR
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHR 169

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 11/136 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           ++   +    +G+G FGSV +         TGA  A+K++          +  +  ++EI
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREI 75

Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           ++L  L  + IV+Y G         L + +EY+  G +  +++ H   +  S +  ++  
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135

Query: 466 ILNGLAYLHSTNTIHR 481
           I  G+ YL S   +HR
Sbjct: 136 ICKGMEYLGSRRCVHR 151

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 35/133 (26%), Positives = 57/133 (42%), Gaps = 16/133 (12%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + +  +++GRG FG V     R      AIK++       +S    K    E++ L  +
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-------ESESERKAFIVELRQLSRV 58

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLA 471
            H NIV+ YG     + + + +EY   GS+   +   E     T +   ++      G+A
Sbjct: 59  NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 472 YLHSTNT---IHR 481
           YLHS      IHR
Sbjct: 117 YLHSMQPKALIHR 129

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 24/139 (17%), Positives = 51/139 (36%), Gaps = 17/139 (12%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           + +  +++  G F  VY   +  +G   A+K +          E  + + QE+  +  L 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLS 83

Query: 415 -HENIVQYYGSEVVD-------DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTR 464
            H NIVQ+  +  +           ++ L  +  G +  ++   E    ++   V     
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 465 HILNGLAYLHSTNT--IHR 481
                + ++H      IHR
Sbjct: 144 QTCRAVQHMHRQKPPIIHR 162

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 19/140 (13%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P++  +   K+IG G+FG VY     ++G   AIK+   +  D +         +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFK------NRELQIM 101

Query: 411 GHLKHENIVQ----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRN 461
             L H NIV+    +Y S    D +Y+ L  +YV P ++ R  R + R    +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160

Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   +   LAY+HS    HR
Sbjct: 161 YMYQLFRSLAYIHSFGICHR 180

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 39/179 (21%), Positives = 75/179 (41%), Gaps = 24/179 (13%)

Query: 312 SNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
           S    NA    +    L  P   +            +   ++  +   K+IG G+FG V+
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIAYTNCKVIGNGSFGVVF 57

Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ----YYGSEVV 427
                E+    AIK+   +  D +         +E++++  +KH N+V     +Y +   
Sbjct: 58  QAKLVESD-EVAIKK---VLQDKRFK------NRELQIMRIVKHPNVVDLKAFFYSNGDK 107

Query: 428 DDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHR 481
            D +++ L  EYV P ++ R  R + +    +   +++ +   +L  LAY+HS    HR
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 37/176 (21%), Positives = 60/176 (34%), Gaps = 25/176 (14%)

Query: 317 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVY 371
               LP PP    PP         P    K     KK+          +++G G  G V 
Sbjct: 24  PTPALPHPPAQPPPPPPQQ----FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79

Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEV 426
              N+ T    A+K   ++ D         +  +E+++     +  +IV+          
Sbjct: 80  QIFNKRTQEKFALK---MLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 427 VDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               L I +E +  G + +R      +  TE       + I   + YLHS N  HR
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 86.0 bits (214), Expect = 7e-19
 Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
            +QK + IG GT+G VY   N+ TG   A+K++ +  +    P +A  I+    EI +L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IR----EISLLK 57

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 470
            L H NIV+       ++ LY+  E++H   + +++       I   +++++   +L GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 471 AYLHSTNTIHR 481
           A+ HS   +HR
Sbjct: 117 AFCHSHRVLHR 127

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + IG G+FG+V+       G+  A+K   I+ +    AE + +  +E+ ++  L+H NI
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHST 476
           V + G+     +L I  EY+  GS+ R + +      + E    +    +  G+ YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 477 NT--IHR 481
           N   +HR
Sbjct: 157 NPPIVHR 163

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 32/134 (23%), Positives = 58/134 (43%), Gaps = 8/134 (5%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-NRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIK 408
            +   +  + +G G+FG V  G  +  +G +   A+K   + PD     E +    +E+ 
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVN 73

Query: 409 VLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            +  L H N+++ YG  VV    + +  E    GS+   +R+H        +  +   + 
Sbjct: 74  AMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 468 NGLAYLHSTNTIHR 481
            G+ YL S   IHR
Sbjct: 132 EGMGYLESKRFIHR 145

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 9/129 (6%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
            + K   +G GT+ +VY G ++ T    A+KE+ +  ++  P +A  I+    E+ +L  
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IR----EVSLLKD 56

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           LKH NIV  +     +  L +  EY+    + +Y+ +    I    V+ F   +L GLAY
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 473 LHSTNTIHR 481
            H    +HR
Sbjct: 116 CHRQKVLHR 124

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 37/153 (24%), Positives = 56/153 (36%), Gaps = 14/153 (9%)

Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
             PH  E+P  + +              K+IG G  G V  G  R  G      AIK   
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--- 83

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
            +       +    L  E  ++G   H NI++  G         I  EY+  GS++ ++R
Sbjct: 84  ALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142

Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            H    T   +    R +  G+ YL     +HR
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 11/130 (8%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
           ++   + IG GT+G VY   N   G + A+K++ +  +D   P +   I+    EI +L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT--IR----EISILK 55

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            LKH NIV+ Y        L +  E++    + + +      +     ++F   +LNG+A
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 472 YLHSTNTIHR 481
           Y H    +HR
Sbjct: 115 YCHDRRVLHR 124

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 33/148 (22%), Positives = 67/148 (45%), Gaps = 19/148 (12%)

Query: 345 EKPSASPKKSQWQKGKL--------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--- 393
               +S +++ + +G +        +G GT+G VY   +   G   A+K + +  +D   
Sbjct: 4   HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62

Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
           P +A  I+    EI +L  L H NIV        +  L +  E++    + + + E+   
Sbjct: 63  PSTA--IR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG 115

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           + +S ++ +   +L G+A+ H    +HR
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHR 143

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 31/135 (22%), Positives = 60/135 (44%), Gaps = 11/135 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G       +     AIK    + +        + L  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEIL-DEA 68

Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
            V+  + + ++ +  G  +     + +  + +  G +  YVREH  +I    + N+   I
Sbjct: 69  YVMASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 467 LNGLAYLHSTNTIHR 481
             G+ YL     +HR
Sbjct: 127 AKGMNYLEDRRLVHR 141

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 12/136 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
            K   +K + +G G FG V +     TN  TG   A+K +          +     +QEI
Sbjct: 29  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEI 84

Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
            +L  L HE+I++Y G   +     L + +EYV  GS+  Y+  H   I  + +  F + 
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQ 142

Query: 466 ILNGLAYLHSTNTIHR 481
           I  G+AYLH+ + IHR
Sbjct: 143 ICEGMAYLHAQHYIHR 158

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 42/140 (30%), Positives = 70/140 (50%), Gaps = 19/140 (13%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++Q  ++ G+GTFG+V +G  + TG S AIK+   +  DP+     ++L Q ++ L  L
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPR--FRNREL-QIMQDLAVL 76

Query: 414 KHENIVQ-----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFT 463
            H NIVQ     Y   E     +Y+ +  EYV P +++R  R + R        +++ F 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 464 RHILNGLAYLH--STNTIHR 481
             ++  +  LH  S N  HR
Sbjct: 136 FQLIRSIGCLHLPSVNVCHR 155

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 27/126 (21%), Positives = 58/126 (46%), Gaps = 12/126 (9%)

Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
           K K +G G+F       ++++  + A+K   II    K  E     ++EI  L   + H 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVK---II---SKRME--ANTQKEITALKLCEGHP 66

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
           NIV+ +       H ++ +E ++ G +  R  ++     +E+      R +++ ++++H 
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHD 124

Query: 476 TNTIHR 481
              +HR
Sbjct: 125 VGVVHR 130

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 29/136 (21%), Positives = 63/136 (46%), Gaps = 13/136 (9%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ 405
           +  +++K   +G G F +VY   ++ T    AIK++ +           ++A  ++    
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR---- 61

Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           EIK+L  L H NI+    +     ++ +  +++    +   ++++   +T S ++ +   
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 466 ILNGLAYLHSTNTIHR 481
            L GL YLH    +HR
Sbjct: 121 TLQGLEYLHQHWILHR 136

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 13/128 (10%)

Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
           +  ++G G    V    N  T    A+K   II   P       ++ +E+++L   + H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPG--HIRSRVFREVEMLYQCQGHR 71

Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
           N+++    E  ++    YL  E +  GSI +   +       E       + + + L +L
Sbjct: 72  NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFL 127

Query: 474 HSTNTIHR 481
           H+    HR
Sbjct: 128 HNKGIAHR 135

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 28/127 (22%), Positives = 59/127 (46%), Gaps = 9/127 (7%)

Query: 358 KGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           + K +G G FG+V  G    ++   + A+K   I+ ++        +L  E  V+  L +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDN 77

Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
             IV+  G  + +     + +E    G +N+Y++++ R + +  +      +  G+ YL 
Sbjct: 78  PYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE 134

Query: 475 STNTIHR 481
            +N +HR
Sbjct: 135 ESNFVHR 141

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 42/134 (31%), Positives = 73/134 (54%), Gaps = 12/134 (8%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLG 411
           SQ+++ + +G GT+ +VY G N+ TG   A+KEV +  ++  P +A  I+    EI ++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IR----EISLMK 58

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVH---PGSI-NRYVREHCRDITESIVRNFTRHIL 467
            LKHENIV+ Y     ++ L +  E++       + +R V    R +  ++V+ F   +L
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 468 NGLAYLHSTNTIHR 481
            GLA+ H    +HR
Sbjct: 119 QGLAFCHENKILHR 132

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 36/162 (22%), Positives = 56/162 (34%), Gaps = 30/162 (18%)

Query: 340 MPHIMEKPSAS----PKKSQWQKG----------KLIGRGTFGSVYIGTNRETGASCAIK 385
           M H     S+      +  + +K           +++G G  G V    +R TG  CA+K
Sbjct: 1   MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60

Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHP 440
              ++ D PK         QE+          +IV               L I +E +  
Sbjct: 61  ---LLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 441 GSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           G + +R      +  TE       R I   + +LHS N  HR
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 20/128 (15%), Positives = 42/128 (32%), Gaps = 10/128 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              +     G ++ G  +  G    +K   ++     S    +   +E   L    H N+
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 419 VQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHS 475
           +   G        H  +   ++  GS+   + E     + +S    F   +  G+A+LH+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 476 TNT--IHR 481
                   
Sbjct: 130 LEPLIPRH 137

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 26/137 (18%), Positives = 53/137 (38%), Gaps = 12/137 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLE 404
           +       + +G+GTF  ++ G  RE G           +K +D            +   
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSESFF 60

Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
           +   ++  L H+++V  YG  V  D   +  E+V  GS++ Y++++   I         +
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 465 HILNGLAYLHSTNTIHR 481
            +   + +L     IH 
Sbjct: 121 QLAAAMHFLEENTLIHG 137

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 32/133 (24%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            +++   LIG G++G V    ++      AIK++  + +D       K++ +EI +L  L
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRL 109

Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
            H+++V+             D LY+ LE        +  R     +TE  ++    ++L 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLV 167

Query: 469 GLAYLHSTNTIHR 481
           G+ Y+HS   +HR
Sbjct: 168 GVKYVHSAGILHR 180

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 14/141 (9%)

Query: 349 ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
            SP   +W            +G G +G VY G  ++   + A+K    + +D    E   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54

Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVR 460
           +  +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R  ++  ++ 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114

Query: 461 NFTRHILNGLAYLHSTNTIHR 481
                I + + YL   N IHR
Sbjct: 115 YMATQISSAMEYLEKKNFIHR 135

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 32/137 (23%), Positives = 57/137 (41%), Gaps = 22/137 (16%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
              + +G+G +G V+ G+ +  G + A+K   I     + +      E E+     L+HE
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSW---FRETELYNTVMLRHE 62

Query: 417 NIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           NI+ +  S++   H    L++   Y   GS+  Y++    D    +       I +GLA+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL--RIVLSIASGLAH 120

Query: 473 LHSTNT--------IHR 481
           LH             HR
Sbjct: 121 LHIEIFGTQGKPAIAHR 137

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 29/127 (22%), Positives = 57/127 (44%), Gaps = 10/127 (7%)

Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
            +++G G FG VY G    ++    + A+K       D       K +  E  ++ +L H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
            +IV+  G  ++++   +I +E    G +  Y+  +   +    +  ++  I   +AYL 
Sbjct: 73  PHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 475 STNTIHR 481
           S N +HR
Sbjct: 131 SINCVHR 137

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 15/154 (9%)

Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEV 387
               +   P+ +  K           + K+IG G FG VY G     + +     AIK  
Sbjct: 22  FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-- 79

Query: 388 DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV 447
             +       + +  L  E  ++G   H NI++  G       + I  EY+  G++++++
Sbjct: 80  -TLKAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137

Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           RE   + +   +    R I  G+ YL + N +HR
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 171

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 30/154 (19%)

Query: 344 MEKPSASPKKSQWQK-----------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
           M+         Q  +            + IG G++       ++ T    A+K   II  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---II-- 55

Query: 393 DPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV- 447
             KS        +EI++L    +H NI+     +V DD  Y+Y+  E +  G + ++ + 
Sbjct: 56  -DKSKRDPT---EEIEILLRYGQHPNIITLK--DVYDDGKYVYVVTELMKGGELLDKILR 109

Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           ++     +E         I   + YLH+   +HR
Sbjct: 110 QKF---FSEREASAVLFTITKTVEYLHAQGVVHR 140

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 9/124 (7%)

Query: 359 GKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
            K +G G FG V +G    +     A+K   +I +   S +   +  QE + +  L H  
Sbjct: 13  LKELGSGQFGVVKLGKWKGQY--DVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPK 64

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           +V++YG    +  +YI  EY+  G +  Y+R H + +  S +      +  G+A+L S  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 478 TIHR 481
            IHR
Sbjct: 125 FIHR 128

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 33/135 (24%), Positives = 61/135 (45%), Gaps = 11/135 (8%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++ +K K++G G FG+V+ G              IK   +I D        + +   +
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQS-FQAVTDHM 66

Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
             +G L H +IV+  G  +     L +  +Y+  GS+  +VR+H   +   ++ N+   I
Sbjct: 67  LAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 467 LNGLAYLHSTNTIHR 481
             G+ YL     +HR
Sbjct: 125 AKGMYYLEEHGMVHR 139

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 32/123 (26%), Positives = 51/123 (41%), Gaps = 7/123 (5%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + IG G FG V++G         AIK    I +   S E      +E +V+  L H  +
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKD-KVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKL 65

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           VQ YG  +    + +  E++  G ++ Y+R          +      +  G+AYL     
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 479 IHR 481
           IHR
Sbjct: 126 IHR 128

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 14/153 (9%)

Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
           V PH  E P+ +  +             K++G G FG V  G  +       S AIK + 
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
           +   + +  +       E  ++G   H NI++  G       + I  EY+  GS++ ++R
Sbjct: 83  VGYTEKQRRD----FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138

Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +H    T   +    R I +G+ YL     +HR
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 31/137 (22%), Positives = 58/137 (42%), Gaps = 22/137 (16%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           Q  K IG+G +G V++G  R  G   A+K   +     +++      E EI     ++HE
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVK---VFFTTEEASW---FRETEIYQTVLMRHE 91

Query: 417 NIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           NI+ +  +++        LY+  +Y   GS+  Y++     +    +       ++GL +
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCH 149

Query: 473 LHSTNT--------IHR 481
           LH+            HR
Sbjct: 150 LHTEIFSTQGKPAIAHR 166

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 9/134 (6%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           K+++++K K++G G FG+VY G       +     AIK    + +   S +  K++  E 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT-SPKANKEILDEA 68

Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I 
Sbjct: 69  YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 468 NGLAYLHSTNTIHR 481
            G+ YL     +HR
Sbjct: 128 KGMNYLEDRRLVHR 141

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 31/129 (24%), Positives = 55/129 (42%), Gaps = 14/129 (10%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           G+ IG G FG V+ G      N     + AIK      +    +   K L QE   +   
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPAL--AVAIK---TCKNCTSDSVREKFL-QEALTMRQF 73

Query: 414 KHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
            H +IV+  G  V+ ++ ++I +E    G +  +++     +  + +  +   +   LAY
Sbjct: 74  DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131

Query: 473 LHSTNTIHR 481
           L S   +HR
Sbjct: 132 LESKRFVHR 140

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 36/147 (24%), Positives = 56/147 (38%), Gaps = 17/147 (11%)

Query: 344 MEKPS-ASPKKSQW-------QKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDP 394
              PS A      W          K +G G FG V  G    +     AIK +       
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMI------K 57

Query: 395 KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI 454
           + +    +  +E KV+ +L HE +VQ YG       ++I  EY+  G +  Y+RE     
Sbjct: 58  EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF 117

Query: 455 TESIVRNFTRHILNGLAYLHSTNTIHR 481
               +    + +   + YL S   +HR
Sbjct: 118 QTQQLLEMCKDVCEAMEYLESKQFLHR 144

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 36/182 (19%), Positives = 65/182 (35%), Gaps = 31/182 (17%)

Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT---- 374
           G+   P     S +  HI+E P                     +G G FG V++      
Sbjct: 6   GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 375 -NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
              +     A+K +        S    +  ++E ++L  L+H++IV+++G       L +
Sbjct: 66  LPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120

Query: 434 YLEYVHPGSINRYVREHCRDITESIVRN--------------FTRHILNGLAYLHSTNTI 479
             EY+  G +NR++R H  D                          +  G+ YL   + +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180

Query: 480 HR 481
           HR
Sbjct: 181 HR 182

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 36/202 (17%), Positives = 73/202 (36%), Gaps = 13/202 (6%)

Query: 287 LRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEK 346
           L +     F +R +   + +   +    +     +     ++S                 
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379

Query: 347 PSASPK---KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECI 400
           PS       + + + G+ IG G FG V+ G          + AIK      +    +   
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVRE 436

Query: 401 KQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIV 459
           K L QE   +    H +IV+  G  V+ ++ ++I +E    G +  +++     +  + +
Sbjct: 437 KFL-QEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
             +   +   LAYL S   +HR
Sbjct: 494 ILYAYQLSTALAYLESKRFVHR 515

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 14/143 (9%)

Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
              SP   +W            +G G +G VY G  ++   + A+K   +  D  +  E 
Sbjct: 206 YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 262

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESI 458
                +E  V+  +KH N+VQ  G    +   YI  E++  G++  Y+RE  R  ++  +
Sbjct: 263 ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319

Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
           +      I + + YL   N IHR
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHR 342

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 37/152 (24%), Positives = 58/152 (38%), Gaps = 28/152 (18%)

Query: 348 SASPKKSQW------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           S  P   Q          + IG+G FG V+ G  R  G   A+K   I     + +    
Sbjct: 30  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVK---IFSSREERSW--- 81

Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITES 457
             E EI     L+HENI+ +  ++  D+     L++  +Y   GS+  Y+  +   +   
Sbjct: 82  FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM 141

Query: 458 IVRNFTRHILNGLAYLHSTNT--------IHR 481
           I         +GLA+LH             HR
Sbjct: 142 I--KLALSTASGLAHLHMEIVGTQGKPAIAHR 171

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.0 bits (197), Expect = 4e-16
 Identities = 42/219 (19%), Positives = 73/219 (33%), Gaps = 16/219 (7%)

Query: 273 SPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPK 332
             L      SS SN         P    +L    + +   N+               P  
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307

Query: 333 SSVTSAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASC--A 383
             + ++V       P     K       +       +G G FGSV  G  R        A
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367

Query: 384 IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGS 442
           IK   +     K+    +++ +E +++  L +  IV+  G  V     L + +E    G 
Sbjct: 368 IKV--LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGP 421

Query: 443 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +++++     +I  S V      +  G+ YL   N +HR
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 22/147 (14%)

Query: 346 KPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
                  +S W       +  + IG+G FG V +G  R      A+K +       K+  
Sbjct: 6   AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-------KNDA 56

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRD-I 454
             +    E  V+  L+H N+VQ  G  V+      LYI  EY+  GS+  Y+R   R  +
Sbjct: 57  TAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114

Query: 455 TESIVRNFTRHILNGLAYLHSTNTIHR 481
               +  F+  +   + YL   N +HR
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHR 141

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 34/149 (22%), Positives = 63/149 (42%), Gaps = 16/149 (10%)

Query: 341 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
           P +  KP    +K  W       +  K +G G FG V++ T  +     A+K   + P  
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKT--MKPGS 224

Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CR 452
                       E  V+  L+H+ +V+ +   V  + +YI  E++  GS+  +++     
Sbjct: 225 MSVEA----FLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGS 279

Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
                 + +F+  I  G+A++   N IHR
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 10/127 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
            LIGRG++G VY+  ++ T  + AIK+V+ + +D       K++ +EI +L  LK + I+
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYII 88

Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           + Y        +  D LYI LE      + +  +     +TE  ++    ++L G  ++H
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH 146

Query: 475 STNTIHR 481
            +  IHR
Sbjct: 147 ESGIIHR 153

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 43/231 (18%), Positives = 78/231 (33%), Gaps = 23/231 (9%)

Query: 258 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 317
           SP+ P   + +   H    +           SP         +      K+    N +  
Sbjct: 2   SPIDPMGHHHHH--HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59

Query: 318 -AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
            A+ + +   AL+P        V+                   ++IGRG FG VY GT  
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGP--------SSLIVHFNEVIGRGHFGCVYHGTLL 111

Query: 377 ETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDH 430
           +       CA+K    +       E + Q   E  ++    H N++   G  +    +  
Sbjct: 112 DNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGS 165

Query: 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
             + L Y+  G +  ++R    + T   +  F   +  G+ +L S   +HR
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 29/123 (23%), Positives = 52/123 (42%), Gaps = 9/123 (7%)

Query: 362 IGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FGSV  G  R        AIK   ++          +++ +E +++  L +  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQG-TEKADTEEMMREAQIMHQLDNPYIV 73

Query: 420 QYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           +  G  V     L + +E    G +++++     +I  S V      +  G+ YL   N 
Sbjct: 74  RLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 479 IHR 481
           +HR
Sbjct: 132 VHR 134

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 12/129 (9%)

Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
            ++IGRG FG VY GT  +       CA+K    +       E + Q   E  ++    H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85

Query: 416 ENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
            N++   G  +    +    + L Y+  G +  ++R    + T   +  F   +  G+ Y
Sbjct: 86  PNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 473 LHSTNTIHR 481
           L S   +HR
Sbjct: 144 LASKKFVHR 152

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 25/209 (11%), Positives = 55/209 (26%), Gaps = 36/209 (17%)

Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIG 363
           ++LL+    L  +         +    +VT+ V P           S  + + +  + + 
Sbjct: 12  RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71

Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423
            G    V++  + E     A+K          S   +++L +       L  E+  +   
Sbjct: 72  VGDRSVVFLVRDVERLEDFALKV--FTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 424 SE--------------------------VVDDHLYIYLEYVH-----PGSINRYVREHCR 452
                                           +  + +           S   +V     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHR 481
           D     +   T  ++   A L S   +H 
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHG 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 25/161 (15%)

Query: 335 VTSAVMPHIMEKPSASPK---KSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAI 384
            T  + P +ME   A+     +S W       +  + IG+G FG V +G  R  G   A+
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAV 221

Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPG 441
           K +       K+    +    E  V+  L+H N+VQ  G  V+      LYI  EY+  G
Sbjct: 222 KCI-------KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKG 272

Query: 442 SINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHR 481
           S+  Y+R   R  +    +  F+  +   + YL   N +HR
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 19/133 (14%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             +Q  + +GRG +  V+   N        +K   + P   K        ++EIK+L +L
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKI------KREIKILENL 87

Query: 414 K-HENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +   NI+     ++V D       +  E+V+     +      + +T+  +R +   IL 
Sbjct: 88  RGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILK 141

Query: 469 GLAYLHSTNTIHR 481
            L Y HS   +HR
Sbjct: 142 ALDYCHSMGIMHR 154

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 29/131 (22%), Positives = 60/131 (45%), Gaps = 12/131 (9%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
              ++IG+G FG VY G   +   +   CAIK    +    +  + ++   +E  ++  L
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQ-VEAFLREGLLMRGL 79

Query: 414 KHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
            H N++   G  ++   +   ++ L Y+  G + +++R   R+ T   + +F   +  G+
Sbjct: 80  NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 471 AYLHSTNTIHR 481
            YL     +HR
Sbjct: 138 EYLAEQKFVHR 148

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 26/198 (13%), Positives = 59/198 (29%), Gaps = 39/198 (19%)

Query: 320 PLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
                    S   S V++++         +     +     +G ++G+    +    T++
Sbjct: 36  VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 95

Query: 377 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---------------------- 414
           ETG S  +        +   +  IKQ+++E+  L  L+                      
Sbjct: 96  ETGESFEVHVPYF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153

Query: 415 ---HENIVQYYGSEVVDDHLYIYLEYVHP--------GSINRYVREHCRDITESIVRNFT 463
               + +++    E     L  +  Y             +  +   H + +        T
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLT 212

Query: 464 RHILNGLAYLHSTNTIHR 481
             ++  LA LH    +H 
Sbjct: 213 LQVIRLLASLHHYGLVHT 230

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 29/169 (17%), Positives = 64/169 (37%), Gaps = 51/169 (30%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++  GK +G G+FG V    + E+G   A+K+   +  DP+         +E+ ++  L
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKN------RELDIMKVL 57

Query: 414 KHENIVQ--------------------------------------YYGSEVVDDHLYIYL 435
            H NI++                                         +   + +L + +
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 436 EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHR 481
           EYV P ++++ ++   R    I  +++  +   +   + ++HS    HR
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 16/151 (10%)

Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
            +    +  +    K  W       +    +G+G FG V++GT   T    AIK   + P
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKP 218

Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
                   +    QE +V+  L+HE +VQ Y   V ++ +YI  EY+  GS+  +++   
Sbjct: 219 GTMSPEAFL----QEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET 273

Query: 452 RD-ITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +    + +    I +G+AY+   N +HR
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 42/208 (20%), Positives = 69/208 (33%), Gaps = 24/208 (11%)

Query: 293 VYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSS-VTSAVMPHIMEKPSASP 351
            Y    H      + E L          L  P   LS  ++S + +   P+       S 
Sbjct: 3   YYHHHHHHDYDIPTTENL-YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61

Query: 352 KKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAEC 399
                          + +G G FG VY G      N  +    A+K +   P+     + 
Sbjct: 62  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD- 117

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
                 E  ++    H+NIV+  G  +     +I LE +  G +  ++RE          
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +    + +  R I  G  YL   + IHR
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHR 205

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 28/134 (20%), Positives = 57/134 (42%), Gaps = 13/134 (9%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             +     +G G +GSV    ++ +G   AIK++         A   K+  +E+ +L H+
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYRELLLLKHM 80

Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           +HEN++          S       Y+ + ++    + + +       +E  ++     +L
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQML 136

Query: 468 NGLAYLHSTNTIHR 481
            GL Y+HS   +HR
Sbjct: 137 KGLKYIHSAGVVHR 150

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 12/134 (8%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++Q    +G G +GSV    + +TG   A+K++         A   K+  +E+++L H+
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 85

Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           KHEN++          S    + +Y+    +    +N  V+  C+ +T+  V+     IL
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQIL 142

Query: 468 NGLAYLHSTNTIHR 481
            GL Y+HS + IHR
Sbjct: 143 RGLKYIHSADIIHR 156

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 38/185 (20%), Positives = 68/185 (36%), Gaps = 27/185 (14%)

Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
           + S++H + H   L P      ++ +   V+             +    GK++G G FGS
Sbjct: 1   MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDR-----------NLLILGKILGEGEFGS 49

Query: 370 VYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--- 423
           V  G       T    A+K +     D  S   I++   E   +    H N+++  G   
Sbjct: 50  VMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106

Query: 424 --SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHST 476
             S        + L ++  G ++ Y+         + I    +  F   I  G+ YL + 
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166

Query: 477 NTIHR 481
           N +HR
Sbjct: 167 NFLHR 171

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 29/124 (23%), Positives = 56/124 (45%), Gaps = 9/124 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + +G G FG V++G         A+K    +     S +       E  ++  L+H+ +
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRL 70

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
           V+ Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A++   N
Sbjct: 71  VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 478 TIHR 481
            IHR
Sbjct: 130 YIHR 133

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 12/127 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
            L+G G +G V   T++ TG   AIK+++   D P  A    +  +EIK+L H KHENI+
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA---LRTLREIKILKHFKHENII 72

Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
             +      S    + +YI  E +    ++R +    + +++  ++ F    L  +  LH
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 475 STNTIHR 481
            +N IHR
Sbjct: 130 GSNVIHR 136

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 24/142 (16%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
              Q  ++  RG FG V+           A+K        P   +   Q E E+  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF------PIQDKQSWQNEYEVYSLPGM 75

Query: 414 KHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           KHENI+Q+ G+E         L++   +   GS++ +++ +   ++ + + +    +  G
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARG 133

Query: 470 LAYLHSTNT----------IHR 481
           LAYLH               HR
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHR 155

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 14/162 (8%)

Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASC 382
            G  + P+    S       + P    KK    ++ GK++G G+F +V +     T    
Sbjct: 2   DGTAAEPRPGAGS---LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREY 58

Query: 383 AIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439
           AIK ++   II +       +    +E  V+  L H   V+ Y +   D+ LY  L Y  
Sbjct: 59  AIKILEKRHIIKE--NKVPYVT---RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
            G + +Y+R       E+  R +T  I++ L YLH    IHR
Sbjct: 114 NGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHR 154

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 27/137 (19%), Positives = 57/137 (41%), Gaps = 17/137 (12%)

Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           G+++G+G FGSV     ++   S    A+K +     D  ++  I++  +E   +    H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASSDIEEFLREAACMKEFDH 84

Query: 416 ENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTR 464
            ++ +  G      ++       + L ++  G ++ ++          ++    +  F  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 465 HILNGLAYLHSTNTIHR 481
            I  G+ YL S N IHR
Sbjct: 145 DIACGMEYLSSRNFIHR 161

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 29/188 (15%), Positives = 55/188 (29%), Gaps = 55/188 (29%)

Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIP- 391
           AS   + ++  + +GRG FG V+   N+    + AIK                EV  +  
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60

Query: 392 ------------------------------------DDPKSAECIKQLEQEIKVLGHLKH 415
                                                   S   +     +I+ +     
Sbjct: 61  LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 473
           +N V          +LYI ++     ++  ++  R    D    +  +    I   + +L
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 474 HSTNTIHR 481
           HS   +HR
Sbjct: 181 HSKGLMHR 188

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 24/142 (16%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 410
           S+++K   IG+GTFG V+   +R+TG   A+K+V +  +    P +A       +EIK+L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKIL 70

Query: 411 GHLKHENIVQYYGSEVV----------DDHLYIYLEYV-HPGSINRYVREHCRDITESIV 459
             LKHEN+V     E+              +Y+  ++  H   +   +       T S +
Sbjct: 71  QLLKHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           +   + +LNGL Y+H    +HR
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHR 148

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 26/152 (17%)

Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECI 400
           P  S   S+++    IG G +G+VY   +  +G   A+K V +          P S   +
Sbjct: 2   PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--V 59

Query: 401 KQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVREH 450
           +    E+ +L  L+   H N+V+    +V        +  + +  E+V    +  Y+ + 
Sbjct: 60  R----EVALLRRLEAFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA 112

Query: 451 -CRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
               +    +++  R  L GL +LH+   +HR
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 144

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 39/165 (23%), Positives = 60/165 (36%), Gaps = 34/165 (20%)

Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
           P+  P   +W         GK +G G FG V   T       +   + A+K   ++    
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSA 65

Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
              E  + L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 66  HLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 454 ITESIVRN-----------------FTRHILNGLAYLHSTNTIHR 481
              S                     F+  +  G+A+L S N IHR
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 22/142 (15%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S++   K +G G  G V+   + +     AIK+  I+  DP+S    K   +EIK++  L
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSV---KHALREIKIIRRL 65

Query: 414 KHENIV--------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
            H+NIV                 GS    + +YI  EY+    +   +      + E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHA 122

Query: 460 RNFTRHILNGLAYLHSTNTIHR 481
           R F   +L GL Y+HS N +HR
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHR 144

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 35/139 (25%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQEI 407
           S +   + I  G++G+V  G +   G   AIK V     D ++   +      K++ +EI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 408 KVLGHLKHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
           ++L H  H NI+          E     LY+  E +    + + + +    I+   ++ F
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 463 TRHILNGLAYLHSTNTIHR 481
             HIL GL  LH    +HR
Sbjct: 140 MYHILLGLHVLHEAGVVHR 158

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 29/133 (21%), Positives = 56/133 (42%), Gaps = 12/133 (9%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++     IG G +G V    +       AIK++    +        ++  +EIK+L   
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYC---QRTLREIKILLRF 82

Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +HENI+         +      +YI  + +    + + ++   + ++   +  F   IL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILR 139

Query: 469 GLAYLHSTNTIHR 481
           GL Y+HS N +HR
Sbjct: 140 GLKYIHSANVLHR 152

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 37/154 (24%), Positives = 67/154 (43%), Gaps = 26/154 (16%)

Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD---PKSAEC 399
           MEK        Q++    IG G +G V+   + +  G   A+K V +   +   P S   
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-- 58

Query: 400 IKQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVRE 449
           I+    E+ VL HL+   H N+V+ +  +V        +  L +  E+V    +  Y+ +
Sbjct: 59  IR----EVAVLRHLETFEHPNVVRLF--DVCTVSRTDRETKLTLVFEHVD-QDLTTYL-D 110

Query: 450 HCRD--ITESIVRNFTRHILNGLAYLHSTNTIHR 481
              +  +    +++    +L GL +LHS   +HR
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR 144

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 34/156 (21%), Positives = 62/156 (39%), Gaps = 31/156 (19%)

Query: 345 EKPSASPKKSQWQKGKL---IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC 399
            K S+  ++ +         +GRGT+G VY    ++       A+K+++       SA  
Sbjct: 9   VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR 67

Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYV----------HPGSINR 445
                 EI +L  LKH N++     +V   H    +++  +Y           H  S   
Sbjct: 68  ------EIALLRELKHPNVISLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
                   +   +V++    IL+G+ YLH+   +HR
Sbjct: 120 KKPVQ---LPRGMVKSLLYQILDGIHYLHANWVLHR 152

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 28/137 (20%), Positives = 51/137 (37%), Gaps = 18/137 (13%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + +G+G+FG VY G        E     AIK    + +     E   +   E  V+   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------FTR 464
              ++V+  G         + +E +  G +  Y+R     +  + V              
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 465 HILNGLAYLHSTNTIHR 481
            I +G+AYL++   +HR
Sbjct: 146 EIADGMAYLNANKFVHR 162

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 36/154 (23%), Positives = 61/154 (39%), Gaps = 26/154 (16%)

Query: 344 MEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           ME  ++ P       +  +LIGRG +G+VY G+  E     A+K   +     +      
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVK---VFSFANRQNF--- 52

Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITE 456
             E+ I  +  ++H+NI ++   +            + +EY   GS+ +Y+  H  D   
Sbjct: 53  INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS 112

Query: 457 SIVRNFTRHILNGLAYLHSTNT---------IHR 481
           S        +  GLAYLH+             HR
Sbjct: 113 SC--RLAHSVTRGLAYLHTELPRGDHYKPAISHR 144

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 22/159 (13%)

Query: 341 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVD 388
           P+       S                + +G G FG VY G      N  +    A+K + 
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL- 68

Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
             P+     +       E  ++    H+NIV+  G  +     +I +E +  G +  ++R
Sbjct: 69  --PEVCSEQD-ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125

Query: 449 EHCRD------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           E          +    + +  R I  G  YL   + IHR
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 164

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 25/143 (17%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + +G G FG V++         +     A+K    + D   +A   K  ++E ++L +L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAAR--KDFQREAELLTNL 74

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
           +HE+IV++YG     D L +  EY+  G +N+++R H  D    +               
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 462 ---FTRHILNGLAYLHSTNTIHR 481
                  I +G+ YL S + +HR
Sbjct: 135 MLHIASQIASGMVYLASQHFVHR 157

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 29/135 (21%), Positives = 58/135 (42%), Gaps = 15/135 (11%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 81

Query: 414 KHENIVQ-------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
            H+NI+            E   D +YI +E +   ++ + ++    ++    +      +
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQ---MELDHERMSYLLYQM 136

Query: 467 LNGLAYLHSTNTIHR 481
           L G+ +LHS   IHR
Sbjct: 137 LCGIKHLHSAGIIHR 151

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 30/161 (18%)

Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
           P+  P   +W       Q GK +G G FG V   T       +     A+K   ++    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTA 88

Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
            + E  + L  E+K++ HL +HENIV   G+      + +  EY   G +  ++R   R 
Sbjct: 89  HADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 454 ITESIVRNFTRHILN-------------GLAYLHSTNTIHR 481
           +             +             G+A+L S N IHR
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 35/124 (28%), Positives = 60/124 (48%), Gaps = 9/124 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              +G+G FG V++GT   T    AIK   + P        +    QE +V+  L+HE +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKPGTMSPEAFL----QEAQVMKKLRHEKL 324

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
           VQ Y   V ++ +YI  EY+  GS+  +++      +    + +    I +G+AY+   N
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 478 TIHR 481
            +HR
Sbjct: 384 YVHR 387

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 35/166 (21%), Positives = 62/166 (37%), Gaps = 39/166 (23%)

Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE 398
            +  +W         GK +G G FG V   T      R    + A+K   ++ ++   +E
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE 69

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
            ++ L  E  VL  + H ++++ YG+   D  L + +EY   GS+  ++RE  +     +
Sbjct: 70  -LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128

Query: 459 VRN-----------------------FTRHILNGLAYLHSTNTIHR 481
                                     F   I  G+ YL     +HR
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 28/128 (21%), Positives = 59/128 (46%), Gaps = 12/128 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           + +G G +G+V    +  TGA  AIK++         A   K+  +E+++L H++HEN++
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYRELRLLKHMRHENVI 87

Query: 420 QYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
                     +       Y+ + ++    + + ++     + E  ++     +L GL Y+
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 144

Query: 474 HSTNTIHR 481
           H+   IHR
Sbjct: 145 HAAGIIHR 152

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 13/127 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 418
           K +G+G +G V+   +R TG   A+K++     +   A   ++  +EI +L  L  HENI
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREIMILTELSGHENI 71

Query: 419 VQYYGSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           V      V+    D  +Y+  +Y+    ++  +R     +     +     ++  + YLH
Sbjct: 72  VNLL--NVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLH 126

Query: 475 STNTIHR 481
           S   +HR
Sbjct: 127 SGGLLHR 133

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 27/143 (18%), Positives = 46/143 (32%), Gaps = 24/143 (16%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + +G   FG VY G        E   + AIK    + D  +     +    E  +   L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREE-FRHEAMLRARL 69

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
           +H N+V   G    D  L +   Y   G ++ ++             +            
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 462 ---FTRHILNGLAYLHSTNTIHR 481
                  I  G+ YL S + +H+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHK 152

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 22/141 (15%)

Query: 359 GKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KH 415
             +IG G FG V     ++ G     AIK    + +     +  +    E++VL  L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN-------------- 461
            NI+   G+     +LY+ +EY   G++  ++R+     T+                   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 462 -FTRHILNGLAYLHSTNTIHR 481
            F   +  G+ YL     IHR
Sbjct: 146 HFAADVARGMDYLSQKQFIHR 166

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 40/174 (22%)

Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKE 386
           +  H    P      S+W       + GK +GRG FG V            T  + A+K 
Sbjct: 8   LDEHCERLP---YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64

Query: 387 VDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---DDHLYIYLEYVHPGS 442
           +    +    +E  + L  E+K+L H+  H N+V   G          L + +E+   G+
Sbjct: 65  L---KEGATHSE-HRALMSELKILIHIGHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGN 118

Query: 443 INRYVREHCRDITESIVRN---------------FTRHILNGLAYLHSTNTIHR 481
           ++ Y+R    +     V                 ++  +  G+ +L S   IHR
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 46/224 (20%), Positives = 83/224 (37%), Gaps = 38/224 (16%)

Query: 288 RSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKP 347
           + P  V+   +   L +      ES++ +N+   PL         ++ T  +        
Sbjct: 12  QDPPAVHKLTKRIPLRRQVTVSAESSSSMNS-NTPLVRITTRLSSTADTPMLAG---VSE 67

Query: 348 SASPKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDD 393
              P+  +W         GK +G G FG V +           +   + A+K   ++ DD
Sbjct: 68  YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDD 124

Query: 394 PKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
               + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R    
Sbjct: 125 ATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 453 DITESIVRN---------------FTRHILNGLAYLHSTNTIHR 481
              E                     T  +  G+ YL S   IHR
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 37/161 (22%), Positives = 63/161 (39%), Gaps = 34/161 (21%)

Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
           P+  +W         GK +G G FG V +           +   + A+K   ++ DD   
Sbjct: 25  PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATE 81

Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y+R       
Sbjct: 82  KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140

Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHR 481
           E                     T  +  G+ YL S   IHR
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 34/161 (21%), Positives = 59/161 (36%), Gaps = 34/161 (21%)

Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
           P+  +W         GK +G G FG V +                 A+K   ++  D   
Sbjct: 59  PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATE 115

Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 116 KD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174

Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHR 481
           E                        +  G+ YL S   IHR
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 28/151 (18%), Positives = 53/151 (35%), Gaps = 32/151 (21%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + IG G FG V+          E     A+K   ++ ++  +       ++E  ++   
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
            + NIV+  G   V   + +  EY+  G +N ++R        S+  +            
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 462 -----------FTRHILNGLAYLHSTNTIHR 481
                        R +  G+AYL     +HR
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 26/134 (19%), Positives = 57/134 (42%), Gaps = 13/134 (9%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++Q  K IG G  G V    +     + AIK++     +   A   K+  +E+ ++  +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 118

Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            H+NI+          +      +Y+ +E +   ++ + ++    ++    +      +L
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQML 174

Query: 468 NGLAYLHSTNTIHR 481
            G+ +LHS   IHR
Sbjct: 175 CGIKHLHSAGIIHR 188

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 32/151 (21%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           GK++G G FG V   T             A+K +    +   S+E  + L  E+K++  L
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSE-REALMSELKMMTQL 105

Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR------------ 460
             HENIV   G+  +   +Y+  EY   G +  Y+R      +E  +             
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 461 ----------NFTRHILNGLAYLHSTNTIHR 481
                      F   +  G+ +L   + +HR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 13/130 (10%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++ G+ IG G+FG +Y+GT+   G   AIK       +    +   QL  E K+   ++
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKH-PQLHIESKIYKMMQ 62

Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
               I  +++ G+E   D+  + +E + P S+        R  +   V      +++ + 
Sbjct: 63  GGVGIPTIRWCGAE--GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119

Query: 472 YLHSTNTIHR 481
           Y+HS N IHR
Sbjct: 120 YIHSKNFIHR 129

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 31/125 (24%), Positives = 57/125 (45%), Gaps = 10/125 (8%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K+IGRG FG V +  ++ T    A+K   + ++I      +       +E  ++      
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--SDSAFFW---EERDIMAFANSP 129

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +VQ + +   D +LY+ +EY+  G +   +     D+ E   R +T  ++  L  +HS 
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM 187

Query: 477 NTIHR 481
             IHR
Sbjct: 188 GFIHR 192

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 9/125 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K +G G+FG V +  ++E+G   A+K +    ++    K  E       E ++L  +   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTL---NEKRILQAVNFP 101

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +V+   S   + +LY+ +EYV  G +  ++R      +E   R +   I+    YLHS 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 477 NTIHR 481
           + I+R
Sbjct: 161 DLIYR 165

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 26/125 (20%), Positives = 57/125 (45%), Gaps = 9/125 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           + +G G+FG V++  +R  G   A+K   +  ++    K  E       E  +L  + H 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTN---DERLMLSIVTHP 66

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            I++ +G+      +++ ++Y+  G +   +R   +     + + +   +   L YLHS 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSK 125

Query: 477 NTIHR 481
           + I+R
Sbjct: 126 DIIYR 130

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 30/130 (23%), Positives = 56/130 (43%), Gaps = 13/130 (10%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
            ++ G+ IG G+FG ++ GTN       AIK       +P+ ++   QL  E +    L 
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDA-PQLRDEYRTYKLLA 63

Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
               I  V Y+G E    H  + ++ + P S+   +    R  +   V    + +L  + 
Sbjct: 64  GCTGIPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 472 YLHSTNTIHR 481
            +H  + ++R
Sbjct: 121 SIHEKSLVYR 130

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 24/196 (12%), Positives = 58/196 (29%), Gaps = 39/196 (19%)

Query: 322 PLPPGALSPPKSSVTSAVMP---HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRET 378
                  S   S V++++         +     +     +G ++G+    +    T++ET
Sbjct: 43  TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 102

Query: 379 GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL----------------------KHE 416
           G S  +        +   +  IKQ+++E+  L  L                      K  
Sbjct: 103 GESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160

Query: 417 NIVQYYGSEVVDDHLYIYLEYV-----------HPGSINRYVREHCRDITESIVRNFTRH 465
              +     + +  +++   +                +  +   H + +        T  
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQ 219

Query: 466 ILNGLAYLHSTNTIHR 481
           ++  LA LH    +H 
Sbjct: 220 VIRLLASLHHYGLVHT 235

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 18/130 (13%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
           K+IG+G+FG V    + +     A+K   ++ ++ +     +Q  +EI++L HL+ +   
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFH---RQAAEEIRILEHLRKQDKD 156

Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
              N++    +    +H+ +  E +   S+N Y    +   +  +  +VR F   IL  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 471 AYLHSTNTIH 480
             LH    IH
Sbjct: 214 DALHKNRIIH 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 29/127 (22%), Positives = 61/127 (48%), Gaps = 13/127 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
           + IG+G+FG V I    +T    A+K +          +C+++ E     +E++++  L+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLE 73

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H  +V  + S   ++ +++ ++ +  G + RY  +      E  V+ F   ++  L YL 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ 132

Query: 475 STNTIHR 481
           +   IHR
Sbjct: 133 NQRIIHR 139

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 44/320 (13%), Positives = 95/320 (29%), Gaps = 15/320 (4%)

Query: 171 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 230
            T     +     +     ++ I     +     +  +  +  +    + P         
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212

Query: 231 SSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSP 290
           +         +W+      L                  ++ +  + S     S+      
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272

Query: 291 RKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSAS 350
              +  L  +     +  +    +  N         A     +        + + K   +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332

Query: 351 PKKSQWQKG-----KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
             + + +        ++G+G+FG V +   + T    A+K +    +I DD    EC   
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTM- 389

Query: 403 LEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
              E +VL    K   + Q +      D LY  +EYV+ G +  ++ +      E     
Sbjct: 390 --VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVF 446

Query: 462 FTRHILNGLAYLHSTNTIHR 481
           +   I  GL +L S   I+R
Sbjct: 447 YAAEIAIGLFFLQSKGIIYR 466

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 29/125 (23%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K+IGRG F  V +   ++TG   A+K +   D++        C ++   E  VL +    
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFRE---ERDVLVNGDRR 121

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            I Q + +   +++LY+ +EY   G +   + +    I   + R +   I+  +  +H  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 477 NTIHR 481
             +HR
Sbjct: 182 GYVHR 186

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 27/137 (19%), Positives = 50/137 (36%), Gaps = 33/137 (24%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
           + +G GTFG V +  + +     A+K   ++ +  K        + E  +L  ++++   
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTR---SAKIEADILKKIQNDDIN 94

Query: 417 --NIVQYYGS-----------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
             NIV+Y+G            E +   LY  +        N Y            ++ + 
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR------NNYNG-----FHIEDIKLYC 143

Query: 464 RHILNGLAYLHSTNTIH 480
             IL  L YL   +  H
Sbjct: 144 IEILKALNYLRKMSLTH 160

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 9/125 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           KL+G+GTFG V +   + TG   A+K +    II  D            E +VL + +H 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTV---TESRVLQNTRHP 65

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +     +    D L   +EY + G +  ++    R  TE   R +   I++ L YLHS 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124

Query: 477 NTIHR 481
           + ++R
Sbjct: 125 DVVYR 129

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 3/123 (2%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              +G G   +VY+  +       AIK +       +  E +K+ E+E+     L H+NI
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V     +  DD  Y+ +EY+   +++ Y+  H   ++     NFT  IL+G+ + H    
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRI 132

Query: 479 IHR 481
           +HR
Sbjct: 133 VHR 135

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 25/125 (20%), Positives = 56/125 (44%), Gaps = 8/125 (6%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           K+IGRG FG V +   +      A+K +   +++        C ++   E  VL +   +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFRE---ERDVLVNGDSK 134

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            I   + +   D++LY+ ++Y   G +   + +    + E + R +   ++  +  +H  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 477 NTIHR 481
           + +HR
Sbjct: 195 HYVHR 199

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 34/183 (18%), Positives = 72/183 (39%), Gaps = 17/183 (9%)

Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKG-------KLI 362
           +   +H + H   +P       + ++ S +        +    K+    G       ++I
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60

Query: 363 GRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKHENI 418
           GRG++  V +   ++T    A++ V    +  D+    + ++    E  V      H  +
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQ---TEKHVFEQASNHPFL 115

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH    
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGI 174

Query: 479 IHR 481
           I+R
Sbjct: 175 IYR 177

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 15/136 (11%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           +     G  +G G FG VY G    T  + A+K++     D  + E  +Q +QEIKV+  
Sbjct: 30  RPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAA-MVDITTEELKQQFDQEIKVMAK 86

Query: 413 LKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRN-FTRH----- 465
            +HEN+V+  G     D    +Y  Y+  GS    + +    +  +   +   R      
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVY-VYMPNGS----LLDRLSCLDGTPPLSWHMRCKIAQG 141

Query: 466 ILNGLAYLHSTNTIHR 481
             NG+ +LH  + IHR
Sbjct: 142 AANGINFLHENHHIHR 157

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 13/130 (10%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++ G+ IG G+FG +Y+GTN +T    AIK  ++    P       QL  E K+   L+
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQ 60

Query: 415 -HENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
               I  V+++G E   D+  + ++ + P S+        R ++   V      ++N + 
Sbjct: 61  GGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 472 YLHSTNTIHR 481
           ++HS + +HR
Sbjct: 118 FVHSKSFLHR 127

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 35/131 (26%), Positives = 54/131 (41%), Gaps = 15/131 (11%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++ GK IG G FG + +G N  T    AIK E       P  +    QL  E +    L
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-------PMKSRA-PQLHLEYRFYKQL 61

Query: 414 KH-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
              + I  V Y+G      +  + LE + P S+        R  +   V      +++ +
Sbjct: 62  GSGDGIPQVYYFGPC--GKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 471 AYLHSTNTIHR 481
            Y+HS N I+R
Sbjct: 119 EYVHSKNLIYR 129

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 9/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +++G+G FG V     R TG   A K+++   I                E ++L  +   
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMAL---NEKQILEKVNSR 244

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHS 475
            +V    +    D L + L  ++ G +  ++    +    E+    +   I  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304

Query: 476 TNTIHR 481
              ++R
Sbjct: 305 ERIVYR 310

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 17/131 (12%)

Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++G+G +G V+     T   TG   A+K +   +I  + K     K    E  +L  +K
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGL 470
           H  IV    +      LY+ LEY+  G     + R          E     +   I   L
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMAL 134

Query: 471 AYLHSTNTIHR 481
            +LH    I+R
Sbjct: 135 GHLHQKGIIYR 145

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 28/129 (21%), Positives = 52/129 (40%), Gaps = 13/129 (10%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           +++GRG FG V+    + TG   A K+++   +        +       E K+L  +   
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAM---VEKKILAKVHSR 245

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAY 472
            IV    +      L + +  ++ G     I     ++     E     +T  I++GL +
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEH 304

Query: 473 LHSTNTIHR 481
           LH  N I+R
Sbjct: 305 LHQRNIIYR 313

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           KL+G+GTFG V +   + TG   A+K +    I+  D            E +VL + +H 
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTL---TENRVLQNSRHP 208

Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
            +     S    D L   +EY + G +  ++    R  +E   R +   I++ L YLHS 
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE 267

Query: 477 -NTIHR 481
            N ++R
Sbjct: 268 KNVVYR 273

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 29/131 (22%), Positives = 47/131 (35%), Gaps = 19/131 (14%)

Query: 360 KLIGRGTFGSVYIGTNRETGA-SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
             +G G FG V    + + G    A+K   I+ +  +  E       EI+VL HL     
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK---IVKNVDRYCE---AARSEIQVLEHLNTTDP 73

Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
                 VQ         H+ I  E +    ++ Y  ++E+         +R     I   
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 470 LAYLHSTNTIH 480
           + +LHS    H
Sbjct: 131 VNFLHSNKLTH 141

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 29/126 (23%), Positives = 56/126 (44%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
           ++IGRG++  V +   ++T    A+K V    +  D+    + ++    E  V      H
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQ---TEKHVFEQASNH 69

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +V  +     +  L+  +EYV+ G +  +++   R + E   R ++  I   L YLH 
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE 128

Query: 476 TNTIHR 481
              I+R
Sbjct: 129 RGIIYR 134

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 23/123 (18%), Positives = 47/123 (38%), Gaps = 3/123 (2%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            +L+GRG  G VY   +       A+K +              ++++E +  G L+  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMS--ETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
           V  +    +D  LY+ +  ++   +   +R     +         R I + L   H+   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 479 IHR 481
            HR
Sbjct: 156 THR 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 25/146 (17%), Positives = 47/146 (32%), Gaps = 23/146 (15%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
            +QW  GK IG G FG +Y+          A     ++  + +       L  E+K    
Sbjct: 36  GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH---VVKVEYQEN---GPLFSELKFYQR 89

Query: 413 LKHENIVQYYGSEVVDDHLYI-YLEY--VHPGSINRY--------------VREHCRDIT 455
           +  ++ ++ +      D+L I       +       Y              +        
Sbjct: 90  VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK 149

Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
           +S V      +L+ L Y+H    +H 
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHG 175

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 28/127 (22%), Positives = 50/127 (39%), Gaps = 13/127 (10%)

Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           GK +GRG FG V            T  + A+K +    +    +E  + L  E+K+L H+
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSE-HRALMSELKILIHI 82

Query: 414 -KHENIVQYYG-SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
             H N+V   G        L + +E+   G+++ Y+R    +      +        G  
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA--RFRQGKD 140

Query: 472 YLHSTNT 478
           Y+ +   
Sbjct: 141 YVGAIPV 147

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 37/135 (27%), Positives = 59/135 (43%), Gaps = 31/135 (22%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           LIG G FG VY G  R+ GA  A+K        P+S++ I++ E EI+ L   +H ++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKRRT-----PESSQGIEEFETEIETLSFCRHPHLVS 99

Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----------- 468
             G     +  + IY +Y+  G+    ++ H          +     ++           
Sbjct: 100 LIGFCDERNEMILIY-KYMENGN----LKRHLYG------SDLPTMSMSWEQRLEICIGA 148

Query: 469 --GLAYLHSTNTIHR 481
             GL YLH+   IHR
Sbjct: 149 ARGLHYLHTRAIIHR 163

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 27/148 (18%), Positives = 51/148 (34%), Gaps = 44/148 (29%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 414
           + +G G F +V++  +       A+K   I+  D    E     E EIK+L  +      
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTE---AAEDEIKLLQRVNDADNT 78

Query: 415 ------HENIVQYYGS---------------EVVDDHLYIYLEYVHPGSINRYVREHCRD 453
                   +I++                   EV+ ++L   ++         +       
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK------YEHRG----- 127

Query: 454 ITESIVRNFTRHILNGLAYLHS-TNTIH 480
           I    V+  ++ +L GL Y+H     IH
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIH 155

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 31/132 (23%), Positives = 54/132 (40%), Gaps = 20/132 (15%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
            LIG+G+FG V    +R      AIK   II +         Q + E+++L  +      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFL---NQAQIEVRLLELMNKHDTE 113

Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
               IV      +  +HL +  E +   S N Y      + R ++ ++ R F + +   L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 471 AYLHST--NTIH 480
            +L +   + IH
Sbjct: 171 LFLATPELSIIH 182

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
            ++G+G+FG V +   + T    A+K +    +I DD    EC      E +VL    K 
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTM---VEKRVLALPGKP 80

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             + Q +      D LY  +EYV+ G +  ++ +      E     +   I  GL +L S
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 476 TNTIHR 481
              I+R
Sbjct: 140 KGIIYR 145

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
           +++G+G+FG V +   +ETG   A+K +    I+ DD    EC      E ++L     H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTM---TEKRILSLARNH 83

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             + Q +      D L+  +E+V+ G +  +++   R   E+  R +   I++ L +LH 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD 142

Query: 476 TNTIHR 481
              I+R
Sbjct: 143 KGIIYR 148

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 31/126 (24%), Positives = 62/126 (49%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
           K++G+G+FG V++   ++T    AIK +    ++ DD    EC      E +VL    +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTM---VEKRVLSLAWEH 77

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +   + +    ++L+  +EY++ G +  +++  C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136

Query: 476 TNTIHR 481
              ++R
Sbjct: 137 KGIVYR 142

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 25/127 (19%), Positives = 42/127 (33%), Gaps = 7/127 (5%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
           G+++G G    V++  +       A+K +    D  +      +  +E +    L H  I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 419 VQYY--GSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           V  Y  G          Y+  EYV   ++   V      +T              L + H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH 133

Query: 475 STNTIHR 481
               IHR
Sbjct: 134 QNGIIHR 140

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 52.2 bits (124), Expect = 2e-07
 Identities = 33/177 (18%), Positives = 52/177 (29%), Gaps = 47/177 (26%)

Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-- 405
           S      + Q+ + IG G FG V+      T    AIK + I   D  +    K  E+  
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 406 -EIKVLGHL---------KHENIVQYYGSEVV---------------------------- 427
            EI +   L         + E  +       V                            
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 428 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR 481
             DD L+I LE+   G     +R     +     ++    +   LA   ++    HR
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHR 186

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 19/131 (14%)

Query: 360 KLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
             +G GTFG V    +   G +  A+K   II +  K     +    EI VL  +K +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK---IIRNVGKYR---EAARLEINVLKKIKEKDK 78

Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
                 V          H+ I  E +     N +  ++E+  +      VR+    + + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 470 LAYLHSTNTIH 480
           L +LH     H
Sbjct: 136 LRFLHENQLTH 146

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 10/126 (7%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLG-HLKH 415
           K+IG+G+FG V +  ++      A+K +    I+       + I     E  VL  ++KH
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIM---SERNVLLKNVKH 98

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             +V  + S    D LY  L+Y++ G +  +++   R   E   R +   I + L YLHS
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS 157

Query: 476 TNTIHR 481
            N ++R
Sbjct: 158 LNIVYR 163

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 23/148 (15%), Positives = 48/148 (32%), Gaps = 24/148 (16%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
            + W+ G  IG+G FG +Y+  +  +  S       ++  +P        L  E+K    
Sbjct: 34  AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQR 89

Query: 413 LKHENIVQ-----------------YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRD 453
                 +Q                   G    +   Y ++  +      + +    + + 
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR 148

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
            +   V   +  IL+ L Y+H    +H 
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHG 176

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 30/128 (23%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
           K++G G +G V++    +  +TG   A+K +    I    K+ E  +    E +VL H++
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIR 116

Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
               +V  + +   +  L++ L+Y++ G +  ++       TE  V+ +   I+  L +L
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175

Query: 474 HSTNTIHR 481
           H    I+R
Sbjct: 176 HKLGIIYR 183

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 12/128 (9%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           ++IGRG FG VY     +TG   A+K +D   I                E  +L  +   
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLAL---NERIMLSLVSTG 249

Query: 417 N---IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +   IV    +    D L   L+ ++ G ++ ++       +E+ +R +   I+ GL ++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHM 308

Query: 474 HSTNTIHR 481
           H+   ++R
Sbjct: 309 HNRFVVYR 316

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 10/121 (8%), Positives = 27/121 (22%), Gaps = 5/121 (4%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
             G       +   +       A+  VD  P      + +++       L  +    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
                       +  E++  GS+           +        + +       H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 481 R 481
            
Sbjct: 153 S 153

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 29/127 (22%), Positives = 45/127 (35%), Gaps = 13/127 (10%)

Query: 361 LIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
            I  G  G +Y+       G    +K           AE       E + L  + H +IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           Q +          D   YI +EYV   S+ R   +    +  +    +   IL  L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH 199

Query: 475 STNTIHR 481
           S   ++ 
Sbjct: 200 SIGLVYN 206

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 28/132 (21%), Positives = 57/132 (43%), Gaps = 21/132 (15%)

Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHL 413
           K++G+G+FG V++    +  +     A+K +    +   D            E  +L  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTK----MERDILVEV 83

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNG 469
            H  IV+ + +   +  LY+ L+++  G     +++ V       TE  V+ +   +   
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALA 138

Query: 470 LAYLHSTNTIHR 481
           L +LHS   I+R
Sbjct: 139 LDHLHSLGIIYR 150

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 17/130 (13%)

Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
           ++GRG FG VY G     G   A+K +     + ++     Q + E++++    H N+++
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRL----KEERTQGGELQFQTEVEMISMAVHRNLLR 91

Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH-----ILNGLAYLH 474
             G  +     L +Y  Y+  GS+   +RE      +  +    R         GLAYLH
Sbjct: 92  LRGFCMTPTERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLH 148

Query: 475 ---STNTIHR 481
                  IHR
Sbjct: 149 DHCDPKIIHR 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 23/148 (15%), Positives = 43/148 (29%), Gaps = 24/148 (16%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------ASCAIKEVDIIPDDPKSAECIKQLE 404
             QW+      R   G +Y      T            ++K   +   D +        +
Sbjct: 41  GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ 97

Query: 405 QEIKV--------LGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHC--RD 453
           +  K         L       I    G  V  D + ++ L  +   S+     +      
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHV 155

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           ++E  V      +L+ L +LH    +H 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHG 183

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 1e-04
 Identities = 48/384 (12%), Positives = 103/384 (26%), Gaps = 106/384 (27%)

Query: 133 LNIESVKNDLRPSVPVRSTPTSL-------SSSHA-----------VSPQRSN---LQNP 171
           L I S++ +LR  +  +     L       ++               +  +     L   
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284

Query: 172 TPLHNPKSISTRRRGFSHDLNIE-CANY-SSRADIIPKSAPTSVFSSPAVSPQSSKTGNV 229
           T  H   S+       + D        Y   R   +P+   T        +P+       
Sbjct: 285 TTTH--ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-------TNPR------R 329

Query: 230 FSSFWA-----PKEIQDWSTAEVPDLGRFVG-CTSPVSPFK-RNVYSA-----DHSPLPS 277
            S              +W       L   +    + + P + R ++         + +P+
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389

Query: 278 PPRQS--SQSNLRSPRKVYFPLRHKSL-PQNSKE------------LLESNNHLNAH--- 319
                            V   L   SL  +  KE             ++  N    H   
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 320 ------PLPLPPGALSPPKSS--VTSAVMPHIM-----EKPSASPKKSQ---WQKGKLIG 363
                 P       L PP       S +  H+      E+ +          + + K+  
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR- 508

Query: 364 RGTFGSVYIGTNRETGASCA--IKEVD-----IIPDDPKSAECIKQLEQEIKVLG-HL-- 413
                  +  T      S    ++++      I  +DPK    +  +   +  +  +L  
Sbjct: 509 -------HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC 561

Query: 414 -KHENIVQYYGSEVVDDHLYIYLE 436
            K+ ++++     ++ +   I+ E
Sbjct: 562 SKYTDLLR---IALMAEDEAIFEE 582

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	481
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.94
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.94
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.93
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.93
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.93
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.93
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.92
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.92
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.92
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.91
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.91
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.91
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.91
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.9
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.88
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.88
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.88
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.88
3uqc_A	286	Probable conserved transmembrane protein; structur	99.87
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.87
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.86
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.86
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.86
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.86
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.86
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.85
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.85
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.85
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.85
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.85
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.85
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.85
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.85
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.85
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.85
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.85
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.85
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.85
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.84
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.84
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.84
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.84
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.84
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.84
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.84
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.84
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.84
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.84
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.84
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.84
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.84
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.84
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.84
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.84
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.84
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.84
3bhy_A	283	Death-associated protein kinase 3; death associate	99.84
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.84
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.84
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.84
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.84
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.84
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.84
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.84
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.83
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.83
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.83
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.83
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.83
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.83
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.83
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.83
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.83
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.83
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.83
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.83
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.83
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.83
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.83
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.83
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.83
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.83
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.83
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.83
3niz_A	311	Rhodanese family protein; structural genomics, str	99.83
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.83
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.83
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.83
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.83
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.83
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.83
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.83
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.83
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.83
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.83
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.83
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.82
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.82
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.82
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.82
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.82
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.82
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.82
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.82
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.82
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.82
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.82
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.82
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.82
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.82
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.82
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.82
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.82
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.82
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.82
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.82
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.82
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.82
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.82
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.82
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.82
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.82
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.82
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.82
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.82
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.82
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.82
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.82
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.82
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.81
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.81
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.81
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.81
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.81
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.81
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.81
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.81
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.81
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.81
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.81
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.81
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.81
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.81
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.81
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.81
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.81
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.81
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.81
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.81
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.81
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.81
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.81
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.8
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.8
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.8
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.8
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.8
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.8
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.8
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.8
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.8
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.8
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.8
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.8
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.8
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.8
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.8
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.8
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.8
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.8
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.8
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.8
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.8
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.8
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.79
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.79
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.79
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.79
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.79
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.79
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.79
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.79
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.79
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.79
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.79
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.79
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.79
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.79
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.79
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.79
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.78
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.78
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.78
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.78
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.78
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.78
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.78
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.78
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.78
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.78
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.77
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.77
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.77
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.77
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.77
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.77
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.77
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.77
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.77
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.77
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.77
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.77
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.77
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.77
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.76
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.76
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.76
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.76
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.76
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.76
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.76
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.76
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.76
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.76
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.76
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.76
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.76
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.76
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.75
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.75
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.75
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.74
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.74
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.74
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.74
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.74
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.74
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.73
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.72
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.72
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.69
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.69
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.68
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.63
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.58
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.58
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.55
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.44
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.21
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.71
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.51
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.06
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.8
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.75
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	95.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	93.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	92.91
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	90.0
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.22
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	82.92
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	80.94

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.94  E-value=4.1e-26  Score=234.02  Aligned_cols=126  Identities=27%  Similarity=0.433  Sum_probs=109.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++...   ......+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            468999999999999999999999999999999997532   23445678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.++|.... ..++|..++.|+.||+.||+|||++|||||
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHR  149 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR  149 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEET
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999999999997643 457999999999999999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.94  E-value=1.1e-26  Score=234.90  Aligned_cols=125  Identities=28%  Similarity=0.476  Sum_probs=112.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.....  ......+.+.+|+++|+.|+|||||+++++|.+++.+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            479999999999999999999999999999999963210  011224678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|.++|+.. +.++|..++.|+.||+.||+|||++|||||
T Consensus       110 vmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHR  156 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR  156 (311)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            99999999999999875 789999999999999999999999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.93  E-value=9.4e-26  Score=231.04  Aligned_cols=122  Identities=29%  Similarity=0.488  Sum_probs=111.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|++.++||+|+||+||+|.++.+|+.||||+++......     .+.+.+|+.+|+.|+|||||+|+++|.+++.+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            467999999999999999999999999999999997543211     245778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.+++..  +.+++..++.|+.||+.||+|||++|||||
T Consensus       148 ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR  194 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR  194 (346)
T ss_dssp             EEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999975  579999999999999999999999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.93  E-value=2e-25  Score=234.27  Aligned_cols=123  Identities=28%  Similarity=0.485  Sum_probs=112.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ....|++.++||+|+||.||+|.++.+|+.||||++......  .   .+.+.+|+.+|+.|+|||||+|+++|.+++.+
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--R---RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--S---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--H---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence            346799999999999999999999999999999999754321  1   24577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++++.  +.+++..++.|+.||+.||+|||++|||||
T Consensus       224 ~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHR  271 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR  271 (423)
T ss_dssp             EEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999999999999999965  569999999999999999999999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.93  E-value=1.9e-25  Score=221.67  Aligned_cols=125  Identities=25%  Similarity=0.466  Sum_probs=107.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++....  ...+..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            4689999999999999999999999999999999974321  22333467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||| +|+|.++|... +.+++..++.|+.||+.||+|||++|||||
T Consensus        90 ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHR  136 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHR  136 (275)
T ss_dssp             EEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999 68999999774 789999999999999999999999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.93  E-value=2.8e-25  Score=222.46  Aligned_cols=126  Identities=29%  Similarity=0.554  Sum_probs=109.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....+|.+.++||+|+||+||+|++.     .++..||||+++.     ......+++.+|+++|++|+|||||+++|++
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            34568999999999999999999875     3578899999863     2345567899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+++.+|||||||++|+|.++|+.++            ..+++..+..|+.||+.||+|||+++||||
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR  152 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHR  152 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            99999999999999999999997642            469999999999999999999999999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.92  E-value=4.1e-25  Score=225.38  Aligned_cols=119  Identities=25%  Similarity=0.431  Sum_probs=109.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ....|++.++||+|+||.||+|+++.+|+.||||+++....          ..+|+.+|+.|+|||||+++++|.+++.+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34679999999999999999999999999999999974221          13599999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|||||
T Consensus       126 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR  174 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHG  174 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999999999999999875 789999999999999999999999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.92  E-value=1.2e-24  Score=220.62  Aligned_cols=126  Identities=23%  Similarity=0.454  Sum_probs=111.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....+|.+.++||+|+||+||+|+++     .++..||||+++.     ......+.|.+|+++|++|+|||||+|+|+|
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34568999999999999999999975     3578899999862     2455667899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~--------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+.+|||||||++|+|.++|+.+.              +.+++..+..|+.||+.||+|||+++||||
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR  182 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR  182 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            99999999999999999999997532              358999999999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.92  E-value=1.8e-24  Score=216.10  Aligned_cols=124  Identities=28%  Similarity=0.511  Sum_probs=110.5

Q ss_pred             CCe-EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----C
Q 011617          354 SQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----D  428 (481)
Q Consensus       354 ~~Y-~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----~  428 (481)
                      ++| ++.++||+|+||.||+|.++.++..||||++....   ......+.+.+|+.+|+.|+|||||+++++|.+    +
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            344 78889999999999999999999999999997432   234456789999999999999999999999875    3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                      +.+|||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|  ||||
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR  155 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  155 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCC
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEec
Confidence            5699999999999999999875 78999999999999999999999998  9998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.91  E-value=2.7e-24  Score=214.92  Aligned_cols=124  Identities=23%  Similarity=0.494  Sum_probs=106.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----  429 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d----  429 (481)
                      .+|++++.||+|+||+||+|.++.+|+.||||+++..    ......+.+.+|+.+|++|+|||||+++++|...+    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence            3699999999999999999999999999999999742    23445577899999999999999999999987654    


Q ss_pred             --------EEEEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 --------HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 --------~lyLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                              .+|||||||+||+|.+++....  ....+..++.|+.||+.||+|||++|||||
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR  142 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR  142 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccc
Confidence                    4899999999999999997642  124567789999999999999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.91  E-value=2.3e-24  Score=217.09  Aligned_cols=126  Identities=25%  Similarity=0.423  Sum_probs=111.3

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ++....+++++++||+|+||+||+|++..   .||||+++...   ...+..+.|.+|+.+|++++|||||+++|++. +
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~  103 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K  103 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence            45567789999999999999999998653   59999987432   34566788999999999999999999999865 5


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||+||+|.++|......+++..+..|+.||+.||+|||+++||||
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR  156 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR  156 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            67899999999999999998766789999999999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.91  E-value=3.6e-25  Score=222.74  Aligned_cols=124  Identities=23%  Similarity=0.317  Sum_probs=104.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      .+|++++.||+|+||+||+|++.   .+++.||||+++........   ...+.+|+.+|++|+|||||+++++|.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            57999999999999999999974   46789999999642211111   1256779999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|||||
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR  150 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYR  150 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            99999999999999999875 789999999999999999999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.91  E-value=3.9e-24  Score=222.12  Aligned_cols=124  Identities=28%  Similarity=0.461  Sum_probs=110.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-----  427 (481)
                      .++|+++++||+|+||.||+|.++.+|+.||||+++..   .......+.+.+|+++|+.|+|||||++++++..     
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            46899999999999999999999999999999998642   2334556778899999999999999999998764     


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+.+|||||||+ |+|.++|.. .+.+++..++.|++||+.||+|||++|||||
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHR  182 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR  182 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCC
Confidence             357999999995 789999976 4789999999999999999999999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.91  E-value=2.9e-24  Score=215.87  Aligned_cols=127  Identities=21%  Similarity=0.334  Sum_probs=108.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....++++.++||+|+||+||+|.+.     .+++.||||+++...    .....+.|.+|+.+|++|+|||||+|+|++
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            34567899999999999999999864     356789999986322    222346788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..++.+|||||||++|+|.++|....               ..+++..+..|+.||+.||+|||+++||||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR  169 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK  169 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999996531               358999999999999999999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.90  E-value=9.5e-24  Score=228.36  Aligned_cols=124  Identities=23%  Similarity=0.364  Sum_probs=114.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||+++.     ......+.+.+|+.+|+.|+|||||+|+++|.+++.+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec-----cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            4689999999999999999999999999999999863     22334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.++|....+.+++.+++.|+.||+.||+|||++|||||
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR  279 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  279 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999999999997656789999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.88  E-value=8.8e-23  Score=225.15  Aligned_cols=130  Identities=21%  Similarity=0.257  Sum_probs=112.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC-CCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~-d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ...++|+++++||+|+||+||+|+++.+|+.||||+++.... .............++.+++.++|||||+|+++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            345689999999999999999999999999999999964211 1122333344445677888899999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||.||+|.++|... +.++|..++.|+.||+.||+|||++|||||
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHR  316 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYR  316 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999999999875 789999999999999999999999999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.88  E-value=1e-22  Score=208.56  Aligned_cols=128  Identities=24%  Similarity=0.395  Sum_probs=109.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCC-----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g  423 (481)
                      +...++|+++++||+|+||+||+|.+...+     +.||||.++.    .......+.+.+|+++|.++.| +|||+|+|
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~----~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            455678999999999999999999986543     5799998863    2234456778999999999975 89999999


Q ss_pred             EEEeC-CEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~-d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|... +.+|||||||++|+|.++|+...               ..+++..+..|+.||+.||+|||+++||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR  209 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  209 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence            98764 57999999999999999997632               348999999999999999999999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.88  E-value=2.4e-22  Score=200.42  Aligned_cols=118  Identities=28%  Similarity=0.377  Sum_probs=100.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----  429 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d----  429 (481)
                      ++|.+.++||+|+||.||+|++  +|+.||||+++..      .......+.|+..+..++|||||++++++..++    
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            4689999999999999999997  4889999998631      111223345777778899999999999998764    


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk--------gIIHR  481 (481)
                      .+|||||||++|+|.++|+.  ..+++..+..|+.||+.||+|||++        +||||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR  132 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR  132 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred             EEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence            68999999999999999975  5689999999999999999999987        99998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.88  E-value=2.7e-22  Score=205.40  Aligned_cols=118  Identities=21%  Similarity=0.334  Sum_probs=105.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      .++|+++++||+|+||+||+|+++   .+++.||||++...    ..   ..++.+|+++|+.+ +|+|||+++++|.++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cC---HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            457999999999999999999875   45788999988532    11   24577899999998 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++|||||||+||+|.+++    +.+++.+++.|+.||+.||+|||++|||||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHR  141 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHR  141 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            9999999999999999998    349999999999999999999999999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.87  E-value=1.2e-21  Score=192.16  Aligned_cols=126  Identities=7%  Similarity=0.023  Sum_probs=112.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++..  .....+..+.+.+|+.++..++|+||+++++++..++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  105 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ--GVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG  105 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTT--CCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcc--cccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence            3457899999999999999999999999999999998642  22345666788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+|++|.++++.  + .....+..|+.||+.||+|||++|||||
T Consensus       106 ~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~  153 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALS  153 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            9999999999999999953  3 4666788999999999999999999997

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.87  E-value=1.8e-21  Score=190.26  Aligned_cols=126  Identities=31%  Similarity=0.500  Sum_probs=116.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|+++++||+|+||.||+|.+..+++.||+|++..     ......+.+.+|+.+|+.++|+||+++++++..++.
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            345789999999999999999999999999999998842     345666789999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++|+|.++++.....+++..+..|+.||+.||+|||++|||||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  132 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR  132 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            999999999999999998866789999999999999999999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.87  E-value=2.3e-21  Score=194.22  Aligned_cols=127  Identities=28%  Similarity=0.499  Sum_probs=116.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+++|+.++|+||+++++++...+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            34578999999999999999999999999999999997432   244556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||++|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHr  138 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHR  138 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            99999999999999999875 779999999999999999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.87  E-value=3.8e-21  Score=187.86  Aligned_cols=128  Identities=26%  Similarity=0.473  Sum_probs=117.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||||++...  .....+..+.+.+|+.++..++|+||+++++++...+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECC--SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccC--ccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            3457899999999999999999999999999999998642  23445667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||++|++|.+++... +.+++..+..|+.||+.||+|||++||+||
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  135 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHR  135 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999875 679999999999999999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=3e-21  Score=192.07  Aligned_cols=124  Identities=20%  Similarity=0.282  Sum_probs=113.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++++.||+|+||.||+|.+..+++.||+|+++..      ......+.+|+.+|+.++|+||+++++++.+.+.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            357899999999999999999999999999999998631      22345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~  126 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF  126 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence            99999999999999997655679999999999999999999999999997

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.86  E-value=6.7e-21  Score=192.94  Aligned_cols=129  Identities=22%  Similarity=0.434  Sum_probs=117.2

Q ss_pred             CCCCCCeEEeEEeccC--CcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          350 SPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~G--tFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....++|+++++||+|  +||.||+|.+..+|+.||||+++...   ...+..+.+.+|+.+|+.++|+|||++++++..
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4456799999999999  99999999999999999999997532   334567788899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||++|+|.+++... ...+++..++.|+.||+.||+|||++|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  152 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR  152 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999999999764 3669999999999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.86  E-value=2.6e-21  Score=196.94  Aligned_cols=131  Identities=22%  Similarity=0.395  Sum_probs=115.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ....+.|++++.||+|+||.||+|.++.+|+.||||+++....... .....+.+.+|+.+|++++||||++++++|.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            3455789999999999999999999999999999999975432211 111235688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||.||+|.+++.. .+.+++..+..|+.||+.||.|||++|||||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  139 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF  139 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999999999999999966 4779999999999999999999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.86  E-value=1.6e-21  Score=196.09  Aligned_cols=130  Identities=28%  Similarity=0.429  Sum_probs=111.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.+.||+|+||.||+|.++.+++.||||+++............+.+.+|+.+|+.++|+||+++++++..++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34689999999999999999999999999999999864211001111235688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+|++|.+++...   ...+++..++.|+.||+.||+|||++|||||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHr  154 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR  154 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999999999999888653   2358999999999999999999999999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.85  E-value=5.3e-21  Score=190.19  Aligned_cols=128  Identities=23%  Similarity=0.398  Sum_probs=115.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++++.||+|+||.||++.+..+++.||+|++....  .......+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh--hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            35678999999999999999999999999999999986422  2234556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  165 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHR  165 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Confidence            99999999999999999774 779999999999999999999999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.85  E-value=8e-21  Score=184.13  Aligned_cols=124  Identities=32%  Similarity=0.524  Sum_probs=111.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.++||+|+||.||+|.+..+++.||||+++....   .....+.+.+|+.+|+.++|+||+++++++..++.+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC---cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            589999999999999999999999999999999975332   23344677889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||. ++|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~  125 (292)
T 3o0g_A           79 VFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR  125 (292)
T ss_dssp             EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            999997 67777776656889999999999999999999999999997

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.85  E-value=8.3e-21  Score=191.45  Aligned_cols=127  Identities=24%  Similarity=0.344  Sum_probs=115.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ...+|++++.||+|+||.||+|+++.+++.||||+++...  .......+.+.+|+.+|.++ +|+||++++++|.+.+.
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH--hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            4568999999999999999999999999999999997432  23445567788999999987 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  134 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYR  134 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            99999999999999999875 679999999999999999999999999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.85  E-value=7.4e-21  Score=192.47  Aligned_cols=124  Identities=26%  Similarity=0.398  Sum_probs=112.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||||++....  ...    +.+.+|+.+++.++|+||+++++++...+.
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AID----ENVQREIINHRSLRHPNIVRFKEVILTPTH   90 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--ccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence            34678999999999999999999999999999999997422  111    457789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.+|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~  140 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHR  140 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999775 679999999999999999999999999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.85  E-value=1.2e-20  Score=179.62  Aligned_cols=126  Identities=26%  Similarity=0.423  Sum_probs=112.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~l  431 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||||+++....   .......+.+|+.++..+ +|+||+++++++...+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT---TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            4679999999999999999999999999999999874322   223346777899999998 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++++|.+++...   ...+++..++.|+.||+.||.|||++||+||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  139 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM  139 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            9999999999999999764   2669999999999999999999999999997

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.85  E-value=6.3e-21  Score=189.51  Aligned_cols=128  Identities=26%  Similarity=0.396  Sum_probs=114.7

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      .....+|++.++||+|+||.||+|.+..+++   .||||+++..    ......+.+.+|+.+|+.++|+||+++++++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4556799999999999999999999986655   4999998632    23455678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+||||||+++|+|.++++...+.+++..+..|+.||+.||.|||++|||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  175 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR  175 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            9999999999999999999998766789999999999999999999999999997

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.85  E-value=3.9e-21  Score=193.76  Aligned_cols=126  Identities=25%  Similarity=0.354  Sum_probs=112.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||+++....  ........+.+|+.+|+.++|+||+++++++...+.+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            4689999999999999999999999999999999963210  01112356778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|..++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  129 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999999775 779999999999999999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.85  E-value=1.2e-20  Score=191.18  Aligned_cols=125  Identities=25%  Similarity=0.375  Sum_probs=114.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+.+|+.++|+|||++++++.+.+.+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            457999999999999999999999999999999997432   23455677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||.||+|.+++.. ...+++..+..|+.||+.||.|||++|||||
T Consensus       105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  152 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHR  152 (362)
T ss_dssp             EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            99999999999999976 3679999999999999999999999999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.85  E-value=5.2e-21  Score=194.00  Aligned_cols=128  Identities=22%  Similarity=0.372  Sum_probs=111.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ...++|+++++||+|+||.||+|+++.+|+.||||+++...  .......+.+.+|+.+|..+ +|+||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            44678999999999999999999999999999999997311  01122345677899999988 6999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+||+|..++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHr  148 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYR  148 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999875 779999999999999999999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.85  E-value=4.3e-21  Score=188.30  Aligned_cols=128  Identities=19%  Similarity=0.300  Sum_probs=114.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ...++|+++++||+|+||.||+|.+..+++.||||+++..  ..........+.+|+.+++.++|+||+++++++...+ 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT--TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc--ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            4567899999999999999999999999999999998742  2344566678899999999999999999999987654 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ---~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ..||||||++|++|.++++.. +.+++..++.|+.||+.||.|||++|||||
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  140 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHR  140 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence               359999999999999999875 679999999999999999999999999997

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.85  E-value=5.1e-21  Score=187.57  Aligned_cols=124  Identities=31%  Similarity=0.525  Sum_probs=111.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.....  ..   .+.+.+|+.+|+.++|+||+++++++...+.
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PK---KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            345789999999999999999999999999999999874322  11   2457789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||++|+|.+++..  ..+++..++.|+.||+.||.|||++|||||
T Consensus        92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Confidence            9999999999999999976  469999999999999999999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.85  E-value=4.5e-21  Score=194.63  Aligned_cols=129  Identities=26%  Similarity=0.408  Sum_probs=116.4

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++++.||+|+||.||+|.+..+++.||||+++..    ...+..+.+.+|+.+|+.++|+||+++++++..+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            345567999999999999999999999999999999998631    2344556788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||++|+|.++++.....+++..+..|+.||+.||+|||++|||||
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  237 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR  237 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCc
Confidence            99999999999999999998766679999999999999999999999999997

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.85  E-value=2.7e-20  Score=178.63  Aligned_cols=126  Identities=25%  Similarity=0.371  Sum_probs=115.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+.+|+.+++.++|+||+++++++...+..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            4578999999999999999999999999999999997432   2445567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||+.+++|.+++... ..+++..+..|+.||+.||.|||++||+||
T Consensus        81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHR  129 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcC
Confidence            9999999999999999775 779999999999999999999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.84  E-value=1.2e-20  Score=187.64  Aligned_cols=129  Identities=24%  Similarity=0.387  Sum_probs=113.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..+.|++++.||+|+||.||+|.+..+|+.||||+++....... .....+.+.+|+.+|+.++|+||+++++++...+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34679999999999999999999999999999999975432211 11124568889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||++|+|.+++.. .+.+++..++.|+.||+.||.|||++||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  138 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHF  138 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcC
Confidence            9999999999999999976 4779999999999999999999999999997

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.84  E-value=4.3e-21  Score=190.85  Aligned_cols=125  Identities=28%  Similarity=0.560  Sum_probs=110.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|+++++||+|+||.||+|.+..+++.||||++....    .....+.+.+|+.+++.++|+||+++++++...+.+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            4578999999999999999999999999999999986422    122335678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~  129 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR  129 (323)
T ss_dssp             EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999999965 3679999999999999999999999999997

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.84  E-value=2.4e-20  Score=180.61  Aligned_cols=128  Identities=23%  Similarity=0.398  Sum_probs=115.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+.+|+.+++.++|+||+++++++...+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh--ccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            45678999999999999999999999999999999986432  2234556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++... +.+++..+..|+.||+.||+|||++||+||
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  139 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHR  139 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999774 779999999999999999999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.84  E-value=6e-21  Score=183.71  Aligned_cols=126  Identities=21%  Similarity=0.384  Sum_probs=112.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCC-------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG  423 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g  423 (481)
                      ...++|++.+.||+|+||.||+|.+..++       ..||+|++...     .....+.+.+|+.+|++++|+||+++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~   79 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYG   79 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            34578999999999999999999998777       46999998531     2233467889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+..||||||+++|+|.+++......+++..+..|+.||+.||.|||++|||||
T Consensus        80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  137 (289)
T 4fvq_A           80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHG  137 (289)
T ss_dssp             EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence            9999999999999999999999998765569999999999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.84  E-value=1.2e-20  Score=183.88  Aligned_cols=124  Identities=23%  Similarity=0.483  Sum_probs=106.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----  429 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d----  429 (481)
                      ++|++++.||+|+||.||+|.++.+|+.||||+++...    .....+.+.+|+.+|+.++|+|||+++++|...+    
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            57999999999999999999999999999999997432    2234467889999999999999999999986543    


Q ss_pred             -----------------------------------------------------EEEEEEeccCCCCHHHHHHHhC--CCC
Q 011617          430 -----------------------------------------------------HLYIYLEYVHPGSINRYVREHC--RDI  454 (481)
Q Consensus       430 -----------------------------------------------------~lyLVmEy~~GGSL~~lL~~~~--~~L  454 (481)
                                                                           .+|||||||++++|.++++...  ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 3899999999999999997642  235


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          455 TESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       455 se~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+..++.|+.||+.||+|||++|||||
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~  188 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHR  188 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            667799999999999999999999997

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.84  E-value=6.7e-21  Score=184.60  Aligned_cols=127  Identities=30%  Similarity=0.537  Sum_probs=112.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEE----ECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~----dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....++|+++++||+|+||.||+|.    +..+++.||||+++.     ......+.+.+|+.+|+.++|+||+++++++
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   80 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVC   80 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456799999999999999999998    466889999999862     3455567889999999999999999999998


Q ss_pred             EeC--CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~--d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...  ..+|||||||++|+|.+++......+++..+..|+.||+.||+|||++|||||
T Consensus        81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  138 (295)
T 3ugc_A           81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR  138 (295)
T ss_dssp             CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            653  56899999999999999998765669999999999999999999999999997

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.84  E-value=4.8e-21  Score=191.12  Aligned_cols=127  Identities=20%  Similarity=0.378  Sum_probs=112.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++.+.||+|+||.||+|.++.+|+.||||+++....  ......+.+.+|+.+|+.++|+||+++++++.+.+.+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            34689999999999999999999999999999999963210  0011235677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus        82 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  130 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYR  130 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999874 779999999999999999999999999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.84  E-value=1.4e-20  Score=182.96  Aligned_cols=134  Identities=28%  Similarity=0.462  Sum_probs=115.9

Q ss_pred             cCCCCCCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCe
Q 011617          344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI  418 (481)
Q Consensus       344 ~~~~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNI  418 (481)
                      .+........++|++++.||+|+||.||+|.+.     .++..||||+++.    .......+.+.+|+.+|+.++|+||
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~i   88 (314)
T 2ivs_A           13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE----NASPSELRDLLSEFNVLKQVNHPHV   88 (314)
T ss_dssp             -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCce
Confidence            344555667789999999999999999999983     4557899999863    2345566788999999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHS  475 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~-----------------------~~Lse~~I~~I~~QIl~GL~YLHs  475 (481)
                      +++++++...+.+||||||+++|+|.+++....                       ..+++..+..|+.||+.||.|||+
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998642                       238999999999999999999999


Q ss_pred             CCCccC
Q 011617          476 TNTIHR  481 (481)
Q Consensus       476 kgIIHR  481 (481)
                      +||+||
T Consensus       169 ~~ivH~  174 (314)
T 2ivs_A          169 MKLVHR  174 (314)
T ss_dssp             TTEECC
T ss_pred             CCCccc
Confidence            999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.84  E-value=2.8e-20  Score=181.22  Aligned_cols=125  Identities=29%  Similarity=0.413  Sum_probs=112.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|+++++||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+.+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            36899999999999999999999999999999988532   234455677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++++|.+++.. .+.+++..+..|+.||+.||+|||++||+||
T Consensus        79 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~  126 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHR  126 (311)
T ss_dssp             EEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            99999999999988865 4779999999999999999999999999997

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.84  E-value=7.9e-21  Score=192.20  Aligned_cols=128  Identities=26%  Similarity=0.372  Sum_probs=113.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|+++.+|+.||||+++....  ......+.+.+|+.+|+.++|+||+++++++.+.+.
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            345789999999999999999999999999999999863210  011123567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  165 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999875 679999999999999999999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.84  E-value=1.7e-20  Score=192.77  Aligned_cols=125  Identities=18%  Similarity=0.281  Sum_probs=113.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++...     .......+.+|+.+|+.++|+||+++++++.+.+.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            346899999999999999999999999999999998632     233345788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||.+|+|.+++......+++..+..|+.||+.||+|||++|||||
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  173 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL  173 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            99999999999999997655679999999999999999999999999997

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.84  E-value=1.2e-20  Score=185.55  Aligned_cols=127  Identities=25%  Similarity=0.418  Sum_probs=110.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ....+|+++++||+|+||.||+|.+..+++.||||+++....    ....+.+.+|+++|+.++|+||+++++++...+ 
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            345789999999999999999999999999999999864221    112356678999999999999999999998765 


Q ss_pred             -EEEEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -~lyLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+|||||||++++|.+++....  ..+++..++.|+.||+.||+|||++|||||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  136 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR  136 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence             7899999999999999997642  239999999999999999999999999997

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.84  E-value=1.3e-20  Score=180.25  Aligned_cols=125  Identities=25%  Similarity=0.382  Sum_probs=111.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|++.+.||+|+||.||+|.+.. ++.||||++....   ...   +.+.+|+.+|++++|+||+++++++.+.+
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA---MSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS---BCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc---cCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4456789999999999999999999874 6779999986321   122   46788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  130 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999999998766779999999999999999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.84  E-value=1.7e-20  Score=184.79  Aligned_cols=128  Identities=23%  Similarity=0.392  Sum_probs=113.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS  424 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~  424 (481)
                      ....++|++++.||+|+||.||+|.+.     .+++.||||+++..    ......+.+.+|+.+|+.++|+||++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345678999999999999999999987     34588999998632    234556788999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~~-----------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +...+.+||||||+++|+|.+++....                       ..+++..++.|+.||+.||.|||++|||||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            999999999999999999999997642                       568999999999999999999999999997

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.84  E-value=1.3e-20  Score=194.95  Aligned_cols=128  Identities=23%  Similarity=0.332  Sum_probs=112.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ....+|+++++||+|+||+||+|+++.+++.||||+++....  ...+..+.+..|+.+|.++ +|||||+++++|.+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            445789999999999999999999999999999999975322  1223345677899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||.||+|..++... +.+++..++.|+.||+.||+|||++|||||
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHr  177 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYR  177 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence            999999999999999999875 779999999999999999999999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.84  E-value=1.2e-20  Score=192.95  Aligned_cols=128  Identities=28%  Similarity=0.387  Sum_probs=104.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHH-HhhCCCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~i-L~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....+|++++.||+|+||+||+|+++.+++.||||+++....  ......+.+..|..+ ++.++|+||++++++|.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGB--C-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            445789999999999999999999999999999999974321  122233456667766 57789999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+||+|.+++... +.+.+..++.|+.||+.||+|||++|||||
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHr  163 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYR  163 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999999999999999999875 779999999999999999999999999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.84  E-value=1.8e-20  Score=186.34  Aligned_cols=129  Identities=22%  Similarity=0.282  Sum_probs=106.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....+|++.++||+|+||.||+|++.   .+++.||||+++.... .........+.+|+.+|+.++|+||+++++++..
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            34578999999999999999999985   6889999999864221 1122334567789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+|||||||+||+|.+++... +.+.+..++.|+.||+.||.|||++|||||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  145 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYR  145 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence            99999999999999999999875 779999999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.84  E-value=2.3e-20  Score=182.15  Aligned_cols=125  Identities=21%  Similarity=0.317  Sum_probs=110.8

Q ss_pred             CCCCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          351 PKKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       351 ~~~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      ...+.|++. ++||+|+||.||+|.+..+++.||||+++...  ..   ....+.+|+.+|.++ +|+||+++++++..+
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--ch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345689985 78999999999999999999999999997432  11   235677899999885 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++|||||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  135 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHR  135 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Confidence            9999999999999999999875 679999999999999999999999999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.84  E-value=3e-20  Score=178.26  Aligned_cols=127  Identities=24%  Similarity=0.408  Sum_probs=112.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++....... .....+.+.+|+.+|++++|+||+++++++...+.+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999975432211 1112457888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+++++|.+++... ..+++..+..|+.||+.||.|||++||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  132 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHF  132 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            999999999999999774 679999999999999999999999999997

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.84  E-value=8.9e-21  Score=191.89  Aligned_cols=128  Identities=21%  Similarity=0.350  Sum_probs=110.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ....+|++.+.||+|+||.||+|+++.+|+.||||+++....  ......+.+..|+.+|..+ +|+||+++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            456799999999999999999999999999999999973210  0011234567788888876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+||+|.++++.. +.+++..++.|+.||+.||+|||++|||||
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  142 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYR  142 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            999999999999999999875 779999999999999999999999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.84  E-value=2.8e-20  Score=178.76  Aligned_cols=122  Identities=27%  Similarity=0.497  Sum_probs=110.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe------
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV------  427 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~------  427 (481)
                      ++|++++.||+|+||.||+|.+..+++.||||+++.      .....+.+.+|+.+|+.++|+||+++++++..      
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            479999999999999999999999999999999862      34556788899999999999999999998865      


Q ss_pred             -------CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -------~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                             .+.+||||||+++|+|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  140 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHR  140 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecc
Confidence                   356999999999999999998765678899999999999999999999999997

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.84  E-value=6.1e-21  Score=198.27  Aligned_cols=129  Identities=21%  Similarity=0.285  Sum_probs=113.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|+++++||+|+||.||+|+++.+|+.||||+++...  .......+.+.+|+.+|..++|+||++++++|.+.+.
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            34578999999999999999999999999999999996311  0011122347789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHr  186 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR  186 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999999999999999998765689999999999999999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.84  E-value=2.1e-20  Score=189.79  Aligned_cols=128  Identities=26%  Similarity=0.467  Sum_probs=112.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-------CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY  421 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-------~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL  421 (481)
                      ....++|++++.||+|+||.||+|.+.       .++..||||+++..    ......+.+.+|+.+|+.+ +|+||+++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            445678999999999999999999975       34557999998632    3455667899999999999 89999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++...+.+||||||+++|+|.+++....               ..+++..+..|+.||+.||+|||++|||||
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  227 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  227 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            999999999999999999999999998642               348899999999999999999999999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.84  E-value=7e-20  Score=178.64  Aligned_cols=129  Identities=31%  Similarity=0.506  Sum_probs=113.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||+++..  ........+.+.+|+.+|+.++|+||+++++++...+.
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTT--SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehh--hccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            3456899999999999999999999999999999998642  22345566788899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++..   ....+++..+..|+.||+.||.|||++||+||
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  160 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR  160 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence            9999999999999999865   24668999999999999999999999999997

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.84  E-value=2.4e-20  Score=178.75  Aligned_cols=123  Identities=26%  Similarity=0.425  Sum_probs=111.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.++||+|+||.||+|.+..++..||+|++.....  .   ..+.+.+|+.+|+.++|+||+++++++...+.+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--E---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--S---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--c---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            4579999999999999999999999999999999874321  1   2356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+++++|.+++... ..+++..+..|+.||+.||+|||++||+||
T Consensus        83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHR  130 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            999999999999999775 779999999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.84  E-value=9.8e-21  Score=181.58  Aligned_cols=128  Identities=32%  Similarity=0.606  Sum_probs=113.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|++++.||+|+||.||+|.+..+|+.||||++.....  ......+.+.+|+.+++.++|+||+++++++...+.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            34689999999999999999999999999999999863110  0111235788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++++|.+++......+++..++.|+.||+.||.|||++||+||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  136 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR  136 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999999999998766789999999999999999999999999997

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.84  E-value=2.8e-20  Score=194.82  Aligned_cols=126  Identities=23%  Similarity=0.298  Sum_probs=112.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            3468999999999999999999999999999999987432   2344556788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||.||+|.+++... +.+++..+..|+.||+.||.|||++|||||
T Consensus        86 ~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHr  134 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHR  134 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999874 779999999999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.83  E-value=7.2e-21  Score=195.98  Aligned_cols=129  Identities=19%  Similarity=0.351  Sum_probs=114.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||++.....  ......+.+.+|+.+|+.++|+|||+++++|.+.+
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4456789999999999999999999999999999999863210  01112456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||.||+|..++.. .+.+++..++.|+.||+.||.|||++|||||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHr  139 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHR  139 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            99999999999999999976 4779999999999999999999999999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.83  E-value=1.5e-20  Score=185.25  Aligned_cols=129  Identities=21%  Similarity=0.372  Sum_probs=113.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..++|++++.||+|+||.||+|.+..+|+.||||+++....... .....+.+.+|+.+|+.+.|+||+++++++...+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            45679999999999999999999999999999999975432211 11124568889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~  139 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF  139 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            9999999999999999976 4779999999999999999999999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.83  E-value=3.7e-20  Score=179.27  Aligned_cols=127  Identities=28%  Similarity=0.481  Sum_probs=109.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEE----ECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~----dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      .....|++++.||+|+||.||+|.    +..+++.||||+++...    .....+.+.+|+.+|+.++|+||+++++++.
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            345679999999999999999999    46788999999986432    1223457888999999999999999999998


Q ss_pred             eC--CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~--d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..  +.+||||||+++|+|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  150 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR  150 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccC
Confidence            76  66999999999999999997766789999999999999999999999999997

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.83  E-value=4.4e-20  Score=181.30  Aligned_cols=128  Identities=18%  Similarity=0.319  Sum_probs=114.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++...  .......+.+.+|+.+++.++|+||+++++++..++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            34578999999999999999999999999999999986321  2345556788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++... +.+++..+..|+.||+.||.|||++||+||
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  158 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHR  158 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcC
Confidence            99999999999999999875 779999999999999999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.83  E-value=4.2e-20  Score=193.51  Aligned_cols=128  Identities=19%  Similarity=0.277  Sum_probs=112.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|+++++||+|+||.||+|+++.+++.||||+++....  ........+.+|+.+|..++|+||++++++|.+.+.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh--hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            45689999999999999999999999999999999963110  0000112377899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||.||+|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHr  199 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR  199 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            99999999999999998756789999999999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.83  E-value=5.2e-20  Score=177.90  Aligned_cols=130  Identities=22%  Similarity=0.366  Sum_probs=114.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc----HHHHHHHHHHHHHHhhCC-CCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLK-HENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s----~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f  425 (481)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||+++........    ....+.+.+|+.+|+++. |+||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4567999999999999999999999999999999999754322222    233466788999999996 99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+.+||||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  148 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHR  148 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999999999999999999875 779999999999999999999999999997

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.83  E-value=2.3e-20  Score=185.14  Aligned_cols=126  Identities=22%  Similarity=0.484  Sum_probs=108.8

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|+++++||+|+||.||+|.+..+++.||||+++...   ......+.+.+|+.+|+.++|+||+++++++..++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            44568999999999999999999999999999999986432   223344567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+ |+|.+++... ..+++..++.|+.||+.||+|||++|||||
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~  156 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHR  156 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECC
Confidence            999999997 6999999774 679999999999999999999999999997

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.83  E-value=1.9e-20  Score=180.01  Aligned_cols=127  Identities=28%  Similarity=0.397  Sum_probs=109.2

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .+....++|++.+.||+|+||.||+|.+. ++..||||+++...   ...   +.+.+|+++|..++|+||+++++++..
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCH---HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCH---HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            33456679999999999999999999876 56789999986321   122   467889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+||||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  144 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR  144 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            999999999999999999998755779999999999999999999999999997

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.83  E-value=6.9e-20  Score=177.57  Aligned_cols=126  Identities=25%  Similarity=0.446  Sum_probs=112.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.++||+|+||.||+|.+..++..||+|++......    ...+.+.+|+++|+.++|+||+++++++...+.+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            346899999999999999999999999999999999753221    1235778899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++|+|.+++...   ...+++..++.|+.||+.||+|||++||+||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  148 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK  148 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEEC
Confidence            9999999999999998642   4679999999999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.83  E-value=2.3e-20  Score=191.75  Aligned_cols=120  Identities=21%  Similarity=0.284  Sum_probs=103.0

Q ss_pred             CCCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHH-hhCCCCCeeeeeeEEEe--
Q 011617          352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVV--  427 (481)
Q Consensus       352 ~~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL-~~L~HPNIVqL~g~f~~--  427 (481)
                      ..++|.+. ++||+|+||+||+|.+..+++.||||+++.      .    ..+.+|+.++ +.++|+||++++++|..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------c----hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            34577776 799999999999999999999999999862      1    2456788876 45689999999999876  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 --DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 --~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        .+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  185 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR  185 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence              567999999999999999997642 459999999999999999999999999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.83  E-value=3.3e-20  Score=195.41  Aligned_cols=130  Identities=23%  Similarity=0.395  Sum_probs=111.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC--------cHHHHHHHHHHHHHHhhCCCCCeeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK--------SAECIKQLEQEIKVLGHLKHENIVQYY  422 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~--------s~e~~k~l~~EI~iL~~L~HPNIVqL~  422 (481)
                      ....+|+++++||+|+||.||+|.++.+++.||||+++.......        .....+.+.+|+.+|+.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            345789999999999999999999999999999999974321110        012346788999999999999999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++.+.+.+|||||||.||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  170 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHR  170 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            9999999999999999999999999775 779999999999999999999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.83  E-value=2.7e-20  Score=180.28  Aligned_cols=126  Identities=33%  Similarity=0.538  Sum_probs=112.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++...     .....+.+.+|+.+|+.++|+||+++++++..++.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            4567899999999999999999999999999999998632     12234577889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  141 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR  141 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            999999999999999998766789999999999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.83  E-value=6.2e-20  Score=178.85  Aligned_cols=124  Identities=29%  Similarity=0.415  Sum_probs=110.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||+++...     ....+.+.+|+.+|+.++|+||+++++++...+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            3468999999999999999999999999999999997421     12234678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHR  130 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999999999999775 679999999999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.83  E-value=2.5e-20  Score=178.22  Aligned_cols=128  Identities=27%  Similarity=0.504  Sum_probs=113.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.....  ...+..+.+.+|+.+|+.++|+||+++++++...+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            445789999999999999999999999999999999863210  011224578889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  135 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHR  135 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCC
T ss_pred             EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            99999999999999999875 679999999999999999999999999997

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.83  E-value=9.5e-20  Score=181.68  Aligned_cols=125  Identities=21%  Similarity=0.328  Sum_probs=112.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-----CCCeeeeeeE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYGS  424 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-----HPNIVqL~g~  424 (481)
                      ....++|++.++||+|+||.||+|.+..+++.||||+++      ......+.+..|+.+|+.+.     |+||++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR------NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC------SCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEec------cchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            345679999999999999999999999999999999986      23445567788999999986     9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +...+.+||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  161 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT  161 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            99999999999999 899999998643 459999999999999999999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.83  E-value=3.4e-20  Score=179.69  Aligned_cols=123  Identities=27%  Similarity=0.479  Sum_probs=108.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|++++.||+|+||.||+|.+ .+++.||||+++....+   ....+.+.+|+.+|+.++|+||+++++++...+.+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            5799999999999999999998 67899999998643221   1123467789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+. ++|.+++....+.+++..++.|+.||+.||+|||++||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  124 (288)
T 1ob3_A           78 VFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (288)
T ss_dssp             EEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999997 59999998766789999999999999999999999999997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.83  E-value=1.7e-20  Score=190.88  Aligned_cols=128  Identities=25%  Similarity=0.438  Sum_probs=113.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      .....+|++.+.||+|+||.||+|++.   .++..||||+++..    ......+.+.+|+.+|++++|+||+++++++.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            345578999999999999999999976   45677999998642    23455678899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+|||||||++|+|.++++.....+++..+..|+.||+.||+|||++|||||
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR  171 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            9999999999999999999998766689999999999999999999999999997

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.83  E-value=2.3e-20  Score=179.47  Aligned_cols=128  Identities=27%  Similarity=0.492  Sum_probs=112.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..++..||||++....  .........+.+|+.+++.++|+||+++++++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            34578999999999999999999999999999999986311  0111123568889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++... ..+++..+..|+.||+.||.|||++||+||
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHR  133 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            99999999999999999875 779999999999999999999999999997

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.83  E-value=2.5e-20  Score=177.78  Aligned_cols=125  Identities=27%  Similarity=0.444  Sum_probs=110.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|+++...   ..   .+.+.+|+.+|..++|+||+++++++...+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---Cc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678999999999999999999876 46679999986422   12   245788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  128 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR  128 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            9999999999999999998866679999999999999999999999999997

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.83  E-value=5.8e-20  Score=179.44  Aligned_cols=126  Identities=17%  Similarity=0.235  Sum_probs=110.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe---
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~---  427 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++..     ......+.+.+|+.+++.++|+||+++++++..   
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            345789999999999999999999999999999999863     234556778899999999999999999999873   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+.+|+||||+.+|+|.+++..   ....+++..++.|+.||+.||.|||++||+||
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  158 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR  158 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             3479999999999999999976   24679999999999999999999999999997

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.83  E-value=2.9e-20  Score=183.32  Aligned_cols=127  Identities=23%  Similarity=0.397  Sum_probs=109.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      +...++|+++++||+|+||.||+|.+. +|+.||||+++...   ......+.+.+|+.+|+.++|+||+++++++..++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            345679999999999999999999985 48999999986432   22233467788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+ ++|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus        93 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  143 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHR  143 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            9999999997 68999887766779999999999999999999999999997

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.83  E-value=3.6e-20  Score=188.68  Aligned_cols=122  Identities=24%  Similarity=0.410  Sum_probs=105.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|...+.||+|+||.||+|.+..+|+.||||+++.     ......+.+.+|+.+|++++|+||+++++++...+.+|||
T Consensus        90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEEEEEECC-----CEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc-----cccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            34457889999999999999999999999999973     2234456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||++++|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  211 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL  211 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999997765679999999999999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.83  E-value=1.3e-20  Score=183.07  Aligned_cols=128  Identities=27%  Similarity=0.439  Sum_probs=105.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC---------------------CcHHHHHHHHHHHHHH
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------------------KSAECIKQLEQEIKVL  410 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~---------------------~s~e~~k~l~~EI~iL  410 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.......                     ......+.+.+|+.+|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            4578999999999999999999999999999999996432111                     0112245688999999


Q ss_pred             hhCCCCCeeeeeeEEEe--CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          411 GHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       411 ~~L~HPNIVqL~g~f~~--~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.++|+||+++++++..  .+.+||||||+++++|.+++.  ...+++..++.|+.||+.||+|||++|||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  161 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHR  161 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            99999999999999987  578999999999999988753  3679999999999999999999999999997

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.83  E-value=3.8e-20  Score=186.17  Aligned_cols=123  Identities=25%  Similarity=0.305  Sum_probs=106.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++...       ..+.+.+|+.+|+.++|+||+++++++...+.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            34568999999999999999999999999999999987321       23467789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++|+|.+++.. .+.+++..++.|+.||+.||.|||++|||||
T Consensus       123 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  172 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHR  172 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999999999999999976 4679999999999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.83  E-value=1.8e-20  Score=190.28  Aligned_cols=128  Identities=23%  Similarity=0.277  Sum_probs=111.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ....+|+++++||+|+||.||+|.++.+++.||||+++....  ......+.+..|+.+|..+ +|+||+++++++.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            446789999999999999999999999999999999973210  0011235677899999988 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+||+|.++++.. +.+++..++.|+.||+.||+|||++|||||
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHr  145 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYR  145 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence            999999999999999999875 679999999999999999999999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.83  E-value=2.4e-20  Score=185.32  Aligned_cols=128  Identities=25%  Similarity=0.405  Sum_probs=110.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEE-----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~d-----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      ....++|++++.||+|+||.||+|.+     ..+++.||||+++..    ......+.+.+|+++|.++ +|+||+++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            34567999999999999999999994     456688999998632    3344567789999999999 7899999999


Q ss_pred             EEEeCCE-EEEEEeccCCCCHHHHHHHhCC--------------------------------------------------
Q 011617          424 SEVVDDH-LYIYLEYVHPGSINRYVREHCR--------------------------------------------------  452 (481)
Q Consensus       424 ~f~~~d~-lyLVmEy~~GGSL~~lL~~~~~--------------------------------------------------  452 (481)
                      ++...+. +|||||||.+|+|.++++....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9987654 9999999999999999976422                                                  


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          453 ---------------DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       453 ---------------~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                     .+++..++.|+.||+.||+|||++|||||
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~  217 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  217 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence                           18999999999999999999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.83  E-value=5.2e-20  Score=191.10  Aligned_cols=126  Identities=25%  Similarity=0.347  Sum_probs=109.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|+++++||+|+||.||+|+++.+++.||||+++.....  .....+.+.+|+.+|..++|+|||+++++|.+.+.+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            456899999999999999999999999999999998631100  000112367899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++++.  ..+++..++.|+.||+.||+|||++|||||
T Consensus       145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHr  192 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHR  192 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            999999999999999975  569999999999999999999999999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.83  E-value=2.9e-20  Score=188.27  Aligned_cols=127  Identities=24%  Similarity=0.351  Sum_probs=110.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEE-----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~d-----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ....+|+++++||+|+||.||+|.+     ..+++.||||+++.    .........+.+|+.+|+.++|+|||++++++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc----ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4457899999999999999999994     45677899999852    22345556788899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+..|||||||++|+|.++++...      ..+++..++.|+.||+.||+|||++|||||
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  205 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  205 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            99999999999999999999998753      358999999999999999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.83  E-value=3e-20  Score=176.09  Aligned_cols=127  Identities=17%  Similarity=0.235  Sum_probs=112.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-  428 (481)
                      ....++|++.+.||+|+||.||+|.+.  +..||||+++..   .......+.+.+|+.+|+.++|+||+++++++... 
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCT---TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            445678999999999999999999985  788999998742   23445567899999999999999999999999877 


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~-~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                       +.+||||||+++|+|.+++..... .+++..+..|+.||+.||+|||+++  |+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~  137 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH  137 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecC
Confidence             789999999999999999986432 5899999999999999999999999  9997

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.83  E-value=1.2e-19  Score=182.85  Aligned_cols=126  Identities=31%  Similarity=0.535  Sum_probs=113.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ...|++.+.||+|+||.||+|.+..+++.||||++...  ........+.+.+|+.+|+.++|+||+++++++..++.+|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESC--SSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccc--cccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            35699999999999999999999999999999998742  2234455678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||. |+|.+++......+++..+..|+.||+.||.|||++|||||
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  178 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  178 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            9999997 78999887766889999999999999999999999999997

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.83  E-value=3.9e-20  Score=175.65  Aligned_cols=125  Identities=25%  Similarity=0.365  Sum_probs=111.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|++.+.||+|+||.||+|.+. ++..||+|+++...   ..   .+.+.+|+.+++.++|+||+++++++..++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   76 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   76 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT---BC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678999999999999999999986 56789999986422   12   246788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  128 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  128 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999998766779999999999999999999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.83  E-value=2.3e-20  Score=179.90  Aligned_cols=129  Identities=25%  Similarity=0.462  Sum_probs=113.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||++.....  ......+.+.+|+.+++.++|+||+++++++...+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            3456789999999999999999999999999999999863110  00112356888999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++... +.+++..+..|+.||+.||.|||++||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  138 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHR  138 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999999999999999999875 679999999999999999999999999997

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.82  E-value=7.1e-20  Score=192.41  Aligned_cols=125  Identities=25%  Similarity=0.397  Sum_probs=108.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|+++++||+|+||.||+|.+..++..||||+++.......   ....+.+|+.+|+.++|||||+++++|...+.+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999974322111   2356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||.+|+|.+++... ..+++..++.|+.||+.||.|||++|||||
T Consensus       113 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  160 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHR  160 (494)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999999999999999775 779999999999999999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.82  E-value=5.6e-20  Score=181.82  Aligned_cols=122  Identities=25%  Similarity=0.297  Sum_probs=110.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ...+|++++.||+|+||.||+|.+..+++.||||++.....       .+.+.+|+.+|+.+ +|+||+++++++...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            45789999999999999999999999999999999864321       12467899999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+ +++|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHr  129 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR  129 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999 899999998766789999999999999999999999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.82  E-value=4.2e-20  Score=183.81  Aligned_cols=119  Identities=18%  Similarity=0.334  Sum_probs=107.6

Q ss_pred             CCeEEe---EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC
Q 011617          354 SQWQKG---KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD  429 (481)
Q Consensus       354 ~~Y~i~---k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d  429 (481)
                      .+|++.   +.||+|+||.||+|.+..+++.||||++...        ....+.+|+.+|+.+. |+||+++++++.+++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            356664   7899999999999999999999999998631        2346778999999997 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||++|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~  130 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHR  130 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence            999999999999999999874 789999999999999999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.82  E-value=2.6e-20  Score=179.10  Aligned_cols=127  Identities=24%  Similarity=0.430  Sum_probs=113.9

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++.+.||+|+||.||+|.+..++..||||+++..      ....+.+.+|+.+|+.++|+||+++++++..+
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            345678899999999999999999999999999999998631      12346788899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+||||||+.+++|.+++... ...+++..+..|+.||+.||.|||++||+||
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  135 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR  135 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCC
Confidence            9999999999999999999874 3458999999999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.82  E-value=4.6e-20  Score=192.59  Aligned_cols=128  Identities=23%  Similarity=0.432  Sum_probs=113.9

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.++||+|+||.||+|.+..+|+.||||++.......  ....+.+.+|+.+|++++|+||+++++++...+.
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34468999999999999999999999999999999996433221  1224578889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.+|+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  150 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHR  150 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            99999999999999999764 779999999999999999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.82  E-value=7e-20  Score=176.57  Aligned_cols=128  Identities=22%  Similarity=0.363  Sum_probs=111.3

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ......+|++++.||+|+||.||+|.+..+   +..||||+++.    .......+.+.+|+.+|+.++|+||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            345667999999999999999999998654   45699998753    23345567788999999999999999999997


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .++.+||||||+.+++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (281)
T 1mp8_A           86 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR  140 (281)
T ss_dssp             -CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence             4567899999999999999998765679999999999999999999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.82  E-value=8.5e-20  Score=180.01  Aligned_cols=127  Identities=25%  Similarity=0.466  Sum_probs=112.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEE----ECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~----dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      .....+|++.+.||+|+||.||+|.    +..+++.||||++..     ......+.+.+|+.+|+.++|+||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-----SGPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc-----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            3556799999999999999999999    467789999999863     2345567789999999999999999999998


Q ss_pred             E--eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 V--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~--~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .  ..+.+||||||+++++|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  151 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR  151 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            7  4567999999999999999998766779999999999999999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.82  E-value=1e-19  Score=181.84  Aligned_cols=127  Identities=24%  Similarity=0.416  Sum_probs=115.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.++||+|+||.||+|.+..+++.||+|+++..    ......+.+.+|+.+|+.++|+||+++++++..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            34567899999999999999999999999999999998742    23455678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      .+|||||||++++|.+++... +.+++..+..|+.||+.||.|||++ |||||
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~  156 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHR  156 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS
T ss_pred             EEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence            999999999999999999875 6799999999999999999999996 99997

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.82  E-value=4.9e-20  Score=181.87  Aligned_cols=124  Identities=31%  Similarity=0.594  Sum_probs=95.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ..+|++++.||+|+||.||+|.+..+|+.||||+++.......    .+.+.+|+.+|+.++|+||+++++++..++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            4589999999999999999999999999999999975332221    245678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~-----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+ |+|.+++....     ..+.+..++.|+.||+.||.|||++|||||
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~  132 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR  132 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            9999997 79999997642     358999999999999999999999999997

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.82  E-value=1.9e-20  Score=188.86  Aligned_cols=126  Identities=25%  Similarity=0.444  Sum_probs=110.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.....  ...+..+.+.+|+.+|+.++|+||+++++++...+.+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45789999999999999999999999999999999863110  0011124678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+ +|+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus        85 ~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~  132 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHR  132 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             EEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999999 79999999775 779999999999999999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.82  E-value=8.2e-20  Score=180.97  Aligned_cols=131  Identities=26%  Similarity=0.470  Sum_probs=112.3

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEEC-------CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCe
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI  418 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk-------~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNI  418 (481)
                      ..+....++|++++.||+|+||.||+|.+.       .++..||||+++..    ......+.+.+|+.+|+.+ +|+||
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~i  103 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNI  103 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCCE
Confidence            344566789999999999999999999986       35678999998632    2445567889999999999 89999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++++...+.+||||||+++|+|.+++....               ..+++..+..|+.||+.||.|||++||+||
T Consensus       104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (334)
T 2pvf_A          104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  181 (334)
T ss_dssp             CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            999999999999999999999999999997642               248999999999999999999999999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.82  E-value=2.1e-19  Score=173.65  Aligned_cols=128  Identities=28%  Similarity=0.474  Sum_probs=113.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--  427 (481)
                      ......|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+.+|+.+|+.++|+||+++++++..  
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            345567999999999999999999999999999999987432   234556788999999999999999999999875  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 --~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                        ...+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+++  |+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~  155 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  155 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEEC
Confidence              45699999999999999999875 77999999999999999999999999  9997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.82  E-value=5.8e-20  Score=192.43  Aligned_cols=126  Identities=21%  Similarity=0.394  Sum_probs=112.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ...+|+++++||+|+||.||+|.+..+++.||||++........   ....+.+|+.+|++++||||+++++++...+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch---HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            45689999999999999999999999999999999864221111   135678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||.+|+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus        97 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  145 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            9999999999999999775 779999999999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.82  E-value=1.8e-20  Score=185.16  Aligned_cols=129  Identities=22%  Similarity=0.382  Sum_probs=109.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.+..+++.||||++.............+.+.+|+.+|+.++|+||+++++++.+.+.+|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46899999999999999999999999999999998642211112334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHh---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 011617          433 IYLEYVHPGSINRYVREH---------------------------------------CRDITESIVRNFTRHILNGLAYL  473 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~---------------------------------------~~~Lse~~I~~I~~QIl~GL~YL  473 (481)
                      ||||||+||+|.+++...                                       ...+++..++.|+.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998421                                       11236788999999999999999


Q ss_pred             HHCCCccC
Q 011617          474 HSTNTIHR  481 (481)
Q Consensus       474 HskgIIHR  481 (481)
                      |++|||||
T Consensus       185 H~~~ivH~  192 (345)
T 3hko_A          185 HNQGICHR  192 (345)
T ss_dssp             HHTTEECC
T ss_pred             HHCCcccc
Confidence            99999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.82  E-value=3.1e-20  Score=192.54  Aligned_cols=125  Identities=25%  Similarity=0.425  Sum_probs=101.9

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ..++|+++++||+|+||.||+|.++.+++.||||++...   .......+.+.+|+.+|+.++|+|||++++++...   
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh---hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            346899999999999999999999999999999998532   23455567889999999999999999999998543   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        +.+||||||+ +++|.++++. ...+++..++.|+.||+.||+|||++|||||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHr  180 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHR  180 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             cCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCC
Confidence              5699999998 5899999976 4779999999999999999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.82  E-value=6.8e-20  Score=184.57  Aligned_cols=120  Identities=19%  Similarity=0.271  Sum_probs=107.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ..++|++++.||+|+||.||+|.++.+++.||||+++....         ...+|+++|.++ +|+||+++++++.+.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            35689999999999999999999999999999999974321         123577888777 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHr  140 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHR  140 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            99999999999999999764 779999999999999999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.82  E-value=2.4e-20  Score=193.31  Aligned_cols=128  Identities=26%  Similarity=0.350  Sum_probs=105.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|+++++||+|+||.||+|.+..+|+.||||+++....  ........+.+|+.+|+.++|+||+++++++...+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            445789999999999999999999999999999999974211  122334567789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      +|||||||++|+|.+++... +.+++..++.|+.||+.||+|||+ +|||||
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr  273 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYR  273 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             EEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence            99999999999999999775 779999999999999999999998 999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.82  E-value=4.1e-20  Score=181.88  Aligned_cols=127  Identities=26%  Similarity=0.391  Sum_probs=106.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC---CCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d---~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......   .........+.+|+.+|+.++|+||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            35799999999999999999999999999999998642211   112223345788999999999999999999987655


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       +||||||+++++|.+++.. ...+++..++.|+.||+.||.|||++||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  138 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHR  138 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence             8999999999999999965 4789999999999999999999999999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.82  E-value=2.5e-20  Score=179.82  Aligned_cols=128  Identities=28%  Similarity=0.496  Sum_probs=96.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||++....    .....+.+.+|+.+|+.++|+||+++++++...+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            456789999999999999999999998899999999885321    1233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVRE-------HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~-------~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++..       ....+++..+..|+.||+.||.|||++||+||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  145 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR  145 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999974       23568999999999999999999999999997

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.82  E-value=6.4e-20  Score=178.10  Aligned_cols=128  Identities=27%  Similarity=0.410  Sum_probs=112.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEE-----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~d-----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      .....+|++++.||+|+||.||+|.+     ..+++.||||+++..    ......+.+.+|+.+|+++ +|+||+++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            44567899999999999999999985     356788999998632    2334457788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHCR-----------------DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~~-----------------~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+.+||||||+++|+|.+++.....                 .+++..+..|+.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  169 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR  169 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999999999999999999987532                 48999999999999999999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.82  E-value=1.3e-19  Score=176.70  Aligned_cols=125  Identities=30%  Similarity=0.568  Sum_probs=106.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|++.+.||+|+||.||+|.+..+|+.||||++....       ..+.+.+|+.+|+.++|+||+++++++...+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            345678999999999999999999999999999999987421       1246778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR  149 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            9999999999999999998666889999999999999999999999999997

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.82  E-value=6.4e-20  Score=181.79  Aligned_cols=126  Identities=27%  Similarity=0.467  Sum_probs=104.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEE----EEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~V----AIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ....+|++.++||+|+||.||+|.+..+++.+    |+|.++.    .......+.+.+|+.+|++++|+||+++++++.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            44578999999999999999999998887765    6666542    122334467889999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+ .++||||+.+|+|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus        88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  141 (327)
T 3poz_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR  141 (327)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence            754 789999999999999998876789999999999999999999999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.82  E-value=9.6e-20  Score=180.00  Aligned_cols=129  Identities=26%  Similarity=0.409  Sum_probs=112.7

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .......+|++.+.||+|+||.||+|++  +|..||||++...   .......+.+.+|+.+|++++|+||+++++++..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQ---DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCC---CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCC---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            3345567999999999999999999987  4788999998632   2345566788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                      .+.+|||||||++|+|.+++....  ..+++..+..|+.||+.||+|||++|  ||||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~  163 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR  163 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCT
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECC
Confidence            999999999999999999997632  23999999999999999999999999  9997

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=1.4e-19  Score=180.16  Aligned_cols=128  Identities=26%  Similarity=0.430  Sum_probs=112.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCC----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      .....+|++.+.||+|+||.||+|.+..++    ..||||+++..    ........+.+|+.+|+.++|+||+++++++
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            456789999999999999999999986553    35999998632    2344556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+.+||||||+++|+|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR  171 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            99999999999999999999998766789999999999999999999999999997

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.82  E-value=1.4e-19  Score=183.54  Aligned_cols=129  Identities=23%  Similarity=0.436  Sum_probs=113.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCC-------CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ  420 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~t-------g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVq  420 (481)
                      +....++|+++++||+|+||.||+|.+..+       +..||||+++..    ......+.+.+|+++|+.+ +|+|||+
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            345667999999999999999999997543       357999998632    3445567889999999999 8999999


Q ss_pred             eeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       421 L~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++..++.+||||||+++|+|.+++....               ..+++..++.|+.||+.||.|||++|||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  215 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  215 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            9999999999999999999999999998753               359999999999999999999999999997

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.82  E-value=1.1e-19  Score=179.79  Aligned_cols=127  Identities=27%  Similarity=0.415  Sum_probs=114.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|+++++||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            4567899999999999999999999999999999998632   2344556678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+++++|.+++.. ...+++..+..|+.||+.||.|||++|||||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  148 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHR  148 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEcc
Confidence            9999999998888887755 4679999999999999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=2.1e-20  Score=186.75  Aligned_cols=130  Identities=22%  Similarity=0.415  Sum_probs=105.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++++.||+|+||.||+|.+..+|+.||||+++............+.+.+|+.+|+.++|+||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999999999999999987432222222233467789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||++ ++|.+++......+++..++.|+.||+.||+|||++||+||
T Consensus        87 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  136 (346)
T 1ua2_A           87 ISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR  136 (346)
T ss_dssp             CEEEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             eEEEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Confidence            999999997 58999997765679999999999999999999999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.82  E-value=4.5e-20  Score=176.08  Aligned_cols=123  Identities=28%  Similarity=0.579  Sum_probs=111.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++++.||+|+||.||+|.+..+++.||||+++....    ....+.+.+|+.+++.++|+||+++++++...+.+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            579999999999999999999999999999999874321    2344678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (276)
T 2yex_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR  129 (276)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            9999999999999865 3679999999999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.82  E-value=2.3e-19  Score=173.48  Aligned_cols=125  Identities=22%  Similarity=0.406  Sum_probs=112.3

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||+|+||.||+|.+..+++.||||++........   ..+.+.+|+.+|+.++|+||+++++++...+.+|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH---HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            4689999999999999999999999999999999874332222   2356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+.+++|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus        98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  145 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999999999999999765 679999999999999999999999999997

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.82  E-value=7.9e-20  Score=178.87  Aligned_cols=129  Identities=22%  Similarity=0.378  Sum_probs=112.3

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG  423 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g  423 (481)
                      +....++|++.+.||+|+||.||+|.+.     .+++.||||++..    .........+.+|+.+|+.++|+||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc----ccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            3455678999999999999999999876     3577899999863    233445567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+.+||||||+++|+|.+++....         ..+++..+..|+.||+.||.|||++||+||
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  162 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR  162 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            9999999999999999999999997532         457899999999999999999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.82  E-value=4.6e-20  Score=188.35  Aligned_cols=127  Identities=25%  Similarity=0.418  Sum_probs=110.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d-  429 (481)
                      ...++|+++++||+|+||.||+|.+..+|+.||||+++....    ....+.+.+|+++|+.++|+||+++++++...+ 
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            345789999999999999999999999999999999863221    112356678999999999999999999998765 


Q ss_pred             -EEEEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -~lyLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+|||||||++|+|.++++...  ..+++..++.|+.||+.||+|||++|||||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  136 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR  136 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence             7899999999999999997532  339999999999999999999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.82  E-value=1.2e-19  Score=187.84  Aligned_cols=126  Identities=29%  Similarity=0.493  Sum_probs=112.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--  428 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||||+++..   .......+.+.+|+++|+.++|+||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST---TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch---hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            3457899999999999999999999999999999998632   23455567889999999999999999999998776  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +.+||||||+. ++|.++++. ...+++..++.|+.||+.||+|||++|||||
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHr  153 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHR  153 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Confidence               57999999996 799999976 4779999999999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.81  E-value=1.4e-19  Score=174.38  Aligned_cols=128  Identities=25%  Similarity=0.399  Sum_probs=111.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHH---HHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~---k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...... ......   +.+.+|+.+|+.++|+||+++++++..
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE-GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTT-CCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccc-cchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4567899999999999999999999999999999998643222 222222   678899999999999999999999866


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                      ..  +|||||+++|+|.+++......+++..+..|+.||+.||+|||++|  ||||
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~  148 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR  148 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCS
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecC
Confidence            55  6999999999999999776678999999999999999999999999  9997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.81  E-value=6.5e-20  Score=184.14  Aligned_cols=124  Identities=15%  Similarity=0.235  Sum_probs=105.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEE-----EECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC---CCCeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQY  421 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla-----~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~---HPNIVqL  421 (481)
                      .....+|.+.++||+|+||.||+|     .+..+++.||||+++..     .   ...+..|+.++..+.   |+||+++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~---~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----N---PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----C---HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----C---hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            345678999999999999999999     46778899999998631     1   235666777777776   9999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~----~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++...+..|||||||++|+|.+++..    ....+++..++.|+.||+.||+|||++|||||
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHr  196 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG  196 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence            9999999999999999999999999975    24669999999999999999999999999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.81  E-value=9e-20  Score=179.83  Aligned_cols=127  Identities=24%  Similarity=0.364  Sum_probs=108.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEE-----ECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~-----dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ...++|++++.||+|+||.||+|.     +..++..||||++..    .........+.+|+.+|+.++|+||+++++++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc----ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            456799999999999999999999     556788999999852    22345556788999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+.+||||||+++++|.+++....      ..+++..++.|+.||+.||.|||++||+||
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  164 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  164 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence            99999999999999999999998753      348999999999999999999999999997

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.81  E-value=2.5e-20  Score=197.35  Aligned_cols=129  Identities=26%  Similarity=0.492  Sum_probs=113.8

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|.+++.||+|+||.||+|.+..+|+.||||+++....  ...+....+.+|+.+|+.++|+||+++++++...+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3456789999999999999999999999999999999963210  01112457889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  140 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHR  140 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcc
Confidence            99999999999999999975 4779999999999999999999999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.81  E-value=1.8e-19  Score=177.39  Aligned_cols=128  Identities=29%  Similarity=0.464  Sum_probs=112.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCc-----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      .....+|++++.||+|+||.||+|.+..+++     .||+|+++..    ......+.+.+|+.+|+.+ +|+||+++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----AHADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----cChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4556899999999999999999999977664     7999998632    2344567788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHh-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREH-------------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~-------------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+.+||||||+++|+|.+++...             ...+++..+..|+.||+.||.|||++||+||
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  188 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR  188 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            999999999999999999999999753             2458999999999999999999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.81  E-value=3.9e-19  Score=174.98  Aligned_cols=125  Identities=21%  Similarity=0.239  Sum_probs=106.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEeCCEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~~d~l  431 (481)
                      .++|++.++||+|+||.||+|.+..+|+.||||++....   ...........|+..+.. ++|+||+++++++...+.+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF---RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC---CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc---cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            367999999999999999999999999999999875322   222333344445555544 5899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||| +++|.+++......+++..++.|+.||+.||+|||+++||||
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL  181 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            9999999 689999998876789999999999999999999999999997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=7e-20  Score=181.20  Aligned_cols=129  Identities=25%  Similarity=0.415  Sum_probs=109.1

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeee
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY  422 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~  422 (481)
                      +.....+|++++.||+|+||.||+|.+.     .++..||||+++...    .....+.+.+|+.+|..+ .|+||++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            3455679999999999999999999973     356679999986321    223346788999999999 899999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHCR----------------------DITESIVRNFTRHILNGLAYLHSTNTIH  480 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~----------------------~Lse~~I~~I~~QIl~GL~YLHskgIIH  480 (481)
                      +++...+.+||||||+++|+|.+++.....                      .+++..+..|+.||+.||.|||++||+|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999999999999999999999999976432                      3789999999999999999999999999


Q ss_pred             C
Q 011617          481 R  481 (481)
Q Consensus       481 R  481 (481)
                      |
T Consensus       196 ~  196 (344)
T 1rjb_A          196 R  196 (344)
T ss_dssp             T
T ss_pred             C
Confidence            7

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.81  E-value=3.8e-19  Score=174.32  Aligned_cols=126  Identities=33%  Similarity=0.612  Sum_probs=111.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEe-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV-  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~-  427 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||++.....      ....+.+|+.+|+.+ +|+||+++++++.. 
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            4457899999999999999999999999999999999874321      124677899999998 79999999999987 


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -----~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           .+.+||||||+++|+|.+++... ...+++..++.|+.||+.||.|||++||+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  153 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR  153 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence                 56899999999999999999864 2579999999999999999999999999997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.81  E-value=6.2e-20  Score=193.80  Aligned_cols=127  Identities=24%  Similarity=0.438  Sum_probs=113.5

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++.++||+|+||.||+|.+..++..||||+++...   ..   .+.+.+|+.+|++++|+|||++++++...
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---ME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4456678999999999999999999999889999999986321   12   35688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||.+|+|.++++.. ...+++..+..|+.||+.||+|||++|||||
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr  342 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR  342 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999999864 3568999999999999999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.81  E-value=1.6e-19  Score=175.56  Aligned_cols=124  Identities=35%  Similarity=0.595  Sum_probs=111.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ....|++++.||+|+||.||+|.+..+++.||||++.....    ....+.+.+|+.+|+.++|+||+++++++...+.+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            34579999999999999999999999999999999974322    12346788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+++++|.+++..  +.+++..+..++.||+.||.|||++||+||
T Consensus        96 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  143 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR  143 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            999999999999999854  679999999999999999999999999997

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.81  E-value=1e-19  Score=180.91  Aligned_cols=126  Identities=27%  Similarity=0.464  Sum_probs=108.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEE----EEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~V----AIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ....+|++.++||+|+||.||+|.+..+++.+    |+|.+...    ......+.+.+|+.+|+.++|+||+++++++.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence            45678999999999999999999998888766    55555321    12223457888999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+ .++||||+.+|+|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus        88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  141 (327)
T 3lzb_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR  141 (327)
T ss_dssp             SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCC
Confidence            755 889999999999999998877789999999999999999999999999997

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.81  E-value=1.5e-19  Score=179.21  Aligned_cols=120  Identities=26%  Similarity=0.485  Sum_probs=108.6

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLV  434 (481)
                      .|...+.||+|+||.||+|.+..+|+.||||++.....  .   ..+.+.+|+.+|+.++|+||+++++++...+.+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--Q---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--C---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--h---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            58889999999999999999999999999999874321  1   234677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||+++++|.+++..  ..+++..+..|+.||+.||.|||++||+||
T Consensus       121 ~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  165 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHR  165 (321)
T ss_dssp             ECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999854  579999999999999999999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.81  E-value=2.1e-19  Score=171.97  Aligned_cols=127  Identities=24%  Similarity=0.390  Sum_probs=111.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DD  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d  429 (481)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+.+|+.+|+.++|+||+++++++..  .+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            3468999999999999999999999999999999997432   234556788999999999999999999998865  56


Q ss_pred             EEEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccC
Q 011617          430 HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN-----TIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskg-----IIHR  481 (481)
                      .+||||||+++++|.+++...   ...+++..+..|+.||+.||+|||+++     |+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~  140 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR  140 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEe
Confidence            899999999999999999753   234999999999999999999999999     9997

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.81  E-value=2.1e-19  Score=173.67  Aligned_cols=125  Identities=28%  Similarity=0.545  Sum_probs=107.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++.+.||+|+||.||+|.+..+|+.||||+++...   ......+.+.+|+.++++++|+||+++++++..++.+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   78 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCc---cchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceE
Confidence            468999999999999999999999999999999986422   11222356778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||
T Consensus        79 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  127 (299)
T 2r3i_A           79 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR  127 (299)
T ss_dssp             EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            9999997 79999997643 568999999999999999999999999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=1.8e-19  Score=173.80  Aligned_cols=126  Identities=24%  Similarity=0.448  Sum_probs=109.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ....|.++++||+|+||.||+|.+..++.   .||+|+++.    .......+.+.+|+.+|+.++|+||+++++++...
T Consensus        19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   94 (298)
T 3pls_A           19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP   94 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence            34468889999999999999999765554   699998853    23445667888999999999999999999999876


Q ss_pred             CEE-EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~l-yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.. ++||||+.+|+|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  148 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR  148 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            665 99999999999999998766789999999999999999999999999997

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.81  E-value=4.7e-20  Score=182.53  Aligned_cols=123  Identities=28%  Similarity=0.444  Sum_probs=107.6

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++++.||+|+||.||+|.+..+++.||||+++....    ......+.+|+.+|+.++|+||+++++++...+.+||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            579999999999999999999999999999999864221    1111234569999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+. |+|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            999997 79999998866779999999999999999999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.81  E-value=1.6e-19  Score=177.05  Aligned_cols=129  Identities=20%  Similarity=0.372  Sum_probs=101.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ....++|++++.||+|+||.||+|.+..++.   .||||+++...   ......+.+.+|+.+|+.++|+||+++++++.
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---IASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---cCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3456789999999999999999999877665   79999986322   12234577889999999999999999999998


Q ss_pred             eCCEE------EEEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHL------YIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~l------yLVmEy~~GGSL~~lL~~~~-----~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+..      |+||||+.+|+|.+++....     ..+++..+..|+.||+.||+|||++|||||
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~  161 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR  161 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence            77665      99999999999999996532     158999999999999999999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.81  E-value=1.6e-19  Score=178.09  Aligned_cols=126  Identities=25%  Similarity=0.451  Sum_probs=109.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEE--EEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~V--AIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      ..++|++.+.||+|+||.||+|.+..++..+  |||.++..    ......+.+.+|+.+|+.+ +|+||+++++++...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            4578999999999999999999998888865  89988632    2233446788899999999 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+||||||+++|+|.+++....               ..+++..++.|+.||+.||.|||++||+||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  166 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR  166 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            99999999999999999997642               369999999999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.81  E-value=2.2e-19  Score=174.09  Aligned_cols=123  Identities=28%  Similarity=0.469  Sum_probs=104.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE----
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV----  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~----  426 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||||++..     ......+.+.+|+.+|+.++|+||+++++++.    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec-----CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            346789999999999999999999999999999999863     23456678889999999999999999999873    


Q ss_pred             ----------eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 ----------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ----------~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                ..+.+||||||+. |+|.++++.  +.+++..++.|+.||+.||+|||++||+||
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  144 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHR  144 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence                      3468999999997 799999854  679999999999999999999999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.81  E-value=6e-20  Score=189.59  Aligned_cols=127  Identities=24%  Similarity=0.377  Sum_probs=107.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC---CCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d---~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .++|.+.++||+|+||.||+|.+..+++.||||++......   .........+.+|+.+|++++|+||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            46899999999999999999999999999999999743211   112223345788999999999999999999975 55


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||++|+|.+++.. .+.+++..++.|+.||+.||+|||++|||||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            68999999999999998865 4779999999999999999999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.81  E-value=1.9e-20  Score=185.20  Aligned_cols=127  Identities=26%  Similarity=0.430  Sum_probs=107.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcE----EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~----VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      .....+|++.++||+|+||.||+|.+..+++.    ||+|.+.....    ....+.+.+|+.+++.++|+||+++++++
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            45667999999999999999999999888876    66666542211    11223466799999999999999999987


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      . ++.+++||||+.+|+|.+++....+.+++..+..|+.||+.||+|||++|||||
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  139 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHR  139 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            6 567899999999999999998755689999999999999999999999999997

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.81  E-value=1.2e-19  Score=177.07  Aligned_cols=130  Identities=22%  Similarity=0.399  Sum_probs=104.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~  427 (481)
                      ...++|++.++||+|+||.||+|.+..+++.||||+++..............+.+|+.+++.+   .|+||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            345789999999999999999999999999999999975432221111123455677666665   59999999999987


Q ss_pred             CC-----EEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DD-----HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d-----~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..     .++|||||+. ++|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  144 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR  144 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            65     5899999996 79999997643 339999999999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.81  E-value=4.9e-19  Score=170.69  Aligned_cols=123  Identities=21%  Similarity=0.267  Sum_probs=110.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ...++|++++.||+|+||.||+|.+..+++.||||++.....       .+.+.+|+.+++.+ +|+||+++++++...+
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            456789999999999999999999999999999999863221       12466799999999 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..||||||+ +++|.+++......+++..+..|+.||+.||.|||++|||||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  130 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR  130 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            999999999 899999998765679999999999999999999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.80  E-value=3.9e-19  Score=170.71  Aligned_cols=128  Identities=23%  Similarity=0.355  Sum_probs=107.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||+++..   .......+.+.++..+++.++|+||+++++++..++
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc---cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            34567899999999999999999999999999999998632   122333344555666688899999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          430 HLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      .+||||||++ |+|.+++..   ....+++..++.|+.||+.||+|||++ ||+||
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  134 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR  134 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCC
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC
Confidence            9999999997 688887754   346799999999999999999999998 99997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.80  E-value=2.3e-19  Score=171.50  Aligned_cols=120  Identities=28%  Similarity=0.541  Sum_probs=106.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-----  427 (481)
                      ..+|++.+.||+|+||.||+|.+..+++.||||+++...         ..+.+|+.+|+.++|+||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            357999999999999999999999999999999997421         245679999999999999999999865     


Q ss_pred             -----------CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -----------DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -----------~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                 ...+||||||+++++|.+++... ...+++..+..|+.||+.||.|||++||+||
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  146 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINR  146 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence                       34589999999999999999764 3679999999999999999999999999997

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.80  E-value=2.3e-19  Score=177.08  Aligned_cols=127  Identities=30%  Similarity=0.533  Sum_probs=111.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEE----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~d----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      .....+|++++.||+|+||.||+|.+    ..+++.||||++..     ......+.+.+|+.+|+.++|+||+++++++
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34567899999999999999999984    56789999999863     2234557789999999999999999999998


Q ss_pred             EeCC--EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d--~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+  .++|||||+++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  169 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR  169 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            7654  6899999999999999998866679999999999999999999999999997

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.80  E-value=4.7e-19  Score=176.74  Aligned_cols=125  Identities=21%  Similarity=0.370  Sum_probs=111.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC--CCeeeeeeEEEeC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVD  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H--PNIVqL~g~f~~~  428 (481)
                      ....+|++++.||+|+||.||+|.+. +++.||||++....   ......+.+.+|+.+|..+.|  +||+++++++..+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            45678999999999999999999974 58899999987432   345566788999999999986  9999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||| .+++|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHr  132 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHS  132 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            999999995 579999999874 789999999999999999999999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=3.9e-19  Score=171.80  Aligned_cols=126  Identities=23%  Similarity=0.370  Sum_probs=108.9

Q ss_pred             CCCCCeEEeE-EeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGK-LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k-~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...++|.+.+ .||+|+||.||+|.+.  .++..||||+++..    ......+.+.+|+.+|+.++|+||+++++++ .
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~   80 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q   80 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence            3456777776 9999999999999864  46778999998632    2455667889999999999999999999998 5


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+||||||+.+++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  134 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR  134 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            667999999999999999997655779999999999999999999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.80  E-value=2.7e-19  Score=173.16  Aligned_cols=127  Identities=24%  Similarity=0.455  Sum_probs=108.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCC---cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE-
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg---~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~-  426 (481)
                      .....|++.++||+|+||.||+|.+..++   ..||+|.++.    .......+.+.+|+.+|++++|+||+++++++. 
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            34567999999999999999999976433   3588998753    234556678899999999999999999999864 


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .++..|+||||+++|+|.++++.....+++..+..|+.||+.||+|||++||+||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~  152 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR  152 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            4567899999999999999998766779999999999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.80  E-value=5e-19  Score=170.27  Aligned_cols=128  Identities=21%  Similarity=0.357  Sum_probs=110.4

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      .....++|++.+.||+|+||.||+|.+...   +..||+|+++..    ......+.+.+|+.+|+.++|+||+++++++
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            345667999999999999999999997543   345999988632    2345567889999999999999999999997


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .. +..|+||||+.+++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (281)
T 3cc6_A           83 EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR  137 (281)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            64 55789999999999999998876779999999999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=3.3e-19  Score=180.70  Aligned_cols=123  Identities=24%  Similarity=0.422  Sum_probs=101.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCC--
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD--  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d--  429 (481)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|..+. |+||+++++++...+  
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            46899999999999999999999999999999998532   234455677889999999997 999999999998655  


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||+ ++|..+++.  ..+++..+..|+.||+.||+|||++|||||
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr  133 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHR  133 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            6999999997 799999976  579999999999999999999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.80  E-value=2.4e-19  Score=173.78  Aligned_cols=126  Identities=24%  Similarity=0.424  Sum_probs=108.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      .+...++|+++++||+|+||.||+|++..   .||||+++..   .......+.+.+|+.+|+.++|+||++++++ ...
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~   91 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA   91 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEecc---CCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence            35667899999999999999999998643   5999998643   2345566788999999999999999999995 456


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+++|||||++++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~  144 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR  144 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            67899999999999999997666779999999999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.80  E-value=2.8e-19  Score=175.53  Aligned_cols=118  Identities=23%  Similarity=0.385  Sum_probs=106.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEe--C
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV--D  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~--~  428 (481)
                      ..++|+++++||+|+||.||+|.+..+++.||||+++..     .   .+.+.+|+.+|+.+. |+||+++++++..  .
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~  105 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVS  105 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----c---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence            457899999999999999999999999999999998621     1   256788999999997 9999999999988  6


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+|||||+.+++|.++++    .+++..++.|+.||+.||+|||++|||||
T Consensus       106 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  154 (330)
T 3nsz_A          106 RTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHR  154 (330)
T ss_dssp             CCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            67999999999999999874    38999999999999999999999999997

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.80  E-value=2.9e-19  Score=173.02  Aligned_cols=127  Identities=20%  Similarity=0.373  Sum_probs=108.6

Q ss_pred             CCCCCCeEEeE-EeccCCcEEEEEEEE--CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGK-LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k-~IG~GtFG~VYla~d--k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      .....+|++.+ .||+|+||.||+|.+  ..+++.||||+++...   ......+.+.+|+.+++.++|+||+++++++ 
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34567899998 999999999999965  5567889999986422   2233456788999999999999999999998 


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+||||||+++++|.+++... ..+++..+..|+.||+.||.|||++||+||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  141 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHR  141 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcC
Confidence            667889999999999999999874 779999999999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.80  E-value=2.9e-19  Score=172.06  Aligned_cols=123  Identities=34%  Similarity=0.566  Sum_probs=106.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+|....+||+|+||.||+|.+..+++.||||++...     .....+.+.+|+.+++.++|+||+++++++...+.++|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            3444556999999999999999999999999998742     12334678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~--~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++++|.+++.....  .+.+..+..|+.||+.||.|||++||+||
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  146 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR  146 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence            9999999999999987533  46799999999999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.80  E-value=5.9e-19  Score=178.53  Aligned_cols=127  Identities=22%  Similarity=0.439  Sum_probs=112.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC---cHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~---s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      .+|++.+.||+|+||.||+|.+..+|+.||||+++.......   ..+..+.+.+|+.+|+.+ +|+||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999975332211   123356688999999999 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||++|++|.+++... ..+++..+..|+.||+.||.|||++||+||
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~  224 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHR  224 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            999999999999999999875 679999999999999999999999999997

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.80  E-value=2.6e-19  Score=170.71  Aligned_cols=126  Identities=30%  Similarity=0.503  Sum_probs=105.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.+.||+|+||.||+|.+.  +..||||+++.... .......+.+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCc-ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            35678999999999999999999975  78899999864321 1222335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN---TIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg---IIHR  481 (481)
                      +||||||+++++|.+++.  ...+++..+..|+.||+.||.|||++|   |+||
T Consensus        81 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~  132 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR  132 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCS
T ss_pred             eEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Confidence            999999999999999985  367999999999999999999999999   8897

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.80  E-value=3e-19  Score=177.74  Aligned_cols=126  Identities=29%  Similarity=0.466  Sum_probs=109.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----  427 (481)
                      ..++|+++++||+|+||.||+|.+..+|+.||||++........   ....+.+|+.+|+.++|+||+++++++..    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            45789999999999999999999999999999999864332221   22456689999999999999999999987    


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ----~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+.+|||||||+ |+|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus        92 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~  148 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR  148 (351)
T ss_dssp             -----CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence                456999999997 68888887766789999999999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.80  E-value=2e-19  Score=174.89  Aligned_cols=128  Identities=25%  Similarity=0.417  Sum_probs=109.5

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      ....++|++++.||+|+||.||+|.+.     .+++.||||+++..    ......+.+.+|+.+|..+ +|+||+++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            345679999999999999999999853     46788999998632    2344556788999999999 6899999999


Q ss_pred             EEEeCC-EEEEEEeccCCCCHHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDD-HLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d-~lyLVmEy~~GGSL~~lL~~~~~~---------------Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+ .+|+||||+++|+|.+++......               +++..+..|+.||+.||.|||++||+||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~  172 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  172 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            987755 599999999999999999764322               8899999999999999999999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.80  E-value=8.2e-20  Score=182.74  Aligned_cols=128  Identities=17%  Similarity=0.333  Sum_probs=111.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC---cHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~---s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.......   .......+.+|+.+|+.++|+||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4689999999999999999999999999999999975332111   1112235667999999999999999999999999


Q ss_pred             EEEEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||++|||||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  154 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHR  154 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe
Confidence            999999999766 99999976 4679999999999999999999999999997

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.80  E-value=1.6e-19  Score=196.02  Aligned_cols=129  Identities=20%  Similarity=0.255  Sum_probs=112.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|++.++||+|+||.||+|.++.+|+.||||++.....  ........+.+|+.+|+.++|+|||++++++.+.+.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            445789999999999999999999999999999999963210  001123457789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHr  310 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR  310 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            999999999999999997642 349999999999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=2.4e-19  Score=181.72  Aligned_cols=124  Identities=23%  Similarity=0.484  Sum_probs=104.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            457899999999999999999999999999999998532   234556678899999999999999999999998653  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+||||||+ +++|.++++.  ..+++..++.|+.||+.||+|||++||+||
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~  152 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR  152 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence                469999999 7999999975  579999999999999999999999999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.80  E-value=2.9e-19  Score=176.72  Aligned_cols=122  Identities=26%  Similarity=0.370  Sum_probs=106.2

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|+++++||+|+||.||+|++.  ++.||||+++..      .........|+.+|..++|+|||++++++....
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            345678999999999999999999876  789999998631      223345567999999999999999999998743


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST----------NTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk----------gIIHR  481 (481)
                          .+|||||||++|+|.++++.  ..+++..+..|+.||+.||+|||++          |||||
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~  155 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR  155 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred             CCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence                48999999999999999976  4599999999999999999999999          99997

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.80  E-value=5.5e-19  Score=184.03  Aligned_cols=124  Identities=29%  Similarity=0.487  Sum_probs=109.1

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++.++||+|+||.||+|.+.  ++.||||+++...       ..+.+.+|+.+|++++|+|||++++++...
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            4556779999999999999999999985  6799999986321       235688899999999999999999998776


Q ss_pred             C-EEEEEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 D-HLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d-~lyLVmEy~~GGSL~~lL~~~~~-~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      + .+|||||||++|+|.++++.... .+++..+..|+.||+.||+|||++|||||
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  313 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR  313 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            5 79999999999999999987643 37999999999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.79  E-value=1.1e-18  Score=172.98  Aligned_cols=124  Identities=29%  Similarity=0.499  Sum_probs=110.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC--
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~--  428 (481)
                      ...++|++++.||+|+||.||+|.+..+|+.||||+++.    .........+.+|+.+|+.++|+||+++++++...  
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----cccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            456799999999999999999999999999999999853    23345566788999999999999999999987754  


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         +.+||||||+. ++|.+++..  +.+++..+..|+.||+.||.|||++|||||
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  136 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHR  136 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence               67999999996 799999875  579999999999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.79  E-value=8.7e-20  Score=178.12  Aligned_cols=131  Identities=19%  Similarity=0.290  Sum_probs=102.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhC----CCCCeeeeeeE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHL----KHENIVQYYGS  424 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L----~HPNIVqL~g~  424 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||+++....... .......+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4456789999999999999999999999999999999864322111 111223456788999888    89999999999


Q ss_pred             EEeCCEEEEEEec-cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EVVDDHLYIYLEY-VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~~~d~lyLVmEy-~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +...+..++|||| +.+++|.+++... +.+++..++.|+.||+.||.|||++||+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  163 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHR  163 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999999999 7889999999875 679999999999999999999999999997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.79  E-value=8.1e-19  Score=171.18  Aligned_cols=121  Identities=21%  Similarity=0.283  Sum_probs=105.6

Q ss_pred             CCCCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHH-hhCCCCCeeeeeeEEEe-
Q 011617          351 PKKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVV-  427 (481)
Q Consensus       351 ~~~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL-~~L~HPNIVqL~g~f~~-  427 (481)
                      ....+|.+. +.||+|+||.||+|.+..+++.||||+++.      .    ..+.+|+.++ +.++|+||+++++++.. 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------c----HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            344678777 889999999999999999999999999862      1    3456788887 66789999999999987 


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ---DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ---~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         ...+||||||+++|+|.+++.... ..+++..++.|+.||+.||.|||++||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  141 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR  141 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence               677999999999999999998743 369999999999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.79  E-value=4.3e-19  Score=177.54  Aligned_cols=123  Identities=20%  Similarity=0.370  Sum_probs=106.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC--------CCCeeeeee
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--------HENIVQYYG  423 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~--------HPNIVqL~g  423 (481)
                      ..++|++.++||+|+||.||+|.+..+++.||||+++      ......+.+.+|+.+|+.+.        |+||+++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK------SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------SCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEe------cCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            4578999999999999999999999999999999986      22445667888999999885        788999999


Q ss_pred             EEE----eCCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          424 SEV----VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       424 ~f~----~~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      +|.    ....+||||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ |||||
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr  171 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT  171 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            988    456799999999 57777766553 36799999999999999999999999 99998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.79  E-value=9e-19  Score=177.51  Aligned_cols=121  Identities=23%  Similarity=0.434  Sum_probs=102.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe---
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~---  427 (481)
                      ....+|++++.||+|+||.||+|.+..+|+.||||++.....         ...+|+.+|+.++|+|||+++++|..   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence            345689999999999999999999999999999999863221         12359999999999999999999854   


Q ss_pred             -----------------------------------CCEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHH
Q 011617          428 -----------------------------------DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNG  469 (481)
Q Consensus       428 -----------------------------------~d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~G  469 (481)
                                                         ...++||||||+ |+|.+++..   ....+++..++.|+.||+.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               334999999997 688877753   34679999999999999999


Q ss_pred             HHHHHHCCCccC
Q 011617          470 LAYLHSTNTIHR  481 (481)
Q Consensus       470 L~YLHskgIIHR  481 (481)
                      |+|||++||+||
T Consensus       154 L~~LH~~gi~H~  165 (383)
T 3eb0_A          154 VGFIHSLGICHR  165 (383)
T ss_dssp             HHHHHTTTEECS
T ss_pred             HHHHHHCcCccC
Confidence            999999999997

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.79  E-value=2.3e-19  Score=193.30  Aligned_cols=129  Identities=22%  Similarity=0.271  Sum_probs=112.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ....+|.+.++||+|+||.||+|.++.+|+.||||+++....  ........+.+|+.+|+.++|+||++++++|...+.
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            345789999999999999999999999999999999963210  001123567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~---~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.+++...   ...+++..++.|+.||+.||.|||++|||||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHr  313 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR  313 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence            99999999999999999763   2469999999999999999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.79  E-value=7.9e-19  Score=171.41  Aligned_cols=129  Identities=23%  Similarity=0.403  Sum_probs=107.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECC---CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~---tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ....++|++++.||+|+||.||+|.+..   ++..||||+++..   .......+.+.+|+.+|+.++|+||+++++++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc---ccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            4456789999999999999999998765   4558999998642   234555678899999999999999999999998


Q ss_pred             eCC-----EEEEEEeccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDD-----HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d-----~lyLVmEy~~GGSL~~lL~~~-----~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+     ..|+||||+++|+|.+++...     ...+++..++.|+.||+.||.|||++||+||
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHR  171 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            755     359999999999999999542     2569999999999999999999999999997

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=1.7e-19  Score=181.56  Aligned_cols=129  Identities=22%  Similarity=0.318  Sum_probs=109.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC---CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk---~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~  426 (481)
                      ....+|+++++||+|+||.||+|++.   .+++.||||+++..... ......+.+.+|+.+|+++ +|+||+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            34578999999999999999999984   57899999998632110 0011123456689999999 6999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+|||||||++|+|.+++... ..+++..++.|+.||+.||.|||++|||||
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  183 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYR  183 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             eCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999999999999999999875 679999999999999999999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.79  E-value=9.4e-19  Score=179.02  Aligned_cols=124  Identities=21%  Similarity=0.378  Sum_probs=110.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC--CCCeeeeeeEEEeCC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVDD  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~--HPNIVqL~g~f~~~d  429 (481)
                      ....|+++++||+|+||.||+|.+.. ++.||||++....   ......+.+.+|+.+|..+.  |+|||++++++..++
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc---ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            34579999999999999999999765 8899999997432   34556678999999999996  599999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||| +.+++|.+++... ..+++..++.|+.||+.||.|||++|||||
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHr  179 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHS  179 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999 5579999999874 689999999999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.79  E-value=1.5e-18  Score=174.43  Aligned_cols=123  Identities=24%  Similarity=0.416  Sum_probs=109.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ...+|+++++||+|+||.||+|.+..+++.||||++..    .......+.+.+|+++|..++|+||+++++++...   
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            45689999999999999999999999999999999863    23445567788999999999999999999998765   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+||||||+. |+|.++++.  ..+++..++.|+.||+.||+|||++|||||
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  152 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR  152 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence              36999999996 799999975  569999999999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.79  E-value=1e-18  Score=170.42  Aligned_cols=125  Identities=22%  Similarity=0.317  Sum_probs=109.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEE-CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC------Ceeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE------NIVQYY  422 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~d-k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP------NIVqL~  422 (481)
                      ....++|++.+.||+|+||.||+|.+ ..+++.||||+++.      .....+.+.+|+.+++.++|+      +|++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            34567999999999999999999998 56788999999862      234556788899999988665      499999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++...+.+||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  142 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT  142 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            9999999999999999 899999997753 368999999999999999999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.79  E-value=2.8e-19  Score=171.51  Aligned_cols=126  Identities=22%  Similarity=0.424  Sum_probs=107.6

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .+....++|++++.||+|+||.||+|.+. .+..||||+++...   ..   .+.+.+|+.+|+.++|+||+++++++. 
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MS---PDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---cc---HHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            34556689999999999999999999975 46789999986321   12   356788999999999999999999876 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+|+||||+++++|.+++.... ..+++..+..|+.||+.||.|||++||+||
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  133 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR  133 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            556899999999999999996532 369999999999999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.79  E-value=1.4e-18  Score=175.57  Aligned_cols=122  Identities=21%  Similarity=0.327  Sum_probs=108.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC---
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d---  429 (481)
                      .++|++++.||+|+||.||+|.+..+++.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+   
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---cCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            46899999999999999999999999999999998732   234455677889999999999999999999998665   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ---~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         .+|||||||+ ++|.+++.   ..+++..+..|+.||+.||.|||++|||||
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  151 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHR  151 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence               7999999997 68888885   458999999999999999999999999997

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.79  E-value=6.6e-19  Score=184.93  Aligned_cols=122  Identities=20%  Similarity=0.333  Sum_probs=107.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      .++|+++++||+|+||.||+|.+..+++.||||++...   .......+.+.+|+.+|+.++|+|||++++++...    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            47899999999999999999999999999999999632   23455667888999999999999999999999654    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ..+|||||||+ ++|.+++.   ..+++..++.|+.||+.||+|||++|||||
T Consensus       138 ~~~~~~lv~E~~~-~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHr  188 (464)
T 3ttj_A          138 EFQDVYLVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHR  188 (464)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cCCeEEEEEeCCC-CCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence              46899999997 56777763   459999999999999999999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.79  E-value=3.8e-19  Score=185.15  Aligned_cols=125  Identities=22%  Similarity=0.411  Sum_probs=108.5

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++.+.||+|+||.||+|.+.. +..||||+++...   .   ..+.+.+|+.+|+.++|+|||++++++. .
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---M---SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS---B---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC---c---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            44566789999999999999999999864 6779999986321   1   2457889999999999999999999976 6


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||.+|+|.++++... ..+++..+..|+.||+.||+|||+++||||
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr  308 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR  308 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            77999999999999999997532 468999999999999999999999999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.79  E-value=1.3e-18  Score=188.98  Aligned_cols=126  Identities=23%  Similarity=0.363  Sum_probs=106.8

Q ss_pred             CCCCCeEEeE-EeccCCcEEEEEEEECC--CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGK-LIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k-~IG~GtFG~VYla~dk~--tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....++.+.+ .||+|+||.||+|.++.  ++..||||+++...    .....+.+.+|+++|++++|+|||++++++..
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3445666666 89999999999998763  45679999986421    12234678889999999999999999999875


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       +.+|||||||.+|+|.+++......+++..+..|+.||+.||+|||++|||||
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr  460 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR  460 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence             56999999999999999997666779999999999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.78  E-value=1e-18  Score=174.33  Aligned_cols=128  Identities=28%  Similarity=0.436  Sum_probs=110.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC------CcHHHHHHHHHHHHHHhhCCCCCeeeeeeEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQEIKVLGHLKHENIVQYYGSE  425 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~------~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f  425 (481)
                      ..++|++++.||+|+||.||+|.+.. |+.||||++.......      ......+.+.+|+.+|+.++|+||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            45789999999999999999999765 8999999986433221      2344567889999999999999999999998


Q ss_pred             EeC-----CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          426 VVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       426 ~~~-----d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...     ..+||||||+. |+|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  158 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHR  158 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEec
Confidence            653     36999999997 79999987766679999999999999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.78  E-value=3.6e-19  Score=171.04  Aligned_cols=128  Identities=23%  Similarity=0.379  Sum_probs=102.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC-CCc--EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~-tg~--~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...++|++.+.||+|+||.||+|.+.. ++.  .||||+++...  ....+..+.+.+|+.+++.++|+||+++++++..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            456789999999999999999998643 333  58999886321  1223456788899999999999999999999876


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+ +++||||+.+++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  145 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR  145 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            55 899999999999999998766779999999999999999999999999997

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.78  E-value=1.1e-18  Score=171.92  Aligned_cols=122  Identities=31%  Similarity=0.469  Sum_probs=106.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEE----CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-  428 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~d----k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-  428 (481)
                      ..|+++++||+|+||.||++.+    ..+++.||||+++..    ......+.+.+|+.+|+.++|+||+++++++... 
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3459999999999999988865    347888999998632    3345567789999999999999999999999884 


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ..+||||||+++|+|.+++..  ..+++..+..|+.||+.||.|||++|||||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~  158 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHR  158 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence             679999999999999999965  459999999999999999999999999997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.78  E-value=4.1e-19  Score=178.52  Aligned_cols=130  Identities=19%  Similarity=0.361  Sum_probs=104.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC-----CcEEEEEEeecCCCCCCc-HHHH-----HHHHHHHHHHhhCCCCCee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKS-AECI-----KQLEQEIKVLGHLKHENIV  419 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t-----g~~VAIK~Ik~~~~d~~s-~e~~-----k~l~~EI~iL~~L~HPNIV  419 (481)
                      ....+|+++++||+|+||.||+|.+..+     ++.||||++......... ....     ..+..|+..+..++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4556899999999999999999998764     578999998632110000 0011     1233466778888999999


Q ss_pred             eeeeEEEeC----CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          420 QYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       420 qL~g~f~~~----d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++++...    ..+||||||| |++|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr  176 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHG  176 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe
Confidence            999998764    4589999999 999999998866789999999999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.78  E-value=1.4e-18  Score=169.74  Aligned_cols=126  Identities=18%  Similarity=0.326  Sum_probs=109.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEe-
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV-  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~-  427 (481)
                      .....+|++.++||+|+||.||+|.+..+++.||||++..     ......+.+.+|+.+|.++. |+||+++++++.. 
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC-----CchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3445689999999999999999999999999999999853     23455677889999999996 9999999999853 


Q ss_pred             -------CCEEEEEEeccCCCCHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          428 -------DDHLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       428 -------~d~lyLVmEy~~GGSL~~lL~~--~~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                             ...+||||||+. |+|.+++..  ..+.+++..++.|+.||+.||.|||++|  |+||
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~  162 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR  162 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc
Confidence                   345899999995 899999865  3466999999999999999999999999  9997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.78  E-value=1.7e-19  Score=177.40  Aligned_cols=126  Identities=27%  Similarity=0.426  Sum_probs=109.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      ....++|++.+.||+|+||.||+|.+. +++.||||++...     .....+.+.+|+.+|+.++|+||+++++++...+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            345678999999999999999999964 6889999987532     1223567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~---~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||+++|+|.+++....   ..+++..+..|+.||+.||+|||++||+||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~  163 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR  163 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecC
Confidence            9999999999999999986532   358999999999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.78  E-value=3.5e-19  Score=195.76  Aligned_cols=128  Identities=23%  Similarity=0.277  Sum_probs=111.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ....+|+++++||+|+||.||+|.++.+++.||||+++....  ......+.+..|+.+|..+ +|+||++++++|.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            346789999999999999999999999999999999973210  0111234567799999987 6999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+||||||++||+|.++++.. +.+++..++.|+.||+.||+|||++|||||
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHr  466 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYR  466 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECC
T ss_pred             EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            999999999999999999875 779999999999999999999999999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.78  E-value=1.7e-19  Score=182.40  Aligned_cols=127  Identities=15%  Similarity=0.214  Sum_probs=102.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHH---HHHhhCCCCCeeeee-----
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI---KVLGHLKHENIVQYY-----  422 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI---~iL~~L~HPNIVqL~-----  422 (481)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.....  ......+.+.+|+   ++|+.++|||||+++     
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            345789999999999999999999999999999999974322  2223456788999   455566899999998     


Q ss_pred             --eEEEeCC-----------------EEEEEEeccCCCCHHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHC
Q 011617          423 --GSEVVDD-----------------HLYIYLEYVHPGSINRYVREHCRDITE-------SIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       423 --g~f~~~d-----------------~lyLVmEy~~GGSL~~lL~~~~~~Lse-------~~I~~I~~QIl~GL~YLHsk  476 (481)
                        +++...+                 ..||||||+ +|+|.+++... +.+.+       ..+..|+.||+.||+|||++
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence              6666553                 289999999 68999999864 33444       78888999999999999999


Q ss_pred             CCccC
Q 011617          477 NTIHR  481 (481)
Q Consensus       477 gIIHR  481 (481)
                      |||||
T Consensus       226 ~ivHr  230 (377)
T 3byv_A          226 GLVHT  230 (377)
T ss_dssp             TEECS
T ss_pred             CeecC
Confidence            99998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.78  E-value=1.5e-20  Score=186.31  Aligned_cols=125  Identities=23%  Similarity=0.315  Sum_probs=101.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC---CCcHHHHHHHHHHHHHHhhCC---------CCCeee
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLK---------HENIVQ  420 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d---~~s~e~~k~l~~EI~iL~~L~---------HPNIVq  420 (481)
                      .++|+++++||+|+||.||+|++  +|+.||||+++.....   .......+.+.+|+.+|+.++         |+|||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999998  6899999999864321   112223356778888888885         777777


Q ss_pred             eeeEEE------------------------------eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 011617          421 YYGSEV------------------------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL  470 (481)
Q Consensus       421 L~g~f~------------------------------~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL  470 (481)
                      +++++.                              ..+.+|||||||++|++.+.+..  +.+++..++.|+.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            777654                              26789999999999976666533  6689999999999999999


Q ss_pred             HHHH-HCCCccC
Q 011617          471 AYLH-STNTIHR  481 (481)
Q Consensus       471 ~YLH-skgIIHR  481 (481)
                      +||| ++|||||
T Consensus       175 ~~lH~~~~ivHr  186 (336)
T 2vuw_A          175 AVAEASLRFEHR  186 (336)
T ss_dssp             HHHHHHHCCBCS
T ss_pred             HHHHHhCCEeEC
Confidence            9999 9999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.78  E-value=3.3e-19  Score=172.81  Aligned_cols=127  Identities=22%  Similarity=0.407  Sum_probs=105.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE--eCCE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV--VDDH  430 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~--~~d~  430 (481)
                      .++|++++.||+|+||.||+|.+..+++.||||+++..... ......+.+.+|+.+|+.++|+||+++++++.  ..+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            46899999999999999999999999999999998632100 00123467889999999999999999999985  3457


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||||+.++ |.+++... ...+++..+..|+.||+.||.|||++||+||
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~  133 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK  133 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999866 77777653 4679999999999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.77  E-value=5.1e-19  Score=188.71  Aligned_cols=126  Identities=26%  Similarity=0.440  Sum_probs=108.8

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .+.....+|++.++||+|+||.||+|.+.. +..||||+++...   ..   .+.+.+|+.+|++|+|+|||++++++..
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            345667789999999999999999999875 4669999986422   12   2467889999999999999999999765


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       +.+|||||||.+|+|.++|+.. ...+++..+..|+.||+.||+|||++|||||
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHr  387 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  387 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence             7799999999999999999753 3569999999999999999999999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.77  E-value=6.5e-19  Score=183.56  Aligned_cols=125  Identities=26%  Similarity=0.441  Sum_probs=108.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +.....+|++.++||+|+||.||+|.+.. +..||||+++...   ..   .+.+.+|+.+|++++|+||+++++++.. 
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            34566789999999999999999999875 4569999986322   12   2467889999999999999999999765 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||.+|+|.++++.. ...+++..+..|+.||+.||+|||++|||||
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  304 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  304 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            7799999999999999999753 3569999999999999999999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.77  E-value=8.8e-19  Score=170.29  Aligned_cols=125  Identities=28%  Similarity=0.444  Sum_probs=107.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|..++.||+|+||.||+|.+  ++..||||++.... .....+..+.+.+|+.+|+.++|+||+++++++...+.+||
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  107 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV-DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL  107 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCT-TSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccccCCccccCCCeEEEEEEE--CCceEEEEEEeccc-CcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEE
Confidence            4466679999999999999986  57899999986422 12233455678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~--~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++++|.+++...  ...+++..+..|+.||+.||.|||++||+||
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  157 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR  157 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence            99999999999999743  3469999999999999999999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.77  E-value=4.8e-18  Score=163.63  Aligned_cols=122  Identities=24%  Similarity=0.357  Sum_probs=105.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeE-EEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~-f~~~d~  430 (481)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.....   .    ..+.+|+.+++.+.|++++..++. +...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---H----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---C----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---h----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            35789999999999999999999999999999999864221   1    257789999999998876655554 467788


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .||||||+ +++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  129 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR  129 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            99999999 899999998666789999999999999999999999999997

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.77  E-value=9.5e-19  Score=168.02  Aligned_cols=124  Identities=28%  Similarity=0.473  Sum_probs=106.0

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      +....++|++.+.||+|+||.||+|.+.  |+.||||+++..   .    ..+.+.+|+.+|+.++|+||+++++++...
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---A----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch---h----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            3456689999999999999999999874  789999998631   1    235788899999999999999999987654


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       +.+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  141 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR  141 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence             47999999999999999997642 238999999999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.77  E-value=2.7e-18  Score=167.91  Aligned_cols=127  Identities=24%  Similarity=0.440  Sum_probs=103.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEEC-CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEV  426 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk-~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~  426 (481)
                      ...++|++.+.||+|+||.||+|.+. .+|+.||||+++.........   ..+.+|+.+++.+   .|+||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            34578999999999999999999995 678899999987433221111   2344566666655   8999999999987


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 -----VDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 -----~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           ....+||||||+. |+|.+++.... ..+++..++.|+.||+.||.|||++||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~  144 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR  144 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence                 4567999999997 79999997743 449999999999999999999999999997

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.77  E-value=1.3e-18  Score=172.50  Aligned_cols=126  Identities=25%  Similarity=0.346  Sum_probs=109.1

Q ss_pred             CCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCE
Q 011617          353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH  430 (481)
Q Consensus       353 ~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~  430 (481)
                      ..+|.+. ++||+|+||.||+|.+..+++.||||+++.......   ....+.+|+.+|..+. |+||+++++++...+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD---CRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE---CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH---HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4567777 899999999999999999999999999974332222   2356788999999995 6999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||.+|+|.+++... ...+++..++.|+.||+.||+|||++|||||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~  155 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL  155 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999999999998542 3679999999999999999999999999997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.77  E-value=8.3e-19  Score=178.84  Aligned_cols=126  Identities=24%  Similarity=0.446  Sum_probs=107.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCC---cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg---~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-  427 (481)
                      ....|++.++||+|+||.||+|.+..++   ..||+|.++..    ......+.+.+|+.+|++++|+||+++++++.. 
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            3456899999999999999999976433   35899987532    233456788899999999999999999998654 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++..||||||+++|+|.++++.....+++..+..|+.||+.||+|||++|||||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  216 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR  216 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            567899999999999999998766779999999999999999999999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.77  E-value=9.5e-19  Score=177.81  Aligned_cols=123  Identities=28%  Similarity=0.471  Sum_probs=101.6

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~----  428 (481)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...    
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            46899999999999999999999999999999998532   23445567788999999999999999999998754    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 --d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        +.+||||||+ +++|.++++.  ..+++..++.|+.||+.||+|||++|||||
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~  156 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR  156 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence              5689999999 6999999865  679999999999999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.77  E-value=1.8e-18  Score=166.94  Aligned_cols=119  Identities=24%  Similarity=0.394  Sum_probs=100.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh--CCCCCeeeeeeEEEeC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVD  428 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~--L~HPNIVqL~g~f~~~  428 (481)
                      ...++|+++++||+|+||.||+|.+  +++.||||++...        ....+..|.+++..  ++|+||+++++++...
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            3457899999999999999999987  5889999998531        12344456666655  7999999999987653


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccC
Q 011617          429 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHR  481 (481)
Q Consensus       429 ----d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH--------skgIIHR  481 (481)
                          +.+||||||+++|+|.++++.  ..+++..+..|+.||+.||+|||        +++||||
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~  137 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR  137 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence                459999999999999999953  67999999999999999999999        9999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.77  E-value=9e-19  Score=173.17  Aligned_cols=129  Identities=19%  Similarity=0.350  Sum_probs=109.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC------------cHHHHHHHHHHHHHHhhCCCCCe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------------SAECIKQLEQEIKVLGHLKHENI  418 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~------------s~e~~k~l~~EI~iL~~L~HPNI  418 (481)
                      ...++|++++.||+|+||.||+|.+  +++.||||++........            .....+.+.+|+.+|+.++|+||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            3457999999999999999999998  799999999864211100            00112678889999999999999


Q ss_pred             eeeeeEEEeCCEEEEEEeccCCCCHHHH------HHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          419 VQYYGSEVVDDHLYIYLEYVHPGSINRY------VREH-CRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       419 VqL~g~f~~~d~lyLVmEy~~GGSL~~l------L~~~-~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      +++++++...+.+||||||+++|+|.++      +... ...+++..++.|+.||+.||.|||+ +||+||
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  176 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR  176 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence            9999999999999999999999999998      5442 4679999999999999999999999 999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.77  E-value=4.8e-18  Score=176.11  Aligned_cols=124  Identities=23%  Similarity=0.404  Sum_probs=109.2

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC------CCCCeeeeeeE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL------KHENIVQYYGS  424 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L------~HPNIVqL~g~  424 (481)
                      ....+|+++++||+|+||.||+|.+..+++.||||+++.      .....+.+.+|+.+|+.+      .|+||++++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            345689999999999999999999999999999999862      334456677888888877      57799999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +...+.+||||||+. ++|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  224 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC  224 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECS
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            999999999999995 79999997743 459999999999999999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.77  E-value=4.8e-18  Score=163.24  Aligned_cols=122  Identities=24%  Similarity=0.352  Sum_probs=102.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeE-EEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~-f~~~d~  430 (481)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.....       ...+.+|+.+++.+.|++++..++. +...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            45789999999999999999999999999999998753221       1246779999999998776666554 467788


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||+ +++|.+++......+++..+..|+.||+.||.|||++||+||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~  129 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR  129 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            99999999 899999998766789999999999999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.77  E-value=4e-18  Score=165.79  Aligned_cols=128  Identities=24%  Similarity=0.318  Sum_probs=102.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD  429 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d  429 (481)
                      .....+|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+.++..+++.++|+||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            445678999999999999999999999999999999997422   22233344555556788899999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      .+||||||+ ++.+..++......+++..+..|+.||+.||.|||++ ||+||
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~  149 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR  149 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeC
Confidence            999999999 6777777766567899999999999999999999995 99997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.77  E-value=2.9e-18  Score=173.34  Aligned_cols=122  Identities=23%  Similarity=0.469  Sum_probs=108.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL-  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l-  431 (481)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+.. 
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            46899999999999999999999999999999998632   23455667888999999999999999999999877654 


Q ss_pred             -----EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 -----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 -----yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           ||||||+. ++|.+++.   ..+++..++.|+.||+.||+|||++|||||
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  168 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHR  168 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence                 99999997 78888773   459999999999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.76  E-value=1.2e-18  Score=174.03  Aligned_cols=119  Identities=18%  Similarity=0.224  Sum_probs=103.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCC--------CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeee---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRET--------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ---  420 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~t--------g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVq---  420 (481)
                      ..++|++++.||+|+||.||+|.+..+        ++.||||++...          +.+.+|+.+|+.++|+||++   
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhh
Confidence            457999999999999999999999874        788999998632          35678999999999999887   


Q ss_pred             ------------eeeEEEe-CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          421 ------------YYGSEVV-DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       421 ------------L~g~f~~-~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                                  +++++.. ++.+||||||+ +++|.+++... ...+++..+..|+.||+.||.|||++|||||
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  183 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHG  183 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence                        6777776 78899999999 99999999864 3679999999999999999999999999997

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.76  E-value=7.5e-19  Score=172.53  Aligned_cols=126  Identities=24%  Similarity=0.392  Sum_probs=107.6

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ...++|++.+.||+|+||.||+|.+. +++.||||+++.....    .....+.+|+.+|+.++|+||+++++++...+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            45578999999999999999999854 5889999998643211    111257889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHST---NTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~---~~Lse~~I~~I~~QIl~GL~YLHsk---gIIHR  481 (481)
                      .+||||||.+|+|.+++....   ..+++..+..|+.||+.||.|||++   |||||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~  158 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR  158 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence            999999999999999997642   3489999999999999999999999   99997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.76  E-value=1.1e-18  Score=174.28  Aligned_cols=129  Identities=21%  Similarity=0.292  Sum_probs=102.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC---CCcEEEEEEeecCCCCCCc-HHH-----HHHHHHHHHHHhhCCCCCeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKS-AEC-----IKQLEQEIKVLGHLKHENIVQY  421 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~---tg~~VAIK~Ik~~~~d~~s-~e~-----~k~l~~EI~iL~~L~HPNIVqL  421 (481)
                      ...++|+++++||+|+||.||+|.+..   ++..||||++......... ...     ...+.+|+.++..+.|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            456789999999999999999999987   7888999998642111000 001     1235678899999999999999


Q ss_pred             eeEEEe----CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~----~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++..    .+.+||||||| +++|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  175 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHG  175 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            999988    77899999999 99999999764 589999999999999999999999999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.76  E-value=5.2e-18  Score=165.90  Aligned_cols=126  Identities=21%  Similarity=0.370  Sum_probs=110.9

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC--CCCeeeeeeEEEe
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVV  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~--HPNIVqL~g~f~~  427 (481)
                      ....++|++++.||+|+||.||+|.+. +++.||||++....   ......+.+.+|+.+|..+.  |+||+++++++..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            345678999999999999999999975 48899999997432   34556678899999999997  5999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+||||| +.+++|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  151 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHS  151 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            999999999 5579999999874 789999999999999999999999999997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.76  E-value=4.4e-18  Score=166.86  Aligned_cols=118  Identities=26%  Similarity=0.486  Sum_probs=100.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh--CCCCCeeeeeeEEEeC-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVD-  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~--L~HPNIVqL~g~f~~~-  428 (481)
                      ..++|+++++||+|+||.||+|++.  ++.||||++...      ..  ..+..|.+++..  ++|+||+++++++... 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EE--ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------cc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3468999999999999999999985  889999998631      11  233345555554  4899999999999887 


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk--------gIIHR  481 (481)
                         +.+|||||||++|+|.++++.  ..+++..+..|+.||+.||.|||++        |||||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~  166 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR  166 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence               789999999999999999965  4699999999999999999999999        99997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.76  E-value=4.3e-18  Score=169.56  Aligned_cols=123  Identities=21%  Similarity=0.376  Sum_probs=108.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-----------CCCeee
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQ  420 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-----------HPNIVq  420 (481)
                      ...+|++++.||+|+||.||+|++..+++.||||++.      ......+.+.+|+.+|+.+.           |+||++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------SCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEec------CCccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            4578999999999999999999999999999999986      23344567788999998886           889999


Q ss_pred             eeeEEEeCC----EEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          421 YYGSEVVDD----HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       421 L~g~f~~~d----~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      +++++...+    .++|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ |||||
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~  156 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT  156 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence            999998654    799999999 89999999874 35599999999999999999999998 99997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.76  E-value=5e-18  Score=166.93  Aligned_cols=124  Identities=20%  Similarity=0.290  Sum_probs=107.3

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCC-cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC------eeeeee
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN------IVQYYG  423 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN------IVqL~g  423 (481)
                      ...++|++.+.||+|+||.||+|.+..++ ..||||+++.      .....+.+.+|+.+|+.+.|++      |+.+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            34579999999999999999999998777 6899999862      2344567888999999887655      999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++...+.+||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~  147 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT  147 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            999999999999999 678888776643 569999999999999999999999999997

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.76  E-value=7.5e-18  Score=165.76  Aligned_cols=127  Identities=24%  Similarity=0.350  Sum_probs=107.6

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHH-HHhhCCCCCeeeeeeEEEeC
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~-iL~~L~HPNIVqL~g~f~~~  428 (481)
                      .....+|++++.||+|+||.||+|.+..+|+.||||+++..    ........+..|+. +++.++|+||+++++++...
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            45668999999999999999999999999999999999742    22333445555665 77888999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHST-NTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~----~~~~Lse~~I~~I~~QIl~GL~YLHsk-gIIHR  481 (481)
                      +.+||||||+. |+|.+++..    ....+++..+..|+.||+.||.|||++ ||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~  150 (327)
T 3aln_A           94 GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHR  150 (327)
T ss_dssp             SEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCS
T ss_pred             CceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeEC
Confidence            99999999997 588888763    246789999999999999999999999 99997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.76  E-value=4.4e-18  Score=169.77  Aligned_cols=122  Identities=25%  Similarity=0.297  Sum_probs=101.6

Q ss_pred             CCCCCeEEeE-EeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--
Q 011617          351 PKKSQWQKGK-LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--  427 (481)
Q Consensus       351 ~~~~~Y~i~k-~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--  427 (481)
                      ...++|++.+ +||+|+||.||+|.++.+++.||||++..      .....+   +....++.+.|+||+++++++..  
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ---EVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES------SHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC------cHHHHH---HHHHHHHhcCCCChHHHHHHHhhcc
Confidence            4456899955 69999999999999999999999999862      222222   22334667799999999999876  


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 --DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 --~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        ...+|||||||++|+|.+++.... ..+++..++.|+.||+.||.|||++||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~  152 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR  152 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence              456999999999999999998643 369999999999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.76  E-value=2.8e-18  Score=171.16  Aligned_cols=122  Identities=22%  Similarity=0.456  Sum_probs=107.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE--
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--  430 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~--  430 (481)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+.  
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            46899999999999999999999999999999998632   2345556788899999999999999999999987654  


Q ss_pred             ----EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 ----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 ----lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          +||||||+. ++|.+++.   ..+++..+..|+.||+.||.|||++||+||
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~  150 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHR  150 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence                599999997 78887763   459999999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.76  E-value=4.6e-18  Score=185.69  Aligned_cols=123  Identities=22%  Similarity=0.390  Sum_probs=104.1

Q ss_pred             CCeEE-eEEeccCCcEEEEEEEE--CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          354 SQWQK-GKLIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i-~k~IG~GtFG~VYla~d--k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..+.+ .++||+|+||.||+|.+  ..+++.||||+++...   ......+.+.+|+.+|++++|+|||++++++. .+.
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~  443 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES  443 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCC
Confidence            34444 45899999999999965  4566889999987432   22233467889999999999999999999986 456


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||++|+|.++++. ...+++..++.|+.||+.||+|||++|||||
T Consensus       444 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr  493 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHR  493 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence            8999999999999999976 4779999999999999999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.76  E-value=3e-19  Score=174.17  Aligned_cols=128  Identities=27%  Similarity=0.470  Sum_probs=110.4

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ......++|++++.||+|+||.||+|.+..   .+|+|+++.......   ..+.+.+|+.+++.++|+||+++++++..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            335567899999999999999999999864   499999875332221   12356679999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+||||||+++++|.+++......+++..+..|+.||+.||+|||++||+||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~  154 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK  154 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            999999999999999999997755579999999999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.76  E-value=1.5e-18  Score=171.49  Aligned_cols=131  Identities=24%  Similarity=0.384  Sum_probs=111.3

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCC-cHHHHHHHHHHHHHHhhCC--CCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLK--HENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~-s~e~~k~l~~EI~iL~~L~--HPNIVqL~g~f~  426 (481)
                      ....++|++++.||+|+||.||+|.+..+++.||||+++....... .....+.+.+|+.+|+++.  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            4456789999999999999999999999999999999975322110 0011234567899999996  599999999999


Q ss_pred             eCCEEEEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~G-GSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.+++||||+.+ ++|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  173 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHR  173 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeC
Confidence            99999999999986 8999999875 789999999999999999999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.76  E-value=5.3e-18  Score=175.08  Aligned_cols=120  Identities=28%  Similarity=0.403  Sum_probs=101.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC---
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~---  428 (481)
                      ...+|+++++||+|+||.||+|++..+|+.||||++.....         .+.+|+++|+.++|+|||+++++|...   
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            34579999999999999999999999999999999863211         123599999999999999999998642   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 ---d~lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                         .+++|||||+. ++|.+++..   ....+++..++.|+.||+.||+|||++|||||
T Consensus       123 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  180 (420)
T 1j1b_A          123 KDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR  180 (420)
T ss_dssp             TTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             CcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence               24789999997 577776643   34679999999999999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.75  E-value=1.8e-18  Score=189.22  Aligned_cols=123  Identities=25%  Similarity=0.358  Sum_probs=106.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECC-CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~-tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..++|++.++||+|+||.||+|.+.. +++.||||++..    ....+....+.+|+.+|.+++|+|||++++++...+.
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            45799999999999999999999976 789999998853    2334556678899999999999999999999987665


Q ss_pred             -----EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 -----lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                           +|||||||+|++|.+++..   .+++..++.|+.||+.||.|||++|||||
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHr  206 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYN  206 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence                 7999999999999988743   69999999999999999999999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.75  E-value=2.8e-18  Score=168.53  Aligned_cols=119  Identities=28%  Similarity=0.451  Sum_probs=103.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||++..       ....+.+.+|+.+|+.++|+||+++++++.  +.+
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   74 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV   74 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence            4568999999999999999999975  68899998852       123467888999999999999999999876  458


Q ss_pred             EEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHS---TNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHs---kgIIHR  481 (481)
                      ||||||+++|+|.+++....  ..+.+..+..|+.||+.||+|||+   +|||||
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~  129 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR  129 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence            99999999999999997642  247899999999999999999999   899997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.75  E-value=4.5e-18  Score=171.38  Aligned_cols=126  Identities=11%  Similarity=0.052  Sum_probs=91.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC--CCCCeeeee-------e
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL--KHENIVQYY-------G  423 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L--~HPNIVqL~-------g  423 (481)
                      ...|++++.||+|+||.||+|.+..+|+.||||+++...  .......+.+.+|+.+++.|  +||||++++       +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA--ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS--TTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc--cccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            446999999999999999999999999999999997432  22345566778885544444  699988865       4


Q ss_pred             EEEeC-----------------CEEEEEEeccCCCCHHHHHHHhCCCCCHHHH------HHHHHHHHHHHHHHHHCCCcc
Q 011617          424 SEVVD-----------------DHLYIYLEYVHPGSINRYVREHCRDITESIV------RNFTRHILNGLAYLHSTNTIH  480 (481)
Q Consensus       424 ~f~~~-----------------d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I------~~I~~QIl~GL~YLHskgIIH  480 (481)
                      ++...                 +.+|||||||+ |+|.+++......+.+...      ..|+.||+.||+|||++||||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            44433                 34899999998 9999999875445555555      677799999999999999999


Q ss_pred             C
Q 011617          481 R  481 (481)
Q Consensus       481 R  481 (481)
                      |
T Consensus       218 r  218 (371)
T 3q60_A          218 G  218 (371)
T ss_dssp             T
T ss_pred             C
Confidence            8

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.74  E-value=1.6e-17  Score=163.41  Aligned_cols=122  Identities=25%  Similarity=0.374  Sum_probs=98.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--  427 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--  427 (481)
                      ....++|+++++||+|+||.||+|++  +++.||||+++..     ... ....+.|+..+..++|+||+++++.+..  
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chh-hHHHHHHHHHHHhccCcchhhheecccccc
Confidence            45678999999999999999999986  5789999998631     111 1122334444556899999999986643  


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccC
Q 011617          428 ---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---------NTIHR  481 (481)
Q Consensus       428 ---~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk---------gIIHR  481 (481)
                         ...+|||||||++|+|.++++.  ..+++..+..|+.||+.||+|||++         |||||
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~  144 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR  144 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeec
Confidence               2368999999999999999976  4468999999999999999999999         99997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.74  E-value=8.6e-18  Score=165.44  Aligned_cols=117  Identities=26%  Similarity=0.404  Sum_probs=103.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh--CCCCCeeeeeeEEEeCC-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVDD-  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~--L~HPNIVqL~g~f~~~d-  429 (481)
                      .++|++.+.||+|+||.||+|++  +++.||||++...        ....+.+|++++..  ++|+||+++++++...+ 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            35899999999999999999998  4889999998521        12456678888887  78999999999998876 


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccC
Q 011617          430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHR  481 (481)
Q Consensus       430 ---~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH--------skgIIHR  481 (481)
                         .+||||||+++|+|.+++..  ..+++..+..|+.||+.||.|||        ++|||||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~  171 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR  171 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred             ccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence               89999999999999999975  56999999999999999999999        8999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.74  E-value=1.1e-17  Score=183.21  Aligned_cols=126  Identities=22%  Similarity=0.371  Sum_probs=109.7

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCC---CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~t---g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ....+|++++.||+|+||.||+|.+..+   +..||||.++.    .......+.+.+|+.+|+.++|+||+++++++. 
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS----TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            4457899999999999999999998654   45689998753    123455678889999999999999999999974 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||++|+|.++++.....+++..+..|+.||+.||.|||++|||||
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  515 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR  515 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            567899999999999999998766679999999999999999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.74  E-value=1.7e-17  Score=175.90  Aligned_cols=122  Identities=25%  Similarity=0.373  Sum_probs=107.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~d~  430 (481)
                      ..++|+++++||+|+||.||+|.+..+++.||||+++.....       .++..|+++++.|.| ++|..+..++...+.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            457899999999999999999999999999999988643221       246679999999987 566677777788899


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .||||||| +++|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr  127 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR  127 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            99999999 899999998766789999999999999999999999999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.74  E-value=6.3e-18  Score=172.50  Aligned_cols=120  Identities=25%  Similarity=0.493  Sum_probs=95.2

Q ss_pred             CCeEE-eEEeccCCcEEEEEEEEC--CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--C
Q 011617          354 SQWQK-GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--D  428 (481)
Q Consensus       354 ~~Y~i-~k~IG~GtFG~VYla~dk--~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~  428 (481)
                      +.|.+ +++||+|+||.||+|.++  .+++.||||+++..   ...    ..+.+|+.+|+.|+|+|||++++++..  .
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GIS----MSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            45666 668999999999999976  46889999998632   112    356789999999999999999999965  6


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~--------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+||||||+. |+|.+++....        ..+++..++.|+.||+.||+|||++|||||
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~  152 (405)
T 3rgf_A           93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR  152 (405)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC
Confidence            78999999996 78888886321        249999999999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.73  E-value=1.1e-17  Score=166.20  Aligned_cols=123  Identities=30%  Similarity=0.439  Sum_probs=91.5

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~-  430 (481)
                      ..++|++.++||+|+||.||+|.+..+|+.||||++.....  ..    ....+|++.+..++|+||++++++|...+. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--cc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34689999999999999999999999999999999863221  11    234557788888999999999999976433 


Q ss_pred             ------EEEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccC
Q 011617          431 ------LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLH--STNTIHR  481 (481)
Q Consensus       431 ------lyLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLH--skgIIHR  481 (481)
                            +||||||+. ++|...+..   ....+.+..++.|+.||+.||.|||  ++|||||
T Consensus        95 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~  155 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR  155 (360)
T ss_dssp             CTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred             cccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence                  899999997 566655543   3467899999999999999999999  9999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.72  E-value=2.3e-17  Score=168.78  Aligned_cols=119  Identities=27%  Similarity=0.429  Sum_probs=97.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ...+|+++++||+|+||.||+|++..+++ ||+|++.....         ...+|+.+|+.++|+||++++++|...+  
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            45689999999999999999999987666 88888753211         1225999999999999999999996543  


Q ss_pred             ----EEEEEEeccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~---~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+|||||||.+ ++...+.   .....+++..++.|+.||+.||+|||++|||||
T Consensus       108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  165 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR  165 (394)
T ss_dssp             SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence                38999999975 4444443   224679999999999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.72  E-value=5.2e-17  Score=164.51  Aligned_cols=124  Identities=23%  Similarity=0.395  Sum_probs=108.0

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CC-----CeeeeeeE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE-----NIVQYYGS  424 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HP-----NIVqL~g~  424 (481)
                      ...++|++.++||+|+||.||+|.+..+++.||||+++.      .......+..|+.+++.+. |+     +|++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            345799999999999999999999999999999999862      3345567788998888875 44     49999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCccC
Q 011617          425 EVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLH--STNTIHR  481 (481)
Q Consensus       425 f~~~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLH--skgIIHR  481 (481)
                      +...+.+||||||+. |+|.+++.... ..+++..++.|+.||+.||.|||  ++|||||
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr  183 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC  183 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC
Confidence            999999999999996 69999998743 56999999999999999999999  5799998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.69  E-value=1.1e-17  Score=174.09  Aligned_cols=120  Identities=22%  Similarity=0.326  Sum_probs=101.1

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~  430 (481)
                      ...+|.+.++||+|+||.||.. ...+++.||||++....        ...+.+|+.+|+.+ +|+|||++++++.+.+.
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC--------FSFADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT--------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            3457999999999999997643 34568999999985311        11345699999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||. |+|.+++......+.+..+..|+.||+.||.|||++|||||
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  142 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR  142 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeC
Confidence            999999996 79999998765567777788999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.69  E-value=7e-17  Score=167.36  Aligned_cols=121  Identities=31%  Similarity=0.392  Sum_probs=97.4

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCC
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD  429 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d  429 (481)
                      ...+.|.+.++||+|+||+||.+. ..+|+.||||++...        ..+.+.+|+.+|.++ +|||||++++++..++
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            345567888999999999998754 456899999998631        124567899999876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~------Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+|||||||. |+|.+++......      ..+..+..|+.||+.||+|||++|||||
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  139 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR  139 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999995 7999999753211      1333567899999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.68  E-value=8.8e-18  Score=185.46  Aligned_cols=125  Identities=26%  Similarity=0.428  Sum_probs=108.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-----
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-----  427 (481)
                      .++|+++++||+|+||.||+|.+..+|+.||||+++..    ......+.+.+|+.+|+.++|+||+++++++..     
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            46899999999999999999999999999999988631    245556778999999999999999999998755     


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~--~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+..|||||||+||+|.+++....  ..+++..++.|+.||+.||+|||++|||||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr  145 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR  145 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence             667899999999999999997642  268999999999999999999999999997

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.63  E-value=4.1e-16  Score=168.45  Aligned_cols=118  Identities=14%  Similarity=0.020  Sum_probs=91.2

Q ss_pred             EEeccCCcEEEEEEEECCCCcEEEEEEeecCCC-----CCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeCCEEEE
Q 011617          360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----DPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       360 k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~-----d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..++.|.+|.+..+...-.|+.||||++.....     ........+++.+|+++|+++ .|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345667777777776666799999999975321     112334456799999999999 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+|++|.++|+.. +.+++.   .|+.||+.||+|||++|||||
T Consensus       320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHR  363 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHD  363 (569)
T ss_dssp             EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEES
T ss_pred             EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceec
Confidence            99999999999999864 777765   478999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.58  E-value=1.2e-15  Score=163.68  Aligned_cols=114  Identities=18%  Similarity=0.152  Sum_probs=85.1

Q ss_pred             EEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC---CcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~---~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ...++||+|+||.||+|..  .+..+++|++.......   ......+++.+|+++|++++|+||+++..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4567999999999999953  46789999875322111   111224568999999999999999976666667888899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+|++|.++++.         +..|+.||+.||+|||++|||||
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHr  455 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHN  455 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECT
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccC
Confidence            9999999999999854         56899999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.58  E-value=1.9e-15  Score=148.85  Aligned_cols=115  Identities=18%  Similarity=0.208  Sum_probs=88.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC----CcH---------HHHHHHHHHHHHHhhCCCCCeee
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSA---------ECIKQLEQEIKVLGHLKHENIVQ  420 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~----~s~---------e~~k~l~~EI~iL~~L~HPNIVq  420 (481)
                      ..|.+++.||+|+||.||+|.+ .+|+.||||+++......    ...         .....+.+|+.+|+.++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3456679999999999999999 889999999986321110    001         23567889999999999  5 67


Q ss_pred             eeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       421 L~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++++.. +..|||||||+|++|.+ +.       ......|+.||+.||.|||++|||||
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHr  217 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHG  217 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeC
Confidence            7775543 55699999999999987 31       13355799999999999999999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.55  E-value=8.8e-15  Score=150.67  Aligned_cols=127  Identities=16%  Similarity=0.198  Sum_probs=93.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCee---------e-
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV---------Q-  420 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIV---------q-  420 (481)
                      ....|+++++||+|+||.||+|.+..+|+.||||+++...  .......+.+.+|+.+++.+.| .|+.         . 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC--C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC--CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            3456899999999999999999999999999999986322  2222345678899999999987 3211         1 


Q ss_pred             -----------eeeEEEe-----CCEEEEEEeccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011617          421 -----------YYGSEVV-----DDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNT  478 (481)
Q Consensus       421 -----------L~g~f~~-----~d~lyLVmEy~~GGSL~~lL~~~------~~~Lse~~I~~I~~QIl~GL~YLHskgI  478 (481)
                                 ++.++..     ...++++|+++ +++|.++++..      ...+++..+..|+.||+.||+|||++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  232 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  232 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence                       1111111     22468888876 69999998532      3447788999999999999999999999


Q ss_pred             ccC
Q 011617          479 IHR  481 (481)
Q Consensus       479 IHR  481 (481)
                      |||
T Consensus       233 iHr  235 (413)
T 3dzo_A          233 VHT  235 (413)
T ss_dssp             ECS
T ss_pred             ccC
Confidence            998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.44  E-value=3.6e-14  Score=137.34  Aligned_cols=119  Identities=18%  Similarity=0.221  Sum_probs=88.2

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcE--EEEEEeecCCCCCC-------------------cHHHHHHHHHHHHHHhhC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGHL  413 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~--VAIK~Ik~~~~d~~-------------------s~e~~k~l~~EI~iL~~L  413 (481)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||+++.......                   .......+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778999  99998753211100                   112234678899999999


Q ss_pred             CCCCe--eeeeeEEEeCCEEEEEEeccCC-C----CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccC
Q 011617          414 KHENI--VQYYGSEVVDDHLYIYLEYVHP-G----SINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHR  481 (481)
Q Consensus       414 ~HPNI--VqL~g~f~~~d~lyLVmEy~~G-G----SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH-skgIIHR  481 (481)
                      .|++|  ..++++    +..+|||||+.+ |    .|.+++..    +++..+..++.||+.||.||| ++|||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            88764  344432    356899999932 3    67766432    335678899999999999999 9999997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.21  E-value=1.7e-11  Score=127.71  Aligned_cols=117  Identities=14%  Similarity=0.086  Sum_probs=80.0

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC------------CCcHH-----HHHHHHHHHHHHhhCCCCC
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------------PKSAE-----CIKQLEQEIKVLGHLKHEN  417 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d------------~~s~e-----~~k~l~~EI~iL~~L~HPN  417 (481)
                      -|.++.+||.|+||.||+|.+. +|+.||||+++.....            .....     ...+...|...|..+.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4899999999999999999975 5899999998632110            00110     1112345777777775554


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |....-+...  ..+|||||++|+.|.++.       .......++.||+.+|.|||.+|||||
T Consensus       175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHr  229 (397)
T 4gyi_A          175 FPVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHG  229 (397)
T ss_dssp             CSCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CCCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            4322222122  237999999988885543       123456788999999999999999998

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.32  E-value=1.9e-06  Score=81.71  Aligned_cols=109  Identities=12%  Similarity=0.024  Sum_probs=84.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~ly  432 (481)
                      ..|++...++.|+++.||++...  +..+++|+........     ...+.+|+.+|+.|. +..|.++++++...+..|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            46888999999999999998743  6789999885321111     124778999999885 677889999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS  475 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs  475 (481)
                      +||||++|.+|.+.+.      .......++.+++.+|..||.
T Consensus        87 lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhC
Confidence            9999999999876531      122345788999999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.71  E-value=3.6e-05  Score=71.72  Aligned_cols=106  Identities=9%  Similarity=0.030  Sum_probs=74.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC--eeeeeeEEEeCCEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHL  431 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN--IVqL~g~f~~~d~l  431 (481)
                      ..|.+..+.+.|..+.||++.. .+|..+++|+....        ....+..|+.+|+.+.+.+  |.++++++...+..
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            3566655555677799999864 45778999987521        1134667888888886444  56788888888889


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |+||||++|.+|.  +    ....   ...++.+++..|..||...
T Consensus        91 ~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~  127 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLD  127 (264)
T ss_dssp             EEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred             EEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCC
Confidence            9999999988873  2    1122   2356778888888888753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.51  E-value=0.00013  Score=72.71  Aligned_cols=110  Identities=11%  Similarity=0.141  Sum_probs=78.6

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEee--cCCCCCCcHHHHHHHHHHHHHHhhCC--CCCeeeeeeEEEeC---CE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD---DH  430 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik--~~~~d~~s~e~~k~l~~EI~iL~~L~--HPNIVqL~g~f~~~---d~  430 (481)
                      ..+.|+.|.++.||+....  +..+++|+..  ..    ........+.+|+.+|+.|.  +..|.+++.++.+.   +.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~----~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS----KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC----CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            4678899999999998754  4567888653  11    11112346778999999987  45678888887765   45


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      .|+||||++|..+.+..   ...+++.....++.+++..|..||..
T Consensus       116 ~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~  158 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTV  158 (359)
T ss_dssp             CEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             eEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999987774311   23477888899999999999999985

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.80  E-value=0.013  Score=55.19  Aligned_cols=102  Identities=14%  Similarity=0.074  Sum_probs=75.7

Q ss_pred             eccCCcE-EEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEEEEEeccC
Q 011617          362 IGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVH  439 (481)
Q Consensus       362 IG~GtFG-~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~lyLVmEy~~  439 (481)
                      +..|..| .||.......+..+.+|+-..        .....+..|..+|+.|. +--|.++++++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            3445444 689887766677888997641        23456778999998875 3347788888899999999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       440 GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      |.++.+.....     ......+..++...|.-||..
T Consensus       104 G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~  135 (272)
T 4gkh_A          104 GKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSI  135 (272)
T ss_dssp             SEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTS
T ss_pred             CccccccccCC-----HHHHHHHHHHHHHHHHHhcCC
Confidence            88988876542     233456788899999999975

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.79  E-value=0.011  Score=58.08  Aligned_cols=104  Identities=14%  Similarity=0.101  Sum_probs=78.4

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCC---CeeeeeeEEE-eCCEEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE---NIVQYYGSEV-VDDHLYIY  434 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HP---NIVqL~g~f~-~~d~lyLV  434 (481)
                      .+.++.|....||+.     +..+++|+..       .......+..|..+|+.|.+.   .|.+++.+.. ..+..|+|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            456788999999987     4668888742       234456788999999998752   3556666654 34567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |||++|..|....-   ..++......++.++...|..||...
T Consensus        92 ~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~  131 (306)
T 3tdw_A           92 YRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFP  131 (306)
T ss_dssp             EECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             EeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            99999888876432   34678888999999999999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.31  E-value=0.0075  Score=58.55  Aligned_cols=103  Identities=12%  Similarity=0.100  Sum_probs=74.1

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCC--eeeeeeEEEeCC---EEE
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HEN--IVQYYGSEVVDD---HLY  432 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPN--IVqL~g~f~~~d---~ly  432 (481)
                      .+.|+.|.+..||+..     ..+++|+..       .......+.+|..+|+.+. +..  +.+++......+   ..|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~-------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPK-------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEES-------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecC-------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            3458999999999753     458888753       1234567889999998874 333  345544433333   348


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      +||||++|..|.....   ..++..+...++.|++..|..||..
T Consensus        93 ~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~  133 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSI  133 (304)
T ss_dssp             EEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             EEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcC
Confidence            8999999888865433   3478888999999999999999975

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.80  E-value=0.011  Score=59.74  Aligned_cols=109  Identities=15%  Similarity=0.058  Sum_probs=61.3

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC--CCCcHHHHHHHHHHHHHHhhCCC--C-CeeeeeeEEEeCCEEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKH--E-NIVQYYGSEVVDDHLY  432 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~--d~~s~e~~k~l~~EI~iL~~L~H--P-NIVqL~g~f~~~d~ly  432 (481)
                      ..+.||.|.++.||++.....++.++||.......  ..........+..|.++|+.+..  + .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35789999999999997655677899998642110  00000012345668888877642  2 34466643  455568


Q ss_pred             EEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 011617          433 IYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLH  474 (481)
Q Consensus       433 LVmEy~~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLH  474 (481)
                      |||||+.+. .+...+..  +....    .++.+++..|+-+|
T Consensus       112 lvmE~l~g~~~~~~~l~~--~~~~~----~~~~~l~~~La~lH  148 (397)
T 2olc_A          112 TVMEDLSHLKIARKGLIE--GENYP----HLSQHIGEFLGKTL  148 (397)
T ss_dssp             EEECCCTTSEEHHHHHHT--TCCCT----THHHHHHHHHHHHH
T ss_pred             EEEEeCCCcchHHHHHhc--CCcCH----HHHHHHHHHHHHHh
Confidence            999999864 34333322  11111    23455666666676

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.75  E-value=0.023  Score=56.75  Aligned_cols=95  Identities=15%  Similarity=0.190  Sum_probs=71.3

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEEEEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYIY  434 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~lyLV  434 (481)
                      -.+.|+.|.+..+|+...  .+..+++|+...     .   ....+..|...|+.|.   ...|.+++.+....+..|+|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-----S---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----G---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----c---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            457789999999999874  366788887642     1   1346778888888774   35688888888888899999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       435 mEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |||++|..+.           .    ....++...|+-||...
T Consensus       110 me~l~G~~~~-----------~----~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          110 LEALNKSKNK-----------Q----SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             EECCCCCCCC-----------T----THHHHHHHHHHHHHHCC
T ss_pred             EEeccCCCCC-----------c----hhHHHHHHHHHHHHcCC
Confidence            9999977541           1    24567888999999864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=93.96  E-value=0.049  Score=53.69  Aligned_cols=119  Identities=14%  Similarity=0.102  Sum_probs=75.6

Q ss_pred             eEEeEEe-ccCCcEEEEEEEEC--C----CCcEEEEEEeecCCC-CCCcHHHHHHHHHHHHHHhhCC-C--CCeeeeeeE
Q 011617          356 WQKGKLI-GRGTFGSVYIGTNR--E----TGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLK-H--ENIVQYYGS  424 (481)
Q Consensus       356 Y~i~k~I-G~GtFG~VYla~dk--~----tg~~VAIK~Ik~~~~-d~~s~e~~k~l~~EI~iL~~L~-H--PNIVqL~g~  424 (481)
                      ....+.| +.|..+.+|+....  .    .+..+++|....... ....   ...+..|+.+|+.|. +  -.|.+++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3445778 88999999988643  1    155688887542110 0000   124566888887774 2  356778777


Q ss_pred             EEeC---CEEEEEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          425 EVVD---DHLYIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       425 f~~~---d~lyLVmEy~~GGSL~~lL~~~~-----~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      +.+.   +..|+||||++|..+.+.+....     ..++..+...++.+++..|.-||...
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~  159 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIP  159 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             ccCCCccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            6554   34689999999877754321100     13566667788999999999999753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=92.91  E-value=0.66  Score=44.38  Aligned_cols=99  Identities=17%  Similarity=0.077  Sum_probs=63.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC---CCeeeeeeEEEeCCE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEVVDDH  430 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H---PNIVqL~g~f~~~d~  430 (481)
                      .+..-.+.+|.|..+.||+... .+|+.|.+|+....  ....   ...+..|...|+.|..   --+.+++++  +.  
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--   84 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--   84 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--Ccch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence            3566788899999999999985 46888999975321  1111   1246678888887742   234555543  22  


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      -++||||++++..           ....    ..++...|.-||...
T Consensus        85 ~~lv~e~l~~~~~-----------~~~~----~~~lg~~La~lH~~~  116 (288)
T 3f7w_A           85 RTLAMEWVDERPP-----------TPEA----AERFGHQLAAMHLAG  116 (288)
T ss_dssp             TEEEEECCCCCCC-----------CHHH----HHHHHHHHHHHHHTC
T ss_pred             ceEEEEeecccCC-----------ChHH----HHHHHHHHHhhhhcc
Confidence            3789999975432           2222    234567778888753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=90.00  E-value=1.3  Score=42.51  Aligned_cols=95  Identities=15%  Similarity=0.178  Sum_probs=52.3

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC--CCCeeeeee------EEEeCC
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYG------SEVVDD  429 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~--HPNIVqL~g------~f~~~d  429 (481)
                      ..+.|+.|..+.||++...  +..+++|+...      ..   ..+..|+.+++.|.  .-.|.+++.      +....+
T Consensus        36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~------~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~  104 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHR------PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS  104 (346)
T ss_dssp             EEEECC----CEEEEEEET--TEEEEEEEECS------CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred             EeeeccccccCcEEEEEeC--CCCEEEEecCC------CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence            3456676788999998753  33588998752      12   22334455555442  113344442      224567


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS  475 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs  475 (481)
                      ..|++|||++|..+..        ...    ..+.+++..|+-||.
T Consensus       105 ~~~~l~~~i~G~~~~~--------~~~----~~~~~~g~~La~lH~  138 (346)
T 2q83_A          105 FLFVVYDWIEGRPFEL--------TVK----QDLEFIMKGLADFHT  138 (346)
T ss_dssp             EEEEEEECCCCBCCCT--------TSH----HHHHHHHHHHHHHHH
T ss_pred             EEEEEEEeecCccCCC--------CCH----HHHHHHHHHHHHHHH
Confidence            8899999999765520        111    124666777777775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.22  E-value=0.065  Score=56.29  Aligned_cols=57  Identities=7%  Similarity=0.019  Sum_probs=14.0

Q ss_pred             cEEEEEEEECCCCcEEEE------EEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          367 FGSVYIGTNRETGASCAI------KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       367 FG~VYla~dk~tg~~VAI------K~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ||.||+|.+......||+      |.++   .+....+....+.+|..+++.++|+|+++.+++..
T Consensus       152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~---~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          152 YTTLNREPAYKKHMPVLKETHDERDSTG---QDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             BCCC---------CCBGGGC--------------------------------------CBCCCEEE
T ss_pred             chhhhcccccccCCchhhhhccCccccc---cccccccccccccccccccccccccccCCCcceEE
Confidence            999999998765456888      6543   22223344456778888999999999999988754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=82.92  E-value=2.6  Score=42.74  Aligned_cols=108  Identities=17%  Similarity=0.178  Sum_probs=60.0

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecC----CCC-CCcHHHHHHHHHHHHHHh-hCCCCCeeeeeeEEEeCCEE
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDII----PDD-PKSAECIKQLEQEIKVLG-HLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~----~~d-~~s~e~~k~l~~EI~iL~-~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..+.||.|..+.||++..  .+..++||.....    ... ..... ...++.|+..+. ......+.+++.+.  .+..
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~-~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~  112 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKE-RAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA  112 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTT-HHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchh-HHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence            357789999999999863  4677899943211    111 00000 112233333222 22234566777654  5667


Q ss_pred             EEEEecc-CCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          432 YIYLEYV-HPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       432 yLVmEy~-~GG-SL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      ++||||+ +|. .+...+... ... .    .++.+++..|+-||..
T Consensus       113 ~lv~e~l~~g~~~l~~~l~~~-~~~-~----~~~~~lg~~La~lH~~  153 (420)
T 2pyw_A          113 LIGMRYLEPPHIILRKGLIAG-IEY-P----FLADHMSDYMAKTLFF  153 (420)
T ss_dssp             EEEECCCCTTCEEHHHHHHHT-CCC-T----THHHHHHHHHHHHHHT
T ss_pred             EEEEeecCCcchhHHHHHhcC-CCC-H----HHHHHHHHHHHHHHHh
Confidence            9999999 873 554444331 111 1    2456677777777754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=80.94  E-value=8.7  Score=40.05  Aligned_cols=101  Identities=21%  Similarity=0.211  Sum_probs=62.6

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCe-eeeeeEEEeCCEEEEEEe
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLE  436 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNI-VqL~g~f~~~d~lyLVmE  436 (481)
                      ..+.|+.|-...+|++.....+..+.+|+.........+      ...|..+|..|...+| .++++.+  .+.  +|||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id------R~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e  181 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN------REREKKISCILYNKNIAKKIYVFF--TNG--RIEE  181 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC------HHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC------HHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEE
Confidence            456788888899999987644577888876421111111      2468888888865444 5777765  332  5999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       437 y~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      |++|..|..      ..+..   ..++.+|+..|+-||...
T Consensus       182 ~I~G~~l~~------~~l~~---~~~~~~ia~~La~LH~~~  213 (458)
T 2qg7_A          182 FMDGYALSR------EDIKN---PKFQKLIAKNLKLLHDIK  213 (458)
T ss_dssp             CCCSEECCT------TTTTS---HHHHHHHHHHHHHHHTCC
T ss_pred             eeCCccCCh------hhcCC---HHHHHHHHHHHHHHhcCC
Confidence            998655421      11211   245778889999999754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	481
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-29
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-29
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-29
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-28
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-28
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-26
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-26
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-25
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-25
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-24
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-23
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-23
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-23
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-22
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-21
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-20
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-20
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-20
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-20
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-20
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-20
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-20
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-19
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-13

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-33
 Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           W+    +G G FG VY   N+ET    A K +D      KS E ++    EI +L    H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 68

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+   +   +++L+I +E+   G+++  + E  R +TES ++   +  L+ L YLH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 476 TNTIHR 481
              IHR
Sbjct: 129 NKIIHR 134

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 7e-32
 Identities = 36/131 (27%), Positives = 64/131 (48%), Gaps = 5/131 (3%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
           P    W   + +G G +G V +  NR T  + A+K VD+     ++ +C + +++EI + 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 57

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
             L HEN+V++YG     +  Y++LEY   G +   +      + E   + F   ++ G+
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116

Query: 471 AYLHSTNTIHR 481
            YLH     HR
Sbjct: 117 VYLHGIGITHR 127

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 23/126 (18%), Positives = 52/126 (41%), Gaps = 5/126 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +   + +G G FG V+    + TG     K ++              ++ EI ++  L H
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHH 85

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
             ++  + +      + + LE++  G +   +      ++E+ V N+ R    GL ++H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 476 TNTIHR 481
            + +H 
Sbjct: 146 HSIVHL 151

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-29
 Identities = 33/131 (25%), Positives = 64/131 (48%), Gaps = 6/131 (4%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K   ++K   +G G  G V+  +++ +G   A K + +            Q+ +E++VL 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLH 59

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
                 IV +YG+   D  + I +E++  GS+++ +++  R I E I+   +  ++ GL 
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118

Query: 472 YLHSTNTI-HR 481
           YL   + I HR
Sbjct: 119 YLREKHKIMHR 129

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 3/128 (2%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             ++ G+ +G+G FG+VY+   +++    A+K +       + A    QL +E+++  HL
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 63

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
           +H NI++ YG       +Y+ LEY   G++ R ++       E     +   + N L+Y 
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 122

Query: 474 HSTNTIHR 481
           HS   IHR
Sbjct: 123 HSKRVIHR 130

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (285), Expect = 5e-29
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 3/129 (2%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           +  +   + IG G+FG+VY   +       AIK++       +S E  + + +E++ L  
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQK 71

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L+H N +QY G  + +   ++ +EY   GS +  +  H + + E  +   T   L GLAY
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 473 LHSTNTIHR 481
           LHS N IHR
Sbjct: 131 LHSHNMIHR 139

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 6e-29
 Identities = 26/126 (20%), Positives = 52/126 (41%), Gaps = 6/126 (4%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +   + +GRG FG V+      +  +   K V +   D         +++EI +L   +H
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NI+  + S    + L +  E++    I   +     ++ E  + ++   +   L +LHS
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 476 TNTIHR 481
            N  H 
Sbjct: 121 HNIGHF 126

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 7e-29
 Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 5/129 (3%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           +  +    ++G G F  V +  ++ T    AIK +     + K       +E EI VL  
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHK 63

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           +KH NIV          HLY+ ++ V  G +   + E     TE         +L+ + Y
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKY 122

Query: 473 LHSTNTIHR 481
           LH    +HR
Sbjct: 123 LHDLGIVHR 131

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 1e-28
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 11/143 (7%)

Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
           I+EK     S    K ++ + + IG+G  G+VY   +  TG   AI+++++     +   
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQP 59

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
             + +  EI V+   K+ NIV Y  S +V D L++ +EY+  GS+   V E C D  E  
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQ 117

Query: 459 VRNFTRHILNGLAYLHSTNTIHR 481
           +    R  L  L +LHS   IHR
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHR 140

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 29/140 (20%), Positives = 60/140 (42%), Gaps = 14/140 (10%)

Query: 342 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
           H+++          +   + +G G FG V+  T R TG + A K V             +
Sbjct: 23  HVLDH---------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKE 68

Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
            + +EI+ +  L+H  +V  + +   D+ + +  E++  G +   V +    ++E     
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128

Query: 462 FTRHILNGLAYLHSTNTIHR 481
           + R +  GL ++H  N +H 
Sbjct: 129 YMRQVCKGLCHMHENNYVHL 148

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-27
 Identities = 30/130 (23%), Positives = 55/130 (42%), Gaps = 7/130 (5%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
              Q   G+ IG G+FG+VY G         A+K   ++     + + ++  + E+ VL 
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLR 59

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
             +H NI+ + G       L I  ++    S+  ++           + +  R    G+ 
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 472 YLHSTNTIHR 481
           YLH+ + IHR
Sbjct: 119 YLHAKSIIHR 128

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-27
 Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 6/134 (4%)

Query: 351 PKK---SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
           P+K     ++ GK++G G+F +V +     T    AIK ++           +  + +E 
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRER 59

Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
            V+  L H   V+ Y +   D+ LY  L Y   G + +Y+R       E+  R +T  I+
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIV 118

Query: 468 NGLAYLHSTNTIHR 481
           + L YLH    IHR
Sbjct: 119 SALEYLHGKGIIHR 132

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 6e-27
 Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 3/134 (2%)

Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKV 409
           P +SQ+Q G L+G G FGSVY G         AIK V+     D        ++  E+ +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 410 LGHLK--HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
           L  +      +++        D   + LE   P             + E + R+F   +L
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 468 NGLAYLHSTNTIHR 481
             + + H+   +HR
Sbjct: 121 EAVRHCHNCGVLHR 134

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (271), Expect = 1e-26
 Identities = 30/127 (23%), Positives = 58/127 (45%), Gaps = 2/127 (1%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLK 414
           +   ++IGRG FG VY     +TG   A+K +D      K  E +   E   + ++    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
              IV    +    D L   L+ ++ G ++ ++ +H     E+ +R +   I+ GL ++H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMH 124

Query: 475 STNTIHR 481
           +   ++R
Sbjct: 125 NRFVVYR 131

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 7/128 (5%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+    + IG G FG V++G         AIK +       + A   +   +E +V+  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H  +VQ YG  +    + +  E++  G ++ Y+R          +      +  G+AYL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 474 HSTNTIHR 481
                IHR
Sbjct: 118 EEACVIHR 125

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 25/131 (19%), Positives = 47/131 (35%), Gaps = 7/131 (5%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++ G+++G G    V++  +       A+K +    D  +      +  +E +    L 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 65

Query: 415 HENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           H  IV  Y +   +       YI +EYV   ++   V      +T              L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124

Query: 471 AYLHSTNTIHR 481
            + H    IHR
Sbjct: 125 NFSHQNGIIHR 135

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  106 bits (265), Expect = 2e-26
 Identities = 30/132 (22%), Positives = 61/132 (46%), Gaps = 6/132 (4%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVL 410
            ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 411 GHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
             +  H NI+Q   +   +   ++  + +  G +  Y+ E    ++E   R   R +L  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122

Query: 470 LAYLHSTNTIHR 481
           +  LH  N +HR
Sbjct: 123 ICALHKLNIVHR 134

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-26
 Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 11/130 (8%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            + +  + IG+G FG V +G  R  G   A+K +       K+    +    E  V+  L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQL 57

Query: 414 KHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
           +H N+VQ  G  V +   LYI  EY+  GS+  Y+R   R  +    +  F+  +   + 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 472 YLHSTNTIHR 481
           YL   N +HR
Sbjct: 118 YLEGNNFVHR 127

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 28/128 (21%), Positives = 53/128 (41%), Gaps = 1/128 (0%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S  +  ++IG G FG V  G  +  G       +  +     + +  +    E  ++G  
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF 84

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H N++   G       + I  E++  GS++ ++R++    T   +    R I  G+ YL
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 474 HSTNTIHR 481
              N +HR
Sbjct: 145 ADMNYVHR 152

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 8/133 (6%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
           ++ + + G+ IG G FG V+ G          + AIK       D       ++  QE  
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEAL 60

Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
            +    H +IV+  G  + ++ ++I +E    G +  +++     +  + +  +   +  
Sbjct: 61  TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 469 GLAYLHSTNTIHR 481
            LAYL S   +HR
Sbjct: 120 ALAYLESKRFVHR 132

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 6/129 (4%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
            +  + +G G+FG V  G          S A+K +   PD     E +    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
           L H N+++ YG  V+   + +  E    GS+   +R+H        +  +   +  G+ Y
Sbjct: 68  LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 473 LHSTNTIHR 481
           L S   IHR
Sbjct: 127 LESKRFIHR 135

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-25
 Identities = 28/130 (21%), Positives = 58/130 (44%), Gaps = 9/130 (6%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           +   +  + +G G FG V++G         A+K +       + +        E  ++  
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK------QGSMSPDAFLAEANLMKQ 64

Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 471
           L+H+ +V+ Y   V  + +YI  EY+  GS+  +++      +T + + +    I  G+A
Sbjct: 65  LQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 472 YLHSTNTIHR 481
           ++   N IHR
Sbjct: 124 FIEERNYIHR 133

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 3e-25
 Identities = 27/122 (22%), Positives = 55/122 (45%), Gaps = 1/122 (0%)

Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
             +G G F +VY   ++ T    AIK++ +           +   +EIK+L  L H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
               +     ++ +  +++    +   ++++   +T S ++ +    L GL YLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 480 HR 481
           HR
Sbjct: 123 HR 124

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 4e-25
 Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 3/126 (2%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +QK + IG GT+G VY   N+ TG   A+K    I  D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 60

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
            NIV+       ++ LY+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 476 TNTIHR 481
              +HR
Sbjct: 121 HRVLHR 126

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 4e-25
 Identities = 27/124 (21%), Positives = 56/124 (45%), Gaps = 7/124 (5%)

Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
           K +G G FG+V  G  +  +   + A+K   I+ ++        +L  E  V+  L +  
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
           IV+  G     +   + +E    G +N+Y++++   + +  +      +  G+ YL  +N
Sbjct: 70  IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN 127

Query: 478 TIHR 481
            +HR
Sbjct: 128 FVHR 131

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 4e-25
 Identities = 31/127 (24%), Positives = 55/127 (43%), Gaps = 2/127 (1%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLK 414
           +  G+ +G G F  V     + TG   A K +        +     + +E+E+ +L  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H N++  +        + + LE V  G +  ++ E    +TE     F + ILNG+ YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH 130

Query: 475 STNTIHR 481
           S    H 
Sbjct: 131 SLQIAHF 137

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-25
 Identities = 27/127 (21%), Positives = 61/127 (48%), Gaps = 4/127 (3%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LK 414
           +   K++G+G+FG V++   ++T    AIK +    D     + ++    E +VL    +
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H  +   + +    ++L+  +EY++ G +  +++   +    S    +   I+ GL +LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 475 STNTIHR 481
           S   ++R
Sbjct: 121 SKGIVYR 127

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 8e-25
 Identities = 28/122 (22%), Positives = 51/122 (41%), Gaps = 7/122 (5%)

Query: 362 IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
           +G G FGSV  G  R        AIK +             +++ +E +++  L +  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
           +  G     + L + +E    G +++++     +I  S V      +  G+ YL   N +
Sbjct: 73  RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 480 HR 481
           HR
Sbjct: 132 HR 133

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 1/130 (0%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           K+++++K K++G G FG+VY G     G    I        +  S +  K++  E  V+ 
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
            + + ++ +  G   +   + +  + +  G +  YVREH  +I    + N+   I  G+ 
Sbjct: 67  SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 472 YLHSTNTIHR 481
           YL     +HR
Sbjct: 126 YLEDRRLVHR 135

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 37/170 (21%), Positives = 62/170 (36%), Gaps = 34/170 (20%)

Query: 342 HIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDI 389
           ++   P+  P   +W         GK +G G FG V   T       +   + A+K +  
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK- 62

Query: 390 IPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
                      + L  E+KVL +L  H NIV   G+  +     +  EY   G +  ++R
Sbjct: 63  ---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 449 EHCRD-----------------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
                                 +    + +F+  +  G+A+L S N IHR
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 33/128 (25%), Positives = 52/128 (40%), Gaps = 7/128 (5%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
                 K +G G FG V  G  R      AIK +       + +    +  +E KV+ +L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK------EGSMSEDEFIEEAKVMMNL 56

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            HE +VQ YG       ++I  EY+  G +  Y+RE         +    + +   + YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 474 HSTNTIHR 481
            S   +HR
Sbjct: 117 ESKQFLHR 124

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 8/133 (6%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
           ++ ++  + +G G +G+V    +  TGA  AIK    +    +S    K+  +E+++L H
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKH 73

Query: 413 LKHENIVQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           ++HEN++         E +DD    YL     G+    + +H + + E  ++     +L 
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLK 132

Query: 469 GLAYLHSTNTIHR 481
           GL Y+H+   IHR
Sbjct: 133 GLRYIHAAGIIHR 145

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 29/136 (21%), Positives = 52/136 (38%), Gaps = 13/136 (9%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++    IG G++G       +  G     K    +     +    + L  E+ +L  LKH
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGL 470
            NIV+YY    +  +  LYI +EY   G +   + +  ++   + E  V      +   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 471 AYLHSTNT-----IHR 481
              H  +      +HR
Sbjct: 123 KECHRRSDGGHTVLHR 138

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 31/131 (23%), Positives = 62/131 (47%), Gaps = 7/131 (5%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           +++       +G G +G VY G  ++   + A+K +       +    +++  +E  V+ 
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMK 68

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
            +KH N+VQ  G    +   YI  E++  G++  Y+RE  R +++  ++      I + +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 471 AYLHSTNTIHR 481
            YL   N IHR
Sbjct: 129 EYLEKKNFIHR 139

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 31/128 (24%), Positives = 54/128 (42%), Gaps = 9/128 (7%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++ G+ IG G+FG +Y+GT+   G   AIK   +    P       QL  E K+   ++
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQ 60

Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
               I          D+  + +E +   S+        R  +   V      +++ + Y+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 474 HSTNTIHR 481
           HS N IHR
Sbjct: 120 HSKNFIHR 127

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 8e-24
 Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 24/153 (15%)

Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLG 411
           +   + GK++G G FG V   T      +    +V + +  +   +   + L  E+K++ 
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----------------- 453
            L  HENIV   G+  +   +Y+  EY   G +  Y+R                      
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 454 -----ITESIVRNFTRHILNGLAYLHSTNTIHR 481
                +T   +  F   +  G+ +L   + +HR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 98.0 bits (243), Expect = 1e-23
 Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 5/127 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           ++   + IG GT+G VY   N   G + A+K    I  + +         +EI +L  LK
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKELK 58

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H NIV+ Y        L +  E++               +     ++F   +LNG+AY H
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117

Query: 475 STNTIHR 481
               +HR
Sbjct: 118 DRRVLHR 124

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 24/128 (18%), Positives = 57/128 (44%), Gaps = 3/128 (2%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
             +Q  + +G G+FG V++  +R  G   A+K +    +     + ++    E  +L  +
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 61

Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
            H  I++ +G+      +++ ++Y+  G     +    +     + + +   +   L YL
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 474 HSTNTIHR 481
           HS + I+R
Sbjct: 121 HSKDIIYR 128

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 35/129 (27%), Positives = 63/129 (48%), Gaps = 10/129 (7%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
              IGRG+F +VY G + ET    A      + D   +    ++ ++E ++L  L+H NI
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 419 VQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           V++Y S          + +  E +  G++  Y++     +   ++R++ R IL GL +LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129

Query: 475 STNT--IHR 481
           +     IHR
Sbjct: 130 TRTPPIIHR 138

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 2e-23
 Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 21/158 (13%)

Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
           S VT+ V      +    P++  +   K+IG G+FG VY     ++G   AIK    +  
Sbjct: 1   SKVTTVVA--TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQ 55

Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRY 446
           D       +   +E++++  L H NIV+        G +  + +L + L+YV P ++ R 
Sbjct: 56  DK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV 108

Query: 447 VREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHR 481
            R + R    +    V+ +   +   LAY+HS    HR
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 25/129 (19%), Positives = 47/129 (36%), Gaps = 16/129 (12%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417
            +++G G  G V    N+ T    A+K +              +  +E+++     +  +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPH 66

Query: 418 IVQYYG----SEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAY 472
           IV+              L I +E +  G +   +++      TE       + I   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 473 LHSTNTIHR 481
           LHS N  HR
Sbjct: 127 LHSINIAHR 135

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 3e-23
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 3/127 (2%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
            +   KL+G+GTFG V +   + TG   A+K +    +   + + +     E +VL + +
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H  +     +    D L   +EY + G +  ++       TE   R +   I++ L YLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122

Query: 475 STNTIHR 481
           S + ++R
Sbjct: 123 SRDVVYR 129

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 6e-23
 Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 10/132 (7%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
            ++     IG G +G V    +       AIK++             ++  +EIK+L   
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRF 63

Query: 414 KHENIVQYYG---SEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +HENI+       +  ++    +YL  ++    + + ++   + ++   +  F   IL G
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRG 121

Query: 470 LAYLHSTNTIHR 481
           L Y+HS N +HR
Sbjct: 122 LKYIHSANVLHR 133

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (237), Expect = 1e-22
 Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 4/127 (3%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
           +++K + IG GT+G+V+   NRET    A+K    +  D           +EI +L  LK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELK 59

Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           H+NIV+ +     D  L +  E+     + +Y      D+   IV++F   +L GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 475 STNTIHR 481
           S N +HR
Sbjct: 119 SRNVLHR 125

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-22
 Identities = 33/132 (25%), Positives = 58/132 (43%), Gaps = 8/132 (6%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKV 409
           S   + K+IG G FG VY G  + +        AIK +     +    +       E  +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGI 62

Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
           +G   H NI++  G       + I  EY+  G++++++RE   + +   +    R I  G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 470 LAYLHSTNTIHR 481
           + YL + N +HR
Sbjct: 123 MKYLANMNYVHR 134

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 5e-22
 Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 6/133 (4%)

Query: 355 QWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           Q++    IG G +G V+   + +  G   A+K V +   +        +    ++ L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 414 KHENIVQYYGSEVV-----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
           +H N+V+ +    V     +  L +  E+V         +     +    +++    +L 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 469 GLAYLHSTNTIHR 481
           GL +LHS   +HR
Sbjct: 128 GLDFLHSHRVVHR 140

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 93.3 bits (231), Expect = 7e-22
 Identities = 28/126 (22%), Positives = 53/126 (42%), Gaps = 7/126 (5%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           ++ G+ IG G+FG ++ GTN       AIK     P     A  ++   +  K+L     
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRR-SDAPQLRDEYRTYKLLAGCTG 62

Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
              V Y+G E    H  + ++ + P S+   +    R  +   V    + +L  +  +H 
Sbjct: 63  IPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 476 TNTIHR 481
            + ++R
Sbjct: 120 KSLVYR 125

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.1 bits (233), Expect = 1e-21
 Identities = 37/139 (26%), Positives = 68/139 (48%), Gaps = 4/139 (2%)

Query: 344 MEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
            E PS +  +  Q+ + K +G G+FG V +  ++E+G   A+K +D         + I+ 
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEH 87

Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
              E ++L  +    +V+   S   + +LY+ +EYV  G +  ++R   R  +E   R +
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFY 146

Query: 463 TRHILNGLAYLHSTNTIHR 481
              I+    YLHS + I+R
Sbjct: 147 AAQIVLTFEYLHSLDLIYR 165

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 1e-21
 Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 12/136 (8%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
           S+++K   IG+GTFG V+   +R+TG   A+K    +  + +         +EIK+L  L
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLL 66

Query: 414 KHENIVQYYGS--------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           KHEN+V                   +Y+  ++         +       T S ++   + 
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQM 125

Query: 466 ILNGLAYLHSTNTIHR 481
           +LNGL Y+H    +HR
Sbjct: 126 LLNGLYYIHRNKILHR 141

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 1e-21
 Identities = 29/131 (22%), Positives = 64/131 (48%), Gaps = 6/131 (4%)

Query: 355 QWQKGKLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
            ++  K++G G +G V++    +  +TG   A+K +       + A+  +    E +VL 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLE 83

Query: 412 HLKHE-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           H++    +V  + +   +  L++ L+Y++ G +  ++ +  R  TE  V+ +   I+  L
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLAL 142

Query: 471 AYLHSTNTIHR 481
            +LH    I+R
Sbjct: 143 EHLHKLGIIYR 153

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 2e-21
 Identities = 34/130 (26%), Positives = 63/130 (48%), Gaps = 10/130 (7%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           Q    +G G +GSV    + +TG   A+K    +    +S    K+  +E+++L H+KHE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 417 NIVQYYGS-----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
           N++           + + +    + ++    +N  V+  C+ +T+  V+     IL GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135

Query: 472 YLHSTNTIHR 481
           Y+HS + IHR
Sbjct: 136 YIHSADIIHR 145

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (224), Expect = 1e-20
 Identities = 25/131 (19%), Positives = 49/131 (37%), Gaps = 13/131 (9%)

Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
           Q  K IG G  G V    +     + AIK    +    ++    K+  +E+ ++  + H+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 417 NIVQYYGSEVVDD------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
           NI+                 +Y+ +E +         +    ++    +      +L G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGI 132

Query: 471 AYLHSTNTIHR 481
            +LHS   IHR
Sbjct: 133 KHLHSAGIIHR 143

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 1e-20
 Identities = 32/146 (21%), Positives = 59/146 (40%), Gaps = 22/146 (15%)

Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
           +  +   +IG G FG V     ++ G     AIK +     +  S +  +    E++VL 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLC 65

Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------IT 455
            L  H NI+   G+     +LY+ +EY   G++  ++R+                   ++
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHR 481
              + +F   +  G+ YL     IHR
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHR 151

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.4 bits (221), Expect = 1e-20
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 9/131 (6%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
            +   +    +G+G FG V++GT   T    AIK +             +   QE +V+ 
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK------PGTMSPEAFLQEAQVMK 67

Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGL 470
            L+HE +VQ Y   V ++ +YI  EY+  GS+  +++ E  + +    + +    I +G+
Sbjct: 68  KLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 471 AYLHSTNTIHR 481
           AY+   N +HR
Sbjct: 127 AYVERMNYVHR 137

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 2e-20
 Identities = 36/152 (23%), Positives = 63/152 (41%), Gaps = 11/152 (7%)

Query: 337 SAVMPHIMEKPSA---SPKKSQWQKGKLIGRGTFGSVYIGT---NRETGASCAIKEVDII 390
           SA+ P +++        P        ++IGRG FG VY GT   N      CA+K ++ I
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVRE 449
            D       + Q   E  ++    H N++   G  +  +    + L Y+  G +  ++R 
Sbjct: 67  TDI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122

Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
              + T   +  F   +  G+ +L S   +HR
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 89.1 bits (220), Expect = 2e-20
 Identities = 31/166 (18%), Positives = 59/166 (35%), Gaps = 37/166 (22%)

Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE 398
           +E P     ++  +  + IG G FG V+          E     A+K +     +  SA+
Sbjct: 8   LEYP-----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASAD 58

Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----- 453
                ++E  ++    + NIV+  G   V   + +  EY+  G +N ++R          
Sbjct: 59  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 454 ------------------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
                             ++ +      R +  G+AYL     +HR
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 6e-20
 Identities = 32/161 (19%), Positives = 61/161 (37%), Gaps = 34/161 (21%)

Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS 396
           P+  +W         GK +G G FG V +                 A+K +        +
Sbjct: 3   PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDAT 58

Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-- 453
            + +  L  E++++  + KH+NI+   G+   D  LY+ +EY   G++  Y++       
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 454 -------------ITESIVRNFTRHILNGLAYLHSTNTIHR 481
                        ++   + +    +  G+ YL S   IHR
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 88.0 bits (217), Expect = 7e-20
 Identities = 28/129 (21%), Positives = 55/129 (42%), Gaps = 15/129 (11%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
           +Q  + +GRG +  V+   N        +K +             K++++EIK+L +L+ 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 415 HENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
             NI+       + V     +  E+V+        ++  + +T+  +R +   IL  L Y
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDY 144

Query: 473 LHSTNTIHR 481
            HS   +HR
Sbjct: 145 CHSMGIMHR 153

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 1e-19
 Identities = 26/140 (18%), Positives = 52/140 (37%), Gaps = 10/140 (7%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
            + +    + +G+G+FG VY G  +          V I   ++  S     +   E  V+
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRN 461
                 ++V+  G         + +E +  G +  Y+R               + S +  
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 462 FTRHILNGLAYLHSTNTIHR 481
               I +G+AYL++   +HR
Sbjct: 138 MAGEIADGMAYLNANKFVHR 157

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (206), Expect = 2e-18
 Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 22/135 (16%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
            + IG+G FG V+ G  +  G   A+K            E     E EI     L+HENI
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFS------SREERSWFREAEIYQTVMLRHENI 59

Query: 419 VQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
           + +  ++  D+     L++  +Y   GS+  Y+  +   +T   +        +GLA+LH
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117

Query: 475 S--------TNTIHR 481
                        HR
Sbjct: 118 MEIVGTQGKPAIAHR 132

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 6e-17
 Identities = 28/148 (18%), Positives = 57/148 (38%), Gaps = 18/148 (12%)

Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
            + + + GK +GRG FG V          +   + V + +  +  +    + L  E+K+L
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 411 GHLKHENIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD--------------- 453
            H+ H   V             L + +E+   G+++ Y+R    +               
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHR 481
           +T   +  ++  +  G+ +L S   IHR
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHR 158

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.6 bits (172), Expect = 9e-15
 Identities = 23/136 (16%), Positives = 45/136 (33%), Gaps = 26/136 (19%)

Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD-------------IIPDDPKSAECIKQLEQ 405
           GKL+G G   +V+   + E    C +K                   D   S   I+    
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
           E + L  L+   + + Y     + +  + +E +    + R   E+  ++           
Sbjct: 64  EFRALQKLQGLAVPKVYA---WEGN-AVLMELIDAKELYRVRVENPDEV--------LDM 111

Query: 466 ILNGLAYLHSTNTIHR 481
           IL  +A  +    +H 
Sbjct: 112 ILEEVAKFYHRGIVHG 127

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.9 bits (167), Expect = 2e-13
 Identities = 22/142 (15%), Positives = 50/142 (35%), Gaps = 22/142 (15%)

Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
           +   + +G G F +V++  +       A+K V             +  E EIK+L  +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVND 68

Query: 416 ENIVQ-------------YYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVR 460
            +  +              + +    + +++ + +   G     +  +   R I    V+
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 461 NFTRHILNGLAYL-HSTNTIHR 481
             ++ +L GL Y+      IH 
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHT 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	481
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.93
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.93
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.93
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.92
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.92
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.92
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.92
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.92
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.92
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.92
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.92
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.92
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.92
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.92
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.92
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.91
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.91
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.91
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.91
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.91
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.9
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.9
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.9
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.9
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.89
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.89
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.89
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.89
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.89
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.89
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.89
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.89
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.89
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.88
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.88
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.88
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.88
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.88
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.88
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.88
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.87
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.87
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.87
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.87
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.87
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.87
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.87
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.87
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.86
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.86
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.86
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.86
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.86
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.85
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.85
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.84
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.84
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.84
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.84
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.83
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.81
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.7
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.06
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	89.59

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.5e-26  Score=221.36  Aligned_cols=129  Identities=24%  Similarity=0.402  Sum_probs=115.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC-CcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH  430 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~-~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~  430 (481)
                      ..++|++++.||+|+||+||+|.++.+|+.||||+++...... ......+.+.+|+.+|++++|||||+++++|.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3467999999999999999999999999999999997543222 222234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||||+||+|.++|... +.+++..++.|+.||+.||+|||++|||||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHr  137 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHF  137 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeec
Confidence            99999999999999999875 689999999999999999999999999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.6e-26  Score=224.53  Aligned_cols=123  Identities=20%  Similarity=0.290  Sum_probs=112.6

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||+++..      ......+.+|+++|+.++|||||+++++|.+++.+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999999999999999999632      122345788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.++|......+++.+++.|+.||+.||+|||++|||||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHr  126 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF  126 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence            9999999999999997765679999999999999999999999999998

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.8e-26  Score=222.83  Aligned_cols=125  Identities=28%  Similarity=0.560  Sum_probs=111.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|+++++||+|+||+||+|.++.+|+.||||+++...    ..+..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            3568999999999999999999999999999999997432    223345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++|+. .+.+++..++.|+.||+.||+|||++|||||
T Consensus        79 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHr  127 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR  127 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            999999999999999965 4789999999999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-25  Score=220.76  Aligned_cols=124  Identities=31%  Similarity=0.520  Sum_probs=113.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .+.|++++.||+|+||.||+|.++.+|+.||||+++...     ....+.+.+|+++|++++|||||++++++.+++.+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            357999999999999999999999999999999987421     223456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHr  134 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR  134 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEe
Confidence            9999999999999987766789999999999999999999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.92  E-value=5.5e-25  Score=214.96  Aligned_cols=128  Identities=22%  Similarity=0.385  Sum_probs=115.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCc----HHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEe
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLK-HENIVQYYGSEVV  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s----~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~  427 (481)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++........    ....+.+.+|+.+|++|. |+|||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999999999999999999865443333    223456788999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|||||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHr  134 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHR  134 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence            99999999999999999999875 789999999999999999999999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-25  Score=218.28  Aligned_cols=126  Identities=28%  Similarity=0.509  Sum_probs=112.4

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+++.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            3579999999999999999999999999999999863210  01112356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHr  130 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHR  130 (263)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             EEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeee
Confidence            999999999999999875 779999999999999999999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.92  E-value=3e-25  Score=223.95  Aligned_cols=124  Identities=23%  Similarity=0.364  Sum_probs=113.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||++..     ......+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc-----cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4589999999999999999999999999999999863     22344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHr  148 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  148 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeee
Confidence            9999999999999996655779999999999999999999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-25  Score=219.93  Aligned_cols=123  Identities=32%  Similarity=0.531  Sum_probs=111.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.++||+|+||.||+|.++.+|+.||||+++....  ..   .+.+.+|+.+|++++|||||+++++|.+++.+
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   92 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence            34689999999999999999999999999999999975322  12   25678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.+++..  +.+++..++.|+.||+.||+|||++|||||
T Consensus        93 ~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHr  140 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (293)
T ss_dssp             EEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999999998865  569999999999999999999999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.92  E-value=3.8e-25  Score=223.40  Aligned_cols=124  Identities=19%  Similarity=0.288  Sum_probs=113.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||+++..     .....+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35799999999999999999999999999999998732     2233467889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.+++......+++.+++.|+.||+.||+|||++|||||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHR  151 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL  151 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999999999887665679999999999999999999999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=6.7e-25  Score=217.70  Aligned_cols=125  Identities=29%  Similarity=0.482  Sum_probs=113.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ..|++.+.||+|+||.||+|.+..+|+.||||+++..  .....+..+.+.+|+.+|++|+|||||++++++.+++.+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--SSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--hccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            4699999999999999999999999999999998742  23345566789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||.+|+|..++.. .+.+++..++.|+.||+.||.|||++|||||
T Consensus        93 v~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHr  139 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  139 (309)
T ss_dssp             EEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            9999999998777655 4789999999999999999999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.92  E-value=2e-25  Score=218.78  Aligned_cols=128  Identities=23%  Similarity=0.435  Sum_probs=114.4

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      .++...++|+++++||+|+||.||+|.++.+++.||||+++..   ...   .+++.+|+.+|++++|||||+++++|.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            3455667899999999999999999999999999999998632   222   3568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr  139 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR  139 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            99999999999999999999763 4678999999999999999999999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=2.6e-25  Score=220.24  Aligned_cols=125  Identities=26%  Similarity=0.365  Sum_probs=109.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..+.|+++++||+|+||+||+|+++.+|+.||||++......    ...+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            356799999999999999999999999999999999743221    1235678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++|.. .+.+++..++.|+.||+.||+|||++|||||
T Consensus        83 ~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr  131 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHR  131 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeE
Confidence            999999999999999976 4789999999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.3e-25  Score=220.06  Aligned_cols=125  Identities=25%  Similarity=0.425  Sum_probs=113.4

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      ..++|++.++||+|+||.||+|.++.+|+.||||+++...    .....+++.+|+.+|++++|||||+++++|.+++.+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4568999999999999999999999999999999997432    123346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      |||||||+||+|.+++... +.+++..++.|+.||+.||.|||+ +|||||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHR  129 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHR  129 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS
T ss_pred             EEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence            9999999999999999875 779999999999999999999997 599998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.2e-25  Score=219.17  Aligned_cols=125  Identities=28%  Similarity=0.476  Sum_probs=112.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|+++++||+|+||+||+|.++.+|+.||||+++....  ......+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            469999999999999999999999999999999863210  011123568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHr  132 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR  132 (288)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcC
Confidence            99999999999999875 789999999999999999999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.92  E-value=1.2e-24  Score=210.47  Aligned_cols=126  Identities=19%  Similarity=0.310  Sum_probs=113.7

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC---
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d---  429 (481)
                      .++|++.+.||+|+||.||+|.++.+|+.||||+++..  ...+.+..+.+.+|+.+|+.++|||||++++++...+   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            46799999999999999999999999999999998742  2345566778999999999999999999999998754   


Q ss_pred             -EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 -~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .+|||||||+|++|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHr  135 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHR  135 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCc
Confidence             489999999999999999775 789999999999999999999999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=9.7e-25  Score=219.34  Aligned_cols=126  Identities=25%  Similarity=0.354  Sum_probs=113.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|+++++||+|+||.||+|+++.+|+.||||+++....  ......+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            4579999999999999999999999999999999973210  01112466788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||+||+|.+++... +.++|..++.|+.||+.||+|||++|||||
T Consensus        82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHR  129 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             cceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCcccc
Confidence            999999999999999875 789999999999999999999999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.7e-24  Score=207.59  Aligned_cols=123  Identities=28%  Similarity=0.492  Sum_probs=109.6

Q ss_pred             CeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----CCE
Q 011617          355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDH  430 (481)
Q Consensus       355 ~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----~d~  430 (481)
                      .|++.++||+|+||.||+|.+..+++.||+|++....   ......+.+.+|+++|++++|||||+++++|..    ++.
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            3478889999999999999999999999999987432   234456778999999999999999999999875    456


Q ss_pred             EEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccC
Q 011617          431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHR  481 (481)
Q Consensus       431 lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg--IIHR  481 (481)
                      +|||||||++|+|.+++... ..+++..++.|+.||+.||+|||+++  ||||
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr  138 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR  138 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred             EEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence            99999999999999999875 77999999999999999999999998  9998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.91  E-value=2.3e-24  Score=212.20  Aligned_cols=127  Identities=24%  Similarity=0.402  Sum_probs=111.1

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECCCCc---EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~---~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...++|++.++||+|+||+||+|.++.+++   .||||.+..    .......+.+.+|+.+|++++|||||+++|++..
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            345689999999999999999999987665   478887652    2344556789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+|||||||++|+|.+++....+.+++..+..|+.||+.||+|||+++||||
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHr  152 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR  152 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccC
Confidence            999999999999999999998766789999999999999999999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.9e-24  Score=207.85  Aligned_cols=125  Identities=25%  Similarity=0.395  Sum_probs=106.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe--CCEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHL  431 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~--~d~l  431 (481)
                      ++|++.+.||+|+||.||+|+++.+|+.||||+++...   ......+.+.+|+++|++++|||||++++++.+  ++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            57999999999999999999999999999999986432   234556778999999999999999999999865  4569


Q ss_pred             EEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccC
Q 011617          432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTN-----TIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~---~~~~Lse~~I~~I~~QIl~GL~YLHskg-----IIHR  481 (481)
                      |||||||+||+|.+++..   ....+++..++.|+.||+.||+|||++|     ||||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr  138 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR  138 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC
Confidence            999999999999999864   2467999999999999999999999976     9998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.5e-24  Score=209.65  Aligned_cols=124  Identities=28%  Similarity=0.547  Sum_probs=106.4

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|+++++||+|+||.||+|+++.+|+.||||+++...   ......+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            58999999999999999999999999999999996432   122234678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~-~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||. +.+..++. .....+++..++.|+.||+.||+|||++|||||
T Consensus        79 v~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHr  126 (298)
T d1gz8a_          79 VFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR  126 (298)
T ss_dssp             EEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEcc
Confidence            999996 55555554 445679999999999999999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.1e-24  Score=206.11  Aligned_cols=122  Identities=25%  Similarity=0.399  Sum_probs=109.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|+++++||+|+||.||+|.+. +++.||||+++..   ....   +++.+|+++|++++|||||+++|++..++.+|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            358999999999999999999986 4678999998632   2222   46788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++|+|.+++......+++..+..|+.||+.||+|||+++||||
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr  125 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  125 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeec
Confidence            9999999999999998766779999999999999999999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.1e-24  Score=212.78  Aligned_cols=125  Identities=21%  Similarity=0.366  Sum_probs=108.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHh-hCCCCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~-~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....  ...+..+.+..|+.++. .++|||||++++++.+++.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            579999999999999999999999999999999963110  00112344556666655 689999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++|+|.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        80 ivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHr  127 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYR  127 (320)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             EEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999875 779999999999999999999999999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.90  E-value=2.6e-24  Score=213.87  Aligned_cols=125  Identities=20%  Similarity=0.390  Sum_probs=111.7

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++....  ......+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            579999999999999999999999999999999963210  011124578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||+||+|..++.. ...+.+..++.|+.||+.||+|||++|||||
T Consensus        82 vmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHr  128 (316)
T d1fota_          82 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYR  128 (316)
T ss_dssp             EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEcc
Confidence            9999999999999977 4779999999999999999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.6e-24  Score=208.05  Aligned_cols=126  Identities=24%  Similarity=0.410  Sum_probs=109.5

Q ss_pred             CCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       349 ~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ++...++|+++++||+|+||.||+|++.   ..||||+++....+   .+..+.+.+|+.+|++++|||||++++++ .+
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~   75 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   75 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEE-ec
Confidence            3456778999999999999999999854   35999998754322   33457888999999999999999999986 45


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||++|+|.+++......+++..+..|+.||+.||+|||+++||||
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHr  128 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR  128 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEecc
Confidence            67899999999999999998766789999999999999999999999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.2e-24  Score=210.63  Aligned_cols=123  Identities=23%  Similarity=0.363  Sum_probs=102.0

Q ss_pred             EeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEEEEec
Q 011617          358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       358 i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      ++++||+|+||+||+|.++.+|+.||||+++............+.+.+|+.+|++++|+|||+++++|..++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999875332222223345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |.++++..++ .....+++..++.|++||+.||+|||++|||||
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHr  124 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR  124 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecc
Confidence            9877666555 445779999999999999999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.2e-23  Score=204.33  Aligned_cols=125  Identities=23%  Similarity=0.386  Sum_probs=107.5

Q ss_pred             CCCCeEEeEE-eccCCcEEEEEEEECCC--CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKL-IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~-IG~GtFG~VYla~dk~t--g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ...+|.+.+. ||+|+||.||+|.++.+  +..||||+++..    ......+.+.+|+++|++++|||||+++|++.. 
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            3457888885 99999999999987643  457999998632    344556789999999999999999999999864 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||++|+|.+++......+++..+..|+.||+.||+|||++|||||
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHr  133 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR  133 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            56899999999999999987656789999999999999999999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=1.7e-23  Score=211.81  Aligned_cols=128  Identities=21%  Similarity=0.267  Sum_probs=110.0

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCC-CCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~-d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~l  431 (481)
                      .++|+++++||+|+||.||+|+++.+|+.||||++..... ............+|+.+|+.++|||||+++++|.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            4689999999999999999999999999999999863210 011222233334567888889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |||||||+||+|.++|... ..+.+..++.|+.||+.||+|||++|||||
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHr  131 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYR  131 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccce
Confidence            9999999999999999875 779999999999999999999999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=7.8e-24  Score=204.50  Aligned_cols=121  Identities=28%  Similarity=0.428  Sum_probs=109.5

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|+++++||+|+||.||+|+++ ++..||||+++...   ...   +.+.+|+.+|.+++|||||+++|++.+++.+|+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            57899999999999999999985 67789999997422   222   467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+++|+|.+++......+.+..+..|+.||+.||+|||++||+||
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~  124 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR  124 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCS
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence            999999999999987766889999999999999999999999999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.89  E-value=1.2e-23  Score=211.89  Aligned_cols=126  Identities=26%  Similarity=0.373  Sum_probs=112.6

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.....  ......+.+.+|+++|+.++|||||++++++...+.+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            4689999999999999999999999999999999863110  01122456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +||||+.||+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus       118 ~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHR  165 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            999999999999999775 789999999999999999999999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.4e-23  Score=200.09  Aligned_cols=127  Identities=22%  Similarity=0.368  Sum_probs=110.1

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCC---cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg---~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      +...++|+++++||+|+||.||+|.+..++   ..||||.++.    .......+.+.+|+.+|++++|||||+++|++.
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345578999999999999999999987543   4588888753    233455677899999999999999999999985


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ++.+|||||||++|+|.+++....+.+++..++.|+.||+.||.|||+++||||
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHr  132 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR  132 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeecc
Confidence             577999999999999999988776789999999999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.4e-23  Score=198.75  Aligned_cols=124  Identities=31%  Similarity=0.463  Sum_probs=112.8

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...   ......+++.+|+.+|++++|+|||++++++...+.++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            58999999999999999999999999999999997533   223456788899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||+.+++|..++.. .+.+.+..++.++.|++.||+|||++|||||
T Consensus        79 v~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHr  125 (292)
T d1unla_          79 VFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR  125 (292)
T ss_dssp             EEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             Eeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeee
Confidence            9999998888887765 5789999999999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=8e-23  Score=198.96  Aligned_cols=126  Identities=26%  Similarity=0.443  Sum_probs=111.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCC----cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg----~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~  427 (481)
                      ...+|++.++||+|+||.||+|.++.++    ..||||+++..    ........+.+|+.+|++++|+|||+++|++..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc----cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            4468999999999999999999987654    36999998632    233445678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+++|||||.+|++.+++......+++..+..|+.||+.||+|||+++||||
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHr  134 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR  134 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccC
Confidence            999999999999999999998777889999999999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.9e-23  Score=202.55  Aligned_cols=127  Identities=22%  Similarity=0.414  Sum_probs=108.0

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ..++....+|++++.||+|+||.||+|.++ ++..||||+++..   ...   .+.+.+|+.+|.+++|+|||+++|++.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMS---PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCC---HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            344556679999999999999999999976 5678999998632   122   246889999999999999999999764


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ++.+|||||||++|+|.+++... ...+++..+..|+.||+.||.|||+++||||
T Consensus        79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHr  133 (272)
T d1qpca_          79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR  133 (272)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             56789999999999999987542 2469999999999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6e-23  Score=199.97  Aligned_cols=121  Identities=22%  Similarity=0.395  Sum_probs=101.6

Q ss_pred             eEEe-EEeccCCcEEEEEEEECC--CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEE
Q 011617          356 WQKG-KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       356 Y~i~-k~IG~GtFG~VYla~dk~--tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~ly  432 (481)
                      +.+. ++||+|+||.||+|.+..  +++.||||+++...   .+....+.+.+|+++|++++|||||+++|++.. +..|
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~   83 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM   83 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEE
Confidence            3443 579999999999998753  45789999986422   223445678999999999999999999999864 5678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||||||++|+|.++++.. ..+++..+..|+.||+.||+|||+++||||
T Consensus        84 lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr  131 (277)
T d1xbba_          84 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHR  131 (277)
T ss_dssp             EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence            999999999999999874 779999999999999999999999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=4.2e-23  Score=204.97  Aligned_cols=128  Identities=25%  Similarity=0.427  Sum_probs=107.0

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCc-----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeee
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG  423 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~-----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g  423 (481)
                      +...++|+++++||+|+||+||+|.+..+++     .||+|.+....    .......+.+|+.+|.++ +|||||++++
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            3455789999999999999999999876543     58999885322    223345678899999988 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          424 SEVVDDHLYIYLEYVHPGSINRYVREHC----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       424 ~f~~~d~lyLVmEy~~GGSL~~lL~~~~----------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.+.+.+|||||||++|+|.++|+...                      ..+++..++.|+.||+.||+|||+++||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999997642                      247899999999999999999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=4.8e-23  Score=206.21  Aligned_cols=119  Identities=21%  Similarity=0.288  Sum_probs=104.1

Q ss_pred             CCCeEEe-EEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhh-CCCCCeeeeeeEEEe---
Q 011617          353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV---  427 (481)
Q Consensus       353 ~~~Y~i~-k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~-L~HPNIVqL~g~f~~---  427 (481)
                      .++|++. ++||+|+||.||+|.++.+++.||||+++.      .    +.+.+|+.++.+ ++|||||+++++|.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------c----HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            4689876 569999999999999999999999999862      1    356679988654 589999999999876   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 -~d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ++.+|||||||+||+|.++|+..+ ..+++.+++.|+.||+.||+|||++|||||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHR  135 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR  135 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence             466999999999999999998643 469999999999999999999999999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.3e-23  Score=201.81  Aligned_cols=129  Identities=24%  Similarity=0.376  Sum_probs=110.2

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCC-CcHHHHHHHHHHHHHHhhCC--CCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~-~s~e~~k~l~~EI~iL~~L~--HPNIVqL~g~f~~~  428 (481)
                      ..++|+++++||+|+||.||+|.++.+|+.||||+++...... ......+++.+|+.+|++++  |+|||+++++|.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            3568999999999999999999999999999999997432111 11111234567999999986  89999999999999


Q ss_pred             CEEEEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~G-GSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|+||||+.+ +++.+++... +.+++..++.|+.||+.||+|||++|||||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHr  134 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHR  134 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            999999999986 5888888775 789999999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.3e-22  Score=199.93  Aligned_cols=126  Identities=25%  Similarity=0.464  Sum_probs=107.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcE--EEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~--VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~f~~~  428 (481)
                      ..++|+++++||+|+||.||+|.++.+|..  ||||.++...    ..+..+.+.+|+++|.++ +|+|||+++|++.++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            446899999999999999999999888875  6777765321    223345788999999998 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~---------------~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|||||||++|+|.++|+..               ...+++..+..|+.||+.||.|||+++||||
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHr  151 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR  151 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccc
Confidence            9999999999999999999743               2568999999999999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.88  E-value=6.7e-23  Score=198.46  Aligned_cols=123  Identities=26%  Similarity=0.423  Sum_probs=107.2

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCCEEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d~lyL  433 (481)
                      ++|++.++||+|+||.||+|+++ +|+.||||+++....   .....+.+.+|+.+|++++|+|||+++++|..++.+||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            58999999999999999999986 689999999965322   12224578889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       434 VmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||+.++.+..+. ...+.+++..++.|+.||+.||+|||++|||||
T Consensus        78 ~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHr  124 (286)
T d1ob3a_          78 VFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (286)
T ss_dssp             EEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEec
Confidence            99999766665555 445889999999999999999999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=8.5e-23  Score=200.24  Aligned_cols=127  Identities=27%  Similarity=0.457  Sum_probs=108.7

Q ss_pred             CCCCCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       347 ~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      .+++...++|++++.||+|+||+||+|.++.+ +.||||+++...   ..   .+.+.+|+.+|++++|+|||+++|++.
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~   82 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVS   82 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CC---HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence            34455667899999999999999999998765 569999986322   22   246888999999999999999999974


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~-~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       ++.+|||||||++|+|..++... ...+++..+..|+.||+.||+|||++|||||
T Consensus        83 -~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~  137 (285)
T d1fmka3          83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  137 (285)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             -cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecc
Confidence             56789999999999999988643 3569999999999999999999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2e-22  Score=199.19  Aligned_cols=124  Identities=27%  Similarity=0.469  Sum_probs=104.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCc----EEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~----~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ..+|+++++||+|+||+||+|.+..+|+    .||+|+++..    ...+..+.+.+|+++|++++|||||+++|++.+ 
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-   82 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-   82 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4579999999999999999999988876    4777877522    122234678899999999999999999999876 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +..+++|||+.+|+|.+++......+++..++.|+.||+.||+|||++|||||
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr  135 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR  135 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence            45678889999999999998877889999999999999999999999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.6e-22  Score=201.22  Aligned_cols=124  Identities=23%  Similarity=0.484  Sum_probs=104.3

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--  429 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d--  429 (481)
                      ...+|+++++||+|+||.||+|.++.+|+.||||+++..   .......+.+.+|+.+|++++|+|||+++++|...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            457899999999999999999999999999999998632   234556678899999999999999999999998654  


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 ----~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          .+||||||| +.+|..+++.  +.+++..++.|+.||+.||+|||++|||||
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHr  145 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR  145 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence                579999999 6788888754  679999999999999999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.9e-22  Score=197.76  Aligned_cols=132  Identities=23%  Similarity=0.463  Sum_probs=107.3

Q ss_pred             CCCCCCCCCCeEEeEEeccCCcEEEEEEEECCCC-------cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCC
Q 011617          346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN  417 (481)
Q Consensus       346 ~~~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg-------~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPN  417 (481)
                      ++.+....++|++++.||+|+||.||+|++..++       ..||||+++.    .........+.+|+.++.++ +|+|
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT----TCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc----ccChHHHHHHHHHHHHHHHhcCCCe
Confidence            3445667789999999999999999999876544       3699998863    22344556788888888887 7999


Q ss_pred             eeeeeeEEEeCCEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       418 IVqL~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ||+++++|.+++.+|+|||||++|+|.++|....               ..+++..++.|+.||+.||+|||+++||||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr  159 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  159 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence            9999999999999999999999999999997542               358999999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=3.1e-22  Score=197.28  Aligned_cols=130  Identities=26%  Similarity=0.386  Sum_probs=112.5

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY  421 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL  421 (481)
                      .++....+|+++++||+|+||.||+|++.     .+++.||||+++..    ........+.+|+.+++++ +|+|||++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            44556679999999999999999999863     45678999998642    2344456788999999999 69999999


Q ss_pred             eeEEEeCCEEEEEEeccCCCCHHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       422 ~g~f~~~d~lyLVmEy~~GGSL~~lL~~~~-----------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++++...+.+|||||||++|+|.++|+...                 ..+++..+..|+.||+.||+|||+++||||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr  169 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR  169 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999999999997632                 258999999999999999999999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.3e-22  Score=197.12  Aligned_cols=127  Identities=23%  Similarity=0.389  Sum_probs=101.7

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECC-CC--cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~-tg--~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~  428 (481)
                      ..++|++.+.||+|+||.||+|++.. ++  ..||||+++...  ....+..+.+.+|+.+|++++|+|||+++|++.+ 
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh--cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            34679999999999999999998753 33  358999886322  2233456789999999999999999999999965 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.++||||||++|+|.+++....+.+++..++.|+.||+.||+|||++|||||
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHr  135 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR  135 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeee
Confidence            57889999999999999988776789999999999999999999999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.87  E-value=1.2e-22  Score=200.29  Aligned_cols=118  Identities=23%  Similarity=0.381  Sum_probs=104.8

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeC--
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--  428 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~--  428 (481)
                      ..++|+++++||+|+||+||+|+++.+|+.||||+++..     .   .+++.+|+.+|+.+. |+||++++++|...  
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----H---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            346899999999999999999999999999999998631     1   256788999999995 99999999999854  


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|+|||||.+++|..+.    +.+++..++.|+.||+.||+|||++|||||
T Consensus       105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHr  153 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHR  153 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccc
Confidence            5699999999999987653    569999999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2e-22  Score=199.75  Aligned_cols=123  Identities=27%  Similarity=0.409  Sum_probs=107.3

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----  428 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-----  428 (481)
                      ++|+++++||+|+||.||+|.++.+|+.||||+++..   .......+.+.+|+.+|++++|+|||++++++...     
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            5799999999999999999999999999999998632   23455567788999999999999999999998643     


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ...+++|||+.||+|.+++..  +.+++..++.|+.||+.||+|||++|||||
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHr  145 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR  145 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence            334666777789999999853  679999999999999999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.1e-22  Score=196.85  Aligned_cols=123  Identities=28%  Similarity=0.478  Sum_probs=105.4

Q ss_pred             CCCCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-C
Q 011617          350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-D  428 (481)
Q Consensus       350 ~~~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-~  428 (481)
                      +...++|++++.||+|+||.||+|.++  |..||||+++..    .   ..+.+.+|+++|++++|||||+++|++.. +
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----A---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH----H---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            445678999999999999999999985  778999998631    1   23568899999999999999999999865 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~-~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+||||||+++|+|.++|.... ..+++..++.|+.||+.||.|||+++||||
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~  127 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR  127 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence            66899999999999999997642 358999999999999999999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=8.4e-22  Score=197.28  Aligned_cols=121  Identities=21%  Similarity=0.316  Sum_probs=104.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe------
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV------  427 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~------  427 (481)
                      ++|+++++||+|+||+||+|.++.+|+.||||+++..   .......+.+.+|+.+|++++|+|||+++++|..      
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            6799999999999999999999999999999999742   2345566788999999999999999999999964      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      .+.+|||||||. |++.+.+   ...+++..++.|+.||+.||+|||++|||||
T Consensus        94 ~~~~~iv~Ey~~-~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHr  143 (355)
T d2b1pa1          94 FQDVYLVMELMD-ANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHR  143 (355)
T ss_dssp             CCEEEEEEECCS-EEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CceeEEEEeccc-hHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccc
Confidence            368999999996 4555554   3569999999999999999999999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=7.5e-22  Score=196.91  Aligned_cols=122  Identities=23%  Similarity=0.422  Sum_probs=103.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC---
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---  429 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d---  429 (481)
                      ..+|+++++||+|+||+||+|.++.+|+.||||+++..    ......+.+.+|+.+|++|+|+|||++++++....   
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            45799999999999999999999999999999998632    23455678889999999999999999999987643   


Q ss_pred             --EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          430 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       430 --~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                        .+||+ ||+.+|+|.++++.  +.+++..++.|+.||+.||+|||++|||||
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHR  133 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHR  133 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             cceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence              35555 45668999999975  579999999999999999999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=9.4e-22  Score=196.56  Aligned_cols=119  Identities=26%  Similarity=0.345  Sum_probs=99.9

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeC-----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----  428 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~-----  428 (481)
                      .+|+.+++||+|+||+||+|+++.+|+.||||+++....         .+.+|+.+|++++|+|||+++++|...     
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            379999999999999999999999999999999974221         223699999999999999999998643     


Q ss_pred             -CEEEEEEeccCCCCHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 -DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 -d~lyLVmEy~~GGSL~~lL~--~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                       .++|||||||.++.+..+..  .....+++..++.|+.||+.||+|||++|||||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr  146 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR  146 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence             35899999997554333332  234679999999999999999999999999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.86  E-value=1.2e-21  Score=192.05  Aligned_cols=126  Identities=23%  Similarity=0.412  Sum_probs=110.6

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEEC-----CCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEE
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV  426 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk-----~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~  426 (481)
                      ..++|++.+.||+|+||.||+|+++     .++..||||+++.    ....+..+++.+|+.+|++++|+||+++++++.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh----hcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            4568999999999999999999975     3567899999863    233455678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          427 VDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       427 ~~d~lyLVmEy~~GGSL~~lL~~~~-----------------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ..+.++++|||+.+|+|.++|....                       ..+++..+..|+.||+.||+|||+++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence            9999999999999999999997531                       237899999999999999999999999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.2e-21  Score=193.08  Aligned_cols=130  Identities=22%  Similarity=0.364  Sum_probs=111.9

Q ss_pred             CCCCCCCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeee
Q 011617          348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY  422 (481)
Q Consensus       348 ~~~~~~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~  422 (481)
                      .++...++|++++.||+|+||.||+|.++.     ++..||||+++.    .........+.+|+.+|++++|+|||+++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~----~~~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc----ccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            345666899999999999999999998752     356799999863    23444556788999999999999999999


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~---------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +++..++.++||||||.+|+|.+++....         ..+++..+..|+.||+.||.|||+++||||
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHr  157 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR  157 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            99999999999999999999999986431         346899999999999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=8.7e-22  Score=193.05  Aligned_cols=126  Identities=29%  Similarity=0.456  Sum_probs=104.0

Q ss_pred             CCCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe----
Q 011617          352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----  427 (481)
Q Consensus       352 ~~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~----  427 (481)
                      ..++|+++++||+|+||+||+|.++.+|+.||||++.......   ...+++.+|+.+|++++|+||+++++++..    
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            3579999999999999999999999999999999986433221   233567789999999999999999999865    


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ----~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          ++.+|||||||.++.+. ++......+.+..++.|+.||+.||.|||++|||||
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHr  141 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR  141 (318)
T ss_dssp             ------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEec
Confidence                34689999999756554 444445789999999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=6e-21  Score=188.77  Aligned_cols=121  Identities=24%  Similarity=0.464  Sum_probs=104.9

Q ss_pred             EEeEEeccCCcEEEEEEEECCCC---cEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEe-CCEEE
Q 011617          357 QKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHLY  432 (481)
Q Consensus       357 ~i~k~IG~GtFG~VYla~dk~tg---~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~-~d~ly  432 (481)
                      ...++||+|+||+||+|.+..++   ..||||+++.    .......+.+.+|+++|++++|||||+++|++.. ++.+|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            34789999999999999986643   3589999863    2345667889999999999999999999999876 56899


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||++|+|.+++......+.+..+..|+.||+.||.|||+++||||
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHr  154 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR  154 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccC
Confidence            9999999999999998766778899999999999999999999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.1e-21  Score=187.69  Aligned_cols=126  Identities=24%  Similarity=0.410  Sum_probs=100.8

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCC-CcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC---CCCCeeeeeeEEEe-
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV-  427 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~t-g~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L---~HPNIVqL~g~f~~-  427 (481)
                      .++|+++++||+|+||.||+|.+..+ ++.||||+++........   ...+.+|+.+|+.|   +|||||+++++|.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            46899999999999999999999765 567999999753222111   12344566666554   89999999999864 


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       428 ----~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                          ...+||+||||.++.+..+.......+++..++.|+.||+.||+|||++|||||
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHr  140 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR  140 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence                346999999998777765555555779999999999999999999999999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=8e-22  Score=196.02  Aligned_cols=127  Identities=22%  Similarity=0.345  Sum_probs=109.1

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEE---CCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeC
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD  428 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~d---k~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~  428 (481)
                      .++|++++.||+|+||.||+|++   ..+|+.||||+++..... ......+.+.+|+++|++++| +||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-cchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            46799999999999999999987   447899999998632110 011123456789999999976 8999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       429 d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +.+|++||||.+|+|.+++... +.+.+..++.++.||+.||+|||++|||||
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr  153 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYR  153 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             CceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence            9999999999999999999875 778999999999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=4.9e-21  Score=186.61  Aligned_cols=127  Identities=25%  Similarity=0.397  Sum_probs=103.5

Q ss_pred             CCCCCeEEeEEeccCCcEEEEEEEECC-----CCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhC-CCCCeeeeeeE
Q 011617          351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS  424 (481)
Q Consensus       351 ~~~~~Y~i~k~IG~GtFG~VYla~dk~-----tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L-~HPNIVqL~g~  424 (481)
                      ...++|+++++||+|+||.||+|.+..     +++.||||+++..    ......+.+.+|+.++.++ +|+|||.++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            445789999999999999999999754     3467999998632    2334456677788877776 68999999998


Q ss_pred             EEeC-CEEEEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          425 EVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       425 f~~~-d~lyLVmEy~~GGSL~~lL~~~~---------------~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +... +.+|||||||++|+|.++|+...               ..+++..+..|+.||+.||+|||++|||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr  158 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  158 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            7764 46999999999999999997532               348899999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.84  E-value=2.5e-20  Score=181.34  Aligned_cols=121  Identities=25%  Similarity=0.378  Sum_probs=104.2

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCC-eeeeeeEEEeCCEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHL  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPN-IVqL~g~f~~~d~l  431 (481)
                      .++|++++.||+|+||.||+|.+..+|+.||||++......       ..+..|+++++.++|+| |+.+++++...+..
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            35799999999999999999999999999999998743211       24667999999998765 55666777888999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      +|||||| +++|.+++....+.+++..+..|+.||+.||+|||++|||||
T Consensus        79 ~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHr  127 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR  127 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            9999999 578888877766889999999999999999999999999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=2.1e-20  Score=182.57  Aligned_cols=121  Identities=21%  Similarity=0.284  Sum_probs=108.5

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC-CCeeeeeeEEEeCCEE
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHL  431 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H-PNIVqL~g~f~~~d~l  431 (481)
                      .++|+++++||+|+||+||+|.+..+|+.||||++....+.       ..+.+|+++++.|.| +||+.+++++..+...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            46899999999999999999999999999999988643221       245678899999975 8999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       432 yLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      |+||||| +++|.++++.....+++..+..|+.||+.||+|||++|||||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHr  125 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR  125 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceec
Confidence            9999999 699999998776789999999999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=4.6e-20  Score=181.36  Aligned_cols=118  Identities=28%  Similarity=0.378  Sum_probs=99.1

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCCCCeeeeeeEEEeCC----
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----  429 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~HPNIVqL~g~f~~~d----  429 (481)
                      .+|.+.++||+|+||.||+|++  +|+.||||+++..      .......+.|+..+.+++|||||++++++..++    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            4789999999999999999996  4889999998631      111122334666667889999999999998754    


Q ss_pred             EEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccC
Q 011617          430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHR  481 (481)
Q Consensus       430 ~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHs--------kgIIHR  481 (481)
                      .+|||||||++|+|.++|+.  ..+++..+..++.||+.||.|||.        +|||||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr  132 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR  132 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred             EEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence            68999999999999999976  468999999999999999999996        699998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.70  E-value=2.9e-17  Score=162.28  Aligned_cols=123  Identities=20%  Similarity=0.340  Sum_probs=98.9

Q ss_pred             CCCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-----------CCCeeee
Q 011617          353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQY  421 (481)
Q Consensus       353 ~~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-----------HPNIVqL  421 (481)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++.      .....+.+.+|+.+|+.+.           |+|||++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            3579999999999999999999999999999999862      3344466778998888775           5789999


Q ss_pred             eeEEEe--CCEEEEEEeccCCCC-HHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccC
Q 011617          422 YGSEVV--DDHLYIYLEYVHPGS-INRYVR-EHCRDITESIVRNFTRHILNGLAYLHS-TNTIHR  481 (481)
Q Consensus       422 ~g~f~~--~d~lyLVmEy~~GGS-L~~lL~-~~~~~Lse~~I~~I~~QIl~GL~YLHs-kgIIHR  481 (481)
                      ++++..  .+..+++|+++..+. ...+.. .....+.+..++.++.||+.||+|||+ +|||||
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr  150 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT  150 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence            988764  466777777765543 333332 234678999999999999999999998 899998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.55  E-value=5.6e-15  Score=134.43  Aligned_cols=113  Identities=18%  Similarity=0.221  Sum_probs=86.0

Q ss_pred             eEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCC-------------CCcHHHHHHHHHHHHHHhhCCCCCeeeee
Q 011617          356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQEIKVLGHLKHENIVQYY  422 (481)
Q Consensus       356 Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d-------------~~s~e~~k~l~~EI~iL~~L~HPNIVqL~  422 (481)
                      +.++++||+|+||.||+|.+. +|+.||||+++.....             ............|+..|..+.|.+|+..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 6889999987532110             00112234456788999999999999988


Q ss_pred             eEEEeCCEEEEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 011617          423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR  481 (481)
Q Consensus       423 g~f~~~d~lyLVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskgIIHR  481 (481)
                      ++.  .  .+|+|||+++..+.        .+.+..+..++.||+.+|.|||++|||||
T Consensus        81 ~~~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHr  127 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHG  127 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             Eec--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEc
Confidence            653  2  27999999865542        24556677899999999999999999998

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.27  E-value=0.0047  Score=55.77  Aligned_cols=111  Identities=12%  Similarity=0.030  Sum_probs=74.0

Q ss_pred             CCeEEeEEeccCCcEEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCC-CCCeeeeeeEEEeCCEEE
Q 011617          354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY  432 (481)
Q Consensus       354 ~~Y~i~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~-HPNIVqL~g~f~~~d~ly  432 (481)
                      ..|+..+..+.++.+.||+..  ..+..+.+|........     ....+.+|..+|..|. +--|.+++.++..++..|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            356766665555567899876  34566778876432111     1123566887877664 334678888888889999


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011617          433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN  477 (481)
Q Consensus       433 LVmEy~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHskg  477 (481)
                      +|||+++|..+.+.+..      ......++.++...|..||+..
T Consensus        87 lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~  125 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             EEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSC
T ss_pred             EEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccC
Confidence            99999998888665421      1223446778888899999753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.06  E-value=0.16  Score=49.27  Aligned_cols=88  Identities=14%  Similarity=0.023  Sum_probs=50.5

Q ss_pred             eEEeccCCcEEEEEEEECCCCcEEEEEEeecC-CCCCC-cHHHHHHHHHHHHHHhhCC---CCCeeeeeeEEEeCCEEEE
Q 011617          359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDII-PDDPK-SAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYI  433 (481)
Q Consensus       359 ~k~IG~GtFG~VYla~dk~tg~~VAIK~Ik~~-~~d~~-s~e~~k~l~~EI~iL~~L~---HPNIVqL~g~f~~~d~lyL  433 (481)
                      .+.||.|....||+..+...++.+++|.-... ...+. ......+...|.+.|..+.   ...+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            56789999999999987777788999965311 00000 0001123445777776553   2346666644  4556678


Q ss_pred             EEeccCCCC-HHHHHH
Q 011617          434 YLEYVHPGS-INRYVR  448 (481)
Q Consensus       434 VmEy~~GGS-L~~lL~  448 (481)
                      |||++.+.. +...+.
T Consensus       109 vmE~L~~~~~~~~~l~  124 (392)
T d2pula1         109 VMEDLSHLKIARKGLI  124 (392)
T ss_dssp             EECCCTTSEEHHHHHH
T ss_pred             EEeccCCcccchhhhc
Confidence            999997654 344443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=89.59  E-value=0.35  Score=42.55  Aligned_cols=98  Identities=11%  Similarity=0.040  Sum_probs=62.0

Q ss_pred             EeccCCc-EEEEEEEECCCCcEEEEEEeecCCCCCCcHHHHHHHHHHHHHHhhCCC--CCeeeeeeEEEeCCEEEEEEec
Q 011617          361 LIGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEY  437 (481)
Q Consensus       361 ~IG~GtF-G~VYla~dk~tg~~VAIK~Ik~~~~d~~s~e~~k~l~~EI~iL~~L~H--PNIVqL~g~f~~~d~lyLVmEy  437 (481)
                      .+..|.. +.||+... ..+..+.+|......  .      ..+..|...|+.|..  -.+.+++.+..+.+..|+||||
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--L------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--T------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--H------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            3344543 67898874 446668888764211  1      235567777776643  3367788888888889999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011617          438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST  476 (481)
Q Consensus       438 ~~GGSL~~lL~~~~~~Lse~~I~~I~~QIl~GL~YLHsk  476 (481)
                      ++|..+.+      ......   .++.++...|.-||..
T Consensus        88 i~G~~~~~------~~~~~~---~~~~~l~~~la~LH~~  117 (255)
T d1nd4a_          88 VPGQDLLS------SHLAPA---EKVSIMADAMRRLHTL  117 (255)
T ss_dssp             CSSEETTT------SCCCHH---HHHHHHHHHHHHHTTS
T ss_pred             eecccccc------ccccHH---HHHHHHHHHHHHHccC
Confidence            98766532      122322   2345677778888864